data_2lrn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lrn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.7 p -67.39 112.19 4.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.661 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.8 -10.39 23.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.991 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -79.5 146.25 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.678 0.275 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.94 136.79 24.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.95 142.21 24.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.83 162.4 25.49 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.837 2.358 . . . . 0.0 112.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.66 133.35 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 23' ' ' SER . 5.0 mp -93.37 142.3 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.825 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -115.74 94.2 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.0 110.481 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA3' ' HB ' ' A' ' 91' ' ' VAL . . . -116.42 144.84 18.58 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.471 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 68.4 mt -87.79 132.44 32.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.491 0.186 . . . . 0.0 110.526 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 -175.68 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.817 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 9.6 mtmp? -84.03 -41.3 17.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.151 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 18.96 1.31 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.582 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -94.0 144.33 25.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 105.89 13.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.7 t -103.71 135.7 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.883 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 2.0 m -108.95 176.89 4.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.951 0.405 . . . . 0.0 110.542 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.26 -32.91 69.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.917 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 1.7 p-10 -65.06 -22.46 66.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.992 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -72.77 -18.52 61.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.992 0.425 . . . . 0.0 110.971 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.21 19.21 15.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.9 tttm -80.03 56.14 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.013 -174.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.86 0.7 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -149.03 171.76 15.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -76.46 111.63 12.13 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 64' ' ' THR . 48.1 t -97.4 114.32 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.061 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.2 tm? -88.47 105.35 17.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.507 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 44.1 t -89.89 110.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 68' ' ' VAL . 28.9 t70 -106.61 122.27 46.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.46 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -94.7 114.19 26.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 69' ' ' SER . 16.4 p-90 -148.35 172.45 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.708 0.766 . . . . 0.0 111.884 -175.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.54 ' HA ' ' HG ' ' A' ' 69' ' ' SER . 38.2 p90 -170.36 159.92 7.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.661 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.63 69.33 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -6.07 89.2 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.09 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 34.9 t -89.75 112.64 23.99 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.48 -0.424 . . . . 0.0 110.206 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -64.23 -42.91 96.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.569 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -77.29 -31.66 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 94.5 m -57.6 -38.57 75.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -18.07 65.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -85.36 -34.13 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.453 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 45.5 mt-10 -96.44 1.64 51.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.594 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 84.4 m -50.21 -51.53 62.02 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.329 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 65.5 Cg_exo -52.52 -43.02 57.95 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.259 1.973 . . . . 0.0 113.156 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.409 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.8 m-85 -65.1 -46.0 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.9 -40.21 94.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.633 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.423 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 60.9 tp -59.42 -47.29 86.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.92 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 133' ' ' TYR . 38.6 ttpt -62.87 -47.27 84.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.151 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 35.7 m -58.55 -47.91 82.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.711 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HB2' HD13 ' A' ' 65' ' ' ILE . 88.8 t80 -60.03 -51.32 70.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.868 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -66.55 -26.08 66.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.71 -27.43 18.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 71.0 m-85 -108.45 -11.86 15.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 21.6 pttp -54.91 -39.15 68.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.811 0.339 . . . . 0.0 111.388 -176.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.51 -36.52 29.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.439 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HD2' ' CD1' ' A' ' 58' ' ' PHE . 87.9 mttt -58.75 -44.01 90.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.06 43.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.428 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 65.9 t80 -144.08 150.48 38.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 95.7 m -150.8 132.76 15.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.853 0.358 . . . . 0.0 110.583 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 55' ' ' TYR . 42.7 mt -92.44 118.72 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.088 0.47 . . . . 0.0 110.044 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.76 94.43 5.6 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.35 112.0 3.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.759 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.67 ' HB ' HD23 ' A' ' 93' ' ' LEU . 32.1 m -100.21 116.43 43.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.485 0.659 . . . . 0.0 111.004 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.54 ' HG ' ' HA ' ' A' ' 38' ' ' PHE . 7.2 t -128.84 145.39 51.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.947 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 1.051 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.7 t -145.87 54.79 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.014 0.912 . . . . 0.0 110.011 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -68.63 -168.51 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.479 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 0.6 OUTLIER -60.47 -42.86 97.08 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -172.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 56.8 mtp180 -133.11 163.07 30.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.667 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HG3' HD23 ' A' ' 92' ' ' LEU . 16.8 tt0 -75.12 -36.74 61.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 2.0 mp0 -59.57 -39.68 84.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.951 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 2.3 m-20 -74.67 -32.36 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.415 ' O ' HG13 ' A' ' 81' ' ' ILE . 29.4 t90 -62.28 -49.03 77.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.0 mptm? -57.88 -43.44 86.05 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.045 0.45 . . . . 0.0 110.278 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 3.5 ttpm? -60.15 -45.84 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.69 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.01 84.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.328 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 77' ' ' TRP . 82.8 mt -62.99 -38.02 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.423 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 48.4 tp10 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 175.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 36.8 mt-10 -60.49 -56.08 25.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HB3' HG22 ' A' ' 48' ' ' THR . 3.9 m-20 -75.71 -20.92 58.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.859 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 66.3 mmtt 57.49 37.89 27.9 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.824 0.821 . . . . 0.0 109.98 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 p -83.27 82.96 8.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.87 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -82.78 84.55 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 28.7 p90 -154.95 -169.24 3.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.119 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -72.92 84.26 1.24 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.425 0.631 . . . . 0.0 111.021 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -89.23 136.36 33.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.536 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.53 ' HB ' ' HA3' ' A' ' 14' ' ' GLY . 17.1 m -131.01 141.71 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.016 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 74' ' ' GLU . 53.3 tp -88.24 111.16 21.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.626 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 1.051 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 84.3 mt -66.7 124.1 21.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.714 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.1 mt-30 -60.78 143.42 54.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -66.95 -23.32 65.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.582 0.229 . . . . 0.0 111.443 -165.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -87.44 -36.03 17.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 0.0 110.749 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.29 -37.69 86.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 94' ' ' GLN . 63.2 t -50.63 -47.22 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.367 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.05 -55.23 33.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.803 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.25 -53.29 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.204 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.68 -54.32 27.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.783 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 30.5 mt -60.51 -50.63 72.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.009 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.98 -59.66 4.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.308 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.3 m -54.79 -30.98 58.35 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.275 0.984 . . . . 0.0 113.338 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -77.96 10.58 2.75 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.143 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.7 t 64.29 36.13 9.45 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 39.7 mm -106.0 118.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.366 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.48 13.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.214 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.64 160.47 30.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.49 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -133.49 155.98 80.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.446 0.299 . . . . 0.0 110.377 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 4.2 Cg_exo -82.63 -176.5 16.82 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.148 -1.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -163.03 130.8 3.68 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.627 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.502 HG23 HD13 ' A' ' 33' ' ' LEU . 58.0 mt -125.93 130.76 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 30.8 pt -129.15 145.46 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.903 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tt -105.71 110.63 23.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.83 135.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.444 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -82.13 170.37 15.18 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 16.5 Cg_endo -59.65 -16.72 38.27 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.647 2.232 . . . . 0.0 114.028 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HB3' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -88.43 3.94 48.21 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 110.824 175.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.04 57.33 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.985 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 27.2 mttm -113.01 141.54 46.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.939 0.369 . . . . 0.0 110.077 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.41 95.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.494 ' CG2' ' HB3' ' A' ' 117' ' ' ASP . 42.6 t -73.27 -41.95 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.578 -176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.66 167.27 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.63 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.576 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.0 pttp -162.68 171.89 16.16 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 8.8 mm-40 68.01 16.42 9.54 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.286 0.991 . . . . 0.0 111.15 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.64 132.74 54.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 mmp_? -116.02 154.52 29.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.021 -170.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.564 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 46.05 -131.78 10.54 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.966 0.792 . . . . 0.0 113.568 170.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.9 -10.74 59.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.5 t70 -64.27 -31.84 73.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.388 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 3.3 pp -58.9 -41.15 86.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.852 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.513 ' N ' HD13 ' A' ' 132' ' ' LEU . 26.9 t80 -63.6 -54.87 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 109.555 172.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 25.3 m-80 -58.71 -32.41 69.16 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.11 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.515 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 21.7 m -73.91 -40.23 63.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 132' ' ' LEU . 44.9 t -63.93 -39.28 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.501 174.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -41.48 90.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.515 ' HE3' ' HA ' ' A' ' 135' ' ' THR . 15.8 mtmt -52.51 -40.65 62.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.396 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -87.61 -61.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -164.324 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.642 0.258 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -64.3 133.84 53.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 0.0 111.109 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.12 -20.31 50.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.747 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -87.08 156.15 19.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 13.7 p -80.79 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.14 0.495 . . . . 0.0 110.793 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.96 144.51 51.54 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.06 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.05 148.68 81.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.585 2.19 . . . . 0.0 112.165 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.84 99.8 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.7 mm -83.25 132.9 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.5 m -131.74 98.99 4.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.072 0.463 . . . . 0.0 110.402 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.581 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -112.37 -176.23 19.79 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.835 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 19.7 mt -104.68 135.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.714 0.257 . . . . 0.0 110.924 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -101.29 -172.6 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 81' ' ' ILE . 92.6 mt -59.46 -26.89 65.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 16' ' ' ASP . 36.8 mtmm -77.05 -14.7 59.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.229 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.22 57.89 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -102.02 151.17 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -84.42 107.31 16.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.145 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.6 138.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 19.4 m -106.39 172.11 6.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.137 0.494 . . . . 0.0 111.072 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 32' ' ' VAL . 55.7 tp -80.42 -21.0 42.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 110.088 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 4.0 m-20 -65.84 -28.69 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.307 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.53 -23.89 67.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.211 0.529 . . . . 0.0 110.932 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.38 8.48 29.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.006 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 6.2 mtpp -76.51 69.99 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.719 0.771 . . . . 0.0 111.179 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.65 20.37 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.709 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -153.19 -176.45 5.79 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -95.88 111.62 23.56 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.669 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 9.8 p -101.52 133.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.232 0.539 . . . . 0.0 111.407 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 132' ' ' LEU . 10.3 tt -97.55 107.27 19.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.548 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 41.4 t -97.52 105.09 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -102.56 118.46 36.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.069 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 66.5 m-85 -84.43 116.2 22.95 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 69' ' ' SER . 21.9 p-90 -144.4 175.71 9.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.626 0.727 . . . . 0.0 111.874 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -168.38 161.01 11.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.59 -1.187 . . . . 0.0 108.248 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -32.93 73.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.37 -11.66 85.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.196 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 48.3 t -74.53 110.62 8.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.257 0.551 . . . . 0.0 109.946 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -65.48 -28.31 69.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.308 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.525 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 77.2 t-105 -85.52 -30.75 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 90.2 m -58.06 -42.05 84.64 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.3 -13.71 21.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.018 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.5 mptt -84.28 -51.23 7.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -99.73 15.78 25.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.224 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 22.4 m -51.71 -51.97 65.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.5 Cg_exo -54.29 -33.74 77.1 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.97 1.78 . . . . 0.0 112.379 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -76.57 -32.23 58.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.481 HD23 HD11 ' A' ' 132' ' ' LEU . 95.7 mt -62.94 -52.95 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.9 tp -61.07 -40.26 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.533 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -51.69 -53.86 34.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.718 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -67.07 -39.8 86.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.11 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.595 ' HB2' HD11 ' A' ' 65' ' ' ILE . 68.7 t80 -60.84 -46.75 89.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 111.172 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.19 -35.97 78.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.414 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -31.19 51.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' HE1' ' OE1' ' A' ' 137' ' ' GLU . 90.3 m-85 -115.48 3.86 14.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.73 -38.44 69.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.74 -42.12 16.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -55.8 -56.34 21.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.232 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 38.79 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.749 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 49.4 t80 -135.49 147.28 48.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.4 m -153.99 144.06 22.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.843 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 55' ' ' TYR . 29.4 mt -95.58 137.82 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.097 0.475 . . . . 0.0 111.033 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 39.3 t80 -123.43 93.05 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.04 106.8 3.37 Favored Glycine 0 CA--C 1.505 -0.531 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.582 -172.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.1 p -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.631 0.729 . . . . 0.0 111.092 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 12.4 t -112.4 152.9 28.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.528 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.701 HG22 ' HB2' ' A' ' 93' ' ' LEU . 30.6 p -132.54 48.96 2.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 3.7 t70 -75.15 -176.05 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.864 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 71.1 mtm180 -69.85 -39.27 76.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.924 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.567 ' HD2' ' OD1' ' A' ' 76' ' ' ASP . 60.9 mtt180 -138.69 152.71 48.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.672 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.628 ' HG2' ' HZ3' ' A' ' 78' ' ' LYS . 33.3 tt0 -65.91 -37.9 87.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.711 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 mm-40 -68.78 -36.46 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.766 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.567 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -65.25 -34.59 78.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 173.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.465 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 31.5 t90 -64.37 -48.73 74.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 8.7 mmtm -55.3 -50.4 69.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.963 0.887 . . . . 0.0 108.837 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.72 -40.06 90.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.014 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -61.77 -36.17 80.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.422 HD11 HD22 ' A' ' 17' ' ' LEU . 73.1 mt -64.6 -39.64 86.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 38.0 tp10 -65.6 -34.32 77.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.767 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.536 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 53.7 mt-10 -69.76 -52.19 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.765 0.793 . . . . 0.0 110.304 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.78 -18.67 58.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.228 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 85' ' ' LYS . 8.4 mptt 59.04 21.26 9.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.244 0.545 . . . . 0.0 112.244 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.468 ' HB3' ' CZ2' ' A' ' 88' ' ' TRP . 60.3 m -87.07 85.06 7.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.534 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.62 93.31 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.971 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.468 ' CZ2' ' HB3' ' A' ' 86' ' ' SER . 7.6 p90 -153.26 -172.68 4.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.744 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 52.1 m-80 -68.49 99.81 1.01 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.278 0.561 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.32 155.41 30.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.171 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.3 p -140.05 145.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.896 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 tp -108.21 129.57 55.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.483 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.701 ' HB2' HG22 ' A' ' 70' ' ' THR . 15.3 mt -74.69 142.58 44.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.431 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.649 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.4 mt-30 -75.44 163.34 27.51 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.798 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.456 ' CD ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -43.63 -55.37 4.37 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.456 ' H ' ' CD ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -87.8 -33.51 18.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 14.4 t70 -54.76 -39.2 68.09 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.313 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 94' ' ' GLN . 53.8 t -49.9 -48.12 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.876 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.45 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ttpp -56.39 -59.45 4.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.144 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 99' ' ' LYS . 61.2 m-20 -69.86 -34.95 74.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.577 -171.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.09 -37.43 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.685 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.732 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -66.37 -22.89 66.26 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.67 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -82.54 -62.71 1.54 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.249 -0.981 . . . . 0.0 108.813 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.6 m -48.33 -41.55 28.69 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -164.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.34 17.04 1.81 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.714 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.6 t 57.36 54.0 7.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.732 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 19.1 mm -80.33 72.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.636 0.732 . . . . 0.0 110.541 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.51 -25.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.683 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.05 121.18 5.9 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.426 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 3.3 t80 -123.88 140.74 35.17 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HG2' HH12 ' A' ' 128' ' ' ARG . 62.3 Cg_endo -74.9 135.4 40.31 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.566 -1.431 . . . . 0.0 112.108 -0.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CD2' HD13 ' A' ' 107' ' ' ILE . 49.7 t60 -89.02 100.8 13.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.9 120.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.548 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 31.5 pt -122.05 159.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.057 0.456 . . . . 0.0 111.666 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 tp -121.09 120.61 35.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.015 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.669 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 65.4 t -109.2 133.97 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.775 0.321 . . . . 0.0 110.664 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 p30 -77.0 165.79 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.502 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.7 Cg_endo -54.18 -20.33 18.95 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.983 2.455 . . . . 0.0 113.85 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.449 ' C ' ' HZ2' ' A' ' 28' ' ' LYS . 41.7 mt-10 -82.89 -14.33 54.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.34 . . . . 0.0 110.775 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.11 30.37 11.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.923 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.63 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.6 mtmp? -112.27 152.35 28.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.403 -0.469 . . . . 0.0 110.963 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -84.16 108.69 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.83 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.61 -30.31 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.958 0.409 . . . . 0.0 110.976 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 127' ' ' LEU . . . -144.86 155.41 43.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.617 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 17.2 pttp -156.61 162.58 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.617 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 3.1 mm-40 66.51 20.76 10.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 124' ' ' ALA . 71.0 mt -64.14 145.05 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.226 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.492 HH12 ' HG2' ' A' ' 111' ' ' PRO . 25.3 mmt180 -132.48 139.98 48.18 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 39.03 -99.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.338 0 O-C-N 124.521 1.138 . . . . 0.0 115.721 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.1 -35.28 59.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.806 -0.197 . . . . 0.0 111.128 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.914 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 27.8 t70 -69.94 -19.45 63.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.469 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 33' ' ' LEU . 95.0 mt -51.86 -59.59 4.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 168.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.14 -49.14 77.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.922 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.914 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 93.8 m-20 -57.41 -41.55 80.55 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.265 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.51 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 5.1 m -74.6 -36.45 62.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 132' ' ' LEU . 41.6 t -68.87 -41.47 82.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.319 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.549 ' OE1' ' HE1' ' A' ' 58' ' ' PHE . 1.2 tp10 -67.94 -32.33 72.71 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.628 0.728 . . . . 0.0 109.246 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 22.1 ttmt -58.55 -56.92 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.923 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -89.22 -53.28 4.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -168.573 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -68.68 119.18 12.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.35 -8.79 41.48 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.936 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -85.24 149.01 25.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.726 0.298 . . . . 0.0 110.523 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.89 141.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.129 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -85.57 131.2 48.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 37.7 Cg_exo -61.67 153.46 67.06 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.017 2.478 . . . . 0.0 112.219 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.63 134.62 51.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.782 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.596 HG12 HD23 ' A' ' 24' ' ' LEU . 48.5 mm -104.53 129.5 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.474 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.18 93.02 3.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.11 148.04 18.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.378 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.39 124.39 40.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.354 0.597 . . . . 0.0 111.162 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 170.25 16.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.972 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 HD21 ' HG3' ' A' ' 78' ' ' LYS . 5.8 mp -64.96 -14.56 60.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.92 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 36.7 mtmm -96.59 2.38 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.41 20.02 55.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.787 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 m-80 -101.18 132.46 46.65 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.544 -0.386 . . . . 0.0 110.129 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -80.97 112.0 17.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.69 148.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.43 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -100.43 175.05 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.919 0.39 . . . . 0.0 111.193 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.596 HD23 HG12 ' A' ' 12' ' ' ILE . 3.8 pp -80.2 -20.07 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 110.42 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 29.9 p30 -71.68 -17.89 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.66 -25.99 68.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.275 0.56 . . . . 0.0 110.958 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.29 2.8 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.54 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 12.3 tmtt? -60.02 147.54 38.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.388 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.58 5.17 29.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.453 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -134.89 172.66 12.68 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -82.29 110.57 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.587 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 48.4 t -104.4 125.27 59.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.025 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.588 HD23 HD23 ' A' ' 132' ' ' LEU . 22.4 tp -103.06 103.73 13.84 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.893 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.0 t0 -113.78 136.43 52.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -110.98 115.59 29.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.511 ' O ' ' HA ' ' A' ' 69' ' ' SER . 58.5 p-90 -148.06 178.24 8.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 111.369 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -170.28 157.0 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.806 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.12 51.51 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.05 -62.99 5.68 Favored Glycine 0 C--N 1.333 0.363 0 O-C-N 123.581 0.55 . . . . 0.0 112.697 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.3 m -81.42 85.4 6.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.46 0.648 . . . . 0.0 109.813 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.597 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 28.4 p -70.91 -13.73 62.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.451 -176.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -66.97 -33.12 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.966 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.7 ' HG ' ' HB3' ' A' ' 110' ' ' PHE . 19.9 m -61.82 -38.84 89.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.518 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.726 ' HD2' ' OD2' ' A' ' 84' ' ' ASP . 41.0 mtm180 -74.04 -12.68 60.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.322 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HD3' ' O ' ' A' ' 42' ' ' SER . 10.1 mptt -72.49 -14.06 61.57 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.067 -0.395 . . . . 0.0 111.032 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.3 -4.76 26.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.636 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.546 ' HA ' HD12 ' A' ' 51' ' ' LEU . 56.4 m -60.0 -43.4 94.26 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.123 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.0 Cg_exo -52.2 -36.47 67.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.066 1.844 . . . . 0.0 112.669 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -74.05 -34.66 64.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.729 0.299 . . . . 0.0 110.246 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -60.15 -43.0 96.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.086 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.71 -42.26 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.553 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -60.36 -47.54 85.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.109 0.48 . . . . 0.0 110.393 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -62.56 -43.96 97.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.68 ' HB2' HD12 ' A' ' 65' ' ' ILE . 51.2 t80 -65.73 -38.79 90.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -65.67 -28.78 69.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.688 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.97 19.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.309 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.34 13.44 32.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 50.5 pttt -60.43 -20.7 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.53 13.04 15.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 111.527 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -116.08 26.03 10.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.94 55.79 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.399 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 80.4 t80 -133.73 136.54 44.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.994 -0.603 . . . . 0.0 109.596 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 36.7 m -140.85 130.73 24.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.818 0.342 . . . . 0.0 110.758 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 55' ' ' TYR . 58.0 mt -89.91 125.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -108.7 94.49 5.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.454 ' HA3' ' OE1' ' A' ' 90' ' ' GLN . . . -86.5 117.06 4.54 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.913 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 HG11 ' CG2' ' A' ' 91' ' ' VAL . 35.3 m -112.97 126.31 70.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 0.0 110.681 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 46.2 t -122.48 139.37 53.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.667 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -106.4 42.22 1.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.104 0.954 . . . . 0.0 108.627 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.1 177.61 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.875 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -69.56 -48.36 60.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.292 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 22.6 tpt180 -143.25 150.48 39.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.792 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 1.013 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 30.5 tt0 -63.28 -39.93 95.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.419 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.8 mp0 -61.31 -41.36 96.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.74 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.21 -45.7 83.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.469 ' O ' HG13 ' A' ' 81' ' ' ILE . 22.7 t90 -58.39 -49.49 77.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.651 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 1.013 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -55.61 -44.09 76.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 110.781 175.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.37 -44.83 92.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.182 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.43 79.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.805 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.699 HG23 ' HG ' ' A' ' 86' ' ' SER . 93.4 mt -59.82 -40.35 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.447 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -43.89 66.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -50.07 -58.14 6.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.726 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 8.2 m-20 -84.21 -2.51 57.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.115 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 58.17 37.09 26.26 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.381 0.61 . . . . 0.0 111.091 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.699 ' HG ' HG23 ' A' ' 81' ' ' ILE . 33.0 p -79.98 78.37 6.6 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.736 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -83.9 77.75 9.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -158.6 -179.88 8.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.527 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -63.57 115.69 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.31 0.576 . . . . 0.0 111.04 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.454 ' OE1' ' HA3' ' A' ' 67' ' ' GLY . 1.4 tp-100 -123.13 141.08 52.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.786 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.483 ' CG2' HG11 ' A' ' 68' ' ' VAL . 19.1 m -137.87 145.32 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.234 0.54 . . . . 0.0 111.144 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.0 tp -92.91 112.67 24.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.648 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.15 133.9 52.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.035 0.445 . . . . 0.0 110.768 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 98' ' ' VAL . 33.1 mt-30 -68.75 145.1 54.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -63.59 -29.32 70.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -171.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 36.6 t70 -79.28 -39.73 32.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.84 -46.17 85.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.851 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 94' ' ' GLN . 77.2 t -50.14 -37.67 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.826 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.819 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 5.2 ttpm? -52.82 -64.02 0.95 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.151 0.5 . . . . 0.0 111.577 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -72.5 -36.89 68.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.744 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.63 -52.01 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.272 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -58.43 -52.6 64.92 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.848 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -52.99 -61.37 2.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.3 0.375 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.3 m -57.55 -26.27 61.18 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.007 0.817 . . . . 0.0 112.682 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.649 ' HD2' ' HE2' ' A' ' 112' ' ' HIS . 6.5 m-85 -86.84 20.52 2.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 105' ' ' TYR . 31.3 p 50.6 43.75 27.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.872 1.269 . . . . 0.0 110.348 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 12.2 mm -113.03 122.38 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.8 3.59 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.98 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.56 177.16 37.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.955 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.7 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 94.5 m-85 -135.25 166.7 26.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 74.4 Cg_endo -75.33 -174.68 14.67 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.031 -0.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.649 ' HE2' ' HD2' ' A' ' 105' ' ' TYR . 72.4 t60 -166.89 106.52 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.363 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.87 137.16 53.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.646 HG21 ' HB2' ' A' ' 125' ' ' LYS . 46.9 pt -131.62 154.51 40.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 136' ' ' VAL . 64.3 tp -118.96 119.35 34.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.164 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.587 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 19.2 m -109.41 143.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.347 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.558 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 3.3 p30 -78.22 163.78 60.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.334 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 11.9 Cg_endo -58.2 -14.23 18.86 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.134 2.556 . . . . 0.0 113.582 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 1.1 mt-10 -81.52 -29.63 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.33 19.69 6.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.697 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.0 mtmp? -111.23 146.32 37.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.39 104.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.54 -27.26 12.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.451 ' HB2' HD21 ' A' ' 127' ' ' LEU . . . -155.12 142.94 19.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.775 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.646 ' HB2' HG21 ' A' ' 114' ' ' ILE . 12.4 pttp -142.79 163.06 33.83 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.569 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 7.3 mm-40 65.95 30.53 9.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 110.067 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 124' ' ' ALA . 88.2 mt -67.41 156.82 35.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.047 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.629 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 7.8 mmm180 -116.43 166.9 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -30.98 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.052 0 N-CA-C 116.017 1.167 . . . . 0.0 116.017 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -12.52 59.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.572 0.686 . . . . 0.0 111.571 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.607 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.1 t70 -63.43 -42.16 98.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 41.3 mt -47.6 -56.66 6.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.488 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -58.32 -58.92 6.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.558 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.607 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.3 p30 -69.02 -37.66 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.54 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.3 m -72.0 -42.12 66.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.676 0.274 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.706 HG21 HD21 ' A' ' 115' ' ' LEU . 46.9 t -65.62 -35.81 76.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -57.02 -45.88 82.77 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.139 0.495 . . . . 0.0 109.823 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 134' ' ' ASN . 28.9 mtpp -65.96 -35.59 81.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.766 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -80.28 -55.12 5.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 111.619 -171.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -74.46 141.15 44.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.784 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.6 -13.17 58.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.782 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 147.92 34.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.288 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.18 137.33 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.934 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.64 122.96 57.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.492 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.14 134.1 49.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.061 2.507 . . . . 0.0 111.708 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.35 120.22 19.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.065 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.88 HG12 HD23 ' A' ' 24' ' ' LEU . 8.4 mm -65.02 133.17 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.21 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.0 m -120.31 87.88 2.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.468 . . . . 0.0 110.287 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.597 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -124.01 179.27 16.2 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.212 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.4 mt -109.24 130.28 62.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.92 -176.14 5.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.368 . . . . 0.0 110.724 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 94.1 mt -58.75 -34.08 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.866 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 32.7 mttp -78.96 -30.22 44.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.579 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.34 12.01 7.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.583 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 20.7 m-80 -87.14 137.4 32.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.639 0.256 . . . . 0.0 110.462 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.9 p -81.57 93.35 6.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.44 154.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.398 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 20.1 m -117.71 166.4 12.48 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.88 HD23 HG12 ' A' ' 12' ' ' ILE . 3.9 pp -68.41 -18.23 64.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.533 176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.78 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 6.2 t-20 -65.36 -35.52 81.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.37 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.39 -18.03 63.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.413 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.8 4.27 25.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.114 0.483 . . . . 0.0 110.138 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.78 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 41.1 mtpt -69.01 -174.11 0.57 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.953 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.28 10.36 86.27 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -144.84 173.72 11.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.433 ' HB3' HD13 ' A' ' 115' ' ' LEU . 94.5 m-85 -86.97 114.45 23.6 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.499 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 28.5 t -114.16 135.26 54.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.873 0.368 . . . . 0.0 111.356 -173.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt -91.31 134.71 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 61.5 t -110.2 100.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.87 108.41 19.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.06 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.647 ' CE2' ' HD2' ' A' ' 105' ' ' TYR . 72.3 m-85 -84.1 116.86 23.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.55 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 9.3 p-90 -143.04 173.53 11.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.301 0.572 . . . . 0.0 110.929 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 41' ' ' CYS . 28.4 p90 -165.17 148.49 8.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.614 171.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.26 -15.86 63.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.906 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.86 -3.06 83.58 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.659 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 50.8 t -120.33 123.96 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 110.744 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.6 t -64.19 -36.52 84.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.807 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.49 ' HD1' ' CD ' ' A' ' 111' ' ' PRO . 49.9 t-105 -70.95 -29.19 65.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.713 0.292 . . . . 0.0 110.713 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 98.7 m -65.31 -27.7 68.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.388 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.39 -14.22 46.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.594 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mptp? -69.33 -38.35 78.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 0.0 109.96 174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.76 -28.94 68.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 m -53.93 -52.93 63.56 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 53.2 Cg_exo -54.77 -43.72 56.53 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.073 1.848 . . . . 0.0 112.827 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -67.22 -38.86 85.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.308 0.575 . . . . 0.0 109.996 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -65.75 -43.38 89.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.812 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.2 -41.35 98.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.427 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.528 ' HZ1' ' CG ' ' A' ' 130' ' ' ASP . 39.1 ttpt -61.11 -45.92 92.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.189 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.8 m -62.11 -44.63 96.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.838 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.685 ' HB2' HD12 ' A' ' 65' ' ' ILE . 72.8 t80 -56.34 -57.46 12.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.076 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.69 -34.17 75.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.739 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.41 -31.47 29.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 32.5 m-85 -114.67 -2.2 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -55.0 -37.74 66.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.19 13.55 11.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -117.99 20.0 13.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.104 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.35 41.81 16.1 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 67.3 t80 -136.59 139.75 42.35 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -147.64 166.58 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 0.0 110.313 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 55' ' ' TYR . 60.1 mt -122.03 128.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.667 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 20.5 t80 -113.83 93.56 4.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.53 109.19 3.45 Favored Glycine 0 C--O 1.224 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.402 -172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.62 119.48 45.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -110.18 164.36 12.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.828 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.856 ' HB ' HD12 ' A' ' 93' ' ' LEU . 8.8 t -138.39 28.72 2.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.767 0.794 . . . . 0.0 109.149 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.704 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 22.6 m-20 -73.53 123.93 24.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.467 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.704 ' CZ ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -60.87 -34.96 75.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.512 -176.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.654 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 27.6 mtp180 -93.93 102.49 14.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.59 -34.22 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.497 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.654 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -69.38 -31.52 69.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.066 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -76.39 -30.09 57.37 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 81' ' ' ILE . 30.0 t90 -61.77 -52.18 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.951 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 2.0 mptm? -56.55 -43.72 80.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.207 0.527 . . . . 0.0 110.211 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 19.3 tttm -57.51 -56.84 16.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.596 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -57.27 -36.86 71.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.818 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.744 HD11 HE21 ' A' ' 90' ' ' GLN . 48.1 mm -66.09 -41.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.775 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.501 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 40.2 tp10 -70.33 -31.53 68.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.969 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.57 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 51.2 mt-10 -64.3 -50.22 68.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -92.83 -10.91 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.311 -176.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.54 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 58.3 mmtt 71.12 30.66 2.64 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.882 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 p -70.28 86.58 0.59 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.302 0.572 . . . . 0.0 111.223 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.54 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 46.9 m-85 -96.69 99.94 11.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.178 0.513 . . . . 0.0 112.11 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.511 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 6.2 p90 -151.7 -140.81 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.82 170.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 55.7 m-80 -113.31 85.96 2.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.54 0.609 . . . . 0.0 110.541 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.744 HE21 HD11 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -93.85 146.23 24.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.476 0.655 . . . . 0.0 110.876 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.5 p -137.15 139.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.404 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.29 125.98 45.04 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.446 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.856 HD12 ' HB ' ' A' ' 70' ' ' THR . 69.4 mt -58.64 138.25 57.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.356 0.41 . . . . 0.0 110.597 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.639 ' O ' HG21 ' A' ' 98' ' ' VAL . 47.3 mt-30 -85.1 163.08 19.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.711 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -42.95 -49.64 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -87.8 -41.07 13.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 110.316 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.12 -35.57 59.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.728 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 94' ' ' GLN . 54.5 t -50.91 -45.24 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.595 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -66.16 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.913 -171.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.92 -40.55 93.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.311 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' CG1' HD11 ' A' ' 12' ' ' ILE . 27.1 t -63.07 -59.63 4.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 79.9 mt -59.51 -40.53 87.37 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.153 0.502 . . . . 0.0 110.384 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.57 -62.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.253 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 106' ' ' CYS . 49.2 p -56.19 -43.89 78.91 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.497 1.123 . . . . 0.0 113.511 -167.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.647 ' HD2' ' CE2' ' A' ' 36' ' ' PHE . 16.8 m-30 -73.38 11.43 0.77 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.804 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.481 ' H ' ' C ' ' A' ' 104' ' ' SER . 56.3 m 63.36 56.8 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.098 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.7 mp -81.09 110.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.82 -25.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.343 173.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.82 170.39 35.98 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.619 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -121.72 150.23 54.92 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.49 ' CD ' ' HD1' ' A' ' 43' ' ' TRP . 4.4 Cg_exo -78.72 171.32 66.35 Favored 'Cis proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.718 -1.367 . . . . 0.0 112.511 -0.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -145.49 104.3 3.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.52 HD13 HD12 ' A' ' 132' ' ' LEU . 47.0 mt -114.28 139.18 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.909 0.385 . . . . 0.0 111.344 -172.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 39.2 pt -133.48 155.53 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.449 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.874 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 45.8 tp -114.41 117.2 30.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.835 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 10.8 m -103.37 144.22 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 111.649 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 3.8 p30 -80.26 168.79 23.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.177 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 51.5 Cg_exo -55.41 -23.93 40.92 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.978 2.452 . . . . 0.0 113.596 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -78.48 -32.55 48.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.02 0.438 . . . . 0.0 110.442 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.12 22.92 5.08 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.076 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.57 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.8 mtmp? -107.15 147.84 29.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.93 99.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.736 0.303 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.25 -34.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.32 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.874 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . . . -126.52 128.81 47.47 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 1.006 ' HD2' ' HG2' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -129.52 137.63 50.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.802 -0.181 . . . . 0.0 110.897 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 1.006 ' HG2' ' HD2' ' A' ' 125' ' ' LYS . 20.4 pt-20 45.79 75.48 0.11 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.652 1.181 . . . . 0.0 112.236 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 124' ' ' ALA . 84.3 mt -100.97 170.29 8.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.361 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HB2' ' OD1' ' A' ' 131' ' ' ASP . 9.1 mmm180 -111.07 177.37 4.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.45 -76.82 0.13 Allowed Glycine 0 C--N 1.335 0.494 0 O-C-N 123.741 0.651 . . . . 0.0 114.562 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.528 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -76.56 -15.94 59.73 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.338 -0.507 . . . . 0.0 110.863 -178.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.618 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.9 m-20 -62.25 -41.07 98.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.483 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 84.6 mt -51.03 -54.73 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.881 170.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.39 -58.96 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.869 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.618 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 7.0 p30 -68.8 -28.62 66.93 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.638 -171.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 92.7 m -66.58 -51.72 53.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.285 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.2 -38.48 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 110.396 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.508 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 12.3 tm-20 -64.28 -41.78 96.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.252 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -76.34 -17.05 59.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.287 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.42 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.4 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.997 -168.679 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.587 0.232 . . . . 0.0 110.525 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p -72.26 112.6 8.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.66 -4.03 39.6 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 t -86.02 143.53 28.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 50.8 t -69.18 136.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.09 145.84 30.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.653 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 152.89 58.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.846 2.364 . . . . 0.0 112.257 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.78 97.15 7.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.944 HD11 HG22 ' A' ' 101' ' ' VAL . 30.1 mm -86.35 147.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.065 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 11.6 t -142.07 123.52 14.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.533 0.682 . . . . 0.0 110.682 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.5 161.46 18.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.069 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 61.6 mt -96.57 123.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.75 0.309 . . . . 0.0 110.619 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -79.63 -177.23 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.892 0.377 . . . . 0.0 111.069 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.6 -18.48 64.32 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.618 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -25.39 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.355 0.597 . . . . 0.0 110.376 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.12 23.7 7.24 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.604 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.68 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.5 OUTLIER -101.59 138.8 38.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 p -83.99 94.82 8.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.167 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.67 130.99 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 6.0 m -103.12 167.21 9.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.168 0.508 . . . . 0.0 111.088 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.63 -28.62 69.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.943 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.49 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 7.5 t30 -70.79 -20.94 62.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.131 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -81.4 -4.63 56.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.974 0.416 . . . . 0.0 111.025 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.522 ' HE2' HD21 ' A' ' 89' ' ' ASN . 84.3 m-85 -110.21 5.27 21.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.406 0.622 . . . . 0.0 109.544 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 90.2 mttt -70.14 132.91 46.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.168 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.86 -27.68 4.56 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.513 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 42.4 mttm -114.84 166.86 11.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.386 -0.907 . . . . 0.0 108.935 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 115' ' ' LEU . 66.9 m-85 -78.14 116.79 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 t -92.63 110.83 23.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.117 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 2.1 tm? -82.86 101.75 11.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 39.5 t -89.98 118.98 36.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.137 0.494 . . . . 0.0 110.257 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.431 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 6.2 t70 -106.24 112.91 26.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.618 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.466 ' HD2' ' O ' ' A' ' 112' ' ' HIS . 89.6 m-85 -95.44 115.76 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.3 p-90 -155.39 177.08 11.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.621 0.724 . . . . 0.0 112.209 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -170.63 167.28 7.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.761 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.1 72.23 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.616 0.722 . . . . 0.0 110.871 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -44.54 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.568 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 p -84.6 85.17 7.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.488 0.661 . . . . 0.0 109.236 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.6 m -60.65 -22.06 63.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.719 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.413 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 9.4 m95 -70.26 -39.55 74.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.472 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 59.9 m -56.4 -43.51 79.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.742 0.782 . . . . 0.0 109.079 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 42' ' ' SER . 8.1 mmm180 -59.22 -38.36 79.77 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.088 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' A' ' 46' ' ' LYS . 1.3 mptp? -86.44 -8.26 57.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -89.46 -3.74 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 170.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.547 HG22 ' CH2' ' A' ' 88' ' ' TRP . 54.4 m -51.03 -50.74 73.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.536 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.8 Cg_endo -52.07 -40.55 68.0 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.122 1.881 . . . . 0.0 112.461 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.29 -41.26 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.409 . . . . 0.0 110.317 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 132' ' ' LEU . 83.1 mt -61.34 -42.43 98.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.814 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.09 -42.56 93.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.561 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -53.66 -51.49 63.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 109.665 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.5 m -63.68 -49.47 73.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.268 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.577 ' HB2' HD11 ' A' ' 65' ' ' ILE . 23.7 t80 -56.62 -50.28 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.807 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.554 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 38.0 t30 -75.38 -29.5 59.87 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.401 -171.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.92 -19.67 28.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.406 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 40.2 m-85 -121.08 12.81 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.554 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.6 ptmt -70.06 -21.06 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -75.93 -34.06 59.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.439 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.406 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 42.6 mttp -87.19 -167.74 2.0 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.559 -175.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.62 57.63 4.18 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.036 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 88.9 t80 -141.05 147.29 38.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.513 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 9.9 t -158.97 153.14 23.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.274 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 55' ' ' TYR . 45.4 mt -106.35 134.79 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -122.1 94.77 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -85.85 126.6 7.87 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.808 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 93' ' ' LEU . 16.0 m -116.21 119.6 62.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.162 0.506 . . . . 0.0 110.46 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 40.3 t -122.01 139.0 54.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.134 0.492 . . . . 0.0 111.234 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 t -116.2 59.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.095 0.95 . . . . 0.0 108.583 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.69 -178.57 1.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.238 -170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -67.42 -50.28 60.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.28 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 47.4 mtt180 -134.11 163.95 28.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.415 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 33.3 tt0 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -32.26 73.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.269 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.62 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -66.49 -38.57 87.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -64.01 -51.06 66.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' A' ' 74' ' ' GLU . 1.4 mptm? -49.86 -48.64 51.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.84 0.828 . . . . 0.0 109.781 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -65.42 -38.25 89.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.013 -177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.47 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . . . -66.06 -35.98 81.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.717 0.294 . . . . 0.0 111.282 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.18 -44.13 97.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.77 -29.21 68.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.889 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 44.9 mt-10 -59.5 -60.11 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.933 0.397 . . . . 0.0 111.57 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.97 4.92 42.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.225 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 4.4 mptp? 62.1 36.52 15.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 p -77.33 72.57 3.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.932 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -86.89 81.07 8.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.547 ' CH2' HG22 ' A' ' 48' ' ' THR . 9.6 p90 -148.84 -176.63 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.782 169.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.522 HD21 ' HE2' ' A' ' 27' ' ' PHE . 92.7 m-20 -69.48 98.91 1.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.166 0.508 . . . . 0.0 110.735 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -120.15 146.52 45.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.634 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.65 150.12 34.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.799 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.63 117.33 28.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 68' ' ' VAL . 93.6 mt -70.2 135.99 49.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.171 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.664 ' O ' HG21 ' A' ' 98' ' ' VAL . 31.6 mt-30 -58.61 141.56 51.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.52 -23.6 66.92 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.726 -168.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 29.8 t70 -87.35 -36.57 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.448 173.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.9 t70 -56.04 -40.93 74.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.144 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.664 HG21 ' O ' ' A' ' 94' ' ' GLN . 85.3 t -49.83 -35.36 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.7 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.787 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 5.6 ttpm? -53.09 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.75 -41.12 99.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.78 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.944 HG22 HD11 ' A' ' 12' ' ' ILE . 73.4 t -57.72 -61.72 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.892 ' HA ' HD12 ' A' ' 107' ' ' ILE . 40.1 mt -60.16 -39.25 85.73 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.042 -175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.93 -64.08 0.93 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.197 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.7 m -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.3 1.0 . . . . 0.0 113.524 -167.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.9 15.18 0.7 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.699 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.492 ' H ' ' C ' ' A' ' 104' ' ' SER . 63.0 m 55.37 47.8 20.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.299 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 102' ' ' LEU . 53.9 mt -88.16 107.11 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.466 -173.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.02 -8.04 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.285 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.33 170.82 35.7 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.524 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.62 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 98.6 m-85 -135.31 164.15 45.84 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.6 Cg_exo -77.26 133.54 31.29 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 124.176 -1.177 . . . . 0.0 112.579 -0.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.602 ' CD2' HG12 ' A' ' 107' ' ' ILE . 14.5 t60 -107.48 111.76 24.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.1 mt -125.62 131.55 71.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.239 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.58 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 45.3 pt -128.17 149.2 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.738 0.304 . . . . 0.0 110.798 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 31' ' ' TYR . 47.0 tp -112.91 111.21 21.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 73.4 t -97.17 133.0 40.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.798 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 4.1 p30 -78.0 164.78 55.09 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -53.05 -24.34 24.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.2 2.6 . . . . 0.0 114.094 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.467 ' HB2' ' HE2' ' A' ' 121' ' ' LYS . 41.3 mt-10 -77.0 -37.12 55.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 110.055 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.05 23.8 2.62 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.76 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.603 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 34.2 mtmt -107.2 155.5 19.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.79 97.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.95 -34.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.155 0.503 . . . . 0.0 110.768 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.79 158.02 42.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 20.6 pttp -163.26 175.28 11.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 15.6 mm-40 64.69 20.76 12.23 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.413 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 132' ' ' LEU . 47.7 mt -59.62 137.68 57.96 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.614 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.406 ' NH2' ' HB2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -123.38 149.47 44.93 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.275 -170.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 43.45 -125.1 4.95 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.768 0.667 . . . . 0.0 114.437 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.06 -17.0 59.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.622 0.248 . . . . 0.0 110.916 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 31.0 t70 -63.31 -25.72 68.44 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 136' ' ' VAL . 75.8 mt -48.23 -58.52 4.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 109.956 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -60.34 -50.91 71.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.481 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 92.3 m-20 -61.92 -35.19 77.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.859 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.609 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 7.5 m -74.66 -30.71 61.7 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 86.9 t -65.44 -46.31 90.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.239 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.87 -23.34 64.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.442 0.639 . . . . 0.0 109.948 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 23.9 ttpt -77.0 -59.15 2.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.08 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 135' ' ' THR . 47.2 m-85 -88.2 -51.4 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 61.0 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 111.277 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.427 0.156 . . . . 0.0 110.619 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -147.84 128.04 13.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.32 -2.22 86.49 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -70.27 123.99 23.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.16 137.72 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.956 0.407 . . . . 0.0 110.627 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.51 146.54 31.49 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -63.08 163.34 22.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.353 2.702 . . . . 0.0 112.535 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.03 115.66 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' SER . 65.8 mt -83.72 137.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.137 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.439 HG22 ' HG ' ' A' ' 23' ' ' SER . 19.0 m -126.31 89.24 2.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.331 0.586 . . . . 0.0 110.022 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.14 161.23 14.88 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.911 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG2' ' HA2' ' A' ' 19' ' ' GLY . 52.8 mt -91.71 129.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -171.68 2.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.062 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.11 -27.05 68.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.551 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.23 -49.66 9.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.052 0.453 . . . . 0.0 110.198 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 15' ' ' ILE . . . 137.32 23.29 0.47 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.76 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 23.4 m-80 -102.19 149.58 24.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -80.34 99.97 8.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.479 0.657 . . . . 0.0 110.679 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.3 141.93 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.277 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.664 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 6.2 m -116.21 166.1 12.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -174.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.84 -22.67 65.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.122 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.664 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 2.6 p-10 -66.25 -28.57 68.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -72.61 -17.35 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.785 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -113.29 3.88 16.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.686 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -63.11 168.38 4.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.681 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.33 23.04 66.41 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.302 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -145.09 161.4 39.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -78.07 107.58 10.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -109.74 116.93 53.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.581 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 115' ' ' LEU . 43.8 mt -85.0 109.15 17.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 169.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 61.7 t -89.07 111.15 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.431 . . . . 0.0 109.861 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.496 ' CG ' ' HG ' ' A' ' 44' ' ' CYS . 5.3 t70 -105.86 117.13 33.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.559 -175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -98.73 116.1 30.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -144.63 176.55 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.444 0.64 . . . . 0.0 111.77 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -170.73 168.3 7.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.225 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -28.47 68.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.72 -67.66 1.97 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.72 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.9 m -75.65 88.29 2.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.418 0.627 . . . . 0.0 109.859 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.424 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 58.8 p -75.31 11.83 1.11 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.121 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.551 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 40.1 m95 -63.02 -45.34 92.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 29.9 t -62.34 -31.11 71.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.525 0.679 . . . . 0.0 109.779 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.567 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 59.9 mtp180 -76.84 -14.08 59.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.306 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.6 mptt -85.28 -38.36 18.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.966 171.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.04 3.64 45.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.807 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 93.4 m -53.09 -50.38 82.44 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -48.24 -42.54 33.36 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.331 2.021 . . . . 0.0 113.0 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -68.89 -47.39 65.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.484 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.31 -46.65 85.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.799 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 65.4 tp -62.25 -43.11 99.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.818 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -62.05 -47.49 84.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.1 m -63.34 -48.24 78.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.003 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.448 ' HB2' HD12 ' A' ' 65' ' ' ILE . 89.7 t80 -58.78 -49.96 75.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.514 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 39.6 t-20 -60.13 -42.52 94.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.099 0.476 . . . . 0.0 110.546 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.26 76.47 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.722 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 77.2 m-85 -120.69 7.34 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -169.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 16.7 pttm -57.88 -33.8 69.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.359 0.6 . . . . 0.0 111.37 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.97 7.88 45.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.23 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -120.15 26.46 9.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.57 26.7 50.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.627 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 58' ' ' PHE . 66.3 t80 -134.75 142.88 46.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -152.56 165.44 35.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.034 0.445 . . . . 0.0 110.55 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 55' ' ' TYR . 56.3 mt -120.18 124.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.597 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 89' ' ' ASN . 10.9 t80 -101.21 94.51 6.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.34 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 102.71 2.81 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.137 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.88 113.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.013 0.435 . . . . 0.0 110.737 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.5 t -102.56 150.7 23.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.353 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.534 ' HB ' HD13 ' A' ' 93' ' ' LEU . 7.9 t -131.52 28.58 4.62 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.159 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.37 167.94 0.87 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 16.6 mtm180 -53.75 -71.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.163 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -109.67 172.28 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.263 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.472 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 36.2 tt0 -74.3 -33.11 63.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.73 -41.2 97.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.012 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' A' ' 72' ' ' ARG . 59.7 m-20 -60.85 -49.37 77.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.997 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.431 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 24.0 t90 -57.75 -47.87 81.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.108 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.7 mptm? -62.17 -41.6 98.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.419 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.557 ' HZ2' ' HG2' ' A' ' 83' ' ' GLU . 9.6 tmtm? -70.41 -37.99 74.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.55 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.64 75.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.18 -33.98 55.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.533 0.683 . . . . 0.0 110.408 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -28.84 70.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.014 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG2' ' HZ2' ' A' ' 79' ' ' LYS . 38.9 mt-10 -84.03 -59.98 2.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.619 0.247 . . . . 0.0 110.878 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.85 -22.25 56.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.488 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm 70.88 32.39 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -67.44 100.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.665 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -118.13 74.58 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 111.893 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.535 ' HH2' HG22 ' A' ' 48' ' ' THR . 3.3 p90 -133.94 -154.07 0.57 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 88' ' ' TRP . 11.6 m120 -72.45 80.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.355 0.525 . . . . 0.0 110.353 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -82.69 125.24 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.2 m -134.02 143.24 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.347 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.3 tp -102.57 123.97 47.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.534 HD13 ' HB ' ' A' ' 70' ' ' THR . 93.0 mt -63.33 134.09 55.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.842 0.353 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.606 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.2 mt-30 -67.69 149.27 50.22 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -62.44 -17.8 60.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.082 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.63 -48.9 8.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.416 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.68 -33.26 71.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 94' ' ' GLN . 44.3 t -47.01 -43.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.7 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -60.74 -63.04 1.44 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.878 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.21 -33.1 63.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.47 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 55.7 t -70.01 -57.37 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.463 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.647 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 26.6 mt -59.7 -47.37 85.9 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.235 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.76 -61.82 2.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.259 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 106' ' ' CYS . 19.0 t -62.82 -28.24 69.87 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.344 1.027 . . . . 0.0 112.805 -167.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 24.4 m-85 -74.93 8.63 2.36 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.752 0.31 . . . . 0.0 110.634 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' A' ' 104' ' ' SER . 95.4 m 58.22 58.62 3.4 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.089 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.2 mp -75.4 116.73 18.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.583 0.706 . . . . 0.0 110.569 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.45 -21.04 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.128 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.79 178.25 41.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.48 151.38 77.24 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 55.6 Cg_endo -87.98 128.5 9.27 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.681 0.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.8 95.81 10.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.064 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 81.9 mt -113.47 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.506 . . . . 0.0 110.914 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 31.2 pt -114.45 148.76 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.537 -176.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.2 tt -95.48 111.61 23.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.446 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 97.9 t -107.91 132.62 55.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.65 163.74 51.85 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.417 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.482 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 82.0 Cg_exo -48.01 -31.24 15.54 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.355 2.703 . . . . 0.0 114.46 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.525 ' HB3' ' CE ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -88.39 -1.57 58.11 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 88.45 29.23 19.9 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.838 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 11.1 mtmm -110.72 138.26 47.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.5 mt -75.12 118.4 20.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.483 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.9 t -94.96 -38.32 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.89 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.317 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 18.3 pttm -150.15 147.1 27.33 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.935 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 61.97 35.79 15.98 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.502 1.126 . . . . 0.0 111.555 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.49 141.64 57.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.97 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -97.16 166.05 11.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.139 -174.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -35.96 -72.61 0.13 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.2 -35.91 69.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.923 0.362 . . . . 0.0 110.432 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -55.78 -46.15 78.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.727 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 133' ' ' TYR . 4.3 pp -66.85 -38.78 87.03 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.447 ' N ' HD13 ' A' ' 132' ' ' LEU . 87.3 t80 -65.34 -50.8 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -57.4 -42.14 81.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.716 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.2 m -69.04 -47.01 66.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.546 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.79 -43.91 96.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.722 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 4.3 tt0 -63.85 -39.27 93.83 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -57.82 -33.27 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.385 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -87.69 -61.84 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.74 -170.91 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.505 0.193 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 2.9 t -153.74 137.19 15.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.562 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.5 -1.29 88.94 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -82.01 128.25 33.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.095 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 48.7 t -69.04 129.66 33.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.83 0.348 . . . . 0.0 110.123 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -93.45 141.6 24.12 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.441 -177.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 22.4 Cg_exo -66.12 163.3 32.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.167 2.578 . . . . 0.0 111.96 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.71 113.92 24.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.011 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.6 141.9 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -120.64 105.12 10.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.914 0.388 . . . . 0.0 110.05 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.76 167.94 14.5 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.811 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.8 mt -105.61 128.09 59.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -173.13 4.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.035 0.445 . . . . 0.0 111.273 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.402 HD22 ' CD1' ' A' ' 81' ' ' ILE . 75.0 mt -64.6 -30.38 71.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.965 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.14 -32.86 59.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.33 22.01 6.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -95.15 141.19 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 p -82.31 106.01 13.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.77 146.31 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.859 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 m -112.57 157.43 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.172 0.51 . . . . 0.0 111.202 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 32' ' ' VAL . 62.5 tp -61.96 -24.71 67.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.458 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 8.4 t30 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.12 -9.83 59.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.441 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -113.88 1.63 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.34 . . . . 0.0 110.51 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.458 ' CD ' ' HA ' ' A' ' 25' ' ' ASN . 26.3 mtpp -63.61 171.21 2.74 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.395 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.21 83.03 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.583 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -137.55 165.47 26.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.51 114.04 14.79 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 24' ' ' LEU . 46.4 t -111.18 111.7 37.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.015 0.435 . . . . 0.0 111.31 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.3 tp -90.75 113.88 26.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 42.8 t -102.47 119.45 50.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.438 0.161 . . . . 0.0 110.942 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.39 116.81 33.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.86 116.87 29.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.485 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.953 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 11.7 p-90 -150.61 -178.4 6.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HE1' ' HB2' ' A' ' 110' ' ' PHE . 2.2 p90 -170.58 160.08 7.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.926 169.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.52 6.72 3.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.87 -16.73 67.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.086 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 96.3 m -120.88 121.43 38.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.029 0.443 . . . . 0.0 110.483 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.11 -33.36 70.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.459 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -66.73 -31.51 72.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.538 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.953 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 72.9 m -58.45 -41.12 84.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -85.12 -12.12 53.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.5 mptp? -75.69 -28.76 58.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.901 0.382 . . . . 0.0 110.311 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.9 -16.12 55.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.329 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 90.8 m -50.48 -52.13 58.11 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 52.7 Cg_exo -53.0 -42.08 67.02 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.133 1.888 . . . . 0.0 112.803 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.11 -38.26 78.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 132' ' ' LEU . 79.2 mt -63.35 -50.32 70.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 50.5 tp -59.19 -40.54 86.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.475 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -52.2 -51.94 55.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.829 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -68.04 -43.66 78.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.445 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.628 ' HB2' HD13 ' A' ' 65' ' ' ILE . 85.9 t80 -60.93 -48.8 80.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.47 -29.02 69.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.51 -38.05 55.79 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.494 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 94.4 m-85 -120.23 6.74 10.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.61 ' HG2' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -61.65 -36.59 81.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.364 0.602 . . . . 0.0 110.84 -176.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.61 ' N ' ' HG2' ' A' ' 59' ' ' LYS . 2.9 p30 -82.76 6.78 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 58' ' ' PHE . 55.1 mttp -116.5 15.28 15.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.12 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.53 30.98 25.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.719 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 49.5 t80 -133.89 143.33 48.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -146.92 163.78 35.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 109.955 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 55' ' ' TYR . 20.2 mt -116.57 125.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.896 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 57.9 t80 -108.41 99.23 8.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.324 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.542 ' HA3' ' NE2' ' A' ' 90' ' ' GLN . . . -87.15 135.19 13.01 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.019 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.536 ' HB ' HD22 ' A' ' 93' ' ' LEU . 3.2 m -133.4 112.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.574 0.702 . . . . 0.0 110.886 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' HD11 ' A' ' 92' ' ' LEU . 29.7 t -113.12 154.62 26.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.776 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.45 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.9 t -123.91 41.41 3.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.739 0.781 . . . . 0.0 109.018 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.05 169.88 0.15 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -60.66 -38.46 84.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.578 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 38.5 mtt180 -144.72 169.27 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.045 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 1.13 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 31.7 tt0 -75.64 -41.06 55.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.578 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 mp0 -60.78 -36.18 78.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 18.4 t0 -66.65 -48.62 68.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.322 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.643 ' HZ2' ' HG3' ' A' ' 90' ' ' GLN . 34.2 t90 -56.77 -48.25 78.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.143 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 1.13 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 1.6 mptp? -58.83 -38.08 77.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.214 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -60.92 -45.53 94.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.896 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.68 -44.73 96.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.096 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.423 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 70.0 mt -64.34 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.244 0.545 . . . . 0.0 110.753 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.88 -31.19 72.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.305 0.574 . . . . 0.0 110.306 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 41.7 mt-10 -80.32 -53.03 7.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.392 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 81' ' ' ILE . 13.4 p-10 -91.52 -17.98 24.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER 67.41 38.5 3.19 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.305 0.574 . . . . 0.0 111.221 -179.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.3 p -72.76 67.62 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.325 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.12 85.57 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 52' ' ' LEU . 7.4 p90 -141.04 -149.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.01 64.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.713 0.688 . . . . 0.0 109.849 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.643 ' HG3' ' HZ2' ' A' ' 77' ' ' TRP . 8.6 tp-100 -90.97 123.42 34.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.242 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.72 152.72 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.188 0.518 . . . . 0.0 110.888 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 69' ' ' SER . 45.4 tp -90.3 129.88 36.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.574 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 68' ' ' VAL . 79.5 mt -70.03 125.3 26.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 98' ' ' VAL . 40.2 mt-30 -65.12 147.93 52.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.6 -16.75 63.96 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.867 0.365 . . . . 0.0 111.144 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.27 -49.43 8.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.45 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -50.91 -36.73 39.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.061 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 94' ' ' GLN . 25.1 t -45.01 -41.85 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.456 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HB2' ' HZ3' ' A' ' 99' ' ' LYS . 9.6 mtmp? -56.24 -64.27 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 111.682 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.7 -36.44 65.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.906 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 105' ' ' TYR . 55.7 t -68.72 -55.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.257 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.663 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 15.8 mt -60.4 -42.18 95.4 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.555 -175.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -62.04 -62.07 2.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.519 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 106' ' ' CYS . 67.2 m -55.59 -32.11 62.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.491 ' HE2' HG11 ' A' ' 101' ' ' VAL . 62.8 m-85 -83.03 22.14 0.98 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.763 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.424 ' H ' ' C ' ' A' ' 104' ' ' SER . 26.7 p 47.96 48.85 17.69 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.38 1.072 . . . . 0.0 110.56 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 79.6 mt -97.67 110.73 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.689 -175.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.56 18.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.43 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.69 -178.43 41.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.596 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.471 ' HB2' ' HE1' ' A' ' 38' ' ' PHE . 97.7 m-85 -134.84 157.39 77.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.937 0.369 . . . . 0.0 110.293 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.694 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 92.4 Cg_endo -91.61 168.85 25.87 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.762 -1.349 . . . . 0.0 112.91 -1.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.671 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.6 128.97 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.75 HG23 ' HG3' ' A' ' 125' ' ' LYS . 41.7 pt -123.11 153.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.64 113.35 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.1 t -101.1 140.58 19.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.598 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.74 167.29 30.78 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.04 -35.27 50.09 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.82 2.347 . . . . 0.0 113.969 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.4 mt-10 -79.46 -24.23 42.53 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.511 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.36 27.99 3.44 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.538 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -106.05 148.32 27.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.791 0.795 . . . . 0.0 109.309 172.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' THR . 38.2 mt -80.3 104.52 8.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.88 -28.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.75 138.47 30.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.75 ' HG3' HG23 ' A' ' 114' ' ' ILE . 20.8 ttpp -129.81 155.5 45.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.327 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 125' ' ' LYS . 2.3 mm-40 66.08 42.95 3.05 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.897 0.748 . . . . 0.0 110.931 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.465 ' HB3' HD22 ' A' ' 132' ' ' LEU . 83.2 mt -82.16 156.07 24.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.876 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.752 ' HD3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -162.28 167.28 24.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.955 -172.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 44.02 -129.65 6.72 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.933 0.771 . . . . 0.0 113.944 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -77.03 -24.21 52.1 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.62 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HA ' ' CB ' ' A' ' 134' ' ' ASN . 12.5 m-20 -53.67 -27.27 26.62 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.287 0.367 . . . . 0.0 110.43 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 136' ' ' VAL . 71.6 mt -56.18 -64.57 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.357 0.598 . . . . 0.0 109.736 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -58.34 -42.65 87.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.981 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.454 ' CB ' ' HA ' ' A' ' 131' ' ' ASP . 1.9 t-20 -51.13 -52.32 44.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.483 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -72.26 -34.24 68.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.176 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 132' ' ' LEU . 56.2 t -71.71 -42.31 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.879 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.17 -34.85 75.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.77 0.795 . . . . 0.0 109.364 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 12.9 ttmt -64.17 -51.04 65.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.57 -54.86 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 111.405 -172.532 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -64.51 111.2 2.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.92 1.81 52.08 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.447 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.4 m -87.58 131.66 34.33 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.774 -0.25 . . . . 0.0 110.424 178.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 52.0 t -69.64 132.82 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -100.28 148.35 34.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.553 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 30.0 Cg_exo -64.35 163.21 27.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.566 2.844 . . . . 0.0 112.516 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.28 131.75 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.537 HD13 HG23 ' A' ' 101' ' ' VAL . 18.1 mm -87.33 148.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -133.61 94.23 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.322 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 175.9 16.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.646 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.97 117.07 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -174.8 5.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.026 0.441 . . . . 0.0 111.438 -171.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.32 -30.61 66.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.789 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -69.27 -25.68 64.39 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.053 0.454 . . . . 0.0 111.067 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.07 20.89 29.31 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -103.18 148.84 25.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -77.3 97.97 5.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.93 137.41 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.197 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -176.83 3.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -79.42 -28.94 41.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.202 0.525 . . . . 0.0 110.198 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.658 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -66.82 -19.92 65.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.258 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.62 -31.87 71.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 111.204 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -115.62 20.55 14.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.413 0.625 . . . . 0.0 109.78 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.658 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 57.5 tttp -84.06 66.76 9.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.991 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.05 17.91 0.19 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.875 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -149.64 175.21 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -80.27 112.57 17.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.42 114.32 37.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.164 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 tp -92.03 109.85 21.21 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 33.6 t -91.19 117.47 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.822 0.344 . . . . 0.0 110.945 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.93 103.04 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.348 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' HG22 ' A' ' 68' ' ' VAL . 39.3 m-85 -82.19 114.72 20.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.419 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 11.4 p-90 -155.08 173.68 16.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 122.186 0.993 . . . . 0.0 112.731 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -164.71 154.15 13.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.894 -1.957 . . . . 0.0 107.064 165.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.43 -29.35 66.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.09 -38.19 95.15 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.063 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.1 p -87.55 96.62 10.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.407 0.622 . . . . 0.0 110.231 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.3 m -68.15 -11.2 58.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.155 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -69.82 -42.46 73.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.876 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . 20.7 p -67.84 -29.6 68.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 6.6 mmp_? -75.57 -14.29 60.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.135 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.6 mptm? -79.13 -21.68 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.732 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -94.92 -3.58 48.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.255 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 94.1 m -51.16 -51.52 67.33 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.346 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.0 Cg_endo -51.72 -39.05 67.49 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.374 2.05 . . . . 0.0 112.495 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.18 -39.77 62.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.989 0.423 . . . . 0.0 110.629 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 113' ' ' ILE . 97.0 mt -63.18 -45.49 91.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.275 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.37 -41.36 96.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.511 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -57.74 -53.29 59.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.396 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.408 ' HA ' ' HD1' ' A' ' 133' ' ' TYR . 19.6 m -61.93 -42.51 99.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.116 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB2' HD12 ' A' ' 65' ' ' ILE . 56.4 t80 -59.73 -56.32 23.36 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.483 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 28.0 m-80 -58.08 -35.43 71.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.66 48.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 92.5 m-85 -120.2 0.78 10.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HG3' ' OD2' ' A' ' 60' ' ' ASP . 14.6 ptmm? -60.18 161.6 6.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.241 0.543 . . . . 0.0 111.048 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 32.0 m-20 73.7 -49.69 0.68 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.8 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 44.4 mttp -60.64 -88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.786 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 61' ' ' LYS . . . -136.36 15.79 3.9 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.788 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.97 141.59 44.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -150.6 149.54 30.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.253 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.652 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -103.21 129.74 54.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.966 0.412 . . . . 0.0 110.172 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t80 -119.35 98.89 6.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.001 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.74 122.57 6.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.191 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.596 ' HB ' HD23 ' A' ' 93' ' ' LEU . 15.4 m -100.43 111.88 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.656 0.741 . . . . 0.0 110.126 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -104.76 136.51 44.14 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.369 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.532 ' HB ' HD13 ' A' ' 93' ' ' LEU . 12.7 t -122.62 32.38 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.045 0.926 . . . . 0.0 109.065 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.4 175.78 0.54 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.285 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -79.05 -57.77 3.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.315 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.545 ' HB3' ' OD2' ' A' ' 76' ' ' ASP . 22.5 tpt180 -123.78 152.01 42.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.317 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.558 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 17.1 tt0 -64.7 -35.04 79.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.464 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -58.22 -47.07 84.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.739 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.545 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 2.1 p30 -73.51 -36.19 65.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.743 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.443 ' O ' HG12 ' A' ' 81' ' ' ILE . 26.6 t90 -54.4 -54.83 35.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -57.94 -43.13 86.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.87 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 55.9 tttm -57.0 -50.1 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.764 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.14 88.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 77' ' ' TRP . 39.3 mm -59.82 -39.95 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.108 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 37.0 tp10 -73.91 -32.76 63.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.27 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.499 ' CD ' ' HZ3' ' A' ' 79' ' ' LYS . 44.6 mt-10 -77.67 -49.34 14.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.125 0.488 . . . . 0.0 110.897 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.97 -19.6 60.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.903 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 61.0 mmtt 64.3 27.09 13.77 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.312 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 p -87.99 82.32 7.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.11 87.7 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.559 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -150.97 -159.66 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.853 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.24 83.94 7.24 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.357 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -94.74 136.12 35.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.928 0.394 . . . . 0.0 110.695 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -125.83 137.3 58.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.689 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.2 tp -87.79 116.07 25.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.596 HD23 ' HB ' ' A' ' 68' ' ' VAL . 74.5 mt -57.45 130.86 48.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.487 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.636 ' O ' HG22 ' A' ' 98' ' ' VAL . 66.1 mt-30 -64.63 151.94 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.914 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.006 0.432 . . . . 0.0 111.869 -170.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.68 -42.85 12.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.9 t70 -54.07 -31.65 52.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.464 0.705 . . . . 0.0 111.793 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 94' ' ' GLN . 52.6 t -48.0 -33.99 4.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.175 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 54.9 mttp -57.67 -65.62 0.6 Allowed 'General case' 0 C--O 1.223 -0.319 0 O-C-N 123.035 0.209 . . . . 0.0 111.495 -175.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 104' ' ' SER . 24.9 t70 -63.02 -43.48 98.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.394 -170.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.537 HG23 HD13 ' A' ' 12' ' ' ILE . 37.0 t -53.95 -63.21 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.25 0.548 . . . . 0.0 110.397 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.629 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 40.4 mt -66.61 -42.12 87.34 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 12.8 mt-10 -67.34 -64.17 0.91 Allowed 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 122.009 -0.432 . . . . 0.0 111.144 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 38.6 m -62.26 -32.55 73.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.484 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 74.7 m-85 -77.48 7.7 5.14 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.723 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m 61.85 53.35 3.15 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.246 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.7 mm -105.43 98.99 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.905 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.87 13.36 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.772 0.796 . . . . 0.0 110.739 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.64 -162.61 34.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.641 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.39 156.17 69.74 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.969 0.384 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.876 ' HB3' ' HB3' ' A' ' 44' ' ' CYS . 82.7 Cg_endo -96.63 164.12 14.18 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.102 -1.208 . . . . 0.0 113.13 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.552 ' HD1' ' CD ' ' A' ' 126' ' ' GLU . 65.8 m-70 -145.11 130.74 18.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 51' ' ' LEU . 70.5 mt -128.27 113.37 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.759 0.314 . . . . 0.0 110.835 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.819 HG22 ' HG3' ' A' ' 125' ' ' LYS . 42.1 pt -112.51 156.57 13.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.359 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.8 118.56 31.16 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -112.28 136.36 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.623 ' OD1' ' HD2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -78.59 166.76 40.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -50.51 -44.05 41.76 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.871 2.381 . . . . 0.0 113.561 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.455 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.0 mt-10 -65.21 -29.6 70.42 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.046 -0.409 . . . . 0.0 110.589 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.35 33.04 2.6 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.418 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.623 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -110.51 146.56 35.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.97 0.885 . . . . 0.0 109.194 170.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.6 mt -71.17 116.34 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.946 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.44 -37.44 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.25 24.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.819 ' HG3' HG22 ' A' ' 114' ' ' ILE . 88.7 tttt -123.7 128.16 49.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.51 . . . . 0.0 111.337 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.552 ' CD ' ' HD1' ' A' ' 112' ' ' HIS . 44.1 mt-10 58.72 74.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.71 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.755 ' HB2' HD22 ' A' ' 132' ' ' LEU . 43.8 mt -91.3 155.34 18.6 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.53 HH12 ' HG2' ' A' ' 111' ' ' PRO . 28.4 mmt180 -128.07 161.7 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.25 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 50.92 -137.78 27.14 Favored Glycine 0 N--CA 1.452 -0.26 0 O-C-N 123.983 0.802 . . . . 0.0 113.168 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.37 -16.43 58.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.546 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 17.7 m-20 -60.52 -27.26 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.283 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 127' ' ' LEU . 23.6 mt -51.45 -58.18 6.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.742 167.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.408 ' HD1' ' HA ' ' A' ' 54' ' ' THR . 67.3 t80 -62.81 -48.75 77.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 89.3 m-20 -51.7 -47.18 64.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 m -67.84 -44.07 78.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.5 t -63.94 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 15.7 tt0 -66.28 -44.09 84.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 0.0 110.564 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -59.87 -29.14 68.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 -60.66 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.0 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.259 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.13 0.491 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.954 HG21 ' HA ' ' A' ' 123' ' ' VAL . 90.7 m -104.26 130.17 52.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.886 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.67 -10.5 45.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.779 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -77.95 127.06 31.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 54.8 t -69.7 132.87 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.537 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.2 146.5 38.27 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.591 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.82 163.3 19.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.315 2.676 . . . . 0.0 112.094 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 130.73 34.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.36 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.7 mt -94.1 138.88 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.146 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.17 101.42 8.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 0.0 110.55 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.84 156.59 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.783 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -98.98 122.21 50.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -80.84 -175.3 5.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.023 0.439 . . . . 0.0 111.282 -173.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.37 -31.65 69.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.991 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 8.8 mtmp? -80.11 -18.66 49.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 111.294 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 25.73 13.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.119 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.97 144.18 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 94.57 6.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.039 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.29 143.24 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.816 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 15.7 m -119.47 170.35 9.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.72 0.295 . . . . 0.0 110.274 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 34.6 tp -68.17 -7.74 32.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.207 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 28.3 p-10 -65.52 -32.37 73.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.39 -31.82 71.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.683 0.754 . . . . 0.0 111.087 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 95.1 m-85 -85.07 -2.92 58.54 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HE2' ' HA3' ' A' ' 120' ' ' GLY . 51.4 mttt -84.03 99.55 10.51 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.371 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.94 -9.13 5.17 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -121.01 165.55 15.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.32 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.92 117.37 23.89 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 8.5 t -109.32 115.82 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.866 0.365 . . . . 0.0 111.856 -169.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.5 HD11 HD23 ' A' ' 132' ' ' LEU . 34.3 tp -97.01 105.02 17.09 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 15.8 t -96.45 108.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.938 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -102.98 116.83 33.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.26 121.37 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.177 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.53 ' O ' ' HA ' ' A' ' 69' ' ' SER . 29.9 p-90 -152.97 -178.24 6.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -175.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -168.73 162.8 11.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.487 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -30.95 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.65 65.22 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.801 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.92 99.64 6.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.162 0.506 . . . . 0.0 110.634 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.488 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 59.2 m -63.6 -35.04 79.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.384 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 71.3 t-105 -60.67 -33.95 73.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.452 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 111' ' ' PRO . 58.3 m -60.08 -37.88 81.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.504 0.669 . . . . 0.0 110.341 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.698 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 42.2 mtm180 -84.96 -12.21 53.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.648 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 43' ' ' TRP . 51.5 mmtt -70.76 -21.74 62.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.201 0.524 . . . . 0.0 110.865 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.09 -2.05 58.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.973 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 86.7 m -52.48 -49.0 88.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 71.6 Cg_exo -50.68 -44.53 40.11 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.011 1.807 . . . . 0.0 112.454 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -69.27 -39.22 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.71 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.47 -48.57 80.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.41 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.22 -40.42 85.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.43 -50.9 70.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -62.18 -46.56 88.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -55.53 -51.98 65.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.011 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -67.42 -25.97 66.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.83 -27.94 30.53 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 92.9 m-85 -120.59 1.28 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 59.5 pttt -61.35 -27.57 68.6 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.112 0.482 . . . . 0.0 111.786 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' HZ2' ' A' ' 61' ' ' LYS . 9.1 p-10 -82.14 -6.5 59.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.275 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HZ2' ' CG ' ' A' ' 60' ' ' ASP . 49.5 mttp -110.92 31.41 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.424 -171.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 39.21 64.81 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.575 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 51.0 t80 -135.6 140.42 44.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 t -150.06 147.51 27.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.293 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.61 126.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -97.85 93.9 6.61 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.733 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -78.11 107.15 2.4 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.826 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -106.96 111.97 37.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 120.734 0.302 . . . . 0.0 110.421 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 32.6 t -116.06 160.01 20.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.047 0.451 . . . . 0.0 110.43 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.502 ' HB ' HD13 ' A' ' 93' ' ' LEU . 12.3 t -131.31 30.44 4.49 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.493 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -51.84 147.95 6.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.553 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -78.93 -10.75 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.019 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 46.7 mtm180 -137.72 149.4 46.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.653 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 15.8 tt0 -72.68 -32.9 66.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 1.7 mp0 -60.34 -40.89 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.084 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.36 -37.16 68.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.019 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -61.33 -51.2 69.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.306 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -59.17 -39.24 81.88 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.901 0.381 . . . . 0.0 110.419 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HZ1' ' HB3' ' A' ' 79' ' ' LYS . 4.0 ttpm? -61.89 -48.45 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.742 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.35 75.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.373 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.11 -41.24 91.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.268 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.445 ' CD ' ' HZ3' ' A' ' 85' ' ' LYS . 24.2 tp10 -70.82 -37.59 73.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.4 mt-10 -54.22 -48.28 71.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.262 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.698 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.7 m-20 -104.02 0.81 30.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 63.2 mmtt 58.61 34.76 24.09 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.6 p -82.67 75.79 9.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.475 0.655 . . . . 0.0 111.048 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.482 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 69.3 m-85 -87.85 89.47 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.507 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -158.55 -177.15 6.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.04 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.57 100.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.733 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 41.0 mt-30 -123.78 151.71 43.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.678 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.86 154.51 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.824 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.85 130.33 46.03 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 70' ' ' THR . 80.9 mt -65.32 140.24 58.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.693 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.648 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.2 mt-30 -73.08 157.98 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -57.94 -36.82 73.05 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.84 -31.14 18.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.67 0.271 . . . . 0.0 111.075 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -35.89 82.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.217 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 94' ' ' GLN . 87.0 t -48.5 -45.82 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.014 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.16 -62.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.531 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.98 -55.45 12.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.38 -51.91 29.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 O-C-N 123.345 0.403 . . . . 0.0 111.927 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.55 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 34.8 mt -61.97 -51.39 68.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.943 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.79 -60.3 4.06 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.389 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.1 m -50.67 -38.26 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.054 0.942 . . . . 0.0 113.385 -172.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.05 13.74 1.34 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.354 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.4 ' H ' ' C ' ' A' ' 104' ' ' SER . 34.9 m 63.47 44.19 5.5 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.785 0.678 . . . . 0.0 109.614 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 61.2 mt -105.94 92.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.137 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.3 -0.01 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.787 0.803 . . . . 0.0 109.013 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.75 155.66 26.64 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.026 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.406 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 96.9 m-85 -128.64 152.73 79.1 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 44' ' ' CYS . 92.0 Cg_endo -85.51 134.21 18.21 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.593 -1.419 . . . . 0.0 112.736 -0.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -103.32 114.0 27.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 132' ' ' LEU . 61.8 mt -113.97 130.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 29.6 pt -133.34 143.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.3 tp -107.47 118.01 35.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 60.3 t -107.31 138.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.611 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.55 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -84.36 167.98 24.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 2.3 Cg_endo -46.01 -42.61 20.67 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.184 2.589 . . . . 0.0 114.195 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 40.7 mt-10 -76.4 -24.54 54.07 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 122.175 -0.328 . . . . 0.0 111.497 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 109.6 33.13 2.74 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.867 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.501 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 2.1 mptt -100.59 149.45 23.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.774 0.787 . . . . 0.0 109.476 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' THR . 50.7 mt -85.37 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.321 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.954 ' HA ' HG21 ' A' ' 5' ' ' THR . 4.9 p -86.09 -50.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -115.64 153.97 30.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -169.46 153.75 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.148 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 68.43 13.79 9.04 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.273 0.983 . . . . 0.0 111.413 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 124' ' ' ALA . 68.2 mt -70.28 156.78 38.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.814 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.504 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 3.5 mmp_? -101.22 170.45 8.24 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.58 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 132' ' ' LEU . . . -47.23 -68.49 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.29 -31.16 69.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 0.0 110.187 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.91 -38.7 92.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.094 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 63.6 mt -52.16 -51.06 60.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.24 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -59.09 -50.72 72.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -61.91 -42.44 99.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.276 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.587 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 15.9 m -72.78 -39.67 66.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.727 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 132' ' ' LEU . 72.6 t -67.18 -35.61 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.76 -55.17 37.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 18.8 pttp -63.31 -17.33 62.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.058 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.96 -61.43 1.71 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -169.415 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.54 0.21 . . . . 0.0 111.286 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -127.38 128.97 46.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.18 89.96 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.5 m -84.43 140.95 31.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.456 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.42 127.32 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.81 0.338 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 124.96 59.25 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.166 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 25.1 Cg_exo -63.47 158.54 44.86 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.741 2.294 . . . . 0.0 112.311 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 116.13 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.941 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.817 HD11 HG22 ' A' ' 101' ' ' VAL . 43.3 mm -96.29 150.64 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.166 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 9.0 t -131.19 138.91 49.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.85 29.05 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.644 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 92' ' ' LEU . 66.6 mt -79.73 113.87 19.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.477 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 11.9 p30 -81.92 179.1 7.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.721 -173.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.28 -15.59 60.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.693 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.477 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 2.0 mppt? -77.23 -32.76 56.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 109.722 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.91 18.41 4.72 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.985 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -113.97 149.08 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.718 0.294 . . . . 0.0 110.6 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.81 90.58 6.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 23' ' ' SER . 3.8 p -106.36 166.14 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.984 -169.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.703 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 8.3 m -105.13 173.97 6.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.63 HD13 HG12 ' A' ' 32' ' ' VAL . 63.1 tp -57.04 -23.11 44.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 3.3 p-10 -65.59 -16.9 64.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.29 -36.56 78.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 0.0 110.75 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -119.71 10.97 11.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.625 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 48.6 tttp -72.7 121.94 20.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.509 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.96 -23.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.54 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 27.5 mttm -103.09 174.71 5.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.22 109.32 5.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 165.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG12 HD13 ' A' ' 24' ' ' LEU . 57.5 t -94.52 108.07 20.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.18 -171.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.4 tp -85.64 109.94 18.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 114' ' ' ILE . 39.6 t -88.73 121.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.253 0.549 . . . . 0.0 110.369 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.432 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -104.99 108.99 20.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.007 -172.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HZ ' ' HD2' ' A' ' 105' ' ' TYR . 88.1 m-85 -94.37 115.11 27.27 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 5.0 p-90 -155.64 176.59 12.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 0.0 111.475 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -170.07 149.25 3.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.109 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' A' ' 71' ' ' ASP . . . -72.7 5.05 3.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.986 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.13 -14.39 56.16 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.9 t -99.35 134.36 42.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -67.37 -40.26 85.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.439 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -75.36 -28.5 59.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.657 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 85.6 m -58.54 -37.65 76.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.533 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.62 -21.27 66.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.323 0.582 . . . . 0.0 110.714 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.3 mptp? -86.35 -31.9 21.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -78.91 -25.27 43.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.049 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 84' ' ' ASP . 3.5 m -50.98 -51.21 69.59 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 73.1 Cg_exo -52.05 -39.58 69.83 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.278 1.985 . . . . 0.0 112.988 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -71.19 -35.32 71.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 110.813 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.705 HD23 HD12 ' A' ' 113' ' ' ILE . 89.5 mt -66.77 -44.66 80.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.345 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.27 -44.31 92.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.358 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -53.52 -56.36 17.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.707 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.4 m -65.22 -42.8 93.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.51 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.724 ' HB2' HD12 ' A' ' 65' ' ' ILE . 83.3 t80 -61.95 -51.64 67.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.639 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.593 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 49.4 t30 -55.7 -42.17 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.291 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 70.3 m-85 -106.72 -1.12 23.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 56' ' ' ASN . 12.0 pttp -62.85 -25.79 68.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.078 0.466 . . . . 0.0 110.574 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -23.26 64.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.668 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -110.85 -161.96 0.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.556 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.75 47.59 3.32 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.672 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 79.0 t80 -142.71 153.46 43.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 14.8 t -162.56 170.33 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.676 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 55' ' ' TYR . 44.4 mt -120.2 124.43 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.524 ' HH ' HG22 ' A' ' 91' ' ' VAL . 59.8 t80 -105.26 95.81 6.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.277 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -83.14 135.44 13.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.142 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 93' ' ' LEU . 16.8 m -125.84 118.89 53.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.622 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -125.66 151.17 46.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.53 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.759 ' HG1' HG22 ' A' ' 98' ' ' VAL . 10.1 t -131.18 45.38 2.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 108.997 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 39' ' ' ALA . 1.3 m-20 -60.62 -176.5 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.9 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -62.31 -39.8 94.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.286 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.524 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 13.0 tpt180 -151.23 158.29 43.71 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.405 -171.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 25.5 tt0 -66.88 -44.94 79.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.702 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.524 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.1 pm0 -70.5 -27.81 64.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.828 0.346 . . . . 0.0 110.084 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 21.7 t0 -62.01 -42.57 99.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -68.0 -49.69 60.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.825 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -52.72 -44.43 66.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.262 0.554 . . . . 0.0 110.287 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 13.9 ttpp -61.69 -44.29 97.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.062 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.1 78.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.966 0.413 . . . . 0.0 111.193 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.455 ' HA ' ' OG ' ' A' ' 86' ' ' SER . 79.8 mt -62.53 -43.71 98.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.127 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -66.01 -38.84 89.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.72 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.7 mt-10 -58.47 -58.61 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 111.329 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.597 ' HB3' HG23 ' A' ' 48' ' ' THR . 1.1 m-20 -85.2 -5.88 59.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.366 -173.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 3.9 mptp? 61.22 34.03 18.93 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.511 0.672 . . . . 0.0 110.451 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -80.09 58.32 2.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.278 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -79.77 75.06 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.45 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -140.84 -168.35 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.709 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 11.2 m120 -74.46 86.86 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 -174.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.7 mt-30 -113.42 148.27 36.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.524 HG22 ' HH ' ' A' ' 66' ' ' TYR . 26.9 m -131.43 150.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.318 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 49.0 tp -88.38 114.1 24.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.558 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.496 HD13 ' HB ' ' A' ' 68' ' ' VAL . 85.6 mt -69.18 135.51 50.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.295 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.648 ' O ' HG21 ' A' ' 98' ' ' VAL . 61.7 mt-30 -72.11 148.26 45.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 74.2 mmtt -63.06 -30.07 71.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -169.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 22.2 t70 -83.85 -40.16 19.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.871 0.367 . . . . 0.0 110.083 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.1 t70 -56.19 -40.54 74.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.765 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.759 HG22 ' HG1' ' A' ' 70' ' ' THR . 96.8 t -48.39 -37.85 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.563 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 3.6 ttpp -54.74 -56.0 23.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.228 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.86 -40.47 68.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.818 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.817 HG22 HD11 ' A' ' 12' ' ' ILE . 61.9 t -57.17 -60.52 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 49.4 mt -57.13 -57.26 13.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.854 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.68 -61.73 2.12 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.355 0.409 . . . . 0.0 110.711 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 106' ' ' CYS . 39.7 m -53.23 -41.51 65.46 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 124.206 0.941 . . . . 0.0 112.858 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.489 ' HD2' ' HZ ' ' A' ' 36' ' ' PHE . 6.6 m-85 -74.17 12.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.187 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.464 ' H ' ' C ' ' A' ' 104' ' ' SER . 36.3 t 62.95 41.28 8.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.2 mm -112.64 122.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.357 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.18 21.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.665 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.01 168.23 40.97 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.391 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.6 150.7 77.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.583 0.353 . . . . 0.0 110.094 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.35 137.92 8.61 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.025 -1.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -134.09 139.18 45.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.705 HD12 HD23 ' A' ' 51' ' ' LEU . 61.5 mt -128.77 136.7 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.522 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 125' ' ' LYS . 33.0 pt -126.36 159.65 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.45 117.1 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.621 0.248 . . . . 0.0 110.636 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 117' ' ' ASP . 74.1 t -111.84 127.36 69.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.55 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 2.8 p30 -67.68 163.35 49.52 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.815 175.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -49.95 -37.21 46.13 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.309 2.673 . . . . 0.0 113.248 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.47 -36.76 83.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.349 0.595 . . . . 0.0 110.339 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.65 37.51 1.42 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.357 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.55 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.1 mtmp? -117.35 141.93 47.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.854 0.359 . . . . 0.0 110.096 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 mt -80.67 104.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.6 -40.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.2 0.524 . . . . 0.0 110.451 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.69 156.4 42.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.203 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.83 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 0.9 OUTLIER -154.22 171.89 18.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.235 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.83 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 8.7 mm-40 60.75 32.36 20.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.174 0.921 . . . . 0.0 110.32 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.64 134.79 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -77.88 147.34 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.633 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -43.76 -51.19 7.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 177.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.22 -34.33 76.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.6 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.76 -34.05 27.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.071 -168.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.542 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.5 pp -58.2 -32.47 68.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.752 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -71.18 -42.34 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -61.17 -42.71 99.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -69.06 -53.22 21.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.807 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 132' ' ' LEU . 27.4 m -61.02 -38.81 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.96 -41.54 95.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.346 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -66.48 -23.15 66.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.909 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.14 -61.36 1.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.281 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.452 0.168 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -132.36 134.64 45.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.685 0.279 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.33 -11.76 68.62 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.614 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 t -78.25 151.4 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.87 129.0 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.457 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HB1' ' HH ' ' A' ' 105' ' ' TYR . . . -83.52 139.8 41.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' A' ' 105' ' ' TYR . 51.8 Cg_exo -54.63 154.41 20.44 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.928 2.419 . . . . 0.0 112.599 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 91.68 6.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.33 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.484 HG22 HG11 ' A' ' 68' ' ' VAL . 45.6 mt -64.25 135.03 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.158 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 m -133.06 100.4 4.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 110.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.78 176.93 16.82 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.506 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.0 123.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -174.7 5.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.029 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.7 -25.12 67.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.62 -21.93 51.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.1 0.476 . . . . 0.0 110.894 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.24 19.66 27.59 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -96.5 145.14 25.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 p -80.99 99.36 8.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.43 131.12 54.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.873 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 m -110.4 171.57 7.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.972 0.415 . . . . 0.0 110.981 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.7 -23.81 63.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 110.409 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.455 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 8.2 t30 -64.31 -31.47 72.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.375 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -72.74 -5.22 36.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.433 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 7.23 14.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 9.0 mtpm? -71.39 92.35 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.385 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.64 -24.35 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -121.51 172.85 7.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.492 ' HB3' HD13 ' A' ' 115' ' ' LEU . 93.4 m-85 -78.19 116.64 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 116' ' ' VAL . 22.6 t -102.92 119.85 51.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.11 0.481 . . . . 0.0 111.208 -172.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 17.4 tp -94.06 116.18 28.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 46.1 t -102.17 115.89 44.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.613 0.244 . . . . 0.0 110.947 -174.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -92.91 103.72 16.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.51 ' HA ' HG23 ' A' ' 68' ' ' VAL . 91.6 m-85 -83.77 114.12 21.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HZ3' HH12 ' A' ' 45' ' ' ARG . 11.1 p-90 -158.3 178.66 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.6 0.714 . . . . 0.0 112.537 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -169.82 154.25 5.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.95 171.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 86.99 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.476 0.655 . . . . 0.0 110.337 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.1 -46.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.16 101.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.41 0.624 . . . . 0.0 109.464 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 m -66.12 -7.64 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.831 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 67.4 t-105 -78.77 -23.66 45.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.4 m -58.24 -42.4 86.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.527 HH12 ' HZ3' ' A' ' 37' ' ' TRP . 4.7 mpt_? -62.74 -16.48 57.8 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.234 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 2.2 mptm? -85.38 -31.55 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -23.61 30.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.143 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.536 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 10.7 m -48.96 -50.18 63.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -47.42 -47.55 17.42 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.42 2.08 . . . . 0.0 113.041 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.605 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 67.4 m-85 -75.46 -35.4 60.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 113' ' ' ILE . 92.0 mt -58.24 -52.61 64.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.63 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.11 -42.94 99.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.346 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.766 ' HZ2' ' HE1' ' A' ' 133' ' ' TYR . 27.4 tptp -55.07 -52.15 64.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.14 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 63' ' ' PHE . 30.8 m -64.11 -45.44 88.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.147 -178.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.595 ' HB2' HD13 ' A' ' 65' ' ' ILE . 88.8 t80 -58.24 -51.59 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.24 -38.8 92.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.316 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.09 67.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.459 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 21.5 m-85 -120.36 6.7 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.4 pttp -54.47 -50.34 67.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.68 -43.7 65.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.118 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -55.04 -71.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.46 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.07 33.12 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.4 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 78.4 t80 -137.06 139.01 41.02 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 50.3 m -149.58 141.11 23.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 55' ' ' TYR . 33.5 mt -98.36 135.46 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.2 t80 -121.8 95.9 4.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.843 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.5 124.3 6.52 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.979 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.986 ' HB ' HD22 ' A' ' 93' ' ' LEU . 17.3 m -105.65 111.51 35.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.085 0.945 . . . . 0.0 109.78 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.59 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 7.3 m -104.81 137.67 42.24 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.164 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.633 ' HB ' HD13 ' A' ' 93' ' ' LEU . 9.1 t -126.36 42.16 3.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.234 1.016 . . . . 0.0 108.868 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 8.8 m-20 -61.72 176.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.306 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -80.63 -19.09 46.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.499 -168.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.561 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 5.8 tpt85 -165.64 161.72 18.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.412 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.6 tt0 -67.16 -44.15 80.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.286 0.494 . . . . 0.0 110.119 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.561 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 1.8 mp0 -59.41 -39.61 83.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.512 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.14 -46.43 87.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.154 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 81' ' ' ILE . 21.0 t90 -59.08 -52.66 64.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.579 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.8 mptm? -53.81 -46.59 71.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 0.0 110.163 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.19 -42.35 94.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.378 175.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.57 76.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.6 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 77' ' ' TRP . 79.0 mt -63.13 -47.81 90.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -66.63 -37.69 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -58.17 -45.47 87.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.338 0.655 . . . . 0.0 111.075 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 48' ' ' THR . 15.2 t70 -87.2 -26.43 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.895 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.5 mptp? 70.99 21.09 5.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.006 0.523 . . . . 0.0 111.144 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.405 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 1.7 p -82.25 76.0 9.15 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.892 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -84.48 78.62 9.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.41 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -151.62 -172.61 4.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 89' ' ' ASN . 0.9 OUTLIER -69.79 108.46 3.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.196 0.522 . . . . 0.0 111.123 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.51 152.3 40.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.8 146.39 29.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.058 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.26 129.25 35.41 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.986 HD22 ' HB ' ' A' ' 68' ' ' VAL . 65.4 mt -63.92 138.47 58.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.548 ' O ' HG21 ' A' ' 98' ' ' VAL . 75.1 mt-30 -80.11 169.49 17.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.811 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.462 ' HZ2' ' CG ' ' A' ' 96' ' ' ASP . 10.5 ptmm? -51.67 -46.87 63.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -175.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.915 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.6 m-20 -87.67 -33.73 18.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.616 0.246 . . . . 0.0 110.455 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.459 ' OD1' HD23 ' A' ' 93' ' ' LEU . 17.4 t70 -55.97 -45.01 79.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 94' ' ' GLN . 76.2 t -49.64 -53.11 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.851 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.915 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 9.5 mtmp? -60.31 -62.79 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.48 -174.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.49 -42.06 65.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.747 -168.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.533 HG12 ' HE2' ' A' ' 105' ' ' TYR . 53.5 t -68.48 -54.4 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 121.344 -0.142 . . . . 0.0 111.233 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 48.9 mt -58.52 -43.51 89.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.047 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.23 -61.26 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.013 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 106' ' ' CYS . 71.8 m -49.25 -40.59 34.78 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -169.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.699 ' HH ' ' HB1' ' A' ' 9' ' ' ALA . 84.8 m-85 -76.52 11.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.046 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.424 ' H ' ' C ' ' A' ' 104' ' ' SER . 92.7 m 60.18 42.45 15.34 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 109.904 -175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 105' ' ' TYR . 36.1 mm -91.76 74.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.691 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.92 -19.04 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.897 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.9 148.69 20.17 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.428 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.34 155.48 48.38 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.429 ' HG2' ' HD1' ' A' ' 43' ' ' TRP . 2.3 Cg_endo -82.54 166.81 68.85 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.279 -0.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.477 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -144.39 109.08 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.106 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 HD22 ' A' ' 51' ' ' LEU . 79.2 mt -114.73 127.0 72.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.757 0.313 . . . . 0.0 110.267 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 46.6 pt -124.23 160.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.105 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.686 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 66.9 tp -124.9 114.18 18.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 32' ' ' VAL . 4.7 m -104.99 144.65 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.024 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.594 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.5 OUTLIER -76.07 172.91 8.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.439 177.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -51.71 -24.78 18.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.931 2.421 . . . . 0.0 113.721 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.448 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -88.61 1.01 55.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.191 -0.318 . . . . 0.0 111.796 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.04 27.54 58.05 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.709 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -111.62 142.19 44.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.128 0.49 . . . . 0.0 110.241 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mt -72.96 104.68 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.284 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.87 -26.46 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 110.298 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 115' ' ' LEU . . . -144.87 151.02 38.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 20.3 pttp -161.66 154.26 20.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.89 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 28.9 mt-10 62.55 29.93 17.05 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.368 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.21 165.66 22.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.273 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 18.1 mmt180 -115.87 166.25 12.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -42.29 -64.18 1.62 Allowed Glycine 0 C--O 1.234 0.124 0 O-C-N 124.012 0.82 . . . . 0.0 114.432 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.02 -36.58 68.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.837 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.37 -50.24 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.6 pp -57.13 -34.4 68.36 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.872 0.368 . . . . 0.0 110.187 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.766 ' HE1' ' HZ2' ' A' ' 53' ' ' LYS . 50.1 t80 -64.84 -57.43 8.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.094 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.22 -43.83 87.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.412 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 17.6 m -65.94 -49.04 69.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.897 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.24 -40.95 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.146 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 15.1 tt0 -65.29 -36.66 84.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.351 0.596 . . . . 0.0 109.897 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.412 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 14.1 ttpp -61.73 -39.94 93.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.788 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.27 -53.79 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -169.367 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . . . . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.548 0.214 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 p -134.69 131.59 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.0 -3.79 86.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.458 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 9.8 m -69.33 130.17 41.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.368 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.03 133.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 0.0 110.289 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -88.59 137.75 30.23 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.24 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 32.2 Cg_exo -61.34 162.28 20.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.012 2.475 . . . . 0.0 112.011 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.6 96.9 9.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.792 0.33 . . . . 0.0 111.618 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.29 140.25 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.832 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -133.55 89.55 2.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.05 0.929 . . . . 0.0 110.286 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.45 155.51 18.98 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.417 -174.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.7 mt -86.11 130.18 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.606 0.241 . . . . 0.0 110.56 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -174.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.94 -7.13 46.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 34.8 mttp -99.78 -35.68 9.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.549 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.37 10.5 2.99 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.314 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.8 m-80 -91.77 134.18 34.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 p -83.17 98.15 9.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.855 0.359 . . . . 0.0 110.215 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.16 137.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.009 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -97.37 156.6 16.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.194 0.521 . . . . 0.0 111.437 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 tp -61.13 -27.25 68.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.618 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.526 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.0 t30 -65.85 -31.08 71.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.05 -7.64 54.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 110.811 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.84 3.14 18.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.91 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 85.5 mttt -66.38 178.69 1.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.021 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.05 10.56 85.42 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.497 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -143.17 167.43 22.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.9 110.47 17.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 168.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.2 109.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.908 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.7 tp -85.61 110.28 19.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' HG13 ' A' ' 114' ' ' ILE . 58.6 t -98.57 107.99 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.094 0.474 . . . . 0.0 110.664 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.21 121.44 42.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.245 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.24 117.31 28.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.778 0.323 . . . . 0.0 110.166 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.8 p-90 -144.14 177.21 8.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.011 0.434 . . . . 0.0 111.181 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -170.67 162.0 7.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.042 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.33 83.4 2.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 0.0 110.661 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.8 -44.41 0.15 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.472 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.63 117.72 12.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 43.3 m -68.61 -29.81 68.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 23.1 m95 -73.43 -40.69 64.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.463 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 73.2 m -59.52 -25.5 64.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -84.94 -19.93 31.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HD3' ' O ' ' A' ' 42' ' ' SER . 13.6 mptt -85.7 -23.83 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 111.235 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 43' ' ' TRP . 4.0 mm-40 -78.27 -20.44 51.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.384 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' ' 84' ' ' ASP . 6.4 m -52.45 -50.89 77.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 82.4 Cg_exo -49.9 -48.13 20.68 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.164 1.909 . . . . 0.0 112.643 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -67.54 -39.65 85.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.589 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -63.22 -41.29 99.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.89 -42.24 99.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.88 -41.95 98.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.993 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.3 m -60.65 -46.49 90.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.797 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.593 ' HB2' HD12 ' A' ' 65' ' ' ILE . 84.0 t80 -56.1 -57.78 10.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 93.2 m-20 -60.8 -32.54 71.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.057 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.29 41.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 90.2 m-85 -112.06 -2.17 15.12 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.759 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.5 ptmm? -62.91 155.68 26.52 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.269 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' CG ' ' HZ1' ' A' ' 59' ' ' LYS . 14.3 m-20 66.9 10.04 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.476 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.3 mttp -123.25 25.04 8.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.879 0.371 . . . . 0.0 110.958 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.87 27.7 33.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.153 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.46 140.93 46.59 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 160.34 42.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 55' ' ' TYR . 64.0 mt -112.86 126.97 70.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -110.95 95.14 5.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.79 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.26 109.5 2.94 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.884 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.6 HG12 HD22 ' A' ' 93' ' ' LEU . 75.2 t -98.03 112.13 29.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -113.29 145.6 40.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.947 -178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.5 ' HB ' HD12 ' A' ' 93' ' ' LEU . 3.8 t -126.46 45.92 2.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.616 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.52 171.42 12.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.639 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.539 HH22 HG12 ' A' ' 98' ' ' VAL . 22.0 mmt180 -115.52 2.93 13.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.692 0.758 . . . . 0.0 109.208 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -124.05 124.26 42.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.035 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.564 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.0 tt0 -75.81 -33.91 60.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.46 -51.28 70.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.737 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -37.42 87.5 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.11 -52.36 65.21 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 110.73 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.5 mptm? -57.14 -44.94 83.84 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.306 0.574 . . . . 0.0 110.668 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -68.49 -33.81 74.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.082 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.97 82.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.34 -37.68 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.663 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 47.1 tp10 -65.91 -38.1 87.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.647 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 52.1 mt-10 -57.82 -60.06 4.28 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.461 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HB3' HG22 ' A' ' 48' ' ' THR . 39.1 m-20 -85.11 -12.87 51.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.286 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 66.8 mmtt 60.05 37.94 20.88 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 110.972 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.0 p -77.0 114.32 15.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.237 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -112.57 84.98 2.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.589 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 11.1 p90 -158.6 -170.03 2.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.46 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.22 90.05 2.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 110.913 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -109.84 133.13 53.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.675 0.274 . . . . 0.0 110.48 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.28 155.19 41.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.717 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.98 123.52 47.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.6 HD22 HG12 ' A' ' 68' ' ' VAL . 82.1 mt -62.74 140.51 58.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.0 111.166 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 98' ' ' VAL . 44.8 mt-30 -73.41 166.62 22.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.912 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 20.2 mtpt -51.02 -58.43 6.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.508 0.67 . . . . 0.0 111.534 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.27 -26.87 38.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.45 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.436 ' OD2' HD23 ' A' ' 93' ' ' LEU . 28.0 t70 -64.25 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.022 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.2 t -49.8 -42.94 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.15 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -58.56 -56.73 18.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.45 -44.66 62.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.469 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.68 -59.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 123.066 0.229 . . . . 0.0 111.378 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 37.2 mt -59.53 -42.85 93.22 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.45 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.77 -62.17 2.07 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.224 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 106' ' ' CYS . 59.3 p -53.72 -40.21 65.9 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.111 0.882 . . . . 0.0 113.167 -167.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.414 ' HB2' HG12 ' A' ' 107' ' ' ILE . 75.4 m-85 -75.62 12.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' A' ' 104' ' ' SER . 42.8 m 64.45 39.29 7.04 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.478 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.8 mm -92.82 86.83 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.008 -173.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.48 -7.06 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.287 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.05 163.06 35.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.553 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.1 156.27 54.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.497 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 93.4 Cg_endo -80.12 175.73 43.41 Favored 'Cis proline' 0 C--N 1.346 0.444 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.719 -0.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.6 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -159.94 125.92 4.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.959 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.1 135.05 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.16 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.606 HG22 ' HG3' ' A' ' 125' ' ' LYS . 34.7 pt -132.34 146.11 33.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 53.6 tp -107.74 112.6 25.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.982 0.42 . . . . 0.0 110.024 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.403 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 96.2 t -100.5 135.04 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.772 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.549 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.1 OUTLIER -80.42 167.09 35.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 4.1 Cg_endo -47.41 -36.33 23.26 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.61 2.873 . . . . 0.0 114.327 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.67 -29.66 61.31 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.839 0.352 . . . . 0.0 111.236 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 112.49 31.05 2.68 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.671 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -112.67 140.29 47.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.18 107.49 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.39 -24.86 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 111.035 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -140.6 133.81 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.886 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 25.6 ttpp -134.5 137.04 43.56 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.256 -174.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.886 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 49.3 mt-10 68.75 51.6 0.59 Allowed 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.158 0.911 . . . . 0.0 111.666 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.41 157.23 23.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.516 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 11.1 tpt85 -134.18 150.54 51.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.411 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 49.38 -141.02 12.77 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.656 0.598 . . . . 0.0 113.927 168.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.65 -10.92 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.341 0.591 . . . . 0.0 110.138 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.3 m-20 -58.86 -33.17 70.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.126 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -65.89 -36.58 83.8 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -65.42 -50.3 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.017 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -60.71 -34.37 74.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.32 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.0 m -65.65 -51.03 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 132' ' ' LEU . 86.2 t -63.15 -36.1 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 5.2 tp10 -57.98 -44.12 86.91 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.893 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -76.38 -16.39 59.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.059 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.65 -58.1 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.221 -0.299 . . . . 0.0 111.73 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.876 0.369 . . . . 0.0 111.655 -173.267 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.554 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.3 p -136.65 125.21 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.931 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.74 59.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.927 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 p -75.33 132.68 41.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.2 p -72.3 137.1 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.477 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . . . -107.48 145.56 31.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.2 Cg_exo -61.7 154.08 62.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.071 2.514 . . . . 0.0 112.464 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.27 139.14 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.185 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' SER . 53.5 mt -95.03 137.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -120.55 107.87 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 0.0 110.543 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.01 154.11 23.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.719 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.16 122.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -178.82 3.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 95.3 mt -59.56 -31.03 69.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.818 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -78.93 -35.66 42.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.5 3.05 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.08 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -105.88 145.9 30.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 p -77.32 104.53 7.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.236 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.91 143.29 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.999 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 10.2 m -123.04 162.39 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 32.3 tp -63.76 -7.42 7.7 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.539 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.8 -29.6 70.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.457 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.64 -27.76 63.3 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.844 0.83 . . . . 0.0 110.847 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.618 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 88.0 m-85 -87.88 4.03 46.21 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -171.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -84.3 87.45 7.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.798 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.79 -9.7 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.34 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -117.05 163.38 16.34 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -84.95 120.66 26.75 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.8 t -106.35 124.33 61.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.094 0.473 . . . . 0.0 112.091 -169.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.605 HD11 HG21 ' A' ' 113' ' ' ILE . 2.7 tm? -104.19 98.02 7.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.6 t -92.5 124.26 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 21.0 t0 -120.19 144.83 47.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.255 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 110' ' ' PHE . 96.9 m-85 -117.04 119.64 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.127 174.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.717 ' HZ2' HD12 ' A' ' 81' ' ' ILE . 54.1 p-90 -148.07 175.09 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.453 0.644 . . . . 0.0 112.027 -176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD1' ' HE2' ' A' ' 110' ' ' PHE . 1.5 p90 -162.37 166.12 25.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.157 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.7 65.89 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -171.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.57 -38.13 90.16 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.432 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.6 p -85.95 101.83 13.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.373 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.5 m -71.47 5.07 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -174.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -85.8 -30.27 23.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.31 -0.243 . . . . 0.0 111.294 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.588 ' SG ' ' HD2' ' A' ' 45' ' ' ARG . 21.1 p -68.56 -28.61 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.759 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.588 ' HD2' ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -77.62 -14.58 59.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.402 0.62 . . . . 0.0 109.408 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 42' ' ' SER . 2.1 mptm? -79.54 -24.32 42.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 42.5 mt-10 -100.16 -0.24 39.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.22 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 85.5 m -50.43 -52.65 53.11 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.92 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.8 Cg_endo -54.43 -40.99 80.77 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.545 2.163 . . . . 0.0 113.156 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.422 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.9 m-85 -67.61 -44.6 77.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.983 0.421 . . . . 0.0 110.351 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.78 -40.82 97.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.605 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.25 -46.52 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.94 -46.91 87.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.205 0.526 . . . . 0.0 110.312 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 32.0 m -62.1 -49.7 74.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.73 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB2' HD11 ' A' ' 65' ' ' ILE . 79.6 t80 -62.34 -40.73 97.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.64 0.257 . . . . 0.0 110.967 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.16 -34.15 75.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.287 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.439 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.74 -26.91 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 51.1 m-85 -102.8 -8.55 20.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -56.49 -35.01 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.31 0.95 56.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 88.1 mttt -105.54 19.71 20.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.036 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.39 37.47 70.06 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.4 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 39.7 t80 -130.67 143.53 50.81 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -145.76 136.2 24.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 55' ' ' TYR . 55.0 mt -88.26 117.68 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -100.31 93.43 5.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.176 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -87.6 112.2 3.81 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 34.1 t -104.86 119.03 53.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.025 0.441 . . . . 0.0 110.712 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.8 t -124.22 156.17 37.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 4.3 t -137.96 51.3 1.89 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.822 0.82 . . . . 0.0 109.027 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -66.67 -176.89 0.52 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.906 -174.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 3.6 ptm180 -77.23 -26.68 52.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.17 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.547 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 10.6 ttt180 -149.27 128.4 12.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.962 -166.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.06 -42.25 98.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.308 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 pt-20 -64.57 -41.6 96.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 80.7 m-20 -66.28 -34.15 77.36 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.604 ' O ' HG12 ' A' ' 81' ' ' ILE . 31.2 t90 -61.48 -60.65 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HD2' ' CE3' ' A' ' 77' ' ' TRP . 2.6 mptm? -52.23 -43.02 64.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 0.0 110.903 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 29.5 ttmt -59.39 -49.67 76.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.857 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.77 88.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.626 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.717 HD12 ' HZ2' ' A' ' 37' ' ' TRP . 44.2 mm -56.19 -45.7 81.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.738 0.304 . . . . 0.0 110.961 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 10.7 tp10 -58.87 -59.26 5.73 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 4.8 mm-40 -69.62 -33.56 72.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' A' ' 45' ' ' ARG . 35.2 t70 -71.51 -12.25 61.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 110.352 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.711 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 44.0 mmtt 64.54 32.55 11.55 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.093 175.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 48' ' ' THR . 0.3 OUTLIER -96.42 79.51 3.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.713 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -91.46 89.94 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -175.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -156.63 176.68 12.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -64.96 97.58 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.74 0.65 . . . . 0.0 111.711 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.538 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 51.4 mt-30 -123.56 149.64 45.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.41 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.21 150.42 31.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.24 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.43 118.7 35.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.316 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 98' ' ' VAL . 53.9 mt -62.94 137.19 58.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.368 0.604 . . . . 0.0 111.962 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.667 ' O ' HG21 ' A' ' 98' ' ' VAL . 22.4 mt-30 -73.5 145.79 45.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -70.64 -16.1 62.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.681 0.753 . . . . 0.0 111.123 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 3.2 p-10 -78.7 -46.81 18.21 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.399 171.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.23 -34.69 75.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.137 0.575 . . . . 0.0 111.517 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 94' ' ' GLN . 48.7 t -43.59 -43.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.727 . . . . 0.0 112.703 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 96' ' ' ASP . 60.6 mttp -54.97 -63.15 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.557 -169.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.0 -48.63 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.8 t -52.38 -47.93 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.504 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.501 HD21 HG13 ' A' ' 107' ' ' ILE . 25.7 mt -62.63 -59.36 5.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.58 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.62 -61.52 2.23 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.209 0.318 . . . . 0.0 110.793 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 106' ' ' CYS . 70.9 m -56.29 -37.05 69.34 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 124.211 0.945 . . . . 0.0 112.606 -172.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.496 ' CD2' HD13 ' A' ' 114' ' ' ILE . 4.2 m-85 -77.17 13.65 1.08 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 120.956 0.408 . . . . 0.0 110.8 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.415 ' H ' ' C ' ' A' ' 104' ' ' SER . 49.2 t 63.9 60.74 1.01 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.202 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.501 HG13 HD21 ' A' ' 102' ' ' LEU . 9.4 mm -85.44 93.59 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.074 0.94 . . . . 0.0 111.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.13 -31.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.78 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.64 151.66 22.89 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.349 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.621 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.5 p90 -147.2 160.04 40.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 118.948 -0.548 . . . . 0.0 109.78 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.621 ' C ' ' HA ' ' A' ' 110' ' ' PHE . 3.8 Cg_endo -43.54 145.96 1.79 Allowed 'Cis proline' 0 C--N 1.364 1.347 0 CA-C-N 120.325 1.152 . . . . 0.0 114.944 2.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 65.9 t60 -140.91 95.21 2.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.083 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.605 HG21 HD11 ' A' ' 33' ' ' LEU . 96.6 mt -101.61 114.5 41.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -172.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.496 HD13 ' CD2' ' A' ' 105' ' ' TYR . 48.2 pt -127.15 166.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.742 0.306 . . . . 0.0 110.983 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.0 118.14 32.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 78.6 t -110.85 138.55 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.045 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -92.52 170.07 9.67 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 1.5 Cg_endo -48.56 -36.84 32.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.35 2.7 . . . . 0.0 114.107 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.07 -22.07 62.16 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.955 -0.466 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 23.53 11.29 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.208 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 78.8 mttt -99.04 141.74 31.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.828 0.346 . . . . 0.0 110.096 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' THR . 33.2 mt -81.82 98.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.16 -21.89 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.173 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.48 142.19 21.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.554 ' HD2' ' HA ' ' A' ' 4' ' ' ALA . 10.8 ptmm? -129.71 138.54 51.19 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.315 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 67.78 46.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.17 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.431 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 86.7 mt -70.35 151.16 45.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 171.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.693 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 8.4 mmm180 -124.9 146.04 49.53 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.101 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 44.31 -125.51 5.94 Favored Glycine 0 C--O 1.224 -0.479 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.305 169.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.33 -20.92 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 111.037 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.693 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -51.03 -42.98 60.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 177.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -59.62 -34.35 72.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.405 ' HD2' ' HA ' ' A' ' 54' ' ' THR . 40.8 t80 -68.92 -53.45 20.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -61.15 -42.97 99.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.517 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.448 ' O ' ' HD1' ' A' ' 139' ' ' PHE . 24.3 m -66.75 -43.38 84.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.454 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 132' ' ' LEU . 77.9 t -67.54 -40.98 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.88 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.44 -34.27 76.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.488 0.661 . . . . 0.0 109.437 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.846 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 135' ' ' THR . 60.7 m-85 -80.68 -61.73 1.88 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.981 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.203 -169.115 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.689 0.28 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -70.61 119.13 14.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.508 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.89 -18.41 5.93 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.4 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 p -78.14 154.37 31.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.619 0.247 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.41 139.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.145 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.53 137.66 28.73 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 53.7 Cg_exo -53.7 146.48 44.33 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.796 2.331 . . . . 0.0 112.014 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.13 119.55 14.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.108 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 93' ' ' LEU . 45.1 mm -93.24 129.35 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.671 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -134.61 108.1 7.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.29 170.71 14.73 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.356 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 15.7 mt -100.24 115.91 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HB3' HG12 ' A' ' 91' ' ' VAL . 27.6 p30 -75.04 -174.46 2.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.475 0.655 . . . . 0.0 112.63 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.573 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 96.4 mt -60.22 -29.82 68.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.055 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 -38.0 30.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 110.297 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.93 21.79 2.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.318 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.6 OUTLIER -97.58 141.83 30.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -84.58 101.44 12.11 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.46 150.11 19.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.5 m -110.59 164.52 12.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.807 0.337 . . . . 0.0 111.238 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.635 HD21 HG12 ' A' ' 12' ' ' ILE . 3.5 pp -63.85 -27.12 68.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.29 0.567 . . . . 0.0 110.129 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.79 -32.84 72.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.392 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.28 -4.05 51.74 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.395 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -118.77 8.69 11.88 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 118' ' ' PRO . 36.1 mtmt -72.18 159.69 33.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.501 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.95 -28.31 7.05 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -108.56 169.79 8.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.565 ' HE2' HG12 ' A' ' 123' ' ' VAL . 4.1 m-85 -76.04 115.63 15.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 166.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.884 HG23 ' HB ' ' A' ' 116' ' ' VAL . 3.0 m -96.08 115.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.795 0.807 . . . . 0.0 111.741 -171.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tm? -84.66 109.11 17.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.527 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -99.19 107.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.32 129.47 47.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.057 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.73 115.76 31.22 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 28.4 p-90 -147.9 172.67 13.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 111.523 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HB2' ' CG ' ' A' ' 71' ' ' ASP . 20.4 p90 -167.27 155.99 9.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.089 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.59 -24.7 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.524 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.46 -32.64 73.49 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.123 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 33.7 m -93.31 117.98 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.256 0.551 . . . . 0.0 110.676 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.504 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 11.1 m -65.19 -16.49 63.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -82.91 -32.06 27.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 78.7 m -58.71 -32.05 68.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.086 0.47 . . . . 0.0 110.632 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -73.52 -14.41 61.21 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.608 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.61 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -86.64 -44.69 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.065 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mp0 -68.31 -22.32 64.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.588 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 99.8 m -57.43 -53.18 68.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 83.0 Cg_exo -49.97 -41.57 47.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.455 2.103 . . . . 0.0 112.945 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.6 m-85 -65.65 -43.15 90.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.304 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.85 -38.43 85.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.416 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.41 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 5.5 tt -61.63 -44.75 96.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.829 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.859 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 38.1 ttpt -63.74 -42.73 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.005 0.431 . . . . 0.0 110.341 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 m -58.68 -46.72 86.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.1 t80 -64.47 -46.56 82.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.544 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.859 ' ND2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 p30 -68.41 -32.74 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.981 -173.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.83 -27.93 21.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CZ ' ' HG2' ' A' ' 137' ' ' GLU . 51.3 m-85 -105.69 -5.49 19.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 13.6 pttm -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.067 0.46 . . . . 0.0 110.991 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.48 -3.24 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.299 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 75.8 mttt -97.93 3.23 49.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.094 0.473 . . . . 0.0 110.299 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.86 43.39 5.43 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.504 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 41.7 t80 -145.64 127.11 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -130.57 155.88 45.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.0 mt -105.09 120.61 55.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.229 0.537 . . . . 0.0 110.93 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 88.1 t80 -104.2 97.27 7.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.743 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.614 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -91.81 136.65 13.38 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.218 -175.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 5.1 m -121.35 114.9 44.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.662 0.744 . . . . 0.0 110.023 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -90.85 151.48 21.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.275 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.862 ' HA ' ' NZ ' ' A' ' 95' ' ' LYS . 6.5 t -136.09 38.67 2.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.468 0.652 . . . . 0.0 111.983 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 18.2 m-20 -76.34 167.54 21.66 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.991 167.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.696 ' HD2' ' HG3' ' A' ' 95' ' ' LYS . 13.6 mmm180 -96.43 -11.59 25.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 73' ' ' ARG . 40.8 mtp180 -111.21 108.32 17.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.866 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -69.64 -31.16 69.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.984 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -69.82 -36.22 75.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.26 -28.2 56.99 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -62.18 -52.76 62.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.217 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.9 mptm? -56.22 -42.48 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.279 0.562 . . . . 0.0 110.081 175.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 25.1 tttm -59.42 -50.22 74.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.231 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -56.56 -41.45 76.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 111.623 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.457 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 43.5 mm -63.47 -37.95 80.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.801 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -73.52 -33.44 64.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.692 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.2 mt-10 -65.26 -59.53 3.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.4 ' HB3' HG22 ' A' ' 48' ' ' THR . 2.5 m-20 -77.51 -9.72 59.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.815 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.412 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 38.9 mmtm 59.94 35.04 21.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.47 0.652 . . . . 0.0 111.063 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 p -87.65 76.93 8.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.412 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 76.2 m-85 -88.48 91.66 8.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.716 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 26.7 p90 -151.52 -177.45 6.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.816 169.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 66' ' ' TYR . 4.1 p-10 -72.51 88.82 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.805 0.812 . . . . 0.0 111.694 -174.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.614 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt-30 -111.09 144.75 39.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.186 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 29.6 m -132.91 145.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.439 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.65 109.54 19.74 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 HG21 ' A' ' 12' ' ' ILE . 9.0 mt -62.15 147.43 47.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.47 141.73 53.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.862 ' NZ ' ' HA ' ' A' ' 70' ' ' THR . 5.3 mmmt -75.4 -28.68 59.53 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.536 -161.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.702 ' HA ' ' CD ' ' A' ' 99' ' ' LYS . 2.0 m-20 -89.95 -4.98 57.18 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -88.16 -48.17 7.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.562 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -45.13 -40.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.893 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.702 ' CD ' ' HA ' ' A' ' 96' ' ' ASP . 39.6 mtpt -47.52 -59.52 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.977 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.49 -45.77 71.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.59 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.08 -41.8 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.177 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 98' ' ' VAL . 94.6 mt -58.53 -53.84 53.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.419 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.72 -52.47 56.11 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.557 0.536 . . . . 0.0 109.712 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 m -53.28 -30.87 41.0 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 29.9 m-85 -80.44 8.32 7.91 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.867 -0.521 . . . . 0.0 110.892 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 21.9 t 66.2 46.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.716 0.806 . . . . 0.0 109.106 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 20.0 mm -116.44 129.38 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.63 14.0 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.208 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.1 166.87 38.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 119.434 -1.365 . . . . 0.0 114.246 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -130.9 157.54 77.66 Favored Pre-proline 0 N--CA 1.463 0.212 0 C-N-CA 123.032 0.533 . . . . 0.0 110.581 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.22 169.96 71.35 Favored 'Cis proline' 0 C--N 1.352 0.744 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.113 -1.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.435 ' CE1' HG23 ' A' ' 114' ' ' ILE . 39.8 t-80 -147.01 134.51 20.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.675 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.543 HG23 HD21 ' A' ' 132' ' ' LEU . 4.9 mp -129.63 145.08 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.449 177.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 27.7 pt -133.42 163.28 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 172.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.473 HD22 ' HD2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -123.35 118.13 26.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.884 ' HB ' HG23 ' A' ' 32' ' ' VAL . 76.6 t -108.84 138.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.99 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 116' ' ' VAL . 46.7 m-20 -62.62 160.73 32.81 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.576 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.0 Cg_exo -59.91 -15.34 32.25 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.555 2.17 . . . . 0.0 111.726 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -83.18 -29.66 28.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.843 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.56 32.79 3.29 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.595 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.646 ' HZ3' ' HB2' ' A' ' 121' ' ' LYS . 10.1 mtmp? -111.92 150.87 29.88 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.684 -0.303 . . . . 0.0 110.473 176.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.38 96.36 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.565 HG12 ' HE2' ' A' ' 31' ' ' TYR . 14.1 p -83.45 -29.21 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.128 0.49 . . . . 0.0 110.572 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.96 149.21 27.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.993 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 13.0 ptmm? -151.23 163.36 39.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.558 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 23.7 mm-40 76.36 4.44 3.63 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.233 0.958 . . . . 0.0 112.026 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.43 ' O ' ' HD3' ' A' ' 128' ' ' ARG . 43.5 mt -59.7 136.11 57.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 127' ' ' LEU . 23.5 mmt-85 -133.78 173.19 11.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.932 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 45.09 -135.4 7.18 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 124.1 0.875 . . . . 0.0 114.127 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.34 -13.95 59.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.676 0.274 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.7 -27.4 67.86 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 136' ' ' VAL . 79.7 mt -47.66 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 172.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -49.91 75.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.623 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 85.1 m-20 -65.49 -26.49 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.506 -174.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.61 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 16.9 m -77.29 -33.3 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 132' ' ' LEU . 24.4 t -63.33 -42.97 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.807 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.549 ' HG2' ' CZ ' ' A' ' 58' ' ' PHE . 58.3 mm-40 -67.22 -41.06 86.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.034 0.445 . . . . 0.0 110.554 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 22.0 ttpt -56.45 -56.48 20.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.143 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.29 -61.08 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.313 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -169.761 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . 0.457 ' HB2' ' OG ' ' A' ' 7' ' ' SER . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -74.93 109.26 8.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.88 -6.2 20.06 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.97 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 4' ' ' ALA . 50.0 m -76.86 138.7 39.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.706 0.288 . . . . 0.0 110.536 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.0 p -73.96 138.82 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . . . -92.55 150.83 40.51 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.353 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.53 163.18 11.07 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.328 2.685 . . . . 0.0 112.267 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.66 102.46 13.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.853 0.359 . . . . 0.0 111.718 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.617 HD11 ' CE1' ' A' ' 105' ' ' TYR . 50.6 mm -69.78 138.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.572 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.7 t -142.97 137.56 29.46 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.4 172.67 36.08 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.584 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.431 HD11 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -85.89 118.05 31.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -176.99 3.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.177 0.513 . . . . 0.0 111.198 -173.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.93 -29.45 63.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.683 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 29.9 mttp -85.99 -43.85 12.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.65 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.29 15.36 1.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.409 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.6 m-80 -96.51 154.19 17.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -83.96 93.57 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 0.0 110.333 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.17 138.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.753 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -116.68 163.41 16.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.224 0.535 . . . . 0.0 111.407 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . 62.1 tp -63.47 -23.93 67.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.886 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.533 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.4 t30 -64.19 -28.39 69.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.11 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -77.06 -4.58 45.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.1 2.51 16.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.34 0.59 . . . . 0.0 109.42 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.533 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 41.2 mtpt -71.49 111.71 7.02 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.738 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.91 -22.41 2.47 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -115.05 170.51 8.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.619 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.09 117.23 21.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 20.8 t -99.0 116.93 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -90.86 104.1 16.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.566 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 47.9 t -98.67 108.85 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.937 0.399 . . . . 0.0 110.92 -174.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.5 115.83 29.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.29 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.2 115.66 26.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.686 ' HE3' ' HG ' ' A' ' 44' ' ' CYS . 3.1 p-90 -155.7 -177.29 6.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.362 0.601 . . . . 0.0 111.452 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 41' ' ' CYS . 17.9 p90 -157.19 152.78 26.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.853 171.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 77' ' ' TRP . . . -58.19 -45.12 88.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 111.838 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.828 ' HA3' HH12 ' A' ' 72' ' ' ARG . . . -82.76 45.79 3.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.401 -177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . 0.697 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 46.0 t -132.43 136.19 46.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.736 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 p -88.43 -15.09 36.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 39.9 m95 -85.92 -52.53 5.67 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.781 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 12.8 p -63.36 -24.66 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.26 0.552 . . . . 0.0 110.634 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.426 ' NH2' ' HB2' ' A' ' 83' ' ' GLU . 4.8 tpt180 -72.02 -14.39 61.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.888 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.736 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.2 mptm? -79.99 -40.08 28.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.882 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' ' HG3' ' A' ' 111' ' ' PRO . 25.7 mp0 -80.33 -9.58 59.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.655 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 38.3 m -50.74 -50.22 74.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 51.9 Cg_exo -55.4 -42.52 67.39 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.052 1.835 . . . . 0.0 112.617 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.08 -36.79 80.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 47' ' ' GLU . 96.0 mt -64.27 -41.69 96.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.513 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.84 -44.56 96.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.165 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HZ3' ' CG ' ' A' ' 130' ' ' ASP . 84.2 tttt -55.96 -48.88 74.97 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.393 174.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.403 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 33.9 m -62.55 -52.06 64.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.253 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.711 ' HB2' HD11 ' A' ' 65' ' ' ILE . 88.6 t80 -58.59 -43.4 89.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.68 0.276 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -61.79 -39.71 92.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.891 0.377 . . . . 0.0 111.293 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.63 -20.42 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.416 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 77.0 m-85 -121.94 9.12 9.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 17.5 pttm -64.23 -41.14 97.14 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.606 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -24.79 41.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.113 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 92.6 mttt -76.76 -172.11 2.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.169 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 49.64 3.27 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 83.5 t80 -143.62 146.49 33.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.8 m -156.86 136.96 12.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.711 HD11 ' HB2' ' A' ' 55' ' ' TYR . 43.5 mt -89.32 133.46 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.909 0.385 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.76 101.97 9.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.177 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.13 115.61 4.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.444 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 93' ' ' LEU . 44.2 t -98.39 111.34 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 38.5 t -118.72 139.5 51.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.355 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -134.77 35.58 3.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.428 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.584 ' OD1' ' HD2' ' A' ' 72' ' ' ARG . 4.2 t70 -65.8 165.63 12.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.777 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.828 HH12 ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.58 -25.24 61.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.836 -175.152 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 7.2 tpt180 -141.2 131.14 24.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.585 -173.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.532 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 22.2 tt0 -69.83 -32.83 71.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 0.0 110.002 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.498 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 3.5 mp0 -57.66 -42.46 83.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.814 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 31.5 t70 -73.07 -39.86 65.51 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.518 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 27.6 t90 -52.64 -52.12 57.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.654 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -62.46 -44.08 97.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.792 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 18.3 tttm -57.4 -45.73 84.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.85 -45.52 82.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.572 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.0 -34.86 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.885 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.53 -30.01 70.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.0 110.208 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . 67.7 mt-10 -75.89 -60.5 2.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.066 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -83.77 -18.91 36.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.81 -169.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 72.88 28.12 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.592 0.557 . . . . 0.0 110.622 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -67.01 81.06 0.12 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.936 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -96.39 88.99 4.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.15 178.29 10.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.022 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.66 102.72 2.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -173.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -119.85 155.06 33.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.321 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.66 143.74 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.501 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.43 112.31 24.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.467 ' CD1' HG13 ' A' ' 68' ' ' VAL . 8.0 mp -71.83 157.35 38.05 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.307 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -89.88 178.93 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.527 0.68 . . . . 0.0 111.08 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -77.38 -15.03 59.58 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.322 -178.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -83.98 -55.5 4.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.622 -175.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 101' ' ' VAL . 4.6 p30 -79.75 -30.7 40.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.556 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -49.05 -32.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mmtt -53.76 -63.5 1.13 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.711 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -55.67 -55.74 28.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.442 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 93' ' ' LEU . 61.5 t -46.43 -55.85 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.915 0.76 . . . . 0.0 112.129 -176.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.814 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 25.8 mt -62.07 -34.84 77.03 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.643 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.21 -63.04 1.46 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.098 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 106' ' ' CYS . 60.8 p -53.4 -45.28 69.25 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 124.798 1.311 . . . . 0.0 113.27 -164.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.617 ' CE1' HD11 ' A' ' 12' ' ' ILE . 85.0 m-85 -75.75 13.15 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.089 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.445 ' H ' ' C ' ' A' ' 104' ' ' SER . 34.7 m 62.66 57.71 1.74 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.139 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.814 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 2.1 mp -85.43 110.88 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.825 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.16 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.956 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.53 178.48 34.73 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.914 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.6 151.96 79.59 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 43' ' ' TRP . 86.1 Cg_endo -77.34 151.52 92.97 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.32 0.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.59 113.61 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.514 HD13 HH21 ' A' ' 128' ' ' ARG . 86.8 mt -117.74 139.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.4 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.566 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 44.0 pt -134.9 145.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.92 0.39 . . . . 0.0 111.148 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.38 110.08 22.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 88.7 t -102.42 136.94 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.059 -175.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.77 169.85 19.06 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -55.18 -29.14 64.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.802 2.334 . . . . 0.0 113.988 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.63 -4.25 55.65 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.33 30.15 22.97 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.609 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 30.0 mttm -108.96 145.58 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.837 0.351 . . . . 0.0 110.522 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.8 mt -80.17 105.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.16 -48.49 21.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.492 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.01 169.42 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.184 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.6 pttp -159.7 172.59 17.45 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.05 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 2.0 mm-40 64.94 23.31 12.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.652 1.181 . . . . 0.0 111.318 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 132' ' ' LEU . 83.9 mt -61.21 148.33 41.27 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.822 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.514 HH21 HD13 ' A' ' 113' ' ' ILE . 2.9 mmp_? -125.22 151.48 45.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -171.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 40.05 -126.19 2.54 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 124.175 0.922 . . . . 0.0 114.785 170.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.469 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -77.46 -10.04 59.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.674 -177.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.856 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 24.8 t70 -66.39 -33.46 75.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.577 ' O ' HG21 ' A' ' 136' ' ' VAL . 53.5 mt -48.92 -52.95 21.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 170.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.44 -59.06 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.555 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.856 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.6 p30 -66.94 -31.75 72.54 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.314 -172.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.603 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 19.1 m -70.66 -37.35 73.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.36 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 132' ' ' LEU . 81.3 t -61.16 -49.33 85.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.338 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.44 -50.39 72.98 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 15.7 ttpt -48.53 -37.44 17.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.517 0.727 . . . . 0.0 111.734 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -87.96 -48.5 7.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -169.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . 0.97 HG22 ' HA ' ' A' ' 123' ' ' VAL . 24.9 m -56.72 130.23 44.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.159 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.97 -8.01 36.01 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.066 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -78.47 138.2 38.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.56 126.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.54 76.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.549 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 162.15 25.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.051 2.501 . . . . 0.0 111.839 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.97 100.47 11.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.783 0.325 . . . . 0.0 111.712 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.615 HG12 HG11 ' A' ' 101' ' ' VAL . 56.4 mt -72.19 132.47 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.176 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -128.53 97.87 4.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 175.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.89 165.17 12.07 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.543 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 66.2 mt -98.93 122.93 51.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.613 0.244 . . . . 0.0 110.46 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.504 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 31.5 p30 -74.19 -173.84 1.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.971 0.415 . . . . 0.0 111.547 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.84 -16.92 63.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.072 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 1.1 mtpt -87.98 -35.59 17.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.98 21.31 3.52 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.47 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.6 OUTLIER -98.45 142.59 29.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -81.78 102.25 10.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.806 0.336 . . . . 0.0 110.232 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.89 142.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.074 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -103.94 -177.96 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.975 0.416 . . . . 0.0 110.545 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -80.39 -21.56 42.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.587 175.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 50.5 m-80 -68.31 -24.79 64.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.46 -25.61 68.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.11 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -112.4 13.34 20.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.086 0.469 . . . . 0.0 110.317 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 22.6 tttm -68.99 171.35 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.445 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.98 64.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.4 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -141.16 176.17 9.05 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.57 ' HB3' HD11 ' A' ' 115' ' ' LEU . 54.1 m-85 -78.77 109.68 13.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.532 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 47.2 t -96.78 123.32 49.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 19.5 tp -90.54 116.95 28.84 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.499 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 16.7 t -105.05 102.99 14.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.448 ' OD1' HG21 ' A' ' 65' ' ' ILE . 6.5 m-20 -98.4 110.15 22.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.762 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HE2' ' A' ' 110' ' ' PHE . 53.2 m-85 -92.74 116.8 29.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.783 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 12.9 p-90 -154.65 -179.18 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 45.0 p90 -170.01 157.1 6.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.528 168.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.99 -16.99 62.86 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.12 -21.32 69.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.582 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 66.7 m -92.2 131.32 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 0.0 110.274 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -88.39 -28.26 21.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.694 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -67.75 -34.57 77.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.135 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.56 ' HG ' ' HB3' ' A' ' 111' ' ' PRO . 80.0 m -51.95 -38.63 57.22 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.67 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.489 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -64.44 -28.33 69.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.774 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -84.96 -11.34 55.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.181 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -98.04 -21.78 16.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.418 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 84' ' ' ASP . 51.4 m -49.93 -48.23 78.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.2 Cg_endo -48.61 -45.88 25.97 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.205 1.937 . . . . 0.0 112.36 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.94 -37.63 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.238 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -48.55 75.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 88' ' ' TRP . 63.0 tp -63.63 -42.67 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.965 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.678 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 47.4 tttm -60.0 -43.72 95.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.431 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 27.1 m -53.11 -46.1 68.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.205 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.55 ' HB2' HD13 ' A' ' 65' ' ' ILE . 88.4 t80 -56.83 -61.99 2.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.678 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.9 p-10 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.494 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.22 -20.06 29.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HZ ' ' HA ' ' A' ' 137' ' ' GLU . 75.1 m-85 -115.65 -15.2 11.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptmm? -56.28 -23.13 34.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.005 0.431 . . . . 0.0 111.646 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.499 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 3.5 m-20 -106.87 17.25 23.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 89.5 mttt -121.64 14.73 11.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.137 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.99 44.18 9.25 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.515 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.722 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 55.3 t80 -139.0 135.23 34.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -135.74 145.65 46.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.96 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.55 HD13 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -103.72 126.75 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.971 0.415 . . . . 0.0 110.619 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -112.94 96.52 5.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.682 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -75.01 114.54 4.36 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.389 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.975 HG11 HD21 ' A' ' 93' ' ' LEU . 50.0 t -98.69 111.11 27.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 14.7 m -116.7 125.73 52.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.602 ' HB ' HD13 ' A' ' 93' ' ' LEU . 10.1 t -113.5 52.13 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.518 1.152 . . . . 0.0 108.604 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 t70 -70.2 178.96 2.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.128 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -104.3 -21.97 13.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.921 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 51.9 mtt-85 -141.63 150.46 42.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.8 tt0 -75.62 -37.19 59.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.526 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.1 mp0 -62.01 -41.36 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.578 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -74.44 -35.63 63.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.001 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -60.73 -51.96 67.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.434 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.2 mptm? -59.13 -37.17 76.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 27.1 ttpt -59.22 -50.02 75.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.768 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.89 83.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.182 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.44 -38.82 77.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.378 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.75 -55.36 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.892 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.5 mt-10 -53.07 -49.0 67.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.545 . . . . 0.0 111.639 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' HG21 ' A' ' 48' ' ' THR . 6.4 m-20 -85.45 -16.43 39.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.453 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.44 ' HD2' ' OH ' ' A' ' 87' ' ' TYR . 46.9 mmtm 61.74 40.54 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.653 0.739 . . . . 0.0 110.092 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -80.63 86.46 5.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.183 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.44 ' OH ' ' HD2' ' A' ' 85' ' ' LYS . 57.4 m-85 -87.66 78.94 8.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.276 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.408 ' HZ3' ' HA ' ' A' ' 52' ' ' LEU . 23.6 p90 -161.42 175.16 12.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 174.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.47 110.47 9.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.974 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.682 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 48.6 mt-30 -123.39 145.97 48.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.3 m -132.65 149.97 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' SER . 20.7 tp -94.2 132.2 38.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.975 HD21 HG11 ' A' ' 68' ' ' VAL . 72.3 mt -73.45 149.94 42.01 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.611 ' O ' HG21 ' A' ' 98' ' ' VAL . 49.8 mt-30 -80.72 171.18 15.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.412 175.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.15 -39.65 90.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.583 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 13.5 m-20 -87.21 -33.62 19.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.181 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.555 ' OD2' HD22 ' A' ' 93' ' ' LEU . 16.1 t70 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.821 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 94' ' ' GLN . 78.8 t -66.86 -65.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 110.124 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 20.5 pttp -62.55 -62.62 1.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -170.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . 0.407 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 9.0 m-20 -67.94 -36.63 80.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.738 0.304 . . . . 0.0 111.622 -169.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.615 HG11 HG12 ' A' ' 12' ' ' ILE . 59.3 t -79.27 -50.26 18.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.943 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 87.9 mt -56.23 -47.81 77.71 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.89 -47.33 80.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.4 m -54.81 -33.04 61.06 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.99 0.806 . . . . 0.0 112.446 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -79.24 7.75 7.15 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.14 -0.35 . . . . 0.0 111.436 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.5 t 66.57 54.13 0.89 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -171.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 73.8 mt -133.3 93.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.6 -1.5 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.861 0.839 . . . . 0.0 109.392 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.77 165.31 28.83 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.176 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.509 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 95.4 m-85 -127.19 160.7 58.39 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.654 0.227 . . . . 0.0 110.707 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.56 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 5.5 Cg_exo -81.89 172.08 53.64 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.948 -1.271 . . . . 0.0 112.721 -0.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.676 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -155.39 122.53 5.48 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.622 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.1 131.44 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 125' ' ' LYS . 25.9 pt -130.5 158.32 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.57 HD11 ' HB3' ' A' ' 31' ' ' TYR . 58.9 tp -124.51 127.59 47.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.142 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 5.5 m -119.1 145.13 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -59.78 163.3 7.54 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.131 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.32 -22.26 64.54 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -70.19 -34.0 72.42 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.784 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.23 32.68 3.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.05 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.72 ' HZ1' ' HB2' ' A' ' 121' ' ' LYS . 10.5 mtmp? -117.42 147.86 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.632 HG23 ' HD2' ' A' ' 125' ' ' LYS . 34.9 mt -86.19 119.57 34.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.594 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.97 ' HA ' HG22 ' A' ' 5' ' ' THR . 13.2 m -101.75 -35.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.014 0.435 . . . . 0.0 110.832 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.8 140.74 40.72 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.632 ' HD2' HG23 ' A' ' 122' ' ' ILE . 9.4 ptmm? -156.81 153.43 28.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.232 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.676 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 32.4 mt-10 70.0 25.47 4.82 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.205 0.941 . . . . 0.0 110.968 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.9 mt -67.91 159.12 31.17 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.621 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.1 mmp_? -128.9 134.53 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.641 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 43.12 -114.58 0.86 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 168.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 134' ' ' ASN . 4.2 m-20 -63.12 -35.43 80.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.867 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 7.7 t70 -63.63 -39.74 95.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.822 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.0 pp -57.2 -44.47 83.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.52 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -70.64 -46.47 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 11.2 t-20 -50.2 -57.21 8.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.8 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.563 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 19.8 m -72.74 -34.38 67.0 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.998 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.401 HG23 HD23 ' A' ' 115' ' ' LEU . 38.2 t -63.21 -42.32 96.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.325 174.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.503 ' HA ' ' HZ ' ' A' ' 58' ' ' PHE . 3.2 tp10 -61.21 -53.02 62.17 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.563 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 9.2 mtmp? -57.5 -27.58 62.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.733 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -83.15 -61.09 1.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.408 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.466 0.331 0 O-C-N 123.441 0.463 . . . . 0.0 111.543 -173.16 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.61 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -146.34 140.12 26.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.663 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.39 4.52 62.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.477 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -81.06 143.45 32.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 121' ' ' LYS . 31.6 t -69.64 133.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.469 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.58 146.63 31.66 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 -175.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.04 162.31 26.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.888 2.392 . . . . 0.0 111.975 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.39 113.58 25.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.832 0.349 . . . . 0.0 111.547 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.95 137.02 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -134.72 104.88 6.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.86 172.18 18.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.139 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 15' ' ' ILE . 3.8 mp -98.01 119.18 45.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -173.56 3.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 -171.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 81' ' ' ILE . 96.6 mt -62.45 -33.49 74.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.669 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -74.99 -30.68 61.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.608 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.54 19.36 7.93 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.523 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.6 OUTLIER -100.35 144.25 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -87.04 92.46 9.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.66 147.46 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.527 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.42 168.0 9.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 -174.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.72 -35.37 74.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.643 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.551 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 3.2 p-10 -66.81 -17.55 64.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.78 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -74.25 -24.15 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.126 0.489 . . . . 0.0 110.501 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -105.35 8.51 33.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 110.25 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.8 tttp -62.46 160.3 13.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.074 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.28 10.17 57.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.271 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -141.43 177.6 8.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' A' ' 115' ' ' LEU . 97.3 m-85 -85.17 107.03 17.04 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 64' ' ' THR . 42.0 t -100.43 109.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 -174.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 28.1 tp -86.77 118.18 26.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -104.89 115.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.699 0.285 . . . . 0.0 110.835 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -101.79 111.04 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.262 0.553 . . . . 0.0 111.413 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -93.77 118.07 30.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.422 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -151.16 176.93 10.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -170.3 151.39 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.384 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.11 1.85 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.403 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.65 54.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.689 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.0 t -103.48 116.31 32.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 9.5 m -67.97 -26.53 65.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -73.22 -36.2 66.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.92 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.0 m -59.99 -35.58 75.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HE ' ' CG ' ' A' ' 84' ' ' ASP . 26.4 mmm-85 -67.39 -22.21 65.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.546 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 42' ' ' SER . 4.9 mptp? -85.88 -11.45 53.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.327 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 43.8 mt-10 -105.65 -6.87 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.58 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -54.05 -47.09 98.2 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.953 175.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.9 Cg_endo -51.68 -36.81 62.67 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.624 2.216 . . . . 0.0 113.036 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 41.0 m-85 -67.55 -39.62 84.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.031 0.443 . . . . 0.0 110.069 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.58 HD21 HD11 ' A' ' 113' ' ' ILE . 88.5 mt -63.7 -43.12 97.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.692 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -64.15 -43.41 95.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.463 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HZ2' ' CG ' ' A' ' 130' ' ' ASP . 42.8 tttm -54.56 -44.85 73.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.341 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HD1' ' A' ' 58' ' ' PHE . 33.2 m -63.76 -48.7 75.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.679 ' HB2' HD12 ' A' ' 65' ' ' ILE . 53.2 t80 -60.07 -36.04 76.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.843 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -73.34 -33.49 65.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.11 -18.92 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HD1' ' O ' ' A' ' 54' ' ' THR . 84.1 m-85 -111.54 10.98 21.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -75.19 -3.94 35.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 0.0 111.116 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -98.34 -2.33 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.006 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -122.99 174.43 7.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.469 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.05 61.95 2.57 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 74.4 t80 -133.68 130.42 38.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.787 0.327 . . . . 0.0 110.334 -176.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 12.3 p -135.73 137.82 42.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.283 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 55' ' ' TYR . 36.8 mt -97.34 124.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 80.4 t80 -113.25 104.79 12.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.876 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.936 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -86.24 142.12 18.72 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.566 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.7 111.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 15.0 m -115.07 155.17 27.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.008 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -143.96 40.12 1.37 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.935 0.874 . . . . 0.0 108.658 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 4.5 m-20 -71.37 175.78 5.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.399 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -70.21 -45.57 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.409 -172.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.68 150.62 36.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 28.4 tt0 -62.28 -41.81 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 110.459 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.33 -44.21 95.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.254 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.64 -39.78 84.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.152 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -58.48 -54.13 50.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.626 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -57.22 -40.55 77.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 2.7 ttpm? -60.51 -49.44 77.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.363 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -58.15 -40.54 81.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.136 0.493 . . . . 0.0 111.1 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 86' ' ' SER . 80.3 mt -61.67 -38.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.887 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -71.77 -46.41 58.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 46.5 mt-10 -54.69 -54.33 43.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.143 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HB3' HG23 ' A' ' 48' ' ' THR . 5.5 m-20 -85.56 0.18 53.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.068 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 70.0 mmtt 58.4 37.82 25.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.574 0.702 . . . . 0.0 110.706 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.485 ' O ' HG22 ' A' ' 81' ' ' ILE . 36.4 t -82.59 68.15 8.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.708 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -87.1 76.29 9.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.963 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -148.67 -174.57 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.16 90.94 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.504 -171.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.936 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 91.6 mt-30 -108.0 138.76 43.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.912 0.386 . . . . 0.0 111.017 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.09 146.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.95 126.41 37.02 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 98' ' ' VAL . 47.5 mt -67.92 145.7 54.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 0.0 111.383 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.5 mt-30 -67.76 156.0 38.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.433 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -60.92 -44.89 96.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.008 0.433 . . . . 0.0 111.614 -170.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.29 -19.49 31.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.4 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.421 ' CB ' ' HB2' ' A' ' 94' ' ' GLN . 37.0 t70 -80.87 -27.8 36.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.976 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 94' ' ' GLN . 58.3 t -47.91 -51.35 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -47.73 80.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.559 -176.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -67.78 -50.2 58.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.03 -173.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.97 -56.05 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.315 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.533 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.0 mt -57.49 -46.0 84.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.75 -60.71 2.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 m -51.31 -38.58 53.74 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 124.716 1.26 . . . . 0.0 113.292 -170.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -82.07 17.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.463 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.423 ' HB2' ' HZ1' ' A' ' 125' ' ' LYS . 63.8 m 62.88 42.19 7.97 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 123.378 0.671 . . . . 0.0 110.077 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 63.4 mt -100.16 89.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.058 -176.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.5 -18.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.23 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.68 152.48 24.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.006 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -108.75 156.12 39.47 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 95.2 Cg_endo -78.29 177.01 40.62 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 123.238 -1.568 . . . . 0.0 112.779 0.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.06 117.62 4.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.58 HD11 HD21 ' A' ' 51' ' ' LEU . 58.6 mt -127.98 138.43 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.466 ' HB ' HG21 ' A' ' 122' ' ' ILE . 49.2 pt -134.3 158.63 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.013 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 136' ' ' VAL . 60.9 tp -118.59 115.46 24.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.27 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.31 129.98 47.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 8.2 p30 -78.53 166.99 38.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.203 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 6.4 Cg_endo -50.5 -35.88 47.25 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.965 2.443 . . . . 0.0 113.196 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 0.497 ' CD ' ' HZ2' ' A' ' 121' ' ' LYS . 45.3 mt-10 -63.01 -37.4 87.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.62 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.46 3.89 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.55 ' HG2' HG22 ' A' ' 8' ' ' VAL . 28.4 mtmm -111.77 151.76 28.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.815 0.341 . . . . 0.0 110.259 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' A' ' 114' ' ' ILE . 18.0 mt -87.64 92.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.315 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -73.12 -26.98 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 0.0 110.748 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -133.92 119.03 18.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.555 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.566 ' HG2' ' CD ' ' A' ' 126' ' ' GLU . 60.8 tttm -127.46 157.72 39.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.557 -174.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.566 ' CD ' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER 50.24 48.69 21.81 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.999 0.812 . . . . 0.0 110.989 -176.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 132' ' ' LEU . 83.7 mt -72.49 157.37 37.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 13.8 tpt180 -128.7 142.38 51.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.464 -173.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 35.65 -132.45 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . 0.4 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 11.7 t70 -79.02 -10.85 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.562 . . . . 0.0 110.111 176.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.1 m-20 -55.1 -33.47 62.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.266 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 4.3 pp -64.7 -41.42 96.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.912 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.431 ' N ' HD11 ' A' ' 132' ' ' LEU . 32.1 t80 -60.79 -52.14 66.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.712 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -60.07 -36.18 76.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.224 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 85.8 m -71.08 -46.55 61.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.146 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.737 HG22 HD22 ' A' ' 115' ' ' LEU . 96.1 t -67.49 -45.82 84.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.113 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -58.53 -45.72 88.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.409 0.623 . . . . 0.0 109.606 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -56.94 -54.4 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.673 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -65.02 -56.76 11.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.745 -170.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.33 -174.795 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 p -110.17 112.61 24.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.49 -4.36 40.25 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 p -71.96 128.23 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.13 135.66 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.525 ' HB2' ' HH ' ' A' ' 105' ' ' TYR . . . -92.36 144.04 28.3 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.686 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.27 158.44 12.18 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.232 2.622 . . . . 0.0 112.602 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.1 95.33 10.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.184 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.558 HD13 ' CE1' ' A' ' 105' ' ' TYR . 21.5 mm -59.12 131.84 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.462 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -126.96 88.09 2.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 161.58 13.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.976 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.32 125.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.801 0.334 . . . . 0.0 110.372 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -169.5 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.337 0.589 . . . . 0.0 111.681 -173.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.93 -30.09 71.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.931 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.65 -36.24 62.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 0.0 110.28 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.99 16.01 8.17 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.167 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.572 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.64 140.27 32.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -77.48 97.33 4.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 110.249 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.91 147.48 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.796 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.7 m -108.86 156.77 19.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.152 0.501 . . . . 0.0 111.367 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.59 -27.82 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.525 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -25.42 67.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.6 -9.59 58.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.409 0.623 . . . . 0.0 110.528 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.35 4.56 17.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.195 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -62.15 170.28 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.198 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.13 83.4 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.794 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 35.1 mttp -141.01 156.87 45.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -72.63 115.6 12.1 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 57.6 t -103.12 107.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.328 -172.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HB3' HG12 ' A' ' 65' ' ' ILE . 38.9 tp -86.24 106.49 17.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.85 125.86 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.013 0.435 . . . . 0.0 110.891 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.421 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 12.9 t0 -112.06 96.23 5.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.426 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 68' ' ' VAL . 96.0 m-85 -82.07 114.94 20.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 69' ' ' SER . 22.3 p-90 -153.55 175.45 13.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.062 0.934 . . . . 0.0 112.604 -172.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -167.76 162.84 14.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.691 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.95 -19.31 65.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.56 64.65 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.246 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.4 p -95.89 97.99 10.07 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.65 0.738 . . . . 0.0 109.943 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -64.77 -36.18 83.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.981 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -56.27 -41.18 75.44 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -28.56 69.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.007 0.432 . . . . 0.0 110.252 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -81.26 -14.14 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.411 0.624 . . . . 0.0 110.083 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -79.69 -21.86 44.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.212 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -90.31 -7.11 54.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.879 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 98.6 m -48.58 -48.45 68.36 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.7 Cg_endo -49.36 -44.79 33.0 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.33 2.02 . . . . 0.0 112.633 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -73.82 -40.05 63.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.829 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.8 mt -57.21 -51.94 67.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.81 -43.04 94.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -62.63 -44.61 95.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.035 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 59.8 m -59.7 -46.17 89.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.6 ' HB2' HD12 ' A' ' 65' ' ' ILE . 37.5 t80 -65.69 -36.02 82.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.03 -43.64 98.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.091 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.01 -27.12 30.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 54' ' ' THR . 92.1 m-85 -114.57 10.83 16.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 20.1 pttp -64.76 -29.33 70.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 111.31 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.401 ' CG ' ' HZ3' ' A' ' 59' ' ' LYS . 7.1 m-20 -92.22 10.51 29.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.193 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -121.36 -174.16 2.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.37 57.88 4.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.954 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -144.0 142.53 30.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.784 0.326 . . . . 0.0 110.179 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -151.45 150.29 30.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -102.34 125.11 56.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.7 ' HH ' HG21 ' A' ' 91' ' ' VAL . 56.1 t80 -105.66 98.08 7.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.844 -177.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 90' ' ' GLN . . . -79.87 137.42 18.65 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 36' ' ' PHE . 1.5 p -138.45 123.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.107 0.48 . . . . 0.0 110.591 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.5 t -128.87 163.87 24.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.222 0.534 . . . . 0.0 111.439 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.786 ' HB ' HD11 ' A' ' 93' ' ' LEU . 4.3 t -147.75 44.16 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.726 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 2.9 t70 -71.01 -178.93 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.399 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 13.1 ptt180 -67.1 -29.59 69.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.741 -173.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.497 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 56.4 mtt-85 -143.4 158.28 43.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.743 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . 0.768 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 32.3 tt0 -75.72 -38.79 58.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . 0.497 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.3 mp0 -60.72 -44.82 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.794 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 1.9 m-20 -62.52 -42.39 99.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.555 ' CE3' ' HD2' ' A' ' 78' ' ' LYS . 32.6 t90 -56.94 -52.74 64.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.917 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.768 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 3.7 mptp? -54.15 -50.63 66.53 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.29 0.566 . . . . 0.0 110.593 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.46 -44.62 95.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.173 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.34 84.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 65.6 mt -60.39 -43.66 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.512 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -68.6 -46.46 69.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.008 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -59.73 -45.01 93.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.173 0.511 . . . . 0.0 111.138 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.29 -15.71 51.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.247 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 65.02 33.32 9.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.835 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.9 m -92.34 85.59 5.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.77 84.25 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.42 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -153.02 -173.3 4.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -69.52 96.6 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 32.6 mt-30 -123.18 143.63 49.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.143 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.7 HG21 ' HH ' ' A' ' 66' ' ' TYR . 35.7 m -130.3 158.3 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 111.301 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.2 tp -103.55 132.33 49.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.429 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.786 HD11 ' HB ' ' A' ' 70' ' ' THR . 88.7 mt -61.94 140.51 58.31 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.256 0.348 . . . . 0.0 111.169 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.679 ' O ' HG21 ' A' ' 98' ' ' VAL . 42.9 mt-30 -90.06 169.3 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -49.24 -55.07 13.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.237 0.541 . . . . 0.0 111.744 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -82.19 -36.57 27.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.674 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -56.77 -36.92 70.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.629 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 94' ' ' GLN . 54.2 t -52.06 -37.31 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.776 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.9 tptt -62.76 -58.8 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.384 -175.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.07 -49.59 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.592 0.234 . . . . 0.0 111.157 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.401 HG21 HD22 ' A' ' 93' ' ' LEU . 68.8 t -53.7 -59.69 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.714 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.757 ' HA ' HD13 ' A' ' 107' ' ' ILE . 35.1 mt -65.0 -30.41 71.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.988 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.26 -63.92 1.3 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.582 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 106' ' ' CYS . 62.3 m -65.39 -23.44 66.96 Favored 'General case' 0 C--N 1.338 0.077 0 O-C-N 124.213 0.946 . . . . 0.0 113.423 -164.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.558 ' CE1' HD13 ' A' ' 12' ' ' ILE . 54.5 m-85 -81.74 15.38 2.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.302 173.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.413 ' H ' ' C ' ' A' ' 104' ' ' SER . 46.9 t 55.22 44.46 27.59 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.325 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.757 HD13 ' HA ' ' A' ' 102' ' ' LEU . 61.4 mt -86.22 93.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.068 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.6 m -106.28 19.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.261 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.98 168.89 26.72 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.836 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 87.0 m-85 -122.94 159.03 55.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.3 Cg_endo -86.52 171.55 38.7 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.359 -0.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -136.93 104.26 5.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.9 177.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.93 114.92 47.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 38.1 pt -124.93 159.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.06 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.527 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 4.0 tt -116.99 116.3 27.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 95.7 t -102.66 142.99 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.475 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -77.36 165.56 50.81 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.4 Cg_endo -49.0 -29.84 16.51 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.313 2.675 . . . . 0.0 114.09 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . 1.056 ' HB3' ' HZ2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -91.75 2.06 56.75 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 86.75 26.34 32.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.436 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 1.056 ' HZ2' ' HB3' ' A' ' 119' ' ' GLU . 28.4 mttp -107.66 142.36 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.043 0.422 . . . . 0.0 110.465 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.7 mt -76.29 109.73 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.939 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.37 -36.21 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.066 0.46 . . . . 0.0 110.3 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 115' ' ' LEU . . . -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 21.4 pttm -163.08 151.79 14.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.283 -0.167 . . . . 0.0 111.003 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 60.28 48.49 8.01 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.885 0.74 . . . . 0.0 111.09 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.66 156.94 21.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.939 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 129' ' ' GLY . 8.6 tpt180 -101.44 147.71 26.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.804 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -38.27 -58.31 1.66 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.37 -38.0 73.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.168 0.509 . . . . 0.0 110.102 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.8 t70 -83.27 -26.85 30.31 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.804 HD11 ' HA2' ' A' ' 129' ' ' GLY . 75.5 mt -46.26 -57.62 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.1 -47.9 80.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.98 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 94.0 m-20 -53.72 -53.36 53.15 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.236 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.657 ' HA ' ' CE ' ' A' ' 138' ' ' LYS . 4.8 m -62.24 -36.12 81.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 132' ' ' LEU . 50.8 t -69.21 -44.89 80.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.43 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.53 -29.83 69.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.652 0.739 . . . . 0.0 109.962 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.657 ' CE ' ' HA ' ' A' ' 135' ' ' THR . 26.9 ttpt -78.87 -54.2 6.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.966 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . 0.47 ' CD2' HG23 ' A' ' 135' ' ' THR . 61.1 m-85 -87.07 -48.79 7.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 80.3 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.792 0.33 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -152.81 154.1 34.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.12 -1.27 70.31 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -91.69 146.43 23.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.595 -0.302 . . . . 0.0 110.461 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.42 138.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.397 . . . . 0.0 110.095 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.81 149.95 40.67 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.738 -175.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 35.6 Cg_exo -62.9 163.53 21.86 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.522 2.815 . . . . 0.0 112.088 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.89 105.0 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.083 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.36 148.32 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.603 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 13.7 t -136.61 134.99 37.97 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.18 31.18 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.355 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -88.9 119.46 36.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -175.72 5.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.088 0.47 . . . . 0.0 111.127 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 90' ' ' GLN . 95.4 mt -65.07 -28.93 69.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.945 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.58 -28.99 28.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.44 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 25.22 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.251 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.27 148.17 25.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 p -76.82 94.35 3.86 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.04 130.67 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.536 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.4 m -102.58 161.85 13.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.51 -14.86 46.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.615 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 30.2 p-10 -67.28 -20.86 65.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.915 0.388 . . . . 0.0 111.2 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.13 -23.04 47.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.46 5.53 31.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -79.98 63.21 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.702 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.6 13.17 0.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.064 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -144.31 171.38 14.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 120.78 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.317 172.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 64' ' ' THR . 46.1 t -112.47 112.79 41.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.494 -171.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . 0.491 HD22 HG23 ' A' ' 113' ' ' ILE . 10.0 tt -90.58 119.32 30.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 51.5 t -103.77 121.32 55.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.801 0.334 . . . . 0.0 110.915 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.48 ' HB2' ' HA2' ' A' ' 67' ' ' GLY . 29.9 m-20 -84.98 136.75 33.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.418 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.26 114.55 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -158.18 173.36 16.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.691 0.758 . . . . 0.0 112.342 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -170.05 166.59 9.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.614 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB3' HH21 ' A' ' 45' ' ' ARG . . . -63.24 -20.73 65.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -51.47 24.97 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.148 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.4 p -71.45 101.9 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.454 0.645 . . . . 0.0 110.432 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.417 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 18.9 m -69.39 -5.45 23.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.081 -171.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . 0.491 ' HD1' ' HG3' ' A' ' 111' ' ' PRO . 72.4 t-105 -85.37 -29.31 24.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.952 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 75.8 m -57.81 -34.5 69.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 110.631 176.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.557 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 8.6 mmt85 -66.79 -18.38 65.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 110.388 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.7 mptt -85.09 -33.18 22.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.937 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.27 -20.27 37.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.418 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.554 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 46.5 m -48.61 -50.5 59.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.4 Cg_exo -49.65 -45.27 32.19 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.266 1.978 . . . . 0.0 112.843 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.93 -31.82 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.935 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.51 -47.95 81.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.275 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.49 -40.94 96.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.174 0.511 . . . . 0.0 109.965 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.67 -46.44 81.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.591 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.3 m -65.12 -49.29 70.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.275 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.601 ' HB2' HD11 ' A' ' 65' ' ' ILE . 85.1 t80 -57.63 -42.37 83.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 111.44 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -78.06 -35.47 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.468 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -85.37 -19.88 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.648 ' CZ ' HG13 ' A' ' 136' ' ' VAL . 44.6 m-85 -106.22 -4.95 19.61 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 16.9 pttp -67.39 167.15 13.11 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.446 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 1.9 m-20 73.94 -36.9 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.656 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 82.1 mttt -61.69 -41.12 97.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.374 0.607 . . . . 0.0 110.167 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.36 44.62 0.14 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 56.7 t80 -140.59 144.66 35.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -173.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 44.7 m -150.64 142.23 23.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 55' ' ' TYR . 32.6 mt -98.77 134.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 110.139 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -112.89 95.86 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.409 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 35' ' ' ASP . . . -76.96 103.3 1.77 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.397 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 53.7 t -99.05 117.21 43.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.265 0.555 . . . . 0.0 110.614 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 t -128.97 156.61 43.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.116 0.484 . . . . 0.0 110.763 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -136.76 48.76 2.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 10.8 t70 -65.29 -176.12 0.29 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.552 -171.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.521 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.7 mtm180 -54.15 -50.31 67.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.01 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . 0.617 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 55.3 mtp180 -145.65 175.04 10.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.766 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -75.14 -38.63 60.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.92 -42.27 99.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.328 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.617 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 3.4 m-20 -75.56 -28.22 58.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.43 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 21.1 t90 -64.68 -48.22 75.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.2 mptm? -58.9 -37.43 76.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.048 0.451 . . . . 0.0 110.002 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 36.1 ttmt -63.05 -45.68 91.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.932 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.35 74.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 110.943 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.09 -36.97 76.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.079 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 10.1 tp10 -63.0 -40.88 99.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 173.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.1 mt-10 -62.65 -59.7 4.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.265 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.557 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.2 m-20 -82.53 -16.99 46.6 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -172.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 62.99 35.16 13.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 111.12 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 p -81.7 86.17 6.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.951 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -90.4 86.18 6.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -155.42 -175.26 5.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.168 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.52 96.78 0.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.321 0.582 . . . . 0.0 111.446 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . 0.441 ' HB2' HD22 ' A' ' 17' ' ' LEU . 76.0 mm-40 -99.05 140.15 33.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.132 177.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.68 137.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.1 tp -92.85 125.94 37.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.436 HD23 ' OD2' ' A' ' 97' ' ' ASP . 65.9 mt -72.58 137.88 46.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.651 ' O ' HG23 ' A' ' 98' ' ' VAL . 24.8 mt-30 -67.07 147.05 53.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.27 -16.74 61.92 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.191 0.519 . . . . 0.0 110.759 -170.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.15 -33.87 22.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.432 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.436 ' OD2' HD23 ' A' ' 93' ' ' LEU . 7.1 t70 -72.27 -32.55 66.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 94' ' ' GLN . 75.3 t -50.09 -37.09 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.533 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -56.75 -63.76 1.1 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.786 0.803 . . . . 0.0 111.626 -172.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.05 -39.94 63.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.804 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.485 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 68.3 t -58.24 -50.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 19.3 mt -56.21 -62.06 1.97 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.981 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -50.76 70.97 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.532 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 t -57.63 -33.09 67.91 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.651 0.594 . . . . 0.0 112.365 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.485 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 51.2 m-85 -83.8 16.11 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.642 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 2.8 m 67.98 38.82 2.67 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.436 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 78.8 mt -119.94 110.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.116 -170.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.69 20.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.366 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.83 -172.4 40.6 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.658 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.44 156.17 69.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 117.181 0.49 . . . . 0.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.772 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 92.3 Cg_endo -86.36 167.6 47.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.784 -1.34 . . . . 0.0 113.237 -0.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.92 118.64 8.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . 0.575 HG21 HD22 ' A' ' 132' ' ' LEU . 4.1 mp -111.49 120.59 62.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 39.9 pt -122.08 158.1 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.561 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -122.86 117.41 25.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.926 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 117' ' ' ASP . 93.3 t -113.1 135.47 52.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.103 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.541 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 26.3 m-20 -66.96 163.89 40.04 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.749 174.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.85 -27.72 85.03 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.108 1.872 . . . . 0.0 111.404 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.44 -29.87 68.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.761 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 100.34 40.4 3.01 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.372 -175.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.662 ' HZ3' ' HB2' ' A' ' 121' ' ' LYS . 9.4 mtmp? -112.05 148.8 33.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.95 99.4 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.14 -33.74 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.228 0.537 . . . . 0.0 110.639 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.15 152.94 45.09 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.738 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 2.3 ptpt -166.83 172.86 9.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.783 0.325 . . . . 0.0 111.51 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.738 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 0.7 OUTLIER 59.67 28.88 18.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.242 178.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 132' ' ' LEU . 89.7 mt -78.52 154.2 30.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.48 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.33 169.56 8.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.079 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -46.6 -70.94 0.59 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.9 -32.84 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.375 0.607 . . . . 0.0 110.987 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.614 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 39.9 t0 -73.64 -46.16 48.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.582 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 113' ' ' ILE . 4.5 pp -60.04 -37.0 78.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.505 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.502 ' CE2' ' HE1' ' A' ' 58' ' ' PHE . 53.8 t80 -68.14 -55.27 12.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 5.9 p30 -67.42 -27.09 66.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.693 -174.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 43.3 m -83.58 -33.24 25.42 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.648 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.5 p -74.89 -38.77 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 121.77 -0.581 . . . . 0.0 109.963 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 4.0 tp10 -65.6 -32.86 74.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 24.1 ttmt -56.66 -43.65 80.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.796 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.24 -51.13 6.46 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -170.791 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -99.22 131.05 45.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.605 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.26 -1.45 60.62 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.061 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 p -74.93 138.79 42.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.07 128.42 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 130.5 55.32 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.12 154.85 59.76 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.788 2.325 . . . . 0.0 111.396 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.06 103.9 16.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.372 . . . . 0.0 111.61 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.8 mt -63.07 142.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.866 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.0 t -124.27 87.46 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.625 0.726 . . . . 0.0 110.582 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.56 161.65 15.18 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.0 123.48 45.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.609 0.242 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.487 ' HA ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -70.95 -175.66 1.18 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.399 0.619 . . . . 0.0 111.883 -172.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.25 -29.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.653 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -81.47 -50.7 9.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.71 23.6 0.31 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.52 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -108.81 137.47 46.69 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 p -79.99 114.29 18.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.738 0.304 . . . . 0.0 111.039 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.504 HG21 ' HH ' ' A' ' 66' ' ' TYR . 23.9 m -108.78 156.56 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.924 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 8.5 p -107.49 155.76 19.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.013 0.435 . . . . 0.0 110.733 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.409 HD13 HG11 ' A' ' 32' ' ' VAL . 49.4 tp -56.97 -31.62 65.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.867 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.641 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 9.9 t30 -71.17 -17.73 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.371 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -68.37 -29.41 68.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.32 -15.06 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.082 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LYS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 1.4 tmtp? -54.14 145.1 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.235 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.37 -0.35 40.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -133.97 172.59 12.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.481 ' CG ' HG23 ' A' ' 140' ' ' VAL . 94.8 m-85 -77.67 106.52 9.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 24' ' ' LEU . 43.9 t -102.61 108.52 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.881 -173.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 tt -87.02 113.81 23.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 24.3 t -96.03 115.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -103.44 106.67 17.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.545 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.49 ' HA ' HG22 ' A' ' 68' ' ' VAL . 86.5 m-85 -90.5 115.09 27.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.472 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.6 p-90 -159.35 179.82 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.726 0.774 . . . . 0.0 112.348 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -166.63 162.92 16.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.006 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.03 69.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -174.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.38 -46.34 80.53 Favored Glycine 0 C--N 1.332 0.335 0 O-C-N 123.635 0.585 . . . . 0.0 112.688 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.4 p -88.65 78.85 7.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.716 0.77 . . . . 0.0 109.619 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.788 ' HA ' ' HD3' ' A' ' 45' ' ' ARG . 54.8 m -69.4 -1.97 9.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.242 -174.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -74.56 -36.35 63.08 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.529 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 3.3 m -60.7 -35.73 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.875 0.845 . . . . 0.0 108.857 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . 0.788 ' HD3' ' HA ' ' A' ' 42' ' ' SER . 58.5 mtp180 -67.77 -26.6 66.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.886 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptt -86.97 -16.96 34.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.907 0.384 . . . . 0.0 111.603 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -88.62 -10.32 49.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.681 0.753 . . . . 0.0 109.149 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 37.0 m -54.82 -46.22 99.52 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.277 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -46.43 -43.57 21.85 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.369 2.046 . . . . 0.0 113.005 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -70.65 -40.14 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.02 -37.8 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.504 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.88 -43.74 87.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.72 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.88 -43.27 94.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 174.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 57.8 m -58.17 -48.99 78.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.911 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 65' ' ' ILE . 79.2 t80 -56.24 -48.59 76.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 110.991 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.197 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . 0.494 ' O ' ' HE2' ' A' ' 61' ' ' LYS . . . -91.87 -32.13 15.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 97.1 m-85 -111.43 4.59 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -55.2 -32.49 62.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.47 0.652 . . . . 0.0 111.005 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.69 12.0 31.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.626 -174.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 57' ' ' ALA . 34.7 mttm -122.97 23.04 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.71 47.41 40.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.536 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 69.7 t80 -129.87 136.55 49.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -143.01 131.56 22.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.684 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 55' ' ' TYR . 55.7 mt -88.38 122.04 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' TYR . . . . . 0.504 ' HH ' HG21 ' A' ' 22' ' ' VAL . 73.2 t80 -108.14 94.83 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.2 133.12 11.57 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.678 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.741 ' HB ' HD22 ' A' ' 93' ' ' LEU . 9.5 m -119.85 112.99 39.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.472 0.653 . . . . 0.0 110.774 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.7 t -103.88 148.66 25.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.577 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 93' ' ' LEU . 5.8 t -126.34 33.98 4.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.39 170.01 1.49 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.348 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -69.25 -46.84 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.644 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.64 164.91 23.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.59 -37.32 86.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.53 -53.75 52.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.937 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.22 -45.52 90.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -59.03 -53.24 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.951 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -60.53 -40.64 92.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.926 0.394 . . . . 0.0 111.059 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -64.15 -45.85 86.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.38 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.573 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.3 mt -63.74 -42.43 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.366 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.412 ' CD ' ' HZ3' ' A' ' 85' ' ' LYS . 32.5 tp10 -68.05 -41.55 81.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.685 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.88 -51.28 69.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.763 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.48 7.54 42.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.544 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 66.8 mmtt 55.58 36.32 26.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.543 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.454 ' HB3' HG22 ' A' ' 48' ' ' THR . 3.5 p -81.47 68.67 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.319 0.581 . . . . 0.0 111.25 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.544 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 62.3 m-85 -81.8 95.62 7.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.938 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TRP . . . . . 0.588 ' CH2' HG21 ' A' ' 48' ' ' THR . 5.3 p90 -160.99 -178.99 7.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.481 171.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -67.64 100.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.458 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -117.54 150.56 38.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 16' ' ' ASP . 35.8 m -133.81 149.34 30.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.46 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.65 123.79 37.21 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.741 HD22 ' HB ' ' A' ' 68' ' ' VAL . 69.3 mt -62.78 137.73 58.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.489 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLN . . . . . 0.594 ' O ' HG22 ' A' ' 98' ' ' VAL . 43.9 mt-30 -74.16 166.99 22.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.46 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.88 -48.3 64.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.55 -32.34 22.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.789 0.328 . . . . 0.0 110.417 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . 0.438 ' HB3' ' N ' ' A' ' 94' ' ' GLN . 22.1 t70 -58.05 -42.13 84.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.897 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 93' ' ' LEU . 77.7 t -49.65 -57.93 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 35.3 ttmt -65.26 -59.17 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.313 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.25 -51.7 65.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.451 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -52.47 39.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . 0.594 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.1 mt -58.84 -38.39 78.61 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.543 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -61.56 -59.76 4.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.9 m -50.74 -41.14 56.13 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . 0.506 ' HB2' HG12 ' A' ' 107' ' ' ILE . 53.5 m-85 -71.76 5.75 2.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.048 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' CYS . . . . . 0.461 ' H ' ' C ' ' A' ' 104' ' ' SER . 85.3 m 61.72 52.24 3.61 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.989 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.0 mm -99.27 125.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.695 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.23 7.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.421 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 162.38 33.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.136 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 85.2 m-85 -132.1 164.66 41.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' PRO . . . . . 0.751 ' HB2' HH12 ' A' ' 128' ' ' ARG . 15.5 Cg_exo -68.52 157.36 88.33 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.448 0.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.58 104.3 4.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 110.815 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -114.66 122.23 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.286 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 125' ' ' LYS . 39.6 pt -123.94 155.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.539 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.0 tp -120.89 116.73 25.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.714 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.62 126.9 54.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.932 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.535 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 1.9 p30 -72.87 164.31 61.66 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -55.93 -28.86 70.51 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.567 2.178 . . . . 0.0 112.802 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -30.01 70.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.334 0.587 . . . . 0.0 110.017 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.81 29.53 4.62 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.388 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LYS . . . . . 0.553 ' HZ3' ' HB2' ' A' ' 121' ' ' LYS . 8.6 mtmp? -114.96 149.14 37.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.924 0.393 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.89 98.32 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.955 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 m -86.71 -35.22 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.75 151.98 51.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.742 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 9.3 ptpp? -161.37 168.73 23.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.925 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 10.0 mm-40 63.46 19.37 11.65 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.082 0.864 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.28 141.4 57.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.469 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ARG . . . . . 0.751 HH12 ' HB2' ' A' ' 111' ' ' PRO . 17.6 mmt180 -117.78 159.83 22.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.534 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLY . . . . . 0.604 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -21.47 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.466 0.658 0 O-C-N 124.647 1.217 . . . . 0.0 116.131 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.82 -36.33 82.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.93 -42.66 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.147 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.5 pp -57.28 -36.94 71.65 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.655 -175.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' TYR . . . . . 0.46 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.6 t80 -65.66 -46.48 78.97 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.54 -49.63 75.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.48 0.657 . . . . 0.0 110.358 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.3 m -62.53 -46.18 89.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.457 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 132' ' ' LEU . 54.1 t -64.84 -39.13 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . 0.502 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 3.9 tp10 -58.38 -38.33 77.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.124 0.488 . . . . 0.0 109.851 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -77.16 -25.68 52.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.854 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -89.51 -47.15 8.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.481 HG23 ' CG ' ' A' ' 31' ' ' TYR . 37.0 t . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' SD ' ' N ' ' A' ' 1' ' ' MET . 3.9 mpp? . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -62.87 -55.39 26.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.68 151.24 27.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.474 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.45 162.28 35.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.324 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.7 p -67.39 112.19 4.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.661 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.8 -10.39 23.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.991 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -79.5 146.25 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.678 0.275 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.94 136.79 24.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.95 142.21 24.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.83 162.4 25.49 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.837 2.358 . . . . 0.0 112.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.66 133.35 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.531 ' O ' ' HA ' ' A' ' 23' ' ' SER . 5.0 mp -93.37 142.3 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.825 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -115.74 94.2 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.0 110.481 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.53 ' HA3' ' HB ' ' A' ' 91' ' ' VAL . . . -116.42 144.84 18.58 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.471 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.407 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 68.4 mt -87.79 132.44 32.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.491 0.186 . . . . 0.0 110.526 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 -175.68 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.817 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.455 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 9.6 mtmp? -84.03 -41.3 17.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.151 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 18.96 1.31 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.582 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.513 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -94.0 144.33 25.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 105.89 13.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.7 t -103.71 135.7 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.883 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 2.0 m -108.95 176.89 4.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.951 0.405 . . . . 0.0 110.542 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.26 -32.91 69.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.917 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.623 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 1.7 p-10 -65.06 -22.46 66.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.992 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -72.77 -18.52 61.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.992 0.425 . . . . 0.0 110.971 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.21 19.21 15.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.623 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.9 tttm -80.03 56.14 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.013 -174.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.86 0.7 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -149.03 171.76 15.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -76.46 111.63 12.13 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 64' ' ' THR . 48.1 t -97.4 114.32 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.061 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.66 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.2 tm? -88.47 105.35 17.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.507 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 44.1 t -89.89 110.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.449 ' O ' HG23 ' A' ' 68' ' ' VAL . 28.9 t70 -106.61 122.27 46.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.46 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -94.7 114.19 26.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.432 ' O ' ' HA ' ' A' ' 69' ' ' SER . 16.4 p-90 -148.35 172.45 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.708 0.766 . . . . 0.0 111.884 -175.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.54 ' HA ' ' HG ' ' A' ' 69' ' ' SER . 38.2 p90 -170.36 159.92 7.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.661 175.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.63 69.33 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -6.07 89.2 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.09 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.405 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 34.9 t -89.75 112.64 23.99 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.48 -0.424 . . . . 0.0 110.206 -178.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 5.7 m -64.23 -42.91 96.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.569 -173.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -77.29 -31.66 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.609 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 94.5 m -57.6 -38.57 75.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -18.07 65.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 5.9 mptp? -85.36 -34.13 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.453 -178.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.409 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 45.5 mt-10 -96.44 1.64 51.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.594 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.587 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 84.4 m -50.21 -51.53 62.02 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.329 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 65.5 Cg_exo -52.52 -43.02 57.95 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.259 1.973 . . . . 0.0 113.156 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.409 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.8 m-85 -65.1 -46.0 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.9 -40.21 94.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.633 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.423 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 60.9 tp -59.42 -47.29 86.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.92 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.503 ' HE3' ' CD2' ' A' ' 133' ' ' TYR . 38.6 ttpt -62.87 -47.27 84.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.151 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.416 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 35.7 m -58.55 -47.91 82.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.711 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.546 ' HB2' HD13 ' A' ' 65' ' ' ILE . 88.8 t80 -60.03 -51.32 70.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.868 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -66.55 -26.08 66.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.71 -27.43 18.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 71.0 m-85 -108.45 -11.86 15.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.684 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 21.6 pttp -54.91 -39.15 68.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.811 0.339 . . . . 0.0 111.388 -176.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.51 -36.52 29.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.439 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.428 ' HD2' ' CD1' ' A' ' 58' ' ' PHE . 87.9 mttt -58.75 -44.01 90.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.06 43.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.428 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.684 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 65.9 t80 -144.08 150.48 38.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.421 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 95.7 m -150.8 132.76 15.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.853 0.358 . . . . 0.0 110.583 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 55' ' ' TYR . 42.7 mt -92.44 118.72 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.088 0.47 . . . . 0.0 110.044 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.76 94.43 5.6 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.35 112.0 3.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.759 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.67 ' HB ' HD23 ' A' ' 93' ' ' LEU . 32.1 m -100.21 116.43 43.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.485 0.659 . . . . 0.0 111.004 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.54 ' HG ' ' HA ' ' A' ' 38' ' ' PHE . 7.2 t -128.84 145.39 51.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.947 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 1.051 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.7 t -145.87 54.79 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.014 0.912 . . . . 0.0 110.011 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' OD2' ' HG2' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -68.63 -168.51 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.479 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.439 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 0.6 OUTLIER -60.47 -42.86 97.08 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -172.77 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 56.8 mtp180 -133.11 163.07 30.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.667 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.55 ' HG3' HD23 ' A' ' 92' ' ' LEU . 16.8 tt0 -75.12 -36.74 61.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.483 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 2.0 mp0 -59.57 -39.68 84.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.951 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.498 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 2.3 m-20 -74.67 -32.36 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.415 ' O ' HG13 ' A' ' 81' ' ' ILE . 29.4 t90 -62.28 -49.03 77.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.0 mptm? -57.88 -43.44 86.05 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.045 0.45 . . . . 0.0 110.278 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.446 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 3.5 ttpm? -60.15 -45.84 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.69 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.01 84.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.328 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.415 HG13 ' O ' ' A' ' 77' ' ' TRP . 82.8 mt -62.99 -38.02 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.423 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 48.4 tp10 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 175.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.446 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 36.8 mt-10 -60.49 -56.08 25.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' HB3' HG22 ' A' ' 48' ' ' THR . 3.9 m-20 -75.71 -20.92 58.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.859 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.423 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 66.3 mmtt 57.49 37.89 27.9 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.824 0.821 . . . . 0.0 109.98 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 p -83.27 82.96 8.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.87 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -82.78 84.55 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.423 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 28.7 p90 -154.95 -169.24 3.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.119 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -72.92 84.26 1.24 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.425 0.631 . . . . 0.0 111.021 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -89.23 136.36 33.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.536 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.53 ' HB ' ' HA3' ' A' ' 14' ' ' GLY . 17.1 m -131.01 141.71 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.016 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.55 HD23 ' HG3' ' A' ' 74' ' ' GLU . 53.3 tp -88.24 111.16 21.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.626 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 1.051 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 84.3 mt -66.7 124.1 21.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.714 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.1 mt-30 -60.78 143.42 54.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -66.95 -23.32 65.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.582 0.229 . . . . 0.0 111.443 -165.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -87.44 -36.03 17.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 0.0 110.749 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.29 -37.69 86.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 94' ' ' GLN . 63.2 t -50.63 -47.22 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.367 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.05 -55.23 33.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.803 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.25 -53.29 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.204 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.68 -54.32 27.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.783 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.597 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 30.5 mt -60.51 -50.63 72.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.009 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.98 -59.66 4.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.308 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.3 m -54.79 -30.98 58.35 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.275 0.984 . . . . 0.0 113.338 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -77.96 10.58 2.75 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.143 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.7 t 64.29 36.13 9.45 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.597 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 39.7 mm -106.0 118.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.366 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.48 13.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.214 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.64 160.47 30.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.49 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -133.49 155.98 80.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.446 0.299 . . . . 0.0 110.377 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.609 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 4.2 Cg_exo -82.63 -176.5 16.82 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.148 -1.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -163.03 130.8 3.68 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.627 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.502 HG23 HD13 ' A' ' 33' ' ' LEU . 58.0 mt -125.93 130.76 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.507 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 30.8 pt -129.15 145.46 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.903 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tt -105.71 110.63 23.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.83 135.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.444 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.547 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -82.13 170.37 15.18 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 16.5 Cg_endo -59.65 -16.72 38.27 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.647 2.232 . . . . 0.0 114.028 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.498 ' HB3' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -88.43 3.94 48.21 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 110.824 175.955 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.04 57.33 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.985 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.498 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 27.2 mttm -113.01 141.54 46.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.939 0.369 . . . . 0.0 110.077 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.41 95.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.494 ' CG2' ' HB3' ' A' ' 117' ' ' ASP . 42.6 t -73.27 -41.95 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.578 -176.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.66 167.27 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.63 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.576 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.0 pttp -162.68 171.89 16.16 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.576 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 8.8 mm-40 68.01 16.42 9.54 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.286 0.991 . . . . 0.0 111.15 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.64 132.74 54.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.522 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 mmp_? -116.02 154.52 29.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.021 -170.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.564 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 46.05 -131.78 10.54 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.966 0.792 . . . . 0.0 113.568 170.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.9 -10.74 59.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.44 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.5 t70 -64.27 -31.84 73.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.388 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.564 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 3.3 pp -58.9 -41.15 86.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.852 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.513 ' N ' HD13 ' A' ' 132' ' ' LEU . 26.9 t80 -63.6 -54.87 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 109.555 172.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.44 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 25.3 m-80 -58.71 -32.41 69.16 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.11 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.515 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 21.7 m -73.91 -40.23 63.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.513 HG21 ' O ' ' A' ' 132' ' ' LEU . 44.9 t -63.93 -39.28 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.501 174.07 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.45 ' OE1' ' HB2' ' A' ' 141' ' ' ASN . 3.0 tp10 -66.17 -41.48 90.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.515 ' HE3' ' HA ' ' A' ' 135' ' ' THR . 15.8 mtmt -52.51 -40.65 62.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.396 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -87.61 -61.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.08 -35.87 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -164.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.45 ' HB2' ' OE1' ' A' ' 137' ' ' GLU . 66.6 t30 -52.3 -56.75 12.71 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -168.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -164.16 -173.3 32.67 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.901 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 78.84 6.41 2.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 111.501 -178.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' HD2' ' N ' ' A' ' 144' ' ' LYS . 7.4 mptt -131.98 7.77 4.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -36.04 61.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.27 -22.91 36.02 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.239 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 37.13 79.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.575 0.702 . . . . 0.0 111.151 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -80.58 -20.97 42.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.832 -165.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -89.0 -44.93 10.04 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.97 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 166.88 -36.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.14 0.9 . . . . 0.0 109.487 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -122.93 -35.13 3.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.774 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.5 m80 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.916 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.555 ' HB3' ' O ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -119.03 -171.99 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.187 -169.979 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.39 -179.77 5.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.4 -167.14 2.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.694 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -64.3 133.84 53.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 0.0 111.109 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.12 -20.31 50.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.747 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -87.08 156.15 19.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 13.7 p -80.79 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.14 0.495 . . . . 0.0 110.793 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.96 144.51 51.54 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.06 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.05 148.68 81.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.585 2.19 . . . . 0.0 112.165 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.84 99.8 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.7 mm -83.25 132.9 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.5 m -131.74 98.99 4.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.072 0.463 . . . . 0.0 110.402 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.581 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -112.37 -176.23 19.79 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.835 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 19.7 mt -104.68 135.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.714 0.257 . . . . 0.0 110.924 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' OD1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -101.29 -172.6 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.422 HD22 HD11 ' A' ' 81' ' ' ILE . 92.6 mt -59.46 -26.89 65.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.41 ' HZ1' ' CG ' ' A' ' 16' ' ' ASP . 36.8 mtmm -77.05 -14.7 59.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.229 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.22 57.89 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.448 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -102.02 151.17 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -84.42 107.31 16.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.145 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.6 138.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.496 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 19.4 m -106.39 172.11 6.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.137 0.494 . . . . 0.0 111.072 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.631 HD11 HG13 ' A' ' 32' ' ' VAL . 55.7 tp -80.42 -21.0 42.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 110.088 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.491 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 4.0 m-20 -65.84 -28.69 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.307 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.53 -23.89 67.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.211 0.529 . . . . 0.0 110.932 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.38 8.48 29.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.006 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.491 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 6.2 mtpp -76.51 69.99 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.719 0.771 . . . . 0.0 111.179 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.497 ' HA3' ' CG ' ' A' ' 151' ' ' HIS . . . -165.65 20.37 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.709 174.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -153.19 -176.45 5.79 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -95.88 111.62 23.56 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.669 ' CG1' ' HB ' ' A' ' 116' ' ' VAL . 9.8 p -101.52 133.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.232 0.539 . . . . 0.0 111.407 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.639 HD13 HD22 ' A' ' 132' ' ' LEU . 10.3 tt -97.55 107.27 19.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.548 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 41.4 t -97.52 105.09 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -102.56 118.46 36.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.069 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.401 ' HA ' ' O ' ' A' ' 68' ' ' VAL . 66.5 m-85 -84.43 116.2 22.95 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.57 ' O ' ' HA ' ' A' ' 69' ' ' SER . 21.9 p-90 -144.4 175.71 9.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.626 0.727 . . . . 0.0 111.874 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -168.38 161.01 11.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.59 -1.187 . . . . 0.0 108.248 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -32.93 73.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.37 -11.66 85.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.196 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 44' ' ' CYS . 48.3 t -74.53 110.62 8.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.257 0.551 . . . . 0.0 109.946 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.516 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -65.48 -28.31 69.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.308 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.525 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 77.2 t-105 -85.52 -30.75 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.413 ' SG ' ' SG ' ' A' ' 41' ' ' CYS . 90.2 m -58.06 -42.05 84.64 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.3 -13.71 21.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.018 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.5 mptt -84.28 -51.23 7.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 pt-20 -99.73 15.78 25.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.224 -175.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.586 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 22.4 m -51.71 -51.97 65.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.586 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.5 Cg_exo -54.29 -33.74 77.1 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.97 1.78 . . . . 0.0 112.379 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -76.57 -32.23 58.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.481 HD23 HD11 ' A' ' 132' ' ' LEU . 95.7 mt -62.94 -52.95 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.9 tp -61.07 -40.26 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.533 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -51.69 -53.86 34.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.718 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -67.07 -39.8 86.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.11 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.595 ' HB2' HD11 ' A' ' 65' ' ' ILE . 68.7 t80 -60.84 -46.75 89.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 111.172 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.19 -35.97 78.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.414 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -31.19 51.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' HE1' ' OE1' ' A' ' 137' ' ' GLU . 90.3 m-85 -115.48 3.86 14.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.73 -38.44 69.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.74 -42.12 16.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 88.3 mttt -55.8 -56.34 21.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.232 -176.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 38.79 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.749 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 49.4 t80 -135.49 147.28 48.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.4 m -153.99 144.06 22.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.843 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 55' ' ' TYR . 29.4 mt -95.58 137.82 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.097 0.475 . . . . 0.0 111.033 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.458 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 39.3 t80 -123.43 93.05 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.04 106.8 3.37 Favored Glycine 0 CA--C 1.505 -0.531 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.582 -172.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.538 ' HA ' HG12 ' A' ' 91' ' ' VAL . 3.1 p -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.631 0.729 . . . . 0.0 111.092 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.57 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 12.4 t -112.4 152.9 28.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.528 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.701 HG22 ' HB2' ' A' ' 93' ' ' LEU . 30.6 p -132.54 48.96 2.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 3.7 t70 -75.15 -176.05 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.864 -172.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.413 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 71.1 mtm180 -69.85 -39.27 76.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.924 -174.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.567 ' HD2' ' OD1' ' A' ' 76' ' ' ASP . 60.9 mtt180 -138.69 152.71 48.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.672 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.628 ' HG2' ' HZ3' ' A' ' 78' ' ' LYS . 33.3 tt0 -65.91 -37.9 87.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.711 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 mm-40 -68.78 -36.46 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.766 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.567 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -65.25 -34.59 78.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 173.551 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.465 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 31.5 t90 -64.37 -48.73 74.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.711 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 8.7 mmtm -55.3 -50.4 69.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.963 0.887 . . . . 0.0 108.837 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.435 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.72 -40.06 90.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.014 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.536 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -61.77 -36.17 80.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.422 HD11 HD22 ' A' ' 17' ' ' LEU . 73.1 mt -64.6 -39.64 86.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 38.0 tp10 -65.6 -34.32 77.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.767 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.536 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 53.7 mt-10 -69.76 -52.19 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.765 0.793 . . . . 0.0 110.304 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.78 -18.67 58.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.228 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.417 ' HD2' ' HA ' ' A' ' 85' ' ' LYS . 8.4 mptt 59.04 21.26 9.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.244 0.545 . . . . 0.0 112.244 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.468 ' HB3' ' CZ2' ' A' ' 88' ' ' TRP . 60.3 m -87.07 85.06 7.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.534 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.62 93.31 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.971 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.468 ' CZ2' ' HB3' ' A' ' 86' ' ' SER . 7.6 p90 -153.26 -172.68 4.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.744 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 52.1 m-80 -68.49 99.81 1.01 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.278 0.561 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.32 155.41 30.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.171 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.3 p -140.05 145.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.896 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 tp -108.21 129.57 55.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.483 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.701 ' HB2' HG22 ' A' ' 70' ' ' THR . 15.3 mt -74.69 142.58 44.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.431 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.649 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.4 mt-30 -75.44 163.34 27.51 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.798 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.456 ' CD ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -43.63 -55.37 4.37 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.924 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.456 ' H ' ' CD ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -87.8 -33.51 18.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 14.4 t70 -54.76 -39.2 68.09 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.313 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.649 HG23 ' O ' ' A' ' 94' ' ' GLN . 53.8 t -49.9 -48.12 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.876 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.45 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ttpp -56.39 -59.45 4.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.144 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.401 ' CG ' ' HZ1' ' A' ' 99' ' ' LYS . 61.2 m-20 -69.86 -34.95 74.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.577 -171.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.09 -37.43 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.685 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.732 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -66.37 -22.89 66.26 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.67 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -82.54 -62.71 1.54 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.249 -0.981 . . . . 0.0 108.813 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.555 ' O ' ' HB3' ' A' ' 2' ' ' SER . 69.6 m -48.33 -41.55 28.69 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -164.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.34 17.04 1.81 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.714 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.6 t 57.36 54.0 7.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.732 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 19.1 mm -80.33 72.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.636 0.732 . . . . 0.0 110.541 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.51 -25.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.683 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.05 121.18 5.9 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 3.3 t80 -123.88 140.74 35.17 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.492 ' HG2' HH12 ' A' ' 128' ' ' ARG . 62.3 Cg_endo -74.9 135.4 40.31 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.566 -1.431 . . . . 0.0 112.108 -0.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.515 ' CD2' HD13 ' A' ' 107' ' ' ILE . 49.7 t60 -89.02 100.8 13.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.9 120.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.548 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 31.5 pt -122.05 159.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.057 0.456 . . . . 0.0 111.666 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.438 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 tp -121.09 120.61 35.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.015 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.669 ' HB ' ' CG1' ' A' ' 32' ' ' VAL . 65.4 t -109.2 133.97 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.775 0.321 . . . . 0.0 110.664 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.564 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 p30 -77.0 165.79 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.502 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.564 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.7 Cg_endo -54.18 -20.33 18.95 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.983 2.455 . . . . 0.0 113.85 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.449 ' C ' ' HZ2' ' A' ' 28' ' ' LYS . 41.7 mt-10 -82.89 -14.33 54.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.34 . . . . 0.0 110.775 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.11 30.37 11.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.923 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.63 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.6 mtmp? -112.27 152.35 28.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.403 -0.469 . . . . 0.0 110.963 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -84.16 108.69 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.83 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.61 -30.31 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.958 0.409 . . . . 0.0 110.976 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB1' HD22 ' A' ' 127' ' ' LEU . . . -144.86 155.41 43.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.617 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 17.2 pttp -156.61 162.58 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.617 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 3.1 mm-40 66.51 20.76 10.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.428 HD22 ' HB1' ' A' ' 124' ' ' ALA . 71.0 mt -64.14 145.05 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.226 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.492 HH12 ' HG2' ' A' ' 111' ' ' PRO . 25.3 mmt180 -132.48 139.98 48.18 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 39.03 -99.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.338 0 O-C-N 124.521 1.138 . . . . 0.0 115.721 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.1 -35.28 59.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.806 -0.197 . . . . 0.0 111.128 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.914 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 27.8 t70 -69.94 -19.45 63.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.469 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.639 HD22 HD13 ' A' ' 33' ' ' LEU . 95.0 mt -51.86 -59.59 4.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 168.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.14 -49.14 77.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.922 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.914 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 93.8 m-20 -57.41 -41.55 80.55 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.265 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.51 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 5.1 m -74.6 -36.45 62.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 132' ' ' LEU . 41.6 t -68.87 -41.47 82.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.319 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.549 ' OE1' ' HE1' ' A' ' 58' ' ' PHE . 1.2 tp10 -67.94 -32.33 72.71 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.628 0.728 . . . . 0.0 109.246 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.731 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 22.1 ttmt -58.55 -56.92 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.923 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -89.22 -53.28 4.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.434 ' HA ' ' CE1' ' A' ' 147' ' ' HIS . 23.3 t -75.15 -43.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.448 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 15.7 t30 -73.14 -18.51 61.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.215 0.531 . . . . 0.0 110.86 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.29 168.92 22.26 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.808 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.1 80.85 6.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.614 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 1.2 mptm? -117.36 126.28 52.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.686 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.614 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER 54.41 1.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.335 1.454 . . . . 0.0 114.712 174.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.15 80.34 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.404 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.434 ' CE1' ' HA ' ' A' ' 140' ' ' VAL . 33.4 m-70 68.79 26.55 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.309 0.644 . . . . 0.0 110.614 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.4 m80 41.69 61.78 1.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.366 -1.288 . . . . 0.0 113.124 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 75.39 -31.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.905 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.417 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 14.4 t-80 72.33 151.13 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.497 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.1 t-160 -61.17 -38.72 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.905 -0.497 . . . . 0.0 110.063 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.417 ' C ' ' HD1' ' A' ' 150' ' ' HIS . 22.1 t60 . . . . . 0 C--O 1.242 0.697 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.472 ' H ' ' HB3' ' A' ' 106' ' ' CYS . 11.5 m -140.12 136.45 33.55 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.379 0.424 . . . . 0.0 109.999 -175.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.661 HD11 ' HA ' ' A' ' 105' ' ' TYR . 63.9 mt 69.07 146.51 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.651 0.739 . . . . 0.0 112.109 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.22 172.04 13.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.179 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -68.68 119.18 12.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.35 -8.79 41.48 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.936 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -85.24 149.01 25.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.726 0.298 . . . . 0.0 110.523 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.89 141.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.129 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -85.57 131.2 48.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 37.7 Cg_exo -61.67 153.46 67.06 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.017 2.478 . . . . 0.0 112.219 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.63 134.62 51.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.782 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.596 HG12 HD23 ' A' ' 24' ' ' LEU . 48.5 mm -104.53 129.5 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.474 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.18 93.02 3.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.11 148.04 18.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.378 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.39 124.39 40.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.354 0.597 . . . . 0.0 111.162 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 170.25 16.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.972 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 HD21 ' HG3' ' A' ' 78' ' ' LYS . 5.8 mp -64.96 -14.56 60.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.92 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 36.7 mtmm -96.59 2.38 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.41 20.02 55.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.787 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.436 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 m-80 -101.18 132.46 46.65 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.544 -0.386 . . . . 0.0 110.129 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -80.97 112.0 17.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.69 148.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.43 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.531 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -100.43 175.05 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.919 0.39 . . . . 0.0 111.193 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.596 HD23 HG12 ' A' ' 12' ' ' ILE . 3.8 pp -80.2 -20.07 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 110.42 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 29.9 p30 -71.68 -17.89 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.66 -25.99 68.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.275 0.56 . . . . 0.0 110.958 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.29 2.8 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.54 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 12.3 tmtt? -60.02 147.54 38.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.388 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.58 5.17 29.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.453 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -134.89 172.66 12.68 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -82.29 110.57 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.587 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 48.4 t -104.4 125.27 59.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.025 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.588 HD23 HD23 ' A' ' 132' ' ' LEU . 22.4 tp -103.06 103.73 13.84 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.893 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.405 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.0 t0 -113.78 136.43 52.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -110.98 115.59 29.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.511 ' O ' ' HA ' ' A' ' 69' ' ' SER . 58.5 p-90 -148.06 178.24 8.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 111.369 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -170.28 157.0 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.806 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.12 51.51 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.05 -62.99 5.68 Favored Glycine 0 C--N 1.333 0.363 0 O-C-N 123.581 0.55 . . . . 0.0 112.697 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.3 m -81.42 85.4 6.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.46 0.648 . . . . 0.0 109.813 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.597 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 28.4 p -70.91 -13.73 62.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.451 -176.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -66.97 -33.12 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.966 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.7 ' HG ' ' HB3' ' A' ' 110' ' ' PHE . 19.9 m -61.82 -38.84 89.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.518 173.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.726 ' HD2' ' OD2' ' A' ' 84' ' ' ASP . 41.0 mtm180 -74.04 -12.68 60.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.322 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HD3' ' O ' ' A' ' 42' ' ' SER . 10.1 mptt -72.49 -14.06 61.57 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.067 -0.395 . . . . 0.0 111.032 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -101.3 -4.76 26.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.636 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.546 ' HA ' HD12 ' A' ' 51' ' ' LEU . 56.4 m -60.0 -43.4 94.26 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.123 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.0 Cg_exo -52.2 -36.47 67.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.066 1.844 . . . . 0.0 112.669 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -74.05 -34.66 64.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.729 0.299 . . . . 0.0 110.246 178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.546 HD12 ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -60.15 -43.0 96.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.086 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.71 -42.26 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.553 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -60.36 -47.54 85.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.109 0.48 . . . . 0.0 110.393 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -62.56 -43.96 97.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.68 ' HB2' HD12 ' A' ' 65' ' ' ILE . 51.2 t80 -65.73 -38.79 90.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -65.67 -28.78 69.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.688 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.97 19.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.309 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.34 13.44 32.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.407 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 50.5 pttt -60.43 -20.7 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.53 13.04 15.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 111.527 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -116.08 26.03 10.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.94 55.79 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.399 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 80.4 t80 -133.73 136.54 44.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.994 -0.603 . . . . 0.0 109.596 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 36.7 m -140.85 130.73 24.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.818 0.342 . . . . 0.0 110.758 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.68 HD12 ' HB2' ' A' ' 55' ' ' TYR . 58.0 mt -89.91 125.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -108.7 94.49 5.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.454 ' HA3' ' OE1' ' A' ' 90' ' ' GLN . . . -86.5 117.06 4.54 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.913 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 HG11 ' CG2' ' A' ' 91' ' ' VAL . 35.3 m -112.97 126.31 70.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 0.0 110.681 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 46.2 t -122.48 139.37 53.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.667 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -106.4 42.22 1.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.104 0.954 . . . . 0.0 108.627 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.1 177.61 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.875 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -69.56 -48.36 60.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.292 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.419 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 22.6 tpt180 -143.25 150.48 39.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.792 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 1.013 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 30.5 tt0 -63.28 -39.93 95.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.419 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.8 mp0 -61.31 -41.36 96.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.74 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t0 -65.21 -45.7 83.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.469 ' O ' HG13 ' A' ' 81' ' ' ILE . 22.7 t90 -58.39 -49.49 77.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.651 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 1.013 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -55.61 -44.09 76.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 110.781 175.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.6 ttpp -59.37 -44.83 92.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.182 177.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.43 79.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.805 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.699 HG23 ' HG ' ' A' ' 86' ' ' SER . 93.4 mt -59.82 -40.35 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.447 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -43.89 66.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -50.07 -58.14 6.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.726 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 8.2 m-20 -84.21 -2.51 57.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.115 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 58.17 37.09 26.26 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.381 0.61 . . . . 0.0 111.091 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.699 ' HG ' HG23 ' A' ' 81' ' ' ILE . 33.0 p -79.98 78.37 6.6 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.736 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -83.9 77.75 9.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -158.6 -179.88 8.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.527 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -63.57 115.69 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.31 0.576 . . . . 0.0 111.04 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.454 ' OE1' ' HA3' ' A' ' 67' ' ' GLY . 1.4 tp-100 -123.13 141.08 52.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.786 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.483 ' CG2' HG11 ' A' ' 68' ' ' VAL . 19.1 m -137.87 145.32 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.234 0.54 . . . . 0.0 111.144 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.0 tp -92.91 112.67 24.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.648 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.15 133.9 52.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.035 0.445 . . . . 0.0 110.768 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.583 ' O ' HG22 ' A' ' 98' ' ' VAL . 33.1 mt-30 -68.75 145.1 54.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -63.59 -29.32 70.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -171.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.509 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 36.6 t70 -79.28 -39.73 32.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.84 -46.17 85.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.851 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.583 HG22 ' O ' ' A' ' 94' ' ' GLN . 77.2 t -50.14 -37.67 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.826 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.819 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 5.2 ttpm? -52.82 -64.02 0.95 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.151 0.5 . . . . 0.0 111.577 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -72.5 -36.89 68.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.744 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.63 -52.01 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.272 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.569 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -58.43 -52.6 64.92 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.848 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -52.99 -61.37 2.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.3 0.375 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.422 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 28.3 m -57.55 -26.27 61.18 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.007 0.817 . . . . 0.0 112.682 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.661 ' HA ' HD11 ' A' ' 3' ' ' LEU . 6.5 m-85 -86.84 20.52 2.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.472 ' HB3' ' H ' ' A' ' 2' ' ' SER . 31.3 p 50.6 43.75 27.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.872 1.269 . . . . 0.0 110.348 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 12.2 mm -113.03 122.38 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.8 3.59 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.98 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.56 177.16 37.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.955 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.7 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 94.5 m-85 -135.25 166.7 26.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.655 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 74.4 Cg_endo -75.33 -174.68 14.67 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.031 -0.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.649 ' HE2' ' HD2' ' A' ' 105' ' ' TYR . 72.4 t60 -166.89 106.52 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.363 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.87 137.16 53.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.646 HG21 ' HB2' ' A' ' 125' ' ' LYS . 46.9 pt -131.62 154.51 40.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.706 HD21 HG21 ' A' ' 136' ' ' VAL . 64.3 tp -118.96 119.35 34.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.164 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.587 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 19.2 m -109.41 143.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.347 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.558 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 3.3 p30 -78.22 163.78 60.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.334 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.558 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 11.9 Cg_endo -58.2 -14.23 18.86 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.134 2.556 . . . . 0.0 113.582 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.413 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 1.1 mt-10 -81.52 -29.63 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.33 19.69 6.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.697 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.0 mtmp? -111.23 146.32 37.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.39 104.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.54 -27.26 12.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.451 ' HB2' HD21 ' A' ' 127' ' ' LEU . . . -155.12 142.94 19.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.775 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.646 ' HB2' HG21 ' A' ' 114' ' ' ILE . 12.4 pttp -142.79 163.06 33.83 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.569 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.514 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 7.3 mm-40 65.95 30.53 9.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 110.067 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.451 HD21 ' HB2' ' A' ' 124' ' ' ALA . 88.2 mt -67.41 156.82 35.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.047 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.629 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 7.8 mmm180 -116.43 166.9 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -30.98 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.052 0 N-CA-C 116.017 1.167 . . . . 0.0 116.017 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -12.52 59.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.572 0.686 . . . . 0.0 111.571 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.607 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.1 t70 -63.43 -42.16 98.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.629 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 41.3 mt -47.6 -56.66 6.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.488 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -58.32 -58.92 6.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.558 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.607 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.3 p30 -69.02 -37.66 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.54 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.3 m -72.0 -42.12 66.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.676 0.274 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.706 HG21 HD21 ' A' ' 115' ' ' LEU . 46.9 t -65.62 -35.81 76.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -57.02 -45.88 82.77 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.139 0.495 . . . . 0.0 109.823 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 28.9 mtpp -65.96 -35.59 81.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.766 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -80.28 -55.12 5.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.88 -50.37 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 111.619 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -81.43 -62.7 1.58 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.002 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 138' ' ' LYS . . . 167.17 174.44 36.33 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.655 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.69 169.26 19.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.42 ' C ' ' H ' ' A' ' 146' ' ' GLY . 17.6 tptp -83.34 -24.36 32.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.192 0.52 . . . . 0.0 109.882 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.19 31.65 0.27 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.656 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 144' ' ' LYS . . . -76.51 49.04 2.65 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.964 -177.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -97.1 10.54 39.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -155.55 150.7 26.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.524 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -72.6 175.66 6.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.59 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -68.51 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.904 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -134.96 12.41 3.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.517 0.675 . . . . 0.0 109.488 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 C--O 1.241 0.65 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.55 177.924 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.911 ' HB2' ' HD3' ' A' ' 125' ' ' LYS . 14.8 m 58.94 -169.66 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.549 0.53 . . . . 0.0 111.489 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.782 ' H ' HD23 ' A' ' 3' ' ' LEU . 1.2 pt? -75.61 163.77 27.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.373 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.82 156.1 32.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.72 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -74.46 141.15 44.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.784 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.6 -13.17 58.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.782 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 147.92 34.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.288 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.18 137.33 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.934 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.64 122.96 57.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.492 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.14 134.1 49.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.061 2.507 . . . . 0.0 111.708 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.35 120.22 19.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.065 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.88 HG12 HD23 ' A' ' 24' ' ' LEU . 8.4 mm -65.02 133.17 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.21 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.0 m -120.31 87.88 2.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.468 . . . . 0.0 110.287 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.597 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -124.01 179.27 16.2 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.212 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.4 mt -109.24 130.28 62.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.92 -176.14 5.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.368 . . . . 0.0 110.724 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 94.1 mt -58.75 -34.08 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.866 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.583 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 32.7 mttp -78.96 -30.22 44.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.579 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.34 12.01 7.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.583 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 20.7 m-80 -87.14 137.4 32.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.639 0.256 . . . . 0.0 110.462 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.9 p -81.57 93.35 6.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.44 154.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.398 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.635 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 20.1 m -117.71 166.4 12.48 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.88 HD23 HG12 ' A' ' 12' ' ' ILE . 3.9 pp -68.41 -18.23 64.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.533 176.392 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.78 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 6.2 t-20 -65.36 -35.52 81.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.37 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.39 -18.03 63.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.413 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.8 4.27 25.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.114 0.483 . . . . 0.0 110.138 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.78 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 41.1 mtpt -69.01 -174.11 0.57 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.953 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.45 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.28 10.36 86.27 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -144.84 173.72 11.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.433 ' HB3' HD13 ' A' ' 115' ' ' LEU . 94.5 m-85 -86.97 114.45 23.6 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.499 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 28.5 t -114.16 135.26 54.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.873 0.368 . . . . 0.0 111.356 -173.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.478 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt -91.31 134.71 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.465 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 61.5 t -110.2 100.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.87 108.41 19.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.06 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.647 ' CE2' ' HD2' ' A' ' 105' ' ' TYR . 72.3 m-85 -84.1 116.86 23.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.55 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.612 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 9.3 p-90 -143.04 173.53 11.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.301 0.572 . . . . 0.0 110.929 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 41' ' ' CYS . 28.4 p90 -165.17 148.49 8.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.614 171.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.26 -15.86 63.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.906 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.86 -3.06 83.58 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.659 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.432 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 50.8 t -120.33 123.96 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 110.744 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.6 t -64.19 -36.52 84.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.807 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.49 ' HD1' ' CD ' ' A' ' 111' ' ' PRO . 49.9 t-105 -70.95 -29.19 65.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.713 0.292 . . . . 0.0 110.713 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.612 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 98.7 m -65.31 -27.7 68.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.388 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.39 -14.22 46.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.594 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.612 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mptp? -69.33 -38.35 78.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 0.0 109.96 174.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.76 -28.94 68.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.605 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 m -53.93 -52.93 63.56 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.612 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 53.2 Cg_exo -54.77 -43.72 56.53 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.073 1.848 . . . . 0.0 112.827 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -67.22 -38.86 85.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.308 0.575 . . . . 0.0 109.996 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.511 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -65.75 -43.38 89.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.812 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.2 -41.35 98.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.427 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.528 ' HZ1' ' CG ' ' A' ' 130' ' ' ASP . 39.1 ttpt -61.11 -45.92 92.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.189 176.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.8 m -62.11 -44.63 96.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.838 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.685 ' HB2' HD12 ' A' ' 65' ' ' ILE . 72.8 t80 -56.34 -57.46 12.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.076 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.69 -34.17 75.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.739 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.41 -31.47 29.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.515 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 32.5 m-85 -114.67 -2.2 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -55.0 -37.74 66.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.19 13.55 11.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -174.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 65.0 mttm -117.99 20.0 13.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.104 -176.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.35 41.81 16.1 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 67.3 t80 -136.59 139.75 42.35 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -147.64 166.58 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 0.0 110.313 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.685 HD12 ' HB2' ' A' ' 55' ' ' TYR . 60.1 mt -122.03 128.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.667 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.478 ' CZ ' HG12 ' A' ' 91' ' ' VAL . 20.5 t80 -113.83 93.56 4.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.53 109.19 3.45 Favored Glycine 0 C--O 1.224 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.402 -172.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.8 t -97.62 119.48 45.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -173.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -110.18 164.36 12.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.828 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.856 ' HB ' HD12 ' A' ' 93' ' ' LEU . 8.8 t -138.39 28.72 2.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.767 0.794 . . . . 0.0 109.149 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.704 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 22.6 m-20 -73.53 123.93 24.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.467 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.704 ' CZ ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -60.87 -34.96 75.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.512 -176.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.654 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 27.6 mtp180 -93.93 102.49 14.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.59 -34.22 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.497 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.654 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -69.38 -31.52 69.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.066 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.516 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -76.39 -30.09 57.37 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.48 ' O ' HG12 ' A' ' 81' ' ' ILE . 30.0 t90 -61.77 -52.18 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.951 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 2.0 mptm? -56.55 -43.72 80.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.207 0.527 . . . . 0.0 110.211 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.531 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 19.3 tttm -57.51 -56.84 16.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.596 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -57.27 -36.86 71.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.818 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.744 HD11 HE21 ' A' ' 90' ' ' GLN . 48.1 mm -66.09 -41.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.775 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.501 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 40.2 tp10 -70.33 -31.53 68.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.969 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.57 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 51.2 mt-10 -64.3 -50.22 68.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.428 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -92.83 -10.91 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.311 -176.593 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.54 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 58.3 mmtt 71.12 30.66 2.64 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.882 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 p -70.28 86.58 0.59 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.302 0.572 . . . . 0.0 111.223 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.54 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 46.9 m-85 -96.69 99.94 11.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.178 0.513 . . . . 0.0 112.11 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.511 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 6.2 p90 -151.7 -140.81 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.82 170.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 55.7 m-80 -113.31 85.96 2.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.54 0.609 . . . . 0.0 110.541 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.744 HE21 HD11 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -93.85 146.23 24.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.476 0.655 . . . . 0.0 110.876 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.597 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.5 p -137.15 139.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.404 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.29 125.98 45.04 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.446 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.856 HD12 ' HB ' ' A' ' 70' ' ' THR . 69.4 mt -58.64 138.25 57.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.356 0.41 . . . . 0.0 110.597 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.639 ' O ' HG21 ' A' ' 98' ' ' VAL . 47.3 mt-30 -85.1 163.08 19.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.711 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -42.95 -49.64 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.251 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.415 ' N ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -87.8 -41.07 13.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 110.316 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -53.12 -35.57 59.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.728 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.639 HG21 ' O ' ' A' ' 94' ' ' GLN . 54.5 t -50.91 -45.24 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.595 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.435 ' HD2' ' C ' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -66.16 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.913 -171.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.92 -40.55 93.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.311 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' CG1' HD11 ' A' ' 12' ' ' ILE . 27.1 t -63.07 -59.63 4.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.696 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 79.9 mt -59.51 -40.53 87.37 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.153 0.502 . . . . 0.0 110.384 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.57 -62.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.253 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 106' ' ' CYS . 49.2 p -56.19 -43.89 78.91 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.497 1.123 . . . . 0.0 113.511 -167.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.647 ' HD2' ' CE2' ' A' ' 36' ' ' PHE . 16.8 m-30 -73.38 11.43 0.77 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.804 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.542 ' CB ' ' HA ' ' A' ' 2' ' ' SER . 56.3 m 63.36 56.8 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.098 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.696 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.7 mp -81.09 110.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.82 -25.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.343 173.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.82 170.39 35.98 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.619 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -121.72 150.23 54.92 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.49 ' CD ' ' HD1' ' A' ' 43' ' ' TRP . 4.4 Cg_exo -78.72 171.32 66.35 Favored 'Cis proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.718 -1.367 . . . . 0.0 112.511 -0.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -145.49 104.3 3.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.52 HD13 HD12 ' A' ' 132' ' ' LEU . 47.0 mt -114.28 139.18 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.909 0.385 . . . . 0.0 111.344 -172.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.465 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 39.2 pt -133.48 155.53 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.449 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.874 ' HB3' ' HB2' ' A' ' 124' ' ' ALA . 45.8 tp -114.41 117.2 30.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.835 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.499 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 10.8 m -103.37 144.22 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 111.649 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.525 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 3.8 p30 -80.26 168.79 23.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.177 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.492 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 51.5 Cg_exo -55.41 -23.93 40.92 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.978 2.452 . . . . 0.0 113.596 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -78.48 -32.55 48.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.02 0.438 . . . . 0.0 110.442 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.12 22.92 5.08 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.076 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.57 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.8 mtmp? -107.15 147.84 29.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.425 HD13 HD11 ' A' ' 3' ' ' LEU . 49.8 mt -81.93 99.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.736 0.303 . . . . 0.0 110.248 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.25 -34.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.32 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.874 ' HB2' ' HB3' ' A' ' 115' ' ' LEU . . . -126.52 128.81 47.47 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 1.006 ' HD2' ' HG2' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -129.52 137.63 50.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.802 -0.181 . . . . 0.0 110.897 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 1.006 ' HG2' ' HD2' ' A' ' 125' ' ' LYS . 20.4 pt-20 45.79 75.48 0.11 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.652 1.181 . . . . 0.0 112.236 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.464 HD13 ' HB3' ' A' ' 124' ' ' ALA . 84.3 mt -100.97 170.29 8.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.361 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.549 ' HB2' ' OD1' ' A' ' 131' ' ' ASP . 9.1 mmm180 -111.07 177.37 4.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.45 -76.82 0.13 Allowed Glycine 0 C--N 1.335 0.494 0 O-C-N 123.741 0.651 . . . . 0.0 114.562 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.528 ' CG ' ' HZ1' ' A' ' 53' ' ' LYS . 0.1 OUTLIER -76.56 -15.94 59.73 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.338 -0.507 . . . . 0.0 110.863 -178.421 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.618 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.9 m-20 -62.25 -41.07 98.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.483 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 84.6 mt -51.03 -54.73 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.881 170.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.39 -58.96 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.869 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.618 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 7.0 p30 -68.8 -28.62 66.93 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.638 -171.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 92.7 m -66.58 -51.72 53.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.285 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.2 -38.48 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 110.396 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.508 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 12.3 tm-20 -64.28 -41.78 96.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.252 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -76.34 -17.05 59.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.287 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.42 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.4 t -86.86 -26.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.997 -168.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.64 26.94 5.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.161 0.505 . . . . 0.0 110.47 -174.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.32 15.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.434 ' HB2' ' HG3' ' A' ' 145' ' ' GLU . . . -70.65 -29.81 66.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.423 ' HZ1' ' CD ' ' A' ' 137' ' ' GLU . 0.2 OUTLIER 73.88 30.85 1.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.997 0.811 . . . . 0.0 111.42 179.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.434 ' HG3' ' HB2' ' A' ' 143' ' ' ALA . 0.0 OUTLIER -89.0 -39.08 13.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.386 175.712 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.41 ' H ' ' CD ' ' A' ' 145' ' ' GLU . . . 70.94 43.02 58.92 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.013 177.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.77 114.57 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.105 0.452 . . . . 0.0 110.807 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.7 m80 66.56 28.96 9.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.202 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -71.93 79.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.092 0.472 . . . . 0.0 109.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -105.21 25.87 10.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 72.09 -72.26 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.19 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.128 -177.217 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.696 ' HA ' ' SG ' ' A' ' 106' ' ' CYS . 85.1 p 49.73 53.11 13.32 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.819 0.699 . . . . 0.0 109.459 -169.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.7 mt 58.75 -136.19 0.88 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.492 -170.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -160.16 151.69 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.587 0.232 . . . . 0.0 110.525 178.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p -72.26 112.6 8.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.66 -4.03 39.6 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.9 t -86.02 143.53 28.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 50.8 t -69.18 136.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.09 145.84 30.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.653 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 152.89 58.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.846 2.364 . . . . 0.0 112.257 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.78 97.15 7.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.944 HD11 HG22 ' A' ' 101' ' ' VAL . 30.1 mm -86.35 147.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.065 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.464 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 11.6 t -142.07 123.52 14.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.533 0.682 . . . . 0.0 110.682 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.5 161.46 18.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.069 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.455 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 61.6 mt -96.57 123.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.75 0.309 . . . . 0.0 110.619 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -79.63 -177.23 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.892 0.377 . . . . 0.0 111.069 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 5.9 mp -68.6 -18.48 64.32 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.618 -176.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -25.39 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.355 0.597 . . . . 0.0 110.376 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.12 23.7 7.24 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.604 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.68 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.5 OUTLIER -101.59 138.8 38.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 p -83.99 94.82 8.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.167 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.67 130.99 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.464 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 6.0 m -103.12 167.21 9.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.168 0.508 . . . . 0.0 111.088 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.63 -28.62 69.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.943 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.49 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 7.5 t30 -70.79 -20.94 62.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.131 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -81.4 -4.63 56.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.974 0.416 . . . . 0.0 111.025 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.522 ' HE2' HD21 ' A' ' 89' ' ' ASN . 84.3 m-85 -110.21 5.27 21.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.406 0.622 . . . . 0.0 109.544 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.49 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 90.2 mttt -70.14 132.91 46.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.168 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.86 -27.68 4.56 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.513 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 42.4 mttm -114.84 166.86 11.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.386 -0.907 . . . . 0.0 108.935 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.528 ' HB3' HD12 ' A' ' 115' ' ' LEU . 66.9 m-85 -78.14 116.79 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 t -92.63 110.83 23.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.117 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.52 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 2.1 tm? -82.86 101.75 11.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.58 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 39.5 t -89.98 118.98 36.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.137 0.494 . . . . 0.0 110.257 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.431 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 6.2 t70 -106.24 112.91 26.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.618 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.466 ' HD2' ' O ' ' A' ' 112' ' ' HIS . 89.6 m-85 -95.44 115.76 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.467 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.3 p-90 -155.39 177.08 11.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.621 0.724 . . . . 0.0 112.209 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -170.63 167.28 7.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.761 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.1 72.23 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.616 0.722 . . . . 0.0 110.871 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -44.54 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.568 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 p -84.6 85.17 7.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.488 0.661 . . . . 0.0 109.236 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.6 m -60.65 -22.06 63.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.719 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.413 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 9.4 m95 -70.26 -39.55 74.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.472 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.417 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 59.9 m -56.4 -43.51 79.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.742 0.782 . . . . 0.0 109.079 173.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.434 ' HB2' ' O ' ' A' ' 42' ' ' SER . 8.1 mmm180 -59.22 -38.36 79.77 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.088 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.608 ' N ' ' HD2' ' A' ' 46' ' ' LYS . 1.3 mptp? -86.44 -8.26 57.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -89.46 -3.74 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 170.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.547 HG22 ' CH2' ' A' ' 88' ' ' TRP . 54.4 m -51.03 -50.74 73.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.536 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.8 Cg_endo -52.07 -40.55 68.0 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.122 1.881 . . . . 0.0 112.461 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.29 -41.26 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.409 . . . . 0.0 110.317 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.437 HD22 HD11 ' A' ' 132' ' ' LEU . 83.1 mt -61.34 -42.43 98.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.814 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.09 -42.56 93.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.561 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -53.66 -51.49 63.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 109.665 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 21.5 m -63.68 -49.47 73.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.268 -179.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.577 ' HB2' HD11 ' A' ' 65' ' ' ILE . 23.7 t80 -56.62 -50.28 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.807 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.554 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 38.0 t30 -75.38 -29.5 59.87 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.401 -171.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.92 -19.67 28.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.406 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 40.2 m-85 -121.08 12.81 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.554 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.6 ptmt -70.06 -21.06 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -75.93 -34.06 59.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.439 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 42.6 mttp -87.19 -167.74 2.0 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.559 -175.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.62 57.63 4.18 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.036 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.52 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 88.9 t80 -141.05 147.29 38.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.513 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 9.9 t -158.97 153.14 23.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.274 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 55' ' ' TYR . 45.4 mt -106.35 134.79 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -122.1 94.77 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.431 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -85.85 126.6 7.87 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.808 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.484 ' HB ' HD12 ' A' ' 93' ' ' LEU . 16.0 m -116.21 119.6 62.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.162 0.506 . . . . 0.0 110.46 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 40.3 t -122.01 139.0 54.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.134 0.492 . . . . 0.0 111.234 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 t -116.2 59.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.095 0.95 . . . . 0.0 108.583 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.69 -178.57 1.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.238 -170.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -67.42 -50.28 60.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.28 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.62 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 47.4 mtt180 -134.11 163.95 28.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.415 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.594 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 33.3 tt0 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -32.26 73.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.269 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.62 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -66.49 -38.57 87.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.955 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -64.01 -51.06 66.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.594 ' HD3' ' O ' ' A' ' 74' ' ' GLU . 1.4 mptm? -49.86 -48.64 51.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.84 0.828 . . . . 0.0 109.781 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -65.42 -38.25 89.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.013 -177.715 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.47 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . . . -66.06 -35.98 81.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.717 0.294 . . . . 0.0 111.282 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.18 -44.13 97.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.77 -29.21 68.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.889 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 44.9 mt-10 -59.5 -60.11 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.933 0.397 . . . . 0.0 111.57 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.97 4.92 42.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.225 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.416 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 4.4 mptp? 62.1 36.52 15.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 p -77.33 72.57 3.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.932 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -86.89 81.07 8.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.547 ' CH2' HG22 ' A' ' 48' ' ' THR . 9.6 p90 -148.84 -176.63 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.782 169.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.522 HD21 ' HE2' ' A' ' 27' ' ' PHE . 92.7 m-20 -69.48 98.91 1.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.166 0.508 . . . . 0.0 110.735 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -120.15 146.52 45.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.634 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.65 150.12 34.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.799 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.63 117.33 28.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.484 HD12 ' HB ' ' A' ' 68' ' ' VAL . 93.6 mt -70.2 135.99 49.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.171 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.664 ' O ' HG21 ' A' ' 98' ' ' VAL . 31.6 mt-30 -58.61 141.56 51.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.52 -23.6 66.92 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.726 -168.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.529 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 29.8 t70 -87.35 -36.57 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.448 173.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.503 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.9 t70 -56.04 -40.93 74.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.144 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.664 HG21 ' O ' ' A' ' 94' ' ' GLN . 85.3 t -49.83 -35.36 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.7 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.787 ' HB3' ' HZ3' ' A' ' 99' ' ' LYS . 5.6 ttpm? -53.09 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.75 -41.12 99.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.78 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.944 HG22 HD11 ' A' ' 12' ' ' ILE . 73.4 t -57.72 -61.72 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.892 ' HA ' HD12 ' A' ' 107' ' ' ILE . 40.1 mt -60.16 -39.25 85.73 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.042 -175.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.93 -64.08 0.93 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.197 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.7 m -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.3 1.0 . . . . 0.0 113.524 -167.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.9 15.18 0.7 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.699 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.696 ' SG ' ' HA ' ' A' ' 2' ' ' SER . 63.0 m 55.37 47.8 20.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.299 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.892 HD12 ' HA ' ' A' ' 102' ' ' LEU . 53.9 mt -88.16 107.11 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.466 -173.007 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.02 -8.04 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.285 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.33 170.82 35.7 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.524 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.62 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 98.6 m-85 -135.31 164.15 45.84 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.62 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.6 Cg_exo -77.26 133.54 31.29 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 124.176 -1.177 . . . . 0.0 112.579 -0.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.602 ' CD2' HG12 ' A' ' 107' ' ' ILE . 14.5 t60 -107.48 111.76 24.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.1 mt -125.62 131.55 71.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.239 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.58 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 45.3 pt -128.17 149.2 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.738 0.304 . . . . 0.0 110.798 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD12 ' HB3' ' A' ' 31' ' ' TYR . 47.0 tp -112.91 111.21 21.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.445 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 73.4 t -97.17 133.0 40.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.798 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.603 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 4.1 p30 -78.0 164.78 55.09 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.581 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -53.05 -24.34 24.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.2 2.6 . . . . 0.0 114.094 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.467 ' HB2' ' HE2' ' A' ' 121' ' ' LYS . 41.3 mt-10 -77.0 -37.12 55.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 110.055 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.05 23.8 2.62 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.76 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.603 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 34.2 mtmt -107.2 155.5 19.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.79 97.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.95 -34.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.155 0.503 . . . . 0.0 110.768 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.79 158.02 42.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.497 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 20.6 pttp -163.26 175.28 11.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.497 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 15.6 mm-40 64.69 20.76 12.23 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.413 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 132' ' ' LEU . 47.7 mt -59.62 137.68 57.96 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.614 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' NH2' ' HB2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -123.38 149.47 44.93 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.275 -170.498 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 43.45 -125.1 4.95 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.768 0.667 . . . . 0.0 114.437 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.06 -17.0 59.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.622 0.248 . . . . 0.0 110.916 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.507 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 31.0 t70 -63.31 -25.72 68.44 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.494 ' O ' HG22 ' A' ' 136' ' ' VAL . 75.8 mt -48.23 -58.52 4.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 109.956 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 40.9 t80 -60.34 -50.91 71.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.481 177.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.507 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 92.3 m-20 -61.92 -35.19 77.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.859 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.609 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 7.5 m -74.66 -30.71 61.7 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.521 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 86.9 t -65.44 -46.31 90.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.239 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.524 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 2.3 tp10 -68.87 -23.34 64.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.442 0.639 . . . . 0.0 109.948 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.609 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 23.9 ttpt -77.0 -59.15 2.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.08 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.419 ' CD1' HG21 ' A' ' 135' ' ' THR . 47.2 m-85 -88.2 -51.4 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.521 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 61.0 t -66.96 -47.25 82.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 111.277 -173.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.524 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 54.1 t30 -76.66 -18.09 58.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.5 0.666 . . . . 0.0 110.037 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.45 -25.66 14.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.98 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 61.28 17.16 7.97 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.862 0.465 . . . . 0.0 111.607 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 tptt 63.82 77.81 0.31 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.605 0.717 . . . . 0.0 111.503 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.426 ' CD ' ' H ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -103.01 155.09 18.61 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.82 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.426 ' H ' ' CD ' ' A' ' 145' ' ' GLU . . . 148.15 -45.81 0.72 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.2 m80 60.03 -165.56 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.441 0.638 . . . . 0.0 110.828 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -130.9 29.25 4.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -133.55 123.45 25.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.73 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -70.35 100.54 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -93.39 -2.66 54.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 166.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 . . . . . 0 C--O 1.245 0.842 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.559 172.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m 57.93 -163.81 0.19 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.719 0.637 . . . . 0.0 110.404 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.437 ' HB3' HD11 ' A' ' 122' ' ' ILE . 2.8 mm? -73.02 104.4 4.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.119 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.02 -91.12 0.23 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -147.84 128.04 13.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.32 -2.22 86.49 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -70.27 123.99 23.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.16 137.72 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.956 0.407 . . . . 0.0 110.627 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.51 146.54 31.49 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 -178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_exo -63.08 163.34 22.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.353 2.702 . . . . 0.0 112.535 177.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.03 115.66 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 23' ' ' SER . 65.8 mt -83.72 137.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.137 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.439 HG22 ' HG ' ' A' ' 23' ' ' SER . 19.0 m -126.31 89.24 2.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.331 0.586 . . . . 0.0 110.022 176.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.14 161.23 14.88 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.911 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG2' ' HA2' ' A' ' 19' ' ' GLY . 52.8 mt -91.71 129.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -171.68 2.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.062 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.11 -27.05 68.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.551 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 52.0 mtpt -83.23 -49.66 9.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.052 0.453 . . . . 0.0 110.198 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 15' ' ' ILE . . . 137.32 23.29 0.47 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.76 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.416 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 23.4 m-80 -102.19 149.58 24.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -80.34 99.97 8.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.479 0.657 . . . . 0.0 110.679 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.3 141.93 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.277 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.664 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 6.2 m -116.21 166.1 12.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -174.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.84 -22.67 65.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.122 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.664 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 2.6 p-10 -66.25 -28.57 68.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -72.61 -17.35 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.785 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -113.29 3.88 16.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.686 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -63.11 168.38 4.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.681 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.482 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.33 23.04 66.41 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.302 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -145.09 161.4 39.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -78.07 107.58 10.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -109.74 116.93 53.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.581 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.475 HD23 ' HA ' ' A' ' 115' ' ' LEU . 43.8 mt -85.0 109.15 17.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 169.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.512 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 61.7 t -89.07 111.15 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.431 . . . . 0.0 109.861 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.496 ' CG ' ' HG ' ' A' ' 44' ' ' CYS . 5.3 t70 -105.86 117.13 33.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.559 -175.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -98.73 116.1 30.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.5 p-90 -144.63 176.55 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.444 0.64 . . . . 0.0 111.77 -174.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -170.73 168.3 7.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.225 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -28.47 68.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.72 -67.66 1.97 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.72 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.9 m -75.65 88.29 2.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.418 0.627 . . . . 0.0 109.859 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.424 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 58.8 p -75.31 11.83 1.11 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.121 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.551 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 40.1 m95 -63.02 -45.34 92.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.548 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 29.9 t -62.34 -31.11 71.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.525 0.679 . . . . 0.0 109.779 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.567 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 59.9 mtp180 -76.84 -14.08 59.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.306 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.6 mptt -85.28 -38.36 18.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.966 171.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.04 3.64 45.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.807 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.567 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 93.4 m -53.09 -50.38 82.44 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.534 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -48.24 -42.54 33.36 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.331 2.021 . . . . 0.0 113.0 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -68.89 -47.39 65.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.484 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.31 -46.65 85.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.799 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.416 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 65.4 tp -62.25 -43.11 99.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.818 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -62.05 -47.49 84.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.1 m -63.34 -48.24 78.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.003 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.448 ' HB2' HD12 ' A' ' 65' ' ' ILE . 89.7 t80 -58.78 -49.96 75.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.514 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 39.6 t-20 -60.13 -42.52 94.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.099 0.476 . . . . 0.0 110.546 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.26 76.47 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.722 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 77.2 m-85 -120.69 7.34 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -169.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.514 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 16.7 pttm -57.88 -33.8 69.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.359 0.6 . . . . 0.0 111.37 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.97 7.88 45.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.23 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -120.15 26.46 9.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.57 26.7 50.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.627 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 58' ' ' PHE . 66.3 t80 -134.75 142.88 46.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -152.56 165.44 35.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.034 0.445 . . . . 0.0 110.55 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.448 HD12 ' HB2' ' A' ' 55' ' ' TYR . 56.3 mt -120.18 124.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.597 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.401 ' HA ' ' HB2' ' A' ' 89' ' ' ASN . 10.9 t80 -101.21 94.51 6.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.34 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 102.71 2.81 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.137 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.88 113.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.013 0.435 . . . . 0.0 110.737 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.5 t -102.56 150.7 23.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.353 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.534 ' HB ' HD13 ' A' ' 93' ' ' LEU . 7.9 t -131.52 28.58 4.62 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.159 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.37 167.94 0.87 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.483 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 16.6 mtm180 -53.75 -71.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.163 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -109.67 172.28 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.263 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.472 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 36.2 tt0 -74.3 -33.11 63.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.73 -41.2 97.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.012 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.483 ' OD2' ' HB2' ' A' ' 72' ' ' ARG . 59.7 m-20 -60.85 -49.37 77.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.997 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.431 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 24.0 t90 -57.75 -47.87 81.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.108 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.472 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.7 mptm? -62.17 -41.6 98.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.419 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.557 ' HZ2' ' HG2' ' A' ' 83' ' ' GLU . 9.6 tmtm? -70.41 -37.99 74.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.55 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.64 75.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.18 -33.98 55.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.533 0.683 . . . . 0.0 110.408 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -28.84 70.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.014 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.557 ' HG2' ' HZ2' ' A' ' 79' ' ' LYS . 38.9 mt-10 -84.03 -59.98 2.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.619 0.247 . . . . 0.0 110.878 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.85 -22.25 56.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.488 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm 70.88 32.39 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -67.44 100.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.665 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -118.13 74.58 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 111.893 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.535 ' HH2' HG22 ' A' ' 48' ' ' THR . 3.3 p90 -133.94 -154.07 0.57 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.432 ' H ' ' HB2' ' A' ' 88' ' ' TRP . 11.6 m120 -72.45 80.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.355 0.525 . . . . 0.0 110.353 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -82.69 125.24 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.2 m -134.02 143.24 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.347 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.3 tp -102.57 123.97 47.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.534 HD13 ' HB ' ' A' ' 70' ' ' THR . 93.0 mt -63.33 134.09 55.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.842 0.353 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.606 ' O ' HG22 ' A' ' 98' ' ' VAL . 36.2 mt-30 -67.69 149.27 50.22 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -62.44 -17.8 60.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.082 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.63 -48.9 8.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.416 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.68 -33.26 71.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.606 HG22 ' O ' ' A' ' 94' ' ' GLN . 44.3 t -47.01 -43.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.7 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -60.74 -63.04 1.44 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.878 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.21 -33.1 63.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.47 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 55.7 t -70.01 -57.37 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.463 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.647 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 26.6 mt -59.7 -47.37 85.9 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.235 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.76 -61.82 2.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.259 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 106' ' ' CYS . 19.0 t -62.82 -28.24 69.87 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.344 1.027 . . . . 0.0 112.805 -167.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.47 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 24.4 m-85 -74.93 8.63 2.36 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.752 0.31 . . . . 0.0 110.634 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.451 ' H ' ' C ' ' A' ' 104' ' ' SER . 95.4 m 58.22 58.62 3.4 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.089 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.647 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.2 mp -75.4 116.73 18.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.583 0.706 . . . . 0.0 110.569 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.45 -21.04 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.128 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.79 178.25 41.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.48 151.38 77.24 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.551 ' HD3' ' HB2' ' A' ' 43' ' ' TRP . 55.6 Cg_endo -87.98 128.5 9.27 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.681 0.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.8 95.81 10.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.064 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.512 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 81.9 mt -113.47 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.506 . . . . 0.0 110.914 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 31.2 pt -114.45 148.76 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.537 -176.386 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.475 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.2 tt -95.48 111.61 23.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.446 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 97.9 t -107.91 132.62 55.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.65 163.74 51.85 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.417 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.482 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 82.0 Cg_exo -48.01 -31.24 15.54 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.355 2.703 . . . . 0.0 114.46 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.525 ' HB3' ' CE ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -88.39 -1.57 58.11 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 88.45 29.23 19.9 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.838 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.525 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 11.1 mtmm -110.72 138.26 47.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.437 HD11 ' HB3' ' A' ' 3' ' ' LEU . 28.5 mt -75.12 118.4 20.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.483 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.9 t -94.96 -38.32 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.89 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.317 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.448 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 18.3 pttm -150.15 147.1 27.33 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.935 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 61.97 35.79 15.98 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.502 1.126 . . . . 0.0 111.555 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.49 141.64 57.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.97 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.604 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -97.16 166.05 11.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.139 -174.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -35.96 -72.61 0.13 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.2 -35.91 69.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.923 0.362 . . . . 0.0 110.432 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -55.78 -46.15 78.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.727 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.447 HD13 ' N ' ' A' ' 133' ' ' TYR . 4.3 pp -66.85 -38.78 87.03 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.447 ' N ' HD13 ' A' ' 132' ' ' LEU . 87.3 t80 -65.34 -50.8 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -57.4 -42.14 81.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.716 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.2 m -69.04 -47.01 66.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.546 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 52.5 t -64.79 -43.91 96.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.722 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 4.3 tt0 -63.85 -39.27 93.83 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -57.82 -33.27 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.385 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -87.69 -61.84 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.91 -40.39 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.74 -170.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 137' ' ' GLU . 61.9 t30 -84.28 -32.77 24.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.3 25.74 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.157 -0.928 . . . . 0.0 113.459 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.39 -7.32 44.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.483 . . . . 0.0 109.903 174.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -56.85 120.83 8.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.538 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.72 ' OE1' ' HA ' ' A' ' 149' ' ' HIS . 7.2 tp10 -59.44 140.32 56.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.811 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 105.14 -41.47 2.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.164 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -67.5 -37.62 83.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -154.49 101.77 2.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.141 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.72 ' HA ' ' OE1' ' A' ' 145' ' ' GLU . 31.9 p80 -49.37 131.15 20.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.924 -170.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.07 -20.64 30.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.503 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -150.93 -162.32 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.711 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 p80 . . . . . 0 C--O 1.246 0.873 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.89 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.7 ' HA ' ' HB3' ' A' ' 106' ' ' CYS . 13.9 m -89.27 131.13 35.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.774 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.53 HD21 ' HB3' ' A' ' 7' ' ' SER . 73.1 mt -113.94 154.14 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.02 -79.61 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.149 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.502 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 2.9 t -153.74 137.19 15.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.562 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.5 -1.29 88.94 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.53 ' HB3' HD21 ' A' ' 3' ' ' LEU . 6.8 m -82.01 128.25 33.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.095 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 48.7 t -69.04 129.66 33.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.83 0.348 . . . . 0.0 110.123 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.409 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -93.45 141.6 24.12 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.441 -177.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 22.4 Cg_exo -66.12 163.3 32.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.167 2.578 . . . . 0.0 111.96 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.71 113.92 24.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.011 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.6 141.9 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -120.64 105.12 10.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.914 0.388 . . . . 0.0 110.05 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.76 167.94 14.5 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.811 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.8 mt -105.61 128.09 59.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -173.13 4.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.035 0.445 . . . . 0.0 111.273 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.402 HD22 ' CD1' ' A' ' 81' ' ' ILE . 75.0 mt -64.6 -30.38 71.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.965 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.14 -32.86 59.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.33 22.01 6.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -95.15 141.19 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 p -82.31 106.01 13.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.77 146.31 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.859 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 m -112.57 157.43 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.172 0.51 . . . . 0.0 111.202 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.446 HD11 HG11 ' A' ' 32' ' ' VAL . 62.5 tp -61.96 -24.71 67.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.458 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 8.4 t30 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.12 -9.83 59.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.441 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -113.88 1.63 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.34 . . . . 0.0 110.51 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.458 ' CD ' ' HA ' ' A' ' 25' ' ' ASN . 26.3 mtpp -63.61 171.21 2.74 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.395 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.21 83.03 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.583 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -137.55 165.47 26.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.51 114.04 14.79 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.446 HG11 HD11 ' A' ' 24' ' ' LEU . 46.4 t -111.18 111.7 37.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.015 0.435 . . . . 0.0 111.31 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.54 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.3 tp -90.75 113.88 26.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 42.8 t -102.47 119.45 50.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.438 0.161 . . . . 0.0 110.942 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.39 116.81 33.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.86 116.87 29.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.485 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.953 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 11.7 p-90 -150.61 -178.4 6.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.471 ' HE1' ' HB2' ' A' ' 110' ' ' PHE . 2.2 p90 -170.58 160.08 7.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.926 169.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.52 6.72 3.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.87 -16.73 67.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.086 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.54 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 96.3 m -120.88 121.43 38.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.029 0.443 . . . . 0.0 110.483 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 3.8 m -59.11 -33.36 70.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.459 -178.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -66.73 -31.51 72.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.538 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.953 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 72.9 m -58.45 -41.12 84.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -85.12 -12.12 53.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.503 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.5 mptp? -75.69 -28.76 58.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.901 0.382 . . . . 0.0 110.311 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -79.9 -16.12 55.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.329 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.591 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 90.8 m -50.48 -52.13 58.11 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 52.7 Cg_exo -53.0 -42.08 67.02 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.133 1.888 . . . . 0.0 112.803 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 95.7 m-85 -69.11 -38.26 78.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 -178.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD21 HD12 ' A' ' 132' ' ' LEU . 79.2 mt -63.35 -50.32 70.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.421 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 50.5 tp -59.19 -40.54 86.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.475 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -52.2 -51.94 55.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.829 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -68.04 -43.66 78.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.445 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.628 ' HB2' HD13 ' A' ' 65' ' ' ILE . 85.9 t80 -60.93 -48.8 80.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.47 -29.02 69.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.51 -38.05 55.79 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.494 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 94.4 m-85 -120.23 6.74 10.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.61 ' HG2' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -61.65 -36.59 81.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.364 0.602 . . . . 0.0 110.84 -176.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.61 ' N ' ' HG2' ' A' ' 59' ' ' LYS . 2.9 p30 -82.76 6.78 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HD2' ' HA ' ' A' ' 58' ' ' PHE . 55.1 mttp -116.5 15.28 15.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.12 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.53 30.98 25.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.719 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.553 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 49.5 t80 -133.89 143.33 48.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -146.92 163.78 35.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 109.955 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.628 HD13 ' HB2' ' A' ' 55' ' ' TYR . 20.2 mt -116.57 125.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.896 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.41 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 57.9 t80 -108.41 99.23 8.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.324 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.542 ' HA3' ' NE2' ' A' ' 90' ' ' GLN . . . -87.15 135.19 13.01 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.019 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.536 ' HB ' HD22 ' A' ' 93' ' ' LEU . 3.2 m -133.4 112.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.574 0.702 . . . . 0.0 110.886 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' HD11 ' A' ' 92' ' ' LEU . 29.7 t -113.12 154.62 26.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.776 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.45 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.9 t -123.91 41.41 3.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.739 0.781 . . . . 0.0 109.018 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.05 169.88 0.15 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -60.66 -38.46 84.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.578 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 38.5 mtt180 -144.72 169.27 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.045 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 1.13 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 31.7 tt0 -75.64 -41.06 55.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.578 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 mp0 -60.78 -36.18 78.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 18.4 t0 -66.65 -48.62 68.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.322 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.643 ' HZ2' ' HG3' ' A' ' 90' ' ' GLN . 34.2 t90 -56.77 -48.25 78.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.143 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 1.13 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 1.6 mptp? -58.83 -38.08 77.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.214 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.49 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -60.92 -45.53 94.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.896 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.68 -44.73 96.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.096 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.423 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 70.0 mt -64.34 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.244 0.545 . . . . 0.0 110.753 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.88 -31.19 72.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.305 0.574 . . . . 0.0 110.306 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 41.7 mt-10 -80.32 -53.03 7.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.392 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' OD1' ' HA ' ' A' ' 81' ' ' ILE . 13.4 p-10 -91.52 -17.98 24.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.666 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER 67.41 38.5 3.19 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.305 0.574 . . . . 0.0 111.221 -179.212 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.3 p -72.76 67.62 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.325 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.12 85.57 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.421 ' HZ3' ' HB2' ' A' ' 52' ' ' LEU . 7.4 p90 -141.04 -149.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.01 64.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.713 0.688 . . . . 0.0 109.849 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.643 ' HG3' ' HZ2' ' A' ' 77' ' ' TRP . 8.6 tp-100 -90.97 123.42 34.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.242 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.72 152.72 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.188 0.518 . . . . 0.0 110.888 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.419 HD11 ' O ' ' A' ' 69' ' ' SER . 45.4 tp -90.3 129.88 36.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.574 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.536 HD22 ' HB ' ' A' ' 68' ' ' VAL . 79.5 mt -70.03 125.3 26.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.546 ' O ' HG22 ' A' ' 98' ' ' VAL . 40.2 mt-30 -65.12 147.93 52.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.6 -16.75 63.96 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.867 0.365 . . . . 0.0 111.144 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.27 -49.43 8.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.45 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -50.91 -36.73 39.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.061 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.546 HG22 ' O ' ' A' ' 94' ' ' GLN . 25.1 t -45.01 -41.85 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.456 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.539 ' HB2' ' HZ3' ' A' ' 99' ' ' LYS . 9.6 mtmp? -56.24 -64.27 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 111.682 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.7 -36.44 65.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.906 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 105' ' ' TYR . 55.7 t -68.72 -55.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.257 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.663 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 15.8 mt -60.4 -42.18 95.4 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.555 -175.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -62.04 -62.07 2.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.519 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 106' ' ' CYS . 67.2 m -55.59 -32.11 62.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.548 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.491 ' HE2' HG11 ' A' ' 101' ' ' VAL . 62.8 m-85 -83.03 22.14 0.98 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.763 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.7 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 26.7 p 47.96 48.85 17.69 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.38 1.072 . . . . 0.0 110.56 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.663 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 79.6 mt -97.67 110.73 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.689 -175.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.56 18.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.43 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.69 -178.43 41.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.596 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.471 ' HB2' ' HE1' ' A' ' 38' ' ' PHE . 97.7 m-85 -134.84 157.39 77.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.937 0.369 . . . . 0.0 110.293 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.694 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 92.4 Cg_endo -91.61 168.85 25.87 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.762 -1.349 . . . . 0.0 112.91 -1.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.671 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.6 128.97 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.75 HG23 ' HG3' ' A' ' 125' ' ' LYS . 41.7 pt -123.11 153.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.64 113.35 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.1 t -101.1 140.58 19.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.598 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.74 167.29 30.78 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.04 -35.27 50.09 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.82 2.347 . . . . 0.0 113.969 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.425 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.4 mt-10 -79.46 -24.23 42.53 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.511 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.36 27.99 3.44 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.538 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.483 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -106.05 148.32 27.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.791 0.795 . . . . 0.0 109.309 172.369 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.502 ' O ' ' HA ' ' A' ' 5' ' ' THR . 38.2 mt -80.3 104.52 8.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.88 -28.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.75 138.47 30.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.75 ' HG3' HG23 ' A' ' 114' ' ' ILE . 20.8 ttpp -129.81 155.5 45.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.327 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.438 ' HG2' ' HG2' ' A' ' 125' ' ' LYS . 2.3 mm-40 66.08 42.95 3.05 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.897 0.748 . . . . 0.0 110.931 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.465 ' HB3' HD22 ' A' ' 132' ' ' LEU . 83.2 mt -82.16 156.07 24.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.876 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.752 ' HD3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -162.28 167.28 24.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.955 -172.765 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 44.02 -129.65 6.72 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.933 0.771 . . . . 0.0 113.944 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -77.03 -24.21 52.1 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.62 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HA ' ' CB ' ' A' ' 134' ' ' ASN . 12.5 m-20 -53.67 -27.27 26.62 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.287 0.367 . . . . 0.0 110.43 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.529 ' O ' HG21 ' A' ' 136' ' ' VAL . 71.6 mt -56.18 -64.57 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.357 0.598 . . . . 0.0 109.736 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -58.34 -42.65 87.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.981 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.454 ' CB ' ' HA ' ' A' ' 131' ' ' ASP . 1.9 t-20 -51.13 -52.32 44.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.483 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -72.26 -34.24 68.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.176 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 132' ' ' LEU . 56.2 t -71.71 -42.31 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.879 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.568 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 3.9 tp10 -61.17 -34.85 75.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.77 0.795 . . . . 0.0 109.364 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.46 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 12.9 ttmt -64.17 -51.04 65.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.57 -54.86 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.83 -48.52 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 111.405 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.568 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 35.2 t30 -76.4 -23.83 54.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.42 0.629 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.38 14.46 34.56 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.391 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.0 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.061 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.3 -77.76 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -90.12 -0.53 57.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -174.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.86 162.81 53.12 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.511 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -73.77 84.06 1.64 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.216 0.531 . . . . 0.0 110.217 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -81.68 151.53 27.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.263 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -80.67 132.91 35.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.55 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -99.89 163.36 12.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.548 ' ND1' ' H ' ' A' ' 152' ' ' HIS . 8.4 p80 -119.89 -78.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.994 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.548 ' H ' ' ND1' ' A' ' 151' ' ' HIS . 7.7 t60 . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t -78.19 88.28 4.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.242 0.544 . . . . 0.0 109.759 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.509 ' HB2' HD12 ' A' ' 122' ' ' ILE . 72.6 mt -78.53 133.84 37.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.271 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.73 -168.81 1.5 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.342 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -64.51 111.2 2.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.92 1.81 52.08 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.447 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.489 ' HB2' ' HB3' ' A' ' 3' ' ' LEU . 19.4 m -87.58 131.66 34.33 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.774 -0.25 . . . . 0.0 110.424 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 52.0 t -69.64 132.82 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -100.28 148.35 34.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.553 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 30.0 Cg_exo -64.35 163.21 27.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.566 2.844 . . . . 0.0 112.516 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.28 131.75 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.537 HD13 HG23 ' A' ' 101' ' ' VAL . 18.1 mm -87.33 148.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -133.61 94.23 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.322 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 175.9 16.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.646 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.97 117.07 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -174.8 5.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.026 0.441 . . . . 0.0 111.438 -171.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.32 -30.61 66.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.789 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -69.27 -25.68 64.39 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.053 0.454 . . . . 0.0 111.067 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.07 20.89 29.31 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.494 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -103.18 148.84 25.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -77.3 97.97 5.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.93 137.41 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.197 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -176.83 3.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -79.42 -28.94 41.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.202 0.525 . . . . 0.0 110.198 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.658 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -66.82 -19.92 65.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.258 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.62 -31.87 71.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 111.204 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -115.62 20.55 14.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.413 0.625 . . . . 0.0 109.78 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.658 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 57.5 tttp -84.06 66.76 9.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.991 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.05 17.91 0.19 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.875 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -149.64 175.21 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -80.27 112.57 17.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.42 114.32 37.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.164 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 tp -92.03 109.85 21.21 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 33.6 t -91.19 117.47 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.822 0.344 . . . . 0.0 110.945 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.93 103.04 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.348 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' HA ' HG22 ' A' ' 68' ' ' VAL . 39.3 m-85 -82.19 114.72 20.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.419 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 11.4 p-90 -155.08 173.68 16.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 122.186 0.993 . . . . 0.0 112.731 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -164.71 154.15 13.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.894 -1.957 . . . . 0.0 107.064 165.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.43 -29.35 66.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.09 -38.19 95.15 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.063 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.1 p -87.55 96.62 10.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.407 0.622 . . . . 0.0 110.231 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.3 m -68.15 -11.2 58.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.155 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -69.82 -42.46 73.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.876 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . 20.7 p -67.84 -29.6 68.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.529 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 6.6 mmp_? -75.57 -14.29 60.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.135 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.6 mptm? -79.13 -21.68 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.732 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -94.92 -3.58 48.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.255 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.537 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 94.1 m -51.16 -51.52 67.33 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.346 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.0 Cg_endo -51.72 -39.05 67.49 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.374 2.05 . . . . 0.0 112.495 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.18 -39.77 62.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.989 0.423 . . . . 0.0 110.629 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.497 HD21 HD13 ' A' ' 113' ' ' ILE . 97.0 mt -63.18 -45.49 91.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.275 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.37 -41.36 96.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.511 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -57.74 -53.29 59.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.396 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.408 ' HA ' ' HD1' ' A' ' 133' ' ' TYR . 19.6 m -61.93 -42.51 99.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.116 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.652 ' HB2' HD12 ' A' ' 65' ' ' ILE . 56.4 t80 -59.73 -56.32 23.36 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.483 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 28.0 m-80 -58.08 -35.43 71.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.66 48.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.495 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 92.5 m-85 -120.2 0.78 10.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.524 ' HG3' ' OD2' ' A' ' 60' ' ' ASP . 14.6 ptmm? -60.18 161.6 6.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.241 0.543 . . . . 0.0 111.048 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 32.0 m-20 73.7 -49.69 0.68 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.8 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 44.4 mttp -60.64 -88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.786 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.404 ' H ' ' HB2' ' A' ' 61' ' ' LYS . . . -136.36 15.79 3.9 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.788 -179.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.97 141.59 44.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -150.6 149.54 30.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.253 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.652 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -103.21 129.74 54.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.966 0.412 . . . . 0.0 110.172 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t80 -119.35 98.89 6.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.001 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.74 122.57 6.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.191 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.596 ' HB ' HD23 ' A' ' 93' ' ' LEU . 15.4 m -100.43 111.88 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.656 0.741 . . . . 0.0 110.126 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -104.76 136.51 44.14 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.369 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.532 ' HB ' HD13 ' A' ' 93' ' ' LEU . 12.7 t -122.62 32.38 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.045 0.926 . . . . 0.0 109.065 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.4 175.78 0.54 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.285 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -79.05 -57.77 3.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.315 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.545 ' HB3' ' OD2' ' A' ' 76' ' ' ASP . 22.5 tpt180 -123.78 152.01 42.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.317 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.558 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 17.1 tt0 -64.7 -35.04 79.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.464 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -58.22 -47.07 84.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.739 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.545 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 2.1 p30 -73.51 -36.19 65.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.743 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.443 ' O ' HG12 ' A' ' 81' ' ' ILE . 26.6 t90 -54.4 -54.83 35.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.558 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -57.94 -43.13 86.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.87 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.499 ' HZ3' ' CD ' ' A' ' 83' ' ' GLU . 55.9 tttm -57.0 -50.1 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.764 178.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.14 88.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.443 HG12 ' O ' ' A' ' 77' ' ' TRP . 39.3 mm -59.82 -39.95 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.108 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 37.0 tp10 -73.91 -32.76 63.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.27 -179.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.499 ' CD ' ' HZ3' ' A' ' 79' ' ' LYS . 44.6 mt-10 -77.67 -49.34 14.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.125 0.488 . . . . 0.0 110.897 179.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.97 -19.6 60.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.903 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.401 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 61.0 mmtt 64.3 27.09 13.77 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.312 174.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 p -87.99 82.32 7.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.11 87.7 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.559 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -150.97 -159.66 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.853 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.24 83.94 7.24 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.357 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -94.74 136.12 35.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.928 0.394 . . . . 0.0 110.695 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 25.5 m -125.83 137.3 58.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.689 174.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.2 tp -87.79 116.07 25.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.596 HD23 ' HB ' ' A' ' 68' ' ' VAL . 74.5 mt -57.45 130.86 48.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.487 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.636 ' O ' HG22 ' A' ' 98' ' ' VAL . 66.1 mt-30 -64.63 151.94 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.914 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.006 0.432 . . . . 0.0 111.869 -170.516 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.68 -42.85 12.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.515 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.9 t70 -54.07 -31.65 52.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.464 0.705 . . . . 0.0 111.793 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 94' ' ' GLN . 52.6 t -48.0 -33.99 4.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.175 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.586 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 54.9 mttp -57.67 -65.62 0.6 Allowed 'General case' 0 C--O 1.223 -0.319 0 O-C-N 123.035 0.209 . . . . 0.0 111.495 -175.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.501 ' O ' ' HB2' ' A' ' 104' ' ' SER . 24.9 t70 -63.02 -43.48 98.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.394 -170.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.537 HG23 HD13 ' A' ' 12' ' ' ILE . 37.0 t -53.95 -63.21 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.25 0.548 . . . . 0.0 110.397 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.629 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 40.4 mt -66.61 -42.12 87.34 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.586 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 12.8 mt-10 -67.34 -64.17 0.91 Allowed 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 122.009 -0.432 . . . . 0.0 111.144 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 38.6 m -62.26 -32.55 73.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.484 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 74.7 m-85 -77.48 7.7 5.14 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.723 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m 61.85 53.35 3.15 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.246 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.629 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.7 mm -105.43 98.99 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.905 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.87 13.36 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.772 0.796 . . . . 0.0 110.739 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.64 -162.61 34.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.641 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.39 156.17 69.74 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.969 0.384 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.876 ' HB3' ' HB3' ' A' ' 44' ' ' CYS . 82.7 Cg_endo -96.63 164.12 14.18 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.102 -1.208 . . . . 0.0 113.13 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.552 ' HD1' ' CD ' ' A' ' 126' ' ' GLU . 65.8 m-70 -145.11 130.74 18.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.497 HD13 HD21 ' A' ' 51' ' ' LEU . 70.5 mt -128.27 113.37 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.759 0.314 . . . . 0.0 110.835 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.819 HG22 ' HG3' ' A' ' 125' ' ' LYS . 42.1 pt -112.51 156.57 13.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.359 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.8 118.56 31.16 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -112.28 136.36 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.623 ' OD1' ' HD2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -78.59 166.76 40.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.018 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -50.51 -44.05 41.76 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.871 2.381 . . . . 0.0 113.561 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.455 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.0 mt-10 -65.21 -29.6 70.42 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.046 -0.409 . . . . 0.0 110.589 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.35 33.04 2.6 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.418 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.623 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -110.51 146.56 35.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.97 0.885 . . . . 0.0 109.194 170.893 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 3' ' ' LEU . 25.6 mt -71.17 116.34 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.946 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.44 -37.44 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.25 24.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.819 ' HG3' HG22 ' A' ' 114' ' ' ILE . 88.7 tttt -123.7 128.16 49.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.51 . . . . 0.0 111.337 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.552 ' CD ' ' HD1' ' A' ' 112' ' ' HIS . 44.1 mt-10 58.72 74.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.71 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.755 ' HB2' HD22 ' A' ' 132' ' ' LEU . 43.8 mt -91.3 155.34 18.6 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.53 HH12 ' HG2' ' A' ' 111' ' ' PRO . 28.4 mmt180 -128.07 161.7 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.25 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 50.92 -137.78 27.14 Favored Glycine 0 N--CA 1.452 -0.26 0 O-C-N 123.983 0.802 . . . . 0.0 113.168 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.37 -16.43 58.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.546 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 17.7 m-20 -60.52 -27.26 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.283 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.755 HD22 ' HB2' ' A' ' 127' ' ' LEU . 23.6 mt -51.45 -58.18 6.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.742 167.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.408 ' HD1' ' HA ' ' A' ' 54' ' ' THR . 67.3 t80 -62.81 -48.75 77.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.546 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 89.3 m-20 -51.7 -47.18 64.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 m -67.84 -44.07 78.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.5 t -63.94 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 15.7 tt0 -66.28 -44.09 84.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 0.0 110.564 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -59.87 -29.14 68.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 -60.66 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.0 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.7 -44.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.443 ' CB ' ' HG3' ' A' ' 137' ' ' GLU . 52.3 t-20 -62.31 -50.63 70.9 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.66 -166.5 51.47 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.06 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.21 122.9 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.59 1.84 6.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.462 . . . . 0.0 110.498 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -85.94 -36.71 19.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.669 -173.637 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 122.03 64.15 0.23 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.795 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.86 -30.79 71.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -80.94 95.55 6.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.019 0.438 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -84.75 179.48 7.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.64 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -151.84 48.95 0.79 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 109.654 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -173.62 -55.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.037 176.479 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.435 ' HB3' ' CG ' ' A' ' 126' ' ' GLU . 25.1 ptp . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.665 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 9.5 m -123.95 -1.67 8.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.33 0.586 . . . . 0.0 109.711 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.429 ' HG ' ' SG ' ' A' ' 106' ' ' CYS . 98.4 mt -106.98 155.73 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.665 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.25 -171.28 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.13 0.491 . . . . 0.0 111.238 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.954 HG21 ' HA ' ' A' ' 123' ' ' VAL . 90.7 m -104.26 130.17 52.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.886 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.67 -10.5 45.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.779 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -77.95 127.06 31.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.421 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 54.8 t -69.7 132.87 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.537 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -88.2 146.5 38.27 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.591 -177.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -61.82 163.3 19.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.315 2.676 . . . . 0.0 112.094 173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 130.73 34.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.36 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 51.7 mt -94.1 138.88 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.146 178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.17 101.42 8.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 0.0 110.55 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.84 156.59 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.783 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -98.98 122.21 50.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.458 ' CG ' ' HZ3' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -80.84 -175.3 5.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.023 0.439 . . . . 0.0 111.282 -173.854 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.37 -31.65 69.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.991 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 8.8 mtmp? -80.11 -18.66 49.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 111.294 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 25.73 13.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.119 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.565 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.97 144.18 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.684 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 94.57 6.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.039 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.29 143.24 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.816 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 15.7 m -119.47 170.35 9.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.72 0.295 . . . . 0.0 110.274 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.479 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 34.6 tp -68.17 -7.74 32.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.207 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.47 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 28.3 p-10 -65.52 -32.37 73.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.39 -31.82 71.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.683 0.754 . . . . 0.0 111.087 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.479 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 95.1 m-85 -85.07 -2.92 58.54 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.45 ' HE2' ' HA3' ' A' ' 120' ' ' GLY . 51.4 mttt -84.03 99.55 10.51 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.371 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 132.94 -9.13 5.17 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -169.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -121.01 165.55 15.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.32 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.92 117.37 23.89 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 8.5 t -109.32 115.82 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.866 0.365 . . . . 0.0 111.856 -169.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.5 HD11 HD23 ' A' ' 132' ' ' LEU . 34.3 tp -97.01 105.02 17.09 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 15.8 t -96.45 108.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.938 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -102.98 116.83 33.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.26 121.37 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.177 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.53 ' O ' ' HA ' ' A' ' 69' ' ' SER . 29.9 p-90 -152.97 -178.24 6.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -175.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -168.73 162.8 11.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.487 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -30.95 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.65 65.22 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.801 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.92 99.64 6.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.162 0.506 . . . . 0.0 110.634 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.488 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 59.2 m -63.6 -35.04 79.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.384 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.562 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 71.3 t-105 -60.67 -33.95 73.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.452 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 111' ' ' PRO . 58.3 m -60.08 -37.88 81.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.504 0.669 . . . . 0.0 110.341 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.698 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 42.2 mtm180 -84.96 -12.21 53.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.648 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.562 ' HG2' ' HA ' ' A' ' 43' ' ' TRP . 51.5 mmtt -70.76 -21.74 62.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.201 0.524 . . . . 0.0 110.865 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.09 -2.05 58.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.973 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.494 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 86.7 m -52.48 -49.0 88.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 71.6 Cg_exo -50.68 -44.53 40.11 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.011 1.807 . . . . 0.0 112.454 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -69.27 -39.22 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.71 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.47 -48.57 80.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.41 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.22 -40.42 85.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.43 -50.9 70.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -62.18 -46.56 88.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . . . . . . . . . 60.6 t80 -55.53 -51.98 65.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.011 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -67.42 -25.97 66.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.83 -27.94 30.53 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.521 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 92.9 m-85 -120.59 1.28 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 59.5 pttt -61.35 -27.57 68.6 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.112 0.482 . . . . 0.0 111.786 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' CG ' ' HZ2' ' A' ' 61' ' ' LYS . 9.1 p-10 -82.14 -6.5 59.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.275 -177.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HZ2' ' CG ' ' A' ' 60' ' ' ASP . 49.5 mttp -110.92 31.41 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.424 -171.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 39.21 64.81 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.575 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.521 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 51.0 t80 -135.6 140.42 44.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 t -150.06 147.51 27.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.293 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 57.8 mt -87.61 126.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -97.85 93.9 6.61 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.733 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -78.11 107.15 2.4 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.826 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -106.96 111.97 37.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 120.734 0.302 . . . . 0.0 110.421 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 32.6 t -116.06 160.01 20.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.047 0.451 . . . . 0.0 110.43 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.502 ' HB ' HD13 ' A' ' 93' ' ' LEU . 12.3 t -131.31 30.44 4.49 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.493 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -51.84 147.95 6.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.553 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -78.93 -10.75 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.019 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.42 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 46.7 mtm180 -137.72 149.4 46.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.653 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.512 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 15.8 tt0 -72.68 -32.9 66.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.42 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 1.7 mp0 -60.34 -40.89 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.084 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.36 -37.16 68.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.019 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -61.33 -51.2 69.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.306 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.512 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -59.17 -39.24 81.88 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.901 0.381 . . . . 0.0 110.419 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.512 ' HZ1' ' HB3' ' A' ' 79' ' ' LYS . 4.0 ttpm? -61.89 -48.45 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.742 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.35 75.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.373 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.11 -41.24 91.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.268 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.445 ' CD ' ' HZ3' ' A' ' 85' ' ' LYS . 24.2 tp10 -70.82 -37.59 73.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 176.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.408 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.4 mt-10 -54.22 -48.28 71.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.262 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.698 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.7 m-20 -104.02 0.81 30.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.482 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 63.2 mmtt 58.61 34.76 24.09 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.6 p -82.67 75.79 9.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.475 0.655 . . . . 0.0 111.048 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.482 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 69.3 m-85 -87.85 89.47 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.507 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -158.55 -177.15 6.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.04 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.57 100.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.733 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 41.0 mt-30 -123.78 151.71 43.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.678 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.86 154.51 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.824 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.85 130.33 46.03 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.502 HD13 ' HB ' ' A' ' 70' ' ' THR . 80.9 mt -65.32 140.24 58.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.693 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.648 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.2 mt-30 -73.08 157.98 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -57.94 -36.82 73.05 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.84 -31.14 18.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.67 0.271 . . . . 0.0 111.075 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -35.89 82.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.217 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.648 HG23 ' O ' ' A' ' 94' ' ' GLN . 87.0 t -48.5 -45.82 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.014 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.16 -62.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.531 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.98 -55.45 12.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.38 -51.91 29.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 O-C-N 123.345 0.403 . . . . 0.0 111.927 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.55 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 34.8 mt -61.97 -51.39 68.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.943 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.79 -60.3 4.06 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.389 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.4 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.1 m -50.67 -38.26 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.054 0.942 . . . . 0.0 113.385 -172.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 17.2 m-85 -78.05 13.74 1.34 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.354 179.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.665 ' SG ' ' HB2' ' A' ' 2' ' ' SER . 34.9 m 63.47 44.19 5.5 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.785 0.678 . . . . 0.0 109.614 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.55 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 61.2 mt -105.94 92.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.137 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.3 -0.01 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.787 0.803 . . . . 0.0 109.013 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.75 155.66 26.64 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.026 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.406 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 96.9 m-85 -128.64 152.73 79.1 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.266 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 44' ' ' CYS . 92.0 Cg_endo -85.51 134.21 18.21 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.593 -1.419 . . . . 0.0 112.736 -0.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -103.32 114.0 27.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.462 HD13 HD12 ' A' ' 132' ' ' LEU . 61.8 mt -113.97 130.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 29.6 pt -133.34 143.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.699 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.3 tp -107.47 118.01 35.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 60.3 t -107.31 138.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.611 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.55 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -84.36 167.98 24.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 2.3 Cg_endo -46.01 -42.61 20.67 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.184 2.589 . . . . 0.0 114.195 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.496 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 40.7 mt-10 -76.4 -24.54 54.07 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 122.175 -0.328 . . . . 0.0 111.497 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 109.6 33.13 2.74 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.867 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.501 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 2.1 mptt -100.59 149.45 23.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.774 0.787 . . . . 0.0 109.476 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' THR . 50.7 mt -85.37 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.321 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.954 ' HA ' HG21 ' A' ' 5' ' ' THR . 4.9 p -86.09 -50.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.699 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -115.64 153.97 30.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -169.46 153.75 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.148 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.435 ' CG ' ' HB3' ' A' ' 1' ' ' MET . 2.7 mm-40 68.43 13.79 9.04 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.273 0.983 . . . . 0.0 111.413 176.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.515 HD11 ' HB1' ' A' ' 124' ' ' ALA . 68.2 mt -70.28 156.78 38.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.814 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.504 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 3.5 mmp_? -101.22 170.45 8.24 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.58 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 132' ' ' LEU . . . -47.23 -68.49 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.29 -31.16 69.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 0.0 110.187 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.91 -38.7 92.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.094 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 63.6 mt -52.16 -51.06 60.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.24 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -59.09 -50.72 72.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -61.91 -42.44 99.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.276 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.587 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 15.9 m -72.78 -39.67 66.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.727 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.415 HG21 ' O ' ' A' ' 132' ' ' LEU . 72.6 t -67.18 -35.61 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.436 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 3.3 tp10 -59.76 -55.17 37.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.587 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 18.8 pttp -63.31 -17.33 62.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.058 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.96 -61.43 1.71 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 173.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.5 t -82.24 -36.31 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.436 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 51.3 t-20 -71.15 -63.4 1.11 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 39.89 -135.42 1.86 Allowed Glycine 0 C--N 1.337 0.617 0 O-C-N 124.413 1.071 . . . . 0.0 114.662 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.55 128.12 54.54 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.41 ' HD2' ' N ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -138.58 -17.24 1.13 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -171.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.487 ' CD ' ' H ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -93.71 -27.13 16.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.679 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.83 147.34 48.49 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.254 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -59.64 109.33 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -78.92 163.72 25.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.028 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -81.37 145.5 30.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.503 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 1.8 p80 -62.19 154.73 26.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.0 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -93.31 -18.29 22.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.503 ' C ' ' HD1' ' A' ' 150' ' ' HIS . 10.5 m-70 . . . . . 0 C--O 1.241 0.622 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HA ' ' SG ' ' A' ' 106' ' ' CYS . 27.2 ptm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -133.26 -75.66 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.815 0.34 . . . . 0.0 110.13 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.522 HD23 ' HB3' ' A' ' 7' ' ' SER . 68.7 mt -105.55 143.8 33.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.25 -90.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.54 0.21 . . . . 0.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -127.38 128.97 46.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.18 89.96 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.522 ' HB3' HD23 ' A' ' 3' ' ' LEU . 5.5 m -84.43 140.95 31.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.456 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.42 127.32 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.81 0.338 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 124.96 59.25 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.166 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.406 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 25.1 Cg_exo -63.47 158.54 44.86 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.741 2.294 . . . . 0.0 112.311 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 116.13 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.941 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.817 HD11 HG22 ' A' ' 101' ' ' VAL . 43.3 mm -96.29 150.64 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.166 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.418 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 9.0 t -131.19 138.91 49.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.85 29.05 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.644 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.464 ' HB ' ' HB3' ' A' ' 92' ' ' LEU . 66.6 mt -79.73 113.87 19.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.477 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 11.9 p30 -81.92 179.1 7.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.721 -173.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.28 -15.59 60.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.693 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.477 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 2.0 mppt? -77.23 -32.76 56.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 109.722 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.91 18.41 4.72 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.985 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 8.4 m-80 -113.97 149.08 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.718 0.294 . . . . 0.0 110.6 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.81 90.58 6.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 23' ' ' SER . 3.8 p -106.36 166.14 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.984 -169.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.703 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 8.3 m -105.13 173.97 6.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.63 HD13 HG12 ' A' ' 32' ' ' VAL . 63.1 tp -57.04 -23.11 44.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.703 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 3.3 p-10 -65.59 -16.9 64.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.29 -36.56 78.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 0.0 110.75 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -119.71 10.97 11.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.625 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 48.6 tttp -72.7 121.94 20.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.509 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.96 -23.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.54 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 27.5 mttm -103.09 174.71 5.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.22 109.32 5.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 165.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG12 HD13 ' A' ' 24' ' ' LEU . 57.5 t -94.52 108.07 20.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.18 -171.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.507 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.4 tp -85.64 109.94 18.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 114' ' ' ILE . 39.6 t -88.73 121.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.253 0.549 . . . . 0.0 110.369 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.432 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -104.99 108.99 20.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.007 -172.625 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.489 ' HZ ' ' HD2' ' A' ' 105' ' ' TYR . 88.1 m-85 -94.37 115.11 27.27 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 5.0 p-90 -155.64 176.59 12.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 0.0 111.475 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -170.07 149.25 3.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.109 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' H ' ' CG ' ' A' ' 71' ' ' ASP . . . -72.7 5.05 3.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.986 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.13 -14.39 56.16 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.501 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.9 t -99.35 134.36 42.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -67.37 -40.26 85.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.439 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -75.36 -28.5 59.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.657 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.526 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 85.6 m -58.54 -37.65 76.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.533 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.62 -21.27 66.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.323 0.582 . . . . 0.0 110.714 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.3 mptp? -86.35 -31.9 21.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -78.91 -25.27 43.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.049 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.597 HG23 ' HB3' ' A' ' 84' ' ' ASP . 3.5 m -50.98 -51.21 69.59 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 73.1 Cg_exo -52.05 -39.58 69.83 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.278 1.985 . . . . 0.0 112.988 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -71.19 -35.32 71.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 110.813 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.705 HD23 HD12 ' A' ' 113' ' ' ILE . 89.5 mt -66.77 -44.66 80.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.345 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.27 -44.31 92.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.358 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -53.52 -56.36 17.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.707 175.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.4 m -65.22 -42.8 93.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.51 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.724 ' HB2' HD12 ' A' ' 65' ' ' ILE . 83.3 t80 -61.95 -51.64 67.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.639 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.593 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 49.4 t30 -55.7 -42.17 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.291 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 70.3 m-85 -106.72 -1.12 23.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.593 ' HE3' ' HA ' ' A' ' 56' ' ' ASN . 12.0 pttp -62.85 -25.79 68.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.078 0.466 . . . . 0.0 110.574 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -23.26 64.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.668 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -110.85 -161.96 0.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.556 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.75 47.59 3.32 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.672 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.51 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 79.0 t80 -142.71 153.46 43.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.54 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 14.8 t -162.56 170.33 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.676 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 55' ' ' TYR . 44.4 mt -120.2 124.43 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.524 ' HH ' HG22 ' A' ' 91' ' ' VAL . 59.8 t80 -105.26 95.81 6.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.277 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.432 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -83.14 135.44 13.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.142 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 ' HB ' HD13 ' A' ' 93' ' ' LEU . 16.8 m -125.84 118.89 53.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.622 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -125.66 151.17 46.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.53 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.759 ' HG1' HG22 ' A' ' 98' ' ' VAL . 10.1 t -131.18 45.38 2.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 108.997 176.329 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' CG ' ' H ' ' A' ' 39' ' ' ALA . 1.3 m-20 -60.62 -176.5 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.9 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -62.31 -39.8 94.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.286 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.524 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 13.0 tpt180 -151.23 158.29 43.71 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.405 -171.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.401 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 25.5 tt0 -66.88 -44.94 79.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.702 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.524 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.1 pm0 -70.5 -27.81 64.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.828 0.346 . . . . 0.0 110.084 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 21.7 t0 -62.01 -42.57 99.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -68.0 -49.69 60.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.825 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -52.72 -44.43 66.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.262 0.554 . . . . 0.0 110.287 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.409 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 13.9 ttpp -61.69 -44.29 97.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.062 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.1 78.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.966 0.413 . . . . 0.0 111.193 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.455 ' HA ' ' OG ' ' A' ' 86' ' ' SER . 79.8 mt -62.53 -43.71 98.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.127 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -66.01 -38.84 89.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.72 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.403 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.7 mt-10 -58.47 -58.61 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 111.329 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.597 ' HB3' HG23 ' A' ' 48' ' ' THR . 1.1 m-20 -85.2 -5.88 59.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.366 -173.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.421 ' HD2' ' N ' ' A' ' 85' ' ' LYS . 3.9 mptp? 61.22 34.03 18.93 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.511 0.672 . . . . 0.0 110.451 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.455 ' OG ' ' HA ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -80.09 58.32 2.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.278 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -79.77 75.06 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.45 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 25.4 p90 -140.84 -168.35 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.709 170.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.439 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 11.2 m120 -74.46 86.86 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 -174.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.7 mt-30 -113.42 148.27 36.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.524 HG22 ' HH ' ' A' ' 66' ' ' TYR . 26.9 m -131.43 150.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.318 177.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.464 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 49.0 tp -88.38 114.1 24.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.558 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.496 HD13 ' HB ' ' A' ' 68' ' ' VAL . 85.6 mt -69.18 135.51 50.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.295 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.648 ' O ' HG21 ' A' ' 98' ' ' VAL . 61.7 mt-30 -72.11 148.26 45.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.408 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 74.2 mmtt -63.06 -30.07 71.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -169.304 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.518 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 22.2 t70 -83.85 -40.16 19.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.871 0.367 . . . . 0.0 110.083 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.479 ' O ' HG23 ' A' ' 101' ' ' VAL . 2.1 t70 -56.19 -40.54 74.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.765 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.759 HG22 ' HG1' ' A' ' 70' ' ' THR . 96.8 t -48.39 -37.85 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.563 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.518 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 3.6 ttpp -54.74 -56.0 23.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.228 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.86 -40.47 68.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.818 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.817 HG22 HD11 ' A' ' 12' ' ' ILE . 61.9 t -57.17 -60.52 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.497 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 49.4 mt -57.13 -57.26 13.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.854 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.68 -61.73 2.12 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.355 0.409 . . . . 0.0 110.711 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 106' ' ' CYS . 39.7 m -53.23 -41.51 65.46 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 124.206 0.941 . . . . 0.0 112.858 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.489 ' HD2' ' HZ ' ' A' ' 36' ' ' PHE . 6.6 m-85 -74.17 12.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.187 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.548 ' SG ' ' HA ' ' A' ' 1' ' ' MET . 36.3 t 62.95 41.28 8.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.497 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.2 mm -112.64 122.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.357 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.18 21.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.665 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.01 168.23 40.97 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.391 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.6 150.7 77.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.583 0.353 . . . . 0.0 110.094 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.35 137.92 8.61 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.025 -1.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -134.09 139.18 45.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.705 HD12 HD23 ' A' ' 51' ' ' LEU . 61.5 mt -128.77 136.7 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.522 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.534 HG21 ' HB2' ' A' ' 125' ' ' LYS . 33.0 pt -126.36 159.65 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.45 117.1 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.621 0.248 . . . . 0.0 110.636 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 117' ' ' ASP . 74.1 t -111.84 127.36 69.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.55 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 2.8 p30 -67.68 163.35 49.52 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.815 175.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -49.95 -37.21 46.13 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.309 2.673 . . . . 0.0 113.248 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.47 -36.76 83.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.349 0.595 . . . . 0.0 110.339 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.65 37.51 1.42 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.357 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.55 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.1 mtmp? -117.35 141.93 47.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.854 0.359 . . . . 0.0 110.096 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 mt -80.67 104.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.6 -40.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.2 0.524 . . . . 0.0 110.451 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.69 156.4 42.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.203 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.83 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 0.9 OUTLIER -154.22 171.89 18.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.235 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.83 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 8.7 mm-40 60.75 32.36 20.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.174 0.921 . . . . 0.0 110.32 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.64 134.79 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -77.88 147.34 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.633 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.405 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -43.76 -51.19 7.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 177.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.22 -34.33 76.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.6 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.76 -34.05 27.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.071 -168.492 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.542 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.5 pp -58.2 -32.47 68.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.752 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -71.18 -42.34 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -61.17 -42.71 99.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -69.06 -53.22 21.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.807 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.542 HG22 ' O ' ' A' ' 132' ' ' LEU . 27.4 m -61.02 -38.81 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.96 -41.54 95.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.346 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -66.48 -23.15 66.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.909 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.14 -61.36 1.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.5 -47.47 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 63.7 t30 -78.1 -56.88 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 110.362 -174.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.86 67.39 1.28 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.55 129.68 5.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -173.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.433 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 30.0 mmtm -128.49 85.91 2.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.594 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -115.97 -39.26 3.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.891 -174.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.13 35.14 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -42.53 110.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.734 0.778 . . . . 0.0 112.222 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -117.46 3.51 12.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.114 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -154.89 126.05 7.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.443 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -169.9 99.97 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.948 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -117.51 148.81 41.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.142 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.487 ' HB3' ' O ' ' A' ' 105' ' ' TYR . 0.9 OUTLIER -71.26 74.61 0.71 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -173.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.505 ' HB2' HD11 ' A' ' 122' ' ' ILE . 89.4 mt 57.62 17.04 3.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 170.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.7 -135.12 1.22 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.452 0.168 . . . . 0.0 110.915 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -132.36 134.64 45.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.685 0.279 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.33 -11.76 68.62 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.614 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 t -78.25 151.4 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.87 129.0 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.457 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.699 ' HB1' ' HH ' ' A' ' 105' ' ' TYR . . . -83.52 139.8 41.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 178.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' A' ' 105' ' ' TYR . 51.8 Cg_exo -54.63 154.41 20.44 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.928 2.419 . . . . 0.0 112.599 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 91.68 6.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.33 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.484 HG22 HG11 ' A' ' 68' ' ' VAL . 45.6 mt -64.25 135.03 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.158 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 m -133.06 100.4 4.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 110.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.78 176.93 16.82 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.506 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.0 123.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -174.7 5.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.029 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.1 mp -64.7 -25.12 67.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -175.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.62 -21.93 51.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.1 0.476 . . . . 0.0 110.894 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.24 19.66 27.59 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.5 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.8 OUTLIER -96.5 145.14 25.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 p -80.99 99.36 8.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.43 131.12 54.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.873 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 m -110.4 171.57 7.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.972 0.415 . . . . 0.0 110.981 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.7 -23.81 63.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 110.409 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.455 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 8.2 t30 -64.31 -31.47 72.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.375 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -72.74 -5.22 36.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.433 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 7.23 14.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.455 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 9.0 mtpm? -71.39 92.35 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.385 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.64 -24.35 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -121.51 172.85 7.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.492 ' HB3' HD13 ' A' ' 115' ' ' LEU . 93.4 m-85 -78.19 116.64 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.635 ' HB ' HG22 ' A' ' 116' ' ' VAL . 22.6 t -102.92 119.85 51.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.11 0.481 . . . . 0.0 111.208 -172.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 17.4 tp -94.06 116.18 28.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 46.1 t -102.17 115.89 44.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.613 0.244 . . . . 0.0 110.947 -174.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -92.91 103.72 16.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.51 ' HA ' HG23 ' A' ' 68' ' ' VAL . 91.6 m-85 -83.77 114.12 21.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.326 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.527 ' HZ3' HH12 ' A' ' 45' ' ' ARG . 11.1 p-90 -158.3 178.66 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.6 0.714 . . . . 0.0 112.537 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -169.82 154.25 5.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.95 171.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 86.99 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.476 0.655 . . . . 0.0 110.337 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.1 -46.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.16 101.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.41 0.624 . . . . 0.0 109.464 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 m -66.12 -7.64 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.831 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.437 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 67.4 t-105 -78.77 -23.66 45.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.4 m -58.24 -42.4 86.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.527 HH12 ' HZ3' ' A' ' 37' ' ' TRP . 4.7 mpt_? -62.74 -16.48 57.8 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.234 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 2.2 mptm? -85.38 -31.55 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -23.61 30.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.143 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.536 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 10.7 m -48.96 -50.18 63.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.536 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -47.42 -47.55 17.42 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.42 2.08 . . . . 0.0 113.041 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.605 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 67.4 m-85 -75.46 -35.4 60.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 HD22 HD11 ' A' ' 113' ' ' ILE . 92.0 mt -58.24 -52.61 64.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.63 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.11 -42.94 99.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.346 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.766 ' HZ2' ' HE1' ' A' ' 133' ' ' TYR . 27.4 tptp -55.07 -52.15 64.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.14 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.414 HG21 ' CE2' ' A' ' 63' ' ' PHE . 30.8 m -64.11 -45.44 88.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.147 -178.018 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.595 ' HB2' HD13 ' A' ' 65' ' ' ILE . 88.8 t80 -58.24 -51.59 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.24 -38.8 92.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.316 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.09 67.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.611 ' CE1' ' HB2' ' A' ' 141' ' ' ASN . 21.5 m-85 -120.36 6.7 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.4 pttp -54.47 -50.34 67.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.68 -43.7 65.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.118 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.702 ' HZ3' ' HA ' ' A' ' 141' ' ' ASN . 48.4 mtpt -55.04 -71.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.46 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.07 33.12 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.4 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.604 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 78.4 t80 -137.06 139.01 41.02 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 50.3 m -149.58 141.11 23.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.595 HD13 ' HB2' ' A' ' 55' ' ' TYR . 33.5 mt -98.36 135.46 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.442 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.2 t80 -121.8 95.9 4.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.843 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.5 124.3 6.52 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.979 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.986 ' HB ' HD22 ' A' ' 93' ' ' LEU . 17.3 m -105.65 111.51 35.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.085 0.945 . . . . 0.0 109.78 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.59 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 7.3 m -104.81 137.67 42.24 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.164 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.633 ' HB ' HD13 ' A' ' 93' ' ' LEU . 9.1 t -126.36 42.16 3.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.234 1.016 . . . . 0.0 108.868 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.59 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 8.8 m-20 -61.72 176.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.306 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -80.63 -19.09 46.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.499 -168.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.561 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 5.8 tpt85 -165.64 161.72 18.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.412 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.6 tt0 -67.16 -44.15 80.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.286 0.494 . . . . 0.0 110.119 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.561 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 1.8 mp0 -59.41 -39.61 83.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.512 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.14 -46.43 87.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.154 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.422 ' O ' HG13 ' A' ' 81' ' ' ILE . 21.0 t90 -59.08 -52.66 64.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.579 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.412 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.8 mptm? -53.81 -46.59 71.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 0.0 110.163 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.486 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.19 -42.35 94.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.378 175.659 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.57 76.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.6 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 77' ' ' TRP . 79.0 mt -63.13 -47.81 90.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -66.63 -37.69 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -58.17 -45.47 87.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.338 0.655 . . . . 0.0 111.075 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 48' ' ' THR . 15.2 t70 -87.2 -26.43 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.895 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.5 mptp? 70.99 21.09 5.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.006 0.523 . . . . 0.0 111.144 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.405 ' HG ' ' HB3' ' A' ' 84' ' ' ASP . 1.7 p -82.25 76.0 9.15 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.892 175.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -84.48 78.62 9.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.41 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -151.62 -172.61 4.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.431 ' N ' HD21 ' A' ' 89' ' ' ASN . 0.9 OUTLIER -69.79 108.46 3.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.196 0.522 . . . . 0.0 111.123 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.51 152.3 40.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.8 146.39 29.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.058 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.26 129.25 35.41 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.986 HD22 ' HB ' ' A' ' 68' ' ' VAL . 65.4 mt -63.92 138.47 58.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.548 ' O ' HG21 ' A' ' 98' ' ' VAL . 75.1 mt-30 -80.11 169.49 17.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.811 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.462 ' HZ2' ' CG ' ' A' ' 96' ' ' ASP . 10.5 ptmm? -51.67 -46.87 63.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -175.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.915 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.6 m-20 -87.67 -33.73 18.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.616 0.246 . . . . 0.0 110.455 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.459 ' OD1' HD23 ' A' ' 93' ' ' LEU . 17.4 t70 -55.97 -45.01 79.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 94' ' ' GLN . 76.2 t -49.64 -53.11 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.851 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.915 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 9.5 mtmp? -60.31 -62.79 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.48 -174.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.49 -42.06 65.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.747 -168.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.533 HG12 ' HE2' ' A' ' 105' ' ' TYR . 53.5 t -68.48 -54.4 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 121.344 -0.142 . . . . 0.0 111.233 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.473 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 48.9 mt -58.52 -43.51 89.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.047 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.23 -61.26 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.013 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.424 ' C ' ' H ' ' A' ' 106' ' ' CYS . 71.8 m -49.25 -40.59 34.78 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -169.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.699 ' HH ' ' HB1' ' A' ' 9' ' ' ALA . 84.8 m-85 -76.52 11.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.046 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.424 ' H ' ' C ' ' A' ' 104' ' ' SER . 92.7 m 60.18 42.45 15.34 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 109.904 -175.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.527 HG12 ' HB2' ' A' ' 105' ' ' TYR . 36.1 mm -91.76 74.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.691 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.92 -19.04 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.897 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.9 148.69 20.17 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.428 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.34 155.48 48.38 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.429 ' HG2' ' HD1' ' A' ' 43' ' ' TRP . 2.3 Cg_endo -82.54 166.81 68.85 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.279 -0.273 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.477 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -144.39 109.08 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.106 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.503 HD11 HD22 ' A' ' 51' ' ' LEU . 79.2 mt -114.73 127.0 72.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.757 0.313 . . . . 0.0 110.267 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 46.6 pt -124.23 160.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.105 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.686 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 66.9 tp -124.9 114.18 18.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.635 HG22 ' HB ' ' A' ' 32' ' ' VAL . 4.7 m -104.99 144.65 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.024 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.594 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.5 OUTLIER -76.07 172.91 8.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.439 177.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.594 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -51.71 -24.78 18.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.931 2.421 . . . . 0.0 113.721 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.448 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -88.61 1.01 55.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.191 -0.318 . . . . 0.0 111.796 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.04 27.54 58.05 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.709 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -111.62 142.19 44.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.128 0.49 . . . . 0.0 110.241 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.505 HD11 ' HB2' ' A' ' 3' ' ' LEU . 39.3 mt -72.96 104.68 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.284 -173.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.87 -26.46 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 110.298 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.686 ' HB1' ' HB3' ' A' ' 115' ' ' LEU . . . -144.87 151.02 38.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 20.3 pttp -161.66 154.26 20.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.89 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 28.9 mt-10 62.55 29.93 17.05 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.368 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.21 165.66 22.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.273 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.45 ' HA ' ' HD3' ' A' ' 128' ' ' ARG . 18.1 mmt180 -115.87 166.25 12.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -42.29 -64.18 1.62 Allowed Glycine 0 C--O 1.234 0.124 0 O-C-N 124.012 0.82 . . . . 0.0 114.432 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.02 -36.58 68.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.837 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.37 -50.24 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.455 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.6 pp -57.13 -34.4 68.36 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.872 0.368 . . . . 0.0 110.187 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.766 ' HE1' ' HZ2' ' A' ' 53' ' ' LYS . 50.1 t80 -64.84 -57.43 8.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.094 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.22 -43.83 87.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.412 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 17.6 m -65.94 -49.04 69.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.897 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.24 -40.95 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.146 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.459 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 15.1 tt0 -65.29 -36.66 84.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.351 0.596 . . . . 0.0 109.897 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.412 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 14.1 ttpp -61.73 -39.94 93.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.788 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.27 -53.79 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.78 -21.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -169.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.702 ' HA ' ' HZ3' ' A' ' 61' ' ' LYS . 65.8 t30 -93.89 -62.09 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.23 116.88 0.51 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.993 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.5 -44.54 50.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.927 0.394 . . . . 0.0 111.12 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -123.11 137.53 54.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.334 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.52 18.85 2.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.107 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.0 123.36 7.56 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.213 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -70.08 109.5 4.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.255 0.55 . . . . 0.0 110.61 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -92.57 2.94 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.32 0.581 . . . . 0.0 110.011 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -78.8 68.5 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -155.1 6.65 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.704 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.9 t60 61.78 79.6 0.25 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.134 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--O 1.242 0.698 0 CA-C-O 118.213 -0.899 . . . . 0.0 108.797 176.28 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -89.05 166.45 13.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.496 HD23 ' HB3' ' A' ' 7' ' ' SER . 77.0 mt -83.63 144.83 29.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.236 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.468 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . . . -135.18 -92.58 0.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.017 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 p -134.69 131.59 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.0 -3.79 86.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.458 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.496 ' HB3' HD23 ' A' ' 3' ' ' LEU . 9.8 m -69.33 130.17 41.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.368 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.03 133.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 0.0 110.289 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.411 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -88.59 137.75 30.23 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.24 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 32.2 Cg_exo -61.34 162.28 20.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.012 2.475 . . . . 0.0 112.011 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.6 96.9 9.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.792 0.33 . . . . 0.0 111.618 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.29 140.25 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.832 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -133.55 89.55 2.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.05 0.929 . . . . 0.0 110.286 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.45 155.51 18.98 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.417 -174.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.7 mt -86.11 130.18 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.606 0.241 . . . . 0.0 110.56 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -79.4 -174.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 -179.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.94 -7.13 46.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 34.8 mttp -99.78 -35.68 9.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.549 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.37 10.5 2.99 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.314 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.8 m-80 -91.77 134.18 34.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 p -83.17 98.15 9.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.855 0.359 . . . . 0.0 110.215 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.16 137.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.009 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -97.37 156.6 16.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.194 0.521 . . . . 0.0 111.437 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 tp -61.13 -27.25 68.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.618 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.526 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.0 t30 -65.85 -31.08 71.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.05 -7.64 54.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 110.811 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.84 3.14 18.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.91 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.526 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 85.5 mttt -66.38 178.69 1.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.021 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.05 10.56 85.42 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.497 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -143.17 167.43 22.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.9 110.47 17.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 168.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.2 109.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.908 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.7 tp -85.61 110.28 19.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' HG13 ' A' ' 114' ' ' ILE . 58.6 t -98.57 107.99 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.094 0.474 . . . . 0.0 110.664 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.21 121.44 42.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.245 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.24 117.31 28.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.778 0.323 . . . . 0.0 110.166 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.552 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.8 p-90 -144.14 177.21 8.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.011 0.434 . . . . 0.0 111.181 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -170.67 162.0 7.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.042 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.33 83.4 2.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 0.0 110.661 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.8 -44.41 0.15 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.472 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.63 117.72 12.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 43.3 m -68.61 -29.81 68.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.44 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 23.1 m95 -73.43 -40.69 64.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.463 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 73.2 m -59.52 -25.5 64.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -84.94 -19.93 31.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.585 ' HD3' ' O ' ' A' ' 42' ' ' SER . 13.6 mptt -85.7 -23.83 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 111.235 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.44 ' HG2' ' O ' ' A' ' 43' ' ' TRP . 4.0 mm-40 -78.27 -20.44 51.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.384 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.575 HG22 ' HB3' ' A' ' 84' ' ' ASP . 6.4 m -52.45 -50.89 77.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.566 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 82.4 Cg_exo -49.9 -48.13 20.68 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.164 1.909 . . . . 0.0 112.643 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -67.54 -39.65 85.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.589 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -63.22 -41.29 99.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.89 -42.24 99.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.88 -41.95 98.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.993 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.3 m -60.65 -46.49 90.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.797 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.593 ' HB2' HD12 ' A' ' 65' ' ' ILE . 84.0 t80 -56.1 -57.78 10.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 93.2 m-20 -60.8 -32.54 71.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.057 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.29 41.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.516 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 90.2 m-85 -112.06 -2.17 15.12 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.759 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.5 ptmm? -62.91 155.68 26.52 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.269 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' CG ' ' HZ1' ' A' ' 59' ' ' LYS . 14.3 m-20 66.9 10.04 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.476 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.3 mttp -123.25 25.04 8.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.879 0.371 . . . . 0.0 110.958 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.87 27.7 33.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.153 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.46 140.93 46.59 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 160.34 42.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.593 HD12 ' HB2' ' A' ' 55' ' ' TYR . 64.0 mt -112.86 126.97 70.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -110.95 95.14 5.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.79 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.26 109.5 2.94 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.884 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.6 HG12 HD22 ' A' ' 93' ' ' LEU . 75.2 t -98.03 112.13 29.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -113.29 145.6 40.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.947 -178.537 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.5 ' HB ' HD12 ' A' ' 93' ' ' LEU . 3.8 t -126.46 45.92 2.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.616 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.52 171.42 12.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.639 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.539 HH22 HG12 ' A' ' 98' ' ' VAL . 22.0 mmt180 -115.52 2.93 13.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.692 0.758 . . . . 0.0 109.208 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -124.05 124.26 42.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.035 175.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.564 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.0 tt0 -75.81 -33.91 60.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.46 -51.28 70.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.737 178.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -64.57 -37.42 87.5 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.82 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.11 -52.36 65.21 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 110.73 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.564 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.5 mptm? -57.14 -44.94 83.84 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.306 0.574 . . . . 0.0 110.668 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.489 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -68.49 -33.81 74.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.082 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.97 82.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.34 -37.68 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.663 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.403 ' CD ' ' HZ2' ' A' ' 85' ' ' LYS . 47.1 tp10 -65.91 -38.1 87.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.647 175.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.434 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 52.1 mt-10 -57.82 -60.06 4.28 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.461 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HB3' HG22 ' A' ' 48' ' ' THR . 39.1 m-20 -85.11 -12.87 51.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.286 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HZ2' ' CD ' ' A' ' 82' ' ' GLU . 66.8 mmtt 60.05 37.94 20.88 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 110.972 -176.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.0 p -77.0 114.32 15.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.237 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -112.57 84.98 2.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.589 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 11.1 p90 -158.6 -170.03 2.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.46 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.22 90.05 2.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 110.913 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -109.84 133.13 53.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.675 0.274 . . . . 0.0 110.48 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.28 155.19 41.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.717 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.98 123.52 47.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.6 HD22 HG12 ' A' ' 68' ' ' VAL . 82.1 mt -62.74 140.51 58.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.0 111.166 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 98' ' ' VAL . 44.8 mt-30 -73.41 166.62 22.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.912 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.478 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 20.2 mtpt -51.02 -58.43 6.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.508 0.67 . . . . 0.0 111.534 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.27 -26.87 38.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.45 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.436 ' OD2' HD23 ' A' ' 93' ' ' LEU . 28.0 t70 -64.25 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.022 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.2 t -49.8 -42.94 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.15 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -58.56 -56.73 18.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.45 -44.66 62.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.469 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.68 -59.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 123.066 0.229 . . . . 0.0 111.378 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.548 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 37.2 mt -59.53 -42.85 93.22 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.45 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.77 -62.17 2.07 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.224 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 106' ' ' CYS . 59.3 p -53.72 -40.21 65.9 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.111 0.882 . . . . 0.0 113.167 -167.182 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.455 ' HA ' HD11 ' A' ' 3' ' ' LEU . 75.4 m-85 -75.62 12.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.437 ' H ' ' C ' ' A' ' 104' ' ' SER . 42.8 m 64.45 39.29 7.04 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.478 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.8 mm -92.82 86.83 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.008 -173.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.48 -7.06 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.287 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.05 163.06 35.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.553 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.1 156.27 54.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.497 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 93.4 Cg_endo -80.12 175.73 43.41 Favored 'Cis proline' 0 C--N 1.346 0.444 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.719 -0.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.6 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -159.94 125.92 4.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.959 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.1 135.05 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.16 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.606 HG22 ' HG3' ' A' ' 125' ' ' LYS . 34.7 pt -132.34 146.11 33.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.481 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 53.6 tp -107.74 112.6 25.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.982 0.42 . . . . 0.0 110.024 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.403 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 96.2 t -100.5 135.04 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.772 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.549 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.1 OUTLIER -80.42 167.09 35.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 4.1 Cg_endo -47.41 -36.33 23.26 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.61 2.873 . . . . 0.0 114.327 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.67 -29.66 61.31 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.839 0.352 . . . . 0.0 111.236 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.403 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 112.49 31.05 2.68 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.671 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -112.67 140.29 47.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.18 107.49 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.39 -24.86 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 111.035 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.481 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -140.6 133.81 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.886 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 25.6 ttpp -134.5 137.04 43.56 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.256 -174.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.886 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 49.3 mt-10 68.75 51.6 0.59 Allowed 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.158 0.911 . . . . 0.0 111.666 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.41 157.23 23.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.516 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 11.1 tpt85 -134.18 150.54 51.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.411 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 49.38 -141.02 12.77 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.656 0.598 . . . . 0.0 113.927 168.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.65 -10.92 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.341 0.591 . . . . 0.0 110.138 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.454 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.3 m-20 -58.86 -33.17 70.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.126 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -65.89 -36.58 83.8 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 49.2 t80 -65.42 -50.3 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.017 177.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -60.71 -34.37 74.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.32 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.0 m -65.65 -51.03 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 132' ' ' LEU . 86.2 t -63.15 -36.1 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.516 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 5.2 tp10 -57.98 -44.12 86.91 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.893 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -76.38 -16.39 59.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.059 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.65 -58.1 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.221 -0.299 . . . . 0.0 111.73 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.36 -55.03 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.876 0.369 . . . . 0.0 111.655 -173.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -78.01 -64.89 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.247 0.546 . . . . 0.0 111.155 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.82 54.6 0.93 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.7 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 -55.65 30.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.088 0.471 . . . . 0.0 110.415 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -136.1 9.25 3.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.368 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -95.48 -87.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.427 ' O ' ' HB3' ' A' ' 147' ' ' HIS . . . 85.49 39.79 8.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.295 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . 0.427 ' HB3' ' O ' ' A' ' 146' ' ' GLY . 50.4 t-80 77.44 -52.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.411 0.684 . . . . 0.0 111.855 174.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 31.8 m170 45.46 -107.35 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.638 0.586 . . . . 0.0 111.198 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.0 t60 53.9 92.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.939 0.775 . . . . 0.0 112.185 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.16 165.2 12.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.581 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -152.61 148.37 27.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.994 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.027 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 38.9 t 172.76 140.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.009 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.516 HD23 ' HB2' ' A' ' 7' ' ' SER . 97.2 mt -110.75 130.49 55.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.554 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . -102.06 -90.12 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.319 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.434 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.3 p -136.65 125.21 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.931 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.74 59.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.927 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.516 ' HB2' HD23 ' A' ' 3' ' ' LEU . 4.5 p -75.33 132.68 41.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.2 p -72.3 137.1 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.477 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.461 ' HB2' ' CE1' ' A' ' 105' ' ' TYR . . . -107.48 145.56 31.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.2 Cg_exo -61.7 154.08 62.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.071 2.514 . . . . 0.0 112.464 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.27 139.14 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.185 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.404 ' O ' ' HA ' ' A' ' 23' ' ' SER . 53.5 mt -95.03 137.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -120.55 107.87 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 0.0 110.543 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.01 154.11 23.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.719 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.16 122.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -178.82 3.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.423 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 95.3 mt -59.56 -31.03 69.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.818 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -78.93 -35.66 42.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.5 3.05 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.08 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -105.88 145.9 30.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 p -77.32 104.53 7.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.236 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.91 143.29 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.999 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.404 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 10.2 m -123.04 162.39 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.618 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 32.3 tp -63.76 -7.42 7.7 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.539 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.8 -29.6 70.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.457 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.64 -27.76 63.3 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.844 0.83 . . . . 0.0 110.847 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.618 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 88.0 m-85 -87.88 4.03 46.21 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -171.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -84.3 87.45 7.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.798 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.79 -9.7 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.34 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -117.05 163.38 16.34 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -84.95 120.66 26.75 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.478 ' CG2' ' HB3' ' A' ' 27' ' ' PHE . 6.8 t -106.35 124.33 61.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.094 0.473 . . . . 0.0 112.091 -169.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.605 HD11 HG21 ' A' ' 113' ' ' ILE . 2.7 tm? -104.19 98.02 7.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.6 t -92.5 124.26 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 21.0 t0 -120.19 144.83 47.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.255 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.514 ' O ' ' HB2' ' A' ' 110' ' ' PHE . 96.9 m-85 -117.04 119.64 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.127 174.051 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.717 ' HZ2' HD12 ' A' ' 81' ' ' ILE . 54.1 p-90 -148.07 175.09 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.453 0.644 . . . . 0.0 112.027 -176.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CD1' ' HE2' ' A' ' 110' ' ' PHE . 1.5 p90 -162.37 166.12 25.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.157 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.7 65.89 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -171.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.57 -38.13 90.16 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.432 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.6 p -85.95 101.83 13.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.373 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.53 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.5 m -71.47 5.07 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -174.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -85.8 -30.27 23.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.31 -0.243 . . . . 0.0 111.294 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.588 ' SG ' ' HD2' ' A' ' 45' ' ' ARG . 21.1 p -68.56 -28.61 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.759 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.588 ' HD2' ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -77.62 -14.58 59.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.402 0.62 . . . . 0.0 109.408 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.53 ' HD3' ' O ' ' A' ' 42' ' ' SER . 2.1 mptm? -79.54 -24.32 42.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 42.5 mt-10 -100.16 -0.24 39.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.22 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.519 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 85.5 m -50.43 -52.65 53.11 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.92 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.8 Cg_endo -54.43 -40.99 80.77 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.545 2.163 . . . . 0.0 113.156 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.422 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.9 m-85 -67.61 -44.6 77.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.983 0.421 . . . . 0.0 110.351 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.78 -40.82 97.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.605 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.25 -46.52 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.94 -46.91 87.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.205 0.526 . . . . 0.0 110.312 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.405 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 32.0 m -62.1 -49.7 74.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.73 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.551 ' HB2' HD11 ' A' ' 65' ' ' ILE . 79.6 t80 -62.34 -40.73 97.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.64 0.257 . . . . 0.0 110.967 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.16 -34.15 75.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.287 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.439 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.74 -26.91 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.553 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 51.1 m-85 -102.8 -8.55 20.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -56.49 -35.01 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.31 0.95 56.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.439 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 88.1 mttt -105.54 19.71 20.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.036 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.39 37.47 70.06 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.4 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 39.7 t80 -130.67 143.53 50.81 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -145.76 136.2 24.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.551 HD11 ' HB2' ' A' ' 55' ' ' TYR . 55.0 mt -88.26 117.68 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -100.31 93.43 5.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.176 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -87.6 112.2 3.81 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 34.1 t -104.86 119.03 53.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.025 0.441 . . . . 0.0 110.712 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.8 t -124.22 156.17 37.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 4.3 t -137.96 51.3 1.89 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.822 0.82 . . . . 0.0 109.027 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.572 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -66.67 -176.89 0.52 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.906 -174.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.572 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 3.6 ptm180 -77.23 -26.68 52.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.17 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.547 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 10.6 ttt180 -149.27 128.4 12.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.962 -166.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -61.06 -42.25 98.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.308 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 pt-20 -64.57 -41.6 96.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.463 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 80.7 m-20 -66.28 -34.15 77.36 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.604 ' O ' HG12 ' A' ' 81' ' ' ILE . 31.2 t90 -61.48 -60.65 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.498 ' HD2' ' CE3' ' A' ' 77' ' ' TRP . 2.6 mptm? -52.23 -43.02 64.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 0.0 110.903 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 29.5 ttmt -59.39 -49.67 76.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.857 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.77 88.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.626 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.717 HD12 ' HZ2' ' A' ' 37' ' ' TRP . 44.2 mm -56.19 -45.7 81.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.738 0.304 . . . . 0.0 110.961 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.711 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 10.7 tp10 -58.87 -59.26 5.73 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.516 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 4.8 mm-40 -69.62 -33.56 72.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.416 ' CG ' HH21 ' A' ' 45' ' ' ARG . 35.2 t70 -71.51 -12.25 61.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 110.352 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.711 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 44.0 mmtt 64.54 32.55 11.55 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.093 175.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.418 ' HB3' HG22 ' A' ' 48' ' ' THR . 0.3 OUTLIER -96.42 79.51 3.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.713 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -91.46 89.94 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -175.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -156.63 176.68 12.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -64.96 97.58 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.74 0.65 . . . . 0.0 111.711 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.538 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 51.4 mt-30 -123.56 149.64 45.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.41 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.21 150.42 31.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.24 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.43 118.7 35.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.316 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.436 HD11 ' HA ' ' A' ' 98' ' ' VAL . 53.9 mt -62.94 137.19 58.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.368 0.604 . . . . 0.0 111.962 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.667 ' O ' HG21 ' A' ' 98' ' ' VAL . 22.4 mt-30 -73.5 145.79 45.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.193 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -70.64 -16.1 62.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.681 0.753 . . . . 0.0 111.123 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.507 ' HA ' ' NZ ' ' A' ' 99' ' ' LYS . 3.2 p-10 -78.7 -46.81 18.21 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.399 171.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.23 -34.69 75.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.137 0.575 . . . . 0.0 111.517 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.667 HG21 ' O ' ' A' ' 94' ' ' GLN . 48.7 t -43.59 -43.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.727 . . . . 0.0 112.703 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.507 ' NZ ' ' HA ' ' A' ' 96' ' ' ASP . 60.6 mttp -54.97 -63.15 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.557 -169.875 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.0 -48.63 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.8 t -52.38 -47.93 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.504 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.501 HD21 HG13 ' A' ' 107' ' ' ILE . 25.7 mt -62.63 -59.36 5.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.58 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.62 -61.52 2.23 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.209 0.318 . . . . 0.0 110.793 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 106' ' ' CYS . 70.9 m -56.29 -37.05 69.34 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 124.211 0.945 . . . . 0.0 112.606 -172.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.496 ' CD2' HD13 ' A' ' 114' ' ' ILE . 4.2 m-85 -77.17 13.65 1.08 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 120.956 0.408 . . . . 0.0 110.8 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.415 ' H ' ' C ' ' A' ' 104' ' ' SER . 49.2 t 63.9 60.74 1.01 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.202 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.501 HG13 HD21 ' A' ' 102' ' ' LEU . 9.4 mm -85.44 93.59 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.074 0.94 . . . . 0.0 111.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.13 -31.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.78 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.64 151.66 22.89 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.349 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.621 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.5 p90 -147.2 160.04 40.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 118.948 -0.548 . . . . 0.0 109.78 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.621 ' C ' ' HA ' ' A' ' 110' ' ' PHE . 3.8 Cg_endo -43.54 145.96 1.79 Allowed 'Cis proline' 0 C--N 1.364 1.347 0 CA-C-N 120.325 1.152 . . . . 0.0 114.944 2.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 65.9 t60 -140.91 95.21 2.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.083 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.605 HG21 HD11 ' A' ' 33' ' ' LEU . 96.6 mt -101.61 114.5 41.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -172.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.496 HD13 ' CD2' ' A' ' 105' ' ' TYR . 48.2 pt -127.15 166.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.742 0.306 . . . . 0.0 110.983 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.0 118.14 32.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.473 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 78.6 t -110.85 138.55 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.045 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.536 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -92.52 170.07 9.67 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.536 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 1.5 Cg_endo -48.56 -36.84 32.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.35 2.7 . . . . 0.0 114.107 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.07 -22.07 62.16 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.955 -0.466 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 23.53 11.29 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.208 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.549 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 78.8 mttt -99.04 141.74 31.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.828 0.346 . . . . 0.0 110.096 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 5' ' ' THR . 33.2 mt -81.82 98.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.16 -21.89 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.173 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.48 142.19 21.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.554 ' HD2' ' HA ' ' A' ' 4' ' ' ALA . 10.8 ptmm? -129.71 138.54 51.19 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.315 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 67.78 46.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.17 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.431 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 86.7 mt -70.35 151.16 45.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 171.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.693 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 8.4 mmm180 -124.9 146.04 49.53 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.101 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.459 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 44.31 -125.51 5.94 Favored Glycine 0 C--O 1.224 -0.479 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.305 169.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.33 -20.92 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 111.037 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.693 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -51.03 -42.98 60.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 177.223 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -59.62 -34.35 72.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.405 ' HD2' ' HA ' ' A' ' 54' ' ' THR . 40.8 t80 -68.92 -53.45 20.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -61.15 -42.97 99.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.517 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.448 ' O ' ' HD1' ' A' ' 139' ' ' PHE . 24.3 m -66.75 -43.38 84.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.454 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 132' ' ' LEU . 77.9 t -67.54 -40.98 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.88 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.504 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 2.8 tp10 -62.44 -34.27 76.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.488 0.661 . . . . 0.0 109.437 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.977 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 27.7 ttpp -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.515 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 60.7 m-85 -80.68 -61.73 1.88 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.981 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.88 -40.63 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.203 -169.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.504 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 12.0 t30 -86.05 1.65 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 110.295 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.99 32.58 77.32 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.968 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.977 ' HB3' ' HA ' ' A' ' 138' ' ' LYS . . . -68.02 -30.88 70.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.598 0.237 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.42 ' HB2' ' CG ' ' A' ' 138' ' ' LYS . 35.1 mmtm -142.97 -42.77 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 5.6 mp0 -81.87 20.45 0.97 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.174 0.511 . . . . 0.0 111.02 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.54 144.72 47.65 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -83.18 57.91 4.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 110.93 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.6 t60 69.71 -58.11 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.913 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -85.28 125.61 33.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.177 0.513 . . . . 0.0 110.316 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.497 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 4.6 p-80 -102.73 -14.54 16.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.451 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.497 ' HB2' ' O ' ' A' ' 150' ' ' HIS . 3.0 t60 165.36 -38.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 m170 . . . . . 0 C--O 1.244 0.813 0 CA-C-N 112.32 -2.218 . . . . 0.0 106.655 164.247 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.466 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.419 ' HB2' HD12 ' A' ' 3' ' ' LEU . 19.0 m 68.36 -66.74 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.173 0.921 . . . . 0.0 110.606 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -121.04 -177.73 3.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.87 166.44 24.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.539 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -70.61 119.13 14.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.508 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.89 -18.41 5.93 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.4 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 p -78.14 154.37 31.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.619 0.247 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.41 139.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.145 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.53 137.66 28.73 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.569 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 53.7 Cg_exo -53.7 146.48 44.33 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.796 2.331 . . . . 0.0 112.014 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.13 119.55 14.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.108 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.692 HG21 HD23 ' A' ' 93' ' ' LEU . 45.1 mm -93.24 129.35 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.671 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -134.61 108.1 7.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.29 170.71 14.73 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.356 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 15.7 mt -100.24 115.91 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.48 ' HB3' HG12 ' A' ' 91' ' ' VAL . 27.6 p30 -75.04 -174.46 2.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.475 0.655 . . . . 0.0 112.63 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.573 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 96.4 mt -60.22 -29.82 68.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.055 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 -38.0 30.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 110.297 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.93 21.79 2.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.318 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.6 OUTLIER -97.58 141.83 30.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.161 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -84.58 101.44 12.11 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.46 150.11 19.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 24.5 m -110.59 164.52 12.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.807 0.337 . . . . 0.0 111.238 -176.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.635 HD21 HG12 ' A' ' 12' ' ' ILE . 3.5 pp -63.85 -27.12 68.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.29 0.567 . . . . 0.0 110.129 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.79 -32.84 72.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.392 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.28 -4.05 51.74 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.395 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -118.77 8.69 11.88 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.576 ' HB3' ' O ' ' A' ' 118' ' ' PRO . 36.1 mtmt -72.18 159.69 33.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.501 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.95 -28.31 7.05 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.516 ' HG3' ' O ' ' A' ' 152' ' ' HIS . 2.5 mptp? -108.56 169.79 8.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.565 ' HE2' HG12 ' A' ' 123' ' ' VAL . 4.1 m-85 -76.04 115.63 15.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 166.237 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.884 HG23 ' HB ' ' A' ' 116' ' ' VAL . 3.0 m -96.08 115.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.795 0.807 . . . . 0.0 111.741 -171.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.689 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tm? -84.66 109.11 17.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.527 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -99.19 107.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.32 129.47 47.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.057 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.73 115.76 31.22 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.762 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 28.4 p-90 -147.9 172.67 13.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 111.523 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' HB2' ' CG ' ' A' ' 71' ' ' ASP . 20.4 p90 -167.27 155.99 9.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.089 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.59 -24.7 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.524 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.46 -32.64 73.49 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.123 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.431 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 33.7 m -93.31 117.98 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.256 0.551 . . . . 0.0 110.676 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.504 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 11.1 m -65.19 -16.49 63.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -82.91 -32.06 27.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.762 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 78.7 m -58.71 -32.05 68.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.086 0.47 . . . . 0.0 110.632 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -73.52 -14.41 61.21 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.608 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.61 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -86.64 -44.69 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.065 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.405 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mp0 -68.31 -22.32 64.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.588 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.568 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 99.8 m -57.43 -53.18 68.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.61 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 83.0 Cg_exo -49.97 -41.57 47.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.455 2.103 . . . . 0.0 112.945 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.405 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.6 m-85 -65.65 -43.15 90.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.304 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.85 -38.43 85.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.416 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.41 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 5.5 tt -61.63 -44.75 96.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.829 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.859 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 38.1 ttpt -63.74 -42.73 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.005 0.431 . . . . 0.0 110.341 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 m -58.68 -46.72 86.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.611 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.1 t80 -64.47 -46.56 82.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.544 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.859 ' ND2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 p30 -68.41 -32.74 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.981 -173.13 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.83 -27.93 21.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' CZ ' ' HG2' ' A' ' 137' ' ' GLU . 51.3 m-85 -105.69 -5.49 19.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 13.6 pttm -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.067 0.46 . . . . 0.0 110.991 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.48 -3.24 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.299 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.834 ' HB3' ' HE1' ' A' ' 149' ' ' HIS . 75.8 mttt -97.93 3.23 49.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.094 0.473 . . . . 0.0 110.299 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.86 43.39 5.43 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.504 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.689 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 41.7 t80 -145.64 127.11 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -130.57 155.88 45.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.0 mt -105.09 120.61 55.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.229 0.537 . . . . 0.0 110.93 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.62 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 88.1 t80 -104.2 97.27 7.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.743 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.614 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -91.81 136.65 13.38 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.218 -175.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 5.1 m -121.35 114.9 44.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.662 0.744 . . . . 0.0 110.023 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -90.85 151.48 21.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.275 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.862 ' HA ' ' NZ ' ' A' ' 95' ' ' LYS . 6.5 t -136.09 38.67 2.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.468 0.652 . . . . 0.0 111.983 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.439 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 18.2 m-20 -76.34 167.54 21.66 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.991 167.837 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.696 ' HD2' ' HG3' ' A' ' 95' ' ' LYS . 13.6 mmm180 -96.43 -11.59 25.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 73' ' ' ARG . 40.8 mtp180 -111.21 108.32 17.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.866 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -69.64 -31.16 69.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.984 -177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -69.82 -36.22 75.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.544 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.26 -28.2 56.99 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.679 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -62.18 -52.76 62.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.217 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.573 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.9 mptm? -56.22 -42.48 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.279 0.562 . . . . 0.0 110.081 175.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 25.1 tttm -59.42 -50.22 74.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.231 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.512 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -56.56 -41.45 76.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 111.623 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.457 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 43.5 mm -63.47 -37.95 80.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.801 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -73.52 -33.44 64.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.692 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.2 mt-10 -65.26 -59.53 3.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.4 ' HB3' HG22 ' A' ' 48' ' ' THR . 2.5 m-20 -77.51 -9.72 59.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.815 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.412 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 38.9 mmtm 59.94 35.04 21.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.47 0.652 . . . . 0.0 111.063 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 p -87.65 76.93 8.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.412 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 76.2 m-85 -88.48 91.66 8.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.716 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 26.7 p90 -151.52 -177.45 6.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.816 169.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.489 ' ND2' ' HA ' ' A' ' 66' ' ' TYR . 4.1 p-10 -72.51 88.82 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.805 0.812 . . . . 0.0 111.694 -174.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.614 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt-30 -111.09 144.75 39.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.186 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 68' ' ' VAL . 29.6 m -132.91 145.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.439 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.65 109.54 19.74 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.692 HD23 HG21 ' A' ' 12' ' ' ILE . 9.0 mt -62.15 147.43 47.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.47 141.73 53.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.862 ' NZ ' ' HA ' ' A' ' 70' ' ' THR . 5.3 mmmt -75.4 -28.68 59.53 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.536 -161.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.702 ' HA ' ' CD ' ' A' ' 99' ' ' LYS . 2.0 m-20 -89.95 -4.98 57.18 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -88.16 -48.17 7.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.562 172.396 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.547 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -45.13 -40.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.893 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.702 ' CD ' ' HA ' ' A' ' 96' ' ' ASP . 39.6 mtpt -47.52 -59.52 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.977 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.49 -45.77 71.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.59 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.08 -41.8 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.177 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.547 ' HG ' ' O ' ' A' ' 98' ' ' VAL . 94.6 mt -58.53 -53.84 53.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.419 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.72 -52.47 56.11 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.557 0.536 . . . . 0.0 109.712 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 m -53.28 -30.87 41.0 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.569 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 29.9 m-85 -80.44 8.32 7.91 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.867 -0.521 . . . . 0.0 110.892 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 21.9 t 66.2 46.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.716 0.806 . . . . 0.0 109.106 -174.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.493 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 20.0 mm -116.44 129.38 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.63 14.0 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.208 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.1 166.87 38.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 119.434 -1.365 . . . . 0.0 114.246 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -130.9 157.54 77.66 Favored Pre-proline 0 N--CA 1.463 0.212 0 C-N-CA 123.032 0.533 . . . . 0.0 110.581 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.22 169.96 71.35 Favored 'Cis proline' 0 C--N 1.352 0.744 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.113 -1.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.435 ' CE1' HG23 ' A' ' 114' ' ' ILE . 39.8 t-80 -147.01 134.51 20.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.675 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.543 HG23 HD21 ' A' ' 132' ' ' LEU . 4.9 mp -129.63 145.08 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.449 177.071 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 27.7 pt -133.42 163.28 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 172.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.473 HD22 ' HD2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -123.35 118.13 26.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.884 ' HB ' HG23 ' A' ' 32' ' ' VAL . 76.6 t -108.84 138.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.99 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.446 ' O ' HG13 ' A' ' 116' ' ' VAL . 46.7 m-20 -62.62 160.73 32.81 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.576 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.0 Cg_exo -59.91 -15.34 32.25 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.555 2.17 . . . . 0.0 111.726 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -83.18 -29.66 28.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.843 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.56 32.79 3.29 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.595 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.646 ' HZ3' ' HB2' ' A' ' 121' ' ' LYS . 10.1 mtmp? -111.92 150.87 29.88 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.684 -0.303 . . . . 0.0 110.473 176.648 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.38 96.36 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.565 HG12 ' HE2' ' A' ' 31' ' ' TYR . 14.1 p -83.45 -29.21 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.128 0.49 . . . . 0.0 110.572 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.96 149.21 27.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.993 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.558 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 13.0 ptmm? -151.23 163.36 39.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.558 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 23.7 mm-40 76.36 4.44 3.63 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.233 0.958 . . . . 0.0 112.026 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.43 ' O ' ' HD3' ' A' ' 128' ' ' ARG . 43.5 mt -59.7 136.11 57.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.43 ' HD3' ' O ' ' A' ' 127' ' ' LEU . 23.5 mmt-85 -133.78 173.19 11.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.932 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 45.09 -135.4 7.18 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 124.1 0.875 . . . . 0.0 114.127 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.34 -13.95 59.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.676 0.274 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.7 -27.4 67.86 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 136' ' ' VAL . 79.7 mt -47.66 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 172.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -49.91 75.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.623 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.506 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 85.1 m-20 -65.49 -26.49 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.506 -174.324 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.61 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 16.9 m -77.29 -33.3 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 132' ' ' LEU . 24.4 t -63.33 -42.97 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.807 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.98 ' HA ' HD21 ' A' ' 141' ' ' ASN . 58.3 mm-40 -67.22 -41.06 86.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.034 0.445 . . . . 0.0 110.554 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.61 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 22.0 ttpt -56.45 -56.48 20.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.143 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.29 -61.08 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.313 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.99 -31.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.98 HD21 ' HA ' ' A' ' 137' ' ' GLU . 56.9 m-80 -93.69 -15.05 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.936 0.398 . . . . 0.0 110.699 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.1 16.32 78.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.008 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 73.82 16.46 3.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.622 0.769 . . . . 0.0 112.358 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.405 ' HD2' ' N ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -163.08 127.12 2.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.323 0.583 . . . . 0.0 111.218 173.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -98.3 138.61 35.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.795 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.76 -58.37 0.32 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -76.12 77.36 2.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 168.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -52.87 127.29 23.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.487 -167.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.834 ' HE1' ' HB3' ' A' ' 61' ' ' LYS . 2.8 p80 -88.16 27.75 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.146 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 72.43 143.92 0.07 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.357 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -90.79 93.16 9.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.116 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.516 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 9.7 p80 . . . . . 0 C--O 1.243 0.712 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.838 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 m -151.04 -171.22 3.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.83 -87.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . 0.457 ' HB2' ' OG ' ' A' ' 7' ' ' SER . . . 178.79 155.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.792 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -74.93 109.26 8.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.88 -6.2 20.06 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.97 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.457 ' OG ' ' HB2' ' A' ' 4' ' ' ALA . 50.0 m -76.86 138.7 39.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.706 0.288 . . . . 0.0 110.536 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.49 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.0 p -73.96 138.82 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' A' ' 105' ' ' TYR . . . -92.55 150.83 40.51 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.353 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.53 163.18 11.07 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.328 2.685 . . . . 0.0 112.267 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.66 102.46 13.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.853 0.359 . . . . 0.0 111.718 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.617 HD11 ' CE1' ' A' ' 105' ' ' TYR . 50.6 mm -69.78 138.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.572 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.7 t -142.97 137.56 29.46 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.4 172.67 36.08 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.584 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.431 HD11 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -85.89 118.05 31.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -75.34 -176.99 3.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.177 0.513 . . . . 0.0 111.198 -173.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.93 -29.45 63.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.683 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.479 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 29.9 mttp -85.99 -43.85 12.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.65 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.29 15.36 1.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.409 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.479 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.6 m-80 -96.51 154.19 17.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -83.96 93.57 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 0.0 110.333 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.17 138.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.753 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -116.68 163.41 16.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.224 0.535 . . . . 0.0 111.407 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.533 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . 62.1 tp -63.47 -23.93 67.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.886 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.533 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.4 t30 -64.19 -28.39 69.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.11 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -77.06 -4.58 45.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.1 2.51 16.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.34 0.59 . . . . 0.0 109.42 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.533 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 41.2 mtpt -71.49 111.71 7.02 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.738 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.91 -22.41 2.47 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -115.05 170.51 8.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.619 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.09 117.23 21.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 20.8 t -99.0 116.93 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -90.86 104.1 16.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.566 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 47.9 t -98.67 108.85 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.937 0.399 . . . . 0.0 110.92 -174.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.5 115.83 29.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.29 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.2 115.66 26.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.686 ' HE3' ' HG ' ' A' ' 44' ' ' CYS . 3.1 p-90 -155.7 -177.29 6.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.362 0.601 . . . . 0.0 111.452 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 41' ' ' CYS . 17.9 p90 -157.19 152.78 26.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.853 171.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.402 ' HB3' ' HA ' ' A' ' 77' ' ' TRP . . . -58.19 -45.12 88.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 111.838 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.828 ' HA3' HH12 ' A' ' 72' ' ' ARG . . . -82.76 45.79 3.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.401 -177.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . 0.697 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 46.0 t -132.43 136.19 46.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.736 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 p -88.43 -15.09 36.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.531 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 39.9 m95 -85.92 -52.53 5.67 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.781 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.697 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 12.8 p -63.36 -24.66 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.26 0.552 . . . . 0.0 110.634 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.426 ' NH2' ' HB2' ' A' ' 83' ' ' GLU . 4.8 tpt180 -72.02 -14.39 61.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.888 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.736 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.2 mptm? -79.99 -40.08 28.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.882 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' ' HG3' ' A' ' 111' ' ' PRO . 25.7 mp0 -80.33 -9.58 59.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.655 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.569 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 38.3 m -50.74 -50.22 74.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.569 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 51.9 Cg_exo -55.4 -42.52 67.39 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.052 1.835 . . . . 0.0 112.617 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.08 -36.79 80.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.4 ' HG ' ' O ' ' A' ' 47' ' ' GLU . 96.0 mt -64.27 -41.69 96.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.513 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.84 -44.56 96.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.165 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.469 ' HZ3' ' CG ' ' A' ' 130' ' ' ASP . 84.2 tttt -55.96 -48.88 74.97 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.393 174.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.403 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 33.9 m -62.55 -52.06 64.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.253 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.711 ' HB2' HD11 ' A' ' 65' ' ' ILE . 88.6 t80 -58.59 -43.4 89.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.68 0.276 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -61.79 -39.71 92.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.891 0.377 . . . . 0.0 111.293 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.63 -20.42 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.416 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 77.0 m-85 -121.94 9.12 9.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 17.5 pttm -64.23 -41.14 97.14 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.606 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -24.79 41.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.113 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.416 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 92.6 mttt -76.76 -172.11 2.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.169 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 49.64 3.27 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 83.5 t80 -143.62 146.49 33.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.8 m -156.86 136.96 12.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.711 HD11 ' HB2' ' A' ' 55' ' ' TYR . 43.5 mt -89.32 133.46 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.909 0.385 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.76 101.97 9.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.177 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.13 115.61 4.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.444 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.467 HG13 ' CD1' ' A' ' 93' ' ' LEU . 44.2 t -98.39 111.34 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 38.5 t -118.72 139.5 51.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.355 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -134.77 35.58 3.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.428 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.584 ' OD1' ' HD2' ' A' ' 72' ' ' ARG . 4.2 t70 -65.8 165.63 12.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.777 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.828 HH12 ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.58 -25.24 61.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.836 -175.152 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 7.2 tpt180 -141.2 131.14 24.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.585 -173.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.532 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 22.2 tt0 -69.83 -32.83 71.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 0.0 110.002 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 3.5 mp0 -57.66 -42.46 83.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.814 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 31.5 t70 -73.07 -39.86 65.51 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.518 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 27.6 t90 -52.64 -52.12 57.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.654 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.532 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -62.46 -44.08 97.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.792 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.469 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 18.3 tttm -57.4 -45.73 84.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.85 -45.52 82.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.572 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.0 -34.86 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.885 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.53 -30.01 70.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.0 110.208 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.426 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . 67.7 mt-10 -75.89 -60.5 2.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.066 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -83.77 -18.91 36.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.81 -169.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 72.88 28.12 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.592 0.557 . . . . 0.0 110.622 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -67.01 81.06 0.12 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.936 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -96.39 88.99 4.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.15 178.29 10.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.022 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.66 102.72 2.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -173.038 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 44.6 mt-30 -119.85 155.06 33.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.321 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.66 143.74 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.501 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.43 112.31 24.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.467 ' CD1' HG13 ' A' ' 68' ' ' VAL . 8.0 mp -71.83 157.35 38.05 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.307 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -89.88 178.93 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.527 0.68 . . . . 0.0 111.08 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.485 ' HD2' ' N ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -77.38 -15.03 59.58 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.322 -178.132 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.485 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -83.98 -55.5 4.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.622 -175.975 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.412 ' O ' HG21 ' A' ' 101' ' ' VAL . 4.6 p30 -79.75 -30.7 40.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.556 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -49.05 -32.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.482 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mmtt -53.76 -63.5 1.13 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.711 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -55.67 -55.74 28.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.442 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.448 HG22 HD22 ' A' ' 93' ' ' LEU . 61.5 t -46.43 -55.85 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.915 0.76 . . . . 0.0 112.129 -176.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.814 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 25.8 mt -62.07 -34.84 77.03 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.643 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.21 -63.04 1.46 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.098 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.445 ' C ' ' H ' ' A' ' 106' ' ' CYS . 60.8 p -53.4 -45.28 69.25 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 124.798 1.311 . . . . 0.0 113.27 -164.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.617 ' CE1' HD11 ' A' ' 12' ' ' ILE . 85.0 m-85 -75.75 13.15 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.089 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.445 ' H ' ' C ' ' A' ' 104' ' ' SER . 34.7 m 62.66 57.71 1.74 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.139 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.814 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 2.1 mp -85.43 110.88 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.825 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.16 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.956 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.53 178.48 34.73 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.914 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.6 151.96 79.59 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 43' ' ' TRP . 86.1 Cg_endo -77.34 151.52 92.97 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.32 0.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.59 113.61 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.514 HD13 HH21 ' A' ' 128' ' ' ARG . 86.8 mt -117.74 139.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.4 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.566 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 44.0 pt -134.9 145.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.92 0.39 . . . . 0.0 111.148 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.38 110.08 22.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.485 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 88.7 t -102.42 136.94 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.059 -175.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.45 ' O ' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.77 169.85 19.06 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.843 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -55.18 -29.14 64.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.802 2.334 . . . . 0.0 113.988 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.63 -4.25 55.65 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.33 30.15 22.97 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.609 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 30.0 mttm -108.96 145.58 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.837 0.351 . . . . 0.0 110.522 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.8 mt -80.17 105.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.16 -48.49 21.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.492 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.01 169.42 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.184 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.6 pttp -159.7 172.59 17.45 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.05 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.616 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 2.0 mm-40 64.94 23.31 12.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.652 1.181 . . . . 0.0 111.318 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.409 ' HB2' HD21 ' A' ' 132' ' ' LEU . 83.9 mt -61.21 148.33 41.27 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.822 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.514 HH21 HD13 ' A' ' 113' ' ' ILE . 2.9 mmp_? -125.22 151.48 45.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -171.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 40.05 -126.19 2.54 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 124.175 0.922 . . . . 0.0 114.785 170.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.469 ' CG ' ' HZ3' ' A' ' 53' ' ' LYS . 0.2 OUTLIER -77.46 -10.04 59.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.674 -177.209 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.856 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 24.8 t70 -66.39 -33.46 75.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.577 ' O ' HG21 ' A' ' 136' ' ' VAL . 53.5 mt -48.92 -52.95 21.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 170.041 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.44 -59.06 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.555 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.856 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.6 p30 -66.94 -31.75 72.54 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.314 -172.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.603 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 19.1 m -70.66 -37.35 73.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.36 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.577 HG21 ' O ' ' A' ' 132' ' ' LEU . 81.3 t -61.16 -49.33 85.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.338 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.43 ' HG3' ' HB2' ' A' ' 141' ' ' ASN . 6.0 tp10 -61.44 -50.39 72.98 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.603 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 15.7 ttpt -48.53 -37.44 17.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.517 0.727 . . . . 0.0 111.734 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -87.96 -48.5 7.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -87.91 -25.48 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.43 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 25.6 t-20 -54.53 -53.11 58.81 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.52 -39.18 1.98 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.038 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.01 96.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? 62.92 -165.79 0.23 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.003 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.417 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -112.81 -12.0 13.39 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.381 178.06 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.14 77.27 1.18 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.387 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -61.54 165.33 4.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 110.533 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.01 -33.88 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -86.14 96.56 9.94 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.682 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -151.65 -175.22 5.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.432 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -139.88 140.71 36.55 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 74.9 t60 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.259 -0.877 . . . . 0.0 108.81 170.433 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.419 ' HB3' ' H ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.419 ' H ' ' HB3' ' A' ' 1' ' ' MET . 16.5 m 50.12 -95.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.608 0.763 . . . . 0.0 112.048 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.9 114.85 14.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.76 -166.88 1.32 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 111.427 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . 0.97 HG22 ' HA ' ' A' ' 123' ' ' VAL . 24.9 m -56.72 130.23 44.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.159 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.97 -8.01 36.01 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.066 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -78.47 138.2 38.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.56 126.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.54 76.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.549 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 162.15 25.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.051 2.501 . . . . 0.0 111.839 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.97 100.47 11.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.783 0.325 . . . . 0.0 111.712 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.615 HG12 HG11 ' A' ' 101' ' ' VAL . 56.4 mt -72.19 132.47 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.176 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -128.53 97.87 4.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 175.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.89 165.17 12.07 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.543 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 66.2 mt -98.93 122.93 51.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.613 0.244 . . . . 0.0 110.46 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.504 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 31.5 p30 -74.19 -173.84 1.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.971 0.415 . . . . 0.0 111.547 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.84 -16.92 63.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.072 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.416 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 1.1 mtpt -87.98 -35.59 17.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.98 21.31 3.52 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.47 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.636 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.6 OUTLIER -98.45 142.59 29.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -81.78 102.25 10.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.806 0.336 . . . . 0.0 110.232 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.89 142.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.074 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -103.94 -177.96 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.975 0.416 . . . . 0.0 110.545 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -80.39 -21.56 42.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.587 175.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.439 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 50.5 m-80 -68.31 -24.79 64.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.46 -25.61 68.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.11 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -112.4 13.34 20.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.086 0.469 . . . . 0.0 110.317 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.439 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 22.6 tttm -68.99 171.35 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.445 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.98 64.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.4 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -141.16 176.17 9.05 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.57 ' HB3' HD11 ' A' ' 115' ' ' LEU . 54.1 m-85 -78.77 109.68 13.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.532 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 47.2 t -96.78 123.32 49.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.722 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 19.5 tp -90.54 116.95 28.84 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.499 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 16.7 t -105.05 102.99 14.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.448 ' OD1' HG21 ' A' ' 65' ' ' ILE . 6.5 m-20 -98.4 110.15 22.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.762 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HB3' ' HE2' ' A' ' 110' ' ' PHE . 53.2 m-85 -92.74 116.8 29.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.783 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 12.9 p-90 -154.65 -179.18 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.426 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 45.0 p90 -170.01 157.1 6.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.528 168.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.99 -16.99 62.86 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.12 -21.32 69.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.582 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 66.7 m -92.2 131.32 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 0.0 110.274 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -88.39 -28.26 21.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.694 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -67.75 -34.57 77.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.135 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.56 ' HG ' ' HB3' ' A' ' 111' ' ' PRO . 80.0 m -51.95 -38.63 57.22 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.67 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.489 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -64.44 -28.33 69.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.774 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -84.96 -11.34 55.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.181 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -98.04 -21.78 16.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.418 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.536 HG21 ' HB3' ' A' ' 84' ' ' ASP . 51.4 m -49.93 -48.23 78.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.532 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.2 Cg_endo -48.61 -45.88 25.97 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.205 1.937 . . . . 0.0 112.36 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.94 -37.63 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.238 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -55.93 -48.55 75.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 175.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' HZ3' ' A' ' 88' ' ' TRP . 63.0 tp -63.63 -42.67 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.965 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.678 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 47.4 tttm -60.0 -43.72 95.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.431 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 27.1 m -53.11 -46.1 68.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.205 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.55 ' HB2' HD13 ' A' ' 65' ' ' ILE . 88.4 t80 -56.83 -61.99 2.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.678 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.9 p-10 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.494 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.22 -20.06 29.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.503 ' HZ ' ' HA ' ' A' ' 137' ' ' GLU . 75.1 m-85 -115.65 -15.2 11.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.499 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptmm? -56.28 -23.13 34.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.005 0.431 . . . . 0.0 111.646 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.499 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 3.5 m-20 -106.87 17.25 23.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 89.5 mttt -121.64 14.73 11.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.137 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.99 44.18 9.25 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.515 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.722 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 55.3 t80 -139.0 135.23 34.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -135.74 145.65 46.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.96 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.55 HD13 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -103.72 126.75 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.971 0.415 . . . . 0.0 110.619 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -112.94 96.52 5.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.682 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -75.01 114.54 4.36 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.389 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.975 HG11 HD21 ' A' ' 93' ' ' LEU . 50.0 t -98.69 111.11 27.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.421 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 14.7 m -116.7 125.73 52.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.602 ' HB ' HD13 ' A' ' 93' ' ' LEU . 10.1 t -113.5 52.13 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.518 1.152 . . . . 0.0 108.604 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.426 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 t70 -70.2 178.96 2.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.128 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -104.3 -21.97 13.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.921 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.526 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 51.9 mtt-85 -141.63 150.46 42.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.8 tt0 -75.62 -37.19 59.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.526 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.1 mp0 -62.01 -41.36 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.578 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.42 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -74.44 -35.63 63.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.001 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -60.73 -51.96 67.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.434 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.2 mptm? -59.13 -37.17 76.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.473 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 27.1 ttpt -59.22 -50.02 75.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.768 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.89 83.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.182 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.44 -38.82 77.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.378 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.75 -55.36 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.892 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.473 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.5 mt-10 -53.07 -49.0 67.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.545 . . . . 0.0 111.639 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.536 ' HB3' HG21 ' A' ' 48' ' ' THR . 6.4 m-20 -85.45 -16.43 39.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.453 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.44 ' HD2' ' OH ' ' A' ' 87' ' ' TYR . 46.9 mmtm 61.74 40.54 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.653 0.739 . . . . 0.0 110.092 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -80.63 86.46 5.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.183 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.44 ' OH ' ' HD2' ' A' ' 85' ' ' LYS . 57.4 m-85 -87.66 78.94 8.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.276 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.408 ' HZ3' ' HA ' ' A' ' 52' ' ' LEU . 23.6 p90 -161.42 175.16 12.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 174.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.47 110.47 9.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.974 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.682 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 48.6 mt-30 -123.39 145.97 48.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.3 m -132.65 149.97 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.421 ' HA ' ' O ' ' A' ' 69' ' ' SER . 20.7 tp -94.2 132.2 38.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.975 HD21 HG11 ' A' ' 68' ' ' VAL . 72.3 mt -73.45 149.94 42.01 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.611 ' O ' HG21 ' A' ' 98' ' ' VAL . 49.8 mt-30 -80.72 171.18 15.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.412 175.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.15 -39.65 90.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.583 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 13.5 m-20 -87.21 -33.62 19.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.181 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.555 ' OD2' HD22 ' A' ' 93' ' ' LEU . 16.1 t70 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.821 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.611 HG21 ' O ' ' A' ' 94' ' ' GLN . 78.8 t -66.86 -65.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 110.124 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.583 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 20.5 pttp -62.55 -62.62 1.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -170.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . 0.407 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 9.0 m-20 -67.94 -36.63 80.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.738 0.304 . . . . 0.0 111.622 -169.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.615 HG11 HG12 ' A' ' 12' ' ' ILE . 59.3 t -79.27 -50.26 18.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.943 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.504 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 87.9 mt -56.23 -47.81 77.71 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.89 -47.33 80.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.4 m -54.81 -33.04 61.06 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.99 0.806 . . . . 0.0 112.446 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -79.24 7.75 7.15 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.14 -0.35 . . . . 0.0 111.436 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.41 ' HB2' ' HB2' ' A' ' 2' ' ' SER . 42.5 t 66.57 54.13 0.89 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.504 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 73.8 mt -133.3 93.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.6 -1.5 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.861 0.839 . . . . 0.0 109.392 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.77 165.31 28.83 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.176 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.509 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 95.4 m-85 -127.19 160.7 58.39 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.654 0.227 . . . . 0.0 110.707 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.56 ' HB3' ' HG ' ' A' ' 44' ' ' CYS . 5.5 Cg_exo -81.89 172.08 53.64 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.948 -1.271 . . . . 0.0 112.721 -0.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.676 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -155.39 122.53 5.48 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.622 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.1 131.44 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.556 HG23 ' HB2' ' A' ' 125' ' ' LYS . 25.9 pt -130.5 158.32 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.57 HD11 ' HB3' ' A' ' 31' ' ' TYR . 58.9 tp -124.51 127.59 47.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.142 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.532 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 5.5 m -119.1 145.13 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -59.78 163.3 7.54 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.131 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.32 -22.26 64.54 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -70.19 -34.0 72.42 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.784 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.23 32.68 3.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.05 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.72 ' HZ1' ' HB2' ' A' ' 121' ' ' LYS . 10.5 mtmp? -117.42 147.86 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.632 HG23 ' HD2' ' A' ' 125' ' ' LYS . 34.9 mt -86.19 119.57 34.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.594 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.97 ' HA ' HG22 ' A' ' 5' ' ' THR . 13.2 m -101.75 -35.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.014 0.435 . . . . 0.0 110.832 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.8 140.74 40.72 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.632 ' HD2' HG23 ' A' ' 122' ' ' ILE . 9.4 ptmm? -156.81 153.43 28.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.232 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.676 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 32.4 mt-10 70.0 25.47 4.82 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.205 0.941 . . . . 0.0 110.968 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.9 mt -67.91 159.12 31.17 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.621 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.1 mmp_? -128.9 134.53 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.641 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 43.12 -114.58 0.86 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 168.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.463 ' O ' ' HB2' ' A' ' 134' ' ' ASN . 4.2 m-20 -63.12 -35.43 80.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.867 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 7.7 t70 -63.63 -39.74 95.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.822 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.641 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.0 pp -57.2 -44.47 83.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.52 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 68.4 t80 -70.64 -46.47 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.463 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 11.2 t-20 -50.2 -57.21 8.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.8 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.563 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 19.8 m -72.74 -34.38 67.0 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.998 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.401 HG23 HD23 ' A' ' 115' ' ' LEU . 38.2 t -63.21 -42.32 96.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.325 174.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.503 ' HA ' ' HZ ' ' A' ' 58' ' ' PHE . 3.2 tp10 -61.21 -53.02 62.17 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.563 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 9.2 mtmp? -57.5 -27.58 62.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.733 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -83.15 -61.09 1.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.408 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.15 -35.27 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 123.441 0.463 . . . . 0.0 111.543 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.9 90.79 4.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -32.36 -47.84 0.29 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-N 113.741 -1.572 . . . . 0.0 114.659 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.457 ' HB1' ' HA2' ' A' ' 146' ' ' GLY . . . -61.42 109.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.373 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -93.65 -52.5 4.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 0.0 109.65 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -12.65 19.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.876 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.457 ' HA2' ' HB1' ' A' ' 143' ' ' ALA . . . 111.23 -34.09 5.49 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.855 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.26 81.12 0.13 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.045 0.45 . . . . 0.0 110.252 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.69 93.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.188 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.33 -69.25 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -145.81 18.62 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.018 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -69.05 92.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--O 1.246 0.915 0 O-C-N 124.127 0.892 . . . . 0.0 110.104 -170.008 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HB3' ' HG3' ' A' ' 126' ' ' GLU . 27.8 ttt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -60.4 -48.97 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.07 0.462 . . . . 0.0 110.517 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.636 ' HG ' ' SG ' ' A' ' 106' ' ' CYS . 76.9 mt -96.8 34.71 1.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.642 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.9 -140.13 0.96 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.446 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -146.34 140.12 26.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.663 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.39 4.52 62.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.477 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -81.06 143.45 32.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.55 HG22 ' HG2' ' A' ' 121' ' ' LYS . 31.6 t -69.64 133.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.469 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.58 146.63 31.66 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 -175.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.04 162.31 26.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.888 2.392 . . . . 0.0 111.975 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.39 113.58 25.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.832 0.349 . . . . 0.0 111.547 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.95 137.02 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -134.72 104.88 6.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.86 172.18 18.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.139 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.497 ' N ' HD12 ' A' ' 15' ' ' ILE . 3.8 mp -98.01 119.18 45.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -173.56 3.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 -171.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.426 HD22 ' CD1' ' A' ' 81' ' ' ILE . 96.6 mt -62.45 -33.49 74.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.669 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -74.99 -30.68 61.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.608 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.54 19.36 7.93 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.523 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.6 OUTLIER -100.35 144.25 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -87.04 92.46 9.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.66 147.46 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.527 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.42 168.0 9.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 -174.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.72 -35.37 74.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.643 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.551 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 3.2 p-10 -66.81 -17.55 64.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.78 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -74.25 -24.15 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.126 0.489 . . . . 0.0 110.501 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -105.35 8.51 33.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 110.25 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.551 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.8 tttp -62.46 160.3 13.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.074 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.28 10.17 57.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.271 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -141.43 177.6 8.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.463 ' HB3' HD12 ' A' ' 115' ' ' LEU . 97.3 m-85 -85.17 107.03 17.04 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.48 ' HA ' ' O ' ' A' ' 64' ' ' THR . 42.0 t -100.43 109.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 -174.247 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 28.1 tp -86.77 118.18 26.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -104.89 115.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.699 0.285 . . . . 0.0 110.835 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -101.79 111.04 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.262 0.553 . . . . 0.0 111.413 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -93.77 118.07 30.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.422 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -151.16 176.93 10.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -170.3 151.39 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.384 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.11 1.85 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.403 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.65 54.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.689 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.0 t -103.48 116.31 32.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.546 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 9.5 m -67.97 -26.53 65.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -177.22 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -73.22 -36.2 66.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.92 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.0 m -59.99 -35.58 75.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.463 ' HE ' ' CG ' ' A' ' 84' ' ' ASP . 26.4 mmm-85 -67.39 -22.21 65.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.546 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' HD3' ' O ' ' A' ' 42' ' ' SER . 4.9 mptp? -85.88 -11.45 53.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.327 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.435 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 43.8 mt-10 -105.65 -6.87 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.58 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 3.9 m -54.05 -47.09 98.2 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.953 175.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.9 Cg_endo -51.68 -36.81 62.67 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.624 2.216 . . . . 0.0 113.036 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.435 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 41.0 m-85 -67.55 -39.62 84.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.031 0.443 . . . . 0.0 110.069 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.58 HD21 HD11 ' A' ' 113' ' ' ILE . 88.5 mt -63.7 -43.12 97.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.692 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -64.15 -43.41 95.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.463 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . 0.4 ' HZ2' ' CG ' ' A' ' 130' ' ' ASP . 42.8 tttm -54.56 -44.85 73.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.341 175.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HD1' ' A' ' 58' ' ' PHE . 33.2 m -63.76 -48.7 75.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.679 ' HB2' HD12 ' A' ' 65' ' ' ILE . 53.2 t80 -60.07 -36.04 76.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.843 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -73.34 -33.49 65.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.11 -18.92 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HD1' ' O ' ' A' ' 54' ' ' THR . 84.1 m-85 -111.54 10.98 21.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -75.19 -3.94 35.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 0.0 111.116 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -98.34 -2.33 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.006 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -122.99 174.43 7.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.469 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.05 61.95 2.57 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 74.4 t80 -133.68 130.42 38.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.787 0.327 . . . . 0.0 110.334 -176.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 12.3 p -135.73 137.82 42.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.283 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.679 HD12 ' HB2' ' A' ' 55' ' ' TYR . 36.8 mt -97.34 124.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.555 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 80.4 t80 -113.25 104.79 12.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.876 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.936 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -86.24 142.12 18.72 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.566 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.7 111.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 15.0 m -115.07 155.17 27.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.008 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -143.96 40.12 1.37 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.935 0.874 . . . . 0.0 108.658 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.414 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 4.5 m-20 -71.37 175.78 5.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.399 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -70.21 -45.57 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.409 -172.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.5 tpt180 -145.68 150.62 36.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.437 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 28.4 tt0 -62.28 -41.81 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 110.459 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.33 -44.21 95.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.254 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.64 -39.78 84.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.152 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -58.48 -54.13 50.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.626 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.437 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -57.22 -40.55 77.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 2.7 ttpm? -60.51 -49.44 77.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.363 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.563 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -58.15 -40.54 81.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.136 0.493 . . . . 0.0 111.1 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.485 HG22 ' O ' ' A' ' 86' ' ' SER . 80.3 mt -61.67 -38.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.887 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -71.77 -46.41 58.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.565 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 46.5 mt-10 -54.69 -54.33 43.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.143 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.534 ' HB3' HG23 ' A' ' 48' ' ' THR . 5.5 m-20 -85.56 0.18 53.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.068 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.471 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 70.0 mmtt 58.4 37.82 25.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.574 0.702 . . . . 0.0 110.706 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.485 ' O ' HG22 ' A' ' 81' ' ' ILE . 36.4 t -82.59 68.15 8.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.708 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -87.1 76.29 9.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.963 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 30.8 p90 -148.67 -174.57 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 169.252 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.16 90.94 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.504 -171.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.936 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 91.6 mt-30 -108.0 138.76 43.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.912 0.386 . . . . 0.0 111.017 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.09 146.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.95 126.41 37.02 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.518 HD12 ' HA ' ' A' ' 98' ' ' VAL . 47.5 mt -67.92 145.7 54.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 0.0 111.383 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.644 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.5 mt-30 -67.76 156.0 38.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.433 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -60.92 -44.89 96.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.008 0.433 . . . . 0.0 111.614 -170.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.29 -19.49 31.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.4 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.421 ' CB ' ' HB2' ' A' ' 94' ' ' GLN . 37.0 t70 -80.87 -27.8 36.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.976 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.644 HG23 ' O ' ' A' ' 94' ' ' GLN . 58.3 t -47.91 -51.35 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -47.73 80.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.559 -176.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -67.78 -50.2 58.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.03 -173.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.97 -56.05 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.315 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.533 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.0 mt -57.49 -46.0 84.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.75 -60.71 2.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 m -51.31 -38.58 53.74 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 124.716 1.26 . . . . 0.0 113.292 -170.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -82.07 17.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.463 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.636 ' SG ' ' HG ' ' A' ' 3' ' ' LEU . 63.8 m 62.88 42.19 7.97 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 123.378 0.671 . . . . 0.0 110.077 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.533 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 63.4 mt -100.16 89.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.058 -176.305 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.5 -18.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.23 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.68 152.48 24.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.006 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -108.75 156.12 39.47 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.421 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 95.2 Cg_endo -78.29 177.01 40.62 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 123.238 -1.568 . . . . 0.0 112.779 0.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.06 117.62 4.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.58 HD11 HD21 ' A' ' 51' ' ' LEU . 58.6 mt -127.98 138.43 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.466 ' HB ' HG21 ' A' ' 122' ' ' ILE . 49.2 pt -134.3 158.63 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.013 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.737 HD22 HG22 ' A' ' 136' ' ' VAL . 60.9 tp -118.59 115.46 24.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.27 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.31 129.98 47.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.565 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 8.2 p30 -78.53 166.99 38.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.203 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.565 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 6.4 Cg_endo -50.5 -35.88 47.25 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.965 2.443 . . . . 0.0 113.196 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.497 ' CD ' ' HZ2' ' A' ' 121' ' ' LYS . 45.3 mt-10 -63.01 -37.4 87.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.62 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.46 3.89 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.55 ' HG2' HG22 ' A' ' 8' ' ' VAL . 28.4 mtmm -111.77 151.76 28.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.815 0.341 . . . . 0.0 110.259 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.466 HG21 ' HB ' ' A' ' 114' ' ' ILE . 18.0 mt -87.64 92.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.315 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -73.12 -26.98 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 0.0 110.748 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.521 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -133.92 119.03 18.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.555 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.566 ' HG2' ' CD ' ' A' ' 126' ' ' GLU . 60.8 tttm -127.46 157.72 39.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.557 -174.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.566 ' CD ' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER 50.24 48.69 21.81 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.999 0.812 . . . . 0.0 110.989 -176.761 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 132' ' ' LEU . 83.7 mt -72.49 157.37 37.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.508 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 13.8 tpt180 -128.7 142.38 51.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.464 -173.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 35.65 -132.45 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . 0.4 ' CG ' ' HZ2' ' A' ' 53' ' ' LYS . 11.7 t70 -79.02 -10.85 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.562 . . . . 0.0 110.111 176.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.508 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.1 m-20 -55.1 -33.47 62.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.266 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.533 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 4.3 pp -64.7 -41.42 96.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.912 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.431 ' N ' HD11 ' A' ' 132' ' ' LEU . 32.1 t80 -60.79 -52.14 66.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.712 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -60.07 -36.18 76.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.224 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 85.8 m -71.08 -46.55 61.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.146 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.737 HG22 HD22 ' A' ' 115' ' ' LEU . 96.1 t -67.49 -45.82 84.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.113 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.408 ' HG3' HD21 ' A' ' 141' ' ' ASN . 2.6 tp10 -58.53 -45.72 88.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.409 0.623 . . . . 0.0 109.606 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -56.94 -54.4 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.673 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.86 ' HA ' ' HB2' ' A' ' 143' ' ' ALA . 42.4 t80 -65.02 -56.76 11.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.745 -170.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.27 -42.43 95.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.33 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.408 HD21 ' HG3' ' A' ' 137' ' ' GLU . 92.1 m-20 -81.06 -61.29 2.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.125 -173.022 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -113.92 -27.01 3.63 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.324 -0.941 . . . . 0.0 114.919 -167.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.86 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . . . -73.62 72.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.853 0.826 . . . . 0.0 111.734 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -141.89 33.46 1.58 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.15 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 148' ' ' HIS . 17.8 mm-40 -72.2 90.81 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.577 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.92 21.62 6.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.661 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -120.34 32.21 6.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.074 0.464 . . . . 0.0 110.829 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 145' ' ' GLU . 23.6 p80 -125.06 131.34 53.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.009 0.433 . . . . 0.0 111.239 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . 0.401 ' H ' ' CD2' ' A' ' 149' ' ' HIS . 1.8 p80 -79.84 -174.58 4.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -59.04 -50.56 73.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.524 0.202 . . . . 0.0 111.118 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 167.47 -19.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.364 1.066 . . . . 0.0 108.197 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.8 p80 . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 165.492 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.726 ' HG2' ' H ' ' A' ' 2' ' ' SER . 32.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.726 ' H ' ' HG2' ' A' ' 1' ' ' MET . 5.0 p -57.15 -56.35 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.162 0.505 . . . . 0.0 109.89 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.3 mt -115.71 161.54 18.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.423 172.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.98 -163.67 1.49 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.694 0.283 . . . . 0.0 110.451 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 p -110.17 112.61 24.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.49 -4.36 40.25 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 p -71.96 128.23 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.13 135.66 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.525 ' HB2' ' HH ' ' A' ' 105' ' ' TYR . . . -92.36 144.04 28.3 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.686 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.27 158.44 12.18 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.232 2.622 . . . . 0.0 112.602 177.524 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.1 95.33 10.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.184 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.558 HD13 ' CE1' ' A' ' 105' ' ' TYR . 21.5 mm -59.12 131.84 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.462 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -126.96 88.09 2.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 161.58 13.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.976 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.32 125.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.801 0.334 . . . . 0.0 110.372 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -169.5 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.337 0.589 . . . . 0.0 111.681 -173.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.93 -30.09 71.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.931 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.65 -36.24 62.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 0.0 110.28 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.99 16.01 8.17 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.167 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.572 ' N ' HD21 ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.64 140.27 32.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -77.48 97.33 4.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 110.249 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.91 147.48 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.796 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.7 m -108.86 156.77 19.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.152 0.501 . . . . 0.0 111.367 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.59 -27.82 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.525 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -25.42 67.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.6 -9.59 58.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.409 0.623 . . . . 0.0 110.528 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.35 4.56 17.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.195 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -62.15 170.28 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.198 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.13 83.4 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.794 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 35.1 mttp -141.01 156.87 45.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -72.63 115.6 12.1 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 57.6 t -103.12 107.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.328 -172.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.415 ' HB3' HG12 ' A' ' 65' ' ' ILE . 38.9 tp -86.24 106.49 17.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.85 125.86 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.013 0.435 . . . . 0.0 110.891 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.421 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 12.9 t0 -112.06 96.23 5.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.426 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.512 ' HA ' HG12 ' A' ' 68' ' ' VAL . 96.0 m-85 -82.07 114.94 20.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.473 ' O ' ' HA ' ' A' ' 69' ' ' SER . 22.3 p-90 -153.55 175.45 13.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.062 0.934 . . . . 0.0 112.604 -172.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -167.76 162.84 14.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.691 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.95 -19.31 65.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.56 64.65 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.246 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.4 p -95.89 97.99 10.07 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.65 0.738 . . . . 0.0 109.943 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -64.77 -36.18 83.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.981 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -56.27 -41.18 75.44 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -64.93 -28.56 69.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.007 0.432 . . . . 0.0 110.252 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -81.26 -14.14 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.411 0.624 . . . . 0.0 110.083 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -79.69 -21.86 44.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.212 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -90.31 -7.11 54.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.879 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.548 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 98.6 m -48.58 -48.45 68.36 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.7 Cg_endo -49.36 -44.79 33.0 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.33 2.02 . . . . 0.0 112.633 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -73.82 -40.05 63.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.829 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.8 mt -57.21 -51.94 67.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.81 -43.04 94.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -62.63 -44.61 95.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.035 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.482 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 59.8 m -59.7 -46.17 89.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.6 ' HB2' HD12 ' A' ' 65' ' ' ILE . 37.5 t80 -65.69 -36.02 82.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.03 -43.64 98.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.091 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.01 -27.12 30.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.482 ' HD2' ' O ' ' A' ' 54' ' ' THR . 92.1 m-85 -114.57 10.83 16.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.505 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 20.1 pttp -64.76 -29.33 70.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 111.31 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.401 ' CG ' ' HZ3' ' A' ' 59' ' ' LYS . 7.1 m-20 -92.22 10.51 29.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.193 -177.017 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HZ2' ' CD ' ' A' ' 145' ' ' GLU . 80.0 mttt -121.36 -174.16 2.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.769 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.37 57.88 4.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.954 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 t80 -144.0 142.53 30.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.784 0.326 . . . . 0.0 110.179 -177.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -151.45 150.29 30.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.6 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -102.34 125.11 56.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.7 ' HH ' HG21 ' A' ' 91' ' ' VAL . 56.1 t80 -105.66 98.08 7.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.844 -177.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.458 ' O ' ' HA ' ' A' ' 90' ' ' GLN . . . -79.87 137.42 18.65 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.512 HG12 ' HA ' ' A' ' 36' ' ' PHE . 1.5 p -138.45 123.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.107 0.48 . . . . 0.0 110.591 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.473 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.5 t -128.87 163.87 24.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.222 0.534 . . . . 0.0 111.439 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.786 ' HB ' HD11 ' A' ' 93' ' ' LEU . 4.3 t -147.75 44.16 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.726 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.523 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 2.9 t70 -71.01 -178.93 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.399 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.523 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 13.1 ptt180 -67.1 -29.59 69.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.741 -173.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.497 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 56.4 mtt-85 -143.4 158.28 43.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.743 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . 0.768 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 32.3 tt0 -75.72 -38.79 58.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . 0.497 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.3 mp0 -60.72 -44.82 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.794 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 1.9 m-20 -62.52 -42.39 99.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.555 ' CE3' ' HD2' ' A' ' 78' ' ' LYS . 32.6 t90 -56.94 -52.74 64.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.917 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.768 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 3.7 mptp? -54.15 -50.63 66.53 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.29 0.566 . . . . 0.0 110.593 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -60.46 -44.62 95.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.173 -178.253 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.34 84.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 65.6 mt -60.39 -43.66 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.512 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -68.6 -46.46 69.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.008 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -59.73 -45.01 93.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.173 0.511 . . . . 0.0 111.138 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.29 -15.71 51.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.247 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.6 mmtt 65.02 33.32 9.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.835 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.9 m -92.34 85.59 5.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -91.77 84.25 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.42 -176.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -153.02 -173.3 4.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -69.52 96.6 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.458 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 32.6 mt-30 -123.18 143.63 49.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.143 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.7 HG21 ' HH ' ' A' ' 66' ' ' TYR . 35.7 m -130.3 158.3 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 111.301 -179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.2 tp -103.55 132.33 49.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.429 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.786 HD11 ' HB ' ' A' ' 70' ' ' THR . 88.7 mt -61.94 140.51 58.31 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.256 0.348 . . . . 0.0 111.169 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.679 ' O ' HG21 ' A' ' 98' ' ' VAL . 42.9 mt-30 -90.06 169.3 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -49.24 -55.07 13.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.237 0.541 . . . . 0.0 111.744 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -82.19 -36.57 27.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.674 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -56.77 -36.92 70.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.629 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.679 HG21 ' O ' ' A' ' 94' ' ' GLN . 54.2 t -52.06 -37.31 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.776 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.409 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.9 tptt -62.76 -58.8 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.384 -175.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.07 -49.59 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.592 0.234 . . . . 0.0 111.157 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.401 HG21 HD22 ' A' ' 93' ' ' LEU . 68.8 t -53.7 -59.69 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.714 -178.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.757 ' HA ' HD13 ' A' ' 107' ' ' ILE . 35.1 mt -65.0 -30.41 71.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.988 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.26 -63.92 1.3 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.582 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.413 ' C ' ' H ' ' A' ' 106' ' ' CYS . 62.3 m -65.39 -23.44 66.96 Favored 'General case' 0 C--N 1.338 0.077 0 O-C-N 124.213 0.946 . . . . 0.0 113.423 -164.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.558 ' CE1' HD13 ' A' ' 12' ' ' ILE . 54.5 m-85 -81.74 15.38 2.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.302 173.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.413 ' H ' ' C ' ' A' ' 104' ' ' SER . 46.9 t 55.22 44.46 27.59 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.325 -178.083 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.757 HD13 ' HA ' ' A' ' 102' ' ' LEU . 61.4 mt -86.22 93.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.068 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.6 m -106.28 19.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.261 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.98 168.89 26.72 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.836 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.442 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 87.0 m-85 -122.94 159.03 55.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.3 Cg_endo -86.52 171.55 38.7 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.359 -0.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -136.93 104.26 5.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.9 177.317 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.93 114.92 47.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 38.1 pt -124.93 159.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.06 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.527 ' HB3' ' HB1' ' A' ' 124' ' ' ALA . 4.0 tt -116.99 116.3 27.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.524 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 95.7 t -102.66 142.99 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.475 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.419 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -77.36 165.56 50.81 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.4 Cg_endo -49.0 -29.84 16.51 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.313 2.675 . . . . 0.0 114.09 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 1.056 ' HB3' ' HZ2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -91.75 2.06 56.75 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.392 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.433 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 86.75 26.34 32.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.436 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 1.056 ' HZ2' ' HB3' ' A' ' 119' ' ' GLU . 28.4 mttp -107.66 142.36 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.043 0.422 . . . . 0.0 110.465 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.7 mt -76.29 109.73 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.939 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.37 -36.21 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.066 0.46 . . . . 0.0 110.3 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.527 ' HB1' ' HB3' ' A' ' 115' ' ' LEU . . . -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 21.4 pttm -163.08 151.79 14.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.283 -0.167 . . . . 0.0 111.003 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 60.28 48.49 8.01 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.885 0.74 . . . . 0.0 111.09 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.66 156.94 21.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.939 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.488 ' HD2' ' H ' ' A' ' 129' ' ' GLY . 8.6 tpt180 -101.44 147.71 26.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.804 ' HA2' HD11 ' A' ' 132' ' ' LEU . . . -38.27 -58.31 1.66 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.37 -38.0 73.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.168 0.509 . . . . 0.0 110.102 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.455 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.8 t70 -83.27 -26.85 30.31 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.804 HD11 ' HA2' ' A' ' 129' ' ' GLY . 75.5 mt -46.26 -57.62 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.1 -47.9 80.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.98 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 94.0 m-20 -53.72 -53.36 53.15 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.236 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.657 ' HA ' ' CE ' ' A' ' 138' ' ' LYS . 4.8 m -62.24 -36.12 81.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.523 HG22 ' O ' ' A' ' 132' ' ' LEU . 50.8 t -69.21 -44.89 80.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.43 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 141' ' ' ASN . 1.3 tp10 -67.53 -29.83 69.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.652 0.739 . . . . 0.0 109.962 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.657 ' CE ' ' HA ' ' A' ' 135' ' ' THR . 26.9 ttpt -78.87 -54.2 6.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.966 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.47 ' CD2' HG23 ' A' ' 135' ' ' THR . 61.1 m-85 -87.07 -48.79 7.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 80.3 t -65.92 -42.61 92.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 -173.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.485 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 86.4 m-20 -81.9 -25.91 34.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.982 0.42 . . . . 0.0 110.997 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.02 16.46 64.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.411 -173.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 60.21 17.47 6.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' C ' ' H ' ' A' ' 146' ' ' GLY . 34.9 mmtm -147.53 -52.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . 0.562 ' CD ' ' HZ2' ' A' ' 61' ' ' LYS . 43.0 mt-10 71.11 -31.12 0.22 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.422 0.689 . . . . 0.0 112.011 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . 0.444 ' H ' ' C ' ' A' ' 144' ' ' LYS . . . -77.61 -158.73 10.49 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 171.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 59.07 59.16 2.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.57 0.7 . . . . 0.0 109.521 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -80.47 4.68 17.43 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -110.97 140.74 45.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -118.77 87.04 2.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.596 0.713 . . . . 0.0 111.346 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.89 -42.88 0.89 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.0 p80 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.53 174.134 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.1 m 73.47 -93.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 168.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.53 -165.17 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 0.0 111.668 -164.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.82 -80.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.274 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -152.81 154.1 34.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.12 -1.27 70.31 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -91.69 146.43 23.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.595 -0.302 . . . . 0.0 110.461 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.42 138.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.397 . . . . 0.0 110.095 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.42 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.81 149.95 40.67 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.738 -175.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 35.6 Cg_exo -62.9 163.53 21.86 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.522 2.815 . . . . 0.0 112.088 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.89 105.0 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.083 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.36 148.32 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.603 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.479 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 13.7 t -136.61 134.99 37.97 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.18 31.18 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.355 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -88.9 119.46 36.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -175.72 5.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.088 0.47 . . . . 0.0 111.127 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.441 HD22 ' HB2' ' A' ' 90' ' ' GLN . 95.4 mt -65.07 -28.93 69.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.945 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.58 -28.99 28.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.44 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 25.22 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.251 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.27 148.17 25.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 p -76.82 94.35 3.86 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.04 130.67 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.536 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.4 m -102.58 161.85 13.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.51 -14.86 46.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.615 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.536 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 30.2 p-10 -67.28 -20.86 65.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.915 0.388 . . . . 0.0 111.2 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.13 -23.04 47.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.46 5.53 31.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -79.98 63.21 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.702 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.6 13.17 0.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.064 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -144.31 171.38 14.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 120.78 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.317 172.281 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.472 ' HA ' ' O ' ' A' ' 64' ' ' THR . 46.1 t -112.47 112.79 41.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.494 -171.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . 0.491 HD22 HG23 ' A' ' 113' ' ' ILE . 10.0 tt -90.58 119.32 30.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 51.5 t -103.77 121.32 55.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.801 0.334 . . . . 0.0 110.915 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.48 ' HB2' ' HA2' ' A' ' 67' ' ' GLY . 29.9 m-20 -84.98 136.75 33.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.418 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.26 114.55 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -158.18 173.36 16.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.691 0.758 . . . . 0.0 112.342 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -170.05 166.59 9.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.614 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.403 ' HB3' HH21 ' A' ' 45' ' ' ARG . . . -63.24 -20.73 65.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -51.47 24.97 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.148 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.4 p -71.45 101.9 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.454 0.645 . . . . 0.0 110.432 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.417 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 18.9 m -69.39 -5.45 23.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.081 -171.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . 0.491 ' HD1' ' HG3' ' A' ' 111' ' ' PRO . 72.4 t-105 -85.37 -29.31 24.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.952 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.772 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 75.8 m -57.81 -34.5 69.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 110.631 176.474 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.557 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 8.6 mmt85 -66.79 -18.38 65.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 110.388 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.7 mptt -85.09 -33.18 22.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.937 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.27 -20.27 37.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.418 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.554 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 46.5 m -48.61 -50.5 59.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.554 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.4 Cg_exo -49.65 -45.27 32.19 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.266 1.978 . . . . 0.0 112.843 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.93 -31.82 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.935 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.51 -47.95 81.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.275 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.49 -40.94 96.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.174 0.511 . . . . 0.0 109.965 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.67 -46.44 81.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.591 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.3 m -65.12 -49.29 70.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.275 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.601 ' HB2' HD11 ' A' ' 65' ' ' ILE . 85.1 t80 -57.63 -42.37 83.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 111.44 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -78.06 -35.47 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.468 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -85.37 -19.88 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.648 ' CZ ' HG13 ' A' ' 136' ' ' VAL . 44.6 m-85 -106.22 -4.95 19.61 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.446 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 16.9 pttp -67.39 167.15 13.11 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.948 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.446 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 1.9 m-20 73.94 -36.9 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.656 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 82.1 mttt -61.69 -41.12 97.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.374 0.607 . . . . 0.0 110.167 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.36 44.62 0.14 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 56.7 t80 -140.59 144.66 35.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -173.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . 0.472 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 44.7 m -150.64 142.23 23.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.601 HD11 ' HB2' ' A' ' 55' ' ' TYR . 32.6 mt -98.77 134.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 110.139 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -112.89 95.86 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.409 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' A' ' 35' ' ' ASP . . . -76.96 103.3 1.77 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.397 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.48 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 53.7 t -99.05 117.21 43.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.265 0.555 . . . . 0.0 110.614 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 t -128.97 156.61 43.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.116 0.484 . . . . 0.0 110.763 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -136.76 48.76 2.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 10.8 t70 -65.29 -176.12 0.29 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.552 -171.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.521 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.7 mtm180 -54.15 -50.31 67.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.01 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.617 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 55.3 mtp180 -145.65 175.04 10.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.766 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -75.14 -38.63 60.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.92 -42.27 99.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.328 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.617 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 3.4 m-20 -75.56 -28.22 58.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.43 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 21.1 t90 -64.68 -48.22 75.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.43 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.2 mptm? -58.9 -37.43 76.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.048 0.451 . . . . 0.0 110.002 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.424 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 36.1 ttmt -63.05 -45.68 91.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.932 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.35 74.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 110.943 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.09 -36.97 76.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.079 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 10.1 tp10 -63.0 -40.88 99.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 173.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . 0.424 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.1 mt-10 -62.65 -59.7 4.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.265 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.557 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.2 m-20 -82.53 -16.99 46.6 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -172.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 62.99 35.16 13.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 111.12 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 p -81.7 86.17 6.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.951 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -90.4 86.18 6.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -155.42 -175.26 5.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.168 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.52 96.78 0.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.321 0.582 . . . . 0.0 111.446 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . 0.441 ' HB2' HD22 ' A' ' 17' ' ' LEU . 76.0 mm-40 -99.05 140.15 33.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.132 177.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.68 137.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.1 tp -92.85 125.94 37.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.436 HD23 ' OD2' ' A' ' 97' ' ' ASP . 65.9 mt -72.58 137.88 46.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.651 ' O ' HG23 ' A' ' 98' ' ' VAL . 24.8 mt-30 -67.07 147.05 53.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.27 -16.74 61.92 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.191 0.519 . . . . 0.0 110.759 -170.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.15 -33.87 22.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.432 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.436 ' OD2' HD23 ' A' ' 93' ' ' LEU . 7.1 t70 -72.27 -32.55 66.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.651 HG23 ' O ' ' A' ' 94' ' ' GLN . 75.3 t -50.09 -37.09 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.533 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -56.75 -63.76 1.1 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.786 0.803 . . . . 0.0 111.626 -172.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.05 -39.94 63.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.804 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.485 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 68.3 t -58.24 -50.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.547 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 19.3 mt -56.21 -62.06 1.97 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.981 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -50.76 70.97 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.532 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 t -57.63 -33.09 67.91 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.651 0.594 . . . . 0.0 112.365 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.485 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 51.2 m-85 -83.8 16.11 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.642 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 2.8 m 67.98 38.82 2.67 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.436 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.547 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 78.8 mt -119.94 110.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.116 -170.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.69 20.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.366 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.83 -172.4 40.6 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.658 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.44 156.17 69.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 117.181 0.49 . . . . 0.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.772 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 92.3 Cg_endo -86.36 167.6 47.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.784 -1.34 . . . . 0.0 113.237 -0.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.92 118.64 8.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . 0.575 HG21 HD22 ' A' ' 132' ' ' LEU . 4.1 mp -111.49 120.59 62.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.591 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 39.9 pt -122.08 158.1 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.561 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -122.86 117.41 25.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.926 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.486 HG11 ' O ' ' A' ' 117' ' ' ASP . 93.3 t -113.1 135.47 52.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.103 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.541 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 26.3 m-20 -66.96 163.89 40.04 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.749 174.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.85 -27.72 85.03 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.108 1.872 . . . . 0.0 111.404 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.44 -29.87 68.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.761 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . 0.406 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 100.34 40.4 3.01 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.372 -175.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.662 ' HZ3' ' HB2' ' A' ' 121' ' ' LYS . 9.4 mtmp? -112.05 148.8 33.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.95 99.4 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.14 -33.74 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.228 0.537 . . . . 0.0 110.639 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.15 152.94 45.09 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.738 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 2.3 ptpt -166.83 172.86 9.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.783 0.325 . . . . 0.0 111.51 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.738 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 0.7 OUTLIER 59.67 28.88 18.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.242 178.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.521 HD11 ' HA ' ' A' ' 132' ' ' LEU . 89.7 mt -78.52 154.2 30.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.48 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.33 169.56 8.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.079 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.514 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -46.6 -70.94 0.59 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.9 -32.84 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.375 0.607 . . . . 0.0 110.987 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.614 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 39.9 t0 -73.64 -46.16 48.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.582 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.575 HD22 HG21 ' A' ' 113' ' ' ILE . 4.5 pp -60.04 -37.0 78.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.505 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.502 ' CE2' ' HE1' ' A' ' 58' ' ' PHE . 53.8 t80 -68.14 -55.27 12.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . 0.641 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 5.9 p30 -67.42 -27.09 66.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.693 -174.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' THR . . . . . 0.44 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 43.3 m -83.58 -33.24 25.42 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.648 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.5 p -74.89 -38.77 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 121.77 -0.581 . . . . 0.0 109.963 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.57 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 4.0 tp10 -65.6 -32.86 74.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.075 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.641 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 24.1 ttmt -56.66 -43.65 80.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.796 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.24 -51.13 6.46 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.26 -34.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . 0.447 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 55.6 t30 -98.68 -49.91 4.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.764 0.316 . . . . 0.0 110.423 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.36 -159.8 47.23 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.039 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.474 ' C ' ' HD2' ' A' ' 144' ' ' LYS . . . -80.03 150.54 30.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.474 ' HD2' ' C ' ' A' ' 143' ' ' ALA . 20.7 mmmt -114.89 129.67 56.75 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.492 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -128.96 152.93 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.89 151.97 6.62 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 64.88 23.37 12.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.437 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -81.34 -3.19 51.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.222 -0.299 . . . . 0.0 111.481 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -159.15 130.76 6.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.544 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 57.4 t60 -129.49 147.18 51.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.544 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 20.4 t60 72.67 151.72 0.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.645 0.591 . . . . 0.0 109.699 -173.012 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.6 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.158 176.484 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.706 ' HA ' ' HB2' ' A' ' 106' ' ' CYS . 62.1 m -143.83 -179.01 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.039 0.212 . . . . 0.0 110.483 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.23 162.86 5.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.087 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 -171.21 2.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.247 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -99.22 131.05 45.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.605 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.26 -1.45 60.62 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.061 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 p -74.93 138.79 42.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.07 128.42 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 130.5 55.32 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.12 154.85 59.76 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.788 2.325 . . . . 0.0 111.396 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.06 103.9 16.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.372 . . . . 0.0 111.61 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.8 mt -63.07 142.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.866 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.459 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.0 t -124.27 87.46 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.625 0.726 . . . . 0.0 110.582 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.56 161.65 15.18 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.0 123.48 45.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.609 0.242 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.487 ' HA ' HG13 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -70.95 -175.66 1.18 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.399 0.619 . . . . 0.0 111.883 -172.49 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.25 -29.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.653 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -81.47 -50.7 9.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.71 23.6 0.31 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.52 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -108.81 137.47 46.69 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 p -79.99 114.29 18.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.738 0.304 . . . . 0.0 111.039 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.504 HG21 ' HH ' ' A' ' 66' ' ' TYR . 23.9 m -108.78 156.56 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.924 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 8.5 p -107.49 155.76 19.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.013 0.435 . . . . 0.0 110.733 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.409 HD13 HG11 ' A' ' 32' ' ' VAL . 49.4 tp -56.97 -31.62 65.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.867 177.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.641 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 9.9 t30 -71.17 -17.73 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.371 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -68.37 -29.41 68.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.32 -15.06 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.082 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LYS . . . . . 0.641 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 1.4 tmtp? -54.14 145.1 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.235 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.37 -0.35 40.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -133.97 172.59 12.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.481 ' CG ' HG23 ' A' ' 140' ' ' VAL . 94.8 m-85 -77.67 106.52 9.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.409 HG11 HD13 ' A' ' 24' ' ' LEU . 43.9 t -102.61 108.52 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.881 -173.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 tt -87.02 113.81 23.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 24.3 t -96.03 115.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -103.44 106.67 17.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.545 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.49 ' HA ' HG22 ' A' ' 68' ' ' VAL . 86.5 m-85 -90.5 115.09 27.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.472 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.6 p-90 -159.35 179.82 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.726 0.774 . . . . 0.0 112.348 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -166.63 162.92 16.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.006 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.03 69.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -174.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.38 -46.34 80.53 Favored Glycine 0 C--N 1.332 0.335 0 O-C-N 123.635 0.585 . . . . 0.0 112.688 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.4 p -88.65 78.85 7.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.716 0.77 . . . . 0.0 109.619 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.788 ' HA ' ' HD3' ' A' ' 45' ' ' ARG . 54.8 m -69.4 -1.97 9.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.242 -174.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -74.56 -36.35 63.08 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.529 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' CYS . . . . . 0.497 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 3.3 m -60.7 -35.73 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.875 0.845 . . . . 0.0 108.857 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.788 ' HD3' ' HA ' ' A' ' 42' ' ' SER . 58.5 mtp180 -67.77 -26.6 66.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.886 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.444 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptt -86.97 -16.96 34.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.907 0.384 . . . . 0.0 111.603 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -88.62 -10.32 49.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.681 0.753 . . . . 0.0 109.149 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.589 ' HB ' ' O ' ' A' ' 45' ' ' ARG . 37.0 m -54.82 -46.22 99.52 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.277 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -46.43 -43.57 21.85 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.369 2.046 . . . . 0.0 113.005 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -70.65 -40.14 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 97.8 mt -60.02 -37.8 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.504 175.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.88 -43.74 87.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.72 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.88 -43.27 94.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 174.504 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 57.8 m -58.17 -48.99 78.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.911 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TYR . . . . . 0.404 ' HB2' HD11 ' A' ' 65' ' ' ILE . 79.2 t80 -56.24 -48.59 76.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 110.991 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.197 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . 0.494 ' O ' ' HE2' ' A' ' 61' ' ' LYS . . . -91.87 -32.13 15.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 97.1 m-85 -111.43 4.59 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -55.2 -32.49 62.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.47 0.652 . . . . 0.0 111.005 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.69 12.0 31.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.626 -174.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.494 ' HE2' ' O ' ' A' ' 57' ' ' ALA . 34.7 mttm -122.97 23.04 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.71 47.41 40.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.536 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.522 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 69.7 t80 -129.87 136.55 49.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -143.01 131.56 22.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.684 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . 0.404 HD11 ' HB2' ' A' ' 55' ' ' TYR . 55.7 mt -88.38 122.04 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' TYR . . . . . 0.504 ' HH ' HG21 ' A' ' 22' ' ' VAL . 73.2 t80 -108.14 94.83 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.2 133.12 11.57 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.678 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.741 ' HB ' HD22 ' A' ' 93' ' ' LEU . 9.5 m -119.85 112.99 39.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.472 0.653 . . . . 0.0 110.774 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.7 t -103.88 148.66 25.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.577 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.503 ' HB ' HD11 ' A' ' 93' ' ' LEU . 5.8 t -126.34 33.98 4.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.39 170.01 1.49 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.348 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -69.25 -46.84 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.644 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.64 164.91 23.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.59 -37.32 86.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.53 -53.75 52.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.937 178.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.22 -45.52 90.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -59.03 -53.24 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.951 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -60.53 -40.64 92.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.926 0.394 . . . . 0.0 111.059 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -64.15 -45.85 86.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.38 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.573 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.3 mt -63.74 -42.43 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.366 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' CD ' ' HZ3' ' A' ' 85' ' ' LYS . 32.5 tp10 -68.05 -41.55 81.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.685 178.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.88 -51.28 69.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.763 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.48 7.54 42.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.544 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 66.8 mmtt 55.58 36.32 26.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.543 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.454 ' HB3' HG22 ' A' ' 48' ' ' THR . 3.5 p -81.47 68.67 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.319 0.581 . . . . 0.0 111.25 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.544 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 62.3 m-85 -81.8 95.62 7.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.938 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TRP . . . . . 0.588 ' CH2' HG21 ' A' ' 48' ' ' THR . 5.3 p90 -160.99 -178.99 7.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.481 171.231 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -67.64 100.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.458 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -117.54 150.56 38.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . 0.487 HG13 ' HA ' ' A' ' 16' ' ' ASP . 35.8 m -133.81 149.34 30.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.46 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.65 123.79 37.21 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.741 HD22 ' HB ' ' A' ' 68' ' ' VAL . 69.3 mt -62.78 137.73 58.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.489 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLN . . . . . 0.594 ' O ' HG22 ' A' ' 98' ' ' VAL . 43.9 mt-30 -74.16 166.99 22.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.46 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.88 -48.3 64.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.55 -32.34 22.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.789 0.328 . . . . 0.0 110.417 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . 0.438 ' HB3' ' N ' ' A' ' 94' ' ' GLN . 22.1 t70 -58.05 -42.13 84.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.897 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.667 HG21 ' HB2' ' A' ' 93' ' ' LEU . 77.7 t -49.65 -57.93 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 35.3 ttmt -65.26 -59.17 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.313 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.25 -51.7 65.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.451 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -52.47 39.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . 0.594 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.1 mt -58.84 -38.39 78.61 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.543 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -61.56 -59.76 4.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.9 m -50.74 -41.14 56.13 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . 0.506 ' HB2' HG12 ' A' ' 107' ' ' ILE . 53.5 m-85 -71.76 5.75 2.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.048 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' CYS . . . . . 0.706 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 85.3 m 61.72 52.24 3.61 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.989 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.594 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.0 mm -99.27 125.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.695 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.23 7.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.421 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 162.38 33.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.136 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.555 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 85.2 m-85 -132.1 164.66 41.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' PRO . . . . . 0.751 ' HB2' HH12 ' A' ' 128' ' ' ARG . 15.5 Cg_exo -68.52 157.36 88.33 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.448 0.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.58 104.3 4.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 110.815 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -114.66 122.23 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.286 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.455 HG21 ' HB2' ' A' ' 125' ' ' LYS . 39.6 pt -123.94 155.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.539 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 55.0 tp -120.89 116.73 25.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.714 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.62 126.9 54.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.932 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.535 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 1.9 p30 -72.87 164.31 61.66 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -55.93 -28.86 70.51 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.567 2.178 . . . . 0.0 112.802 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -30.01 70.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.334 0.587 . . . . 0.0 110.017 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.81 29.53 4.62 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.388 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.553 ' HZ3' ' HB2' ' A' ' 121' ' ' LYS . 8.6 mtmp? -114.96 149.14 37.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.924 0.393 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.89 98.32 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.955 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 m -86.71 -35.22 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -131.75 151.98 51.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.742 -178.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.487 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 9.3 ptpp? -161.37 168.73 23.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.925 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . 0.487 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 10.0 mm-40 63.46 19.37 11.65 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.082 0.864 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.28 141.4 57.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.469 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.751 HH12 ' HB2' ' A' ' 111' ' ' PRO . 17.6 mmt180 -117.78 159.83 22.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.534 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . 0.604 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -21.47 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.466 0.658 0 O-C-N 124.647 1.217 . . . . 0.0 116.131 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.82 -36.33 82.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.93 -42.66 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.147 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LEU . . . . . 0.604 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.5 pp -57.28 -36.94 71.65 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.655 -175.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' TYR . . . . . 0.46 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.6 t80 -65.66 -46.48 78.97 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.54 -49.63 75.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.48 0.657 . . . . 0.0 110.358 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.3 m -62.53 -46.18 89.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.457 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 132' ' ' LEU . 54.1 t -64.84 -39.13 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . 0.502 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 3.9 tp10 -58.38 -38.33 77.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.124 0.488 . . . . 0.0 109.851 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LYS . . . . . 0.527 ' HG2' ' HB3' ' A' ' 143' ' ' ALA . 2.5 ttpp -77.16 -25.68 52.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.854 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 31.4 m-85 -89.51 -47.15 8.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.481 HG23 ' CG ' ' A' ' 31' ' ' TYR . 37.0 t -87.61 -48.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -84.05 -64.86 1.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.74 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' A' ' 138' ' ' LYS . . . -137.09 146.91 18.9 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.444 -176.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ALA . . . . . 0.527 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . . . 81.29 22.15 0.34 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 111.98 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 49.9 tptt -72.95 -26.93 61.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.3 158.15 16.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.272 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.39 78.71 0.37 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.766 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.29 159.85 22.66 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.625 -0.338 . . . . 0.0 110.622 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -68.81 -22.8 64.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.9 m170 67.16 170.56 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.62 0.575 . . . . 0.0 111.055 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -119.44 4.82 11.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 109.361 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' HIS . . . . . 0.481 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 15.4 t-80 -123.91 -17.05 6.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.402 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 72.8 m80 . . . . . 0 C--O 1.25 1.08 0 O-C-N 124.616 1.198 . . . . 0.0 108.127 -159.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.7 p -67.39 112.19 4.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.661 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.8 -10.39 23.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.991 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -79.5 146.25 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.678 0.275 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.94 136.79 24.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.95 142.21 24.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.83 162.4 25.49 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.837 2.358 . . . . 0.0 112.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.66 133.35 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' SER . 5.0 mp -93.37 142.3 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.825 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -115.74 94.2 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.0 110.481 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 91' ' ' VAL . . . -116.42 144.84 18.58 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.471 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 68.4 mt -87.79 132.44 32.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.491 0.186 . . . . 0.0 110.526 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 -175.68 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.817 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 mtmp? -84.03 -41.3 17.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.151 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 18.96 1.31 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.582 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 2.4 m-20 -94.0 144.33 25.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 105.89 13.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.7 t -103.71 135.7 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.883 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 2.0 m -108.95 176.89 4.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.951 0.405 . . . . 0.0 110.542 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.26 -32.91 69.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.917 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 1.7 p-10 -65.06 -22.46 66.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.992 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -72.77 -18.52 61.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.992 0.425 . . . . 0.0 110.971 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.21 19.21 15.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.9 tttm -80.03 56.14 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.013 -174.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.86 0.7 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -149.03 171.76 15.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -76.46 111.63 12.13 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' THR . 48.1 t -97.4 114.32 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.061 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.2 tm? -88.47 105.35 17.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 44.1 t -89.89 110.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 68' ' ' VAL . 28.9 t70 -106.61 122.27 46.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.46 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -94.7 114.19 26.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' SER . 16.4 p-90 -148.35 172.45 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.708 0.766 . . . . 0.0 111.884 -175.482 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -170.36 159.92 7.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.661 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.63 69.33 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -6.07 89.2 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.09 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.75 112.64 23.99 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.48 -0.424 . . . . 0.0 110.206 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -64.23 -42.91 96.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.569 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -77.29 -31.66 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 94.5 m -57.6 -38.57 75.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -18.07 65.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptp? -85.36 -34.13 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.453 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 45.5 mt-10 -96.44 1.64 51.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.594 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.633 HG21 ' HB3' ' A' ' 84' ' ' ASP . 84.4 m -50.21 -51.53 62.02 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.329 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 65.5 Cg_exo -52.52 -43.02 57.95 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.259 1.973 . . . . 0.0 113.156 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.8 m-85 -65.1 -46.0 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.9 -40.21 94.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.633 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 60.9 tp -59.42 -47.29 86.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.92 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HE3' ' CD2' ' A' ' 133' ' ' TYR . 38.6 ttpt -62.87 -47.27 84.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.151 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 35.7 m -58.55 -47.91 82.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.711 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -60.03 -51.32 70.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.868 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -66.55 -26.08 66.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.71 -27.43 18.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 71.0 m-85 -108.45 -11.86 15.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 21.6 pttp -54.91 -39.15 68.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.811 0.339 . . . . 0.0 111.388 -176.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.51 -36.52 29.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.439 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HD2' ' CD1' ' A' ' 58' ' ' PHE . 87.9 mttt -58.75 -44.01 90.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.06 43.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.428 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.695 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 65.9 t80 -144.08 150.48 38.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 95.7 m -150.8 132.76 15.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.853 0.358 . . . . 0.0 110.583 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 55' ' ' TYR . 42.7 mt -92.44 118.72 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.088 0.47 . . . . 0.0 110.044 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.76 94.43 5.6 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.35 112.0 3.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.759 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HB ' HD21 ' A' ' 93' ' ' LEU . 32.1 m -100.21 116.43 43.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.485 0.659 . . . . 0.0 111.004 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 7.2 t -128.84 145.39 51.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.947 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . 1.037 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.7 t -145.87 54.79 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.014 0.912 . . . . 0.0 110.011 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -68.63 -168.51 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.479 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 0.6 OUTLIER -60.47 -42.86 97.08 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -172.77 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 56.8 mtp180 -133.11 163.07 30.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.667 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG3' HD22 ' A' ' 92' ' ' LEU . 16.8 tt0 -75.12 -36.74 61.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 2.0 mp0 -59.57 -39.68 84.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.951 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 2.3 m-20 -74.67 -32.36 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 92' ' ' LEU . 29.4 t90 -62.28 -49.03 77.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.0 mptm? -57.88 -43.44 86.05 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.045 0.45 . . . . 0.0 110.278 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 3.5 ttpm? -60.15 -45.84 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.69 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.01 84.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.328 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 82.8 mt -62.99 -38.02 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 36.8 mt-10 -60.49 -56.08 25.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.9 m-20 -75.71 -20.92 58.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.859 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 66.3 mmtt 57.49 37.89 27.9 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.824 0.821 . . . . 0.0 109.98 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 p -83.27 82.96 8.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.87 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -82.78 84.55 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.408 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 28.7 p90 -154.95 -169.24 3.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.119 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -72.92 84.26 1.24 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.425 0.631 . . . . 0.0 111.021 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -89.23 136.36 33.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.536 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 14' ' ' GLY . 17.1 m -131.01 141.71 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.016 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.563 HD22 ' HG3' ' A' ' 74' ' ' GLU . 53.3 tp -88.24 111.16 21.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.626 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.037 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 84.3 mt -66.7 124.1 21.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' VAL . 83.4 mt-30 -60.78 143.42 54.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -66.95 -23.32 65.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.582 0.229 . . . . 0.0 111.443 -165.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -87.44 -36.03 17.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 0.0 110.749 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.29 -37.69 86.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' GLN . 63.2 t -50.63 -47.22 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.367 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.05 -55.23 33.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.803 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.25 -53.29 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.204 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.68 -54.32 27.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.783 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 30.5 mt -60.51 -50.63 72.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.009 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.98 -59.66 4.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.308 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.3 m -54.79 -30.98 58.35 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.275 0.984 . . . . 0.0 113.338 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -77.96 10.58 2.75 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.143 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.7 t 64.29 36.13 9.45 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 39.7 mm -106.0 118.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.366 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.48 13.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.214 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.64 160.47 30.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.49 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -133.49 155.98 80.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.446 0.299 . . . . 0.0 110.377 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.619 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 4.2 Cg_exo -82.63 -176.5 16.82 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.148 -1.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -163.03 130.8 3.68 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.627 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 33' ' ' LEU . 58.0 mt -125.93 130.76 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.517 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 30.8 pt -129.15 145.46 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.903 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tt -105.71 110.63 23.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.83 135.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.444 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.549 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -82.13 170.37 15.18 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 16.5 Cg_endo -59.65 -16.72 38.27 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.647 2.232 . . . . 0.0 114.028 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -88.43 3.94 48.21 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 110.824 175.955 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.04 57.33 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.985 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 27.2 mttm -113.01 141.54 46.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.939 0.369 . . . . 0.0 110.077 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.41 95.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 117' ' ' ASP . 42.6 t -73.27 -41.95 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.578 -176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.66 167.27 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.63 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.0 pttp -162.68 171.89 16.16 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 8.8 mm-40 68.01 16.42 9.54 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.286 0.991 . . . . 0.0 111.15 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.64 132.74 54.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 mmp_? -116.02 154.52 29.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.021 -170.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 46.05 -131.78 10.54 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.966 0.792 . . . . 0.0 113.568 170.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.9 -10.74 59.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.5 t70 -64.27 -31.84 73.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.388 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 3.3 pp -58.9 -41.15 86.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.852 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' N ' HD12 ' A' ' 132' ' ' LEU . 26.9 t80 -63.6 -54.87 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 109.555 172.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.44 ' C ' ' HE3' ' A' ' 138' ' ' LYS . 25.3 m-80 -58.71 -32.41 69.16 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.11 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.503 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 21.7 m -73.91 -40.23 63.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 132' ' ' LEU . 44.9 t -63.93 -39.28 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.501 174.07 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -41.48 90.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 135' ' ' THR . 15.8 mtmt -52.51 -40.65 62.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.396 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -87.61 -61.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -164.324 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.642 0.258 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -64.3 133.84 53.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 0.0 111.109 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.12 -20.31 50.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.747 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -87.08 156.15 19.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 13.7 p -80.79 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.14 0.495 . . . . 0.0 110.793 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.96 144.51 51.54 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.06 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.05 148.68 81.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.585 2.19 . . . . 0.0 112.165 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.84 99.8 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.7 mm -83.25 132.9 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.5 m -131.74 98.99 4.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.072 0.463 . . . . 0.0 110.402 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.581 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -112.37 -176.23 19.79 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.835 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 19.7 mt -104.68 135.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.714 0.257 . . . . 0.0 110.924 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -101.29 -172.6 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 81' ' ' ILE . 92.6 mt -59.46 -26.89 65.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.05 -14.7 59.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.22 57.89 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 3.3 m-20 -102.02 151.17 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -84.42 107.31 16.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.145 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.6 138.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 19.4 m -106.39 172.11 6.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.137 0.494 . . . . 0.0 111.072 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.656 HD11 HG11 ' A' ' 32' ' ' VAL . 55.7 tp -80.42 -21.0 42.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 110.088 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 4.0 m-20 -65.84 -28.69 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.307 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.53 -23.89 67.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.211 0.529 . . . . 0.0 110.932 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.38 8.48 29.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.006 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 6.2 mtpp -76.51 69.99 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.719 0.771 . . . . 0.0 111.179 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.65 20.37 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.709 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -153.19 -176.45 5.79 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 64.1 m-85 -95.88 111.62 23.56 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 116' ' ' VAL . 9.8 p -101.52 133.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.232 0.539 . . . . 0.0 111.407 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 132' ' ' LEU . 10.3 tt -97.55 107.27 19.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 41.4 t -97.52 105.09 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -102.56 118.46 36.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.069 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HA ' HG13 ' A' ' 68' ' ' VAL . 66.5 m-85 -84.43 116.2 22.95 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.584 ' O ' ' HA ' ' A' ' 69' ' ' SER . 21.9 p-90 -144.4 175.71 9.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.626 0.727 . . . . 0.0 111.874 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -168.38 161.01 11.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.59 -1.187 . . . . 0.0 108.248 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -32.93 73.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.37 -11.66 85.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.196 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 44' ' ' CYS . 48.3 t -74.53 110.62 8.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.257 0.551 . . . . 0.0 109.946 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -65.48 -28.31 69.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.308 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 77.2 t-105 -85.52 -30.75 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 41' ' ' CYS . 90.2 m -58.06 -42.05 84.64 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.3 -13.71 21.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.018 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.5 mptt -84.28 -51.23 7.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 15.7 pt-20 -99.73 15.78 25.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.224 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 22.4 m -51.71 -51.97 65.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.5 Cg_exo -54.29 -33.74 77.1 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.97 1.78 . . . . 0.0 112.379 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.1 m-85 -76.57 -32.23 58.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 132' ' ' LEU . 95.7 mt -62.94 -52.95 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.9 tp -61.07 -40.26 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.533 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -51.69 -53.86 34.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.718 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -67.07 -39.8 86.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.11 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.7 t80 -60.84 -46.75 89.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 111.172 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.19 -35.97 78.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.414 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -31.19 51.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' HE1' ' OE1' ' A' ' 137' ' ' GLU . 90.3 m-85 -115.48 3.86 14.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.73 -38.44 69.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.74 -42.12 16.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 88.3 mttt -55.8 -56.34 21.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.232 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 38.79 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.749 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 49.4 t80 -135.49 147.28 48.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.4 m -153.99 144.06 22.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.843 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 55' ' ' TYR . 29.4 mt -95.58 137.82 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.097 0.475 . . . . 0.0 111.033 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 39.3 t80 -123.43 93.05 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.04 106.8 3.37 Favored Glycine 0 CA--C 1.505 -0.531 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.582 -172.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 91' ' ' VAL . 3.1 p -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.631 0.729 . . . . 0.0 111.092 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 12.4 t -112.4 152.9 28.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.528 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 93' ' ' LEU . 30.6 p -132.54 48.96 2.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -75.15 -176.05 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.864 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -69.85 -39.27 76.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.924 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HD2' ' OD1' ' A' ' 76' ' ' ASP . 60.9 mtt180 -138.69 152.71 48.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.672 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 33.3 tt0 -65.91 -37.9 87.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 mm-40 -68.78 -36.46 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.766 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -65.25 -34.59 78.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 173.551 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 31.5 t90 -64.37 -48.73 74.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 8.7 mmtm -55.3 -50.4 69.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.963 0.887 . . . . 0.0 108.837 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.72 -40.06 90.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.014 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -61.77 -36.17 80.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.433 HD12 HD21 ' A' ' 17' ' ' LEU . 73.1 mt -64.6 -39.64 86.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 38.0 tp10 -65.6 -34.32 77.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.767 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 53.7 mt-10 -69.76 -52.19 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.765 0.793 . . . . 0.0 110.304 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.78 -18.67 58.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.228 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 85' ' ' LYS . 8.4 mptt 59.04 21.26 9.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.244 0.545 . . . . 0.0 112.244 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 88' ' ' TRP . 60.3 m -87.07 85.06 7.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.534 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.62 93.31 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.971 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 86' ' ' SER . 7.6 p90 -153.26 -172.68 4.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.744 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 52.1 m-80 -68.49 99.81 1.01 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.278 0.561 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.32 155.41 30.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.171 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.3 p -140.05 145.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.896 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 tp -108.21 129.57 55.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.483 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 70' ' ' THR . 15.3 mt -74.69 142.58 44.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.431 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.4 mt-30 -75.44 163.34 27.51 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.798 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.473 ' CD ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -43.63 -55.37 4.37 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.924 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' H ' ' CD ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -87.8 -33.51 18.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 14.4 t70 -54.76 -39.2 68.09 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.313 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 53.8 t -49.9 -48.12 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.876 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ttpp -56.39 -59.45 4.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.144 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -69.86 -34.95 74.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.577 -171.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.09 -37.43 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.685 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.75 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -66.37 -22.89 66.26 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.67 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -82.54 -62.71 1.54 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.249 -0.981 . . . . 0.0 108.813 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.6 m -48.33 -41.55 28.69 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -164.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.34 17.04 1.81 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.714 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.6 t 57.36 54.0 7.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 19.1 mm -80.33 72.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.636 0.732 . . . . 0.0 110.541 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.51 -25.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.683 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.05 121.18 5.9 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 3.3 t80 -123.88 140.74 35.17 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.502 ' HG2' HH12 ' A' ' 128' ' ' ARG . 62.3 Cg_endo -74.9 135.4 40.31 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.566 -1.431 . . . . 0.0 112.108 -0.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 107' ' ' ILE . 49.7 t60 -89.02 100.8 13.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.9 120.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.558 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 31.5 pt -122.05 159.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.057 0.456 . . . . 0.0 111.666 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 tp -121.09 120.61 35.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.015 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 32' ' ' VAL . 65.4 t -109.2 133.97 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.775 0.321 . . . . 0.0 110.664 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 p30 -77.0 165.79 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.502 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.7 Cg_endo -54.18 -20.33 18.95 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.983 2.455 . . . . 0.0 113.85 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 -14.33 54.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.34 . . . . 0.0 110.775 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.11 30.37 11.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.923 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.6 mtmp? -112.27 152.35 28.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.403 -0.469 . . . . 0.0 110.963 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -84.16 108.69 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.83 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.61 -30.31 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.958 0.409 . . . . 0.0 110.976 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -144.86 155.41 43.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 17.2 pttp -156.61 162.58 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 3.1 mm-40 66.51 20.76 10.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.463 HD21 ' HB1' ' A' ' 124' ' ' ALA . 71.0 mt -64.14 145.05 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.226 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.502 HH12 ' HG2' ' A' ' 111' ' ' PRO . 25.3 mmt180 -132.48 139.98 48.18 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 39.03 -99.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.338 0 O-C-N 124.521 1.138 . . . . 0.0 115.721 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.1 -35.28 59.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.806 -0.197 . . . . 0.0 111.128 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.908 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 27.8 t70 -69.94 -19.45 63.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.469 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 33' ' ' LEU . 95.0 mt -51.86 -59.59 4.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 168.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.14 -49.14 77.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.922 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.908 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 93.8 m-20 -57.41 -41.55 80.55 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.265 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.509 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 5.1 m -74.6 -36.45 62.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 132' ' ' LEU . 41.6 t -68.87 -41.47 82.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.319 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.549 ' OE1' ' HE1' ' A' ' 58' ' ' PHE . 1.2 tp10 -67.94 -32.33 72.71 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.628 0.728 . . . . 0.0 109.246 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.738 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 22.1 ttmt -58.55 -56.92 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.923 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -89.22 -53.28 4.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -168.573 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -68.68 119.18 12.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.35 -8.79 41.48 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.936 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -85.24 149.01 25.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.726 0.298 . . . . 0.0 110.523 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.89 141.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.129 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -85.57 131.2 48.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 37.7 Cg_exo -61.67 153.46 67.06 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.017 2.478 . . . . 0.0 112.219 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.63 134.62 51.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.782 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.625 HG12 HD23 ' A' ' 24' ' ' LEU . 48.5 mm -104.53 129.5 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.474 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.18 93.02 3.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.11 148.04 18.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.378 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.39 124.39 40.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.354 0.597 . . . . 0.0 111.162 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 170.25 16.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.972 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.8 mp -64.96 -14.56 60.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.92 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -96.59 2.38 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.41 20.02 55.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.787 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.18 132.46 46.65 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.544 -0.386 . . . . 0.0 110.129 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -80.97 112.0 17.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.69 148.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.43 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -100.43 175.05 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.919 0.39 . . . . 0.0 111.193 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.625 HD23 HG12 ' A' ' 12' ' ' ILE . 3.8 pp -80.2 -20.07 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 110.42 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 29.9 p30 -71.68 -17.89 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.66 -25.99 68.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.275 0.56 . . . . 0.0 110.958 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.29 2.8 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.54 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 12.3 tmtt? -60.02 147.54 38.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.388 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.58 5.17 29.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.453 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -134.89 172.66 12.68 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -82.29 110.57 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.598 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 48.4 t -104.4 125.27 59.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.025 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 132' ' ' LEU . 22.4 tp -103.06 103.73 13.84 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.893 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.0 t0 -113.78 136.43 52.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -110.98 115.59 29.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 69' ' ' SER . 58.5 p-90 -148.06 178.24 8.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 111.369 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -170.28 157.0 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.806 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.12 51.51 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.05 -62.99 5.68 Favored Glycine 0 C--N 1.333 0.363 0 O-C-N 123.581 0.55 . . . . 0.0 112.697 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.3 m -81.42 85.4 6.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.46 0.648 . . . . 0.0 109.813 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.614 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 28.4 p -70.91 -13.73 62.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.451 -176.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -66.97 -33.12 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.966 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.82 -38.84 89.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.518 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.74 ' HD2' ' OD2' ' A' ' 84' ' ' ASP . 41.0 mtm180 -74.04 -12.68 60.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.322 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 42' ' ' SER . 10.1 mptt -72.49 -14.06 61.57 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.067 -0.395 . . . . 0.0 111.032 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 40.7 mt-10 -101.3 -4.76 26.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.636 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 51' ' ' LEU . 56.4 m -60.0 -43.4 94.26 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.123 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.0 Cg_exo -52.2 -36.47 67.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.066 1.844 . . . . 0.0 112.669 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 66.2 m-85 -74.05 -34.66 64.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.729 0.299 . . . . 0.0 110.246 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -60.15 -43.0 96.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.086 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.71 -42.26 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.553 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -60.36 -47.54 85.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.109 0.48 . . . . 0.0 110.393 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -62.56 -43.96 97.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' A' ' 65' ' ' ILE . 51.2 t80 -65.73 -38.79 90.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -65.67 -28.78 69.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.688 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.97 19.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.309 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.34 13.44 32.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 50.5 pttt -60.43 -20.7 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.53 13.04 15.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 111.527 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -116.08 26.03 10.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.94 55.79 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.399 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 80.4 t80 -133.73 136.54 44.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.994 -0.603 . . . . 0.0 109.596 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 36.7 m -140.85 130.73 24.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.818 0.342 . . . . 0.0 110.758 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 55' ' ' TYR . 58.0 mt -89.91 125.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -108.7 94.49 5.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' OE1' ' A' ' 90' ' ' GLN . . . -86.5 117.06 4.54 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.913 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 91' ' ' VAL . 35.3 m -112.97 126.31 70.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 0.0 110.681 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 46.2 t -122.48 139.37 53.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.667 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -106.4 42.22 1.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.104 0.954 . . . . 0.0 108.627 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.1 177.61 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.875 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -69.56 -48.36 60.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.292 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HE ' ' CD ' ' A' ' 75' ' ' GLU . 22.6 tpt180 -143.25 150.48 39.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.792 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 1.018 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 30.5 tt0 -63.28 -39.93 95.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -61.31 -41.36 96.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.74 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 10.4 t0 -65.21 -45.7 83.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.467 ' O ' HG13 ' A' ' 81' ' ' ILE . 22.7 t90 -58.39 -49.49 77.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.651 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 1.018 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -55.61 -44.09 76.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 110.781 175.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 12.6 ttpp -59.37 -44.83 92.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.182 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.43 79.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.805 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 77' ' ' TRP . 93.4 mt -59.82 -40.35 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.447 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -43.89 66.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -50.07 -58.14 6.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.74 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 8.2 m-20 -84.21 -2.51 57.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.115 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 58.17 37.09 26.26 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.381 0.61 . . . . 0.0 111.091 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 p -79.98 78.37 6.6 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.736 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -83.9 77.75 9.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -158.6 -179.88 8.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.527 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -63.57 115.69 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.31 0.576 . . . . 0.0 111.04 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.459 ' OE1' ' HA3' ' A' ' 67' ' ' GLY . 1.4 tp-100 -123.13 141.08 52.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.786 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 68' ' ' VAL . 19.1 m -137.87 145.32 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.234 0.54 . . . . 0.0 111.144 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.0 tp -92.91 112.67 24.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.648 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.15 133.9 52.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.035 0.445 . . . . 0.0 110.768 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.589 ' O ' HG23 ' A' ' 98' ' ' VAL . 32.7 mt-30 -68.75 145.1 54.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -63.59 -29.32 70.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -171.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 36.6 t70 -79.28 -39.73 32.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.84 -46.17 85.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.851 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 94' ' ' GLN . 77.2 t -50.14 -37.67 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.826 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.2 ttpm? -52.82 -64.02 0.95 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.151 0.5 . . . . 0.0 111.577 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -72.5 -36.89 68.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.744 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.63 -52.01 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.272 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -58.43 -52.6 64.92 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.848 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -52.99 -61.37 2.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.3 0.375 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.3 m -57.55 -26.27 61.18 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.007 0.817 . . . . 0.0 112.682 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 107' ' ' ILE . 6.5 m-85 -86.84 20.52 2.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 105' ' ' TYR . 31.3 p 50.6 43.75 27.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.872 1.269 . . . . 0.0 110.348 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 12.2 mm -113.03 122.38 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.8 3.59 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.98 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.56 177.16 37.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.955 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 94.5 m-85 -135.25 166.7 26.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 74.4 Cg_endo -75.33 -174.68 14.67 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.031 -0.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.409 ' ND1' HD11 ' A' ' 107' ' ' ILE . 72.4 t60 -166.89 106.52 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.363 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.87 137.16 53.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 125' ' ' LYS . 46.9 pt -131.62 154.51 40.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.699 HD22 HG22 ' A' ' 136' ' ' VAL . 64.3 tp -118.96 119.35 34.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.164 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 19.2 m -109.41 143.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.347 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.57 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 3.3 p30 -78.22 163.78 60.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.334 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 11.9 Cg_endo -58.2 -14.23 18.86 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.134 2.556 . . . . 0.0 113.582 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.41 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 1.1 mt-10 -81.52 -29.63 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.33 19.69 6.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.697 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 9.0 mtmp? -111.23 146.32 37.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.39 104.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.54 -27.26 12.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -155.12 142.94 19.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.775 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.678 ' HB2' HG22 ' A' ' 114' ' ' ILE . 12.4 pttp -142.79 163.06 33.83 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.569 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 7.3 mm-40 65.95 30.53 9.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 110.067 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 ' HB1' ' A' ' 124' ' ' ALA . 88.2 mt -67.41 156.82 35.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.047 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 7.8 mmm180 -116.43 166.9 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -30.98 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.052 0 N-CA-C 116.017 1.167 . . . . 0.0 116.017 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -12.52 59.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.572 0.686 . . . . 0.0 111.571 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.458 ' HA ' ' OD1' ' A' ' 134' ' ' ASN . 2.1 t70 -63.43 -42.16 98.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 41.3 mt -47.6 -56.66 6.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.488 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -58.32 -58.92 6.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.558 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -69.02 -37.66 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.54 -170.488 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.3 m -72.0 -42.12 66.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.676 0.274 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.699 HG22 HD22 ' A' ' 115' ' ' LEU . 46.9 t -65.62 -35.81 76.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -57.02 -45.88 82.77 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.139 0.495 . . . . 0.0 109.823 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 134' ' ' ASN . 28.9 mtpp -65.96 -35.59 81.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.766 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -80.28 -55.12 5.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 111.619 -171.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -74.46 141.15 44.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.784 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.6 -13.17 58.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.782 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 147.92 34.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.288 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.18 137.33 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.934 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.64 122.96 57.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.492 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.14 134.1 49.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.061 2.507 . . . . 0.0 111.708 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.35 120.22 19.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.065 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 24' ' ' LEU . 8.4 mm -65.02 133.17 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.21 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.0 m -120.31 87.88 2.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.468 . . . . 0.0 110.287 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -124.01 179.27 16.2 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.212 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.4 mt -109.24 130.28 62.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.92 -176.14 5.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.368 . . . . 0.0 110.724 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 94.1 mt -58.75 -34.08 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.866 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 32.7 mttp -78.96 -30.22 44.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.579 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.34 12.01 7.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.597 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 20.7 m-80 -87.14 137.4 32.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.639 0.256 . . . . 0.0 110.462 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.9 p -81.57 93.35 6.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.44 154.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.398 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 20.1 m -117.71 166.4 12.48 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 12' ' ' ILE . 3.9 pp -68.41 -18.23 64.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.533 176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.805 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 6.2 t-20 -65.36 -35.52 81.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.37 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.39 -18.03 63.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.413 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.8 4.27 25.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.114 0.483 . . . . 0.0 110.138 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.805 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 41.1 mtpt -69.01 -174.11 0.57 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.953 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.28 10.36 86.27 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -144.84 173.72 11.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 115' ' ' LEU . 94.5 m-85 -86.97 114.45 23.6 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.51 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 28.5 t -114.16 135.26 54.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.873 0.368 . . . . 0.0 111.356 -173.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt -91.31 134.71 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 61.5 t -110.2 100.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.87 108.41 19.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.06 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.649 ' CE2' ' HD2' ' A' ' 105' ' ' TYR . 72.3 m-85 -84.1 116.86 23.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.55 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 9.3 p-90 -143.04 173.53 11.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.301 0.572 . . . . 0.0 110.929 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 41' ' ' CYS . 28.4 p90 -165.17 148.49 8.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.614 171.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.26 -15.86 63.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.906 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.86 -3.06 83.58 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.659 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 50.8 t -120.33 123.96 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 110.744 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.6 t -64.19 -36.52 84.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.807 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.491 ' HD1' ' CD ' ' A' ' 111' ' ' PRO . 49.9 t-105 -70.95 -29.19 65.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.713 0.292 . . . . 0.0 110.713 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 98.7 m -65.31 -27.7 68.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.388 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.39 -14.22 46.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.594 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mptp? -69.33 -38.35 78.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 0.0 109.96 174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.76 -28.94 68.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 m -53.93 -52.93 63.56 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.2 Cg_exo -54.77 -43.72 56.53 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.073 1.848 . . . . 0.0 112.827 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -67.22 -38.86 85.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.308 0.575 . . . . 0.0 109.996 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 65' ' ' ILE . 13.3 tp -65.75 -43.38 89.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.812 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.2 -41.35 98.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.427 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.11 -45.92 92.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.189 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.8 m -62.11 -44.63 96.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.838 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.724 ' HB2' HD12 ' A' ' 65' ' ' ILE . 72.8 t80 -56.34 -57.46 12.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.076 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.69 -34.17 75.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.739 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.41 -31.47 29.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 32.5 m-85 -114.67 -2.2 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -55.0 -37.74 66.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.19 13.55 11.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 65.0 mttm -117.99 20.0 13.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.104 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.35 41.81 16.1 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 67.3 t80 -136.59 139.75 42.35 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -147.64 166.58 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 0.0 110.313 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 55' ' ' TYR . 60.1 mt -122.03 128.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.667 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 20.5 t80 -113.83 93.56 4.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.53 109.19 3.45 Favored Glycine 0 C--O 1.224 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.402 -172.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' HA ' HG13 ' A' ' 91' ' ' VAL . 20.8 t -97.62 119.48 45.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -110.18 164.36 12.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.828 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.87 ' HB ' HD12 ' A' ' 93' ' ' LEU . 8.8 t -138.39 28.72 2.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.767 0.794 . . . . 0.0 109.149 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.708 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 22.6 m-20 -73.53 123.93 24.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.467 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.708 ' CZ ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -60.87 -34.96 75.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.512 -176.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 27.6 mtp180 -93.93 102.49 14.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.59 -34.22 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.497 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.645 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -69.38 -31.52 69.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.066 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -76.39 -30.09 57.37 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 81' ' ' ILE . 30.0 t90 -61.77 -52.18 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.951 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 2.0 mptm? -56.55 -43.72 80.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.207 0.527 . . . . 0.0 110.211 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 19.3 tttm -57.51 -56.84 16.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.596 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.577 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -57.27 -36.86 71.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.818 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.782 HD12 HE21 ' A' ' 90' ' ' GLN . 48.1 mm -66.09 -41.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.775 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.33 -31.53 68.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.969 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 51.2 mt-10 -64.3 -50.22 68.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -92.83 -10.91 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.311 -176.593 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.551 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 58.3 mmtt 71.12 30.66 2.64 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.882 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 p -70.28 86.58 0.59 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.302 0.572 . . . . 0.0 111.223 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.551 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 46.9 m-85 -96.69 99.94 11.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.178 0.513 . . . . 0.0 112.11 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.495 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 6.2 p90 -151.7 -140.81 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.82 170.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 55.7 m-80 -113.31 85.96 2.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.54 0.609 . . . . 0.0 110.541 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.782 HE21 HD12 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -93.85 146.23 24.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.476 0.655 . . . . 0.0 110.876 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.584 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.5 p -137.15 139.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.404 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.29 125.98 45.04 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.446 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.87 HD12 ' HB ' ' A' ' 70' ' ' THR . 69.4 mt -58.64 138.25 57.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.356 0.41 . . . . 0.0 110.597 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.646 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.3 mt-30 -85.1 163.08 19.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.711 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -42.95 -49.64 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.251 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -87.8 -41.07 13.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 110.316 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 24.7 t70 -53.12 -35.57 59.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.728 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.5 t -50.91 -45.24 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.595 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -66.16 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.913 -171.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.92 -40.55 93.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.311 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.475 HG13 HD12 ' A' ' 12' ' ' ILE . 27.1 t -63.07 -59.63 4.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 79.9 mt -59.51 -40.53 87.37 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.153 0.502 . . . . 0.0 110.384 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.57 -62.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.253 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 106' ' ' CYS . 49.2 p -56.19 -43.89 78.91 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.497 1.123 . . . . 0.0 113.511 -167.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.649 ' HD2' ' CE2' ' A' ' 36' ' ' PHE . 16.8 m-30 -73.38 11.43 0.77 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.804 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.45 ' H ' ' C ' ' A' ' 104' ' ' SER . 56.3 m 63.36 56.8 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.098 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.7 mp -81.09 110.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.82 -25.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.343 173.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.82 170.39 35.98 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.619 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -121.72 150.23 54.92 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.491 ' CD ' ' HD1' ' A' ' 43' ' ' TRP . 4.4 Cg_exo -78.72 171.32 66.35 Favored 'Cis proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.718 -1.367 . . . . 0.0 112.511 -0.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -145.49 104.3 3.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 132' ' ' LEU . 47.0 mt -114.28 139.18 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.909 0.385 . . . . 0.0 111.344 -172.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 39.2 pt -133.48 155.53 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.449 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 45.8 tp -114.41 117.2 30.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.835 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 10.8 m -103.37 144.22 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 111.649 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 3.8 p30 -80.26 168.79 23.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.177 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 51.5 Cg_exo -55.41 -23.93 40.92 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.978 2.452 . . . . 0.0 113.596 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -78.48 -32.55 48.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.02 0.438 . . . . 0.0 110.442 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.12 22.92 5.08 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.076 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.8 mtmp? -107.15 147.84 29.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.93 99.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.736 0.303 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.25 -34.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.32 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -126.52 128.81 47.47 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 1.011 ' HD2' ' HG2' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -129.52 137.63 50.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.802 -0.181 . . . . 0.0 110.897 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 1.011 ' HG2' ' HD2' ' A' ' 125' ' ' LYS . 20.4 pt-20 45.79 75.48 0.11 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.652 1.181 . . . . 0.0 112.236 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.5 HD11 ' HB1' ' A' ' 124' ' ' ALA . 84.3 mt -100.97 170.29 8.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.361 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OD1' ' A' ' 131' ' ' ASP . 9.1 mmm180 -111.07 177.37 4.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.45 -76.82 0.13 Allowed Glycine 0 C--N 1.335 0.494 0 O-C-N 123.741 0.651 . . . . 0.0 114.562 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -15.94 59.73 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.338 -0.507 . . . . 0.0 110.863 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.569 ' OD1' ' HB2' ' A' ' 128' ' ' ARG . 2.9 m-20 -62.25 -41.07 98.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.483 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 84.6 mt -51.03 -54.73 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.881 170.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.39 -58.96 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.869 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 131' ' ' ASP . 1.1 p-10 -68.8 -28.62 66.93 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.638 -171.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 92.7 m -66.58 -51.72 53.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.285 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.2 -38.48 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 110.396 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 12.3 tm-20 -64.28 -41.78 96.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.252 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -76.34 -17.05 59.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.287 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.42 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.4 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.997 -168.679 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.587 0.232 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p -72.26 112.6 8.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.66 -4.03 39.6 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 47.9 t -86.02 143.53 28.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 50.8 t -69.18 136.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.09 145.84 30.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.653 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 152.89 58.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.846 2.364 . . . . 0.0 112.257 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.78 97.15 7.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.965 HD12 HG22 ' A' ' 101' ' ' VAL . 30.1 mm -86.35 147.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.065 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 11.6 t -142.07 123.52 14.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.533 0.682 . . . . 0.0 110.682 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.5 161.46 18.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.069 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 61.6 mt -96.57 123.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.75 0.309 . . . . 0.0 110.619 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -79.63 -177.23 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.892 0.377 . . . . 0.0 111.069 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -68.6 -18.48 64.32 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.618 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -25.39 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.355 0.597 . . . . 0.0 110.376 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.12 23.7 7.24 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.604 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 1.5 m-20 -101.59 138.8 38.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 p -83.99 94.82 8.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.167 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.67 130.99 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 6.0 m -103.12 167.21 9.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.168 0.508 . . . . 0.0 111.088 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.63 -28.62 69.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.943 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.498 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 7.5 t30 -70.79 -20.94 62.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.131 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -81.4 -4.63 56.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.974 0.416 . . . . 0.0 111.025 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.21 5.27 21.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.406 0.622 . . . . 0.0 109.544 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 90.2 mttt -70.14 132.91 46.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.168 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.86 -27.68 4.56 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.545 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 42.4 mttm -114.84 166.86 11.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.386 -0.907 . . . . 0.0 108.935 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 115' ' ' LEU . 66.9 m-85 -78.14 116.79 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 t -92.63 110.83 23.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.117 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 2.1 tm? -82.86 101.75 11.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 39.5 t -89.98 118.98 36.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.137 0.494 . . . . 0.0 110.257 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 6.2 t70 -106.24 112.91 26.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.618 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 112' ' ' HIS . 89.6 m-85 -95.44 115.76 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.3 p-90 -155.39 177.08 11.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.621 0.724 . . . . 0.0 112.209 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -170.63 167.28 7.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.761 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.1 72.23 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.616 0.722 . . . . 0.0 110.871 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -44.54 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.568 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 p -84.6 85.17 7.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.488 0.661 . . . . 0.0 109.236 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.6 m -60.65 -22.06 63.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.719 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.41 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 9.4 m95 -70.26 -39.55 74.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.472 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 59.9 m -56.4 -43.51 79.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.742 0.782 . . . . 0.0 109.079 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' SER . 8.1 mmm180 -59.22 -38.36 79.77 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.088 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.621 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 1.3 mptp? -86.44 -8.26 57.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -89.46 -3.74 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 170.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.573 HG23 ' CH2' ' A' ' 88' ' ' TRP . 54.4 m -51.03 -50.74 73.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.536 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.8 Cg_endo -52.07 -40.55 68.0 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.122 1.881 . . . . 0.0 112.461 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.29 -41.26 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.409 . . . . 0.0 110.317 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 132' ' ' LEU . 83.1 mt -61.34 -42.43 98.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.814 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.09 -42.56 93.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.561 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -53.66 -51.49 63.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 109.665 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 133' ' ' TYR . 21.5 m -63.68 -49.47 73.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.268 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' HD12 ' A' ' 65' ' ' ILE . 23.7 t80 -56.62 -50.28 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.807 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.578 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 38.0 t30 -75.38 -29.5 59.87 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.401 -171.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.92 -19.67 28.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 40.2 m-85 -121.08 12.81 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.6 ptmt -70.06 -21.06 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -75.93 -34.06 59.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.439 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 42.6 mttp -87.19 -167.74 2.0 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.559 -175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.62 57.63 4.18 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.036 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 88.9 t80 -141.05 147.29 38.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 9.9 t -158.97 153.14 23.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.274 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 55' ' ' TYR . 45.4 mt -106.35 134.79 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -122.1 94.77 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -85.85 126.6 7.87 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.808 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.0 m -116.21 119.6 62.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.162 0.506 . . . . 0.0 110.46 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 40.3 t -122.01 139.0 54.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.134 0.492 . . . . 0.0 111.234 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 t -116.2 59.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.095 0.95 . . . . 0.0 108.583 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.69 -178.57 1.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.238 -170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -67.42 -50.28 60.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.28 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 47.4 mtt180 -134.11 163.95 28.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.415 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 33.3 tt0 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -32.26 73.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.269 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -66.49 -38.57 87.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.955 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -64.01 -51.06 66.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 74' ' ' GLU . 1.4 mptm? -49.86 -48.64 51.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.84 0.828 . . . . 0.0 109.781 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -65.42 -38.25 89.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.013 -177.715 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.466 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . . . -66.06 -35.98 81.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.717 0.294 . . . . 0.0 111.282 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.18 -44.13 97.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.77 -29.21 68.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.889 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 44.9 mt-10 -59.5 -60.11 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.933 0.397 . . . . 0.0 111.57 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.97 4.92 42.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.225 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 4.4 mptp? 62.1 36.52 15.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 p -77.33 72.57 3.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.932 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -86.89 81.07 8.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.573 ' CH2' HG23 ' A' ' 48' ' ' THR . 9.6 p90 -148.84 -176.63 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.782 169.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -69.48 98.91 1.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.166 0.508 . . . . 0.0 110.735 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -120.15 146.52 45.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.634 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.65 150.12 34.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.799 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.63 117.33 28.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 68' ' ' VAL . 93.6 mt -70.2 135.99 49.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.171 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.673 ' O ' HG23 ' A' ' 98' ' ' VAL . 31.6 mt-30 -58.61 141.56 51.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.52 -23.6 66.92 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.726 -168.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.546 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 29.8 t70 -87.35 -36.57 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.448 173.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.9 t70 -56.04 -40.93 74.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.144 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 94' ' ' GLN . 85.3 t -49.83 -35.36 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.7 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.6 ttpm? -53.09 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.75 -41.12 99.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.78 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.965 HG22 HD12 ' A' ' 12' ' ' ILE . 73.4 t -57.72 -61.72 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.911 ' HA ' HD12 ' A' ' 107' ' ' ILE . 40.1 mt -60.16 -39.25 85.73 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.042 -175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.93 -64.08 0.93 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.197 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.7 m -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.3 1.0 . . . . 0.0 113.524 -167.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.9 15.18 0.7 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.699 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.457 ' H ' ' C ' ' A' ' 104' ' ' SER . 63.0 m 55.37 47.8 20.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.299 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 102' ' ' LEU . 53.9 mt -88.16 107.11 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.466 -173.007 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.02 -8.04 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.285 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.33 170.82 35.7 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.524 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.641 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 98.6 m-85 -135.31 164.15 45.84 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.6 Cg_exo -77.26 133.54 31.29 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 124.176 -1.177 . . . . 0.0 112.579 -0.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 5.3 t-160 -107.48 111.76 24.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.1 mt -125.62 131.55 71.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.239 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.588 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 45.3 pt -128.17 149.2 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.738 0.304 . . . . 0.0 110.798 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 31' ' ' TYR . 47.0 tp -112.91 111.21 21.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 73.4 t -97.17 133.0 40.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.798 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 4.1 p30 -78.0 164.78 55.09 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -53.05 -24.34 24.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.2 2.6 . . . . 0.0 114.094 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.504 ' HB2' ' HE2' ' A' ' 121' ' ' LYS . 41.3 mt-10 -77.0 -37.12 55.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 110.055 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.05 23.8 2.62 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.76 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 34.2 mtmt -107.2 155.5 19.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.79 97.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.95 -34.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.155 0.503 . . . . 0.0 110.768 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.79 158.02 42.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 20.6 pttp -163.26 175.28 11.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 15.6 mm-40 64.69 20.76 12.23 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.413 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.435 ' HB2' HD23 ' A' ' 132' ' ' LEU . 47.7 mt -59.62 137.68 57.96 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.614 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -123.38 149.47 44.93 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.275 -170.498 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 43.45 -125.1 4.95 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.768 0.667 . . . . 0.0 114.437 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.06 -17.0 59.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.622 0.248 . . . . 0.0 110.916 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 31.0 t70 -63.31 -25.72 68.44 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 136' ' ' VAL . 75.8 mt -48.23 -58.52 4.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 109.956 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.4 ' HA ' HG23 ' A' ' 54' ' ' THR . 40.9 t80 -60.34 -50.91 71.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.481 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 92.3 m-20 -61.92 -35.19 77.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.859 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.618 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 7.5 m -74.66 -30.71 61.7 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 86.9 t -65.44 -46.31 90.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.239 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.87 -23.34 64.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.442 0.639 . . . . 0.0 109.948 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 23.9 ttpt -77.0 -59.15 2.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.08 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.429 ' CD1' HG23 ' A' ' 135' ' ' THR . 47.2 m-85 -88.2 -51.4 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 61.0 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 111.277 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.427 0.156 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -147.84 128.04 13.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.32 -2.22 86.49 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 14.6 m -70.27 123.99 23.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.16 137.72 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.956 0.407 . . . . 0.0 110.627 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -96.51 146.54 31.49 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 27.7 Cg_exo -63.08 163.34 22.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.353 2.702 . . . . 0.0 112.535 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.03 115.66 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' SER . 65.8 mt -83.72 137.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.137 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 m -126.31 89.24 2.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.331 0.586 . . . . 0.0 110.022 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.14 161.23 14.88 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.911 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG2' ' HA2' ' A' ' 19' ' ' GLY . 52.8 mt -91.71 129.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -171.68 2.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.062 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.11 -27.05 68.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.551 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 52.0 mtpt -83.23 -49.66 9.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.052 0.453 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 15' ' ' ILE . . . 137.32 23.29 0.47 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.76 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 23.4 m-80 -102.19 149.58 24.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -80.34 99.97 8.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.479 0.657 . . . . 0.0 110.679 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.3 141.93 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.277 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.674 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 6.2 m -116.21 166.1 12.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -174.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.84 -22.67 65.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.122 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.674 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 2.6 p-10 -66.25 -28.57 68.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -72.61 -17.35 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.785 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -113.29 3.88 16.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.686 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -63.11 168.38 4.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.681 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.33 23.04 66.41 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.302 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -145.09 161.4 39.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -78.07 107.58 10.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -109.74 116.93 53.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.581 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 115' ' ' LEU . 43.8 mt -85.0 109.15 17.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 169.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 61.7 t -89.07 111.15 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.431 . . . . 0.0 109.861 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -105.86 117.13 33.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.559 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -98.73 116.1 30.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.5 p-90 -144.63 176.55 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.444 0.64 . . . . 0.0 111.77 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -170.73 168.3 7.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.225 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -28.47 68.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.72 -67.66 1.97 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.72 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.9 m -75.65 88.29 2.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.418 0.627 . . . . 0.0 109.859 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 58.8 p -75.31 11.83 1.11 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.121 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.562 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 40.1 m95 -63.02 -45.34 92.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 29.9 t -62.34 -31.11 71.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.525 0.679 . . . . 0.0 109.779 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 59.9 mtp180 -76.84 -14.08 59.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.306 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.6 mptt -85.28 -38.36 18.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.966 171.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.04 3.64 45.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.807 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 93.4 m -53.09 -50.38 82.44 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -48.24 -42.54 33.36 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.331 2.021 . . . . 0.0 113.0 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -68.89 -47.39 65.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.484 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.31 -46.65 85.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.799 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 65.4 tp -62.25 -43.11 99.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.818 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -62.05 -47.49 84.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.1 m -63.34 -48.24 78.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.003 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' A' ' 65' ' ' ILE . 89.7 t80 -58.78 -49.96 75.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 39.6 t-20 -60.13 -42.52 94.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.099 0.476 . . . . 0.0 110.546 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.26 76.47 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 77.2 m-85 -120.69 7.34 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -169.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 16.7 pttm -57.88 -33.8 69.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.359 0.6 . . . . 0.0 111.37 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.97 7.88 45.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.23 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -120.15 26.46 9.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.57 26.7 50.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.627 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 58' ' ' PHE . 66.3 t80 -134.75 142.88 46.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -152.56 165.44 35.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.034 0.445 . . . . 0.0 110.55 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 55' ' ' TYR . 56.3 mt -120.18 124.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.597 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 89' ' ' ASN . 10.9 t80 -101.21 94.51 6.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.34 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 102.71 2.81 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.137 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.88 113.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.013 0.435 . . . . 0.0 110.737 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 10.5 t -102.56 150.7 23.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.353 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 93' ' ' LEU . 7.9 t -131.52 28.58 4.62 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.159 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.37 167.94 0.87 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 16.6 mtm180 -53.75 -71.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.163 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -109.67 172.28 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.263 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 36.2 tt0 -74.3 -33.11 63.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.73 -41.2 97.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.012 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 72' ' ' ARG . 59.7 m-20 -60.85 -49.37 77.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.997 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 24.0 t90 -57.75 -47.87 81.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.108 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.7 mptm? -62.17 -41.6 98.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.419 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 9.6 tmtm? -70.41 -37.99 74.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.55 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.64 75.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.18 -33.98 55.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.533 0.683 . . . . 0.0 110.408 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -28.84 70.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.014 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 38.9 mt-10 -84.03 -59.98 2.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.619 0.247 . . . . 0.0 110.878 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.85 -22.25 56.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.488 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm 70.88 32.39 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -67.44 100.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.665 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -118.13 74.58 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 111.893 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.546 ' HH2' HG23 ' A' ' 48' ' ' THR . 3.3 p90 -133.94 -154.07 0.57 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 11.6 m120 -72.45 80.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.355 0.525 . . . . 0.0 110.353 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -82.69 125.24 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.2 m -134.02 143.24 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.347 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' HB2' ' CE3' ' A' ' 77' ' ' TRP . 34.3 tp -102.57 123.97 47.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 70' ' ' THR . 93.0 mt -63.33 134.09 55.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.842 0.353 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' VAL . 36.2 mt-30 -67.69 149.27 50.22 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -62.44 -17.8 60.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.082 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.63 -48.9 8.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.416 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.68 -33.26 71.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 94' ' ' GLN . 44.3 t -47.01 -43.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.7 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -60.74 -63.04 1.44 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.878 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.21 -33.1 63.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 55.7 t -70.01 -57.37 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.463 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.646 HD22 HG12 ' A' ' 107' ' ' ILE . 26.6 mt -59.7 -47.37 85.9 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.235 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.76 -61.82 2.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.259 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 106' ' ' CYS . 19.0 t -62.82 -28.24 69.87 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.344 1.027 . . . . 0.0 112.805 -167.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 24.4 m-85 -74.93 8.63 2.36 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.752 0.31 . . . . 0.0 110.634 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.43 ' H ' ' C ' ' A' ' 104' ' ' SER . 95.4 m 58.22 58.62 3.4 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.089 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.646 HG12 HD22 ' A' ' 102' ' ' LEU . 1.2 mp -75.4 116.73 18.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.583 0.706 . . . . 0.0 110.569 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.45 -21.04 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.128 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.79 178.25 41.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.48 151.38 77.24 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 55.6 Cg_endo -87.98 128.5 9.27 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.681 0.727 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.8 95.81 10.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.064 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 81.9 mt -113.47 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.506 . . . . 0.0 110.914 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 31.2 pt -114.45 148.76 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.537 -176.386 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.2 tt -95.48 111.61 23.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 97.9 t -107.91 132.62 55.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.65 163.74 51.85 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.417 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.48 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 82.0 Cg_exo -48.01 -31.24 15.54 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.355 2.703 . . . . 0.0 114.46 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.552 ' HB3' ' CE ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -88.39 -1.57 58.11 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.444 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 88.45 29.23 19.9 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.838 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.552 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 11.1 mtmm -110.72 138.26 47.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.5 mt -75.12 118.4 20.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.483 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.411 ' HB ' HD22 ' A' ' 115' ' ' LEU . 27.9 t -94.96 -38.32 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.89 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.317 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 18.3 pttm -150.15 147.1 27.33 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.935 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 61.97 35.79 15.98 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.502 1.126 . . . . 0.0 111.555 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.49 141.64 57.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.97 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -97.16 166.05 11.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.139 -174.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -35.96 -72.61 0.13 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.2 -35.91 69.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.923 0.362 . . . . 0.0 110.432 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -55.78 -46.15 78.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.727 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.3 pp -66.85 -38.78 87.03 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.452 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.3 t80 -65.34 -50.8 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -57.4 -42.14 81.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.716 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.2 m -69.04 -47.01 66.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.546 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' LEU . 52.5 t -64.79 -43.91 96.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 4.3 tt0 -63.85 -39.27 93.83 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -57.82 -33.27 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.385 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -87.69 -61.84 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.74 -170.91 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.505 0.193 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 2.9 t -153.74 137.19 15.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.562 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.5 -1.29 88.94 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -82.01 128.25 33.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.095 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 48.7 t -69.04 129.66 33.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.83 0.348 . . . . 0.0 110.123 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -93.45 141.6 24.12 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.441 -177.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 22.4 Cg_exo -66.12 163.3 32.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.167 2.578 . . . . 0.0 111.96 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.71 113.92 24.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.011 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.6 141.9 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -120.64 105.12 10.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.914 0.388 . . . . 0.0 110.05 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.76 167.94 14.5 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.811 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.8 mt -105.61 128.09 59.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -173.13 4.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.035 0.445 . . . . 0.0 111.273 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' ILE . 75.0 mt -64.6 -30.38 71.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.965 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.14 -32.86 59.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.33 22.01 6.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -95.15 141.19 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 p -82.31 106.01 13.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.77 146.31 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.859 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 m -112.57 157.43 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.172 0.51 . . . . 0.0 111.202 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 32' ' ' VAL . 62.5 tp -61.96 -24.71 67.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 8.4 t30 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.12 -9.83 59.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.441 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -113.88 1.63 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.34 . . . . 0.0 110.51 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' CD ' ' HA ' ' A' ' 25' ' ' ASN . 26.3 mtpp -63.61 171.21 2.74 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.395 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.21 83.03 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.583 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -137.55 165.47 26.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.51 114.04 14.79 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 24' ' ' LEU . 46.4 t -111.18 111.7 37.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.015 0.435 . . . . 0.0 111.31 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.559 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.3 tp -90.75 113.88 26.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 42.8 t -102.47 119.45 50.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.438 0.161 . . . . 0.0 110.942 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.39 116.81 33.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.86 116.87 29.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.485 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.98 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 11.7 p-90 -150.61 -178.4 6.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HE1' ' HB2' ' A' ' 110' ' ' PHE . 2.2 p90 -170.58 160.08 7.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.926 169.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.52 6.72 3.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.87 -16.73 67.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.086 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 96.3 m -120.88 121.43 38.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.029 0.443 . . . . 0.0 110.483 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 3.8 m -59.11 -33.36 70.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.459 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -66.73 -31.51 72.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.538 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 72.9 m -58.45 -41.12 84.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -85.12 -12.12 53.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.5 mptp? -75.69 -28.76 58.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.901 0.382 . . . . 0.0 110.311 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 11.8 mm-40 -79.9 -16.12 55.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.329 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 90.8 m -50.48 -52.13 58.11 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 52.7 Cg_exo -53.0 -42.08 67.02 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.133 1.888 . . . . 0.0 112.803 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 95.7 m-85 -69.11 -38.26 78.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 132' ' ' LEU . 79.2 mt -63.35 -50.32 70.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 50.5 tp -59.19 -40.54 86.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.475 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -52.2 -51.94 55.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.829 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -68.04 -43.66 78.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.445 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.9 t80 -60.93 -48.8 80.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.47 -29.02 69.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.51 -38.05 55.79 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.467 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 94.4 m-85 -120.23 6.74 10.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -61.65 -36.59 81.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.364 0.602 . . . . 0.0 110.84 -176.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.573 ' N ' ' HG2' ' A' ' 59' ' ' LYS . 2.9 p30 -82.76 6.78 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 58' ' ' PHE . 55.1 mttp -116.5 15.28 15.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.12 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.53 30.98 25.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.719 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 49.5 t80 -133.89 143.33 48.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -146.92 163.78 35.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 109.955 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 55' ' ' TYR . 20.2 mt -116.57 125.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.896 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 57.9 t80 -108.41 99.23 8.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.324 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' NE2' ' A' ' 90' ' ' GLN . . . -87.15 135.19 13.01 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.019 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 93' ' ' LEU . 3.2 m -133.4 112.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.574 0.702 . . . . 0.0 110.886 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 92' ' ' LEU . 29.7 t -113.12 154.62 26.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.776 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.9 t -123.91 41.41 3.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.739 0.781 . . . . 0.0 109.018 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.05 169.88 0.15 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -60.66 -38.46 84.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.589 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 38.5 mtt180 -144.72 169.27 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.045 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 1.12 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 31.7 tt0 -75.64 -41.06 55.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 mp0 -60.78 -36.18 78.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 18.4 t0 -66.65 -48.62 68.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.322 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.665 ' HZ2' ' HG3' ' A' ' 90' ' ' GLN . 34.2 t90 -56.77 -48.25 78.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.143 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 1.12 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 1.6 mptp? -58.83 -38.08 77.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.214 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -60.92 -45.53 94.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.896 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.68 -44.73 96.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.096 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.431 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 70.0 mt -64.34 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.244 0.545 . . . . 0.0 110.753 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.88 -31.19 72.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.305 0.574 . . . . 0.0 110.306 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 41.7 mt-10 -80.32 -53.03 7.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.392 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 81' ' ' ILE . 13.4 p-10 -91.52 -17.98 24.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.67 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER 67.41 38.5 3.19 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.305 0.574 . . . . 0.0 111.221 -179.212 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.3 p -72.76 67.62 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.325 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.12 85.57 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 52' ' ' LEU . 7.4 p90 -141.04 -149.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.01 64.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.713 0.688 . . . . 0.0 109.849 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' ' HZ2' ' A' ' 77' ' ' TRP . 8.6 tp-100 -90.97 123.42 34.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.242 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.72 152.72 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.188 0.518 . . . . 0.0 110.888 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 69' ' ' SER . 45.4 tp -90.3 129.88 36.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.574 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 68' ' ' VAL . 79.5 mt -70.03 125.3 26.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.2 mt-30 -65.12 147.93 52.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.6 -16.75 63.96 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.867 0.365 . . . . 0.0 111.144 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.27 -49.43 8.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.45 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -50.91 -36.73 39.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.061 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' GLN . 25.1 t -45.01 -41.85 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.456 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 9.6 mtmp? -56.24 -64.27 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 111.682 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.7 -36.44 65.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.906 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 105' ' ' TYR . 55.7 t -68.72 -55.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.257 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.673 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 15.8 mt -60.4 -42.18 95.4 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.555 -175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -62.04 -62.07 2.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.519 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.2 m -55.59 -32.11 62.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HE2' HG13 ' A' ' 101' ' ' VAL . 62.8 m-85 -83.03 22.14 0.98 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.763 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.7 p 47.96 48.85 17.69 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.38 1.072 . . . . 0.0 110.56 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 79.6 mt -97.67 110.73 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.689 -175.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.56 18.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.43 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.69 -178.43 41.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.596 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.475 ' HB2' ' HE1' ' A' ' 38' ' ' PHE . 97.7 m-85 -134.84 157.39 77.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.937 0.369 . . . . 0.0 110.293 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.61 168.85 25.87 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.762 -1.349 . . . . 0.0 112.91 -1.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.671 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.6 128.97 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 125' ' ' LYS . 41.7 pt -123.11 153.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.64 113.35 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.1 t -101.1 140.58 19.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.598 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.74 167.29 30.78 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.04 -35.27 50.09 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.82 2.347 . . . . 0.0 113.969 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.4 mt-10 -79.46 -24.23 42.53 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.511 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.36 27.99 3.44 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.538 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -106.05 148.32 27.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.791 0.795 . . . . 0.0 109.309 172.369 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' THR . 38.2 mt -80.3 104.52 8.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.88 -28.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.75 138.47 30.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.774 ' HG3' HG22 ' A' ' 114' ' ' ILE . 20.8 ttpp -129.81 155.5 45.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.327 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 125' ' ' LYS . 2.3 mm-40 66.08 42.95 3.05 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.897 0.748 . . . . 0.0 110.931 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB3' HD23 ' A' ' 132' ' ' LEU . 83.2 mt -82.16 156.07 24.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.876 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.759 ' HD3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -162.28 167.28 24.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.955 -172.765 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 44.02 -129.65 6.72 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.933 0.771 . . . . 0.0 113.944 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -77.03 -24.21 52.1 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.62 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 12.5 m-20 -53.67 -27.27 26.62 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.287 0.367 . . . . 0.0 110.43 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 136' ' ' VAL . 71.6 mt -56.18 -64.57 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.357 0.598 . . . . 0.0 109.736 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -58.34 -42.65 87.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.981 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 1.9 t-20 -51.13 -52.32 44.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.483 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -72.26 -34.24 68.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.176 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 132' ' ' LEU . 56.2 t -71.71 -42.31 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.879 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.17 -34.85 75.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.77 0.795 . . . . 0.0 109.364 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 12.9 ttmt -64.17 -51.04 65.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.57 -54.86 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 111.405 -172.532 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.549 ' N ' ' HG ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -64.51 111.2 2.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.92 1.81 52.08 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.447 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.549 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 19.4 m -87.58 131.66 34.33 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.774 -0.25 . . . . 0.0 110.424 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 52.0 t -69.64 132.82 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -100.28 148.35 34.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.553 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 30.0 Cg_exo -64.35 163.21 27.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.566 2.844 . . . . 0.0 112.516 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.28 131.75 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.592 HD12 HG22 ' A' ' 101' ' ' VAL . 18.1 mm -87.33 148.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -133.61 94.23 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.322 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 175.9 16.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.646 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.97 117.07 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.27 -174.8 5.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.026 0.441 . . . . 0.0 111.438 -171.674 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.32 -30.61 66.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.789 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -69.27 -25.68 64.39 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.053 0.454 . . . . 0.0 111.067 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.07 20.89 29.31 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -103.18 148.84 25.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -77.3 97.97 5.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.93 137.41 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.197 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -176.83 3.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -79.42 -28.94 41.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.202 0.525 . . . . 0.0 110.198 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -66.82 -19.92 65.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.258 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.62 -31.87 71.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 111.204 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -115.62 20.55 14.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.413 0.625 . . . . 0.0 109.78 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 57.5 tttp -84.06 66.76 9.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.991 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.05 17.91 0.19 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.875 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -149.64 175.21 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -80.27 112.57 17.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.42 114.32 37.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.164 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 tp -92.03 109.85 21.21 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 33.6 t -91.19 117.47 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.822 0.344 . . . . 0.0 110.945 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.93 103.04 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.348 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HA ' HG23 ' A' ' 68' ' ' VAL . 39.3 m-85 -82.19 114.72 20.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 11.4 p-90 -155.08 173.68 16.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 122.186 0.993 . . . . 0.0 112.731 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -164.71 154.15 13.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.894 -1.957 . . . . 0.0 107.064 165.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.43 -29.35 66.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.09 -38.19 95.15 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.063 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.1 p -87.55 96.62 10.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.407 0.622 . . . . 0.0 110.231 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.552 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.3 m -68.15 -11.2 58.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.155 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -69.82 -42.46 73.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.91 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . 20.7 p -67.84 -29.6 68.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 6.6 mmp_? -75.57 -14.29 60.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.135 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.6 mptm? -79.13 -21.68 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.732 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -94.92 -3.58 48.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.255 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 94.1 m -51.16 -51.52 67.33 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.346 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.0 Cg_endo -51.72 -39.05 67.49 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.374 2.05 . . . . 0.0 112.495 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.18 -39.77 62.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.989 0.423 . . . . 0.0 110.629 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 113' ' ' ILE . 97.0 mt -63.18 -45.49 91.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.275 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.37 -41.36 96.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.511 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -57.74 -53.29 59.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.396 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD1' ' A' ' 133' ' ' TYR . 19.6 m -61.93 -42.51 99.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.116 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.641 ' HB2' HD12 ' A' ' 65' ' ' ILE . 56.4 t80 -59.73 -56.32 23.36 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.523 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 28.0 m-80 -58.08 -35.43 71.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.66 48.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 92.5 m-85 -120.2 0.78 10.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 60' ' ' ASP . 14.6 ptmm? -60.18 161.6 6.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.241 0.543 . . . . 0.0 111.048 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 32.0 m-20 73.7 -49.69 0.68 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.8 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 44.4 mttp -60.64 -88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.786 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.36 15.79 3.9 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.788 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.97 141.59 44.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -150.6 149.54 30.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.253 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -103.21 129.74 54.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.966 0.412 . . . . 0.0 110.172 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t80 -119.35 98.89 6.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.001 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.74 122.57 6.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.191 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.61 ' HB ' HD21 ' A' ' 93' ' ' LEU . 15.4 m -100.43 111.88 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.656 0.741 . . . . 0.0 110.126 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -104.76 136.51 44.14 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.369 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.552 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.7 t -122.62 32.38 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.045 0.926 . . . . 0.0 109.065 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.4 175.78 0.54 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.285 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -79.05 -57.77 3.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.315 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB3' ' OD2' ' A' ' 76' ' ' ASP . 22.5 tpt180 -123.78 152.01 42.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.317 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 17.1 tt0 -64.7 -35.04 79.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.483 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -58.22 -47.07 84.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.739 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 2.1 p30 -73.51 -36.19 65.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.743 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.463 ' O ' HG12 ' A' ' 81' ' ' ILE . 26.6 t90 -54.4 -54.83 35.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -57.94 -43.13 86.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.87 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -57.0 -50.1 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.764 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.14 88.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 77' ' ' TRP . 39.3 mm -59.82 -39.95 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.108 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.91 -32.76 63.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.27 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.67 -49.34 14.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.125 0.488 . . . . 0.0 110.897 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.97 -19.6 60.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.903 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt 64.3 27.09 13.77 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.312 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 p -87.99 82.32 7.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.11 87.7 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.559 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -150.97 -159.66 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.853 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.24 83.94 7.24 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.357 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -94.74 136.12 35.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.928 0.394 . . . . 0.0 110.695 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 25.5 m -125.83 137.3 58.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.689 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.2 tp -87.79 116.07 25.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 68' ' ' VAL . 74.5 mt -57.45 130.86 48.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.487 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 98' ' ' VAL . 66.1 mt-30 -64.63 151.94 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.9 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.006 0.432 . . . . 0.0 111.869 -170.516 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.68 -42.85 12.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.9 t70 -54.07 -31.65 52.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.464 0.705 . . . . 0.0 111.793 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 94' ' ' GLN . 52.6 t -48.0 -33.99 4.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.175 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 54.9 mttp -57.67 -65.62 0.6 Allowed 'General case' 0 C--O 1.223 -0.319 0 O-C-N 123.035 0.209 . . . . 0.0 111.495 -175.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 104' ' ' SER . 24.9 t70 -63.02 -43.48 98.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.394 -170.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 12' ' ' ILE . 37.0 t -53.95 -63.21 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.25 0.548 . . . . 0.0 110.397 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 40.4 mt -66.61 -42.12 87.34 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 12.8 mt-10 -67.34 -64.17 0.91 Allowed 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 122.009 -0.432 . . . . 0.0 111.144 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 38.6 m -62.26 -32.55 73.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB2' HG12 ' A' ' 107' ' ' ILE . 74.7 m-85 -77.48 7.7 5.14 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.723 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m 61.85 53.35 3.15 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.246 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.7 mm -105.43 98.99 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.905 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.87 13.36 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.772 0.796 . . . . 0.0 110.739 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.64 -162.61 34.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.641 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.39 156.17 69.74 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.969 0.384 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB3' ' A' ' 44' ' ' CYS . 82.7 Cg_endo -96.63 164.12 14.18 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.102 -1.208 . . . . 0.0 113.13 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -145.11 130.74 18.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 51' ' ' LEU . 70.5 mt -128.27 113.37 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.759 0.314 . . . . 0.0 110.835 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.832 HG22 ' HG3' ' A' ' 125' ' ' LYS . 42.1 pt -112.51 156.57 13.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.359 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.8 118.56 31.16 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -112.28 136.36 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -78.59 166.76 40.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.018 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -50.51 -44.05 41.76 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.871 2.381 . . . . 0.0 113.561 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.0 mt-10 -65.21 -29.6 70.42 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.046 -0.409 . . . . 0.0 110.589 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.35 33.04 2.6 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.418 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.629 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -110.51 146.56 35.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.97 0.885 . . . . 0.0 109.194 170.893 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.6 mt -71.17 116.34 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.946 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.44 -37.44 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.25 24.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.832 ' HG3' HG22 ' A' ' 114' ' ' ILE . 88.7 tttt -123.7 128.16 49.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.51 . . . . 0.0 111.337 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.539 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 44.1 mt-10 58.72 74.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.71 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.779 ' HB2' HD23 ' A' ' 132' ' ' LEU . 43.8 mt -91.3 155.34 18.6 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.529 HH12 ' HG2' ' A' ' 111' ' ' PRO . 28.4 mmt180 -128.07 161.7 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.25 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 50.92 -137.78 27.14 Favored Glycine 0 N--CA 1.452 -0.26 0 O-C-N 123.983 0.802 . . . . 0.0 113.168 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.37 -16.43 58.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 17.7 m-20 -60.52 -27.26 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.283 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 ' HB2' ' A' ' 127' ' ' LEU . 23.6 mt -51.45 -58.18 6.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.742 167.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 54' ' ' THR . 67.3 t80 -62.81 -48.75 77.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 89.3 m-20 -51.7 -47.18 64.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 m -67.84 -44.07 78.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.5 t -63.94 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 15.7 tt0 -66.28 -44.09 84.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 0.0 110.564 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -59.87 -29.14 68.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 -60.66 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.0 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.259 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.13 0.491 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.963 HG23 ' HA ' ' A' ' 123' ' ' VAL . 90.7 m -104.26 130.17 52.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.886 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.67 -10.5 45.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.779 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -77.95 127.06 31.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 54.8 t -69.7 132.87 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.537 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 105' ' ' TYR . . . -88.2 146.5 38.27 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.591 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.8 Cg_exo -61.82 163.3 19.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.315 2.676 . . . . 0.0 112.094 173.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 130.73 34.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.36 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' SER . 51.7 mt -94.1 138.88 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.146 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.17 101.42 8.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 0.0 110.55 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.84 156.59 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.783 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -98.98 122.21 50.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.507 ' CG ' ' HZ2' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -80.84 -175.3 5.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.023 0.439 . . . . 0.0 111.282 -173.854 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.37 -31.65 69.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.991 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HZ2' ' CG ' ' A' ' 16' ' ' ASP . 8.8 mtmp? -80.11 -18.66 49.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 111.294 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 25.73 13.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.119 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -97.97 144.18 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 94.57 6.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.039 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.29 143.24 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.816 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 15.7 m -119.47 170.35 9.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.72 0.295 . . . . 0.0 110.274 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 34.6 tp -68.17 -7.74 32.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.207 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 28.3 p-10 -65.52 -32.37 73.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.39 -31.82 71.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.683 0.754 . . . . 0.0 111.087 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.493 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 95.1 m-85 -85.07 -2.92 58.54 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 120' ' ' GLY . 51.4 mttt -84.03 99.55 10.51 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.371 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 118' ' ' PRO . . . 132.94 -9.13 5.17 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -121.01 165.55 15.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.32 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.92 117.37 23.89 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 8.5 t -109.32 115.82 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.866 0.365 . . . . 0.0 111.856 -169.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 132' ' ' LEU . 34.3 tp -97.01 105.02 17.09 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 15.8 t -96.45 108.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.938 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -102.98 116.83 33.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.26 121.37 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.177 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 69' ' ' SER . 29.9 p-90 -152.97 -178.24 6.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -175.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -168.73 162.8 11.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.487 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -30.95 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.65 65.22 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.801 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.92 99.64 6.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.162 0.506 . . . . 0.0 110.634 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.514 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 59.2 m -63.6 -35.04 79.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.384 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 71.3 t-105 -60.67 -33.95 73.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.452 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 111' ' ' PRO . 58.3 m -60.08 -37.88 81.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.504 0.669 . . . . 0.0 110.341 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.706 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 42.2 mtm180 -84.96 -12.21 53.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.648 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 43' ' ' TRP . 51.5 mmtt -70.76 -21.74 62.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.201 0.524 . . . . 0.0 110.865 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.09 -2.05 58.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.973 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 86.7 m -52.48 -49.0 88.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 71.6 Cg_exo -50.68 -44.53 40.11 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.011 1.807 . . . . 0.0 112.454 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -69.27 -39.22 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.71 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.47 -48.57 80.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.41 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.22 -40.42 85.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.43 -50.9 70.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -62.18 -46.56 88.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.449 ' HB2' HD12 ' A' ' 65' ' ' ILE . 60.6 t80 -55.53 -51.98 65.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.011 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -67.42 -25.97 66.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.83 -27.94 30.53 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 92.9 m-85 -120.59 1.28 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 59.5 pttt -61.35 -27.57 68.6 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.112 0.482 . . . . 0.0 111.786 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.14 -6.5 59.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.275 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -110.92 31.41 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.424 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 39.21 64.81 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.575 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 51.0 t80 -135.6 140.42 44.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 t -150.06 147.51 27.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.293 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -87.61 126.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -97.85 93.9 6.61 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -78.11 107.15 2.4 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.826 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -106.96 111.97 37.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 120.734 0.302 . . . . 0.0 110.421 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 32.6 t -116.06 160.01 20.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.047 0.451 . . . . 0.0 110.43 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.516 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.3 t -131.31 30.44 4.49 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.493 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -51.84 147.95 6.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.553 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -78.93 -10.75 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.019 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 46.7 mtm180 -137.72 149.4 46.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.653 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 15.8 tt0 -72.68 -32.9 66.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 1.7 mp0 -60.34 -40.89 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.084 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.36 -37.16 68.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.019 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -61.33 -51.2 69.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.306 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -59.17 -39.24 81.88 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.901 0.381 . . . . 0.0 110.419 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 4.0 ttpm? -61.89 -48.45 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.742 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.35 75.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.373 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.11 -41.24 91.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.268 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -70.82 -37.59 73.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.4 mt-10 -54.22 -48.28 71.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.262 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.706 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.7 m-20 -104.02 0.81 30.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 63.2 mmtt 58.61 34.76 24.09 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.6 p -82.67 75.79 9.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.475 0.655 . . . . 0.0 111.048 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 69.3 m-85 -87.85 89.47 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.507 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -158.55 -177.15 6.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.04 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.57 100.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 41.0 mt-30 -123.78 151.71 43.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.678 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.86 154.51 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.824 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.85 130.33 46.03 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.516 HD12 ' HB ' ' A' ' 70' ' ' THR . 80.9 mt -65.32 140.24 58.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.693 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.2 mt-30 -73.08 157.98 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -57.94 -36.82 73.05 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.84 -31.14 18.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.67 0.271 . . . . 0.0 111.075 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -35.89 82.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.217 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 87.0 t -48.5 -45.82 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.014 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.16 -62.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.531 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.98 -55.45 12.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.38 -51.91 29.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 O-C-N 123.345 0.403 . . . . 0.0 111.927 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 34.8 mt -61.97 -51.39 68.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.943 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.79 -60.3 4.06 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.389 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.1 m -50.67 -38.26 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.054 0.942 . . . . 0.0 113.385 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.464 ' HE1' ' HB1' ' A' ' 9' ' ' ALA . 17.2 m-85 -78.05 13.74 1.34 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.354 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.9 m 63.47 44.19 5.5 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.785 0.678 . . . . 0.0 109.614 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 61.2 mt -105.94 92.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.137 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.3 -0.01 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.787 0.803 . . . . 0.0 109.013 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.75 155.66 26.64 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.026 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.64 152.73 79.1 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 44' ' ' CYS . 92.0 Cg_endo -85.51 134.21 18.21 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.593 -1.419 . . . . 0.0 112.736 -0.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -103.32 114.0 27.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 132' ' ' LEU . 61.8 mt -113.97 130.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 29.6 pt -133.34 143.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.3 tp -107.47 118.01 35.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 60.3 t -107.31 138.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.611 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -84.36 167.98 24.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 2.3 Cg_endo -46.01 -42.61 20.67 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.184 2.589 . . . . 0.0 114.195 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.503 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 40.7 mt-10 -76.4 -24.54 54.07 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 122.175 -0.328 . . . . 0.0 111.497 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 109.6 33.13 2.74 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.867 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 119' ' ' GLU . 2.1 mptt -100.59 149.45 23.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.774 0.787 . . . . 0.0 109.476 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 5' ' ' THR . 50.7 mt -85.37 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.321 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.963 ' HA ' HG23 ' A' ' 5' ' ' THR . 4.9 p -86.09 -50.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -115.64 153.97 30.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -169.46 153.75 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.148 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 68.43 13.79 9.04 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.273 0.983 . . . . 0.0 111.413 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.573 HD11 ' HB1' ' A' ' 124' ' ' ALA . 68.2 mt -70.28 156.78 38.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.814 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 3.5 mmp_? -101.22 170.45 8.24 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.58 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 132' ' ' LEU . . . -47.23 -68.49 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.29 -31.16 69.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 0.0 110.187 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.91 -38.7 92.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.094 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 33' ' ' LEU . 63.6 mt -52.16 -51.06 60.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.24 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -59.09 -50.72 72.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -61.91 -42.44 99.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.276 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.598 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 15.9 m -72.78 -39.67 66.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.727 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 132' ' ' LEU . 72.6 t -67.18 -35.61 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.76 -55.17 37.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 18.8 pttp -63.31 -17.33 62.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.058 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.96 -61.43 1.71 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 173.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -169.415 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.6 ' N ' ' HG ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.54 0.21 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -127.38 128.97 46.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.18 89.96 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 5.5 m -84.43 140.95 31.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.456 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.42 127.32 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.81 0.338 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 124.96 59.25 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.166 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 25.1 Cg_exo -63.47 158.54 44.86 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.741 2.294 . . . . 0.0 112.311 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 116.13 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.941 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 101' ' ' VAL . 43.3 mm -96.29 150.64 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.166 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 9.0 t -131.19 138.91 49.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.85 29.05 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.644 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 92' ' ' LEU . 66.6 mt -79.73 113.87 19.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 11.9 p30 -81.92 179.1 7.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.721 -173.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.28 -15.59 60.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.693 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 2.0 mppt? -77.23 -32.76 56.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 109.722 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.91 18.41 4.72 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.985 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -113.97 149.08 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.718 0.294 . . . . 0.0 110.6 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.81 90.58 6.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 p -106.36 166.14 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.984 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.708 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 8.3 m -105.13 173.97 6.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.65 HD11 HG11 ' A' ' 32' ' ' VAL . 63.1 tp -57.04 -23.11 44.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 3.3 p-10 -65.59 -16.9 64.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.29 -36.56 78.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 0.0 110.75 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -119.71 10.97 11.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 48.6 tttp -72.7 121.94 20.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.509 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.96 -23.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 27.5 mttm -103.09 174.71 5.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.22 109.32 5.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 165.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.65 HG11 HD11 ' A' ' 24' ' ' LEU . 57.5 t -94.52 108.07 20.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.18 -171.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.4 tp -85.64 109.94 18.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' ILE . 39.6 t -88.73 121.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.253 0.549 . . . . 0.0 110.369 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -104.99 108.99 20.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.007 -172.625 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.495 ' HZ ' ' HD2' ' A' ' 105' ' ' TYR . 88.1 m-85 -94.37 115.11 27.27 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 5.0 p-90 -155.64 176.59 12.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 0.0 111.475 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -170.07 149.25 3.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.109 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . . . -72.7 5.05 3.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.986 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.13 -14.39 56.16 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.9 t -99.35 134.36 42.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -67.37 -40.26 85.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.439 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -75.36 -28.5 59.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.657 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 85.6 m -58.54 -37.65 76.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.533 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.62 -21.27 66.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.323 0.582 . . . . 0.0 110.714 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.3 mptp? -86.35 -31.9 21.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -78.91 -25.27 43.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.049 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.5 m -50.98 -51.21 69.59 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 73.1 Cg_exo -52.05 -39.58 69.83 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.278 1.985 . . . . 0.0 112.988 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -71.19 -35.32 71.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 110.813 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.719 HD21 HD13 ' A' ' 113' ' ' ILE . 89.5 mt -66.77 -44.66 80.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.345 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.27 -44.31 92.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.358 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 34.2 ttpt -53.52 -56.36 17.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.707 175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.4 m -65.22 -42.8 93.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.51 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HB2' HD12 ' A' ' 65' ' ' ILE . 83.3 t80 -61.95 -51.64 67.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.639 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.604 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 49.4 t30 -55.7 -42.17 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.291 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 70.3 m-85 -106.72 -1.12 23.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 56' ' ' ASN . 12.0 pttp -62.85 -25.79 68.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.078 0.466 . . . . 0.0 110.574 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -23.26 64.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.668 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -110.85 -161.96 0.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.556 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.75 47.59 3.32 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.672 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 79.0 t80 -142.71 153.46 43.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 14.8 t -162.56 170.33 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.676 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 55' ' ' TYR . 44.4 mt -120.2 124.43 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 59.8 t80 -105.26 95.81 6.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.277 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -83.14 135.44 13.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.142 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.8 m -125.84 118.89 53.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.622 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -125.66 151.17 46.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.53 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -131.18 45.38 2.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 108.997 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 39' ' ' ALA . 1.3 m-20 -60.62 -176.5 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.9 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -62.31 -39.8 94.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.286 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 13.0 tpt180 -151.23 158.29 43.71 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.405 -171.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 25.5 tt0 -66.88 -44.94 79.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.702 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.1 pm0 -70.5 -27.81 64.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.828 0.346 . . . . 0.0 110.084 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 21.7 t0 -62.01 -42.57 99.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -68.0 -49.69 60.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.825 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -52.72 -44.43 66.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.262 0.554 . . . . 0.0 110.287 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 13.9 ttpp -61.69 -44.29 97.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.062 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.1 78.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.966 0.413 . . . . 0.0 111.193 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.46 ' HA ' ' OG ' ' A' ' 86' ' ' SER . 79.8 mt -62.53 -43.71 98.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.127 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -66.01 -38.84 89.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.72 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.7 mt-10 -58.47 -58.61 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 111.329 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.824 ' HB3' HG21 ' A' ' 48' ' ' THR . 1.1 m-20 -85.2 -5.88 59.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.366 -173.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 3.9 mptp? 61.22 34.03 18.93 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.511 0.672 . . . . 0.0 110.451 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -80.09 58.32 2.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.278 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -79.77 75.06 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.45 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 25.4 p90 -140.84 -168.35 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.709 170.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 11.2 m120 -74.46 86.86 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 -174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.7 mt-30 -113.42 148.27 36.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.43 150.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.318 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 49.0 tp -88.38 114.1 24.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.558 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 68' ' ' VAL . 85.6 mt -69.18 135.51 50.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.295 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.658 ' O ' HG23 ' A' ' 98' ' ' VAL . 61.7 mt-30 -72.11 148.26 45.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 74.2 mmtt -63.06 -30.07 71.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -169.304 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 22.2 t70 -83.85 -40.16 19.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.871 0.367 . . . . 0.0 110.083 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.1 t70 -56.19 -40.54 74.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.765 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 94' ' ' GLN . 96.8 t -48.39 -37.85 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.563 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 3.6 ttpp -54.74 -56.0 23.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.228 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.86 -40.47 68.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.818 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 12' ' ' ILE . 61.9 t -57.17 -60.52 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 49.4 mt -57.13 -57.26 13.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.854 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.68 -61.73 2.12 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.355 0.409 . . . . 0.0 110.711 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 106' ' ' CYS . 39.7 m -53.23 -41.51 65.46 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 124.206 0.941 . . . . 0.0 112.858 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.495 ' HD2' ' HZ ' ' A' ' 36' ' ' PHE . 6.6 m-85 -74.17 12.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.187 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.434 ' H ' ' C ' ' A' ' 104' ' ' SER . 36.3 t 62.95 41.28 8.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.2 mm -112.64 122.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.357 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.18 21.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.665 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.01 168.23 40.97 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.391 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.6 150.7 77.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.583 0.353 . . . . 0.0 110.094 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.35 137.92 8.61 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.025 -1.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -134.09 139.18 45.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.719 HD13 HD21 ' A' ' 51' ' ' LEU . 61.5 mt -128.77 136.7 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.522 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 125' ' ' LYS . 33.0 pt -126.36 159.65 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.45 117.1 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.621 0.248 . . . . 0.0 110.636 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 117' ' ' ASP . 74.1 t -111.84 127.36 69.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.563 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 2.8 p30 -67.68 163.35 49.52 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.815 175.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -49.95 -37.21 46.13 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.309 2.673 . . . . 0.0 113.248 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.47 -36.76 83.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.349 0.595 . . . . 0.0 110.339 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.65 37.51 1.42 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.357 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.563 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.1 mtmp? -117.35 141.93 47.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.854 0.359 . . . . 0.0 110.096 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 mt -80.67 104.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.6 -40.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.2 0.524 . . . . 0.0 110.451 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.69 156.4 42.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.203 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.842 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 0.9 OUTLIER -154.22 171.89 18.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.235 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.842 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 8.7 mm-40 60.75 32.36 20.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.174 0.921 . . . . 0.0 110.32 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.64 134.79 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -77.88 147.34 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.633 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.76 -51.19 7.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.22 -34.33 76.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.6 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.76 -34.05 27.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.071 -168.492 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.5 pp -58.2 -32.47 68.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.752 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -71.18 -42.34 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.17 -42.71 99.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -69.06 -53.22 21.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.807 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 132' ' ' LEU . 27.4 m -61.02 -38.81 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.96 -41.54 95.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.346 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -66.48 -23.15 66.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.909 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.14 -61.36 1.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.281 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.452 0.168 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -132.36 134.64 45.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.685 0.279 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.33 -11.76 68.62 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.614 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 t -78.25 151.4 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.87 129.0 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.457 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.52 139.8 41.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' A' ' 105' ' ' TYR . 51.8 Cg_exo -54.63 154.41 20.44 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.928 2.419 . . . . 0.0 112.599 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 91.68 6.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.33 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.526 HG21 HG11 ' A' ' 68' ' ' VAL . 45.6 mt -64.25 135.03 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.158 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 m -133.06 100.4 4.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 110.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.78 176.93 16.82 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.506 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.0 123.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -174.7 5.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.029 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -64.7 -25.12 67.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.62 -21.93 51.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.1 0.476 . . . . 0.0 110.894 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.24 19.66 27.59 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -96.5 145.14 25.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 p -80.99 99.36 8.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.43 131.12 54.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.873 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 m -110.4 171.57 7.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.972 0.415 . . . . 0.0 110.981 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.7 -23.81 63.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 110.409 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 8.2 t30 -64.31 -31.47 72.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.375 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -72.74 -5.22 36.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.433 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 7.23 14.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 9.0 mtpm? -71.39 92.35 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.385 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.64 -24.35 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -121.51 172.85 7.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.526 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 m-85 -78.19 116.64 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.65 ' HB ' HG23 ' A' ' 116' ' ' VAL . 22.6 t -102.92 119.85 51.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.11 0.481 . . . . 0.0 111.208 -172.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 17.4 tp -94.06 116.18 28.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 46.1 t -102.17 115.89 44.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.613 0.244 . . . . 0.0 110.947 -174.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -92.91 103.72 16.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 68' ' ' VAL . 91.6 m-85 -83.77 114.12 21.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.326 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.541 ' HZ3' HH12 ' A' ' 45' ' ' ARG . 11.1 p-90 -158.3 178.66 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.6 0.714 . . . . 0.0 112.537 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -169.82 154.25 5.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.95 171.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 86.99 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.476 0.655 . . . . 0.0 110.337 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.1 -46.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.16 101.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.41 0.624 . . . . 0.0 109.464 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 m -66.12 -7.64 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.831 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.479 ' HE1' ' HD2' ' A' ' 128' ' ' ARG . 67.4 t-105 -78.77 -23.66 45.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.4 m -58.24 -42.4 86.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.541 HH12 ' HZ3' ' A' ' 37' ' ' TRP . 4.7 mpt_? -62.74 -16.48 57.8 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.234 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 2.2 mptm? -85.38 -31.55 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -23.61 30.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.143 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 10.7 m -48.96 -50.18 63.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -47.42 -47.55 17.42 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.42 2.08 . . . . 0.0 113.041 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 67.4 m-85 -75.46 -35.4 60.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD21 HD13 ' A' ' 113' ' ' ILE . 92.0 mt -58.24 -52.61 64.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.63 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.11 -42.94 99.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.346 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HZ1' ' HE1' ' A' ' 133' ' ' TYR . 27.4 tptp -55.07 -52.15 64.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.14 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 63' ' ' PHE . 30.8 m -64.11 -45.44 88.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.147 -178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -58.24 -51.59 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.24 -38.8 92.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.316 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.09 67.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 21.5 m-85 -120.36 6.7 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.4 pttp -54.47 -50.34 67.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.68 -43.7 65.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.118 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -55.04 -71.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.46 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.07 33.12 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.4 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 78.4 t80 -137.06 139.01 41.02 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 50.3 m -149.58 141.11 23.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' TYR . 33.5 mt -98.36 135.46 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.2 t80 -121.8 95.9 4.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.843 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.5 124.3 6.52 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.979 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 1.005 ' HB ' HD21 ' A' ' 93' ' ' LEU . 17.3 m -105.65 111.51 35.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.085 0.945 . . . . 0.0 109.78 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.606 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 7.3 m -104.81 137.67 42.24 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.164 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.1 t -126.36 42.16 3.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.234 1.016 . . . . 0.0 108.868 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.606 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 8.8 m-20 -61.72 176.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.306 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -80.63 -19.09 46.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.499 -168.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 5.8 tpt85 -165.64 161.72 18.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.6 tt0 -67.16 -44.15 80.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.286 0.494 . . . . 0.0 110.119 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.57 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 1.8 mp0 -59.41 -39.61 83.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.512 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.14 -46.43 87.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.154 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.429 ' O ' HG13 ' A' ' 81' ' ' ILE . 21.0 t90 -59.08 -52.66 64.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.579 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.8 mptm? -53.81 -46.59 71.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 0.0 110.163 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.19 -42.35 94.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.378 175.659 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.57 76.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.6 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 77' ' ' TRP . 79.0 mt -63.13 -47.81 90.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -66.63 -37.69 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -58.17 -45.47 87.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.338 0.655 . . . . 0.0 111.075 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 48' ' ' THR . 15.2 t70 -87.2 -26.43 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.895 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.5 mptp? 70.99 21.09 5.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.006 0.523 . . . . 0.0 111.144 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -82.25 76.0 9.15 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.892 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -84.48 78.62 9.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.41 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -151.62 -172.61 4.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.79 108.46 3.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.196 0.522 . . . . 0.0 111.123 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.51 152.3 40.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.8 146.39 29.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.058 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.26 129.25 35.41 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 1.005 HD21 ' HB ' ' A' ' 68' ' ' VAL . 65.4 mt -63.92 138.47 58.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 98' ' ' VAL . 75.1 mt-30 -80.11 169.49 17.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.811 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -51.67 -46.87 63.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.6 m-20 -87.67 -33.73 18.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.616 0.246 . . . . 0.0 110.455 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.482 ' OD1' HD22 ' A' ' 93' ' ' LEU . 17.4 t70 -55.97 -45.01 79.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.2 t -49.64 -53.11 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.851 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 9.5 mtmp? -60.31 -62.79 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.48 -174.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.49 -42.06 65.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.747 -168.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.538 HG13 ' HE2' ' A' ' 105' ' ' TYR . 53.5 t -68.48 -54.4 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 121.344 -0.142 . . . . 0.0 111.233 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 48.9 mt -58.52 -43.51 89.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.047 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.23 -61.26 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.013 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.8 m -49.25 -40.59 34.78 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.555 ' HB2' HG12 ' A' ' 107' ' ' ILE . 84.8 m-85 -76.52 11.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.046 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.7 m 60.18 42.45 15.34 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 109.904 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 105' ' ' TYR . 36.1 mm -91.76 74.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.691 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.92 -19.04 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.897 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.9 148.69 20.17 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.428 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.34 155.48 48.38 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG2' ' HD1' ' A' ' 43' ' ' TRP . 2.3 Cg_endo -82.54 166.81 68.85 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.279 -0.273 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.477 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -144.39 109.08 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.106 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.512 HD13 HD21 ' A' ' 51' ' ' LEU . 79.2 mt -114.73 127.0 72.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.757 0.313 . . . . 0.0 110.267 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 46.6 pt -124.23 160.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.105 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -124.9 114.18 18.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.65 HG23 ' HB ' ' A' ' 32' ' ' VAL . 4.7 m -104.99 144.65 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.024 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.597 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.5 OUTLIER -76.07 172.91 8.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.439 177.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -51.71 -24.78 18.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.931 2.421 . . . . 0.0 113.721 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -88.61 1.01 55.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.191 -0.318 . . . . 0.0 111.796 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.04 27.54 58.05 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.709 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -111.62 142.19 44.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.128 0.49 . . . . 0.0 110.241 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mt -72.96 104.68 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.284 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.87 -26.46 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 110.298 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -144.87 151.02 38.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 20.3 pttp -161.66 154.26 20.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.89 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 28.9 mt-10 62.55 29.93 17.05 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.368 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.21 165.66 22.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.273 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HD2' ' HE1' ' A' ' 43' ' ' TRP . 18.1 mmt180 -115.87 166.25 12.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -42.29 -64.18 1.62 Allowed Glycine 0 C--O 1.234 0.124 0 O-C-N 124.012 0.82 . . . . 0.0 114.432 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.02 -36.58 68.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.837 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.37 -50.24 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.6 pp -57.13 -34.4 68.36 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.872 0.368 . . . . 0.0 110.187 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 50.1 t80 -64.84 -57.43 8.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.094 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.22 -43.83 87.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 17.6 m -65.94 -49.04 69.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.897 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.24 -40.95 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.146 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.441 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 15.1 tt0 -65.29 -36.66 84.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.351 0.596 . . . . 0.0 109.897 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 14.1 ttpp -61.73 -39.94 93.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.788 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.27 -53.79 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -169.367 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . . . . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.548 0.214 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 p -134.69 131.59 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.0 -3.79 86.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.458 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.486 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 9.8 m -69.33 130.17 41.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.368 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.03 133.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 0.0 110.289 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -88.59 137.75 30.23 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.24 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 32.2 Cg_exo -61.34 162.28 20.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.012 2.475 . . . . 0.0 112.011 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.6 96.9 9.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.792 0.33 . . . . 0.0 111.618 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.29 140.25 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.832 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -133.55 89.55 2.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.05 0.929 . . . . 0.0 110.286 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.45 155.51 18.98 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.417 -174.961 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.7 mt -86.11 130.18 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.606 0.241 . . . . 0.0 110.56 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -79.4 -174.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.94 -7.13 46.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 34.8 mttp -99.78 -35.68 9.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.549 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.37 10.5 2.99 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.314 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.8 m-80 -91.77 134.18 34.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 p -83.17 98.15 9.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.855 0.359 . . . . 0.0 110.215 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.16 137.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.009 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -97.37 156.6 16.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.194 0.521 . . . . 0.0 111.437 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 tp -61.13 -27.25 68.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.618 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.0 t30 -65.85 -31.08 71.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.05 -7.64 54.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 110.811 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.84 3.14 18.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.91 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 85.5 mttt -66.38 178.69 1.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.021 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.05 10.56 85.42 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.497 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -143.17 167.43 22.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.9 110.47 17.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 168.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.2 109.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.908 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.7 tp -85.61 110.28 19.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 114' ' ' ILE . 58.6 t -98.57 107.99 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.094 0.474 . . . . 0.0 110.664 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.21 121.44 42.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.245 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.24 117.31 28.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.778 0.323 . . . . 0.0 110.166 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.8 p-90 -144.14 177.21 8.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.011 0.434 . . . . 0.0 111.181 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -170.67 162.0 7.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.042 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.33 83.4 2.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 0.0 110.661 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.8 -44.41 0.15 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.472 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.63 117.72 12.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 43.3 m -68.61 -29.81 68.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 23.1 m95 -73.43 -40.69 64.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.463 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 73.2 m -59.52 -25.5 64.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -84.94 -19.93 31.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' A' ' 42' ' ' SER . 13.6 mptt -85.7 -23.83 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 111.235 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 43' ' ' TRP . 4.0 mm-40 -78.27 -20.44 51.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.384 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.675 HG21 ' HB3' ' A' ' 84' ' ' ASP . 6.4 m -52.45 -50.89 77.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 82.4 Cg_exo -49.9 -48.13 20.68 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.164 1.909 . . . . 0.0 112.643 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -67.54 -39.65 85.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -63.22 -41.29 99.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.89 -42.24 99.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.88 -41.95 98.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.993 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.3 m -60.65 -46.49 90.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.797 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.618 ' HB2' HD12 ' A' ' 65' ' ' ILE . 84.0 t80 -56.1 -57.78 10.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 93.2 m-20 -60.8 -32.54 71.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.057 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.29 41.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 90.2 m-85 -112.06 -2.17 15.12 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.759 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.5 ptmm? -62.91 155.68 26.52 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.269 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 14.3 m-20 66.9 10.04 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.476 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.3 mttp -123.25 25.04 8.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.879 0.371 . . . . 0.0 110.958 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.87 27.7 33.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.153 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.46 140.93 46.59 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 160.34 42.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 55' ' ' TYR . 64.0 mt -112.86 126.97 70.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -110.95 95.14 5.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.79 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.26 109.5 2.94 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.884 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.619 HG13 HD21 ' A' ' 93' ' ' LEU . 75.2 t -98.03 112.13 29.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -113.29 145.6 40.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.947 -178.537 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' HD12 ' A' ' 93' ' ' LEU . 3.8 t -126.46 45.92 2.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.616 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.52 171.42 12.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.639 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.536 HH22 HG11 ' A' ' 98' ' ' VAL . 22.0 mmt180 -115.52 2.93 13.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.692 0.758 . . . . 0.0 109.208 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 76' ' ' ASP . 85.6 mtt180 -124.05 124.26 42.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.035 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.0 tt0 -75.81 -33.91 60.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -60.46 -51.28 70.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.737 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 73' ' ' ARG . 0.3 OUTLIER -64.57 -37.42 87.5 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.82 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.11 -52.36 65.21 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 110.73 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.5 mptm? -57.14 -44.94 83.84 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.306 0.574 . . . . 0.0 110.668 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -68.49 -33.81 74.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.082 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.97 82.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.34 -37.68 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.663 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -65.91 -38.1 87.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.647 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 52.1 mt-10 -57.82 -60.06 4.28 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.461 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.675 ' HB3' HG21 ' A' ' 48' ' ' THR . 39.1 m-20 -85.11 -12.87 51.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.286 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 60.05 37.94 20.88 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 110.972 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.0 p -77.0 114.32 15.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.237 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -112.57 84.98 2.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.583 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 11.1 p90 -158.6 -170.03 2.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.46 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.22 90.05 2.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 110.913 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -109.84 133.13 53.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.675 0.274 . . . . 0.0 110.48 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.28 155.19 41.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.717 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.98 123.52 47.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.619 HD21 HG13 ' A' ' 68' ' ' VAL . 82.1 mt -62.74 140.51 58.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.0 111.166 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 98' ' ' VAL . 44.8 mt-30 -73.41 166.62 22.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.912 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 20.2 mtpt -51.02 -58.43 6.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.508 0.67 . . . . 0.0 111.534 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.27 -26.87 38.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.45 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.429 ' OD2' HD22 ' A' ' 93' ' ' LEU . 28.0 t70 -64.25 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.022 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.2 t -49.8 -42.94 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.15 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -58.56 -56.73 18.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.45 -44.66 62.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.469 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.68 -59.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 123.066 0.229 . . . . 0.0 111.378 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 37.2 mt -59.53 -42.85 93.22 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.45 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.77 -62.17 2.07 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.224 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 59.3 p -53.72 -40.21 65.9 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.111 0.882 . . . . 0.0 113.167 -167.182 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' HB2' HG12 ' A' ' 107' ' ' ILE . 75.4 m-85 -75.62 12.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 42.8 m 64.45 39.29 7.04 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.478 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.8 mm -92.82 86.83 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.008 -173.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.48 -7.06 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.287 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.05 163.06 35.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.553 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.1 156.27 54.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 93.4 Cg_endo -80.12 175.73 43.41 Favored 'Cis proline' 0 C--N 1.346 0.444 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.719 -0.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -159.94 125.92 4.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.959 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.1 135.05 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.16 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.611 HG22 ' HG3' ' A' ' 125' ' ' LYS . 34.7 pt -132.34 146.11 33.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 53.6 tp -107.74 112.6 25.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.982 0.42 . . . . 0.0 110.024 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.402 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 96.2 t -100.5 135.04 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.772 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.1 OUTLIER -80.42 167.09 35.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 4.1 Cg_endo -47.41 -36.33 23.26 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.61 2.873 . . . . 0.0 114.327 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.67 -29.66 61.31 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.839 0.352 . . . . 0.0 111.236 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.402 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 112.49 31.05 2.68 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.671 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -112.67 140.29 47.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.18 107.49 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.39 -24.86 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 111.035 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -140.6 133.81 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.911 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 25.6 ttpp -134.5 137.04 43.56 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.256 -174.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.911 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 49.3 mt-10 68.75 51.6 0.59 Allowed 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.158 0.911 . . . . 0.0 111.666 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.41 157.23 23.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.516 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 11.1 tpt85 -134.18 150.54 51.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.411 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 49.38 -141.02 12.77 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.656 0.598 . . . . 0.0 113.927 168.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.65 -10.92 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.341 0.591 . . . . 0.0 110.138 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.3 m-20 -58.86 -33.17 70.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.126 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -65.89 -36.58 83.8 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.407 ' N ' HD12 ' A' ' 132' ' ' LEU . 49.2 t80 -65.42 -50.3 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.017 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -60.71 -34.37 74.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.32 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.0 m -65.65 -51.03 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 132' ' ' LEU . 86.2 t -63.15 -36.1 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 5.2 tp10 -57.98 -44.12 86.91 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.893 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -76.38 -16.39 59.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.059 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.65 -58.1 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.221 -0.299 . . . . 0.0 111.73 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.876 0.369 . . . . 0.0 111.655 -173.267 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.3 p -136.65 125.21 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.931 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.74 59.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.927 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 p -75.33 132.68 41.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.2 p -72.3 137.1 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.477 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -107.48 145.56 31.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.2 Cg_exo -61.7 154.08 62.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.071 2.514 . . . . 0.0 112.464 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.27 139.14 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.185 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' SER . 53.5 mt -95.03 137.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -120.55 107.87 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 0.0 110.543 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.01 154.11 23.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.719 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.16 122.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -178.82 3.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 95.3 mt -59.56 -31.03 69.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.818 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -78.93 -35.66 42.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.5 3.05 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.08 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.88 145.9 30.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 p -77.32 104.53 7.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.236 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.91 143.29 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.999 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 10.2 m -123.04 162.39 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.637 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 32.3 tp -63.76 -7.42 7.7 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.539 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.8 -29.6 70.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.457 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.64 -27.76 63.3 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.844 0.83 . . . . 0.0 110.847 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.637 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 88.0 m-85 -87.88 4.03 46.21 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -171.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -84.3 87.45 7.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.798 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.79 -9.7 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.34 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -117.05 163.38 16.34 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -84.95 120.66 26.75 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 6.8 t -106.35 124.33 61.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.094 0.473 . . . . 0.0 112.091 -169.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 113' ' ' ILE . 2.7 tm? -104.19 98.02 7.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.6 t -92.5 124.26 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 21.0 t0 -120.19 144.83 47.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.255 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 110' ' ' PHE . 96.9 m-85 -117.04 119.64 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.127 174.051 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.715 ' HZ2' HD11 ' A' ' 81' ' ' ILE . 54.1 p-90 -148.07 175.09 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.453 0.644 . . . . 0.0 112.027 -176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CD1' ' HE2' ' A' ' 110' ' ' PHE . 1.5 p90 -162.37 166.12 25.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.157 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.7 65.89 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -171.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.57 -38.13 90.16 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.432 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.6 p -85.95 101.83 13.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.373 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.5 m -71.47 5.07 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -174.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -85.8 -30.27 23.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.31 -0.243 . . . . 0.0 111.294 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 45' ' ' ARG . 21.1 p -68.56 -28.61 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.759 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.608 ' HD2' ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -77.62 -14.58 59.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.402 0.62 . . . . 0.0 109.408 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 42' ' ' SER . 2.1 mptm? -79.54 -24.32 42.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 42.5 mt-10 -100.16 -0.24 39.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.22 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.526 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 85.5 m -50.43 -52.65 53.11 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.92 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.8 Cg_endo -54.43 -40.99 80.77 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.545 2.163 . . . . 0.0 113.156 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.448 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.9 m-85 -67.61 -44.6 77.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.983 0.421 . . . . 0.0 110.351 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.78 -40.82 97.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.605 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.25 -46.52 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.94 -46.91 87.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.205 0.526 . . . . 0.0 110.312 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 32.0 m -62.1 -49.7 74.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.73 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.6 t80 -62.34 -40.73 97.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.64 0.257 . . . . 0.0 110.967 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.16 -34.15 75.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.287 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.74 -26.91 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 51.1 m-85 -102.8 -8.55 20.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -56.49 -35.01 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.31 0.95 56.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 88.1 mttt -105.54 19.71 20.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.036 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.39 37.47 70.06 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.4 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 39.7 t80 -130.67 143.53 50.81 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -145.76 136.2 24.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.0 mt -88.26 117.68 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -100.31 93.43 5.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.176 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -87.6 112.2 3.81 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 34.1 t -104.86 119.03 53.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.025 0.441 . . . . 0.0 110.712 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.8 t -124.22 156.17 37.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 4.3 t -137.96 51.3 1.89 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.822 0.82 . . . . 0.0 109.027 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.576 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -66.67 -176.89 0.52 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.906 -174.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 3.6 ptm180 -77.23 -26.68 52.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.17 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 10.6 ttt180 -149.27 128.4 12.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.962 -166.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.7 tt0 -61.06 -42.25 98.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 pt-20 -64.57 -41.6 96.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 80.7 m-20 -66.28 -34.15 77.36 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.621 ' O ' HG12 ' A' ' 81' ' ' ILE . 31.2 t90 -61.48 -60.65 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HD2' ' CE3' ' A' ' 77' ' ' TRP . 2.6 mptm? -52.23 -43.02 64.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 0.0 110.903 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 29.5 ttmt -59.39 -49.67 76.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.857 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.77 88.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.626 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.715 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 44.2 mm -56.19 -45.7 81.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.738 0.304 . . . . 0.0 110.961 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 10.7 tp10 -58.87 -59.26 5.73 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 4.8 mm-40 -69.62 -33.56 72.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 45' ' ' ARG . 35.2 t70 -71.51 -12.25 61.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 110.352 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.722 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 44.0 mmtt 64.54 32.55 11.55 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.093 175.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.449 ' HB3' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -96.42 79.51 3.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.713 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -91.46 89.94 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -175.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -156.63 176.68 12.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -64.96 97.58 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.74 0.65 . . . . 0.0 111.711 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.55 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 51.4 mt-30 -123.56 149.64 45.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.41 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.21 150.42 31.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.24 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.43 118.7 35.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.316 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 53.9 mt -62.94 137.19 58.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.368 0.604 . . . . 0.0 111.962 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.1 mt-30 -73.5 145.79 45.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.193 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -70.64 -16.1 62.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.681 0.753 . . . . 0.0 111.123 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 99' ' ' LYS . 3.2 p-10 -78.7 -46.81 18.21 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.399 171.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.23 -34.69 75.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.137 0.575 . . . . 0.0 111.517 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 94' ' ' GLN . 48.7 t -43.59 -43.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.727 . . . . 0.0 112.703 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 96' ' ' ASP . 60.6 mttp -54.97 -63.15 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.557 -169.875 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.0 -48.63 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.8 t -52.38 -47.93 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.504 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.526 HD22 HG13 ' A' ' 107' ' ' ILE . 25.7 mt -62.63 -59.36 5.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.58 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.62 -61.52 2.23 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.209 0.318 . . . . 0.0 110.793 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 70.9 m -56.29 -37.05 69.34 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 124.211 0.945 . . . . 0.0 112.606 -172.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.2 m-85 -77.17 13.65 1.08 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 120.956 0.408 . . . . 0.0 110.8 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 49.2 t 63.9 60.74 1.01 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.202 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.526 HG13 HD22 ' A' ' 102' ' ' LEU . 9.4 mm -85.44 93.59 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.074 0.94 . . . . 0.0 111.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.13 -31.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.78 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.64 151.66 22.89 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.349 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.65 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.5 p90 -147.2 160.04 40.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 118.948 -0.548 . . . . 0.0 109.78 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.65 ' C ' ' HA ' ' A' ' 110' ' ' PHE . 3.8 Cg_endo -43.54 145.96 1.79 Allowed 'Cis proline' 0 C--N 1.364 1.347 0 CA-C-N 120.325 1.152 . . . . 0.0 114.944 2.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 65.9 t60 -140.91 95.21 2.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.083 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 33' ' ' LEU . 96.6 mt -101.61 114.5 41.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -172.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 105' ' ' TYR . 48.2 pt -127.15 166.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.742 0.306 . . . . 0.0 110.983 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.0 118.14 32.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 78.6 t -110.85 138.55 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.045 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -92.52 170.07 9.67 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 1.5 Cg_endo -48.56 -36.84 32.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.35 2.7 . . . . 0.0 114.107 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.07 -22.07 62.16 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.955 -0.466 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 23.53 11.29 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.208 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 78.8 mttt -99.04 141.74 31.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.828 0.346 . . . . 0.0 110.096 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' THR . 33.2 mt -81.82 98.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.16 -21.89 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.173 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.48 142.19 21.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 4' ' ' ALA . 10.8 ptmm? -129.71 138.54 51.19 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.315 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 67.78 46.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.17 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 86.7 mt -70.35 151.16 45.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 171.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.694 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 8.4 mmm180 -124.9 146.04 49.53 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.101 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 44.31 -125.51 5.94 Favored Glycine 0 C--O 1.224 -0.479 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.305 169.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.33 -20.92 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 111.037 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.694 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -51.03 -42.98 60.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 177.223 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -59.62 -34.35 72.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 54' ' ' THR . 40.8 t80 -68.92 -53.45 20.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -61.15 -42.97 99.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.517 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.448 ' O ' ' HD1' ' A' ' 139' ' ' PHE . 24.3 m -66.75 -43.38 84.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.454 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 63' ' ' PHE . 77.9 t -67.54 -40.98 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.88 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.44 -34.27 76.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.488 0.661 . . . . 0.0 109.437 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.846 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 135' ' ' THR . 60.7 m-85 -80.68 -61.73 1.88 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.981 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.203 -169.115 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.689 0.28 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -70.61 119.13 14.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.508 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.89 -18.41 5.93 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.4 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 p -78.14 154.37 31.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.619 0.247 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.41 139.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.145 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.53 137.66 28.73 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.578 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 53.7 Cg_exo -53.7 146.48 44.33 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.796 2.331 . . . . 0.0 112.014 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.13 119.55 14.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.108 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 24' ' ' LEU . 45.1 mm -93.24 129.35 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.671 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -134.61 108.1 7.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.29 170.71 14.73 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.356 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 15.7 mt -100.24 115.91 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 27.6 p30 -75.04 -174.46 2.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.475 0.655 . . . . 0.0 112.63 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 96.4 mt -60.22 -29.82 68.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.055 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 -38.0 30.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 110.297 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.93 21.79 2.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.318 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.483 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 2.1 m-20 -97.58 141.83 30.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -84.58 101.44 12.11 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.46 150.11 19.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 24.5 m -110.59 164.52 12.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.807 0.337 . . . . 0.0 111.238 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 12' ' ' ILE . 3.5 pp -63.85 -27.12 68.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.29 0.567 . . . . 0.0 110.129 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.79 -32.84 72.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.392 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.28 -4.05 51.74 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.395 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -118.77 8.69 11.88 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 118' ' ' PRO . 36.1 mtmt -72.18 159.69 33.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.501 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.95 -28.31 7.05 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -108.56 169.79 8.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.58 ' HE2' HG11 ' A' ' 123' ' ' VAL . 4.1 m-85 -76.04 115.63 15.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 166.237 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 116' ' ' VAL . 3.0 m -96.08 115.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.795 0.807 . . . . 0.0 111.741 -171.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tm? -84.66 109.11 17.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.527 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -99.19 107.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.32 129.47 47.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.057 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.73 115.76 31.22 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.795 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 28.4 p-90 -147.9 172.67 13.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 111.523 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.459 ' HB2' ' CG ' ' A' ' 71' ' ' ASP . 20.4 p90 -167.27 155.99 9.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.089 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.59 -24.7 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.524 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.46 -32.64 73.49 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.123 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 33.7 m -93.31 117.98 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.256 0.551 . . . . 0.0 110.676 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.524 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 11.1 m -65.19 -16.49 63.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -82.91 -32.06 27.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.795 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 78.7 m -58.71 -32.05 68.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.086 0.47 . . . . 0.0 110.632 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -73.52 -14.41 61.21 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.608 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -86.64 -44.69 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.065 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mp0 -68.31 -22.32 64.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.588 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.601 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 99.8 m -57.43 -53.18 68.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 83.0 Cg_exo -49.97 -41.57 47.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.455 2.103 . . . . 0.0 112.945 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.6 m-85 -65.65 -43.15 90.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.304 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.85 -38.43 85.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.416 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.406 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 5.5 tt -61.63 -44.75 96.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.829 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.7 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 38.1 ttpt -63.74 -42.73 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.005 0.431 . . . . 0.0 110.341 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 m -58.68 -46.72 86.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.1 t80 -64.47 -46.56 82.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.544 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.7 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -68.41 -32.74 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.981 -173.13 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.83 -27.93 21.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 137' ' ' GLU . 51.3 m-85 -105.69 -5.49 19.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 13.6 pttm -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.067 0.46 . . . . 0.0 110.991 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.48 -3.24 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.299 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 75.8 mttt -97.93 3.23 49.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.094 0.473 . . . . 0.0 110.299 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.86 43.39 5.43 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.504 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 41.7 t80 -145.64 127.11 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -130.57 155.88 45.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.0 mt -105.09 120.61 55.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.229 0.537 . . . . 0.0 110.93 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 88.1 t80 -104.2 97.27 7.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.743 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.608 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -91.81 136.65 13.38 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.218 -175.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 5.1 m -121.35 114.9 44.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.662 0.744 . . . . 0.0 110.023 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -90.85 151.48 21.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.275 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.879 ' HA ' ' NZ ' ' A' ' 95' ' ' LYS . 6.5 t -136.09 38.67 2.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.468 0.652 . . . . 0.0 111.983 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 18.2 m-20 -76.34 167.54 21.66 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.991 167.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.695 ' HD2' ' HG3' ' A' ' 95' ' ' LYS . 13.6 mmm180 -96.43 -11.59 25.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 73' ' ' ARG . 40.8 mtp180 -111.21 108.32 17.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.866 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.5 tt0 -69.64 -31.16 69.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.984 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -69.82 -36.22 75.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.26 -28.2 56.99 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.679 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -62.18 -52.76 62.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.217 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.9 mptm? -56.22 -42.48 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.279 0.562 . . . . 0.0 110.081 175.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 25.1 tttm -59.42 -50.22 74.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.231 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.511 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -56.56 -41.45 76.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 111.623 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.456 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 43.5 mm -63.47 -37.95 80.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.801 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -73.52 -33.44 64.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.692 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.2 mt-10 -65.26 -59.53 3.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 48' ' ' THR . 2.5 m-20 -77.51 -9.72 59.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.815 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 38.9 mmtm 59.94 35.04 21.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.47 0.652 . . . . 0.0 111.063 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 p -87.65 76.93 8.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.429 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 76.2 m-85 -88.48 91.66 8.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.716 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.406 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 26.7 p90 -151.52 -177.45 6.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.816 169.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.51 88.82 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.805 0.812 . . . . 0.0 111.694 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.608 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt-30 -111.09 144.75 39.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.186 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 29.6 m -132.91 145.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.439 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.65 109.54 19.74 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 12' ' ' ILE . 9.0 mt -62.15 147.43 47.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.47 141.73 53.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.879 ' NZ ' ' HA ' ' A' ' 70' ' ' THR . 5.3 mmmt -75.4 -28.68 59.53 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.536 -161.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 2.0 m-20 -89.95 -4.98 57.18 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.416 ' OD2' HD22 ' A' ' 93' ' ' LEU . 1.6 t70 -88.16 -48.17 7.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.562 172.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -45.13 -40.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.893 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 96' ' ' ASP . 39.6 mtpt -47.52 -59.52 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.977 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.49 -45.77 71.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.59 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.08 -41.8 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.177 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 98' ' ' VAL . 94.6 mt -58.53 -53.84 53.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.419 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.72 -52.47 56.11 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.557 0.536 . . . . 0.0 109.712 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 m -53.28 -30.87 41.0 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.578 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 29.9 m-85 -80.44 8.32 7.91 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.867 -0.521 . . . . 0.0 110.892 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.401 ' O ' HD13 ' A' ' 107' ' ' ILE . 21.9 t 66.2 46.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.716 0.806 . . . . 0.0 109.106 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 20.0 mm -116.44 129.38 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.63 14.0 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.208 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.1 166.87 38.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 119.434 -1.365 . . . . 0.0 114.246 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -130.9 157.54 77.66 Favored Pre-proline 0 N--CA 1.463 0.212 0 C-N-CA 123.032 0.533 . . . . 0.0 110.581 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.22 169.96 71.35 Favored 'Cis proline' 0 C--N 1.352 0.744 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.113 -1.338 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.437 ' CE1' HG23 ' A' ' 114' ' ' ILE . 39.8 t-80 -147.01 134.51 20.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.675 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.561 HG21 HD22 ' A' ' 132' ' ' LEU . 4.9 mp -129.63 145.08 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.449 177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.581 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 27.7 pt -133.42 163.28 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 172.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.463 HD22 ' HD2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -123.35 118.13 26.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 32' ' ' VAL . 76.6 t -108.84 138.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.99 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 46.7 m-20 -62.62 160.73 32.81 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.0 Cg_exo -59.91 -15.34 32.25 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.555 2.17 . . . . 0.0 111.726 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -83.18 -29.66 28.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.843 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.56 32.79 3.29 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.595 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.564 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 10.1 mtmp? -111.92 150.87 29.88 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.684 -0.303 . . . . 0.0 110.473 176.648 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.38 96.36 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.58 HG11 ' HE2' ' A' ' 31' ' ' TYR . 14.1 p -83.45 -29.21 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.128 0.49 . . . . 0.0 110.572 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.96 149.21 27.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.993 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.574 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 13.0 ptmm? -151.23 163.36 39.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 23.7 mm-40 76.36 4.44 3.63 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.233 0.958 . . . . 0.0 112.026 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.44 ' O ' ' HD3' ' A' ' 128' ' ' ARG . 43.5 mt -59.7 136.11 57.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 127' ' ' LEU . 23.5 mmt-85 -133.78 173.19 11.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.932 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 45.09 -135.4 7.18 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 124.1 0.875 . . . . 0.0 114.127 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.34 -13.95 59.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.676 0.274 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.7 -27.4 67.86 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.561 HD22 HG21 ' A' ' 113' ' ' ILE . 79.7 mt -47.66 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 172.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -49.91 75.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.623 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 85.1 m-20 -65.49 -26.49 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.506 -174.324 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 16.9 m -77.29 -33.3 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 132' ' ' LEU . 24.4 t -63.33 -42.97 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.807 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 58' ' ' PHE . 58.3 mm-40 -67.22 -41.06 86.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.034 0.445 . . . . 0.0 110.554 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 22.0 ttpt -56.45 -56.48 20.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.143 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.29 -61.08 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.313 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -169.761 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' OG ' ' A' ' 7' ' ' SER . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -74.93 109.26 8.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.88 -6.2 20.06 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.97 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 4' ' ' ALA . 50.0 m -76.86 138.7 39.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.706 0.288 . . . . 0.0 110.536 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.0 p -73.96 138.82 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 105' ' ' TYR . . . -92.55 150.83 40.51 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.353 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.53 163.18 11.07 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.328 2.685 . . . . 0.0 112.267 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.66 102.46 13.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.853 0.359 . . . . 0.0 111.718 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 105' ' ' TYR . 50.6 mm -69.78 138.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.572 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.7 t -142.97 137.56 29.46 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.4 172.67 36.08 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.584 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -85.89 118.05 31.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.34 -176.99 3.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.177 0.513 . . . . 0.0 111.198 -173.219 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.93 -29.45 63.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.683 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 29.9 mttp -85.99 -43.85 12.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.65 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.29 15.36 1.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.409 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -96.51 154.19 17.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -83.96 93.57 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 0.0 110.333 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.17 138.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.753 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -116.68 163.41 16.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.224 0.535 . . . . 0.0 111.407 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . 62.1 tp -63.47 -23.93 67.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.886 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.4 t30 -64.19 -28.39 69.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.11 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -77.06 -4.58 45.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.1 2.51 16.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.34 0.59 . . . . 0.0 109.42 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 41.2 mtpt -71.49 111.71 7.02 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.738 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.91 -22.41 2.47 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -115.05 170.51 8.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.619 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.09 117.23 21.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 20.8 t -99.0 116.93 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -90.86 104.1 16.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 47.9 t -98.67 108.85 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.937 0.399 . . . . 0.0 110.92 -174.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.5 115.83 29.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.29 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.2 115.66 26.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 3.1 p-90 -155.7 -177.29 6.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.362 0.601 . . . . 0.0 111.452 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 41' ' ' CYS . 17.9 p90 -157.19 152.78 26.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.853 171.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 77' ' ' TRP . . . -58.19 -45.12 88.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 111.838 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . 0.854 ' HA3' HH12 ' A' ' 72' ' ' ARG . . . -82.76 45.79 3.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.401 -177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.693 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 46.0 t -132.43 136.19 46.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 p -88.43 -15.09 36.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 39.9 m95 -85.92 -52.53 5.67 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.781 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 12.8 p -63.36 -24.66 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.26 0.552 . . . . 0.0 110.634 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.437 ' NH2' ' HB2' ' A' ' 83' ' ' GLU . 4.8 tpt180 -72.02 -14.39 61.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.888 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.75 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.2 mptm? -79.99 -40.08 28.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.882 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.459 ' OE1' ' HG3' ' A' ' 111' ' ' PRO . 25.7 mp0 -80.33 -9.58 59.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.655 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 38.3 m -50.74 -50.22 74.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 51.9 Cg_exo -55.4 -42.52 67.39 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.052 1.835 . . . . 0.0 112.617 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.08 -36.79 80.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 47' ' ' GLU . 96.0 mt -64.27 -41.69 96.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.513 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.84 -44.56 96.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.165 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -55.96 -48.88 74.97 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.393 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 33.9 m -62.55 -52.06 64.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.253 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.6 t80 -58.59 -43.4 89.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.68 0.276 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -61.79 -39.71 92.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.891 0.377 . . . . 0.0 111.293 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.63 -20.42 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 77.0 m-85 -121.94 9.12 9.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 17.5 pttm -64.23 -41.14 97.14 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.606 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -24.79 41.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.113 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 92.6 mttt -76.76 -172.11 2.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.169 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 49.64 3.27 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 83.5 t80 -143.62 146.49 33.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.8 m -156.86 136.96 12.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 55' ' ' TYR . 43.5 mt -89.32 133.46 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.909 0.385 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.76 101.97 9.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.177 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.13 115.61 4.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.444 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.501 HG13 ' CD1' ' A' ' 93' ' ' LEU . 44.2 t -98.39 111.34 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 38.5 t -118.72 139.5 51.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.355 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -134.77 35.58 3.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.428 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.593 ' OD1' ' HD2' ' A' ' 72' ' ' ARG . 4.2 t70 -65.8 165.63 12.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.777 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.854 HH12 ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.58 -25.24 61.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.836 -175.152 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 7.2 tpt180 -141.2 131.14 24.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.585 -173.422 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 22.2 tt0 -69.83 -32.83 71.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 0.0 110.002 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.505 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 3.5 mp0 -57.66 -42.46 83.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.814 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 31.5 t70 -73.07 -39.86 65.51 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 27.6 t90 -52.64 -52.12 57.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.654 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.552 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -62.46 -44.08 97.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.792 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 18.3 tttm -57.4 -45.73 84.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.85 -45.52 82.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.572 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.0 -34.86 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.885 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.53 -30.01 70.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.0 110.208 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . 67.7 mt-10 -75.89 -60.5 2.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.066 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -83.77 -18.91 36.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.81 -169.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 72.88 28.12 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.592 0.557 . . . . 0.0 110.622 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -67.01 81.06 0.12 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.936 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -96.39 88.99 4.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.15 178.29 10.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.022 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.66 102.72 2.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -173.038 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 77' ' ' TRP . 44.6 mt-30 -119.85 155.06 33.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.321 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.66 143.74 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.501 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.43 112.31 24.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' CD1' HG13 ' A' ' 68' ' ' VAL . 8.0 mp -71.83 157.35 38.05 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.307 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -89.88 178.93 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.527 0.68 . . . . 0.0 111.08 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.517 ' H ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.38 -15.03 59.58 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.322 -178.132 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.491 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -83.98 -55.5 4.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.622 -175.975 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.6 p30 -79.75 -30.7 40.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.556 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -49.05 -32.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mmtt -53.76 -63.5 1.13 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.711 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -55.67 -55.74 28.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.442 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.485 HG21 HD23 ' A' ' 93' ' ' LEU . 61.5 t -46.43 -55.85 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.915 0.76 . . . . 0.0 112.129 -176.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.834 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 25.8 mt -62.07 -34.84 77.03 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.643 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.21 -63.04 1.46 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.098 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 106' ' ' CYS . 60.8 p -53.4 -45.28 69.25 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 124.798 1.311 . . . . 0.0 113.27 -164.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.631 ' CE1' HD11 ' A' ' 12' ' ' ILE . 85.0 m-85 -75.75 13.15 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.089 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.428 ' H ' ' C ' ' A' ' 104' ' ' SER . 34.7 m 62.66 57.71 1.74 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.139 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.834 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 2.1 mp -85.43 110.88 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.825 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.16 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.956 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.53 178.48 34.73 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.914 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.6 151.96 79.59 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 43' ' ' TRP . 86.1 Cg_endo -77.34 151.52 92.97 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.32 0.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.59 113.61 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 HH21 ' A' ' 128' ' ' ARG . 86.8 mt -117.74 139.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.4 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.576 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 44.0 pt -134.9 145.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.92 0.39 . . . . 0.0 111.148 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.38 110.08 22.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 88.7 t -102.42 136.94 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.059 -175.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.77 169.85 19.06 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.843 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -55.18 -29.14 64.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.802 2.334 . . . . 0.0 113.988 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.63 -4.25 55.65 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.33 30.15 22.97 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.609 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 30.0 mttm -108.96 145.58 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.837 0.351 . . . . 0.0 110.522 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.8 mt -80.17 105.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.16 -48.49 21.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.492 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.01 169.42 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.184 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.6 pttp -159.7 172.59 17.45 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.05 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 2.0 mm-40 64.94 23.31 12.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.652 1.181 . . . . 0.0 111.318 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HB2' HD23 ' A' ' 132' ' ' LEU . 83.9 mt -61.21 148.33 41.27 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.822 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.526 HH21 HD12 ' A' ' 113' ' ' ILE . 2.9 mmp_? -125.22 151.48 45.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -171.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 40.05 -126.19 2.54 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 124.175 0.922 . . . . 0.0 114.785 170.049 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.46 -10.04 59.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.674 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.873 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 24.8 t70 -66.39 -33.46 75.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.5 mt -48.92 -52.95 21.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 170.041 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.44 -59.06 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.555 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.6 p30 -66.94 -31.75 72.54 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.314 -172.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 19.1 m -70.66 -37.35 73.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.36 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.3 t -61.16 -49.33 85.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.338 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.44 -50.39 72.98 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 15.7 ttpt -48.53 -37.44 17.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.517 0.727 . . . . 0.0 111.734 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -87.96 -48.5 7.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -169.952 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.983 HG23 ' HA ' ' A' ' 123' ' ' VAL . 24.9 m -56.72 130.23 44.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.159 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.97 -8.01 36.01 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.066 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -78.47 138.2 38.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.56 126.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.54 76.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.549 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 162.15 25.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.051 2.501 . . . . 0.0 111.839 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.97 100.47 11.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.783 0.325 . . . . 0.0 111.712 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 101' ' ' VAL . 56.4 mt -72.19 132.47 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.176 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -128.53 97.87 4.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 175.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.89 165.17 12.07 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.543 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 66.2 mt -98.93 122.93 51.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.613 0.244 . . . . 0.0 110.46 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 31.5 p30 -74.19 -173.84 1.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.971 0.415 . . . . 0.0 111.547 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.84 -16.92 63.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.072 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 1.1 mtpt -87.98 -35.59 17.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.98 21.31 3.52 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.47 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 2.2 m-20 -98.45 142.59 29.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -81.78 102.25 10.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.806 0.336 . . . . 0.0 110.232 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.89 142.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.074 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -103.94 -177.96 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.975 0.416 . . . . 0.0 110.545 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -80.39 -21.56 42.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.587 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 50.5 m-80 -68.31 -24.79 64.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.46 -25.61 68.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.11 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -112.4 13.34 20.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.086 0.469 . . . . 0.0 110.317 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 25' ' ' ASN . 22.6 tttm -68.99 171.35 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.445 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.98 64.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.4 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -141.16 176.17 9.05 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB3' HD11 ' A' ' 115' ' ' LEU . 54.1 m-85 -78.77 109.68 13.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 47.2 t -96.78 123.32 49.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 19.5 tp -90.54 116.95 28.84 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 114' ' ' ILE . 16.7 t -105.05 102.99 14.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.455 ' OD1' HG23 ' A' ' 65' ' ' ILE . 6.5 m-20 -98.4 110.15 22.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.762 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 110' ' ' PHE . 53.2 m-85 -92.74 116.8 29.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.783 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 12.9 p-90 -154.65 -179.18 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 45.0 p90 -170.01 157.1 6.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.528 168.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.99 -16.99 62.86 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.12 -21.32 69.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.582 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 m -92.2 131.32 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 0.0 110.274 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -88.39 -28.26 21.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.694 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -67.75 -34.57 77.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.135 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 80.0 m -51.95 -38.63 57.22 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.67 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -64.44 -28.33 69.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.774 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -84.96 -11.34 55.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.181 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -98.04 -21.78 16.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.418 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 84' ' ' ASP . 51.4 m -49.93 -48.23 78.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.2 Cg_endo -48.61 -45.88 25.97 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.205 1.937 . . . . 0.0 112.36 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.94 -37.63 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.238 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 ' OD2' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -55.93 -48.55 75.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 175.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.417 ' HA ' ' HZ3' ' A' ' 88' ' ' TRP . 63.0 tp -63.63 -42.67 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.965 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 47.4 tttm -60.0 -43.72 95.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 27.1 m -53.11 -46.1 68.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.205 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.4 t80 -56.83 -61.99 2.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.67 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.9 p-10 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.22 -20.06 29.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.521 ' HZ ' ' HA ' ' A' ' 137' ' ' GLU . 75.1 m-85 -115.65 -15.2 11.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptmm? -56.28 -23.13 34.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.005 0.431 . . . . 0.0 111.646 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 3.5 m-20 -106.87 17.25 23.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 89.5 mttt -121.64 14.73 11.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.137 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.99 44.18 9.25 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.515 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 55.3 t80 -139.0 135.23 34.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -135.74 145.65 46.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.96 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -103.72 126.75 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.971 0.415 . . . . 0.0 110.619 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -112.94 96.52 5.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.692 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -75.01 114.54 4.36 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.389 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.998 HG13 HD21 ' A' ' 93' ' ' LEU . 50.0 t -98.69 111.11 27.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 14.7 m -116.7 125.73 52.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 93' ' ' LEU . 10.1 t -113.5 52.13 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.518 1.152 . . . . 0.0 108.604 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 t70 -70.2 178.96 2.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.128 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -104.3 -21.97 13.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.921 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 51.9 mtt-85 -141.63 150.46 42.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.8 tt0 -75.62 -37.19 59.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.1 mp0 -62.01 -41.36 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.578 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -74.44 -35.63 63.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.001 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -60.73 -51.96 67.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.434 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.2 mptm? -59.13 -37.17 76.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 27.1 ttpt -59.22 -50.02 75.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.768 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.89 83.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.182 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.44 -38.82 77.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.378 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.75 -55.36 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.892 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.5 mt-10 -53.07 -49.0 67.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.545 . . . . 0.0 111.639 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 48' ' ' THR . 6.4 m-20 -85.45 -16.43 39.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.453 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HD2' ' OH ' ' A' ' 87' ' ' TYR . 46.9 mmtm 61.74 40.54 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.653 0.739 . . . . 0.0 110.092 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -80.63 86.46 5.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.183 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' OH ' ' HD2' ' A' ' 85' ' ' LYS . 57.4 m-85 -87.66 78.94 8.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.276 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.417 ' HZ3' ' HA ' ' A' ' 52' ' ' LEU . 23.6 p90 -161.42 175.16 12.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 174.431 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.47 110.47 9.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.974 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.692 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 48.6 mt-30 -123.39 145.97 48.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.3 m -132.65 149.97 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' SER . 20.7 tp -94.2 132.2 38.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.998 HD21 HG13 ' A' ' 68' ' ' VAL . 72.3 mt -73.45 149.94 42.01 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 98' ' ' VAL . 49.8 mt-30 -80.72 171.18 15.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.412 175.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.15 -39.65 90.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 13.5 m-20 -87.21 -33.62 19.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.181 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' OD2' HD22 ' A' ' 93' ' ' LEU . 16.1 t70 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.821 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 94' ' ' GLN . 78.8 t -66.86 -65.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 110.124 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 20.5 pttp -62.55 -62.62 1.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -170.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 9.0 m-20 -67.94 -36.63 80.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.738 0.304 . . . . 0.0 111.622 -169.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 12' ' ' ILE . 59.3 t -79.27 -50.26 18.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.943 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 87.9 mt -56.23 -47.81 77.71 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.89 -47.33 80.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.4 m -54.81 -33.04 61.06 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.99 0.806 . . . . 0.0 112.446 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -79.24 7.75 7.15 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.14 -0.35 . . . . 0.0 111.436 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.5 t 66.57 54.13 0.89 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -171.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 73.8 mt -133.3 93.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.6 -1.5 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.861 0.839 . . . . 0.0 109.392 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.77 165.31 28.83 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.176 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 95.4 m-85 -127.19 160.7 58.39 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.654 0.227 . . . . 0.0 110.707 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 5.5 Cg_exo -81.89 172.08 53.64 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.948 -1.271 . . . . 0.0 112.721 -0.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.674 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -155.39 122.53 5.48 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.622 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.1 131.44 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 125' ' ' LYS . 25.9 pt -130.5 158.32 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' TYR . 58.9 tp -124.51 127.59 47.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.142 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 5.5 m -119.1 145.13 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -59.78 163.3 7.54 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.131 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.32 -22.26 64.54 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -70.19 -34.0 72.42 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.784 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.23 32.68 3.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.05 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -117.42 147.86 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 125' ' ' LYS . 34.9 mt -86.19 119.57 34.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.594 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 5' ' ' THR . 13.2 m -101.75 -35.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.014 0.435 . . . . 0.0 110.832 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.8 140.74 40.72 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HD2' HG21 ' A' ' 122' ' ' ILE . 9.4 ptmm? -156.81 153.43 28.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.232 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.674 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 32.4 mt-10 70.0 25.47 4.82 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.205 0.941 . . . . 0.0 110.968 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.9 mt -67.91 159.12 31.17 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.621 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.1 mmp_? -128.9 134.53 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 43.12 -114.58 0.86 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 168.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 134' ' ' ASN . 4.2 m-20 -63.12 -35.43 80.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.867 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 7.7 t70 -63.63 -39.74 95.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.822 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.0 pp -57.2 -44.47 83.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.52 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.402 ' N ' HD12 ' A' ' 132' ' ' LEU . 68.4 t80 -70.64 -46.47 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 11.2 t-20 -50.2 -57.21 8.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.8 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.559 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 19.8 m -72.74 -34.38 67.0 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.998 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 HD22 ' A' ' 115' ' ' LEU . 38.2 t -63.21 -42.32 96.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.325 174.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.521 ' HA ' ' HZ ' ' A' ' 58' ' ' PHE . 3.2 tp10 -61.21 -53.02 62.17 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 9.2 mtmp? -57.5 -27.58 62.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.733 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -83.15 -61.09 1.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.408 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.466 0.331 0 O-C-N 123.441 0.463 . . . . 0.0 111.543 -173.16 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.61 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -146.34 140.12 26.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.663 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.39 4.52 62.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.477 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -81.06 143.45 32.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 121' ' ' LYS . 31.6 t -69.64 133.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.469 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.58 146.63 31.66 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 -175.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.04 162.31 26.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.888 2.392 . . . . 0.0 111.975 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.39 113.58 25.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.832 0.349 . . . . 0.0 111.547 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.95 137.02 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -134.72 104.88 6.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.86 172.18 18.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.139 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 15' ' ' ILE . 3.8 mp -98.01 119.18 45.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -173.56 3.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 -171.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 81' ' ' ILE . 96.6 mt -62.45 -33.49 74.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.669 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -74.99 -30.68 61.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.608 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.54 19.36 7.93 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.523 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -100.35 144.25 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -87.04 92.46 9.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.66 147.46 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.527 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.42 168.0 9.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 -174.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.72 -35.37 74.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.643 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 3.2 p-10 -66.81 -17.55 64.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.78 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -74.25 -24.15 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.126 0.489 . . . . 0.0 110.501 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -105.35 8.51 33.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 110.25 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.8 tttp -62.46 160.3 13.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.074 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.28 10.17 57.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.271 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -141.43 177.6 8.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 115' ' ' LEU . 97.3 m-85 -85.17 107.03 17.04 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 64' ' ' THR . 42.0 t -100.43 109.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 -174.247 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 28.1 tp -86.77 118.18 26.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -104.89 115.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.699 0.285 . . . . 0.0 110.835 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -101.79 111.04 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.262 0.553 . . . . 0.0 111.413 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -93.77 118.07 30.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.422 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -151.16 176.93 10.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -170.3 151.39 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.384 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.11 1.85 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.403 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.65 54.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.689 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.0 t -103.48 116.31 32.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.564 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 9.5 m -67.97 -26.53 65.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -73.22 -36.2 66.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.92 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.0 m -59.99 -35.58 75.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HE ' ' CG ' ' A' ' 84' ' ' ASP . 26.4 mmm-85 -67.39 -22.21 65.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.546 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 42' ' ' SER . 4.9 mptp? -85.88 -11.45 53.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.327 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 43.8 mt-10 -105.65 -6.87 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.611 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.9 m -54.05 -47.09 98.2 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.953 175.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.9 Cg_endo -51.68 -36.81 62.67 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.624 2.216 . . . . 0.0 113.036 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 41.0 m-85 -67.55 -39.62 84.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.031 0.443 . . . . 0.0 110.069 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.59 HD21 HD13 ' A' ' 113' ' ' ILE . 88.5 mt -63.7 -43.12 97.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.692 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -64.15 -43.41 95.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.463 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -54.56 -44.85 73.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.341 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HD1' ' A' ' 58' ' ' PHE . 33.2 m -63.76 -48.7 75.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.66 ' HB2' HD12 ' A' ' 65' ' ' ILE . 53.2 t80 -60.07 -36.04 76.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.843 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -73.34 -33.49 65.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.11 -18.92 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HD1' ' O ' ' A' ' 54' ' ' THR . 84.1 m-85 -111.54 10.98 21.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -75.19 -3.94 35.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 0.0 111.116 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -98.34 -2.33 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.006 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -122.99 174.43 7.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.469 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.05 61.95 2.57 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 74.4 t80 -133.68 130.42 38.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.787 0.327 . . . . 0.0 110.334 -176.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 12.3 p -135.73 137.82 42.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.283 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 55' ' ' TYR . 36.8 mt -97.34 124.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 80.4 t80 -113.25 104.79 12.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.876 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.963 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -86.24 142.12 18.72 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.566 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.7 111.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 15.0 m -115.07 155.17 27.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.008 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -143.96 40.12 1.37 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.935 0.874 . . . . 0.0 108.658 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 4.5 m-20 -71.37 175.78 5.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.399 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -70.21 -45.57 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.409 -172.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 3.5 tpt180 -145.68 150.62 36.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 28.4 tt0 -62.28 -41.81 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 110.459 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.33 -44.21 95.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.254 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.64 -39.78 84.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.152 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -58.48 -54.13 50.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.626 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -57.22 -40.55 77.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 2.7 ttpm? -60.51 -49.44 77.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.363 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.569 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -58.15 -40.54 81.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.136 0.493 . . . . 0.0 111.1 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 86' ' ' SER . 80.3 mt -61.67 -38.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.887 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -71.77 -46.41 58.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 46.5 mt-10 -54.69 -54.33 43.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.143 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.611 ' HB3' HG21 ' A' ' 48' ' ' THR . 5.5 m-20 -85.56 0.18 53.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.068 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 70.0 mmtt 58.4 37.82 25.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.574 0.702 . . . . 0.0 110.706 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 81' ' ' ILE . 36.4 t -82.59 68.15 8.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.708 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -87.1 76.29 9.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.963 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 30.8 p90 -148.67 -174.57 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 169.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.16 90.94 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.504 -171.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.963 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 91.6 mt-30 -108.0 138.76 43.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.912 0.386 . . . . 0.0 111.017 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.09 146.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.95 126.41 37.02 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 98' ' ' VAL . 47.5 mt -67.92 145.7 54.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 0.0 111.383 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.5 mt-30 -67.76 156.0 38.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.433 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -60.92 -44.89 96.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.008 0.433 . . . . 0.0 111.614 -170.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.29 -19.49 31.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.4 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' CB ' ' HB2' ' A' ' 94' ' ' GLN . 37.0 t70 -80.87 -27.8 36.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.976 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' GLN . 58.3 t -47.91 -51.35 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -47.73 80.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.559 -176.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -67.78 -50.2 58.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.03 -173.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.97 -56.05 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.315 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.0 mt -57.49 -46.0 84.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.75 -60.71 2.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 m -51.31 -38.58 53.74 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 124.716 1.26 . . . . 0.0 113.292 -170.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -82.07 17.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.463 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.423 ' HB2' ' HZ1' ' A' ' 125' ' ' LYS . 63.8 m 62.88 42.19 7.97 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 123.378 0.671 . . . . 0.0 110.077 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 63.4 mt -100.16 89.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.058 -176.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.5 -18.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.23 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.68 152.48 24.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.006 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -108.75 156.12 39.47 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 95.2 Cg_endo -78.29 177.01 40.62 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 123.238 -1.568 . . . . 0.0 112.779 0.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.06 117.62 4.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 51' ' ' LEU . 58.6 mt -127.98 138.43 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.471 ' HB ' HG23 ' A' ' 122' ' ' ILE . 49.2 pt -134.3 158.63 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.013 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 136' ' ' VAL . 60.9 tp -118.59 115.46 24.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.27 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.31 129.98 47.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.567 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 8.2 p30 -78.53 166.99 38.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.203 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 6.4 Cg_endo -50.5 -35.88 47.25 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.965 2.443 . . . . 0.0 113.196 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 45.3 mt-10 -63.01 -37.4 87.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.62 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.46 3.89 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HG2' HG22 ' A' ' 8' ' ' VAL . 28.4 mtmm -111.77 151.76 28.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.815 0.341 . . . . 0.0 110.259 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 114' ' ' ILE . 18.0 mt -87.64 92.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.315 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -73.12 -26.98 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 0.0 110.748 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -133.92 119.03 18.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.555 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HG2' ' CD ' ' A' ' 126' ' ' GLU . 60.8 tttm -127.46 157.72 39.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.557 -174.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.564 ' CD ' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER 50.24 48.69 21.81 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.999 0.812 . . . . 0.0 110.989 -176.761 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 132' ' ' LEU . 83.7 mt -72.49 157.37 37.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 13.8 tpt180 -128.7 142.38 51.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.464 -173.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 35.65 -132.45 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.02 -10.85 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.562 . . . . 0.0 110.111 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.1 m-20 -55.1 -33.47 62.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.266 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 4.3 pp -64.7 -41.42 96.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.912 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.442 ' N ' HD12 ' A' ' 132' ' ' LEU . 32.1 t80 -60.79 -52.14 66.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.712 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -60.07 -36.18 76.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.224 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 85.8 m -71.08 -46.55 61.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.146 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 115' ' ' LEU . 96.1 t -67.49 -45.82 84.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.113 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -58.53 -45.72 88.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.409 0.623 . . . . 0.0 109.606 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -56.94 -54.4 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.673 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -65.02 -56.76 11.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.745 -170.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.33 -174.795 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 p -110.17 112.61 24.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.49 -4.36 40.25 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 p -71.96 128.23 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.13 135.66 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -92.36 144.04 28.3 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.686 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 52.6 Cg_exo -55.27 158.44 12.18 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.232 2.622 . . . . 0.0 112.602 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.1 95.33 10.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.184 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.576 HD11 ' CE1' ' A' ' 105' ' ' TYR . 21.5 mm -59.12 131.84 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.462 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -126.96 88.09 2.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 161.58 13.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.976 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.32 125.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.801 0.334 . . . . 0.0 110.372 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -169.5 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.337 0.589 . . . . 0.0 111.681 -173.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.93 -30.09 71.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.931 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.65 -36.24 62.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 0.0 110.28 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.99 16.01 8.17 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.167 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -97.64 140.27 32.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -77.48 97.33 4.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 110.249 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.91 147.48 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.796 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.7 m -108.86 156.77 19.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.152 0.501 . . . . 0.0 111.367 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.59 -27.82 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.525 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -25.42 67.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.6 -9.59 58.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.409 0.623 . . . . 0.0 110.528 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.35 4.56 17.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.195 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -62.15 170.28 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.198 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.13 83.4 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.794 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 35.1 mttp -141.01 156.87 45.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 63' ' ' PHE . 85.7 m-85 -72.63 115.6 12.1 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 57.6 t -103.12 107.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.328 -172.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.439 ' HB3' HG12 ' A' ' 65' ' ' ILE . 38.9 tp -86.24 106.49 17.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.85 125.86 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.013 0.435 . . . . 0.0 110.891 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 12.9 t0 -112.06 96.23 5.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.426 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' HG13 ' A' ' 68' ' ' VAL . 96.0 m-85 -82.07 114.94 20.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 69' ' ' SER . 22.3 p-90 -153.55 175.45 13.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.062 0.934 . . . . 0.0 112.604 -172.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -167.76 162.84 14.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.691 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.95 -19.31 65.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.56 64.65 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.246 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.4 p -95.89 97.99 10.07 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.65 0.738 . . . . 0.0 109.943 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -64.77 -36.18 83.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.981 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -56.27 -41.18 75.44 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -64.93 -28.56 69.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.007 0.432 . . . . 0.0 110.252 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -81.26 -14.14 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.411 0.624 . . . . 0.0 110.083 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -79.69 -21.86 44.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.212 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -90.31 -7.11 54.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.879 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 98.6 m -48.58 -48.45 68.36 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.7 Cg_endo -49.36 -44.79 33.0 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.33 2.02 . . . . 0.0 112.633 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -73.82 -40.05 63.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.829 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.8 mt -57.21 -51.94 67.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.81 -43.04 94.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -62.63 -44.61 95.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.035 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.48 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 59.8 m -59.7 -46.17 89.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 37.5 t80 -65.69 -36.02 82.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.03 -43.64 98.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.091 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.01 -27.12 30.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD2' ' O ' ' A' ' 54' ' ' THR . 92.1 m-85 -114.57 10.83 16.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 20.1 pttp -64.76 -29.33 70.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 111.31 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.22 10.51 29.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.193 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -121.36 -174.16 2.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.37 57.88 4.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.954 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.414 ' HD1' ' HB2' ' A' ' 31' ' ' TYR . 80.3 t80 -144.0 142.53 30.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.784 0.326 . . . . 0.0 110.179 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -151.45 150.29 30.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -102.34 125.11 56.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -105.66 98.08 7.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.844 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 90' ' ' GLN . . . -79.87 137.42 18.65 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 36' ' ' PHE . 1.5 p -138.45 123.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.107 0.48 . . . . 0.0 110.591 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.5 t -128.87 163.87 24.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.222 0.534 . . . . 0.0 111.439 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.792 ' HB ' HD12 ' A' ' 93' ' ' LEU . 4.3 t -147.75 44.16 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.726 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.529 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 2.9 t70 -71.01 -178.93 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.399 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 13.1 ptt180 -67.1 -29.59 69.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.741 -173.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 56.4 mtt-85 -143.4 158.28 43.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.743 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.784 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 32.3 tt0 -75.72 -38.79 58.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.3 mp0 -60.72 -44.82 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.794 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 1.9 m-20 -62.52 -42.39 99.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.573 ' CE3' ' HD2' ' A' ' 78' ' ' LYS . 32.6 t90 -56.94 -52.74 64.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.917 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 3.7 mptp? -54.15 -50.63 66.53 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.29 0.566 . . . . 0.0 110.593 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 25.0 ttpp -60.46 -44.62 95.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.173 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.34 84.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 65.6 mt -60.39 -43.66 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.512 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -68.6 -46.46 69.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.008 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -59.73 -45.01 93.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.173 0.511 . . . . 0.0 111.138 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.29 -15.71 51.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.247 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HD2' ' HE2' ' A' ' 87' ' ' TYR . 66.6 mmtt 65.02 33.32 9.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.835 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.9 m -92.34 85.59 5.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 98.6 m-85 -91.77 84.25 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.42 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -153.02 -173.3 4.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -69.52 96.6 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 32.6 mt-30 -123.18 143.63 49.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.143 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.3 158.3 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 111.301 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.2 tp -103.55 132.33 49.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.429 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 70' ' ' THR . 88.7 mt -61.94 140.51 58.31 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.256 0.348 . . . . 0.0 111.169 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.691 ' O ' HG23 ' A' ' 98' ' ' VAL . 42.9 mt-30 -90.06 169.3 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -49.24 -55.07 13.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.237 0.541 . . . . 0.0 111.744 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -82.19 -36.57 27.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.674 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 13.3 t70 -56.77 -36.92 70.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.629 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.2 t -52.06 -37.31 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.776 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.9 tptt -62.76 -58.8 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.384 -175.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.07 -49.59 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.592 0.234 . . . . 0.0 111.157 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -53.7 -59.69 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.714 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.776 ' HA ' HD12 ' A' ' 107' ' ' ILE . 35.1 mt -65.0 -30.41 71.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.988 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.26 -63.92 1.3 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.582 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.3 m -65.39 -23.44 66.96 Favored 'General case' 0 C--N 1.338 0.077 0 O-C-N 124.213 0.946 . . . . 0.0 113.423 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.576 ' CE1' HD11 ' A' ' 12' ' ' ILE . 54.5 m-85 -81.74 15.38 2.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.302 173.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 46.9 t 55.22 44.46 27.59 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.325 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 102' ' ' LEU . 61.4 mt -86.22 93.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.068 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.6 m -106.28 19.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.261 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.98 168.89 26.72 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.836 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 87.0 m-85 -122.94 159.03 55.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.3 Cg_endo -86.52 171.55 38.7 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.359 -0.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -136.93 104.26 5.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.9 177.317 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.93 114.92 47.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 38.1 pt -124.93 159.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.06 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 4.0 tt -116.99 116.3 27.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 95.7 t -102.66 142.99 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.475 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -77.36 165.56 50.81 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.4 Cg_endo -49.0 -29.84 16.51 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.313 2.675 . . . . 0.0 114.09 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . 0.787 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -91.75 2.06 56.75 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.392 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 86.75 26.34 32.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.436 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.787 ' HZ3' ' HB3' ' A' ' 119' ' ' GLU . 28.4 mttp -107.66 142.36 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.043 0.422 . . . . 0.0 110.465 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.7 mt -76.29 109.73 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.939 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.37 -36.21 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.066 0.46 . . . . 0.0 110.3 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 21.4 pttm -163.08 151.79 14.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.283 -0.167 . . . . 0.0 111.003 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 60.28 48.49 8.01 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.885 0.74 . . . . 0.0 111.09 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.66 156.94 21.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.939 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HD2' ' H ' ' A' ' 129' ' ' GLY . 8.6 tpt180 -101.44 147.71 26.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -38.27 -58.31 1.66 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.37 -38.0 73.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.168 0.509 . . . . 0.0 110.102 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.8 t70 -83.27 -26.85 30.31 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' A' ' 129' ' ' GLY . 75.5 mt -46.26 -57.62 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.1 -47.9 80.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.98 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 94.0 m-20 -53.72 -53.36 53.15 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.236 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.654 ' HA ' ' CE ' ' A' ' 138' ' ' LYS . 4.8 m -62.24 -36.12 81.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' LEU . 50.8 t -69.21 -44.89 80.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.43 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.53 -29.83 69.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.652 0.739 . . . . 0.0 109.962 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.654 ' CE ' ' HA ' ' A' ' 135' ' ' THR . 26.9 ttpt -78.87 -54.2 6.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.966 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PHE . . . . . 0.489 ' CD2' HG23 ' A' ' 135' ' ' THR . 61.1 m-85 -87.07 -48.79 7.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 80.3 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.792 0.33 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -152.81 154.1 34.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.12 -1.27 70.31 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -91.69 146.43 23.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.595 -0.302 . . . . 0.0 110.461 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.42 138.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.397 . . . . 0.0 110.095 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.81 149.95 40.67 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.738 -175.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 35.6 Cg_exo -62.9 163.53 21.86 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.522 2.815 . . . . 0.0 112.088 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.89 105.0 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.083 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.36 148.32 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.603 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 13.7 t -136.61 134.99 37.97 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.18 31.18 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.355 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -88.9 119.46 36.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -175.72 5.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.088 0.47 . . . . 0.0 111.127 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 90' ' ' GLN . 95.4 mt -65.07 -28.93 69.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.945 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.58 -28.99 28.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.44 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 25.22 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.251 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.27 148.17 25.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 p -76.82 94.35 3.86 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.04 130.67 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.4 m -102.58 161.85 13.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.51 -14.86 46.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.615 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 30.2 p-10 -67.28 -20.86 65.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.915 0.388 . . . . 0.0 111.2 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.13 -23.04 47.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.46 5.53 31.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -79.98 63.21 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.702 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.6 13.17 0.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.064 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -144.31 171.38 14.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 120.78 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.317 172.281 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 64' ' ' THR . 46.1 t -112.47 112.79 41.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.494 -171.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 113' ' ' ILE . 10.0 tt -90.58 119.32 30.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 51.5 t -103.77 121.32 55.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.801 0.334 . . . . 0.0 110.915 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 29.9 m-20 -84.98 136.75 33.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.418 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.26 114.55 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -158.18 173.36 16.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.691 0.758 . . . . 0.0 112.342 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -170.05 166.59 9.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.614 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.73 65.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -51.47 24.97 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.148 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.4 p -71.45 101.9 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.454 0.645 . . . . 0.0 110.432 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 18.9 m -69.39 -5.45 23.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.081 -171.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' TRP . . . . . 0.515 ' HD1' ' HG3' ' A' ' 111' ' ' PRO . 72.4 t-105 -85.37 -29.31 24.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.952 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 75.8 m -57.81 -34.5 69.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 110.631 176.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.573 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 8.6 mmt85 -66.79 -18.38 65.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 110.388 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.7 mptt -85.09 -33.18 22.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.937 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.27 -20.27 37.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.418 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.578 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 46.5 m -48.61 -50.5 59.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.4 Cg_exo -49.65 -45.27 32.19 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.266 1.978 . . . . 0.0 112.843 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.93 -31.82 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.935 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.51 -47.95 81.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.275 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.49 -40.94 96.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.174 0.511 . . . . 0.0 109.965 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.67 -46.44 81.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.591 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.3 m -65.12 -49.29 70.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.275 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.608 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.1 t80 -57.63 -42.37 83.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 111.44 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -78.06 -35.47 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.468 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -85.37 -19.88 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 136' ' ' VAL . 44.6 m-85 -106.22 -4.95 19.61 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 16.9 pttp -67.39 167.15 13.11 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 1.9 m-20 73.94 -36.9 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.656 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 82.1 mttt -61.69 -41.12 97.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.374 0.607 . . . . 0.0 110.167 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.36 44.62 0.14 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 56.7 t80 -140.59 144.66 35.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -173.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 44.7 m -150.64 142.23 23.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.6 mt -98.77 134.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 110.139 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -112.89 95.86 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.409 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 35' ' ' ASP . . . -76.96 103.3 1.77 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.397 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 53.7 t -99.05 117.21 43.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.265 0.555 . . . . 0.0 110.614 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 t -128.97 156.61 43.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.116 0.484 . . . . 0.0 110.763 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -136.76 48.76 2.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 10.8 t70 -65.29 -176.12 0.29 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.552 -171.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.7 mtm180 -54.15 -50.31 67.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.01 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 55.3 mtp180 -145.65 175.04 10.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.766 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 42.0 tt0 -75.14 -38.63 60.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.92 -42.27 99.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.328 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.624 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 3.4 m-20 -75.56 -28.22 58.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.443 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 21.1 t90 -64.68 -48.22 75.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.2 mptm? -58.9 -37.43 76.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.048 0.451 . . . . 0.0 110.002 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 36.1 ttmt -63.05 -45.68 91.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.932 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.35 74.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 110.943 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.09 -36.97 76.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.079 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 10.1 tp10 -63.0 -40.88 99.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 173.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.1 mt-10 -62.65 -59.7 4.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.265 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.573 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.2 m-20 -82.53 -16.99 46.6 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -172.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 62.99 35.16 13.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 111.12 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 p -81.7 86.17 6.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.951 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -90.4 86.18 6.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.304 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -155.42 -175.26 5.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.168 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.52 96.78 0.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.321 0.582 . . . . 0.0 111.446 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.0 mm-40 -99.05 140.15 33.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.132 177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.68 137.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.1 tp -92.85 125.94 37.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' OD2' ' A' ' 97' ' ' ASP . 65.9 mt -72.58 137.88 46.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.665 ' O ' HG23 ' A' ' 98' ' ' VAL . 74.1 mt-30 -67.07 147.05 53.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.27 -16.74 61.92 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.191 0.519 . . . . 0.0 110.759 -170.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.15 -33.87 22.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.432 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' OD2' HD22 ' A' ' 93' ' ' LEU . 7.1 t70 -72.27 -32.55 66.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 94' ' ' GLN . 75.3 t -50.09 -37.09 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.533 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -56.75 -63.76 1.1 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.786 0.803 . . . . 0.0 111.626 -172.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.05 -39.94 63.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.804 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 68.3 t -58.24 -50.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 19.3 mt -56.21 -62.06 1.97 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.981 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -50.76 70.97 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.532 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 t -57.63 -33.09 67.91 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.651 0.594 . . . . 0.0 112.365 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.483 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 51.2 m-85 -83.8 16.11 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 2.8 m 67.98 38.82 2.67 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.436 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 78.8 mt -119.94 110.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.116 -170.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.69 20.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.366 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.83 -172.4 40.6 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.658 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.44 156.17 69.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 117.181 0.49 . . . . 0.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.786 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 92.3 Cg_endo -86.36 167.6 47.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.784 -1.34 . . . . 0.0 113.237 -0.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.92 118.64 8.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 132' ' ' LEU . 4.1 mp -111.49 120.59 62.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 39.9 pt -122.08 158.1 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.561 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -122.86 117.41 25.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.926 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 117' ' ' ASP . 93.3 t -113.1 135.47 52.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.103 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 26.3 m-20 -66.96 163.89 40.04 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.749 174.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.85 -27.72 85.03 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.108 1.872 . . . . 0.0 111.404 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.44 -29.87 68.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.761 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 100.34 40.4 3.01 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.372 -175.744 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.613 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.4 mtmp? -112.05 148.8 33.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.95 99.4 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.14 -33.74 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.228 0.537 . . . . 0.0 110.639 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.15 152.94 45.09 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.743 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 2.3 ptpt -166.83 172.86 9.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.783 0.325 . . . . 0.0 111.51 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.743 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 0.7 OUTLIER 59.67 28.88 18.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.242 178.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 132' ' ' LEU . 89.7 mt -78.52 154.2 30.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.48 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -104.33 169.56 8.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.079 179.052 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -46.6 -70.94 0.59 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.9 -32.84 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.375 0.607 . . . . 0.0 110.987 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 39.9 t0 -73.64 -46.16 48.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.582 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 113' ' ' ILE . 4.5 pp -60.04 -37.0 78.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.505 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.502 ' CE2' ' HE1' ' A' ' 58' ' ' PHE . 53.8 t80 -68.14 -55.27 12.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 5.9 p30 -67.42 -27.09 66.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.693 -174.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 43.3 m -83.58 -33.24 25.42 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.656 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.5 p -74.89 -38.77 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 121.77 -0.581 . . . . 0.0 109.963 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 4.0 tp10 -65.6 -32.86 74.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.075 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 24.1 ttmt -56.66 -43.65 80.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.796 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.24 -51.13 6.46 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -170.791 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -99.22 131.05 45.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.605 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.26 -1.45 60.62 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.061 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 p -74.93 138.79 42.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.07 128.42 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 130.5 55.32 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.12 154.85 59.76 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.788 2.325 . . . . 0.0 111.396 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.06 103.9 16.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.372 . . . . 0.0 111.61 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.8 mt -63.07 142.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.866 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.0 t -124.27 87.46 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.625 0.726 . . . . 0.0 110.582 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.56 161.65 15.18 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.0 123.48 45.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.609 0.242 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HA ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -70.95 -175.66 1.18 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.399 0.619 . . . . 0.0 111.883 -172.49 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.25 -29.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.653 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -81.47 -50.7 9.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.71 23.6 0.31 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.52 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -108.81 137.47 46.69 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 p -79.99 114.29 18.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.738 0.304 . . . . 0.0 111.039 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' THR . 23.9 m -108.78 156.56 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.924 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 8.5 p -107.49 155.76 19.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.013 0.435 . . . . 0.0 110.733 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.4 tp -56.97 -31.62 65.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.867 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 9.9 t30 -71.17 -17.73 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.371 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -68.37 -29.41 68.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.32 -15.06 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.082 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LYS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 1.4 tmtp? -54.14 145.1 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.235 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.37 -0.35 40.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -133.97 172.59 12.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 140' ' ' VAL . 94.8 m-85 -77.67 106.52 9.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.61 108.52 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.881 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 tt -87.02 113.81 23.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 24.3 t -96.03 115.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -103.44 106.67 17.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.545 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' HA ' HG23 ' A' ' 68' ' ' VAL . 86.5 m-85 -90.5 115.09 27.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.482 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.6 p-90 -159.35 179.82 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.726 0.774 . . . . 0.0 112.348 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -166.63 162.92 16.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.006 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.03 69.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -174.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.38 -46.34 80.53 Favored Glycine 0 C--N 1.332 0.335 0 O-C-N 123.635 0.585 . . . . 0.0 112.688 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.4 p -88.65 78.85 7.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.716 0.77 . . . . 0.0 109.619 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.802 ' HA ' ' HD3' ' A' ' 45' ' ' ARG . 54.8 m -69.4 -1.97 9.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.242 -174.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -74.56 -36.35 63.08 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.529 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 3.3 m -60.7 -35.73 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.875 0.845 . . . . 0.0 108.857 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.802 ' HD3' ' HA ' ' A' ' 42' ' ' SER . 58.5 mtp180 -67.77 -26.6 66.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.886 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptt -86.97 -16.96 34.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.907 0.384 . . . . 0.0 111.603 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -88.62 -10.32 49.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.681 0.753 . . . . 0.0 109.149 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.599 HG23 ' CH2' ' A' ' 88' ' ' TRP . 37.0 m -54.82 -46.22 99.52 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.277 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -46.43 -43.57 21.85 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.369 2.046 . . . . 0.0 113.005 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -70.65 -40.14 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 48' ' ' THR . 97.8 mt -60.02 -37.8 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.504 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.88 -43.74 87.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.72 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.88 -43.27 94.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 174.504 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 57.8 m -58.17 -48.99 78.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.911 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.2 t80 -56.24 -48.59 76.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 110.991 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.197 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE2' ' A' ' 61' ' ' LYS . . . -91.87 -32.13 15.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 97.1 m-85 -111.43 4.59 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -55.2 -32.49 62.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.47 0.652 . . . . 0.0 111.005 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.69 12.0 31.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.626 -174.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 57' ' ' ALA . 34.7 mttm -122.97 23.04 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.71 47.41 40.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.536 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 69.7 t80 -129.87 136.55 49.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -143.01 131.56 22.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.684 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.7 mt -88.38 122.04 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -108.14 94.83 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.2 133.12 11.57 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.678 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HB ' HD21 ' A' ' 93' ' ' LEU . 9.5 m -119.85 112.99 39.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.472 0.653 . . . . 0.0 110.774 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.7 t -103.88 148.66 25.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.577 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.518 ' HB ' HD12 ' A' ' 93' ' ' LEU . 5.8 t -126.34 33.98 4.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.39 170.01 1.49 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.348 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -69.25 -46.84 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.644 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.64 164.91 23.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.59 -37.32 86.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 2.1 mp0 -55.53 -53.75 52.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.937 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.22 -45.52 90.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -59.03 -53.24 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.951 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -60.53 -40.64 92.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.926 0.394 . . . . 0.0 111.059 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -64.15 -45.85 86.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.38 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.573 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.3 mt -63.74 -42.43 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.366 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -68.05 -41.55 81.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.685 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.88 -51.28 69.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.763 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.48 7.54 42.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.56 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 66.8 mmtt 55.58 36.32 26.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.543 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.5 p -81.47 68.67 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.319 0.581 . . . . 0.0 111.25 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.56 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 62.3 m-85 -81.8 95.62 7.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.938 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CH2' HG23 ' A' ' 48' ' ' THR . 5.3 p90 -160.99 -178.99 7.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.481 171.231 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -67.64 100.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.458 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -117.54 150.56 38.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 16' ' ' ASP . 35.8 m -133.81 149.34 30.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.46 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.65 123.79 37.21 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 68' ' ' VAL . 69.3 mt -62.78 137.73 58.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.489 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 98' ' ' VAL . 43.9 mt-30 -74.16 166.99 22.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.46 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.88 -48.3 64.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.55 -32.34 22.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.789 0.328 . . . . 0.0 110.417 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB3' ' N ' ' A' ' 94' ' ' GLN . 22.1 t70 -58.05 -42.13 84.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.897 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 93' ' ' LEU . 77.7 t -49.65 -57.93 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 35.3 ttmt -65.26 -59.17 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.313 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.25 -51.7 65.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.451 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -52.47 39.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.1 mt -58.84 -38.39 78.61 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.543 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -61.56 -59.76 4.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.9 m -50.74 -41.14 56.13 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 107' ' ' ILE . 53.5 m-85 -71.76 5.75 2.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.048 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' CYS . . . . . 0.431 ' H ' ' C ' ' A' ' 104' ' ' SER . 85.3 m 61.72 52.24 3.61 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.989 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.0 mm -99.27 125.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.695 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.23 7.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.421 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 162.38 33.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.136 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.583 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 85.2 m-85 -132.1 164.66 41.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' PRO . . . . . 0.754 ' HB2' HH12 ' A' ' 128' ' ' ARG . 15.5 Cg_exo -68.52 157.36 88.33 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.448 0.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.58 104.3 4.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 110.815 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -114.66 122.23 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.286 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 125' ' ' LYS . 39.6 pt -123.94 155.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.539 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 55.0 tp -120.89 116.73 25.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.714 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.62 126.9 54.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.932 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.543 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 1.9 p30 -72.87 164.31 61.66 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -55.93 -28.86 70.51 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.567 2.178 . . . . 0.0 112.802 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -30.01 70.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.334 0.587 . . . . 0.0 110.017 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.81 29.53 4.62 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.388 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 8.6 mtmp? -114.96 149.14 37.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.924 0.393 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.89 98.32 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.955 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 m -86.71 -35.22 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -131.75 151.98 51.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.742 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 9.3 ptpp? -161.37 168.73 23.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.925 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 10.0 mm-40 63.46 19.37 11.65 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.082 0.864 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.28 141.4 57.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.469 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ARG . . . . . 0.754 HH12 ' HB2' ' A' ' 111' ' ' PRO . 17.6 mmt180 -117.78 159.83 22.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.534 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -21.47 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.466 0.658 0 O-C-N 124.647 1.217 . . . . 0.0 116.131 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.82 -36.33 82.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.93 -42.66 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.147 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.5 pp -57.28 -36.94 71.65 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.655 -175.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' TYR . . . . . 0.466 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.6 t80 -65.66 -46.48 78.97 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.54 -49.63 75.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.48 0.657 . . . . 0.0 110.358 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.3 m -62.53 -46.18 89.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.457 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 132' ' ' LEU . 54.1 t -64.84 -39.13 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 3.9 tp10 -58.38 -38.33 77.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.124 0.488 . . . . 0.0 109.851 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -77.16 -25.68 52.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.854 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -89.51 -47.15 8.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' A' ' 31' ' ' TYR . 37.0 t . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -62.87 -55.39 26.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.68 151.24 27.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.474 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.45 162.28 35.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.324 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.7 p -67.39 112.19 4.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.661 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.8 -10.39 23.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.991 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -79.5 146.25 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.678 0.275 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.94 136.79 24.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.95 142.21 24.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.83 162.4 25.49 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.837 2.358 . . . . 0.0 112.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.66 133.35 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' SER . 5.0 mp -93.37 142.3 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.825 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -115.74 94.2 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.0 110.481 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 91' ' ' VAL . . . -116.42 144.84 18.58 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.471 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 68.4 mt -87.79 132.44 32.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.491 0.186 . . . . 0.0 110.526 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 -175.68 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.817 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 mtmp? -84.03 -41.3 17.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.151 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 18.96 1.31 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.582 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.42 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 2.4 m-20 -94.0 144.33 25.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 105.89 13.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.7 t -103.71 135.7 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.883 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 2.0 m -108.95 176.89 4.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.951 0.405 . . . . 0.0 110.542 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.26 -32.91 69.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.917 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 1.7 p-10 -65.06 -22.46 66.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.992 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -72.77 -18.52 61.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.992 0.425 . . . . 0.0 110.971 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.21 19.21 15.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.9 tttm -80.03 56.14 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.013 -174.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.86 0.7 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -149.03 171.76 15.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -76.46 111.63 12.13 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' THR . 48.1 t -97.4 114.32 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.061 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.2 tm? -88.47 105.35 17.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 44.1 t -89.89 110.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 68' ' ' VAL . 28.9 t70 -106.61 122.27 46.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.46 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -94.7 114.19 26.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' SER . 16.4 p-90 -148.35 172.45 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.708 0.766 . . . . 0.0 111.884 -175.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -170.36 159.92 7.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.661 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.63 69.33 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -6.07 89.2 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.09 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.75 112.64 23.99 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.48 -0.424 . . . . 0.0 110.206 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -64.23 -42.91 96.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.569 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -77.29 -31.66 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 94.5 m -57.6 -38.57 75.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -18.07 65.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptp? -85.36 -34.13 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.453 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 45.5 mt-10 -96.44 1.64 51.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.594 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.633 HG21 ' HB3' ' A' ' 84' ' ' ASP . 84.4 m -50.21 -51.53 62.02 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.329 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 65.5 Cg_exo -52.52 -43.02 57.95 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.259 1.973 . . . . 0.0 113.156 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.8 m-85 -65.1 -46.0 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.9 -40.21 94.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.633 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 60.9 tp -59.42 -47.29 86.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.92 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HE3' ' CD2' ' A' ' 133' ' ' TYR . 38.6 ttpt -62.87 -47.27 84.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.151 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 35.7 m -58.55 -47.91 82.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.711 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -60.03 -51.32 70.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.868 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -66.55 -26.08 66.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.71 -27.43 18.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 71.0 m-85 -108.45 -11.86 15.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 21.6 pttp -54.91 -39.15 68.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.811 0.339 . . . . 0.0 111.388 -176.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.51 -36.52 29.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.439 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HD2' ' CD1' ' A' ' 58' ' ' PHE . 87.9 mttt -58.75 -44.01 90.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.06 43.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.428 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.695 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 65.9 t80 -144.08 150.48 38.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 95.7 m -150.8 132.76 15.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.853 0.358 . . . . 0.0 110.583 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 55' ' ' TYR . 42.7 mt -92.44 118.72 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.088 0.47 . . . . 0.0 110.044 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.76 94.43 5.6 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.35 112.0 3.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.759 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HB ' HD21 ' A' ' 93' ' ' LEU . 32.1 m -100.21 116.43 43.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.485 0.659 . . . . 0.0 111.004 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 7.2 t -128.84 145.39 51.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.947 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 1.037 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.7 t -145.87 54.79 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.014 0.912 . . . . 0.0 110.011 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -68.63 -168.51 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.479 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 0.6 OUTLIER -60.47 -42.86 97.08 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -172.77 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 56.8 mtp180 -133.11 163.07 30.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.667 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG3' HD22 ' A' ' 92' ' ' LEU . 16.8 tt0 -75.12 -36.74 61.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 2.0 mp0 -59.57 -39.68 84.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.951 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 2.3 m-20 -74.67 -32.36 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 92' ' ' LEU . 29.4 t90 -62.28 -49.03 77.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.0 mptm? -57.88 -43.44 86.05 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.045 0.45 . . . . 0.0 110.278 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 3.5 ttpm? -60.15 -45.84 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.69 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.01 84.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.328 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 82.8 mt -62.99 -38.02 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 36.8 mt-10 -60.49 -56.08 25.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.9 m-20 -75.71 -20.92 58.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.859 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 66.3 mmtt 57.49 37.89 27.9 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.824 0.821 . . . . 0.0 109.98 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 p -83.27 82.96 8.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.87 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -82.78 84.55 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.408 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 28.7 p90 -154.95 -169.24 3.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.119 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -72.92 84.26 1.24 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.425 0.631 . . . . 0.0 111.021 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -89.23 136.36 33.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.536 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 14' ' ' GLY . 17.1 m -131.01 141.71 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.016 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.563 HD22 ' HG3' ' A' ' 74' ' ' GLU . 53.3 tp -88.24 111.16 21.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.626 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.037 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 84.3 mt -66.7 124.1 21.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' VAL . 83.4 mt-30 -60.78 143.42 54.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -66.95 -23.32 65.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.582 0.229 . . . . 0.0 111.443 -165.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -87.44 -36.03 17.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 0.0 110.749 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.29 -37.69 86.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' GLN . 63.2 t -50.63 -47.22 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.367 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.05 -55.23 33.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.803 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.25 -53.29 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.204 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.68 -54.32 27.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.783 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 30.5 mt -60.51 -50.63 72.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.009 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.98 -59.66 4.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.308 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.3 m -54.79 -30.98 58.35 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.275 0.984 . . . . 0.0 113.338 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -77.96 10.58 2.75 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.143 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.7 t 64.29 36.13 9.45 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 39.7 mm -106.0 118.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.366 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.48 13.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.214 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.64 160.47 30.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.49 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -133.49 155.98 80.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.446 0.299 . . . . 0.0 110.377 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.619 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 4.2 Cg_exo -82.63 -176.5 16.82 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.148 -1.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -163.03 130.8 3.68 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.627 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 33' ' ' LEU . 58.0 mt -125.93 130.76 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.517 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 30.8 pt -129.15 145.46 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.903 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tt -105.71 110.63 23.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.83 135.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.444 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.549 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -82.13 170.37 15.18 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 16.5 Cg_endo -59.65 -16.72 38.27 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.647 2.232 . . . . 0.0 114.028 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -88.43 3.94 48.21 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 110.824 175.955 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.04 57.33 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.985 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 27.2 mttm -113.01 141.54 46.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.939 0.369 . . . . 0.0 110.077 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.41 95.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 117' ' ' ASP . 42.6 t -73.27 -41.95 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.578 -176.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.66 167.27 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.63 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.0 pttp -162.68 171.89 16.16 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 8.8 mm-40 68.01 16.42 9.54 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.286 0.991 . . . . 0.0 111.15 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.64 132.74 54.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 mmp_? -116.02 154.52 29.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.021 -170.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 46.05 -131.78 10.54 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.966 0.792 . . . . 0.0 113.568 170.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.9 -10.74 59.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.5 t70 -64.27 -31.84 73.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.388 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 3.3 pp -58.9 -41.15 86.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.852 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' N ' HD12 ' A' ' 132' ' ' LEU . 26.9 t80 -63.6 -54.87 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 109.555 172.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.44 ' C ' ' HE3' ' A' ' 138' ' ' LYS . 25.3 m-80 -58.71 -32.41 69.16 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.11 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.503 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 21.7 m -73.91 -40.23 63.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 132' ' ' LEU . 44.9 t -63.93 -39.28 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.501 174.07 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.439 ' OE1' ' HB2' ' A' ' 141' ' ' ASN . 3.0 tp10 -66.17 -41.48 90.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 135' ' ' THR . 15.8 mtmt -52.51 -40.65 62.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.396 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -87.61 -61.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.08 -35.87 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -164.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.439 ' HB2' ' OE1' ' A' ' 137' ' ' GLU . 66.6 t30 -52.3 -56.75 12.71 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -168.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 143' ' ' ALA . . . -164.16 -173.3 32.67 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.901 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 142' ' ' GLY . . . 78.84 6.41 2.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 111.501 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 144' ' ' LYS . 7.4 mptt -131.98 7.77 4.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -36.04 61.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.27 -22.91 36.02 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.239 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 37.13 79.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.575 0.702 . . . . 0.0 111.151 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -80.58 -20.97 42.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.832 -165.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -89.0 -44.93 10.04 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.97 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 166.88 -36.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.14 0.9 . . . . 0.0 109.487 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -122.93 -35.13 3.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.774 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.5 m80 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.916 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.576 ' HB3' ' O ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -119.03 -171.99 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.187 -169.979 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -90.39 -179.77 5.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.4 -167.14 2.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.694 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -64.3 133.84 53.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 0.0 111.109 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.12 -20.31 50.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.747 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -87.08 156.15 19.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 13.7 p -80.79 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.14 0.495 . . . . 0.0 110.793 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.96 144.51 51.54 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.06 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.05 148.68 81.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.585 2.19 . . . . 0.0 112.165 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.84 99.8 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.7 mm -83.25 132.9 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.5 m -131.74 98.99 4.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.072 0.463 . . . . 0.0 110.402 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.581 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -112.37 -176.23 19.79 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.835 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 19.7 mt -104.68 135.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.714 0.257 . . . . 0.0 110.924 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -101.29 -172.6 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 81' ' ' ILE . 92.6 mt -59.46 -26.89 65.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.05 -14.7 59.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.22 57.89 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB2' ' OD1' ' A' ' 16' ' ' ASP . 3.3 m-20 -102.02 151.17 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -84.42 107.31 16.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.145 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.6 138.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 19.4 m -106.39 172.11 6.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.137 0.494 . . . . 0.0 111.072 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.656 HD11 HG11 ' A' ' 32' ' ' VAL . 55.7 tp -80.42 -21.0 42.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 110.088 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 4.0 m-20 -65.84 -28.69 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.307 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.53 -23.89 67.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.211 0.529 . . . . 0.0 110.932 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.38 8.48 29.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.006 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 6.2 mtpp -76.51 69.99 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.719 0.771 . . . . 0.0 111.179 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.509 ' HA3' ' CG ' ' A' ' 151' ' ' HIS . . . -165.65 20.37 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.709 174.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -153.19 -176.45 5.79 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 64.1 m-85 -95.88 111.62 23.56 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 116' ' ' VAL . 9.8 p -101.52 133.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.232 0.539 . . . . 0.0 111.407 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 132' ' ' LEU . 10.3 tt -97.55 107.27 19.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 41.4 t -97.52 105.09 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -102.56 118.46 36.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.069 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HA ' HG13 ' A' ' 68' ' ' VAL . 66.5 m-85 -84.43 116.2 22.95 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.584 ' O ' ' HA ' ' A' ' 69' ' ' SER . 21.9 p-90 -144.4 175.71 9.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.626 0.727 . . . . 0.0 111.874 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -168.38 161.01 11.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.59 -1.187 . . . . 0.0 108.248 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -32.93 73.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.37 -11.66 85.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.196 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.405 ' CB ' ' HG ' ' A' ' 44' ' ' CYS . 48.3 t -74.53 110.62 8.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.257 0.551 . . . . 0.0 109.946 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -65.48 -28.31 69.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.308 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 77.2 t-105 -85.52 -30.75 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HG ' ' CB ' ' A' ' 41' ' ' CYS . 90.2 m -58.06 -42.05 84.64 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.3 -13.71 21.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.018 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.5 mptt -84.28 -51.23 7.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 15.7 pt-20 -99.73 15.78 25.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.224 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 22.4 m -51.71 -51.97 65.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.5 Cg_exo -54.29 -33.74 77.1 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.97 1.78 . . . . 0.0 112.379 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.1 m-85 -76.57 -32.23 58.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 132' ' ' LEU . 95.7 mt -62.94 -52.95 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.9 tp -61.07 -40.26 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.533 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -51.69 -53.86 34.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.718 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -67.07 -39.8 86.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.11 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.7 t80 -60.84 -46.75 89.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 111.172 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.19 -35.97 78.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.414 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -31.19 51.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' HE1' ' OE1' ' A' ' 137' ' ' GLU . 90.3 m-85 -115.48 3.86 14.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.73 -38.44 69.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.74 -42.12 16.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 88.3 mttt -55.8 -56.34 21.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.232 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 38.79 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.749 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 49.4 t80 -135.49 147.28 48.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.4 m -153.99 144.06 22.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.843 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 55' ' ' TYR . 29.4 mt -95.58 137.82 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.097 0.475 . . . . 0.0 111.033 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 39.3 t80 -123.43 93.05 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.04 106.8 3.37 Favored Glycine 0 CA--C 1.505 -0.531 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.582 -172.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 91' ' ' VAL . 3.1 p -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.631 0.729 . . . . 0.0 111.092 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 12.4 t -112.4 152.9 28.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.528 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 93' ' ' LEU . 30.6 p -132.54 48.96 2.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -75.15 -176.05 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.864 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -69.85 -39.27 76.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.924 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HD2' ' OD1' ' A' ' 76' ' ' ASP . 60.9 mtt180 -138.69 152.71 48.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.672 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 33.3 tt0 -65.91 -37.9 87.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 mm-40 -68.78 -36.46 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.766 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -65.25 -34.59 78.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 173.551 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 31.5 t90 -64.37 -48.73 74.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 8.7 mmtm -55.3 -50.4 69.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.963 0.887 . . . . 0.0 108.837 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.72 -40.06 90.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.014 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -61.77 -36.17 80.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.433 HD12 HD21 ' A' ' 17' ' ' LEU . 73.1 mt -64.6 -39.64 86.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 38.0 tp10 -65.6 -34.32 77.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.767 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 53.7 mt-10 -69.76 -52.19 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.765 0.793 . . . . 0.0 110.304 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.78 -18.67 58.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.228 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 85' ' ' LYS . 8.4 mptt 59.04 21.26 9.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.244 0.545 . . . . 0.0 112.244 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 88' ' ' TRP . 60.3 m -87.07 85.06 7.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.534 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.62 93.31 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.971 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 86' ' ' SER . 7.6 p90 -153.26 -172.68 4.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.744 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 52.1 m-80 -68.49 99.81 1.01 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.278 0.561 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.32 155.41 30.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.171 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.3 p -140.05 145.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.896 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 tp -108.21 129.57 55.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.483 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 70' ' ' THR . 15.3 mt -74.69 142.58 44.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.431 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.4 mt-30 -75.44 163.34 27.51 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.798 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.473 ' CD ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -43.63 -55.37 4.37 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.924 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' H ' ' CD ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -87.8 -33.51 18.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 14.4 t70 -54.76 -39.2 68.09 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.313 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 53.8 t -49.9 -48.12 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.876 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ttpp -56.39 -59.45 4.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.144 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -69.86 -34.95 74.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.577 -171.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.09 -37.43 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.685 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.75 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -66.37 -22.89 66.26 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.67 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -82.54 -62.71 1.54 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.249 -0.981 . . . . 0.0 108.813 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 2' ' ' SER . 69.6 m -48.33 -41.55 28.69 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -164.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.34 17.04 1.81 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.714 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.6 t 57.36 54.0 7.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 19.1 mm -80.33 72.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.636 0.732 . . . . 0.0 110.541 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.51 -25.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.683 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.05 121.18 5.9 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 3.3 t80 -123.88 140.74 35.17 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.502 ' HG2' HH12 ' A' ' 128' ' ' ARG . 62.3 Cg_endo -74.9 135.4 40.31 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.566 -1.431 . . . . 0.0 112.108 -0.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 107' ' ' ILE . 49.7 t60 -89.02 100.8 13.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.9 120.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.558 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 31.5 pt -122.05 159.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.057 0.456 . . . . 0.0 111.666 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 tp -121.09 120.61 35.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.015 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 32' ' ' VAL . 65.4 t -109.2 133.97 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.775 0.321 . . . . 0.0 110.664 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 p30 -77.0 165.79 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.502 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.7 Cg_endo -54.18 -20.33 18.95 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.983 2.455 . . . . 0.0 113.85 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 -14.33 54.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.34 . . . . 0.0 110.775 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.11 30.37 11.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.923 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.6 mtmp? -112.27 152.35 28.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.403 -0.469 . . . . 0.0 110.963 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -84.16 108.69 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.83 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.61 -30.31 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.958 0.409 . . . . 0.0 110.976 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -144.86 155.41 43.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 17.2 pttp -156.61 162.58 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 3.1 mm-40 66.51 20.76 10.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.463 HD21 ' HB1' ' A' ' 124' ' ' ALA . 71.0 mt -64.14 145.05 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.226 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.502 HH12 ' HG2' ' A' ' 111' ' ' PRO . 25.3 mmt180 -132.48 139.98 48.18 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 39.03 -99.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.338 0 O-C-N 124.521 1.138 . . . . 0.0 115.721 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.1 -35.28 59.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.806 -0.197 . . . . 0.0 111.128 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.908 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 27.8 t70 -69.94 -19.45 63.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.469 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 33' ' ' LEU . 95.0 mt -51.86 -59.59 4.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 168.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.14 -49.14 77.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.922 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.908 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 93.8 m-20 -57.41 -41.55 80.55 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.265 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.509 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 5.1 m -74.6 -36.45 62.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 132' ' ' LEU . 41.6 t -68.87 -41.47 82.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.319 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.549 ' OE1' ' HE1' ' A' ' 58' ' ' PHE . 1.2 tp10 -67.94 -32.33 72.71 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.628 0.728 . . . . 0.0 109.246 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.738 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 22.1 ttmt -58.55 -56.92 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.923 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -89.22 -53.28 4.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.452 ' HA ' ' CE1' ' A' ' 147' ' ' HIS . 23.3 t -75.15 -43.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 15.7 t30 -73.14 -18.51 61.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.215 0.531 . . . . 0.0 110.86 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.29 168.92 22.26 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.808 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.1 80.85 6.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 1.2 mptm? -117.36 126.28 52.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.686 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER 54.41 1.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.335 1.454 . . . . 0.0 114.712 174.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.15 80.34 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.404 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 140' ' ' VAL . 33.4 m-70 68.79 26.55 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.309 0.644 . . . . 0.0 110.614 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.4 m80 41.69 61.78 1.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.366 -1.288 . . . . 0.0 113.124 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 75.39 -31.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.905 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.438 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 14.4 t-80 72.33 151.13 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.509 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.1 t-160 -61.17 -38.72 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.905 -0.497 . . . . 0.0 110.063 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.438 ' C ' ' HD1' ' A' ' 150' ' ' HIS . 22.1 t60 . . . . . 0 C--O 1.242 0.697 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 106' ' ' CYS . 11.5 m -140.12 136.45 33.55 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.379 0.424 . . . . 0.0 109.999 -175.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 105' ' ' TYR . 63.9 mt 69.07 146.51 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.651 0.739 . . . . 0.0 112.109 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.22 172.04 13.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.179 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -68.68 119.18 12.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.35 -8.79 41.48 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.936 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -85.24 149.01 25.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.726 0.298 . . . . 0.0 110.523 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.89 141.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.129 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -85.57 131.2 48.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 37.7 Cg_exo -61.67 153.46 67.06 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.017 2.478 . . . . 0.0 112.219 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.63 134.62 51.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.782 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.625 HG12 HD23 ' A' ' 24' ' ' LEU . 48.5 mm -104.53 129.5 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.474 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.18 93.02 3.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.11 148.04 18.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.378 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.39 124.39 40.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.354 0.597 . . . . 0.0 111.162 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 170.25 16.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.972 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.8 mp -64.96 -14.56 60.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.92 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -96.59 2.38 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.41 20.02 55.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.787 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -101.18 132.46 46.65 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.544 -0.386 . . . . 0.0 110.129 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -80.97 112.0 17.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.69 148.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.43 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -100.43 175.05 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.919 0.39 . . . . 0.0 111.193 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.625 HD23 HG12 ' A' ' 12' ' ' ILE . 3.8 pp -80.2 -20.07 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 110.42 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 29.9 p30 -71.68 -17.89 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.66 -25.99 68.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.275 0.56 . . . . 0.0 110.958 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.29 2.8 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.54 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 12.3 tmtt? -60.02 147.54 38.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.388 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.58 5.17 29.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.453 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -134.89 172.66 12.68 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -82.29 110.57 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.598 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 48.4 t -104.4 125.27 59.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.025 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 132' ' ' LEU . 22.4 tp -103.06 103.73 13.84 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.893 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.0 t0 -113.78 136.43 52.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -110.98 115.59 29.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 69' ' ' SER . 58.5 p-90 -148.06 178.24 8.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 111.369 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -170.28 157.0 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.806 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.12 51.51 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.05 -62.99 5.68 Favored Glycine 0 C--N 1.333 0.363 0 O-C-N 123.581 0.55 . . . . 0.0 112.697 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.3 m -81.42 85.4 6.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.46 0.648 . . . . 0.0 109.813 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.614 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 28.4 p -70.91 -13.73 62.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.451 -176.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -66.97 -33.12 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.966 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.82 -38.84 89.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.518 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.74 ' HD2' ' OD2' ' A' ' 84' ' ' ASP . 41.0 mtm180 -74.04 -12.68 60.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.322 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 42' ' ' SER . 10.1 mptt -72.49 -14.06 61.57 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.067 -0.395 . . . . 0.0 111.032 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 40.7 mt-10 -101.3 -4.76 26.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.636 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 51' ' ' LEU . 56.4 m -60.0 -43.4 94.26 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.123 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.0 Cg_exo -52.2 -36.47 67.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.066 1.844 . . . . 0.0 112.669 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 66.2 m-85 -74.05 -34.66 64.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.729 0.299 . . . . 0.0 110.246 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -60.15 -43.0 96.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.086 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.71 -42.26 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.553 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -60.36 -47.54 85.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.109 0.48 . . . . 0.0 110.393 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -62.56 -43.96 97.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' A' ' 65' ' ' ILE . 51.2 t80 -65.73 -38.79 90.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -65.67 -28.78 69.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.688 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.97 19.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.309 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.34 13.44 32.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 50.5 pttt -60.43 -20.7 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.53 13.04 15.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 111.527 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -116.08 26.03 10.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.94 55.79 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.399 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 80.4 t80 -133.73 136.54 44.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.994 -0.603 . . . . 0.0 109.596 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 36.7 m -140.85 130.73 24.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.818 0.342 . . . . 0.0 110.758 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 55' ' ' TYR . 58.0 mt -89.91 125.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -108.7 94.49 5.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' OE1' ' A' ' 90' ' ' GLN . . . -86.5 117.06 4.54 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.913 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 91' ' ' VAL . 35.3 m -112.97 126.31 70.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 0.0 110.681 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 46.2 t -122.48 139.37 53.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.667 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -106.4 42.22 1.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.104 0.954 . . . . 0.0 108.627 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.1 177.61 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.875 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -69.56 -48.36 60.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.292 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HE ' ' CD ' ' A' ' 75' ' ' GLU . 22.6 tpt180 -143.25 150.48 39.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.792 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 1.018 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 30.5 tt0 -63.28 -39.93 95.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -61.31 -41.36 96.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.74 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 10.4 t0 -65.21 -45.7 83.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.467 ' O ' HG13 ' A' ' 81' ' ' ILE . 22.7 t90 -58.39 -49.49 77.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.651 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 1.018 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -55.61 -44.09 76.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 110.781 175.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 12.6 ttpp -59.37 -44.83 92.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.182 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.43 79.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.805 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 77' ' ' TRP . 93.4 mt -59.82 -40.35 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.447 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -43.89 66.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -50.07 -58.14 6.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.74 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 8.2 m-20 -84.21 -2.51 57.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.115 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 58.17 37.09 26.26 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.381 0.61 . . . . 0.0 111.091 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 p -79.98 78.37 6.6 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.736 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -83.9 77.75 9.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -158.6 -179.88 8.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.527 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -63.57 115.69 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.31 0.576 . . . . 0.0 111.04 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.459 ' OE1' ' HA3' ' A' ' 67' ' ' GLY . 1.4 tp-100 -123.13 141.08 52.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.786 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 68' ' ' VAL . 19.1 m -137.87 145.32 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.234 0.54 . . . . 0.0 111.144 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.0 tp -92.91 112.67 24.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.648 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.15 133.9 52.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.035 0.445 . . . . 0.0 110.768 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.589 ' O ' HG23 ' A' ' 98' ' ' VAL . 32.7 mt-30 -68.75 145.1 54.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -63.59 -29.32 70.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -171.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 36.6 t70 -79.28 -39.73 32.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.84 -46.17 85.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.851 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 94' ' ' GLN . 77.2 t -50.14 -37.67 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.826 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.2 ttpm? -52.82 -64.02 0.95 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.151 0.5 . . . . 0.0 111.577 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -72.5 -36.89 68.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.744 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.63 -52.01 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.272 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -58.43 -52.6 64.92 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.848 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -52.99 -61.37 2.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.3 0.375 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 28.3 m -57.55 -26.27 61.18 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.007 0.817 . . . . 0.0 112.682 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.684 ' HA ' HD12 ' A' ' 3' ' ' LEU . 6.5 m-85 -86.84 20.52 2.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.556 ' HB3' ' H ' ' A' ' 2' ' ' SER . 31.3 p 50.6 43.75 27.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.872 1.269 . . . . 0.0 110.348 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 12.2 mm -113.03 122.38 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.8 3.59 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.98 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.56 177.16 37.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.955 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 94.5 m-85 -135.25 166.7 26.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 74.4 Cg_endo -75.33 -174.68 14.67 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.031 -0.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.409 ' ND1' HD11 ' A' ' 107' ' ' ILE . 72.4 t60 -166.89 106.52 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.363 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.87 137.16 53.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 125' ' ' LYS . 46.9 pt -131.62 154.51 40.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.699 HD22 HG22 ' A' ' 136' ' ' VAL . 64.3 tp -118.96 119.35 34.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.164 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 19.2 m -109.41 143.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.347 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.57 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 3.3 p30 -78.22 163.78 60.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.334 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 11.9 Cg_endo -58.2 -14.23 18.86 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.134 2.556 . . . . 0.0 113.582 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.41 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 1.1 mt-10 -81.52 -29.63 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.33 19.69 6.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.697 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 9.0 mtmp? -111.23 146.32 37.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.39 104.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.54 -27.26 12.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -155.12 142.94 19.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.775 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.678 ' HB2' HG22 ' A' ' 114' ' ' ILE . 12.4 pttp -142.79 163.06 33.83 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.569 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 7.3 mm-40 65.95 30.53 9.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 110.067 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 ' HB1' ' A' ' 124' ' ' ALA . 88.2 mt -67.41 156.82 35.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.047 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 7.8 mmm180 -116.43 166.9 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -30.98 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.052 0 N-CA-C 116.017 1.167 . . . . 0.0 116.017 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -12.52 59.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.572 0.686 . . . . 0.0 111.571 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.458 ' HA ' ' OD1' ' A' ' 134' ' ' ASN . 2.1 t70 -63.43 -42.16 98.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 41.3 mt -47.6 -56.66 6.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.488 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -58.32 -58.92 6.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.558 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 138' ' ' LYS . 0.9 OUTLIER -69.02 -37.66 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.54 -170.488 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.3 m -72.0 -42.12 66.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.676 0.274 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.699 HG22 HD22 ' A' ' 115' ' ' LEU . 46.9 t -65.62 -35.81 76.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -57.02 -45.88 82.77 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.139 0.495 . . . . 0.0 109.823 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 28.9 mtpp -65.96 -35.59 81.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.766 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -80.28 -55.12 5.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.88 -50.37 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 111.619 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -81.43 -62.7 1.58 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.002 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 138' ' ' LYS . . . 167.17 174.44 36.33 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.655 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.69 169.26 19.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -83.34 -24.36 32.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.192 0.52 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.19 31.65 0.27 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.656 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.51 49.04 2.65 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.964 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -97.1 10.54 39.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -155.55 150.7 26.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.524 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -72.6 175.66 6.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.59 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -68.51 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.904 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -134.96 12.41 3.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.517 0.675 . . . . 0.0 109.488 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 C--O 1.241 0.65 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.55 177.924 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.921 ' HB2' ' HD3' ' A' ' 125' ' ' LYS . 14.8 m 58.94 -169.66 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.549 0.53 . . . . 0.0 111.489 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.878 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.2 pt? -75.61 163.77 27.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.373 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.82 156.1 32.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.72 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -74.46 141.15 44.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.784 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.6 -13.17 58.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.782 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 147.92 34.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.288 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.18 137.33 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.934 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.64 122.96 57.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.492 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.14 134.1 49.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.061 2.507 . . . . 0.0 111.708 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.35 120.22 19.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.065 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 24' ' ' LEU . 8.4 mm -65.02 133.17 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.21 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.0 m -120.31 87.88 2.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.468 . . . . 0.0 110.287 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -124.01 179.27 16.2 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.212 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.4 mt -109.24 130.28 62.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.92 -176.14 5.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.368 . . . . 0.0 110.724 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 94.1 mt -58.75 -34.08 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.866 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 32.7 mttp -78.96 -30.22 44.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.579 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.34 12.01 7.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.597 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 20.7 m-80 -87.14 137.4 32.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.639 0.256 . . . . 0.0 110.462 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.9 p -81.57 93.35 6.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.44 154.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.398 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 20.1 m -117.71 166.4 12.48 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 12' ' ' ILE . 3.9 pp -68.41 -18.23 64.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.533 176.392 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.805 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 6.2 t-20 -65.36 -35.52 81.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.37 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.39 -18.03 63.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.413 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.8 4.27 25.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.114 0.483 . . . . 0.0 110.138 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.805 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 41.1 mtpt -69.01 -174.11 0.57 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.953 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.28 10.36 86.27 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -144.84 173.72 11.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 115' ' ' LEU . 94.5 m-85 -86.97 114.45 23.6 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.51 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 28.5 t -114.16 135.26 54.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.873 0.368 . . . . 0.0 111.356 -173.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt -91.31 134.71 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 61.5 t -110.2 100.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.87 108.41 19.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.06 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.649 ' CE2' ' HD2' ' A' ' 105' ' ' TYR . 72.3 m-85 -84.1 116.86 23.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.55 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 9.3 p-90 -143.04 173.53 11.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.301 0.572 . . . . 0.0 110.929 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 41' ' ' CYS . 28.4 p90 -165.17 148.49 8.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.614 171.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.26 -15.86 63.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.906 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.86 -3.06 83.58 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.659 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 50.8 t -120.33 123.96 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 110.744 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.6 t -64.19 -36.52 84.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.807 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.491 ' HD1' ' CD ' ' A' ' 111' ' ' PRO . 49.9 t-105 -70.95 -29.19 65.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.713 0.292 . . . . 0.0 110.713 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 98.7 m -65.31 -27.7 68.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.388 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.39 -14.22 46.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.594 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mptp? -69.33 -38.35 78.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 0.0 109.96 174.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.76 -28.94 68.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 m -53.93 -52.93 63.56 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.2 Cg_exo -54.77 -43.72 56.53 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.073 1.848 . . . . 0.0 112.827 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -67.22 -38.86 85.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.308 0.575 . . . . 0.0 109.996 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 65' ' ' ILE . 13.3 tp -65.75 -43.38 89.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.812 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.2 -41.35 98.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.427 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.11 -45.92 92.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.189 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.8 m -62.11 -44.63 96.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.838 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.724 ' HB2' HD12 ' A' ' 65' ' ' ILE . 72.8 t80 -56.34 -57.46 12.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.076 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.69 -34.17 75.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.739 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.41 -31.47 29.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 32.5 m-85 -114.67 -2.2 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -55.0 -37.74 66.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.19 13.55 11.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -174.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 65.0 mttm -117.99 20.0 13.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.104 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.35 41.81 16.1 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 67.3 t80 -136.59 139.75 42.35 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -147.64 166.58 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 0.0 110.313 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 55' ' ' TYR . 60.1 mt -122.03 128.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.667 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 20.5 t80 -113.83 93.56 4.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.53 109.19 3.45 Favored Glycine 0 C--O 1.224 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.402 -172.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' HA ' HG13 ' A' ' 91' ' ' VAL . 20.8 t -97.62 119.48 45.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -110.18 164.36 12.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.828 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.87 ' HB ' HD12 ' A' ' 93' ' ' LEU . 8.8 t -138.39 28.72 2.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.767 0.794 . . . . 0.0 109.149 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.708 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 22.6 m-20 -73.53 123.93 24.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.467 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.708 ' CZ ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -60.87 -34.96 75.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.512 -176.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 27.6 mtp180 -93.93 102.49 14.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.59 -34.22 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.497 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.645 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -69.38 -31.52 69.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.066 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -76.39 -30.09 57.37 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 81' ' ' ILE . 30.0 t90 -61.77 -52.18 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.951 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 2.0 mptm? -56.55 -43.72 80.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.207 0.527 . . . . 0.0 110.211 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 19.3 tttm -57.51 -56.84 16.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.596 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.577 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -57.27 -36.86 71.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.818 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.782 HD12 HE21 ' A' ' 90' ' ' GLN . 48.1 mm -66.09 -41.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.775 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.33 -31.53 68.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.969 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 51.2 mt-10 -64.3 -50.22 68.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -92.83 -10.91 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.311 -176.593 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.551 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 58.3 mmtt 71.12 30.66 2.64 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.882 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 p -70.28 86.58 0.59 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.302 0.572 . . . . 0.0 111.223 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.551 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 46.9 m-85 -96.69 99.94 11.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.178 0.513 . . . . 0.0 112.11 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.495 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 6.2 p90 -151.7 -140.81 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.82 170.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 55.7 m-80 -113.31 85.96 2.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.54 0.609 . . . . 0.0 110.541 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.782 HE21 HD12 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -93.85 146.23 24.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.476 0.655 . . . . 0.0 110.876 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.584 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.5 p -137.15 139.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.404 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.29 125.98 45.04 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.446 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.87 HD12 ' HB ' ' A' ' 70' ' ' THR . 69.4 mt -58.64 138.25 57.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.356 0.41 . . . . 0.0 110.597 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.646 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.3 mt-30 -85.1 163.08 19.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.711 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -42.95 -49.64 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.251 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -87.8 -41.07 13.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 110.316 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 24.7 t70 -53.12 -35.57 59.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.728 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.5 t -50.91 -45.24 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.595 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -66.16 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.913 -171.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.92 -40.55 93.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.311 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.475 HG13 HD12 ' A' ' 12' ' ' ILE . 27.1 t -63.07 -59.63 4.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 79.9 mt -59.51 -40.53 87.37 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.153 0.502 . . . . 0.0 110.384 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.57 -62.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.253 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 106' ' ' CYS . 49.2 p -56.19 -43.89 78.91 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.497 1.123 . . . . 0.0 113.511 -167.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.649 ' HD2' ' CE2' ' A' ' 36' ' ' PHE . 16.8 m-30 -73.38 11.43 0.77 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.804 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 2' ' ' SER . 56.3 m 63.36 56.8 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.098 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.7 mp -81.09 110.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.82 -25.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.343 173.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.82 170.39 35.98 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.619 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -121.72 150.23 54.92 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.491 ' CD ' ' HD1' ' A' ' 43' ' ' TRP . 4.4 Cg_exo -78.72 171.32 66.35 Favored 'Cis proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.718 -1.367 . . . . 0.0 112.511 -0.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -145.49 104.3 3.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 132' ' ' LEU . 47.0 mt -114.28 139.18 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.909 0.385 . . . . 0.0 111.344 -172.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 39.2 pt -133.48 155.53 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.449 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 45.8 tp -114.41 117.2 30.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.835 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 10.8 m -103.37 144.22 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 111.649 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 3.8 p30 -80.26 168.79 23.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.177 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 51.5 Cg_exo -55.41 -23.93 40.92 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.978 2.452 . . . . 0.0 113.596 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -78.48 -32.55 48.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.02 0.438 . . . . 0.0 110.442 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.12 22.92 5.08 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.076 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.8 mtmp? -107.15 147.84 29.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 3' ' ' LEU . 49.8 mt -81.93 99.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.736 0.303 . . . . 0.0 110.248 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.25 -34.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.32 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -126.52 128.81 47.47 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 1.011 ' HD2' ' HG2' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -129.52 137.63 50.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.802 -0.181 . . . . 0.0 110.897 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 1.011 ' HG2' ' HD2' ' A' ' 125' ' ' LYS . 20.4 pt-20 45.79 75.48 0.11 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.652 1.181 . . . . 0.0 112.236 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.5 HD11 ' HB1' ' A' ' 124' ' ' ALA . 84.3 mt -100.97 170.29 8.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.361 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OD1' ' A' ' 131' ' ' ASP . 9.1 mmm180 -111.07 177.37 4.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.45 -76.82 0.13 Allowed Glycine 0 C--N 1.335 0.494 0 O-C-N 123.741 0.651 . . . . 0.0 114.562 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -15.94 59.73 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.338 -0.507 . . . . 0.0 110.863 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.569 ' OD1' ' HB2' ' A' ' 128' ' ' ARG . 2.9 m-20 -62.25 -41.07 98.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.483 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 84.6 mt -51.03 -54.73 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.881 170.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.39 -58.96 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.869 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 131' ' ' ASP . 1.1 p-10 -68.8 -28.62 66.93 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.638 -171.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 92.7 m -66.58 -51.72 53.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.285 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.2 -38.48 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 110.396 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 12.3 tm-20 -64.28 -41.78 96.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.252 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -76.34 -17.05 59.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.287 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.42 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.4 t -86.86 -26.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.997 -168.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.64 26.94 5.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.161 0.505 . . . . 0.0 110.47 -174.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.32 15.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.65 -29.81 66.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.88 30.85 1.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.997 0.811 . . . . 0.0 111.42 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -39.08 13.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.386 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.94 43.02 58.92 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.013 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.77 114.57 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.105 0.452 . . . . 0.0 110.807 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.7 m80 66.56 28.96 9.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.202 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -71.93 79.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.092 0.472 . . . . 0.0 109.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -105.21 25.87 10.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 72.09 -72.26 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.19 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.128 -177.217 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.673 ' HA ' ' SG ' ' A' ' 106' ' ' CYS . 85.1 p 49.73 53.11 13.32 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.819 0.699 . . . . 0.0 109.459 -169.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.7 mt 58.75 -136.19 0.88 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.492 -170.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 7' ' ' SER . . . -160.16 151.69 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.587 0.232 . . . . 0.0 110.525 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p -72.26 112.6 8.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.66 -4.03 39.6 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 47.9 t -86.02 143.53 28.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 50.8 t -69.18 136.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.09 145.84 30.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.653 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 152.89 58.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.846 2.364 . . . . 0.0 112.257 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.78 97.15 7.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.965 HD12 HG22 ' A' ' 101' ' ' VAL . 30.1 mm -86.35 147.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.065 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 11.6 t -142.07 123.52 14.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.533 0.682 . . . . 0.0 110.682 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.5 161.46 18.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.069 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 61.6 mt -96.57 123.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.75 0.309 . . . . 0.0 110.619 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -79.63 -177.23 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.892 0.377 . . . . 0.0 111.069 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -68.6 -18.48 64.32 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.618 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -25.39 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.355 0.597 . . . . 0.0 110.376 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.12 23.7 7.24 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.604 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.463 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 1.5 m-20 -101.59 138.8 38.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 p -83.99 94.82 8.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.167 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.67 130.99 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 6.0 m -103.12 167.21 9.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.168 0.508 . . . . 0.0 111.088 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.63 -28.62 69.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.943 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.498 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 7.5 t30 -70.79 -20.94 62.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.131 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -81.4 -4.63 56.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.974 0.416 . . . . 0.0 111.025 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -110.21 5.27 21.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.406 0.622 . . . . 0.0 109.544 179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 90.2 mttt -70.14 132.91 46.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.168 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.86 -27.68 4.56 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.545 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 42.4 mttm -114.84 166.86 11.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.386 -0.907 . . . . 0.0 108.935 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 115' ' ' LEU . 66.9 m-85 -78.14 116.79 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 t -92.63 110.83 23.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.117 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 2.1 tm? -82.86 101.75 11.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 39.5 t -89.98 118.98 36.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.137 0.494 . . . . 0.0 110.257 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 6.2 t70 -106.24 112.91 26.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.618 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 112' ' ' HIS . 89.6 m-85 -95.44 115.76 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.3 p-90 -155.39 177.08 11.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.621 0.724 . . . . 0.0 112.209 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -170.63 167.28 7.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.761 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.1 72.23 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.616 0.722 . . . . 0.0 110.871 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -44.54 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.568 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 p -84.6 85.17 7.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.488 0.661 . . . . 0.0 109.236 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.6 m -60.65 -22.06 63.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.719 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.41 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 9.4 m95 -70.26 -39.55 74.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.472 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 59.9 m -56.4 -43.51 79.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.742 0.782 . . . . 0.0 109.079 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' SER . 8.1 mmm180 -59.22 -38.36 79.77 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.088 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.621 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 1.3 mptp? -86.44 -8.26 57.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -89.46 -3.74 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 170.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.573 HG23 ' CH2' ' A' ' 88' ' ' TRP . 54.4 m -51.03 -50.74 73.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.536 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.8 Cg_endo -52.07 -40.55 68.0 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.122 1.881 . . . . 0.0 112.461 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.29 -41.26 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.409 . . . . 0.0 110.317 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 132' ' ' LEU . 83.1 mt -61.34 -42.43 98.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.814 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.09 -42.56 93.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.561 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -53.66 -51.49 63.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 109.665 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 133' ' ' TYR . 21.5 m -63.68 -49.47 73.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.268 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' HD12 ' A' ' 65' ' ' ILE . 23.7 t80 -56.62 -50.28 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.807 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.578 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 38.0 t30 -75.38 -29.5 59.87 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.401 -171.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.92 -19.67 28.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 40.2 m-85 -121.08 12.81 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.6 ptmt -70.06 -21.06 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -75.93 -34.06 59.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.439 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 42.6 mttp -87.19 -167.74 2.0 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.559 -175.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.62 57.63 4.18 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.036 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 88.9 t80 -141.05 147.29 38.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 9.9 t -158.97 153.14 23.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.274 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 55' ' ' TYR . 45.4 mt -106.35 134.79 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -122.1 94.77 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -85.85 126.6 7.87 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.808 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.0 m -116.21 119.6 62.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.162 0.506 . . . . 0.0 110.46 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 40.3 t -122.01 139.0 54.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.134 0.492 . . . . 0.0 111.234 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 t -116.2 59.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.095 0.95 . . . . 0.0 108.583 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.69 -178.57 1.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.238 -170.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -67.42 -50.28 60.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.28 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 47.4 mtt180 -134.11 163.95 28.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.415 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 33.3 tt0 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -32.26 73.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.269 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -66.49 -38.57 87.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -64.01 -51.06 66.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 74' ' ' GLU . 1.4 mptm? -49.86 -48.64 51.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.84 0.828 . . . . 0.0 109.781 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -65.42 -38.25 89.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.013 -177.715 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.466 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . . . -66.06 -35.98 81.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.717 0.294 . . . . 0.0 111.282 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.18 -44.13 97.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.77 -29.21 68.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.889 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 44.9 mt-10 -59.5 -60.11 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.933 0.397 . . . . 0.0 111.57 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.97 4.92 42.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.225 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 4.4 mptp? 62.1 36.52 15.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 p -77.33 72.57 3.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.932 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -86.89 81.07 8.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.573 ' CH2' HG23 ' A' ' 48' ' ' THR . 9.6 p90 -148.84 -176.63 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.782 169.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -69.48 98.91 1.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.166 0.508 . . . . 0.0 110.735 -177.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -120.15 146.52 45.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.634 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.65 150.12 34.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.799 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.63 117.33 28.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 68' ' ' VAL . 93.6 mt -70.2 135.99 49.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.171 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.673 ' O ' HG23 ' A' ' 98' ' ' VAL . 31.6 mt-30 -58.61 141.56 51.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.52 -23.6 66.92 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.726 -168.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.546 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 29.8 t70 -87.35 -36.57 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.448 173.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.9 t70 -56.04 -40.93 74.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.144 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 94' ' ' GLN . 85.3 t -49.83 -35.36 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.7 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.6 ttpm? -53.09 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.75 -41.12 99.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.78 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.965 HG22 HD12 ' A' ' 12' ' ' ILE . 73.4 t -57.72 -61.72 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.911 ' HA ' HD12 ' A' ' 107' ' ' ILE . 40.1 mt -60.16 -39.25 85.73 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.042 -175.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.93 -64.08 0.93 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.197 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.7 m -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.3 1.0 . . . . 0.0 113.524 -167.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.9 15.18 0.7 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.699 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 2' ' ' SER . 63.0 m 55.37 47.8 20.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.299 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 102' ' ' LEU . 53.9 mt -88.16 107.11 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.466 -173.007 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.02 -8.04 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.285 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.33 170.82 35.7 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.524 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.641 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 98.6 m-85 -135.31 164.15 45.84 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.6 Cg_exo -77.26 133.54 31.29 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 124.176 -1.177 . . . . 0.0 112.579 -0.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.465 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 5.3 t-160 -107.48 111.76 24.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.1 mt -125.62 131.55 71.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.239 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.588 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 45.3 pt -128.17 149.2 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.738 0.304 . . . . 0.0 110.798 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 31' ' ' TYR . 47.0 tp -112.91 111.21 21.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 73.4 t -97.17 133.0 40.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.798 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 4.1 p30 -78.0 164.78 55.09 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -53.05 -24.34 24.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.2 2.6 . . . . 0.0 114.094 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.504 ' HB2' ' HE2' ' A' ' 121' ' ' LYS . 41.3 mt-10 -77.0 -37.12 55.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 110.055 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.05 23.8 2.62 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.76 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 34.2 mtmt -107.2 155.5 19.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.79 97.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.95 -34.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.155 0.503 . . . . 0.0 110.768 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.79 158.02 42.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HE2' ' O ' ' A' ' 2' ' ' SER . 20.6 pttp -163.26 175.28 11.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 15.6 mm-40 64.69 20.76 12.23 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.413 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.435 ' HB2' HD23 ' A' ' 132' ' ' LEU . 47.7 mt -59.62 137.68 57.96 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.614 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -123.38 149.47 44.93 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.275 -170.498 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 43.45 -125.1 4.95 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.768 0.667 . . . . 0.0 114.437 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.06 -17.0 59.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.622 0.248 . . . . 0.0 110.916 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 31.0 t70 -63.31 -25.72 68.44 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 136' ' ' VAL . 75.8 mt -48.23 -58.52 4.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 109.956 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.4 ' HA ' HG23 ' A' ' 54' ' ' THR . 40.9 t80 -60.34 -50.91 71.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.481 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 92.3 m-20 -61.92 -35.19 77.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.859 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.618 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 7.5 m -74.66 -30.71 61.7 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 86.9 t -65.44 -46.31 90.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.239 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 2.3 tp10 -68.87 -23.34 64.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.442 0.639 . . . . 0.0 109.948 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 23.9 ttpt -77.0 -59.15 2.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.08 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.429 ' CD1' HG23 ' A' ' 135' ' ' THR . 47.2 m-85 -88.2 -51.4 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 61.0 t -66.96 -47.25 82.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 111.277 -173.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 2.6 t-20 -76.66 -18.09 58.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.5 0.666 . . . . 0.0 110.037 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.45 -25.66 14.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.98 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 61.28 17.16 7.97 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.862 0.465 . . . . 0.0 111.607 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 tptt 63.82 77.81 0.31 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.605 0.717 . . . . 0.0 111.503 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -103.01 155.09 18.61 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.82 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.404 ' H ' ' CD ' ' A' ' 145' ' ' GLU . . . 148.15 -45.81 0.72 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.2 m80 60.03 -165.56 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.441 0.638 . . . . 0.0 110.828 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -130.9 29.25 4.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -133.55 123.45 25.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.73 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -70.35 100.54 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -93.39 -2.66 54.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 166.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 . . . . . 0 C--O 1.245 0.842 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.559 172.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m 57.93 -163.81 0.19 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.719 0.637 . . . . 0.0 110.404 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' A' ' 122' ' ' ILE . 2.8 mm? -73.02 104.4 4.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.119 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.02 -91.12 0.23 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -147.84 128.04 13.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.32 -2.22 86.49 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -70.27 123.99 23.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.16 137.72 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.956 0.407 . . . . 0.0 110.627 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -96.51 146.54 31.49 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 27.7 Cg_exo -63.08 163.34 22.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.353 2.702 . . . . 0.0 112.535 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.03 115.66 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' SER . 65.8 mt -83.72 137.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.137 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 m -126.31 89.24 2.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.331 0.586 . . . . 0.0 110.022 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.14 161.23 14.88 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.911 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG2' ' HA2' ' A' ' 19' ' ' GLY . 52.8 mt -91.71 129.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -171.68 2.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.062 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.11 -27.05 68.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.551 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 52.0 mtpt -83.23 -49.66 9.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.052 0.453 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 15' ' ' ILE . . . 137.32 23.29 0.47 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.76 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 23.4 m-80 -102.19 149.58 24.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -80.34 99.97 8.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.479 0.657 . . . . 0.0 110.679 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.3 141.93 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.277 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.674 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 6.2 m -116.21 166.1 12.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -174.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.84 -22.67 65.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.122 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.674 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 2.6 p-10 -66.25 -28.57 68.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -72.61 -17.35 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.785 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -113.29 3.88 16.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.686 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -63.11 168.38 4.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.681 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.33 23.04 66.41 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.302 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -145.09 161.4 39.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -78.07 107.58 10.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -109.74 116.93 53.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.581 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 115' ' ' LEU . 43.8 mt -85.0 109.15 17.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 169.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 61.7 t -89.07 111.15 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.431 . . . . 0.0 109.861 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -105.86 117.13 33.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.559 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -98.73 116.1 30.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.5 p-90 -144.63 176.55 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.444 0.64 . . . . 0.0 111.77 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -170.73 168.3 7.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.225 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -28.47 68.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.72 -67.66 1.97 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.72 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.9 m -75.65 88.29 2.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.418 0.627 . . . . 0.0 109.859 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 58.8 p -75.31 11.83 1.11 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.121 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.562 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 40.1 m95 -63.02 -45.34 92.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 29.9 t -62.34 -31.11 71.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.525 0.679 . . . . 0.0 109.779 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 59.9 mtp180 -76.84 -14.08 59.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.306 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.6 mptt -85.28 -38.36 18.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.966 171.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.04 3.64 45.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.807 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 93.4 m -53.09 -50.38 82.44 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -48.24 -42.54 33.36 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.331 2.021 . . . . 0.0 113.0 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -68.89 -47.39 65.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.484 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.31 -46.65 85.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.799 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 65.4 tp -62.25 -43.11 99.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.818 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -62.05 -47.49 84.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.1 m -63.34 -48.24 78.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.003 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' A' ' 65' ' ' ILE . 89.7 t80 -58.78 -49.96 75.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 39.6 t-20 -60.13 -42.52 94.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.099 0.476 . . . . 0.0 110.546 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.26 76.47 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 77.2 m-85 -120.69 7.34 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -169.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 16.7 pttm -57.88 -33.8 69.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.359 0.6 . . . . 0.0 111.37 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.97 7.88 45.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.23 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -120.15 26.46 9.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.57 26.7 50.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.627 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 58' ' ' PHE . 66.3 t80 -134.75 142.88 46.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -152.56 165.44 35.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.034 0.445 . . . . 0.0 110.55 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 55' ' ' TYR . 56.3 mt -120.18 124.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.597 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 89' ' ' ASN . 10.9 t80 -101.21 94.51 6.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.34 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 102.71 2.81 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.137 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.88 113.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.013 0.435 . . . . 0.0 110.737 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 10.5 t -102.56 150.7 23.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.353 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 93' ' ' LEU . 7.9 t -131.52 28.58 4.62 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.159 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.37 167.94 0.87 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 16.6 mtm180 -53.75 -71.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.163 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -109.67 172.28 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.263 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 36.2 tt0 -74.3 -33.11 63.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.73 -41.2 97.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.012 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 72' ' ' ARG . 59.7 m-20 -60.85 -49.37 77.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.997 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 24.0 t90 -57.75 -47.87 81.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.108 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.7 mptm? -62.17 -41.6 98.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.419 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 9.6 tmtm? -70.41 -37.99 74.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.55 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.64 75.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.18 -33.98 55.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.533 0.683 . . . . 0.0 110.408 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -28.84 70.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.014 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 38.9 mt-10 -84.03 -59.98 2.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.619 0.247 . . . . 0.0 110.878 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.85 -22.25 56.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.488 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm 70.88 32.39 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -67.44 100.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.665 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -118.13 74.58 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 111.893 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.546 ' HH2' HG23 ' A' ' 48' ' ' THR . 3.3 p90 -133.94 -154.07 0.57 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 11.6 m120 -72.45 80.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.355 0.525 . . . . 0.0 110.353 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -82.69 125.24 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.2 m -134.02 143.24 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.347 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' HB2' ' CE3' ' A' ' 77' ' ' TRP . 34.3 tp -102.57 123.97 47.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 70' ' ' THR . 93.0 mt -63.33 134.09 55.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.842 0.353 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' VAL . 36.2 mt-30 -67.69 149.27 50.22 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -62.44 -17.8 60.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.082 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.63 -48.9 8.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.416 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.68 -33.26 71.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 94' ' ' GLN . 44.3 t -47.01 -43.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.7 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -60.74 -63.04 1.44 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.878 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.21 -33.1 63.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 55.7 t -70.01 -57.37 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.463 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.646 HD22 HG12 ' A' ' 107' ' ' ILE . 26.6 mt -59.7 -47.37 85.9 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.235 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.76 -61.82 2.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.259 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 106' ' ' CYS . 19.0 t -62.82 -28.24 69.87 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.344 1.027 . . . . 0.0 112.805 -167.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 24.4 m-85 -74.93 8.63 2.36 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.752 0.31 . . . . 0.0 110.634 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.43 ' H ' ' C ' ' A' ' 104' ' ' SER . 95.4 m 58.22 58.62 3.4 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.089 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.646 HG12 HD22 ' A' ' 102' ' ' LEU . 1.2 mp -75.4 116.73 18.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.583 0.706 . . . . 0.0 110.569 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.45 -21.04 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.128 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.79 178.25 41.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.48 151.38 77.24 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 55.6 Cg_endo -87.98 128.5 9.27 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.681 0.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.8 95.81 10.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.064 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 81.9 mt -113.47 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.506 . . . . 0.0 110.914 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 31.2 pt -114.45 148.76 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.537 -176.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.2 tt -95.48 111.61 23.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 97.9 t -107.91 132.62 55.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.65 163.74 51.85 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.417 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.48 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 82.0 Cg_exo -48.01 -31.24 15.54 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.355 2.703 . . . . 0.0 114.46 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.552 ' HB3' ' CE ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -88.39 -1.57 58.11 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 88.45 29.23 19.9 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.838 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.552 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 11.1 mtmm -110.72 138.26 47.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 3' ' ' LEU . 28.5 mt -75.12 118.4 20.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.483 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.411 ' HB ' HD22 ' A' ' 115' ' ' LEU . 27.9 t -94.96 -38.32 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.89 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.317 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 18.3 pttm -150.15 147.1 27.33 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.935 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 61.97 35.79 15.98 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.502 1.126 . . . . 0.0 111.555 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.49 141.64 57.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.97 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -97.16 166.05 11.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.139 -174.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -35.96 -72.61 0.13 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.2 -35.91 69.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.923 0.362 . . . . 0.0 110.432 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -55.78 -46.15 78.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.727 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.3 pp -66.85 -38.78 87.03 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.452 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.3 t80 -65.34 -50.8 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -57.4 -42.14 81.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.716 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.2 m -69.04 -47.01 66.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.546 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' LEU . 52.5 t -64.79 -43.91 96.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 4.3 tt0 -63.85 -39.27 93.83 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -57.82 -33.27 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.385 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -87.69 -61.84 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.91 -40.39 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.74 -170.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 137' ' ' GLU . 61.9 t30 -84.28 -32.77 24.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.3 25.74 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.157 -0.928 . . . . 0.0 113.459 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.39 -7.32 44.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.483 . . . . 0.0 109.903 174.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -56.85 120.83 8.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.538 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.737 ' OE1' ' HA ' ' A' ' 149' ' ' HIS . 7.2 tp10 -59.44 140.32 56.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.811 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 105.14 -41.47 2.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.164 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 4.1 t-80 -67.5 -37.62 83.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -154.49 101.77 2.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.141 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.737 ' HA ' ' OE1' ' A' ' 145' ' ' GLU . 31.9 p80 -49.37 131.15 20.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.924 -170.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.07 -20.64 30.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.503 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -150.93 -162.32 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.711 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 p80 . . . . . 0 C--O 1.246 0.873 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.89 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.733 ' HA ' ' HB3' ' A' ' 106' ' ' CYS . 13.9 m -89.27 131.13 35.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.774 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 7' ' ' SER . 73.1 mt -113.94 154.14 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.02 -79.61 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.149 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 2.9 t -153.74 137.19 15.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.562 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.5 -1.29 88.94 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB3' HD22 ' A' ' 3' ' ' LEU . 6.8 m -82.01 128.25 33.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.095 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 48.7 t -69.04 129.66 33.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.83 0.348 . . . . 0.0 110.123 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -93.45 141.6 24.12 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.441 -177.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 22.4 Cg_exo -66.12 163.3 32.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.167 2.578 . . . . 0.0 111.96 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.71 113.92 24.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.011 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.6 141.9 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -120.64 105.12 10.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.914 0.388 . . . . 0.0 110.05 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.76 167.94 14.5 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.811 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.8 mt -105.61 128.09 59.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -173.13 4.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.035 0.445 . . . . 0.0 111.273 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' ILE . 75.0 mt -64.6 -30.38 71.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.965 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.14 -32.86 59.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.33 22.01 6.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -95.15 141.19 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 p -82.31 106.01 13.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.77 146.31 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.859 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 m -112.57 157.43 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.172 0.51 . . . . 0.0 111.202 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 32' ' ' VAL . 62.5 tp -61.96 -24.71 67.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 8.4 t30 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.12 -9.83 59.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.441 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -113.88 1.63 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.34 . . . . 0.0 110.51 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' CD ' ' HA ' ' A' ' 25' ' ' ASN . 26.3 mtpp -63.61 171.21 2.74 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.395 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.21 83.03 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.583 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -137.55 165.47 26.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.51 114.04 14.79 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 24' ' ' LEU . 46.4 t -111.18 111.7 37.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.015 0.435 . . . . 0.0 111.31 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.559 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.3 tp -90.75 113.88 26.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 42.8 t -102.47 119.45 50.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.438 0.161 . . . . 0.0 110.942 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.39 116.81 33.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.86 116.87 29.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.485 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.98 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 11.7 p-90 -150.61 -178.4 6.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HE1' ' HB2' ' A' ' 110' ' ' PHE . 2.2 p90 -170.58 160.08 7.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.926 169.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.52 6.72 3.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.87 -16.73 67.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.086 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 96.3 m -120.88 121.43 38.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.029 0.443 . . . . 0.0 110.483 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 3.8 m -59.11 -33.36 70.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.459 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -66.73 -31.51 72.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.538 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 72.9 m -58.45 -41.12 84.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -85.12 -12.12 53.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.5 mptp? -75.69 -28.76 58.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.901 0.382 . . . . 0.0 110.311 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 11.8 mm-40 -79.9 -16.12 55.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.329 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 90.8 m -50.48 -52.13 58.11 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 52.7 Cg_exo -53.0 -42.08 67.02 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.133 1.888 . . . . 0.0 112.803 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 95.7 m-85 -69.11 -38.26 78.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 132' ' ' LEU . 79.2 mt -63.35 -50.32 70.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 50.5 tp -59.19 -40.54 86.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.475 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -52.2 -51.94 55.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.829 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -68.04 -43.66 78.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.445 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.9 t80 -60.93 -48.8 80.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.47 -29.02 69.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.51 -38.05 55.79 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.467 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 94.4 m-85 -120.23 6.74 10.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -61.65 -36.59 81.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.364 0.602 . . . . 0.0 110.84 -176.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.573 ' N ' ' HG2' ' A' ' 59' ' ' LYS . 2.9 p30 -82.76 6.78 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 58' ' ' PHE . 55.1 mttp -116.5 15.28 15.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.12 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.53 30.98 25.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.719 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 49.5 t80 -133.89 143.33 48.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -146.92 163.78 35.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 109.955 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 55' ' ' TYR . 20.2 mt -116.57 125.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.896 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 57.9 t80 -108.41 99.23 8.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.324 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' NE2' ' A' ' 90' ' ' GLN . . . -87.15 135.19 13.01 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.019 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 93' ' ' LEU . 3.2 m -133.4 112.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.574 0.702 . . . . 0.0 110.886 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 92' ' ' LEU . 29.7 t -113.12 154.62 26.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.776 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.9 t -123.91 41.41 3.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.739 0.781 . . . . 0.0 109.018 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.05 169.88 0.15 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -60.66 -38.46 84.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.589 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 38.5 mtt180 -144.72 169.27 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.045 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 1.12 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 31.7 tt0 -75.64 -41.06 55.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 mp0 -60.78 -36.18 78.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 18.4 t0 -66.65 -48.62 68.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.322 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.665 ' HZ2' ' HG3' ' A' ' 90' ' ' GLN . 34.2 t90 -56.77 -48.25 78.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.143 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 1.12 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 1.6 mptp? -58.83 -38.08 77.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.214 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -60.92 -45.53 94.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.896 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.68 -44.73 96.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.096 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.431 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 70.0 mt -64.34 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.244 0.545 . . . . 0.0 110.753 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.88 -31.19 72.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.305 0.574 . . . . 0.0 110.306 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 41.7 mt-10 -80.32 -53.03 7.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.392 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 81' ' ' ILE . 13.4 p-10 -91.52 -17.98 24.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.67 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER 67.41 38.5 3.19 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.305 0.574 . . . . 0.0 111.221 -179.212 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.3 p -72.76 67.62 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.325 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.12 85.57 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 52' ' ' LEU . 7.4 p90 -141.04 -149.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.01 64.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.713 0.688 . . . . 0.0 109.849 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' ' HZ2' ' A' ' 77' ' ' TRP . 8.6 tp-100 -90.97 123.42 34.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.242 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.72 152.72 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.188 0.518 . . . . 0.0 110.888 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 69' ' ' SER . 45.4 tp -90.3 129.88 36.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.574 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 68' ' ' VAL . 79.5 mt -70.03 125.3 26.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.2 mt-30 -65.12 147.93 52.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.6 -16.75 63.96 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.867 0.365 . . . . 0.0 111.144 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.27 -49.43 8.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.45 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -50.91 -36.73 39.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.061 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' GLN . 25.1 t -45.01 -41.85 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.456 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 9.6 mtmp? -56.24 -64.27 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 111.682 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.7 -36.44 65.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.906 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 105' ' ' TYR . 55.7 t -68.72 -55.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.257 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.673 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 15.8 mt -60.4 -42.18 95.4 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.555 -175.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -62.04 -62.07 2.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.519 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.2 m -55.59 -32.11 62.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HE2' HG13 ' A' ' 101' ' ' VAL . 62.8 m-85 -83.03 22.14 0.98 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.763 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.733 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 26.7 p 47.96 48.85 17.69 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.38 1.072 . . . . 0.0 110.56 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 79.6 mt -97.67 110.73 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.689 -175.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.56 18.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.43 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.69 -178.43 41.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.596 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.475 ' HB2' ' HE1' ' A' ' 38' ' ' PHE . 97.7 m-85 -134.84 157.39 77.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.937 0.369 . . . . 0.0 110.293 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.61 168.85 25.87 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.762 -1.349 . . . . 0.0 112.91 -1.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.671 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.6 128.97 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 125' ' ' LYS . 41.7 pt -123.11 153.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.64 113.35 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.1 t -101.1 140.58 19.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.598 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.74 167.29 30.78 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.04 -35.27 50.09 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.82 2.347 . . . . 0.0 113.969 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.4 mt-10 -79.46 -24.23 42.53 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.511 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.36 27.99 3.44 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.538 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -106.05 148.32 27.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.791 0.795 . . . . 0.0 109.309 172.369 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' THR . 38.2 mt -80.3 104.52 8.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.88 -28.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.75 138.47 30.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.774 ' HG3' HG22 ' A' ' 114' ' ' ILE . 20.8 ttpp -129.81 155.5 45.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.327 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 125' ' ' LYS . 2.3 mm-40 66.08 42.95 3.05 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.897 0.748 . . . . 0.0 110.931 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB3' HD23 ' A' ' 132' ' ' LEU . 83.2 mt -82.16 156.07 24.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.876 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.759 ' HD3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -162.28 167.28 24.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.955 -172.765 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 44.02 -129.65 6.72 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.933 0.771 . . . . 0.0 113.944 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -77.03 -24.21 52.1 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.62 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 12.5 m-20 -53.67 -27.27 26.62 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.287 0.367 . . . . 0.0 110.43 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 136' ' ' VAL . 71.6 mt -56.18 -64.57 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.357 0.598 . . . . 0.0 109.736 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -58.34 -42.65 87.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.981 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 1.9 t-20 -51.13 -52.32 44.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.483 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -72.26 -34.24 68.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.176 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 132' ' ' LEU . 56.2 t -71.71 -42.31 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.879 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.576 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 3.9 tp10 -61.17 -34.85 75.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.77 0.795 . . . . 0.0 109.364 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 12.9 ttmt -64.17 -51.04 65.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.57 -54.86 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.83 -48.52 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 111.405 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 35.2 t30 -76.4 -23.83 54.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.42 0.629 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.38 14.46 34.56 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.391 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.0 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.061 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.3 -77.76 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -90.12 -0.53 57.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -174.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.86 162.81 53.12 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.511 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -73.77 84.06 1.64 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.216 0.531 . . . . 0.0 110.217 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -81.68 151.53 27.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.263 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -80.67 132.91 35.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.55 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -99.89 163.36 12.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.444 ' CG ' ' H ' ' A' ' 152' ' ' HIS . 8.4 p80 -119.89 -78.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.994 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.444 ' H ' ' CG ' ' A' ' 151' ' ' HIS . 7.7 t60 . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t -78.19 88.28 4.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.242 0.544 . . . . 0.0 109.759 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.548 ' HB2' HD12 ' A' ' 122' ' ' ILE . 72.6 mt -78.53 133.84 37.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.271 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.73 -168.81 1.5 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.342 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -64.51 111.2 2.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.92 1.81 52.08 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.447 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 3' ' ' LEU . 19.4 m -87.58 131.66 34.33 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.774 -0.25 . . . . 0.0 110.424 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 52.0 t -69.64 132.82 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -100.28 148.35 34.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.553 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 30.0 Cg_exo -64.35 163.21 27.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.566 2.844 . . . . 0.0 112.516 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.28 131.75 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.592 HD12 HG22 ' A' ' 101' ' ' VAL . 18.1 mm -87.33 148.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -133.61 94.23 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.322 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 175.9 16.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.646 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.97 117.07 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.27 -174.8 5.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.026 0.441 . . . . 0.0 111.438 -171.674 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.32 -30.61 66.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.789 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -69.27 -25.68 64.39 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.053 0.454 . . . . 0.0 111.067 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.07 20.89 29.31 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -103.18 148.84 25.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -77.3 97.97 5.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.93 137.41 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.197 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -176.83 3.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -79.42 -28.94 41.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.202 0.525 . . . . 0.0 110.198 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -66.82 -19.92 65.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.258 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.62 -31.87 71.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 111.204 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -115.62 20.55 14.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.413 0.625 . . . . 0.0 109.78 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 57.5 tttp -84.06 66.76 9.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.991 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.05 17.91 0.19 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.875 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -149.64 175.21 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -80.27 112.57 17.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.42 114.32 37.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.164 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 tp -92.03 109.85 21.21 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 33.6 t -91.19 117.47 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.822 0.344 . . . . 0.0 110.945 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.93 103.04 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.348 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HA ' HG23 ' A' ' 68' ' ' VAL . 39.3 m-85 -82.19 114.72 20.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 11.4 p-90 -155.08 173.68 16.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 122.186 0.993 . . . . 0.0 112.731 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -164.71 154.15 13.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.894 -1.957 . . . . 0.0 107.064 165.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.43 -29.35 66.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.09 -38.19 95.15 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.063 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.1 p -87.55 96.62 10.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.407 0.622 . . . . 0.0 110.231 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.552 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.3 m -68.15 -11.2 58.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.155 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -69.82 -42.46 73.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.91 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . 20.7 p -67.84 -29.6 68.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 6.6 mmp_? -75.57 -14.29 60.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.135 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.6 mptm? -79.13 -21.68 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.732 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -94.92 -3.58 48.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.255 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 94.1 m -51.16 -51.52 67.33 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.346 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.0 Cg_endo -51.72 -39.05 67.49 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.374 2.05 . . . . 0.0 112.495 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.18 -39.77 62.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.989 0.423 . . . . 0.0 110.629 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 113' ' ' ILE . 97.0 mt -63.18 -45.49 91.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.275 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.37 -41.36 96.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.511 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -57.74 -53.29 59.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.396 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD1' ' A' ' 133' ' ' TYR . 19.6 m -61.93 -42.51 99.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.116 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.641 ' HB2' HD12 ' A' ' 65' ' ' ILE . 56.4 t80 -59.73 -56.32 23.36 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.523 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 28.0 m-80 -58.08 -35.43 71.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.66 48.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 92.5 m-85 -120.2 0.78 10.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 60' ' ' ASP . 14.6 ptmm? -60.18 161.6 6.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.241 0.543 . . . . 0.0 111.048 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 32.0 m-20 73.7 -49.69 0.68 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.8 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 44.4 mttp -60.64 -88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.786 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.36 15.79 3.9 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.788 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.97 141.59 44.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -150.6 149.54 30.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.253 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -103.21 129.74 54.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.966 0.412 . . . . 0.0 110.172 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t80 -119.35 98.89 6.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.001 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.74 122.57 6.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.191 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.61 ' HB ' HD21 ' A' ' 93' ' ' LEU . 15.4 m -100.43 111.88 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.656 0.741 . . . . 0.0 110.126 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -104.76 136.51 44.14 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.369 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.552 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.7 t -122.62 32.38 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.045 0.926 . . . . 0.0 109.065 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.4 175.78 0.54 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.285 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -79.05 -57.77 3.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.315 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB3' ' OD2' ' A' ' 76' ' ' ASP . 22.5 tpt180 -123.78 152.01 42.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.317 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 17.1 tt0 -64.7 -35.04 79.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.483 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -58.22 -47.07 84.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.739 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 2.1 p30 -73.51 -36.19 65.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.743 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.463 ' O ' HG12 ' A' ' 81' ' ' ILE . 26.6 t90 -54.4 -54.83 35.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -57.94 -43.13 86.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.87 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -57.0 -50.1 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.764 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.14 88.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 77' ' ' TRP . 39.3 mm -59.82 -39.95 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.108 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.91 -32.76 63.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.27 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.67 -49.34 14.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.125 0.488 . . . . 0.0 110.897 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.97 -19.6 60.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.903 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt 64.3 27.09 13.77 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.312 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 p -87.99 82.32 7.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.11 87.7 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.559 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -150.97 -159.66 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.853 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.24 83.94 7.24 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.357 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -94.74 136.12 35.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.928 0.394 . . . . 0.0 110.695 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 25.5 m -125.83 137.3 58.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.689 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.2 tp -87.79 116.07 25.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 68' ' ' VAL . 74.5 mt -57.45 130.86 48.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.487 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 98' ' ' VAL . 66.1 mt-30 -64.63 151.94 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.9 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.006 0.432 . . . . 0.0 111.869 -170.516 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.68 -42.85 12.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.9 t70 -54.07 -31.65 52.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.464 0.705 . . . . 0.0 111.793 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 94' ' ' GLN . 52.6 t -48.0 -33.99 4.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.175 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 54.9 mttp -57.67 -65.62 0.6 Allowed 'General case' 0 C--O 1.223 -0.319 0 O-C-N 123.035 0.209 . . . . 0.0 111.495 -175.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 104' ' ' SER . 24.9 t70 -63.02 -43.48 98.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.394 -170.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 12' ' ' ILE . 37.0 t -53.95 -63.21 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.25 0.548 . . . . 0.0 110.397 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 40.4 mt -66.61 -42.12 87.34 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 12.8 mt-10 -67.34 -64.17 0.91 Allowed 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 122.009 -0.432 . . . . 0.0 111.144 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 38.6 m -62.26 -32.55 73.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB2' HG12 ' A' ' 107' ' ' ILE . 74.7 m-85 -77.48 7.7 5.14 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.723 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m 61.85 53.35 3.15 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.246 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.7 mm -105.43 98.99 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.905 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.87 13.36 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.772 0.796 . . . . 0.0 110.739 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.64 -162.61 34.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.641 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.39 156.17 69.74 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.969 0.384 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB3' ' A' ' 44' ' ' CYS . 82.7 Cg_endo -96.63 164.12 14.18 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.102 -1.208 . . . . 0.0 113.13 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -145.11 130.74 18.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 51' ' ' LEU . 70.5 mt -128.27 113.37 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.759 0.314 . . . . 0.0 110.835 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.832 HG22 ' HG3' ' A' ' 125' ' ' LYS . 42.1 pt -112.51 156.57 13.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.359 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.8 118.56 31.16 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -112.28 136.36 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -78.59 166.76 40.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.018 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -50.51 -44.05 41.76 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.871 2.381 . . . . 0.0 113.561 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.0 mt-10 -65.21 -29.6 70.42 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.046 -0.409 . . . . 0.0 110.589 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.35 33.04 2.6 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.418 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.629 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -110.51 146.56 35.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.97 0.885 . . . . 0.0 109.194 170.893 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.548 HD12 ' HB2' ' A' ' 3' ' ' LEU . 25.6 mt -71.17 116.34 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.946 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.44 -37.44 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.25 24.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.832 ' HG3' HG22 ' A' ' 114' ' ' ILE . 88.7 tttt -123.7 128.16 49.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.51 . . . . 0.0 111.337 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.539 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 44.1 mt-10 58.72 74.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.71 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.779 ' HB2' HD23 ' A' ' 132' ' ' LEU . 43.8 mt -91.3 155.34 18.6 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.529 HH12 ' HG2' ' A' ' 111' ' ' PRO . 28.4 mmt180 -128.07 161.7 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.25 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 50.92 -137.78 27.14 Favored Glycine 0 N--CA 1.452 -0.26 0 O-C-N 123.983 0.802 . . . . 0.0 113.168 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.37 -16.43 58.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 17.7 m-20 -60.52 -27.26 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.283 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 ' HB2' ' A' ' 127' ' ' LEU . 23.6 mt -51.45 -58.18 6.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.742 167.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 54' ' ' THR . 67.3 t80 -62.81 -48.75 77.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 89.3 m-20 -51.7 -47.18 64.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 m -67.84 -44.07 78.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.5 t -63.94 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 15.7 tt0 -66.28 -44.09 84.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 0.0 110.564 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -59.87 -29.14 68.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 -60.66 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.0 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.7 -44.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.461 ' CB ' ' HG3' ' A' ' 137' ' ' GLU . 52.3 t-20 -62.31 -50.63 70.9 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.66 -166.5 51.47 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.06 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.21 122.9 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.59 1.84 6.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.462 . . . . 0.0 110.498 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -85.94 -36.71 19.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.669 -173.637 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 122.03 64.15 0.23 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.795 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.86 -30.79 71.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -80.94 95.55 6.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.019 0.438 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -84.75 179.48 7.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.64 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -151.84 48.95 0.79 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 109.654 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -173.62 -55.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.037 176.479 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' HE2' ' HG3' ' A' ' 125' ' ' LYS . 25.1 ptp . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.668 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 9.5 m -123.95 -1.67 8.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.33 0.586 . . . . 0.0 109.711 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.428 ' HG ' ' SG ' ' A' ' 106' ' ' CYS . 98.4 mt -106.98 155.73 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.665 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.25 -171.28 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.13 0.491 . . . . 0.0 111.238 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.963 HG23 ' HA ' ' A' ' 123' ' ' VAL . 90.7 m -104.26 130.17 52.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.886 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.67 -10.5 45.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.779 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -77.95 127.06 31.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 54.8 t -69.7 132.87 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.537 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 105' ' ' TYR . . . -88.2 146.5 38.27 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.591 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.8 Cg_exo -61.82 163.3 19.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.315 2.676 . . . . 0.0 112.094 173.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 130.73 34.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.36 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' SER . 51.7 mt -94.1 138.88 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.146 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.17 101.42 8.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 0.0 110.55 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.84 156.59 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.783 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -98.98 122.21 50.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.507 ' CG ' ' HZ2' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -80.84 -175.3 5.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.023 0.439 . . . . 0.0 111.282 -173.854 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.37 -31.65 69.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.991 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.507 ' HZ2' ' CG ' ' A' ' 16' ' ' ASP . 8.8 mtmp? -80.11 -18.66 49.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 111.294 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 25.73 13.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.119 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -97.97 144.18 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 94.57 6.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.039 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.29 143.24 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.816 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 15.7 m -119.47 170.35 9.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.72 0.295 . . . . 0.0 110.274 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 34.6 tp -68.17 -7.74 32.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.207 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 28.3 p-10 -65.52 -32.37 73.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.39 -31.82 71.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.683 0.754 . . . . 0.0 111.087 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.493 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 95.1 m-85 -85.07 -2.92 58.54 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 120' ' ' GLY . 51.4 mttt -84.03 99.55 10.51 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.371 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 118' ' ' PRO . . . 132.94 -9.13 5.17 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -121.01 165.55 15.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.32 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.92 117.37 23.89 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 8.5 t -109.32 115.82 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.866 0.365 . . . . 0.0 111.856 -169.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 132' ' ' LEU . 34.3 tp -97.01 105.02 17.09 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 15.8 t -96.45 108.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.938 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -102.98 116.83 33.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.26 121.37 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.177 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 69' ' ' SER . 29.9 p-90 -152.97 -178.24 6.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -175.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -168.73 162.8 11.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.487 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -30.95 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.65 65.22 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.801 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.92 99.64 6.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.162 0.506 . . . . 0.0 110.634 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.514 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 59.2 m -63.6 -35.04 79.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.384 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 71.3 t-105 -60.67 -33.95 73.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.452 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 111' ' ' PRO . 58.3 m -60.08 -37.88 81.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.504 0.669 . . . . 0.0 110.341 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.706 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 42.2 mtm180 -84.96 -12.21 53.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.648 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 43' ' ' TRP . 51.5 mmtt -70.76 -21.74 62.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.201 0.524 . . . . 0.0 110.865 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.09 -2.05 58.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.973 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 86.7 m -52.48 -49.0 88.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 71.6 Cg_exo -50.68 -44.53 40.11 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.011 1.807 . . . . 0.0 112.454 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -69.27 -39.22 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.71 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.47 -48.57 80.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.41 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.22 -40.42 85.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.43 -50.9 70.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -62.18 -46.56 88.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.449 ' HB2' HD12 ' A' ' 65' ' ' ILE . 60.6 t80 -55.53 -51.98 65.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.011 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -67.42 -25.97 66.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.83 -27.94 30.53 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 92.9 m-85 -120.59 1.28 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 59.5 pttt -61.35 -27.57 68.6 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.112 0.482 . . . . 0.0 111.786 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.14 -6.5 59.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.275 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -110.92 31.41 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.424 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 39.21 64.81 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.575 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 51.0 t80 -135.6 140.42 44.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 t -150.06 147.51 27.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.293 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -87.61 126.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -97.85 93.9 6.61 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -78.11 107.15 2.4 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.826 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -106.96 111.97 37.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 120.734 0.302 . . . . 0.0 110.421 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 32.6 t -116.06 160.01 20.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.047 0.451 . . . . 0.0 110.43 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.516 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.3 t -131.31 30.44 4.49 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.493 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -51.84 147.95 6.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.553 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -78.93 -10.75 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.019 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 46.7 mtm180 -137.72 149.4 46.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.653 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 15.8 tt0 -72.68 -32.9 66.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 1.7 mp0 -60.34 -40.89 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.084 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.36 -37.16 68.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.019 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -61.33 -51.2 69.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.306 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -59.17 -39.24 81.88 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.901 0.381 . . . . 0.0 110.419 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 4.0 ttpm? -61.89 -48.45 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.742 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.35 75.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.373 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.11 -41.24 91.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.268 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -70.82 -37.59 73.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.4 mt-10 -54.22 -48.28 71.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.262 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.706 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.7 m-20 -104.02 0.81 30.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 63.2 mmtt 58.61 34.76 24.09 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.6 p -82.67 75.79 9.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.475 0.655 . . . . 0.0 111.048 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 69.3 m-85 -87.85 89.47 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.507 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -158.55 -177.15 6.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.04 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.57 100.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 41.0 mt-30 -123.78 151.71 43.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.678 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.86 154.51 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.824 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.85 130.33 46.03 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.516 HD12 ' HB ' ' A' ' 70' ' ' THR . 80.9 mt -65.32 140.24 58.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.693 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.2 mt-30 -73.08 157.98 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -57.94 -36.82 73.05 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.84 -31.14 18.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.67 0.271 . . . . 0.0 111.075 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -35.89 82.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.217 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 87.0 t -48.5 -45.82 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.014 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.16 -62.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.531 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.98 -55.45 12.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.38 -51.91 29.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 O-C-N 123.345 0.403 . . . . 0.0 111.927 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 34.8 mt -61.97 -51.39 68.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.943 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.79 -60.3 4.06 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.389 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.1 m -50.67 -38.26 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.054 0.942 . . . . 0.0 113.385 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.464 ' HE1' ' HB1' ' A' ' 9' ' ' ALA . 17.2 m-85 -78.05 13.74 1.34 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.354 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 2' ' ' SER . 34.9 m 63.47 44.19 5.5 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.785 0.678 . . . . 0.0 109.614 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 61.2 mt -105.94 92.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.137 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.3 -0.01 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.787 0.803 . . . . 0.0 109.013 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.75 155.66 26.64 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.026 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.64 152.73 79.1 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 44' ' ' CYS . 92.0 Cg_endo -85.51 134.21 18.21 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.593 -1.419 . . . . 0.0 112.736 -0.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -103.32 114.0 27.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 132' ' ' LEU . 61.8 mt -113.97 130.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 29.6 pt -133.34 143.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.3 tp -107.47 118.01 35.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 60.3 t -107.31 138.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.611 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -84.36 167.98 24.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 2.3 Cg_endo -46.01 -42.61 20.67 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.184 2.589 . . . . 0.0 114.195 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.503 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 40.7 mt-10 -76.4 -24.54 54.07 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 122.175 -0.328 . . . . 0.0 111.497 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 109.6 33.13 2.74 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.867 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 119' ' ' GLU . 2.1 mptt -100.59 149.45 23.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.774 0.787 . . . . 0.0 109.476 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 5' ' ' THR . 50.7 mt -85.37 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.321 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.963 ' HA ' HG23 ' A' ' 5' ' ' THR . 4.9 p -86.09 -50.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -115.64 153.97 30.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.455 ' HG3' ' HE2' ' A' ' 1' ' ' MET . 13.1 pttm -169.46 153.75 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.148 -173.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' CG ' ' HB3' ' A' ' 1' ' ' MET . 2.7 mm-40 68.43 13.79 9.04 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.273 0.983 . . . . 0.0 111.413 176.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.573 HD11 ' HB1' ' A' ' 124' ' ' ALA . 68.2 mt -70.28 156.78 38.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.814 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 3.5 mmp_? -101.22 170.45 8.24 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.58 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 132' ' ' LEU . . . -47.23 -68.49 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.29 -31.16 69.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 0.0 110.187 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.91 -38.7 92.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.094 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 33' ' ' LEU . 63.6 mt -52.16 -51.06 60.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.24 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -59.09 -50.72 72.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -61.91 -42.44 99.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.276 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.598 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 15.9 m -72.78 -39.67 66.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.727 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 132' ' ' LEU . 72.6 t -67.18 -35.61 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 3.3 tp10 -59.76 -55.17 37.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 18.8 pttp -63.31 -17.33 62.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.058 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.96 -61.43 1.71 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 173.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.5 t -82.24 -36.31 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 51.3 t-20 -71.15 -63.4 1.11 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 39.89 -135.42 1.86 Allowed Glycine 0 C--N 1.337 0.617 0 O-C-N 124.413 1.071 . . . . 0.0 114.662 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.55 128.12 54.54 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -138.58 -17.24 1.13 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -171.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -93.71 -27.13 16.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.679 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.83 147.34 48.49 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.254 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -59.64 109.33 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -78.92 163.72 25.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.028 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -81.37 145.5 30.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 1.8 p80 -62.19 154.73 26.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.0 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -93.31 -18.29 22.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.509 ' C ' ' HD1' ' A' ' 150' ' ' HIS . 10.5 m-70 . . . . . 0 C--O 1.241 0.622 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HA ' ' SG ' ' A' ' 106' ' ' CYS . 27.2 ptm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -133.26 -75.66 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.815 0.34 . . . . 0.0 110.13 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 7' ' ' SER . 68.7 mt -105.55 143.8 33.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.25 -90.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.54 0.21 . . . . 0.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -127.38 128.97 46.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.18 89.96 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB3' HD22 ' A' ' 3' ' ' LEU . 5.5 m -84.43 140.95 31.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.456 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.42 127.32 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.81 0.338 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 124.96 59.25 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.166 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 25.1 Cg_exo -63.47 158.54 44.86 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.741 2.294 . . . . 0.0 112.311 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 116.13 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.941 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 101' ' ' VAL . 43.3 mm -96.29 150.64 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.166 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 9.0 t -131.19 138.91 49.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.85 29.05 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.644 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 92' ' ' LEU . 66.6 mt -79.73 113.87 19.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 11.9 p30 -81.92 179.1 7.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.721 -173.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.28 -15.59 60.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.693 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 2.0 mppt? -77.23 -32.76 56.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 109.722 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.91 18.41 4.72 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.985 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 7.0 m120 -113.97 149.08 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.718 0.294 . . . . 0.0 110.6 -177.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.81 90.58 6.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 p -106.36 166.14 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.984 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.708 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 8.3 m -105.13 173.97 6.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.65 HD11 HG11 ' A' ' 32' ' ' VAL . 63.1 tp -57.04 -23.11 44.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 3.3 p-10 -65.59 -16.9 64.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.29 -36.56 78.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 0.0 110.75 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -119.71 10.97 11.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 48.6 tttp -72.7 121.94 20.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.509 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.96 -23.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 27.5 mttm -103.09 174.71 5.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.22 109.32 5.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 165.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.65 HG11 HD11 ' A' ' 24' ' ' LEU . 57.5 t -94.52 108.07 20.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.18 -171.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.4 tp -85.64 109.94 18.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' ILE . 39.6 t -88.73 121.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.253 0.549 . . . . 0.0 110.369 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -104.99 108.99 20.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.007 -172.625 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.495 ' HZ ' ' HD2' ' A' ' 105' ' ' TYR . 88.1 m-85 -94.37 115.11 27.27 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 5.0 p-90 -155.64 176.59 12.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 0.0 111.475 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -170.07 149.25 3.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.109 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . . . -72.7 5.05 3.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.986 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.13 -14.39 56.16 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.9 t -99.35 134.36 42.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -67.37 -40.26 85.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.439 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -75.36 -28.5 59.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.657 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 85.6 m -58.54 -37.65 76.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.533 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.62 -21.27 66.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.323 0.582 . . . . 0.0 110.714 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.3 mptp? -86.35 -31.9 21.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -78.91 -25.27 43.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.049 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.5 m -50.98 -51.21 69.59 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 73.1 Cg_exo -52.05 -39.58 69.83 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.278 1.985 . . . . 0.0 112.988 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -71.19 -35.32 71.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 110.813 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.719 HD21 HD13 ' A' ' 113' ' ' ILE . 89.5 mt -66.77 -44.66 80.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.345 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.27 -44.31 92.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.358 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 34.2 ttpt -53.52 -56.36 17.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.707 175.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.4 m -65.22 -42.8 93.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.51 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HB2' HD12 ' A' ' 65' ' ' ILE . 83.3 t80 -61.95 -51.64 67.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.639 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.604 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 49.4 t30 -55.7 -42.17 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.291 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 70.3 m-85 -106.72 -1.12 23.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 56' ' ' ASN . 12.0 pttp -62.85 -25.79 68.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.078 0.466 . . . . 0.0 110.574 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -23.26 64.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.668 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -110.85 -161.96 0.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.556 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.75 47.59 3.32 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.672 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 79.0 t80 -142.71 153.46 43.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 14.8 t -162.56 170.33 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.676 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 55' ' ' TYR . 44.4 mt -120.2 124.43 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 59.8 t80 -105.26 95.81 6.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.277 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -83.14 135.44 13.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.142 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.8 m -125.84 118.89 53.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.622 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -125.66 151.17 46.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.53 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -131.18 45.38 2.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 108.997 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 39' ' ' ALA . 1.3 m-20 -60.62 -176.5 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.9 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -62.31 -39.8 94.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.286 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 13.0 tpt180 -151.23 158.29 43.71 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.405 -171.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 25.5 tt0 -66.88 -44.94 79.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.702 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.1 pm0 -70.5 -27.81 64.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.828 0.346 . . . . 0.0 110.084 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 21.7 t0 -62.01 -42.57 99.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -68.0 -49.69 60.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.825 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -52.72 -44.43 66.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.262 0.554 . . . . 0.0 110.287 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 13.9 ttpp -61.69 -44.29 97.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.062 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.1 78.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.966 0.413 . . . . 0.0 111.193 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.46 ' HA ' ' OG ' ' A' ' 86' ' ' SER . 79.8 mt -62.53 -43.71 98.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.127 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -66.01 -38.84 89.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.72 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.7 mt-10 -58.47 -58.61 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 111.329 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.824 ' HB3' HG21 ' A' ' 48' ' ' THR . 1.1 m-20 -85.2 -5.88 59.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.366 -173.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 3.9 mptp? 61.22 34.03 18.93 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.511 0.672 . . . . 0.0 110.451 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -80.09 58.32 2.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.278 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -79.77 75.06 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.45 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 25.4 p90 -140.84 -168.35 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.709 170.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 11.2 m120 -74.46 86.86 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 -174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.7 mt-30 -113.42 148.27 36.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.43 150.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.318 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 49.0 tp -88.38 114.1 24.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.558 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 68' ' ' VAL . 85.6 mt -69.18 135.51 50.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.295 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.658 ' O ' HG23 ' A' ' 98' ' ' VAL . 61.7 mt-30 -72.11 148.26 45.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 74.2 mmtt -63.06 -30.07 71.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -169.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 22.2 t70 -83.85 -40.16 19.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.871 0.367 . . . . 0.0 110.083 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.1 t70 -56.19 -40.54 74.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.765 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 94' ' ' GLN . 96.8 t -48.39 -37.85 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.563 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 3.6 ttpp -54.74 -56.0 23.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.228 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.86 -40.47 68.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.818 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 12' ' ' ILE . 61.9 t -57.17 -60.52 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 49.4 mt -57.13 -57.26 13.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.854 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.68 -61.73 2.12 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.355 0.409 . . . . 0.0 110.711 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 106' ' ' CYS . 39.7 m -53.23 -41.51 65.46 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 124.206 0.941 . . . . 0.0 112.858 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.495 ' HD2' ' HZ ' ' A' ' 36' ' ' PHE . 6.6 m-85 -74.17 12.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.187 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 1' ' ' MET . 36.3 t 62.95 41.28 8.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.2 mm -112.64 122.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.357 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.18 21.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.665 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.01 168.23 40.97 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.391 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.6 150.7 77.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.583 0.353 . . . . 0.0 110.094 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.35 137.92 8.61 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.025 -1.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -134.09 139.18 45.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.719 HD13 HD21 ' A' ' 51' ' ' LEU . 61.5 mt -128.77 136.7 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.522 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 125' ' ' LYS . 33.0 pt -126.36 159.65 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.45 117.1 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.621 0.248 . . . . 0.0 110.636 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 117' ' ' ASP . 74.1 t -111.84 127.36 69.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.563 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 2.8 p30 -67.68 163.35 49.52 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.815 175.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -49.95 -37.21 46.13 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.309 2.673 . . . . 0.0 113.248 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.47 -36.76 83.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.349 0.595 . . . . 0.0 110.339 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.65 37.51 1.42 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.357 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.563 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.1 mtmp? -117.35 141.93 47.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.854 0.359 . . . . 0.0 110.096 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 mt -80.67 104.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.6 -40.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.2 0.524 . . . . 0.0 110.451 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.69 156.4 42.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.203 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.842 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 0.9 OUTLIER -154.22 171.89 18.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.235 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.842 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 8.7 mm-40 60.75 32.36 20.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.174 0.921 . . . . 0.0 110.32 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.64 134.79 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -77.88 147.34 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.633 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.76 -51.19 7.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.22 -34.33 76.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.6 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.76 -34.05 27.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.071 -168.492 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.5 pp -58.2 -32.47 68.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.752 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -71.18 -42.34 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -61.17 -42.71 99.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -69.06 -53.22 21.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.807 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 132' ' ' LEU . 27.4 m -61.02 -38.81 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 141' ' ' ASN . 37.0 tt0 -64.96 -41.54 95.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.346 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -66.48 -23.15 66.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.909 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.14 -61.36 1.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.5 -47.47 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.428 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 63.7 t30 -78.1 -56.88 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 110.362 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.86 67.39 1.28 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.55 129.68 5.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -173.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 30.0 mmtm -128.49 85.91 2.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.594 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -115.97 -39.26 3.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.891 -174.285 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.13 35.14 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -42.53 110.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.734 0.778 . . . . 0.0 112.222 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -117.46 3.51 12.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.114 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -154.89 126.05 7.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.443 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -169.9 99.97 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.948 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -117.51 148.81 41.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.142 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 105' ' ' TYR . 0.9 OUTLIER -71.26 74.61 0.71 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -173.115 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.518 ' HB2' HD12 ' A' ' 122' ' ' ILE . 89.4 mt 57.62 17.04 3.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 170.527 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.7 -135.12 1.22 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.452 0.168 . . . . 0.0 110.915 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -132.36 134.64 45.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.685 0.279 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.33 -11.76 68.62 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.614 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 t -78.25 151.4 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.87 129.0 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.457 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.52 139.8 41.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' A' ' 105' ' ' TYR . 51.8 Cg_exo -54.63 154.41 20.44 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.928 2.419 . . . . 0.0 112.599 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 91.68 6.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.33 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.526 HG21 HG11 ' A' ' 68' ' ' VAL . 45.6 mt -64.25 135.03 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.158 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 m -133.06 100.4 4.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 110.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.78 176.93 16.82 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.506 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.0 123.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -174.7 5.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.029 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -64.7 -25.12 67.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.62 -21.93 51.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.1 0.476 . . . . 0.0 110.894 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.24 19.66 27.59 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -96.5 145.14 25.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 p -80.99 99.36 8.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.43 131.12 54.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.873 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 m -110.4 171.57 7.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.972 0.415 . . . . 0.0 110.981 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.7 -23.81 63.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 110.409 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 8.2 t30 -64.31 -31.47 72.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.375 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -72.74 -5.22 36.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.433 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 7.23 14.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 9.0 mtpm? -71.39 92.35 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.385 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.64 -24.35 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -121.51 172.85 7.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.526 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 m-85 -78.19 116.64 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.65 ' HB ' HG23 ' A' ' 116' ' ' VAL . 22.6 t -102.92 119.85 51.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.11 0.481 . . . . 0.0 111.208 -172.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 17.4 tp -94.06 116.18 28.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 46.1 t -102.17 115.89 44.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.613 0.244 . . . . 0.0 110.947 -174.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -92.91 103.72 16.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 68' ' ' VAL . 91.6 m-85 -83.77 114.12 21.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.326 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.541 ' HZ3' HH12 ' A' ' 45' ' ' ARG . 11.1 p-90 -158.3 178.66 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.6 0.714 . . . . 0.0 112.537 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -169.82 154.25 5.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.95 171.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 86.99 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.476 0.655 . . . . 0.0 110.337 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.1 -46.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.16 101.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.41 0.624 . . . . 0.0 109.464 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 m -66.12 -7.64 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.831 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.479 ' HE1' ' HD2' ' A' ' 128' ' ' ARG . 67.4 t-105 -78.77 -23.66 45.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.4 m -58.24 -42.4 86.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.541 HH12 ' HZ3' ' A' ' 37' ' ' TRP . 4.7 mpt_? -62.74 -16.48 57.8 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.234 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 2.2 mptm? -85.38 -31.55 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -23.61 30.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.143 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 10.7 m -48.96 -50.18 63.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -47.42 -47.55 17.42 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.42 2.08 . . . . 0.0 113.041 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 67.4 m-85 -75.46 -35.4 60.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD21 HD13 ' A' ' 113' ' ' ILE . 92.0 mt -58.24 -52.61 64.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.63 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.11 -42.94 99.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.346 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HZ1' ' HE1' ' A' ' 133' ' ' TYR . 27.4 tptp -55.07 -52.15 64.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.14 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 63' ' ' PHE . 30.8 m -64.11 -45.44 88.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.147 -178.018 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -58.24 -51.59 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.24 -38.8 92.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.316 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.09 67.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 141' ' ' ASN . 21.5 m-85 -120.36 6.7 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.4 pttp -54.47 -50.34 67.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.68 -43.7 65.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.118 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.644 ' NZ ' ' HA ' ' A' ' 141' ' ' ASN . 48.4 mtpt -55.04 -71.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.46 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.07 33.12 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.4 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 78.4 t80 -137.06 139.01 41.02 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 50.3 m -149.58 141.11 23.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' TYR . 33.5 mt -98.36 135.46 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.2 t80 -121.8 95.9 4.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.843 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.5 124.3 6.52 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.979 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 1.005 ' HB ' HD21 ' A' ' 93' ' ' LEU . 17.3 m -105.65 111.51 35.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.085 0.945 . . . . 0.0 109.78 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.606 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 7.3 m -104.81 137.67 42.24 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.164 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.1 t -126.36 42.16 3.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.234 1.016 . . . . 0.0 108.868 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.606 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 8.8 m-20 -61.72 176.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.306 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -80.63 -19.09 46.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.499 -168.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 5.8 tpt85 -165.64 161.72 18.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.6 tt0 -67.16 -44.15 80.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.286 0.494 . . . . 0.0 110.119 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.57 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 1.8 mp0 -59.41 -39.61 83.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.512 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.14 -46.43 87.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.154 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.429 ' O ' HG13 ' A' ' 81' ' ' ILE . 21.0 t90 -59.08 -52.66 64.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.579 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.8 mptm? -53.81 -46.59 71.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 0.0 110.163 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.19 -42.35 94.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.378 175.659 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.57 76.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.6 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 77' ' ' TRP . 79.0 mt -63.13 -47.81 90.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -66.63 -37.69 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -58.17 -45.47 87.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.338 0.655 . . . . 0.0 111.075 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 48' ' ' THR . 15.2 t70 -87.2 -26.43 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.895 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.5 mptp? 70.99 21.09 5.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.006 0.523 . . . . 0.0 111.144 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -82.25 76.0 9.15 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.892 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -84.48 78.62 9.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.41 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -151.62 -172.61 4.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.6 m-20 -69.79 108.46 3.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.196 0.522 . . . . 0.0 111.123 -175.029 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.51 152.3 40.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.8 146.39 29.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.058 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.26 129.25 35.41 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 1.005 HD21 ' HB ' ' A' ' 68' ' ' VAL . 65.4 mt -63.92 138.47 58.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 98' ' ' VAL . 75.1 mt-30 -80.11 169.49 17.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.811 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -51.67 -46.87 63.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.6 m-20 -87.67 -33.73 18.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.616 0.246 . . . . 0.0 110.455 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.482 ' OD1' HD22 ' A' ' 93' ' ' LEU . 17.4 t70 -55.97 -45.01 79.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.2 t -49.64 -53.11 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.851 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 9.5 mtmp? -60.31 -62.79 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.48 -174.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.49 -42.06 65.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.747 -168.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.538 HG13 ' HE2' ' A' ' 105' ' ' TYR . 53.5 t -68.48 -54.4 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 121.344 -0.142 . . . . 0.0 111.233 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 48.9 mt -58.52 -43.51 89.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.047 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.23 -61.26 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.013 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.8 m -49.25 -40.59 34.78 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.555 ' HB2' HG12 ' A' ' 107' ' ' ILE . 84.8 m-85 -76.52 11.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.046 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.7 m 60.18 42.45 15.34 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 109.904 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 105' ' ' TYR . 36.1 mm -91.76 74.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.691 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.92 -19.04 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.897 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.9 148.69 20.17 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.428 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.34 155.48 48.38 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG2' ' HD1' ' A' ' 43' ' ' TRP . 2.3 Cg_endo -82.54 166.81 68.85 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.279 -0.273 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.477 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -144.39 109.08 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.106 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.512 HD13 HD21 ' A' ' 51' ' ' LEU . 79.2 mt -114.73 127.0 72.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.757 0.313 . . . . 0.0 110.267 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 46.6 pt -124.23 160.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.105 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -124.9 114.18 18.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.65 HG23 ' HB ' ' A' ' 32' ' ' VAL . 4.7 m -104.99 144.65 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.024 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.597 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.5 OUTLIER -76.07 172.91 8.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.439 177.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -51.71 -24.78 18.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.931 2.421 . . . . 0.0 113.721 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -88.61 1.01 55.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.191 -0.318 . . . . 0.0 111.796 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.04 27.54 58.05 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.709 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -111.62 142.19 44.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.128 0.49 . . . . 0.0 110.241 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 3' ' ' LEU . 39.3 mt -72.96 104.68 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.284 -173.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.87 -26.46 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 110.298 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -144.87 151.02 38.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 20.3 pttp -161.66 154.26 20.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.89 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 28.9 mt-10 62.55 29.93 17.05 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.368 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.21 165.66 22.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.273 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HD2' ' HE1' ' A' ' 43' ' ' TRP . 18.1 mmt180 -115.87 166.25 12.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -42.29 -64.18 1.62 Allowed Glycine 0 C--O 1.234 0.124 0 O-C-N 124.012 0.82 . . . . 0.0 114.432 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.02 -36.58 68.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.837 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.37 -50.24 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.6 pp -57.13 -34.4 68.36 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.872 0.368 . . . . 0.0 110.187 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 50.1 t80 -64.84 -57.43 8.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.094 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.22 -43.83 87.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 17.6 m -65.94 -49.04 69.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.897 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.24 -40.95 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.146 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 15.1 tt0 -65.29 -36.66 84.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.351 0.596 . . . . 0.0 109.897 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 14.1 ttpp -61.73 -39.94 93.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.788 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.27 -53.79 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.78 -21.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -169.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.644 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . 65.8 t30 -93.89 -62.09 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.23 116.88 0.51 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.993 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.5 -44.54 50.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.927 0.394 . . . . 0.0 111.12 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -123.11 137.53 54.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.334 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.52 18.85 2.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.107 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.0 123.36 7.56 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.213 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -70.08 109.5 4.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.255 0.55 . . . . 0.0 110.61 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -92.57 2.94 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.32 0.581 . . . . 0.0 110.011 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -78.8 68.5 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -155.1 6.65 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.704 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.9 t60 61.78 79.6 0.25 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.134 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--O 1.242 0.698 0 CA-C-O 118.213 -0.899 . . . . 0.0 108.797 176.28 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -89.05 166.45 13.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 7' ' ' SER . 77.0 mt -83.63 144.83 29.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.236 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . . . -135.18 -92.58 0.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.017 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 p -134.69 131.59 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.0 -3.79 86.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.458 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.521 ' HB3' HD22 ' A' ' 3' ' ' LEU . 9.8 m -69.33 130.17 41.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.368 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.03 133.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 0.0 110.289 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -88.59 137.75 30.23 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.24 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 32.2 Cg_exo -61.34 162.28 20.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.012 2.475 . . . . 0.0 112.011 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.6 96.9 9.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.792 0.33 . . . . 0.0 111.618 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.29 140.25 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.832 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -133.55 89.55 2.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.05 0.929 . . . . 0.0 110.286 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.45 155.51 18.98 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.417 -174.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.7 mt -86.11 130.18 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.606 0.241 . . . . 0.0 110.56 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -79.4 -174.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.94 -7.13 46.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 34.8 mttp -99.78 -35.68 9.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.549 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.37 10.5 2.99 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.314 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.8 m-80 -91.77 134.18 34.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 p -83.17 98.15 9.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.855 0.359 . . . . 0.0 110.215 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.16 137.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.009 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -97.37 156.6 16.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.194 0.521 . . . . 0.0 111.437 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 tp -61.13 -27.25 68.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.618 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.0 t30 -65.85 -31.08 71.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.05 -7.64 54.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 110.811 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.84 3.14 18.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.91 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 85.5 mttt -66.38 178.69 1.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.021 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.05 10.56 85.42 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.497 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -143.17 167.43 22.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.9 110.47 17.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 168.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.2 109.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.908 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.7 tp -85.61 110.28 19.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 114' ' ' ILE . 58.6 t -98.57 107.99 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.094 0.474 . . . . 0.0 110.664 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.21 121.44 42.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.245 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.24 117.31 28.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.778 0.323 . . . . 0.0 110.166 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.8 p-90 -144.14 177.21 8.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.011 0.434 . . . . 0.0 111.181 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -170.67 162.0 7.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.042 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.33 83.4 2.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 0.0 110.661 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.8 -44.41 0.15 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.472 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.63 117.72 12.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 43.3 m -68.61 -29.81 68.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 23.1 m95 -73.43 -40.69 64.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.463 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 73.2 m -59.52 -25.5 64.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -84.94 -19.93 31.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' A' ' 42' ' ' SER . 13.6 mptt -85.7 -23.83 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 111.235 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 43' ' ' TRP . 4.0 mm-40 -78.27 -20.44 51.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.384 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.675 HG21 ' HB3' ' A' ' 84' ' ' ASP . 6.4 m -52.45 -50.89 77.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 82.4 Cg_exo -49.9 -48.13 20.68 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.164 1.909 . . . . 0.0 112.643 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -67.54 -39.65 85.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -63.22 -41.29 99.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.89 -42.24 99.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.88 -41.95 98.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.993 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.3 m -60.65 -46.49 90.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.797 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.618 ' HB2' HD12 ' A' ' 65' ' ' ILE . 84.0 t80 -56.1 -57.78 10.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 93.2 m-20 -60.8 -32.54 71.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.057 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.29 41.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 90.2 m-85 -112.06 -2.17 15.12 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.759 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.5 ptmm? -62.91 155.68 26.52 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.269 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 14.3 m-20 66.9 10.04 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.476 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.3 mttp -123.25 25.04 8.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.879 0.371 . . . . 0.0 110.958 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.87 27.7 33.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.153 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.46 140.93 46.59 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 160.34 42.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 55' ' ' TYR . 64.0 mt -112.86 126.97 70.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -110.95 95.14 5.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.79 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.26 109.5 2.94 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.884 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.619 HG13 HD21 ' A' ' 93' ' ' LEU . 75.2 t -98.03 112.13 29.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -113.29 145.6 40.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.947 -178.537 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' HD12 ' A' ' 93' ' ' LEU . 3.8 t -126.46 45.92 2.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.616 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.52 171.42 12.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.639 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.536 HH22 HG11 ' A' ' 98' ' ' VAL . 22.0 mmt180 -115.52 2.93 13.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.692 0.758 . . . . 0.0 109.208 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 76' ' ' ASP . 85.6 mtt180 -124.05 124.26 42.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.035 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.0 tt0 -75.81 -33.91 60.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -60.46 -51.28 70.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.737 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 73' ' ' ARG . 0.3 OUTLIER -64.57 -37.42 87.5 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.82 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.11 -52.36 65.21 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 110.73 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.5 mptm? -57.14 -44.94 83.84 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.306 0.574 . . . . 0.0 110.668 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -68.49 -33.81 74.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.082 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.97 82.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.34 -37.68 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.663 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -65.91 -38.1 87.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.647 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 52.1 mt-10 -57.82 -60.06 4.28 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.461 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.675 ' HB3' HG21 ' A' ' 48' ' ' THR . 39.1 m-20 -85.11 -12.87 51.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.286 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 60.05 37.94 20.88 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 110.972 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.0 p -77.0 114.32 15.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.237 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -112.57 84.98 2.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.583 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 11.1 p90 -158.6 -170.03 2.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.46 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.22 90.05 2.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 110.913 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -109.84 133.13 53.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.675 0.274 . . . . 0.0 110.48 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.28 155.19 41.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.717 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.98 123.52 47.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.619 HD21 HG13 ' A' ' 68' ' ' VAL . 82.1 mt -62.74 140.51 58.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.0 111.166 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 98' ' ' VAL . 44.8 mt-30 -73.41 166.62 22.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.912 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 20.2 mtpt -51.02 -58.43 6.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.508 0.67 . . . . 0.0 111.534 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.27 -26.87 38.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.45 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.429 ' OD2' HD22 ' A' ' 93' ' ' LEU . 28.0 t70 -64.25 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.022 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.2 t -49.8 -42.94 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.15 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -58.56 -56.73 18.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.45 -44.66 62.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.469 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.68 -59.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 123.066 0.229 . . . . 0.0 111.378 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 37.2 mt -59.53 -42.85 93.22 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.45 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.77 -62.17 2.07 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.224 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 59.3 p -53.72 -40.21 65.9 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.111 0.882 . . . . 0.0 113.167 -167.182 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.486 ' HA ' HD12 ' A' ' 3' ' ' LEU . 75.4 m-85 -75.62 12.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 42.8 m 64.45 39.29 7.04 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.478 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.8 mm -92.82 86.83 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.008 -173.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.48 -7.06 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.287 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.05 163.06 35.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.553 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.1 156.27 54.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 93.4 Cg_endo -80.12 175.73 43.41 Favored 'Cis proline' 0 C--N 1.346 0.444 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.719 -0.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -159.94 125.92 4.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.959 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.1 135.05 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.16 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.611 HG22 ' HG3' ' A' ' 125' ' ' LYS . 34.7 pt -132.34 146.11 33.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 53.6 tp -107.74 112.6 25.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.982 0.42 . . . . 0.0 110.024 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.402 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 96.2 t -100.5 135.04 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.772 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.1 OUTLIER -80.42 167.09 35.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 4.1 Cg_endo -47.41 -36.33 23.26 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.61 2.873 . . . . 0.0 114.327 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.67 -29.66 61.31 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.839 0.352 . . . . 0.0 111.236 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.402 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 112.49 31.05 2.68 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.671 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -112.67 140.29 47.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.18 107.49 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.39 -24.86 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 111.035 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -140.6 133.81 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.911 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 25.6 ttpp -134.5 137.04 43.56 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.256 -174.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.911 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 49.3 mt-10 68.75 51.6 0.59 Allowed 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.158 0.911 . . . . 0.0 111.666 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.41 157.23 23.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.516 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 11.1 tpt85 -134.18 150.54 51.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.411 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 49.38 -141.02 12.77 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.656 0.598 . . . . 0.0 113.927 168.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.65 -10.92 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.341 0.591 . . . . 0.0 110.138 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.3 m-20 -58.86 -33.17 70.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.126 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -65.89 -36.58 83.8 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.407 ' N ' HD12 ' A' ' 132' ' ' LEU . 49.2 t80 -65.42 -50.3 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.017 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -60.71 -34.37 74.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.32 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.0 m -65.65 -51.03 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 132' ' ' LEU . 86.2 t -63.15 -36.1 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 5.2 tp10 -57.98 -44.12 86.91 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.893 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -76.38 -16.39 59.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.059 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.65 -58.1 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.221 -0.299 . . . . 0.0 111.73 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.36 -55.03 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.876 0.369 . . . . 0.0 111.655 -173.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -78.01 -64.89 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.247 0.546 . . . . 0.0 111.155 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.82 54.6 0.93 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.7 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 -55.65 30.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.088 0.471 . . . . 0.0 110.415 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -136.1 9.25 3.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.368 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.459 ' HB3' ' H ' ' A' ' 146' ' ' GLY . 1.2 tm-20 -95.48 -87.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . 85.49 39.79 8.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.295 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . 0.441 ' HB3' ' O ' ' A' ' 146' ' ' GLY . 50.4 t-80 77.44 -52.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.411 0.684 . . . . 0.0 111.855 174.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 31.8 m170 45.46 -107.35 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.638 0.586 . . . . 0.0 111.198 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.0 t60 53.9 92.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.939 0.775 . . . . 0.0 112.185 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.16 165.2 12.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.581 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -152.61 148.37 27.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.994 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.027 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 1' ' ' MET . 38.9 t 172.76 140.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.009 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 7' ' ' SER . 97.2 mt -110.75 130.49 55.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . -102.06 -90.12 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.319 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.3 p -136.65 125.21 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.931 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.74 59.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.927 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.531 ' HB2' HD22 ' A' ' 3' ' ' LEU . 4.5 p -75.33 132.68 41.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.2 p -72.3 137.1 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.477 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -107.48 145.56 31.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.2 Cg_exo -61.7 154.08 62.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.071 2.514 . . . . 0.0 112.464 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.27 139.14 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.185 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' SER . 53.5 mt -95.03 137.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -120.55 107.87 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 0.0 110.543 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.01 154.11 23.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.719 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.16 122.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -178.82 3.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 95.3 mt -59.56 -31.03 69.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.818 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -78.93 -35.66 42.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.5 3.05 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.08 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -105.88 145.9 30.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 p -77.32 104.53 7.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.236 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.91 143.29 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.999 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 10.2 m -123.04 162.39 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.637 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 32.3 tp -63.76 -7.42 7.7 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.539 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.8 -29.6 70.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.457 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.64 -27.76 63.3 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.844 0.83 . . . . 0.0 110.847 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.637 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 88.0 m-85 -87.88 4.03 46.21 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -171.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -84.3 87.45 7.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.798 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.79 -9.7 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.34 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -117.05 163.38 16.34 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -84.95 120.66 26.75 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 6.8 t -106.35 124.33 61.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.094 0.473 . . . . 0.0 112.091 -169.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 113' ' ' ILE . 2.7 tm? -104.19 98.02 7.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.6 t -92.5 124.26 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 21.0 t0 -120.19 144.83 47.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.255 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 110' ' ' PHE . 96.9 m-85 -117.04 119.64 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.127 174.051 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.715 ' HZ2' HD11 ' A' ' 81' ' ' ILE . 54.1 p-90 -148.07 175.09 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.453 0.644 . . . . 0.0 112.027 -176.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CD1' ' HE2' ' A' ' 110' ' ' PHE . 1.5 p90 -162.37 166.12 25.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.157 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.7 65.89 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -171.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.57 -38.13 90.16 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.432 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.6 p -85.95 101.83 13.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.373 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.5 m -71.47 5.07 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -174.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -85.8 -30.27 23.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.31 -0.243 . . . . 0.0 111.294 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 45' ' ' ARG . 21.1 p -68.56 -28.61 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.759 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.608 ' HD2' ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -77.62 -14.58 59.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.402 0.62 . . . . 0.0 109.408 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 42' ' ' SER . 2.1 mptm? -79.54 -24.32 42.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 42.5 mt-10 -100.16 -0.24 39.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.22 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.526 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 85.5 m -50.43 -52.65 53.11 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.92 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.8 Cg_endo -54.43 -40.99 80.77 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.545 2.163 . . . . 0.0 113.156 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.448 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.9 m-85 -67.61 -44.6 77.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.983 0.421 . . . . 0.0 110.351 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.78 -40.82 97.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.605 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.25 -46.52 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.94 -46.91 87.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.205 0.526 . . . . 0.0 110.312 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 32.0 m -62.1 -49.7 74.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.73 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.6 t80 -62.34 -40.73 97.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.64 0.257 . . . . 0.0 110.967 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.16 -34.15 75.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.287 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.74 -26.91 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 51.1 m-85 -102.8 -8.55 20.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -56.49 -35.01 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.31 0.95 56.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 88.1 mttt -105.54 19.71 20.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.036 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.39 37.47 70.06 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.4 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 39.7 t80 -130.67 143.53 50.81 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -145.76 136.2 24.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.0 mt -88.26 117.68 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -100.31 93.43 5.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.176 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -87.6 112.2 3.81 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 34.1 t -104.86 119.03 53.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.025 0.441 . . . . 0.0 110.712 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.8 t -124.22 156.17 37.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 4.3 t -137.96 51.3 1.89 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.822 0.82 . . . . 0.0 109.027 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.576 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -66.67 -176.89 0.52 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.906 -174.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 3.6 ptm180 -77.23 -26.68 52.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.17 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 10.6 ttt180 -149.27 128.4 12.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.962 -166.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.7 tt0 -61.06 -42.25 98.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 pt-20 -64.57 -41.6 96.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 80.7 m-20 -66.28 -34.15 77.36 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.621 ' O ' HG12 ' A' ' 81' ' ' ILE . 31.2 t90 -61.48 -60.65 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HD2' ' CE3' ' A' ' 77' ' ' TRP . 2.6 mptm? -52.23 -43.02 64.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 0.0 110.903 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 29.5 ttmt -59.39 -49.67 76.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.857 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.77 88.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.626 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.715 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 44.2 mm -56.19 -45.7 81.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.738 0.304 . . . . 0.0 110.961 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 10.7 tp10 -58.87 -59.26 5.73 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 4.8 mm-40 -69.62 -33.56 72.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 45' ' ' ARG . 35.2 t70 -71.51 -12.25 61.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 110.352 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.722 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 44.0 mmtt 64.54 32.55 11.55 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.093 175.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.449 ' HB3' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -96.42 79.51 3.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.713 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -91.46 89.94 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -175.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -156.63 176.68 12.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -64.96 97.58 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.74 0.65 . . . . 0.0 111.711 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.55 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 51.4 mt-30 -123.56 149.64 45.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.41 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.21 150.42 31.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.24 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.43 118.7 35.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.316 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 53.9 mt -62.94 137.19 58.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.368 0.604 . . . . 0.0 111.962 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 98' ' ' VAL . 70.1 mt-30 -73.5 145.79 45.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.193 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -70.64 -16.1 62.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.681 0.753 . . . . 0.0 111.123 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 99' ' ' LYS . 3.2 p-10 -78.7 -46.81 18.21 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.399 171.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.23 -34.69 75.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.137 0.575 . . . . 0.0 111.517 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 94' ' ' GLN . 48.7 t -43.59 -43.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.727 . . . . 0.0 112.703 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 96' ' ' ASP . 60.6 mttp -54.97 -63.15 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.557 -169.875 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.0 -48.63 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.8 t -52.38 -47.93 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.504 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.526 HD22 HG13 ' A' ' 107' ' ' ILE . 25.7 mt -62.63 -59.36 5.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.58 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.62 -61.52 2.23 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.209 0.318 . . . . 0.0 110.793 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 70.9 m -56.29 -37.05 69.34 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 124.211 0.945 . . . . 0.0 112.606 -172.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.2 m-85 -77.17 13.65 1.08 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 120.956 0.408 . . . . 0.0 110.8 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 49.2 t 63.9 60.74 1.01 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.202 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.526 HG13 HD22 ' A' ' 102' ' ' LEU . 9.4 mm -85.44 93.59 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.074 0.94 . . . . 0.0 111.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.13 -31.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.78 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.64 151.66 22.89 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.349 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.65 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.5 p90 -147.2 160.04 40.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 118.948 -0.548 . . . . 0.0 109.78 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.65 ' C ' ' HA ' ' A' ' 110' ' ' PHE . 3.8 Cg_endo -43.54 145.96 1.79 Allowed 'Cis proline' 0 C--N 1.364 1.347 0 CA-C-N 120.325 1.152 . . . . 0.0 114.944 2.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 65.9 t60 -140.91 95.21 2.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.083 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 33' ' ' LEU . 96.6 mt -101.61 114.5 41.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -172.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 105' ' ' TYR . 48.2 pt -127.15 166.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.742 0.306 . . . . 0.0 110.983 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.0 118.14 32.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 78.6 t -110.85 138.55 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.045 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -92.52 170.07 9.67 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 1.5 Cg_endo -48.56 -36.84 32.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.35 2.7 . . . . 0.0 114.107 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.07 -22.07 62.16 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.955 -0.466 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 23.53 11.29 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.208 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 78.8 mttt -99.04 141.74 31.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.828 0.346 . . . . 0.0 110.096 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' THR . 33.2 mt -81.82 98.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.16 -21.89 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.173 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.48 142.19 21.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 4' ' ' ALA . 10.8 ptmm? -129.71 138.54 51.19 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.315 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 67.78 46.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.17 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 86.7 mt -70.35 151.16 45.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 171.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.694 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 8.4 mmm180 -124.9 146.04 49.53 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.101 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 44.31 -125.51 5.94 Favored Glycine 0 C--O 1.224 -0.479 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.305 169.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.33 -20.92 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 111.037 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.694 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -51.03 -42.98 60.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 177.223 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -59.62 -34.35 72.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 54' ' ' THR . 40.8 t80 -68.92 -53.45 20.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -61.15 -42.97 99.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.517 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.448 ' O ' ' HD1' ' A' ' 139' ' ' PHE . 24.3 m -66.75 -43.38 84.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.454 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 63' ' ' PHE . 77.9 t -67.54 -40.98 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.88 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 2.8 tp10 -62.44 -34.27 76.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.488 0.661 . . . . 0.0 109.437 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 1.037 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 27.7 ttpp -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 60.7 m-85 -80.68 -61.73 1.88 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.981 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.88 -40.63 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.203 -169.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 12.0 t30 -86.05 1.65 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 110.295 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.99 32.58 77.32 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.968 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 1.037 ' HB3' ' HA ' ' A' ' 138' ' ' LYS . . . -68.02 -30.88 70.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.598 0.237 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HB2' ' CG ' ' A' ' 138' ' ' LYS . 35.1 mmtm -142.97 -42.77 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 5.6 mp0 -81.87 20.45 0.97 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.174 0.511 . . . . 0.0 111.02 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.54 144.72 47.65 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -83.18 57.91 4.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 110.93 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.6 t60 69.71 -58.11 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.913 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -85.28 125.61 33.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.177 0.513 . . . . 0.0 110.316 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 4.6 p-80 -102.73 -14.54 16.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.451 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 150' ' ' HIS . 3.0 t60 165.36 -38.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 m170 . . . . . 0 C--O 1.244 0.813 0 CA-C-N 112.32 -2.218 . . . . 0.0 106.655 164.247 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB2' HD13 ' A' ' 3' ' ' LEU . 19.0 m 68.36 -66.74 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.173 0.921 . . . . 0.0 110.606 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -121.04 -177.73 3.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.927 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.87 166.44 24.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.539 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -70.61 119.13 14.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.508 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.89 -18.41 5.93 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.4 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 p -78.14 154.37 31.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.619 0.247 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.41 139.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.145 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.53 137.66 28.73 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.578 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 53.7 Cg_exo -53.7 146.48 44.33 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.796 2.331 . . . . 0.0 112.014 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.13 119.55 14.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.108 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 24' ' ' LEU . 45.1 mm -93.24 129.35 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.671 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -134.61 108.1 7.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.29 170.71 14.73 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.356 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 15.7 mt -100.24 115.91 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 27.6 p30 -75.04 -174.46 2.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.475 0.655 . . . . 0.0 112.63 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 96.4 mt -60.22 -29.82 68.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.055 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 -38.0 30.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 110.297 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.93 21.79 2.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.318 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.483 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 2.1 m-20 -97.58 141.83 30.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.161 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -84.58 101.44 12.11 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.46 150.11 19.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 24.5 m -110.59 164.52 12.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.807 0.337 . . . . 0.0 111.238 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 12' ' ' ILE . 3.5 pp -63.85 -27.12 68.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.29 0.567 . . . . 0.0 110.129 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.79 -32.84 72.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.392 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.28 -4.05 51.74 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.395 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -118.77 8.69 11.88 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 118' ' ' PRO . 36.1 mtmt -72.18 159.69 33.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.501 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.95 -28.31 7.05 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 152' ' ' HIS . 2.5 mptp? -108.56 169.79 8.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.58 ' HE2' HG11 ' A' ' 123' ' ' VAL . 4.1 m-85 -76.04 115.63 15.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 166.237 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 116' ' ' VAL . 3.0 m -96.08 115.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.795 0.807 . . . . 0.0 111.741 -171.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tm? -84.66 109.11 17.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.527 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -99.19 107.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.32 129.47 47.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.057 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.73 115.76 31.22 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.795 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 28.4 p-90 -147.9 172.67 13.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 111.523 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.459 ' HB2' ' CG ' ' A' ' 71' ' ' ASP . 20.4 p90 -167.27 155.99 9.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.089 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.59 -24.7 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.524 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.46 -32.64 73.49 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.123 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 33.7 m -93.31 117.98 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.256 0.551 . . . . 0.0 110.676 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.524 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 11.1 m -65.19 -16.49 63.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -82.91 -32.06 27.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.795 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 78.7 m -58.71 -32.05 68.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.086 0.47 . . . . 0.0 110.632 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -73.52 -14.41 61.21 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.608 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -86.64 -44.69 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.065 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mp0 -68.31 -22.32 64.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.588 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.601 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 99.8 m -57.43 -53.18 68.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 83.0 Cg_exo -49.97 -41.57 47.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.455 2.103 . . . . 0.0 112.945 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.6 m-85 -65.65 -43.15 90.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.304 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.85 -38.43 85.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.416 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.406 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 5.5 tt -61.63 -44.75 96.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.829 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.7 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 38.1 ttpt -63.74 -42.73 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.005 0.431 . . . . 0.0 110.341 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 m -58.68 -46.72 86.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.1 t80 -64.47 -46.56 82.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.544 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.7 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 0.9 OUTLIER -68.41 -32.74 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.981 -173.13 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.83 -27.93 21.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 137' ' ' GLU . 51.3 m-85 -105.69 -5.49 19.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 13.6 pttm -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.067 0.46 . . . . 0.0 110.991 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.48 -3.24 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.299 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.836 ' HB3' ' HE1' ' A' ' 149' ' ' HIS . 75.8 mttt -97.93 3.23 49.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.094 0.473 . . . . 0.0 110.299 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.86 43.39 5.43 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.504 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 41.7 t80 -145.64 127.11 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -130.57 155.88 45.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.0 mt -105.09 120.61 55.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.229 0.537 . . . . 0.0 110.93 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 88.1 t80 -104.2 97.27 7.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.743 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.608 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -91.81 136.65 13.38 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.218 -175.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 5.1 m -121.35 114.9 44.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.662 0.744 . . . . 0.0 110.023 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -90.85 151.48 21.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.275 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.879 ' HA ' ' NZ ' ' A' ' 95' ' ' LYS . 6.5 t -136.09 38.67 2.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.468 0.652 . . . . 0.0 111.983 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 18.2 m-20 -76.34 167.54 21.66 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.991 167.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.695 ' HD2' ' HG3' ' A' ' 95' ' ' LYS . 13.6 mmm180 -96.43 -11.59 25.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 73' ' ' ARG . 40.8 mtp180 -111.21 108.32 17.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.866 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.5 tt0 -69.64 -31.16 69.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.984 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -69.82 -36.22 75.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.26 -28.2 56.99 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.679 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -62.18 -52.76 62.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.217 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.9 mptm? -56.22 -42.48 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.279 0.562 . . . . 0.0 110.081 175.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 25.1 tttm -59.42 -50.22 74.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.231 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.511 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -56.56 -41.45 76.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 111.623 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.456 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 43.5 mm -63.47 -37.95 80.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.801 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -73.52 -33.44 64.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.692 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.2 mt-10 -65.26 -59.53 3.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 48' ' ' THR . 2.5 m-20 -77.51 -9.72 59.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.815 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 38.9 mmtm 59.94 35.04 21.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.47 0.652 . . . . 0.0 111.063 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 p -87.65 76.93 8.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.429 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 76.2 m-85 -88.48 91.66 8.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.716 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.406 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 26.7 p90 -151.52 -177.45 6.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.816 169.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -72.51 88.82 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.805 0.812 . . . . 0.0 111.694 -174.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.608 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt-30 -111.09 144.75 39.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.186 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 29.6 m -132.91 145.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.439 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.65 109.54 19.74 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 12' ' ' ILE . 9.0 mt -62.15 147.43 47.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.47 141.73 53.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.879 ' NZ ' ' HA ' ' A' ' 70' ' ' THR . 5.3 mmmt -75.4 -28.68 59.53 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.536 -161.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 2.0 m-20 -89.95 -4.98 57.18 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.416 ' OD2' HD22 ' A' ' 93' ' ' LEU . 1.6 t70 -88.16 -48.17 7.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.562 172.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -45.13 -40.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.893 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 96' ' ' ASP . 39.6 mtpt -47.52 -59.52 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.977 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.49 -45.77 71.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.59 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.08 -41.8 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.177 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 98' ' ' VAL . 94.6 mt -58.53 -53.84 53.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.419 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.72 -52.47 56.11 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.557 0.536 . . . . 0.0 109.712 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 m -53.28 -30.87 41.0 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.578 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 29.9 m-85 -80.44 8.32 7.91 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.867 -0.521 . . . . 0.0 110.892 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.401 ' O ' HD13 ' A' ' 107' ' ' ILE . 21.9 t 66.2 46.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.716 0.806 . . . . 0.0 109.106 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 20.0 mm -116.44 129.38 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.63 14.0 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.208 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.1 166.87 38.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 119.434 -1.365 . . . . 0.0 114.246 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -130.9 157.54 77.66 Favored Pre-proline 0 N--CA 1.463 0.212 0 C-N-CA 123.032 0.533 . . . . 0.0 110.581 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.22 169.96 71.35 Favored 'Cis proline' 0 C--N 1.352 0.744 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.113 -1.338 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.437 ' CE1' HG23 ' A' ' 114' ' ' ILE . 39.8 t-80 -147.01 134.51 20.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.675 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.561 HG21 HD22 ' A' ' 132' ' ' LEU . 4.9 mp -129.63 145.08 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.449 177.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.581 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 27.7 pt -133.42 163.28 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 172.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.463 HD22 ' HD2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -123.35 118.13 26.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 32' ' ' VAL . 76.6 t -108.84 138.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.99 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 46.7 m-20 -62.62 160.73 32.81 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.0 Cg_exo -59.91 -15.34 32.25 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.555 2.17 . . . . 0.0 111.726 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -83.18 -29.66 28.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.843 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.56 32.79 3.29 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.595 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.564 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 10.1 mtmp? -111.92 150.87 29.88 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.684 -0.303 . . . . 0.0 110.473 176.648 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.38 96.36 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.58 HG11 ' HE2' ' A' ' 31' ' ' TYR . 14.1 p -83.45 -29.21 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.128 0.49 . . . . 0.0 110.572 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.96 149.21 27.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.993 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.574 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 13.0 ptmm? -151.23 163.36 39.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 23.7 mm-40 76.36 4.44 3.63 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.233 0.958 . . . . 0.0 112.026 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.44 ' O ' ' HD3' ' A' ' 128' ' ' ARG . 43.5 mt -59.7 136.11 57.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 127' ' ' LEU . 23.5 mmt-85 -133.78 173.19 11.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.932 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 45.09 -135.4 7.18 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 124.1 0.875 . . . . 0.0 114.127 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.34 -13.95 59.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.676 0.274 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.7 -27.4 67.86 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.561 HD22 HG21 ' A' ' 113' ' ' ILE . 79.7 mt -47.66 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 172.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -49.91 75.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.623 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 85.1 m-20 -65.49 -26.49 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.506 -174.324 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 16.9 m -77.29 -33.3 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 132' ' ' LEU . 24.4 t -63.33 -42.97 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.807 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.952 ' HA ' HD22 ' A' ' 141' ' ' ASN . 58.3 mm-40 -67.22 -41.06 86.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.034 0.445 . . . . 0.0 110.554 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 22.0 ttpt -56.45 -56.48 20.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.143 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.29 -61.08 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.313 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.99 -31.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.952 HD22 ' HA ' ' A' ' 137' ' ' GLU . 56.9 m-80 -93.69 -15.05 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.936 0.398 . . . . 0.0 110.699 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.1 16.32 78.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.008 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 73.82 16.46 3.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.622 0.769 . . . . 0.0 112.358 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.08 127.12 2.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.323 0.583 . . . . 0.0 111.218 173.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -98.3 138.61 35.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.795 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.76 -58.37 0.32 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -76.12 77.36 2.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 168.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -52.87 127.29 23.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.487 -167.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.836 ' HE1' ' HB3' ' A' ' 61' ' ' LYS . 2.8 p80 -88.16 27.75 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.146 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 72.43 143.92 0.07 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.357 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -90.79 93.16 9.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.116 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.534 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 9.7 p80 . . . . . 0 C--O 1.243 0.712 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.838 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 m -151.04 -171.22 3.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.83 -87.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' OG ' ' A' ' 7' ' ' SER . . . 178.79 155.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.792 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -74.93 109.26 8.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.88 -6.2 20.06 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.97 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 4' ' ' ALA . 50.0 m -76.86 138.7 39.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.706 0.288 . . . . 0.0 110.536 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.0 p -73.96 138.82 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 105' ' ' TYR . . . -92.55 150.83 40.51 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.353 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.53 163.18 11.07 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.328 2.685 . . . . 0.0 112.267 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.66 102.46 13.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.853 0.359 . . . . 0.0 111.718 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 105' ' ' TYR . 50.6 mm -69.78 138.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.572 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.7 t -142.97 137.56 29.46 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.4 172.67 36.08 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.584 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -85.89 118.05 31.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.34 -176.99 3.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.177 0.513 . . . . 0.0 111.198 -173.219 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.93 -29.45 63.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.683 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' H ' ' CG ' ' A' ' 16' ' ' ASP . 29.9 mttp -85.99 -43.85 12.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.65 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.29 15.36 1.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.409 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -96.51 154.19 17.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -83.96 93.57 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 0.0 110.333 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.17 138.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.753 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -116.68 163.41 16.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.224 0.535 . . . . 0.0 111.407 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . 62.1 tp -63.47 -23.93 67.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.886 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.4 t30 -64.19 -28.39 69.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.11 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -77.06 -4.58 45.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.1 2.51 16.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.34 0.59 . . . . 0.0 109.42 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 41.2 mtpt -71.49 111.71 7.02 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.738 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.91 -22.41 2.47 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -115.05 170.51 8.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.619 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.09 117.23 21.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 20.8 t -99.0 116.93 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -90.86 104.1 16.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 47.9 t -98.67 108.85 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.937 0.399 . . . . 0.0 110.92 -174.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.5 115.83 29.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.29 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.2 115.66 26.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 3.1 p-90 -155.7 -177.29 6.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.362 0.601 . . . . 0.0 111.452 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 41' ' ' CYS . 17.9 p90 -157.19 152.78 26.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.853 171.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 77' ' ' TRP . . . -58.19 -45.12 88.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 111.838 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . 0.854 ' HA3' HH12 ' A' ' 72' ' ' ARG . . . -82.76 45.79 3.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.401 -177.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.693 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 46.0 t -132.43 136.19 46.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 p -88.43 -15.09 36.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 39.9 m95 -85.92 -52.53 5.67 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.781 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 12.8 p -63.36 -24.66 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.26 0.552 . . . . 0.0 110.634 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.437 ' NH2' ' HB2' ' A' ' 83' ' ' GLU . 4.8 tpt180 -72.02 -14.39 61.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.888 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.75 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.2 mptm? -79.99 -40.08 28.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.882 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.459 ' OE1' ' HG3' ' A' ' 111' ' ' PRO . 25.7 mp0 -80.33 -9.58 59.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.655 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 38.3 m -50.74 -50.22 74.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 51.9 Cg_exo -55.4 -42.52 67.39 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.052 1.835 . . . . 0.0 112.617 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.08 -36.79 80.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 47' ' ' GLU . 96.0 mt -64.27 -41.69 96.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.513 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.84 -44.56 96.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.165 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -55.96 -48.88 74.97 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.393 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 33.9 m -62.55 -52.06 64.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.253 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.6 t80 -58.59 -43.4 89.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.68 0.276 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -61.79 -39.71 92.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.891 0.377 . . . . 0.0 111.293 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.63 -20.42 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 77.0 m-85 -121.94 9.12 9.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 17.5 pttm -64.23 -41.14 97.14 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.606 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -24.79 41.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.113 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 92.6 mttt -76.76 -172.11 2.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.169 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 49.64 3.27 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 83.5 t80 -143.62 146.49 33.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.8 m -156.86 136.96 12.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 55' ' ' TYR . 43.5 mt -89.32 133.46 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.909 0.385 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.76 101.97 9.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.177 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.13 115.61 4.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.444 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.501 HG13 ' CD1' ' A' ' 93' ' ' LEU . 44.2 t -98.39 111.34 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 38.5 t -118.72 139.5 51.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.355 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -134.77 35.58 3.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.428 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.593 ' OD1' ' HD2' ' A' ' 72' ' ' ARG . 4.2 t70 -65.8 165.63 12.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.777 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.854 HH12 ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.58 -25.24 61.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.836 -175.152 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 7.2 tpt180 -141.2 131.14 24.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.585 -173.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 22.2 tt0 -69.83 -32.83 71.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 0.0 110.002 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 3.5 mp0 -57.66 -42.46 83.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.814 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 31.5 t70 -73.07 -39.86 65.51 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 27.6 t90 -52.64 -52.12 57.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.654 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.552 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -62.46 -44.08 97.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.792 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 18.3 tttm -57.4 -45.73 84.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.85 -45.52 82.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.572 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.0 -34.86 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.885 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.53 -30.01 70.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.0 110.208 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . 67.7 mt-10 -75.89 -60.5 2.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.066 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -83.77 -18.91 36.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.81 -169.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 72.88 28.12 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.592 0.557 . . . . 0.0 110.622 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -67.01 81.06 0.12 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.936 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -96.39 88.99 4.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.15 178.29 10.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.022 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.66 102.72 2.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -173.038 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 77' ' ' TRP . 44.6 mt-30 -119.85 155.06 33.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.321 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.66 143.74 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.501 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.43 112.31 24.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' CD1' HG13 ' A' ' 68' ' ' VAL . 8.0 mp -71.83 157.35 38.05 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.307 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -89.88 178.93 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.527 0.68 . . . . 0.0 111.08 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.517 ' H ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.38 -15.03 59.58 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.322 -178.132 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.491 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -83.98 -55.5 4.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.622 -175.975 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.6 p30 -79.75 -30.7 40.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.556 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -49.05 -32.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mmtt -53.76 -63.5 1.13 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.711 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -55.67 -55.74 28.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.442 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.485 HG21 HD23 ' A' ' 93' ' ' LEU . 61.5 t -46.43 -55.85 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.915 0.76 . . . . 0.0 112.129 -176.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.834 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 25.8 mt -62.07 -34.84 77.03 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.643 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.21 -63.04 1.46 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.098 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 106' ' ' CYS . 60.8 p -53.4 -45.28 69.25 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 124.798 1.311 . . . . 0.0 113.27 -164.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.631 ' CE1' HD11 ' A' ' 12' ' ' ILE . 85.0 m-85 -75.75 13.15 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.089 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.428 ' H ' ' C ' ' A' ' 104' ' ' SER . 34.7 m 62.66 57.71 1.74 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.139 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.834 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 2.1 mp -85.43 110.88 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.825 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.16 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.956 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.53 178.48 34.73 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.914 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.6 151.96 79.59 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 43' ' ' TRP . 86.1 Cg_endo -77.34 151.52 92.97 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.32 0.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.59 113.61 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 HH21 ' A' ' 128' ' ' ARG . 86.8 mt -117.74 139.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.4 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.576 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 44.0 pt -134.9 145.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.92 0.39 . . . . 0.0 111.148 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.38 110.08 22.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 88.7 t -102.42 136.94 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.059 -175.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.77 169.85 19.06 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.843 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -55.18 -29.14 64.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.802 2.334 . . . . 0.0 113.988 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.63 -4.25 55.65 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.33 30.15 22.97 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.609 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 30.0 mttm -108.96 145.58 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.837 0.351 . . . . 0.0 110.522 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.8 mt -80.17 105.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.16 -48.49 21.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.492 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.01 169.42 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.184 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.6 pttp -159.7 172.59 17.45 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.05 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 2.0 mm-40 64.94 23.31 12.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.652 1.181 . . . . 0.0 111.318 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HB2' HD23 ' A' ' 132' ' ' LEU . 83.9 mt -61.21 148.33 41.27 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.822 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.526 HH21 HD12 ' A' ' 113' ' ' ILE . 2.9 mmp_? -125.22 151.48 45.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -171.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 40.05 -126.19 2.54 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 124.175 0.922 . . . . 0.0 114.785 170.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.46 -10.04 59.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.674 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.873 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 24.8 t70 -66.39 -33.46 75.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.5 mt -48.92 -52.95 21.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 170.041 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.44 -59.06 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.555 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.6 p30 -66.94 -31.75 72.54 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.314 -172.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 19.1 m -70.66 -37.35 73.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.36 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.3 t -61.16 -49.33 85.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.338 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 141' ' ' ASN . 6.0 tp10 -61.44 -50.39 72.98 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 15.7 ttpt -48.53 -37.44 17.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.517 0.727 . . . . 0.0 111.734 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -87.96 -48.5 7.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -87.91 -25.48 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 25.6 t-20 -54.53 -53.11 58.81 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.52 -39.18 1.98 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.038 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.01 96.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? 62.92 -165.79 0.23 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.003 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -112.81 -12.0 13.39 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.381 178.06 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.14 77.27 1.18 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.387 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -61.54 165.33 4.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 110.533 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.01 -33.88 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -86.14 96.56 9.94 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.682 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -151.65 -175.22 5.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.432 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -139.88 140.71 36.55 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 74.9 t60 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.259 -0.877 . . . . 0.0 108.81 170.433 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HB3' ' H ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.492 ' H ' ' HB3' ' A' ' 1' ' ' MET . 16.5 m 50.12 -95.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.608 0.763 . . . . 0.0 112.048 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.9 114.85 14.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.76 -166.88 1.32 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 111.427 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.983 HG23 ' HA ' ' A' ' 123' ' ' VAL . 24.9 m -56.72 130.23 44.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.159 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.97 -8.01 36.01 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.066 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -78.47 138.2 38.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.56 126.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.54 76.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.549 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 162.15 25.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.051 2.501 . . . . 0.0 111.839 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.97 100.47 11.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.783 0.325 . . . . 0.0 111.712 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 101' ' ' VAL . 56.4 mt -72.19 132.47 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.176 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -128.53 97.87 4.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 175.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.89 165.17 12.07 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.543 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 66.2 mt -98.93 122.93 51.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.613 0.244 . . . . 0.0 110.46 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 31.5 p30 -74.19 -173.84 1.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.971 0.415 . . . . 0.0 111.547 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.84 -16.92 63.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.072 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 1.1 mtpt -87.98 -35.59 17.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.98 21.31 3.52 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.47 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HB2' ' OD2' ' A' ' 16' ' ' ASP . 2.2 m-20 -98.45 142.59 29.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -81.78 102.25 10.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.806 0.336 . . . . 0.0 110.232 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.89 142.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.074 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -103.94 -177.96 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.975 0.416 . . . . 0.0 110.545 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -80.39 -21.56 42.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.587 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 50.5 m-80 -68.31 -24.79 64.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.46 -25.61 68.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.11 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -112.4 13.34 20.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.086 0.469 . . . . 0.0 110.317 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 25' ' ' ASN . 22.6 tttm -68.99 171.35 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.445 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.98 64.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.4 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -141.16 176.17 9.05 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB3' HD11 ' A' ' 115' ' ' LEU . 54.1 m-85 -78.77 109.68 13.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 47.2 t -96.78 123.32 49.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 19.5 tp -90.54 116.95 28.84 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 114' ' ' ILE . 16.7 t -105.05 102.99 14.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' OD1' HG23 ' A' ' 65' ' ' ILE . 6.5 m-20 -98.4 110.15 22.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.762 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 110' ' ' PHE . 53.2 m-85 -92.74 116.8 29.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.783 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 12.9 p-90 -154.65 -179.18 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 45.0 p90 -170.01 157.1 6.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.528 168.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.99 -16.99 62.86 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.12 -21.32 69.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.582 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 m -92.2 131.32 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 0.0 110.274 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -88.39 -28.26 21.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.694 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -67.75 -34.57 77.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.135 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 80.0 m -51.95 -38.63 57.22 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.67 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -64.44 -28.33 69.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.774 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -84.96 -11.34 55.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.181 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -98.04 -21.78 16.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.418 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 84' ' ' ASP . 51.4 m -49.93 -48.23 78.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.2 Cg_endo -48.61 -45.88 25.97 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.205 1.937 . . . . 0.0 112.36 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.94 -37.63 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.238 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 ' OD2' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -55.93 -48.55 75.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 175.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.417 ' HA ' ' HZ3' ' A' ' 88' ' ' TRP . 63.0 tp -63.63 -42.67 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.965 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 47.4 tttm -60.0 -43.72 95.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 27.1 m -53.11 -46.1 68.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.205 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.4 t80 -56.83 -61.99 2.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.67 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.9 p-10 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.22 -20.06 29.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.521 ' HZ ' ' HA ' ' A' ' 137' ' ' GLU . 75.1 m-85 -115.65 -15.2 11.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptmm? -56.28 -23.13 34.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.005 0.431 . . . . 0.0 111.646 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 3.5 m-20 -106.87 17.25 23.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 89.5 mttt -121.64 14.73 11.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.137 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.99 44.18 9.25 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.515 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 55.3 t80 -139.0 135.23 34.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -135.74 145.65 46.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.96 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -103.72 126.75 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.971 0.415 . . . . 0.0 110.619 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -112.94 96.52 5.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.692 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -75.01 114.54 4.36 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.389 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.998 HG13 HD21 ' A' ' 93' ' ' LEU . 50.0 t -98.69 111.11 27.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 14.7 m -116.7 125.73 52.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 93' ' ' LEU . 10.1 t -113.5 52.13 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.518 1.152 . . . . 0.0 108.604 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 t70 -70.2 178.96 2.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.128 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -104.3 -21.97 13.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.921 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 51.9 mtt-85 -141.63 150.46 42.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.8 tt0 -75.62 -37.19 59.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.1 mp0 -62.01 -41.36 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.578 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -74.44 -35.63 63.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.001 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -60.73 -51.96 67.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.434 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.2 mptm? -59.13 -37.17 76.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 27.1 ttpt -59.22 -50.02 75.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.768 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.89 83.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.182 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.44 -38.82 77.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.378 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.75 -55.36 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.892 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.5 mt-10 -53.07 -49.0 67.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.545 . . . . 0.0 111.639 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 48' ' ' THR . 6.4 m-20 -85.45 -16.43 39.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.453 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HD2' ' OH ' ' A' ' 87' ' ' TYR . 46.9 mmtm 61.74 40.54 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.653 0.739 . . . . 0.0 110.092 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -80.63 86.46 5.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.183 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' OH ' ' HD2' ' A' ' 85' ' ' LYS . 57.4 m-85 -87.66 78.94 8.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.276 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.417 ' HZ3' ' HA ' ' A' ' 52' ' ' LEU . 23.6 p90 -161.42 175.16 12.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 174.431 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.47 110.47 9.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.974 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.692 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 48.6 mt-30 -123.39 145.97 48.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.3 m -132.65 149.97 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' SER . 20.7 tp -94.2 132.2 38.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.998 HD21 HG13 ' A' ' 68' ' ' VAL . 72.3 mt -73.45 149.94 42.01 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 98' ' ' VAL . 49.8 mt-30 -80.72 171.18 15.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.412 175.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.15 -39.65 90.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 13.5 m-20 -87.21 -33.62 19.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.181 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' OD2' HD22 ' A' ' 93' ' ' LEU . 16.1 t70 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.821 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 94' ' ' GLN . 78.8 t -66.86 -65.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 110.124 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 20.5 pttp -62.55 -62.62 1.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -170.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 9.0 m-20 -67.94 -36.63 80.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.738 0.304 . . . . 0.0 111.622 -169.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 12' ' ' ILE . 59.3 t -79.27 -50.26 18.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.943 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 87.9 mt -56.23 -47.81 77.71 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.89 -47.33 80.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.4 m -54.81 -33.04 61.06 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.99 0.806 . . . . 0.0 112.446 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -79.24 7.75 7.15 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.14 -0.35 . . . . 0.0 111.436 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 2' ' ' SER . 42.5 t 66.57 54.13 0.89 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 73.8 mt -133.3 93.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.6 -1.5 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.861 0.839 . . . . 0.0 109.392 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.77 165.31 28.83 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.176 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 95.4 m-85 -127.19 160.7 58.39 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.654 0.227 . . . . 0.0 110.707 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 5.5 Cg_exo -81.89 172.08 53.64 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.948 -1.271 . . . . 0.0 112.721 -0.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.674 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -155.39 122.53 5.48 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.622 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.1 131.44 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 125' ' ' LYS . 25.9 pt -130.5 158.32 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' TYR . 58.9 tp -124.51 127.59 47.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.142 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 5.5 m -119.1 145.13 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -59.78 163.3 7.54 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.131 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.32 -22.26 64.54 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -70.19 -34.0 72.42 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.784 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.23 32.68 3.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.05 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -117.42 147.86 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 125' ' ' LYS . 34.9 mt -86.19 119.57 34.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.594 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 5' ' ' THR . 13.2 m -101.75 -35.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.014 0.435 . . . . 0.0 110.832 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.8 140.74 40.72 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HD2' HG21 ' A' ' 122' ' ' ILE . 9.4 ptmm? -156.81 153.43 28.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.232 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.674 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 32.4 mt-10 70.0 25.47 4.82 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.205 0.941 . . . . 0.0 110.968 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.9 mt -67.91 159.12 31.17 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.621 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.1 mmp_? -128.9 134.53 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 43.12 -114.58 0.86 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 168.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 134' ' ' ASN . 4.2 m-20 -63.12 -35.43 80.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.867 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 7.7 t70 -63.63 -39.74 95.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.822 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.0 pp -57.2 -44.47 83.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.52 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.402 ' N ' HD12 ' A' ' 132' ' ' LEU . 68.4 t80 -70.64 -46.47 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 11.2 t-20 -50.2 -57.21 8.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.8 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.559 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 19.8 m -72.74 -34.38 67.0 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.998 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 HD22 ' A' ' 115' ' ' LEU . 38.2 t -63.21 -42.32 96.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.325 174.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.521 ' HA ' ' HZ ' ' A' ' 58' ' ' PHE . 3.2 tp10 -61.21 -53.02 62.17 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 9.2 mtmp? -57.5 -27.58 62.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.733 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -83.15 -61.09 1.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.408 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.15 -35.27 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 123.441 0.463 . . . . 0.0 111.543 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.9 90.79 4.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -32.36 -47.84 0.29 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-N 113.741 -1.572 . . . . 0.0 114.659 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.462 ' HB1' ' HA2' ' A' ' 146' ' ' GLY . . . -61.42 109.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.373 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -93.65 -52.5 4.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 0.0 109.65 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -12.65 19.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.876 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLY . . . . . 0.462 ' HA2' ' HB1' ' A' ' 143' ' ' ALA . . . 111.23 -34.09 5.49 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.855 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.26 81.12 0.13 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.045 0.45 . . . . 0.0 110.252 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.69 93.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.188 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.33 -69.25 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -145.81 18.62 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.018 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -69.05 92.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--O 1.246 0.915 0 O-C-N 124.127 0.892 . . . . 0.0 110.104 -170.008 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.522 ' HB3' ' HG3' ' A' ' 126' ' ' GLU . 27.8 ttt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -60.4 -48.97 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.07 0.462 . . . . 0.0 110.517 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.636 ' HG ' ' SG ' ' A' ' 106' ' ' CYS . 76.9 mt -96.8 34.71 1.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.642 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.9 -140.13 0.96 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.446 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -146.34 140.12 26.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.663 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.39 4.52 62.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.477 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -81.06 143.45 32.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 121' ' ' LYS . 31.6 t -69.64 133.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.469 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.58 146.63 31.66 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 -175.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.04 162.31 26.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.888 2.392 . . . . 0.0 111.975 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.39 113.58 25.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.832 0.349 . . . . 0.0 111.547 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.95 137.02 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -134.72 104.88 6.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.86 172.18 18.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.139 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 15' ' ' ILE . 3.8 mp -98.01 119.18 45.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -173.56 3.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 -171.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 81' ' ' ILE . 96.6 mt -62.45 -33.49 74.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.669 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -74.99 -30.68 61.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.608 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.54 19.36 7.93 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.523 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -100.35 144.25 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -87.04 92.46 9.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.66 147.46 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.527 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.42 168.0 9.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 -174.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.72 -35.37 74.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.643 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 3.2 p-10 -66.81 -17.55 64.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.78 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -74.25 -24.15 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.126 0.489 . . . . 0.0 110.501 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -105.35 8.51 33.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 110.25 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.8 tttp -62.46 160.3 13.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.074 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.28 10.17 57.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.271 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -141.43 177.6 8.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 115' ' ' LEU . 97.3 m-85 -85.17 107.03 17.04 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 64' ' ' THR . 42.0 t -100.43 109.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 -174.247 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 28.1 tp -86.77 118.18 26.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -104.89 115.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.699 0.285 . . . . 0.0 110.835 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -101.79 111.04 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.262 0.553 . . . . 0.0 111.413 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -93.77 118.07 30.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.422 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -151.16 176.93 10.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -170.3 151.39 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.384 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.11 1.85 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.403 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.65 54.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.689 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.0 t -103.48 116.31 32.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.564 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 9.5 m -67.97 -26.53 65.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -177.22 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -73.22 -36.2 66.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.92 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.0 m -59.99 -35.58 75.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HE ' ' CG ' ' A' ' 84' ' ' ASP . 26.4 mmm-85 -67.39 -22.21 65.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.546 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 42' ' ' SER . 4.9 mptp? -85.88 -11.45 53.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.327 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 43.8 mt-10 -105.65 -6.87 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.611 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.9 m -54.05 -47.09 98.2 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.953 175.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.9 Cg_endo -51.68 -36.81 62.67 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.624 2.216 . . . . 0.0 113.036 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 41.0 m-85 -67.55 -39.62 84.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.031 0.443 . . . . 0.0 110.069 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD21 HD13 ' A' ' 113' ' ' ILE . 88.5 mt -63.7 -43.12 97.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.692 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -64.15 -43.41 95.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.463 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -54.56 -44.85 73.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.341 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HD1' ' A' ' 58' ' ' PHE . 33.2 m -63.76 -48.7 75.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.66 ' HB2' HD12 ' A' ' 65' ' ' ILE . 53.2 t80 -60.07 -36.04 76.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.843 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -73.34 -33.49 65.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.11 -18.92 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HD1' ' O ' ' A' ' 54' ' ' THR . 84.1 m-85 -111.54 10.98 21.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -75.19 -3.94 35.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 0.0 111.116 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -98.34 -2.33 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.006 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -122.99 174.43 7.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.469 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.05 61.95 2.57 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 74.4 t80 -133.68 130.42 38.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.787 0.327 . . . . 0.0 110.334 -176.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 12.3 p -135.73 137.82 42.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.283 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 55' ' ' TYR . 36.8 mt -97.34 124.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 80.4 t80 -113.25 104.79 12.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.876 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.963 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -86.24 142.12 18.72 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.566 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.7 111.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 15.0 m -115.07 155.17 27.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.008 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -143.96 40.12 1.37 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.935 0.874 . . . . 0.0 108.658 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 4.5 m-20 -71.37 175.78 5.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.399 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -70.21 -45.57 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.409 -172.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 3.5 tpt180 -145.68 150.62 36.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 28.4 tt0 -62.28 -41.81 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 110.459 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.33 -44.21 95.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.254 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.64 -39.78 84.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.152 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -58.48 -54.13 50.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.626 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -57.22 -40.55 77.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 2.7 ttpm? -60.51 -49.44 77.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.363 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.569 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -58.15 -40.54 81.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.136 0.493 . . . . 0.0 111.1 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 86' ' ' SER . 80.3 mt -61.67 -38.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.887 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -71.77 -46.41 58.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 46.5 mt-10 -54.69 -54.33 43.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.143 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.611 ' HB3' HG21 ' A' ' 48' ' ' THR . 5.5 m-20 -85.56 0.18 53.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.068 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 70.0 mmtt 58.4 37.82 25.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.574 0.702 . . . . 0.0 110.706 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 81' ' ' ILE . 36.4 t -82.59 68.15 8.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.708 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -87.1 76.29 9.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.963 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 30.8 p90 -148.67 -174.57 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 169.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.16 90.94 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.504 -171.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.963 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 91.6 mt-30 -108.0 138.76 43.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.912 0.386 . . . . 0.0 111.017 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.09 146.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.95 126.41 37.02 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 98' ' ' VAL . 47.5 mt -67.92 145.7 54.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 0.0 111.383 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.5 mt-30 -67.76 156.0 38.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.433 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -60.92 -44.89 96.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.008 0.433 . . . . 0.0 111.614 -170.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.29 -19.49 31.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.4 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' CB ' ' HB2' ' A' ' 94' ' ' GLN . 37.0 t70 -80.87 -27.8 36.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.976 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' GLN . 58.3 t -47.91 -51.35 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -47.73 80.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.559 -176.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -67.78 -50.2 58.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.03 -173.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.97 -56.05 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.315 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.0 mt -57.49 -46.0 84.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.75 -60.71 2.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 m -51.31 -38.58 53.74 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 124.716 1.26 . . . . 0.0 113.292 -170.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -82.07 17.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.463 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.636 ' SG ' ' HG ' ' A' ' 3' ' ' LEU . 63.8 m 62.88 42.19 7.97 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 123.378 0.671 . . . . 0.0 110.077 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 63.4 mt -100.16 89.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.058 -176.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.5 -18.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.23 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.68 152.48 24.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.006 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -108.75 156.12 39.47 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 95.2 Cg_endo -78.29 177.01 40.62 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 123.238 -1.568 . . . . 0.0 112.779 0.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.06 117.62 4.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 51' ' ' LEU . 58.6 mt -127.98 138.43 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.471 ' HB ' HG23 ' A' ' 122' ' ' ILE . 49.2 pt -134.3 158.63 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.013 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 136' ' ' VAL . 60.9 tp -118.59 115.46 24.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.27 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.31 129.98 47.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.567 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 8.2 p30 -78.53 166.99 38.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.203 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 6.4 Cg_endo -50.5 -35.88 47.25 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.965 2.443 . . . . 0.0 113.196 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 45.3 mt-10 -63.01 -37.4 87.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.62 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.46 3.89 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HG2' HG22 ' A' ' 8' ' ' VAL . 28.4 mtmm -111.77 151.76 28.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.815 0.341 . . . . 0.0 110.259 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 114' ' ' ILE . 18.0 mt -87.64 92.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.315 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -73.12 -26.98 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 0.0 110.748 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -133.92 119.03 18.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.555 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HG2' ' CD ' ' A' ' 126' ' ' GLU . 60.8 tttm -127.46 157.72 39.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.557 -174.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.564 ' CD ' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER 50.24 48.69 21.81 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.999 0.812 . . . . 0.0 110.989 -176.761 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 132' ' ' LEU . 83.7 mt -72.49 157.37 37.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 13.8 tpt180 -128.7 142.38 51.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.464 -173.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 35.65 -132.45 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.02 -10.85 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.562 . . . . 0.0 110.111 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.1 m-20 -55.1 -33.47 62.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.266 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 4.3 pp -64.7 -41.42 96.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.912 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.442 ' N ' HD12 ' A' ' 132' ' ' LEU . 32.1 t80 -60.79 -52.14 66.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.712 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -60.07 -36.18 76.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.224 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 85.8 m -71.08 -46.55 61.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.146 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 115' ' ' LEU . 96.1 t -67.49 -45.82 84.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.113 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' HG3' HD22 ' A' ' 141' ' ' ASN . 2.6 tp10 -58.53 -45.72 88.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.409 0.623 . . . . 0.0 109.606 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -56.94 -54.4 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.673 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.921 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 42.4 t80 -65.02 -56.76 11.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.745 -170.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.27 -42.43 95.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.33 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.472 HD22 ' HG3' ' A' ' 137' ' ' GLU . 92.1 m-20 -81.06 -61.29 2.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.125 -173.022 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -113.92 -27.01 3.63 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.324 -0.941 . . . . 0.0 114.919 -167.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.921 ' HB3' ' HA ' ' A' ' 139' ' ' PHE . . . -73.62 72.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.853 0.826 . . . . 0.0 111.734 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -141.89 33.46 1.58 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.15 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 148' ' ' HIS . 17.8 mm-40 -72.2 90.81 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.577 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.92 21.62 6.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.661 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -120.34 32.21 6.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.074 0.464 . . . . 0.0 110.829 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 145' ' ' GLU . 23.6 p80 -125.06 131.34 53.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.009 0.433 . . . . 0.0 111.239 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' HIS . . . . . 0.484 ' H ' ' CD2' ' A' ' 149' ' ' HIS . 1.8 p80 -79.84 -174.58 4.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -59.04 -50.56 73.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.524 0.202 . . . . 0.0 111.118 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 167.47 -19.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.364 1.066 . . . . 0.0 108.197 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.8 p80 . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 165.492 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.746 ' HG2' ' H ' ' A' ' 2' ' ' SER . 32.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.746 ' H ' ' HG2' ' A' ' 1' ' ' MET . 5.0 p -57.15 -56.35 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.162 0.505 . . . . 0.0 109.89 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.3 mt -115.71 161.54 18.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.423 172.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.98 -163.67 1.49 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.694 0.283 . . . . 0.0 110.451 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 p -110.17 112.61 24.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.49 -4.36 40.25 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 p -71.96 128.23 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.13 135.66 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -92.36 144.04 28.3 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.686 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 52.6 Cg_exo -55.27 158.44 12.18 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.232 2.622 . . . . 0.0 112.602 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.1 95.33 10.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.184 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.576 HD11 ' CE1' ' A' ' 105' ' ' TYR . 21.5 mm -59.12 131.84 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.462 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -126.96 88.09 2.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 161.58 13.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.976 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.32 125.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.801 0.334 . . . . 0.0 110.372 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -169.5 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.337 0.589 . . . . 0.0 111.681 -173.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.93 -30.09 71.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.931 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.65 -36.24 62.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 0.0 110.28 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.99 16.01 8.17 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.167 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.3 m-20 -97.64 140.27 32.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -77.48 97.33 4.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 110.249 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.91 147.48 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.796 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.7 m -108.86 156.77 19.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.152 0.501 . . . . 0.0 111.367 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.59 -27.82 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.525 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -25.42 67.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.6 -9.59 58.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.409 0.623 . . . . 0.0 110.528 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.35 4.56 17.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.195 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -62.15 170.28 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.198 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.13 83.4 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.794 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 35.1 mttp -141.01 156.87 45.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 63' ' ' PHE . 85.7 m-85 -72.63 115.6 12.1 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 57.6 t -103.12 107.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.328 -172.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.439 ' HB3' HG12 ' A' ' 65' ' ' ILE . 38.9 tp -86.24 106.49 17.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.85 125.86 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.013 0.435 . . . . 0.0 110.891 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 12.9 t0 -112.06 96.23 5.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.426 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' HG13 ' A' ' 68' ' ' VAL . 96.0 m-85 -82.07 114.94 20.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 69' ' ' SER . 22.3 p-90 -153.55 175.45 13.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.062 0.934 . . . . 0.0 112.604 -172.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -167.76 162.84 14.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.691 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.95 -19.31 65.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.56 64.65 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.246 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.4 p -95.89 97.99 10.07 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.65 0.738 . . . . 0.0 109.943 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -64.77 -36.18 83.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.981 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -56.27 -41.18 75.44 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -64.93 -28.56 69.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.007 0.432 . . . . 0.0 110.252 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -81.26 -14.14 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.411 0.624 . . . . 0.0 110.083 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -79.69 -21.86 44.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.212 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -90.31 -7.11 54.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.879 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 98.6 m -48.58 -48.45 68.36 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.7 Cg_endo -49.36 -44.79 33.0 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.33 2.02 . . . . 0.0 112.633 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -73.82 -40.05 63.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.829 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.8 mt -57.21 -51.94 67.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.81 -43.04 94.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -62.63 -44.61 95.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.035 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.48 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 59.8 m -59.7 -46.17 89.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 37.5 t80 -65.69 -36.02 82.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.03 -43.64 98.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.091 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.01 -27.12 30.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD2' ' O ' ' A' ' 54' ' ' THR . 92.1 m-85 -114.57 10.83 16.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 20.1 pttp -64.76 -29.33 70.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 111.31 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.22 10.51 29.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.193 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HZ3' ' CD ' ' A' ' 145' ' ' GLU . 80.0 mttt -121.36 -174.16 2.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.769 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.37 57.88 4.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.954 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' HD1' ' HB2' ' A' ' 31' ' ' TYR . 80.3 t80 -144.0 142.53 30.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.784 0.326 . . . . 0.0 110.179 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -151.45 150.29 30.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -102.34 125.11 56.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -105.66 98.08 7.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.844 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 90' ' ' GLN . . . -79.87 137.42 18.65 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 36' ' ' PHE . 1.5 p -138.45 123.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.107 0.48 . . . . 0.0 110.591 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.5 t -128.87 163.87 24.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.222 0.534 . . . . 0.0 111.439 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.792 ' HB ' HD12 ' A' ' 93' ' ' LEU . 4.3 t -147.75 44.16 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.726 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.529 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 2.9 t70 -71.01 -178.93 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.399 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 13.1 ptt180 -67.1 -29.59 69.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.741 -173.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 56.4 mtt-85 -143.4 158.28 43.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.743 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.784 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 32.3 tt0 -75.72 -38.79 58.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.3 mp0 -60.72 -44.82 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.794 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 1.9 m-20 -62.52 -42.39 99.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.573 ' CE3' ' HD2' ' A' ' 78' ' ' LYS . 32.6 t90 -56.94 -52.74 64.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.917 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 3.7 mptp? -54.15 -50.63 66.53 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.29 0.566 . . . . 0.0 110.593 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 25.0 ttpp -60.46 -44.62 95.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.173 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.34 84.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 65.6 mt -60.39 -43.66 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.512 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -68.6 -46.46 69.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.008 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -59.73 -45.01 93.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.173 0.511 . . . . 0.0 111.138 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.29 -15.71 51.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.247 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HD2' ' HE2' ' A' ' 87' ' ' TYR . 66.6 mmtt 65.02 33.32 9.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.835 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.9 m -92.34 85.59 5.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 98.6 m-85 -91.77 84.25 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.42 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -153.02 -173.3 4.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -69.52 96.6 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 32.6 mt-30 -123.18 143.63 49.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.143 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.3 158.3 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 111.301 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.2 tp -103.55 132.33 49.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.429 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 70' ' ' THR . 88.7 mt -61.94 140.51 58.31 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.256 0.348 . . . . 0.0 111.169 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.691 ' O ' HG23 ' A' ' 98' ' ' VAL . 42.9 mt-30 -90.06 169.3 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -49.24 -55.07 13.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.237 0.541 . . . . 0.0 111.744 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -82.19 -36.57 27.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.674 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 13.3 t70 -56.77 -36.92 70.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.629 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.2 t -52.06 -37.31 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.776 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.9 tptt -62.76 -58.8 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.384 -175.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.07 -49.59 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.592 0.234 . . . . 0.0 111.157 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -53.7 -59.69 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.714 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.776 ' HA ' HD12 ' A' ' 107' ' ' ILE . 35.1 mt -65.0 -30.41 71.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.988 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.26 -63.92 1.3 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.582 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.3 m -65.39 -23.44 66.96 Favored 'General case' 0 C--N 1.338 0.077 0 O-C-N 124.213 0.946 . . . . 0.0 113.423 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.576 ' CE1' HD11 ' A' ' 12' ' ' ILE . 54.5 m-85 -81.74 15.38 2.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.302 173.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 46.9 t 55.22 44.46 27.59 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.325 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 102' ' ' LEU . 61.4 mt -86.22 93.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.068 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.6 m -106.28 19.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.261 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.98 168.89 26.72 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.836 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 87.0 m-85 -122.94 159.03 55.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.3 Cg_endo -86.52 171.55 38.7 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.359 -0.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -136.93 104.26 5.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.9 177.317 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.93 114.92 47.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 38.1 pt -124.93 159.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.06 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 4.0 tt -116.99 116.3 27.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 95.7 t -102.66 142.99 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.475 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -77.36 165.56 50.81 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.4 Cg_endo -49.0 -29.84 16.51 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.313 2.675 . . . . 0.0 114.09 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.787 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -91.75 2.06 56.75 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.392 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 86.75 26.34 32.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.436 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.787 ' HZ3' ' HB3' ' A' ' 119' ' ' GLU . 28.4 mttp -107.66 142.36 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.043 0.422 . . . . 0.0 110.465 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.7 mt -76.29 109.73 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.939 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.37 -36.21 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.066 0.46 . . . . 0.0 110.3 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 21.4 pttm -163.08 151.79 14.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.283 -0.167 . . . . 0.0 111.003 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 60.28 48.49 8.01 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.885 0.74 . . . . 0.0 111.09 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.66 156.94 21.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.939 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HD2' ' H ' ' A' ' 129' ' ' GLY . 8.6 tpt180 -101.44 147.71 26.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -38.27 -58.31 1.66 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.37 -38.0 73.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.168 0.509 . . . . 0.0 110.102 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.8 t70 -83.27 -26.85 30.31 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' A' ' 129' ' ' GLY . 75.5 mt -46.26 -57.62 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.1 -47.9 80.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.98 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 94.0 m-20 -53.72 -53.36 53.15 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.236 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.654 ' HA ' ' CE ' ' A' ' 138' ' ' LYS . 4.8 m -62.24 -36.12 81.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' LEU . 50.8 t -69.21 -44.89 80.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.43 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 141' ' ' ASN . 1.3 tp10 -67.53 -29.83 69.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.652 0.739 . . . . 0.0 109.962 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.654 ' CE ' ' HA ' ' A' ' 135' ' ' THR . 26.9 ttpt -78.87 -54.2 6.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.966 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.489 ' CD2' HG23 ' A' ' 135' ' ' THR . 61.1 m-85 -87.07 -48.79 7.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 80.3 t -65.92 -42.61 92.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 -173.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 86.4 m-20 -81.9 -25.91 34.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.982 0.42 . . . . 0.0 110.997 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.02 16.46 64.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.411 -173.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 60.21 17.47 6.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 34.9 mmtm -147.53 -52.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.511 ' CD ' ' HZ3' ' A' ' 61' ' ' LYS . 43.0 mt-10 71.11 -31.12 0.22 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.422 0.689 . . . . 0.0 112.011 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.61 -158.73 10.49 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 171.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 59.07 59.16 2.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.57 0.7 . . . . 0.0 109.521 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -80.47 4.68 17.43 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -110.97 140.74 45.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -118.77 87.04 2.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.596 0.713 . . . . 0.0 111.346 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.89 -42.88 0.89 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.0 p80 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.53 174.134 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.1 m 73.47 -93.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 168.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.53 -165.17 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 0.0 111.668 -164.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.82 -80.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.274 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -152.81 154.1 34.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.12 -1.27 70.31 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -91.69 146.43 23.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.595 -0.302 . . . . 0.0 110.461 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.42 138.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.397 . . . . 0.0 110.095 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.81 149.95 40.67 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.738 -175.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 35.6 Cg_exo -62.9 163.53 21.86 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.522 2.815 . . . . 0.0 112.088 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.89 105.0 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.083 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.36 148.32 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.603 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 13.7 t -136.61 134.99 37.97 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.18 31.18 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.355 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -88.9 119.46 36.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -175.72 5.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.088 0.47 . . . . 0.0 111.127 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 90' ' ' GLN . 95.4 mt -65.07 -28.93 69.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.945 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.58 -28.99 28.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.44 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 25.22 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.251 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.27 148.17 25.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 p -76.82 94.35 3.86 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.04 130.67 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.4 m -102.58 161.85 13.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.51 -14.86 46.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.615 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 30.2 p-10 -67.28 -20.86 65.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.915 0.388 . . . . 0.0 111.2 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.13 -23.04 47.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.46 5.53 31.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -79.98 63.21 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.702 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.6 13.17 0.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.064 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -144.31 171.38 14.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 120.78 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.317 172.281 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 64' ' ' THR . 46.1 t -112.47 112.79 41.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.494 -171.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 113' ' ' ILE . 10.0 tt -90.58 119.32 30.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 51.5 t -103.77 121.32 55.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.801 0.334 . . . . 0.0 110.915 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 29.9 m-20 -84.98 136.75 33.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.418 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.26 114.55 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -158.18 173.36 16.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.691 0.758 . . . . 0.0 112.342 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -170.05 166.59 9.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.614 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.73 65.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -51.47 24.97 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.148 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.4 p -71.45 101.9 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.454 0.645 . . . . 0.0 110.432 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 18.9 m -69.39 -5.45 23.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.081 -171.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' TRP . . . . . 0.515 ' HD1' ' HG3' ' A' ' 111' ' ' PRO . 72.4 t-105 -85.37 -29.31 24.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.952 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 75.8 m -57.81 -34.5 69.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 110.631 176.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.573 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 8.6 mmt85 -66.79 -18.38 65.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 110.388 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.7 mptt -85.09 -33.18 22.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.937 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.27 -20.27 37.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.418 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.578 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 46.5 m -48.61 -50.5 59.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.4 Cg_exo -49.65 -45.27 32.19 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.266 1.978 . . . . 0.0 112.843 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.93 -31.82 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.935 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.51 -47.95 81.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.275 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.49 -40.94 96.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.174 0.511 . . . . 0.0 109.965 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.67 -46.44 81.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.591 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.3 m -65.12 -49.29 70.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.275 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.608 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.1 t80 -57.63 -42.37 83.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 111.44 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -78.06 -35.47 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.468 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -85.37 -19.88 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 136' ' ' VAL . 44.6 m-85 -106.22 -4.95 19.61 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 16.9 pttp -67.39 167.15 13.11 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.948 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 1.9 m-20 73.94 -36.9 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.656 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 82.1 mttt -61.69 -41.12 97.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.374 0.607 . . . . 0.0 110.167 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.36 44.62 0.14 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 56.7 t80 -140.59 144.66 35.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -173.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 44.7 m -150.64 142.23 23.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.6 mt -98.77 134.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 110.139 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -112.89 95.86 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.409 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 35' ' ' ASP . . . -76.96 103.3 1.77 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.397 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 53.7 t -99.05 117.21 43.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.265 0.555 . . . . 0.0 110.614 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 t -128.97 156.61 43.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.116 0.484 . . . . 0.0 110.763 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -136.76 48.76 2.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 10.8 t70 -65.29 -176.12 0.29 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.552 -171.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.7 mtm180 -54.15 -50.31 67.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.01 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 55.3 mtp180 -145.65 175.04 10.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.766 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 42.0 tt0 -75.14 -38.63 60.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.92 -42.27 99.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.328 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.624 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 3.4 m-20 -75.56 -28.22 58.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.443 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 21.1 t90 -64.68 -48.22 75.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.2 mptm? -58.9 -37.43 76.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.048 0.451 . . . . 0.0 110.002 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 36.1 ttmt -63.05 -45.68 91.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.932 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.35 74.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 110.943 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.09 -36.97 76.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.079 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 10.1 tp10 -63.0 -40.88 99.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 173.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.1 mt-10 -62.65 -59.7 4.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.265 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.573 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.2 m-20 -82.53 -16.99 46.6 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -172.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 62.99 35.16 13.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 111.12 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 p -81.7 86.17 6.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.951 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -90.4 86.18 6.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -155.42 -175.26 5.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.168 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.52 96.78 0.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.321 0.582 . . . . 0.0 111.446 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.0 mm-40 -99.05 140.15 33.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.132 177.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.68 137.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.1 tp -92.85 125.94 37.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' OD2' ' A' ' 97' ' ' ASP . 65.9 mt -72.58 137.88 46.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.665 ' O ' HG23 ' A' ' 98' ' ' VAL . 74.1 mt-30 -67.07 147.05 53.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.27 -16.74 61.92 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.191 0.519 . . . . 0.0 110.759 -170.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.15 -33.87 22.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.432 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' OD2' HD22 ' A' ' 93' ' ' LEU . 7.1 t70 -72.27 -32.55 66.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 94' ' ' GLN . 75.3 t -50.09 -37.09 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.533 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -56.75 -63.76 1.1 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.786 0.803 . . . . 0.0 111.626 -172.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.05 -39.94 63.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.804 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 68.3 t -58.24 -50.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 19.3 mt -56.21 -62.06 1.97 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.981 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -50.76 70.97 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.532 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 t -57.63 -33.09 67.91 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.651 0.594 . . . . 0.0 112.365 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.483 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 51.2 m-85 -83.8 16.11 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 2.8 m 67.98 38.82 2.67 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.436 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 78.8 mt -119.94 110.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.116 -170.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.69 20.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.366 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.83 -172.4 40.6 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.658 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.44 156.17 69.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 117.181 0.49 . . . . 0.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.786 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 92.3 Cg_endo -86.36 167.6 47.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.784 -1.34 . . . . 0.0 113.237 -0.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.92 118.64 8.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 132' ' ' LEU . 4.1 mp -111.49 120.59 62.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 39.9 pt -122.08 158.1 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.561 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -122.86 117.41 25.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.926 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 117' ' ' ASP . 93.3 t -113.1 135.47 52.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.103 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 26.3 m-20 -66.96 163.89 40.04 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.749 174.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.85 -27.72 85.03 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.108 1.872 . . . . 0.0 111.404 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.44 -29.87 68.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.761 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 100.34 40.4 3.01 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.372 -175.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.613 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.4 mtmp? -112.05 148.8 33.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.95 99.4 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.14 -33.74 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.228 0.537 . . . . 0.0 110.639 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.15 152.94 45.09 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.743 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 2.3 ptpt -166.83 172.86 9.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.783 0.325 . . . . 0.0 111.51 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.743 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 0.7 OUTLIER 59.67 28.88 18.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.242 178.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 132' ' ' LEU . 89.7 mt -78.52 154.2 30.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.48 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -104.33 169.56 8.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.079 179.052 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -46.6 -70.94 0.59 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.9 -32.84 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.375 0.607 . . . . 0.0 110.987 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 39.9 t0 -73.64 -46.16 48.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.582 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 113' ' ' ILE . 4.5 pp -60.04 -37.0 78.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.505 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.502 ' CE2' ' HE1' ' A' ' 58' ' ' PHE . 53.8 t80 -68.14 -55.27 12.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 5.9 p30 -67.42 -27.09 66.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.693 -174.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 43.3 m -83.58 -33.24 25.42 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.656 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.5 p -74.89 -38.77 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 121.77 -0.581 . . . . 0.0 109.963 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 4.0 tp10 -65.6 -32.86 74.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 24.1 ttmt -56.66 -43.65 80.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.796 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.24 -51.13 6.46 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.26 -34.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ASN . . . . . 0.46 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 55.6 t30 -98.68 -49.91 4.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.764 0.316 . . . . 0.0 110.423 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.36 -159.8 47.23 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.039 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 144' ' ' LYS . . . -80.03 150.54 30.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 143' ' ' ALA . 20.7 mmmt -114.89 129.67 56.75 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.492 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -128.96 152.93 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.89 151.97 6.62 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 64.88 23.37 12.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.437 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -81.34 -3.19 51.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.222 -0.299 . . . . 0.0 111.481 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 64.8 t60 -159.15 130.76 6.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.548 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 57.4 t60 -129.49 147.18 51.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 20.4 t60 72.67 151.72 0.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.645 0.591 . . . . 0.0 109.699 -173.012 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.6 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.158 176.484 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.753 ' HA ' ' HB2' ' A' ' 106' ' ' CYS . 62.1 m -143.83 -179.01 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.039 0.212 . . . . 0.0 110.483 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.23 162.86 5.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.087 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 -171.21 2.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.247 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -99.22 131.05 45.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.605 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.26 -1.45 60.62 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.061 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 p -74.93 138.79 42.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.07 128.42 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 130.5 55.32 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.12 154.85 59.76 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.788 2.325 . . . . 0.0 111.396 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.06 103.9 16.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.372 . . . . 0.0 111.61 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.8 mt -63.07 142.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.866 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.0 t -124.27 87.46 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.625 0.726 . . . . 0.0 110.582 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.56 161.65 15.18 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.0 123.48 45.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.609 0.242 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HA ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -70.95 -175.66 1.18 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.399 0.619 . . . . 0.0 111.883 -172.49 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.25 -29.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.653 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -81.47 -50.7 9.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.71 23.6 0.31 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.52 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -108.81 137.47 46.69 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 p -79.99 114.29 18.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.738 0.304 . . . . 0.0 111.039 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' THR . 23.9 m -108.78 156.56 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.924 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 8.5 p -107.49 155.76 19.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.013 0.435 . . . . 0.0 110.733 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.4 tp -56.97 -31.62 65.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.867 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 9.9 t30 -71.17 -17.73 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.371 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -68.37 -29.41 68.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.32 -15.06 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.082 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LYS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 1.4 tmtp? -54.14 145.1 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.235 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.37 -0.35 40.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -133.97 172.59 12.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 140' ' ' VAL . 94.8 m-85 -77.67 106.52 9.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.61 108.52 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.881 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 tt -87.02 113.81 23.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 24.3 t -96.03 115.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -103.44 106.67 17.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.545 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' HA ' HG23 ' A' ' 68' ' ' VAL . 86.5 m-85 -90.5 115.09 27.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.482 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.6 p-90 -159.35 179.82 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.726 0.774 . . . . 0.0 112.348 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -166.63 162.92 16.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.006 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.03 69.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -174.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.38 -46.34 80.53 Favored Glycine 0 C--N 1.332 0.335 0 O-C-N 123.635 0.585 . . . . 0.0 112.688 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.4 p -88.65 78.85 7.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.716 0.77 . . . . 0.0 109.619 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.802 ' HA ' ' HD3' ' A' ' 45' ' ' ARG . 54.8 m -69.4 -1.97 9.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.242 -174.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -74.56 -36.35 63.08 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.529 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 3.3 m -60.7 -35.73 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.875 0.845 . . . . 0.0 108.857 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.802 ' HD3' ' HA ' ' A' ' 42' ' ' SER . 58.5 mtp180 -67.77 -26.6 66.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.886 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptt -86.97 -16.96 34.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.907 0.384 . . . . 0.0 111.603 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -88.62 -10.32 49.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.681 0.753 . . . . 0.0 109.149 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.599 HG23 ' CH2' ' A' ' 88' ' ' TRP . 37.0 m -54.82 -46.22 99.52 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.277 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -46.43 -43.57 21.85 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.369 2.046 . . . . 0.0 113.005 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -70.65 -40.14 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 48' ' ' THR . 97.8 mt -60.02 -37.8 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.504 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.88 -43.74 87.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.72 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.88 -43.27 94.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 174.504 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 57.8 m -58.17 -48.99 78.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.911 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.2 t80 -56.24 -48.59 76.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 110.991 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.197 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE2' ' A' ' 61' ' ' LYS . . . -91.87 -32.13 15.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 97.1 m-85 -111.43 4.59 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -55.2 -32.49 62.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.47 0.652 . . . . 0.0 111.005 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.69 12.0 31.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.626 -174.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 57' ' ' ALA . 34.7 mttm -122.97 23.04 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.71 47.41 40.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.536 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 69.7 t80 -129.87 136.55 49.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -143.01 131.56 22.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.684 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.7 mt -88.38 122.04 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -108.14 94.83 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.2 133.12 11.57 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.678 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HB ' HD21 ' A' ' 93' ' ' LEU . 9.5 m -119.85 112.99 39.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.472 0.653 . . . . 0.0 110.774 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.7 t -103.88 148.66 25.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.577 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.518 ' HB ' HD12 ' A' ' 93' ' ' LEU . 5.8 t -126.34 33.98 4.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.39 170.01 1.49 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.348 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -69.25 -46.84 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.644 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.64 164.91 23.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.59 -37.32 86.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 2.1 mp0 -55.53 -53.75 52.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.937 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.22 -45.52 90.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -59.03 -53.24 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.951 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -60.53 -40.64 92.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.926 0.394 . . . . 0.0 111.059 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -64.15 -45.85 86.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.38 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.573 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.3 mt -63.74 -42.43 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.366 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -68.05 -41.55 81.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.685 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.88 -51.28 69.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.763 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.48 7.54 42.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.56 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 66.8 mmtt 55.58 36.32 26.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.543 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.5 p -81.47 68.67 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.319 0.581 . . . . 0.0 111.25 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.56 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 62.3 m-85 -81.8 95.62 7.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.938 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CH2' HG23 ' A' ' 48' ' ' THR . 5.3 p90 -160.99 -178.99 7.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.481 171.231 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -67.64 100.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.458 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -117.54 150.56 38.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 16' ' ' ASP . 35.8 m -133.81 149.34 30.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.46 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.65 123.79 37.21 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 68' ' ' VAL . 69.3 mt -62.78 137.73 58.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.489 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 98' ' ' VAL . 43.9 mt-30 -74.16 166.99 22.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.46 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.88 -48.3 64.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.55 -32.34 22.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.789 0.328 . . . . 0.0 110.417 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB3' ' N ' ' A' ' 94' ' ' GLN . 22.1 t70 -58.05 -42.13 84.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.897 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 93' ' ' LEU . 77.7 t -49.65 -57.93 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 35.3 ttmt -65.26 -59.17 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.313 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.25 -51.7 65.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.451 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -52.47 39.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.1 mt -58.84 -38.39 78.61 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.543 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -61.56 -59.76 4.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.9 m -50.74 -41.14 56.13 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 107' ' ' ILE . 53.5 m-85 -71.76 5.75 2.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.048 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' CYS . . . . . 0.753 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 85.3 m 61.72 52.24 3.61 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.989 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.0 mm -99.27 125.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.695 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.23 7.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.421 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 162.38 33.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.136 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.583 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 85.2 m-85 -132.1 164.66 41.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' PRO . . . . . 0.754 ' HB2' HH12 ' A' ' 128' ' ' ARG . 15.5 Cg_exo -68.52 157.36 88.33 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.448 0.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.58 104.3 4.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 110.815 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -114.66 122.23 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.286 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 125' ' ' LYS . 39.6 pt -123.94 155.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.539 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 55.0 tp -120.89 116.73 25.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.714 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.62 126.9 54.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.932 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.543 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 1.9 p30 -72.87 164.31 61.66 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -55.93 -28.86 70.51 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.567 2.178 . . . . 0.0 112.802 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -30.01 70.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.334 0.587 . . . . 0.0 110.017 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.81 29.53 4.62 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.388 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 8.6 mtmp? -114.96 149.14 37.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.924 0.393 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.89 98.32 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.955 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 m -86.71 -35.22 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -131.75 151.98 51.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.742 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 9.3 ptpp? -161.37 168.73 23.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.925 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 10.0 mm-40 63.46 19.37 11.65 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.082 0.864 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.28 141.4 57.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.469 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.754 HH12 ' HB2' ' A' ' 111' ' ' PRO . 17.6 mmt180 -117.78 159.83 22.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.534 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -21.47 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.466 0.658 0 O-C-N 124.647 1.217 . . . . 0.0 116.131 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.82 -36.33 82.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.93 -42.66 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.147 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.5 pp -57.28 -36.94 71.65 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.655 -175.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' TYR . . . . . 0.466 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.6 t80 -65.66 -46.48 78.97 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.54 -49.63 75.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.48 0.657 . . . . 0.0 110.358 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.3 m -62.53 -46.18 89.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.457 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 132' ' ' LEU . 54.1 t -64.84 -39.13 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 3.9 tp10 -58.38 -38.33 77.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.124 0.488 . . . . 0.0 109.851 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 143' ' ' ALA . 2.5 ttpp -77.16 -25.68 52.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.854 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 31.4 m-85 -89.51 -47.15 8.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' A' ' 31' ' ' TYR . 37.0 t -87.61 -48.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -84.05 -64.86 1.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.74 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 143' ' ' ALA . . . -137.09 146.91 18.9 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.444 -176.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . . . 81.29 22.15 0.34 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 111.98 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 49.9 tptt -72.95 -26.93 61.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.3 158.15 16.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.272 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.39 78.71 0.37 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.766 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.29 159.85 22.66 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.625 -0.338 . . . . 0.0 110.622 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -68.81 -22.8 64.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.9 m170 67.16 170.56 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.62 0.575 . . . . 0.0 111.055 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -119.44 4.82 11.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 109.361 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 15.4 t-80 -123.91 -17.05 6.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.402 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 72.8 m80 . . . . . 0 C--O 1.25 1.08 0 O-C-N 124.616 1.198 . . . . 0.0 108.127 -159.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.267 0 N-CA-C 110.324 -0.251 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.7 p -67.39 112.19 4.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.661 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.8 -10.39 23.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.991 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -79.5 146.25 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.678 0.275 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.94 136.79 24.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.95 142.21 24.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.83 162.4 25.49 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.837 2.358 . . . . 0.0 112.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.66 133.35 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' SER . 5.0 mp -93.37 142.3 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.825 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -115.74 94.2 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.0 110.481 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 91' ' ' VAL . . . -116.42 144.84 18.58 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.471 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 68.4 mt -87.79 132.44 32.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.491 0.186 . . . . 0.0 110.526 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 -175.68 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.817 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 mtmp? -84.03 -41.3 17.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.151 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 18.96 1.31 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.582 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.528 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -94.0 144.33 25.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 105.89 13.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.7 t -103.71 135.7 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.883 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 2.0 m -108.95 176.89 4.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.951 0.405 . . . . 0.0 110.542 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.26 -32.91 69.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.917 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 1.7 p-10 -65.06 -22.46 66.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.992 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -72.77 -18.52 61.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.992 0.425 . . . . 0.0 110.971 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.21 19.21 15.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.9 tttm -80.03 56.14 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.013 -174.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.86 0.7 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -149.03 171.76 15.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -76.46 111.63 12.13 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' THR . 48.1 t -97.4 114.32 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.061 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.2 tm? -88.47 105.35 17.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 44.1 t -89.89 110.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 68' ' ' VAL . 28.9 t70 -106.61 122.27 46.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.46 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -94.7 114.19 26.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' SER . 16.4 p-90 -148.35 172.45 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.708 0.766 . . . . 0.0 111.884 -175.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -170.36 159.92 7.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.661 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.63 69.33 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -6.07 89.2 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.09 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.75 112.64 23.99 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.48 -0.424 . . . . 0.0 110.206 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -64.23 -42.91 96.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.569 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -77.29 -31.66 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 94.5 m -57.6 -38.57 75.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -18.07 65.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptp? -85.36 -34.13 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.453 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 45.5 mt-10 -96.44 1.64 51.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.594 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.633 HG21 ' HB3' ' A' ' 84' ' ' ASP . 84.4 m -50.21 -51.53 62.02 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.329 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 65.5 Cg_exo -52.52 -43.02 57.95 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.259 1.973 . . . . 0.0 113.156 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.8 m-85 -65.1 -46.0 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.9 -40.21 94.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.633 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 60.9 tp -59.42 -47.29 86.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.92 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HE3' ' CD2' ' A' ' 133' ' ' TYR . 38.6 ttpt -62.87 -47.27 84.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.151 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 35.7 m -58.55 -47.91 82.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.711 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -60.03 -51.32 70.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.868 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -66.55 -26.08 66.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.71 -27.43 18.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 71.0 m-85 -108.45 -11.86 15.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 21.6 pttp -54.91 -39.15 68.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.811 0.339 . . . . 0.0 111.388 -176.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.51 -36.52 29.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.439 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HD2' ' CD1' ' A' ' 58' ' ' PHE . 87.9 mttt -58.75 -44.01 90.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.06 43.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.428 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.695 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 65.9 t80 -144.08 150.48 38.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 95.7 m -150.8 132.76 15.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.853 0.358 . . . . 0.0 110.583 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 55' ' ' TYR . 42.7 mt -92.44 118.72 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.088 0.47 . . . . 0.0 110.044 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.76 94.43 5.6 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.35 112.0 3.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.759 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HB ' HD21 ' A' ' 93' ' ' LEU . 32.1 m -100.21 116.43 43.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.485 0.659 . . . . 0.0 111.004 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 7.2 t -128.84 145.39 51.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.947 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 1.037 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.7 t -145.87 54.79 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.014 0.912 . . . . 0.0 110.011 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -68.63 -168.51 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.479 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 0.6 OUTLIER -60.47 -42.86 97.08 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -172.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 56.8 mtp180 -133.11 163.07 30.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.667 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG3' HD22 ' A' ' 92' ' ' LEU . 16.8 tt0 -75.12 -36.74 61.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 2.0 mp0 -59.57 -39.68 84.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.951 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 2.3 m-20 -74.67 -32.36 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 92' ' ' LEU . 29.4 t90 -62.28 -49.03 77.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.0 mptm? -57.88 -43.44 86.05 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.045 0.45 . . . . 0.0 110.278 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 3.5 ttpm? -60.15 -45.84 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.69 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.01 84.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.328 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 82.8 mt -62.99 -38.02 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 36.8 mt-10 -60.49 -56.08 25.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.9 m-20 -75.71 -20.92 58.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.859 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 66.3 mmtt 57.49 37.89 27.9 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.824 0.821 . . . . 0.0 109.98 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 p -83.27 82.96 8.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.87 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -82.78 84.55 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.408 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 28.7 p90 -154.95 -169.24 3.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.119 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -72.92 84.26 1.24 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.425 0.631 . . . . 0.0 111.021 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -89.23 136.36 33.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.536 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 14' ' ' GLY . 17.1 m -131.01 141.71 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.016 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.563 HD22 ' HG3' ' A' ' 74' ' ' GLU . 53.3 tp -88.24 111.16 21.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.626 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.037 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 84.3 mt -66.7 124.1 21.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.1 mt-30 -60.78 143.42 54.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -66.95 -23.32 65.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.582 0.229 . . . . 0.0 111.443 -165.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -87.44 -36.03 17.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 0.0 110.749 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.29 -37.69 86.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' GLN . 63.2 t -50.63 -47.22 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.367 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.05 -55.23 33.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.803 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.25 -53.29 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.204 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.68 -54.32 27.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.783 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 30.5 mt -60.51 -50.63 72.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.009 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.98 -59.66 4.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.308 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.3 m -54.79 -30.98 58.35 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.275 0.984 . . . . 0.0 113.338 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -77.96 10.58 2.75 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.143 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.7 t 64.29 36.13 9.45 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 39.7 mm -106.0 118.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.366 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.48 13.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.214 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.64 160.47 30.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.49 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -133.49 155.98 80.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.446 0.299 . . . . 0.0 110.377 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.619 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 4.2 Cg_exo -82.63 -176.5 16.82 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.148 -1.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -163.03 130.8 3.68 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.627 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 33' ' ' LEU . 58.0 mt -125.93 130.76 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.517 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 30.8 pt -129.15 145.46 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.903 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tt -105.71 110.63 23.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.83 135.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.444 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.549 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -82.13 170.37 15.18 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 16.5 Cg_endo -59.65 -16.72 38.27 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.647 2.232 . . . . 0.0 114.028 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -88.43 3.94 48.21 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 110.824 175.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.04 57.33 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.985 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 27.2 mttm -113.01 141.54 46.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.939 0.369 . . . . 0.0 110.077 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.41 95.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 117' ' ' ASP . 42.6 t -73.27 -41.95 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.578 -176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.66 167.27 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.63 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.0 pttp -162.68 171.89 16.16 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 8.8 mm-40 68.01 16.42 9.54 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.286 0.991 . . . . 0.0 111.15 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.64 132.74 54.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 mmp_? -116.02 154.52 29.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.021 -170.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 46.05 -131.78 10.54 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.966 0.792 . . . . 0.0 113.568 170.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.9 -10.74 59.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.5 t70 -64.27 -31.84 73.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.388 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 3.3 pp -58.9 -41.15 86.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.852 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.52 ' N ' HD12 ' A' ' 132' ' ' LEU . 26.9 t80 -63.6 -54.87 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 109.555 172.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.44 ' C ' ' HE3' ' A' ' 138' ' ' LYS . 25.3 m-80 -58.71 -32.41 69.16 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.11 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.503 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 21.7 m -73.91 -40.23 63.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 132' ' ' LEU . 44.9 t -63.93 -39.28 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.501 174.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -41.48 90.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 176.211 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 135' ' ' THR . 15.8 mtmt -52.51 -40.65 62.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.396 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -87.61 -61.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.1 t . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -164.324 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.271 0 CA-C-O 120.642 0.258 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -64.3 133.84 53.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 0.0 111.109 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.12 -20.31 50.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.747 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -87.08 156.15 19.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 13.7 p -80.79 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.14 0.495 . . . . 0.0 110.793 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.96 144.51 51.54 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.06 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.05 148.68 81.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.585 2.19 . . . . 0.0 112.165 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.84 99.8 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.7 mm -83.25 132.9 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.5 m -131.74 98.99 4.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.072 0.463 . . . . 0.0 110.402 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.581 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -112.37 -176.23 19.79 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.835 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 19.7 mt -104.68 135.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.714 0.257 . . . . 0.0 110.924 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -101.29 -172.6 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 81' ' ' ILE . 92.6 mt -59.46 -26.89 65.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.05 -14.7 59.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.22 57.89 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -102.02 151.17 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -84.42 107.31 16.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.145 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.6 138.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 19.4 m -106.39 172.11 6.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.137 0.494 . . . . 0.0 111.072 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.656 HD11 HG11 ' A' ' 32' ' ' VAL . 55.7 tp -80.42 -21.0 42.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 110.088 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 4.0 m-20 -65.84 -28.69 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.307 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.53 -23.89 67.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.211 0.529 . . . . 0.0 110.932 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.38 8.48 29.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.006 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 6.2 mtpp -76.51 69.99 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.719 0.771 . . . . 0.0 111.179 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -165.65 20.37 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.709 174.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -153.19 -176.45 5.79 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 64.1 m-85 -95.88 111.62 23.56 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 116' ' ' VAL . 9.8 p -101.52 133.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.232 0.539 . . . . 0.0 111.407 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 132' ' ' LEU . 10.3 tt -97.55 107.27 19.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 41.4 t -97.52 105.09 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -102.56 118.46 36.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.069 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HA ' HG13 ' A' ' 68' ' ' VAL . 66.5 m-85 -84.43 116.2 22.95 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.584 ' O ' ' HA ' ' A' ' 69' ' ' SER . 21.9 p-90 -144.4 175.71 9.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.626 0.727 . . . . 0.0 111.874 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -168.38 161.01 11.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.59 -1.187 . . . . 0.0 108.248 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -32.93 73.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.37 -11.66 85.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.196 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 44' ' ' CYS . 48.3 t -74.53 110.62 8.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.257 0.551 . . . . 0.0 109.946 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -65.48 -28.31 69.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.308 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 77.2 t-105 -85.52 -30.75 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.425 ' HG ' ' HG ' ' A' ' 41' ' ' CYS . 90.2 m -58.06 -42.05 84.64 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.3 -13.71 21.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.018 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.5 mptt -84.28 -51.23 7.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 15.7 pt-20 -99.73 15.78 25.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.224 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 22.4 m -51.71 -51.97 65.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.5 Cg_exo -54.29 -33.74 77.1 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.97 1.78 . . . . 0.0 112.379 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.1 m-85 -76.57 -32.23 58.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 132' ' ' LEU . 95.7 mt -62.94 -52.95 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.9 tp -61.07 -40.26 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.533 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -51.69 -53.86 34.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.718 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -67.07 -39.8 86.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.11 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.7 t80 -60.84 -46.75 89.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 111.172 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.19 -35.97 78.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.414 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -31.19 51.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.549 ' HE1' ' OE1' ' A' ' 137' ' ' GLU . 90.3 m-85 -115.48 3.86 14.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.73 -38.44 69.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.74 -42.12 16.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 88.3 mttt -55.8 -56.34 21.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.232 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 38.79 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.749 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 49.4 t80 -135.49 147.28 48.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.4 m -153.99 144.06 22.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.843 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 55' ' ' TYR . 29.4 mt -95.58 137.82 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.097 0.475 . . . . 0.0 111.033 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 39.3 t80 -123.43 93.05 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.04 106.8 3.37 Favored Glycine 0 CA--C 1.505 -0.531 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.582 -172.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 91' ' ' VAL . 3.1 p -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.631 0.729 . . . . 0.0 111.092 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 12.4 t -112.4 152.9 28.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.528 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 93' ' ' LEU . 30.6 p -132.54 48.96 2.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -75.15 -176.05 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.864 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -69.85 -39.27 76.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.924 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HD2' ' OD1' ' A' ' 76' ' ' ASP . 60.9 mtt180 -138.69 152.71 48.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.672 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 33.3 tt0 -65.91 -37.9 87.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 mm-40 -68.78 -36.46 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.766 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -65.25 -34.59 78.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 173.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 31.5 t90 -64.37 -48.73 74.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 8.7 mmtm -55.3 -50.4 69.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.963 0.887 . . . . 0.0 108.837 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.72 -40.06 90.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.014 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -61.77 -36.17 80.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.433 HD12 HD21 ' A' ' 17' ' ' LEU . 73.1 mt -64.6 -39.64 86.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 38.0 tp10 -65.6 -34.32 77.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.767 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 53.7 mt-10 -69.76 -52.19 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.765 0.793 . . . . 0.0 110.304 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.78 -18.67 58.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.228 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 85' ' ' LYS . 8.4 mptt 59.04 21.26 9.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.244 0.545 . . . . 0.0 112.244 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 88' ' ' TRP . 60.3 m -87.07 85.06 7.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.534 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.62 93.31 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.971 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 86' ' ' SER . 7.6 p90 -153.26 -172.68 4.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.744 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 52.1 m-80 -68.49 99.81 1.01 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.278 0.561 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.32 155.41 30.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.171 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.3 p -140.05 145.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.896 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 tp -108.21 129.57 55.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.483 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 70' ' ' THR . 15.3 mt -74.69 142.58 44.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.431 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.4 mt-30 -75.44 163.34 27.51 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.798 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.473 ' CD ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -43.63 -55.37 4.37 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.473 ' H ' ' CD ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -87.8 -33.51 18.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 14.4 t70 -54.76 -39.2 68.09 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.313 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 53.8 t -49.9 -48.12 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.876 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ttpp -56.39 -59.45 4.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.144 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -69.86 -34.95 74.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.577 -171.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.09 -37.43 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.685 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.75 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -66.37 -22.89 66.26 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.67 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -82.54 -62.71 1.54 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.249 -0.981 . . . . 0.0 108.813 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.6 m -48.33 -41.55 28.69 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -164.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.34 17.04 1.81 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.714 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.6 t 57.36 54.0 7.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 19.1 mm -80.33 72.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.636 0.732 . . . . 0.0 110.541 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.51 -25.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.683 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.05 121.18 5.9 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 3.3 t80 -123.88 140.74 35.17 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.502 ' HG2' HH12 ' A' ' 128' ' ' ARG . 62.3 Cg_endo -74.9 135.4 40.31 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.566 -1.431 . . . . 0.0 112.108 -0.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 107' ' ' ILE . 49.7 t60 -89.02 100.8 13.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.9 120.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.558 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 31.5 pt -122.05 159.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.057 0.456 . . . . 0.0 111.666 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 tp -121.09 120.61 35.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.015 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 32' ' ' VAL . 65.4 t -109.2 133.97 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.775 0.321 . . . . 0.0 110.664 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 p30 -77.0 165.79 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.502 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.7 Cg_endo -54.18 -20.33 18.95 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.983 2.455 . . . . 0.0 113.85 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 -14.33 54.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.34 . . . . 0.0 110.775 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.11 30.37 11.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.923 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.6 mtmp? -112.27 152.35 28.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.403 -0.469 . . . . 0.0 110.963 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -84.16 108.69 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.83 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.61 -30.31 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.958 0.409 . . . . 0.0 110.976 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -144.86 155.41 43.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 17.2 pttp -156.61 162.58 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 3.1 mm-40 66.51 20.76 10.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.463 HD21 ' HB1' ' A' ' 124' ' ' ALA . 71.0 mt -64.14 145.05 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.226 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.502 HH12 ' HG2' ' A' ' 111' ' ' PRO . 25.3 mmt180 -132.48 139.98 48.18 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 39.03 -99.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.338 0 O-C-N 124.521 1.138 . . . . 0.0 115.721 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.1 -35.28 59.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.806 -0.197 . . . . 0.0 111.128 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.908 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 27.8 t70 -69.94 -19.45 63.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.469 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 33' ' ' LEU . 95.0 mt -51.86 -59.59 4.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 168.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.14 -49.14 77.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.922 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.908 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 93.8 m-20 -57.41 -41.55 80.55 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.265 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.509 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 5.1 m -74.6 -36.45 62.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 132' ' ' LEU . 41.6 t -68.87 -41.47 82.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.319 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.549 ' OE1' ' HE1' ' A' ' 58' ' ' PHE . 1.2 tp10 -67.94 -32.33 72.71 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.628 0.728 . . . . 0.0 109.246 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.738 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 22.1 ttmt -58.55 -56.92 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.923 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -89.22 -53.28 4.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 23.3 t . . . . . 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -168.573 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.305 0 N-CA-C 110.179 -0.304 . . . . 0.0 110.179 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -68.68 119.18 12.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.35 -8.79 41.48 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.936 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -85.24 149.01 25.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.726 0.298 . . . . 0.0 110.523 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.89 141.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.129 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -85.57 131.2 48.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 37.7 Cg_exo -61.67 153.46 67.06 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.017 2.478 . . . . 0.0 112.219 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.63 134.62 51.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.782 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.625 HG12 HD23 ' A' ' 24' ' ' LEU . 48.5 mm -104.53 129.5 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.474 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.432 ' HB ' HE21 ' A' ' 94' ' ' GLN . 0.2 OUTLIER -120.18 93.02 3.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.11 148.04 18.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.378 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.39 124.39 40.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.354 0.597 . . . . 0.0 111.162 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 170.25 16.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.972 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.8 mp -64.96 -14.56 60.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.92 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 36.7 mtmm -96.59 2.38 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.41 20.02 55.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.787 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 m-80 -101.18 132.46 46.65 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.544 -0.386 . . . . 0.0 110.129 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -80.97 112.0 17.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.69 148.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.43 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -100.43 175.05 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.919 0.39 . . . . 0.0 111.193 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.625 HD23 HG12 ' A' ' 12' ' ' ILE . 3.8 pp -80.2 -20.07 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 110.42 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 29.9 p30 -71.68 -17.89 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.66 -25.99 68.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.275 0.56 . . . . 0.0 110.958 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.29 2.8 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.54 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 12.3 tmtt? -60.02 147.54 38.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.388 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.58 5.17 29.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.453 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -134.89 172.66 12.68 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -82.29 110.57 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.598 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 48.4 t -104.4 125.27 59.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.025 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 132' ' ' LEU . 22.4 tp -103.06 103.73 13.84 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.893 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.0 t0 -113.78 136.43 52.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -110.98 115.59 29.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 69' ' ' SER . 58.5 p-90 -148.06 178.24 8.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 111.369 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -170.28 157.0 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.806 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.12 51.51 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.05 -62.99 5.68 Favored Glycine 0 C--N 1.333 0.363 0 O-C-N 123.581 0.55 . . . . 0.0 112.697 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.3 m -81.42 85.4 6.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.46 0.648 . . . . 0.0 109.813 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.614 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 28.4 p -70.91 -13.73 62.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.451 -176.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -66.97 -33.12 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.966 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.82 -38.84 89.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.518 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.74 ' HD2' ' OD2' ' A' ' 84' ' ' ASP . 41.0 mtm180 -74.04 -12.68 60.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.322 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 42' ' ' SER . 10.1 mptt -72.49 -14.06 61.57 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.067 -0.395 . . . . 0.0 111.032 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 40.7 mt-10 -101.3 -4.76 26.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.636 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 51' ' ' LEU . 56.4 m -60.0 -43.4 94.26 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.123 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.0 Cg_exo -52.2 -36.47 67.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.066 1.844 . . . . 0.0 112.669 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 66.2 m-85 -74.05 -34.66 64.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.729 0.299 . . . . 0.0 110.246 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -60.15 -43.0 96.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.086 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.71 -42.26 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.553 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -60.36 -47.54 85.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.109 0.48 . . . . 0.0 110.393 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -62.56 -43.96 97.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' A' ' 65' ' ' ILE . 51.2 t80 -65.73 -38.79 90.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -65.67 -28.78 69.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.688 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.97 19.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.309 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.34 13.44 32.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 50.5 pttt -60.43 -20.7 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.53 13.04 15.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 111.527 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -116.08 26.03 10.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.94 55.79 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.399 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 80.4 t80 -133.73 136.54 44.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.994 -0.603 . . . . 0.0 109.596 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 36.7 m -140.85 130.73 24.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.818 0.342 . . . . 0.0 110.758 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 55' ' ' TYR . 58.0 mt -89.91 125.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -108.7 94.49 5.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' OE1' ' A' ' 90' ' ' GLN . . . -86.5 117.06 4.54 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.913 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 91' ' ' VAL . 35.3 m -112.97 126.31 70.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 0.0 110.681 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 46.2 t -122.48 139.37 53.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.667 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -106.4 42.22 1.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.104 0.954 . . . . 0.0 108.627 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.1 177.61 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.875 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -69.56 -48.36 60.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.292 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HE ' ' CD ' ' A' ' 75' ' ' GLU . 22.6 tpt180 -143.25 150.48 39.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.792 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 1.018 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 30.5 tt0 -63.28 -39.93 95.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.436 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -61.31 -41.36 96.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.74 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 10.4 t0 -65.21 -45.7 83.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.467 ' O ' HG13 ' A' ' 81' ' ' ILE . 22.7 t90 -58.39 -49.49 77.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.651 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 1.018 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -55.61 -44.09 76.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 110.781 175.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 12.6 ttpp -59.37 -44.83 92.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.182 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.43 79.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.805 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 77' ' ' TRP . 93.4 mt -59.82 -40.35 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.447 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -43.89 66.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -50.07 -58.14 6.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.74 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 8.2 m-20 -84.21 -2.51 57.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.115 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 58.17 37.09 26.26 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.381 0.61 . . . . 0.0 111.091 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 p -79.98 78.37 6.6 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.736 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -83.9 77.75 9.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -158.6 -179.88 8.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.527 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -63.57 115.69 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.31 0.576 . . . . 0.0 111.04 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.459 ' OE1' ' HA3' ' A' ' 67' ' ' GLY . 1.4 tp-100 -123.13 141.08 52.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.786 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 68' ' ' VAL . 19.1 m -137.87 145.32 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.234 0.54 . . . . 0.0 111.144 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.0 tp -92.91 112.67 24.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.648 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.15 133.9 52.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.035 0.445 . . . . 0.0 110.768 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.589 ' O ' HG23 ' A' ' 98' ' ' VAL . 33.1 mt-30 -68.75 145.1 54.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -63.59 -29.32 70.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -171.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 36.6 t70 -79.28 -39.73 32.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.84 -46.17 85.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.851 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 94' ' ' GLN . 77.2 t -50.14 -37.67 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.826 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.2 ttpm? -52.82 -64.02 0.95 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.151 0.5 . . . . 0.0 111.577 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -72.5 -36.89 68.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.744 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.63 -52.01 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.272 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -58.43 -52.6 64.92 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.848 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -52.99 -61.37 2.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.3 0.375 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 28.3 m -57.55 -26.27 61.18 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.007 0.817 . . . . 0.0 112.682 -171.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.471 ' O ' HG12 ' A' ' 107' ' ' ILE . 6.5 m-85 -86.84 20.52 2.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.416 ' SG ' ' O ' ' A' ' 105' ' ' TYR . 31.3 p 50.6 43.75 27.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.872 1.269 . . . . 0.0 110.348 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 12.2 mm -113.03 122.38 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.8 3.59 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.98 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.56 177.16 37.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.955 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 94.5 m-85 -135.25 166.7 26.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 74.4 Cg_endo -75.33 -174.68 14.67 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.031 -0.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.409 ' ND1' HD11 ' A' ' 107' ' ' ILE . 72.4 t60 -166.89 106.52 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.363 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.87 137.16 53.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 125' ' ' LYS . 46.9 pt -131.62 154.51 40.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.699 HD22 HG22 ' A' ' 136' ' ' VAL . 64.3 tp -118.96 119.35 34.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.164 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 19.2 m -109.41 143.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.347 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.57 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 3.3 p30 -78.22 163.78 60.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.334 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 11.9 Cg_endo -58.2 -14.23 18.86 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.134 2.556 . . . . 0.0 113.582 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.41 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 1.1 mt-10 -81.52 -29.63 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.33 19.69 6.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.697 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 9.0 mtmp? -111.23 146.32 37.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.39 104.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.54 -27.26 12.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -155.12 142.94 19.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.775 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.678 ' HB2' HG22 ' A' ' 114' ' ' ILE . 12.4 pttp -142.79 163.06 33.83 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.569 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 7.3 mm-40 65.95 30.53 9.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 110.067 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 ' HB1' ' A' ' 124' ' ' ALA . 88.2 mt -67.41 156.82 35.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.047 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 7.8 mmm180 -116.43 166.9 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -30.98 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.052 0 N-CA-C 116.017 1.167 . . . . 0.0 116.017 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -12.52 59.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.572 0.686 . . . . 0.0 111.571 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.608 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.1 t70 -63.43 -42.16 98.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 41.3 mt -47.6 -56.66 6.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.488 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -58.32 -58.92 6.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.558 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.608 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.3 p30 -69.02 -37.66 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.54 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.3 m -72.0 -42.12 66.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.676 0.274 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.699 HG22 HD22 ' A' ' 115' ' ' LEU . 46.9 t -65.62 -35.81 76.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -57.02 -45.88 82.77 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.139 0.495 . . . . 0.0 109.823 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.462 ' HG3' ' O ' ' A' ' 134' ' ' ASN . 28.9 mtpp -65.96 -35.59 81.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.766 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -80.28 -55.12 5.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t . . . . . 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 111.619 -171.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.21 0 CA-C-O 121.051 0.453 . . . . 0.0 111.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -74.46 141.15 44.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.784 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.6 -13.17 58.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.782 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 147.92 34.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.288 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.18 137.33 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.934 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.64 122.96 57.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.492 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.14 134.1 49.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.061 2.507 . . . . 0.0 111.708 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.35 120.22 19.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.065 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 24' ' ' LEU . 8.4 mm -65.02 133.17 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.21 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.0 m -120.31 87.88 2.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.468 . . . . 0.0 110.287 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -124.01 179.27 16.2 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.212 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.4 mt -109.24 130.28 62.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.92 -176.14 5.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.368 . . . . 0.0 110.724 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.577 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 94.1 mt -58.75 -34.08 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.866 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 32.7 mttp -78.96 -30.22 44.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.579 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.34 12.01 7.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.597 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 20.7 m-80 -87.14 137.4 32.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.639 0.256 . . . . 0.0 110.462 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.9 p -81.57 93.35 6.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.44 154.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.398 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 20.1 m -117.71 166.4 12.48 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 12' ' ' ILE . 3.9 pp -68.41 -18.23 64.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.533 176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.805 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 6.2 t-20 -65.36 -35.52 81.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.37 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.39 -18.03 63.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.413 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.8 4.27 25.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.114 0.483 . . . . 0.0 110.138 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.805 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 41.1 mtpt -69.01 -174.11 0.57 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.953 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.28 10.36 86.27 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -144.84 173.72 11.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 115' ' ' LEU . 94.5 m-85 -86.97 114.45 23.6 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.51 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 28.5 t -114.16 135.26 54.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.873 0.368 . . . . 0.0 111.356 -173.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt -91.31 134.71 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 61.5 t -110.2 100.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.87 108.41 19.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.06 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.649 ' CE2' ' HD2' ' A' ' 105' ' ' TYR . 72.3 m-85 -84.1 116.86 23.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.55 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 9.3 p-90 -143.04 173.53 11.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.301 0.572 . . . . 0.0 110.929 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 41' ' ' CYS . 28.4 p90 -165.17 148.49 8.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.614 171.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.26 -15.86 63.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.906 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.86 -3.06 83.58 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.659 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 50.8 t -120.33 123.96 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 110.744 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.6 t -64.19 -36.52 84.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.807 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.491 ' HD1' ' CD ' ' A' ' 111' ' ' PRO . 49.9 t-105 -70.95 -29.19 65.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.713 0.292 . . . . 0.0 110.713 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 98.7 m -65.31 -27.7 68.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.388 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.39 -14.22 46.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.594 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mptp? -69.33 -38.35 78.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 0.0 109.96 174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.76 -28.94 68.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 m -53.93 -52.93 63.56 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.2 Cg_exo -54.77 -43.72 56.53 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.073 1.848 . . . . 0.0 112.827 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -67.22 -38.86 85.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.308 0.575 . . . . 0.0 109.996 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 65' ' ' ILE . 13.3 tp -65.75 -43.38 89.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.812 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.2 -41.35 98.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.427 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.11 -45.92 92.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.189 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.8 m -62.11 -44.63 96.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.838 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.724 ' HB2' HD12 ' A' ' 65' ' ' ILE . 72.8 t80 -56.34 -57.46 12.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.076 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.69 -34.17 75.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.739 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.41 -31.47 29.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 32.5 m-85 -114.67 -2.2 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -55.0 -37.74 66.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.19 13.55 11.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 65.0 mttm -117.99 20.0 13.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.104 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.35 41.81 16.1 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 67.3 t80 -136.59 139.75 42.35 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -147.64 166.58 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 0.0 110.313 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 55' ' ' TYR . 60.1 mt -122.03 128.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.667 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.485 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 20.5 t80 -113.83 93.56 4.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.53 109.19 3.45 Favored Glycine 0 C--O 1.224 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.402 -172.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.401 ' HA ' HG13 ' A' ' 91' ' ' VAL . 20.8 t -97.62 119.48 45.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -110.18 164.36 12.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.828 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.87 ' HB ' HD12 ' A' ' 93' ' ' LEU . 8.8 t -138.39 28.72 2.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.767 0.794 . . . . 0.0 109.149 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.708 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 22.6 m-20 -73.53 123.93 24.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.467 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.708 ' CZ ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -60.87 -34.96 75.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.512 -176.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 27.6 mtp180 -93.93 102.49 14.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.59 -34.22 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.497 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.645 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -69.38 -31.52 69.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.066 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -76.39 -30.09 57.37 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 81' ' ' ILE . 30.0 t90 -61.77 -52.18 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.951 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 2.0 mptm? -56.55 -43.72 80.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.207 0.527 . . . . 0.0 110.211 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 19.3 tttm -57.51 -56.84 16.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.596 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.577 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -57.27 -36.86 71.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.818 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.782 HD12 HE21 ' A' ' 90' ' ' GLN . 48.1 mm -66.09 -41.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.775 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.33 -31.53 68.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.969 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 51.2 mt-10 -64.3 -50.22 68.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -92.83 -10.91 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.311 -176.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.551 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 58.3 mmtt 71.12 30.66 2.64 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.882 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 p -70.28 86.58 0.59 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.302 0.572 . . . . 0.0 111.223 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.551 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 46.9 m-85 -96.69 99.94 11.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.178 0.513 . . . . 0.0 112.11 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.495 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 6.2 p90 -151.7 -140.81 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.82 170.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 55.7 m-80 -113.31 85.96 2.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.54 0.609 . . . . 0.0 110.541 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.782 HE21 HD12 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -93.85 146.23 24.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.476 0.655 . . . . 0.0 110.876 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.584 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.5 p -137.15 139.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.404 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.29 125.98 45.04 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.446 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.87 HD12 ' HB ' ' A' ' 70' ' ' THR . 69.4 mt -58.64 138.25 57.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.356 0.41 . . . . 0.0 110.597 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.646 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.3 mt-30 -85.1 163.08 19.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.711 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -42.95 -49.64 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -87.8 -41.07 13.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 110.316 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 24.7 t70 -53.12 -35.57 59.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.728 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.5 t -50.91 -45.24 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.595 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -66.16 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.913 -171.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.92 -40.55 93.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.311 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.475 HG13 HD12 ' A' ' 12' ' ' ILE . 27.1 t -63.07 -59.63 4.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 79.9 mt -59.51 -40.53 87.37 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.153 0.502 . . . . 0.0 110.384 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.57 -62.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.253 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 106' ' ' CYS . 49.2 p -56.19 -43.89 78.91 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.497 1.123 . . . . 0.0 113.511 -167.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.649 ' HD2' ' CE2' ' A' ' 36' ' ' PHE . 16.8 m-30 -73.38 11.43 0.77 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.804 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.45 ' H ' ' C ' ' A' ' 104' ' ' SER . 56.3 m 63.36 56.8 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.098 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.7 mp -81.09 110.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.82 -25.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.343 173.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.82 170.39 35.98 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.619 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -121.72 150.23 54.92 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.491 ' CD ' ' HD1' ' A' ' 43' ' ' TRP . 4.4 Cg_exo -78.72 171.32 66.35 Favored 'Cis proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.718 -1.367 . . . . 0.0 112.511 -0.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -145.49 104.3 3.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 132' ' ' LEU . 47.0 mt -114.28 139.18 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.909 0.385 . . . . 0.0 111.344 -172.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 39.2 pt -133.48 155.53 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.449 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 45.8 tp -114.41 117.2 30.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.835 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 10.8 m -103.37 144.22 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 111.649 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 3.8 p30 -80.26 168.79 23.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.177 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 51.5 Cg_exo -55.41 -23.93 40.92 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.978 2.452 . . . . 0.0 113.596 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -78.48 -32.55 48.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.02 0.438 . . . . 0.0 110.442 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.12 22.92 5.08 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.076 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.8 mtmp? -107.15 147.84 29.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.8 mt -81.93 99.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.736 0.303 . . . . 0.0 110.248 -179.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.25 -34.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.32 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -126.52 128.81 47.47 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 1.011 ' HD2' ' HG2' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -129.52 137.63 50.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.802 -0.181 . . . . 0.0 110.897 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 1.011 ' HG2' ' HD2' ' A' ' 125' ' ' LYS . 20.4 pt-20 45.79 75.48 0.11 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.652 1.181 . . . . 0.0 112.236 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.5 HD11 ' HB1' ' A' ' 124' ' ' ALA . 84.3 mt -100.97 170.29 8.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.361 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OD1' ' A' ' 131' ' ' ASP . 9.1 mmm180 -111.07 177.37 4.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.45 -76.82 0.13 Allowed Glycine 0 C--N 1.335 0.494 0 O-C-N 123.741 0.651 . . . . 0.0 114.562 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -15.94 59.73 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.338 -0.507 . . . . 0.0 110.863 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.62 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.9 m-20 -62.25 -41.07 98.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.483 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 84.6 mt -51.03 -54.73 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.881 170.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.39 -58.96 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.869 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.62 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 7.0 p30 -68.8 -28.62 66.93 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.638 -171.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 92.7 m -66.58 -51.72 53.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.285 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.2 -38.48 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 110.396 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 12.3 tm-20 -64.28 -41.78 96.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.252 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -76.34 -17.05 59.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.287 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.42 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.4 t . . . . . 0 C--N 1.326 -0.442 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.997 -168.679 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.454 -0.265 0 CA-C-O 120.587 0.232 . . . . 0.0 110.525 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p -72.26 112.6 8.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.66 -4.03 39.6 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 47.9 t -86.02 143.53 28.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 50.8 t -69.18 136.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.09 145.84 30.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.653 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 152.89 58.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.846 2.364 . . . . 0.0 112.257 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.78 97.15 7.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.965 HD12 HG22 ' A' ' 101' ' ' VAL . 30.1 mm -86.35 147.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.065 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 11.6 t -142.07 123.52 14.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.533 0.682 . . . . 0.0 110.682 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.5 161.46 18.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.069 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 61.6 mt -96.57 123.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.75 0.309 . . . . 0.0 110.619 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -79.63 -177.23 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.892 0.377 . . . . 0.0 111.069 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.425 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -68.6 -18.48 64.32 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.618 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -25.39 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.355 0.597 . . . . 0.0 110.376 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.12 23.7 7.24 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.604 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -101.59 138.8 38.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 p -83.99 94.82 8.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.167 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.67 130.99 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 6.0 m -103.12 167.21 9.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.168 0.508 . . . . 0.0 111.088 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.63 -28.62 69.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.943 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.498 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 7.5 t30 -70.79 -20.94 62.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.131 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -81.4 -4.63 56.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.974 0.416 . . . . 0.0 111.025 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HE2' HD22 ' A' ' 89' ' ' ASN . 84.3 m-85 -110.21 5.27 21.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.406 0.622 . . . . 0.0 109.544 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 90.2 mttt -70.14 132.91 46.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.168 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.86 -27.68 4.56 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.545 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 42.4 mttm -114.84 166.86 11.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.386 -0.907 . . . . 0.0 108.935 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 115' ' ' LEU . 66.9 m-85 -78.14 116.79 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 t -92.63 110.83 23.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.117 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 2.1 tm? -82.86 101.75 11.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 39.5 t -89.98 118.98 36.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.137 0.494 . . . . 0.0 110.257 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 6.2 t70 -106.24 112.91 26.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.618 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 112' ' ' HIS . 89.6 m-85 -95.44 115.76 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.3 p-90 -155.39 177.08 11.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.621 0.724 . . . . 0.0 112.209 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -170.63 167.28 7.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.761 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.1 72.23 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.616 0.722 . . . . 0.0 110.871 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -44.54 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.568 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 p -84.6 85.17 7.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.488 0.661 . . . . 0.0 109.236 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.6 m -60.65 -22.06 63.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.719 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.41 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 9.4 m95 -70.26 -39.55 74.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.472 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 59.9 m -56.4 -43.51 79.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.742 0.782 . . . . 0.0 109.079 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' SER . 8.1 mmm180 -59.22 -38.36 79.77 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.088 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.621 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 1.3 mptp? -86.44 -8.26 57.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -89.46 -3.74 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 170.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.573 HG23 ' CH2' ' A' ' 88' ' ' TRP . 54.4 m -51.03 -50.74 73.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.536 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.8 Cg_endo -52.07 -40.55 68.0 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.122 1.881 . . . . 0.0 112.461 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.29 -41.26 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.409 . . . . 0.0 110.317 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 132' ' ' LEU . 83.1 mt -61.34 -42.43 98.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.814 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.09 -42.56 93.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.561 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -53.66 -51.49 63.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 109.665 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 133' ' ' TYR . 21.5 m -63.68 -49.47 73.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.268 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' HD12 ' A' ' 65' ' ' ILE . 23.7 t80 -56.62 -50.28 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.807 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.578 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 38.0 t30 -75.38 -29.5 59.87 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.401 -171.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.92 -19.67 28.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 40.2 m-85 -121.08 12.81 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.6 ptmt -70.06 -21.06 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -75.93 -34.06 59.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.439 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 42.6 mttp -87.19 -167.74 2.0 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.559 -175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.62 57.63 4.18 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.036 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 88.9 t80 -141.05 147.29 38.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 9.9 t -158.97 153.14 23.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.274 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 55' ' ' TYR . 45.4 mt -106.35 134.79 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -122.1 94.77 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -85.85 126.6 7.87 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.808 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.0 m -116.21 119.6 62.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.162 0.506 . . . . 0.0 110.46 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 40.3 t -122.01 139.0 54.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.134 0.492 . . . . 0.0 111.234 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 t -116.2 59.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.095 0.95 . . . . 0.0 108.583 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.69 -178.57 1.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.238 -170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -67.42 -50.28 60.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.28 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 47.4 mtt180 -134.11 163.95 28.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.415 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 33.3 tt0 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -32.26 73.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.269 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -66.49 -38.57 87.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -64.01 -51.06 66.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 74' ' ' GLU . 1.4 mptm? -49.86 -48.64 51.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.84 0.828 . . . . 0.0 109.781 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -65.42 -38.25 89.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.013 -177.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.466 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . . . -66.06 -35.98 81.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.717 0.294 . . . . 0.0 111.282 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.18 -44.13 97.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.77 -29.21 68.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.889 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 44.9 mt-10 -59.5 -60.11 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.933 0.397 . . . . 0.0 111.57 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.97 4.92 42.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.225 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 4.4 mptp? 62.1 36.52 15.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 p -77.33 72.57 3.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.932 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -86.89 81.07 8.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.573 ' CH2' HG23 ' A' ' 48' ' ' THR . 9.6 p90 -148.84 -176.63 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.782 169.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.537 HD22 ' HE2' ' A' ' 27' ' ' PHE . 92.7 m-20 -69.48 98.91 1.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.166 0.508 . . . . 0.0 110.735 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -120.15 146.52 45.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.634 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.65 150.12 34.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.799 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.63 117.33 28.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 68' ' ' VAL . 93.6 mt -70.2 135.99 49.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.171 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.673 ' O ' HG23 ' A' ' 98' ' ' VAL . 31.6 mt-30 -58.61 141.56 51.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.52 -23.6 66.92 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.726 -168.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.546 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 29.8 t70 -87.35 -36.57 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.448 173.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.9 t70 -56.04 -40.93 74.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.144 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 94' ' ' GLN . 85.3 t -49.83 -35.36 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.7 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.6 ttpm? -53.09 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.75 -41.12 99.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.78 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.965 HG22 HD12 ' A' ' 12' ' ' ILE . 73.4 t -57.72 -61.72 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.911 ' HA ' HD12 ' A' ' 107' ' ' ILE . 40.1 mt -60.16 -39.25 85.73 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.042 -175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.93 -64.08 0.93 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.197 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.7 m -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.3 1.0 . . . . 0.0 113.524 -167.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.9 15.18 0.7 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.699 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.457 ' H ' ' C ' ' A' ' 104' ' ' SER . 63.0 m 55.37 47.8 20.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.299 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 102' ' ' LEU . 53.9 mt -88.16 107.11 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.466 -173.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.02 -8.04 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.285 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.33 170.82 35.7 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.524 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.641 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 98.6 m-85 -135.31 164.15 45.84 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.6 Cg_exo -77.26 133.54 31.29 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 124.176 -1.177 . . . . 0.0 112.579 -0.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.606 ' CD2' HG12 ' A' ' 107' ' ' ILE . 14.5 t60 -107.48 111.76 24.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.1 mt -125.62 131.55 71.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.239 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.588 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 45.3 pt -128.17 149.2 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.738 0.304 . . . . 0.0 110.798 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 31' ' ' TYR . 47.0 tp -112.91 111.21 21.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 73.4 t -97.17 133.0 40.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.798 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 4.1 p30 -78.0 164.78 55.09 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -53.05 -24.34 24.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.2 2.6 . . . . 0.0 114.094 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.504 ' HB2' ' HE2' ' A' ' 121' ' ' LYS . 41.3 mt-10 -77.0 -37.12 55.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 110.055 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.05 23.8 2.62 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.76 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 34.2 mtmt -107.2 155.5 19.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.79 97.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.95 -34.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.155 0.503 . . . . 0.0 110.768 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.79 158.02 42.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 20.6 pttp -163.26 175.28 11.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 15.6 mm-40 64.69 20.76 12.23 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.413 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.435 ' HB2' HD23 ' A' ' 132' ' ' LEU . 47.7 mt -59.62 137.68 57.96 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.614 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -123.38 149.47 44.93 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.275 -170.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 43.45 -125.1 4.95 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.768 0.667 . . . . 0.0 114.437 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.06 -17.0 59.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.622 0.248 . . . . 0.0 110.916 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 31.0 t70 -63.31 -25.72 68.44 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 136' ' ' VAL . 75.8 mt -48.23 -58.52 4.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 109.956 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.4 ' HA ' HG23 ' A' ' 54' ' ' THR . 40.9 t80 -60.34 -50.91 71.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.481 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 92.3 m-20 -61.92 -35.19 77.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.859 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.618 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 7.5 m -74.66 -30.71 61.7 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 86.9 t -65.44 -46.31 90.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.239 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -68.87 -23.34 64.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.442 0.639 . . . . 0.0 109.948 176.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 23.9 ttpt -77.0 -59.15 2.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.08 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.429 ' CD1' HG23 ' A' ' 135' ' ' THR . 47.2 m-85 -88.2 -51.4 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 61.0 t . . . . . 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 111.277 -173.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.435 ' N ' ' HG ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.427 0.156 . . . . 0.0 110.619 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -147.84 128.04 13.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.32 -2.22 86.49 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.435 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 14.6 m -70.27 123.99 23.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.16 137.72 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.956 0.407 . . . . 0.0 110.627 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -96.51 146.54 31.49 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 27.7 Cg_exo -63.08 163.34 22.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.353 2.702 . . . . 0.0 112.535 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.03 115.66 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' SER . 65.8 mt -83.72 137.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.137 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 m -126.31 89.24 2.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.331 0.586 . . . . 0.0 110.022 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.14 161.23 14.88 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.911 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG2' ' HA2' ' A' ' 19' ' ' GLY . 52.8 mt -91.71 129.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -171.68 2.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.062 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.11 -27.05 68.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.551 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 52.0 mtpt -83.23 -49.66 9.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.052 0.453 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 15' ' ' ILE . . . 137.32 23.29 0.47 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.76 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 23.4 m-80 -102.19 149.58 24.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -80.34 99.97 8.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.479 0.657 . . . . 0.0 110.679 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.3 141.93 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.277 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.674 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 6.2 m -116.21 166.1 12.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -174.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.84 -22.67 65.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.122 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.674 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 2.6 p-10 -66.25 -28.57 68.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -72.61 -17.35 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.785 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -113.29 3.88 16.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.686 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -63.11 168.38 4.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.681 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.33 23.04 66.41 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.302 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -145.09 161.4 39.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -78.07 107.58 10.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -109.74 116.93 53.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.581 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 115' ' ' LEU . 43.8 mt -85.0 109.15 17.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 169.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 61.7 t -89.07 111.15 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.431 . . . . 0.0 109.861 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -105.86 117.13 33.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.559 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -98.73 116.1 30.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.5 p-90 -144.63 176.55 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.444 0.64 . . . . 0.0 111.77 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -170.73 168.3 7.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.225 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -28.47 68.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.72 -67.66 1.97 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.72 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.9 m -75.65 88.29 2.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.418 0.627 . . . . 0.0 109.859 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 58.8 p -75.31 11.83 1.11 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.121 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.562 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 40.1 m95 -63.02 -45.34 92.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 29.9 t -62.34 -31.11 71.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.525 0.679 . . . . 0.0 109.779 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 59.9 mtp180 -76.84 -14.08 59.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.306 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.6 mptt -85.28 -38.36 18.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.966 171.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.04 3.64 45.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.807 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 93.4 m -53.09 -50.38 82.44 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -48.24 -42.54 33.36 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.331 2.021 . . . . 0.0 113.0 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -68.89 -47.39 65.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.484 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.31 -46.65 85.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.799 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 65.4 tp -62.25 -43.11 99.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.818 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -62.05 -47.49 84.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.1 m -63.34 -48.24 78.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.003 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' A' ' 65' ' ' ILE . 89.7 t80 -58.78 -49.96 75.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 39.6 t-20 -60.13 -42.52 94.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.099 0.476 . . . . 0.0 110.546 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.26 76.47 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 77.2 m-85 -120.69 7.34 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -169.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 16.7 pttm -57.88 -33.8 69.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.359 0.6 . . . . 0.0 111.37 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.97 7.88 45.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.23 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -120.15 26.46 9.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.57 26.7 50.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.627 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 58' ' ' PHE . 66.3 t80 -134.75 142.88 46.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -152.56 165.44 35.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.034 0.445 . . . . 0.0 110.55 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 55' ' ' TYR . 56.3 mt -120.18 124.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.597 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 89' ' ' ASN . 10.9 t80 -101.21 94.51 6.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.34 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 102.71 2.81 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.137 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.88 113.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.013 0.435 . . . . 0.0 110.737 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 10.5 t -102.56 150.7 23.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.353 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 93' ' ' LEU . 7.9 t -131.52 28.58 4.62 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.159 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.37 167.94 0.87 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 16.6 mtm180 -53.75 -71.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.163 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -109.67 172.28 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.263 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 36.2 tt0 -74.3 -33.11 63.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.73 -41.2 97.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.012 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 72' ' ' ARG . 59.7 m-20 -60.85 -49.37 77.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.997 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 24.0 t90 -57.75 -47.87 81.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.108 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.7 mptm? -62.17 -41.6 98.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.419 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 9.6 tmtm? -70.41 -37.99 74.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.55 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.64 75.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.18 -33.98 55.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.533 0.683 . . . . 0.0 110.408 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -28.84 70.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.014 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 38.9 mt-10 -84.03 -59.98 2.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.619 0.247 . . . . 0.0 110.878 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.85 -22.25 56.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.488 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm 70.88 32.39 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -67.44 100.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.665 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -118.13 74.58 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 111.893 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.546 ' HH2' HG23 ' A' ' 48' ' ' THR . 3.3 p90 -133.94 -154.07 0.57 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 11.6 m120 -72.45 80.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.355 0.525 . . . . 0.0 110.353 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -82.69 125.24 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.2 m -134.02 143.24 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.347 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.404 ' HB2' ' CE3' ' A' ' 77' ' ' TRP . 34.3 tp -102.57 123.97 47.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 70' ' ' THR . 93.0 mt -63.33 134.09 55.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.842 0.353 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' VAL . 36.2 mt-30 -67.69 149.27 50.22 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -62.44 -17.8 60.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.082 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.63 -48.9 8.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.416 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.68 -33.26 71.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 94' ' ' GLN . 44.3 t -47.01 -43.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.7 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -60.74 -63.04 1.44 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.878 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.21 -33.1 63.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 55.7 t -70.01 -57.37 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.463 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.646 HD22 HG12 ' A' ' 107' ' ' ILE . 26.6 mt -59.7 -47.37 85.9 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.235 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.76 -61.82 2.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.259 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 106' ' ' CYS . 19.0 t -62.82 -28.24 69.87 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.344 1.027 . . . . 0.0 112.805 -167.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 24.4 m-85 -74.93 8.63 2.36 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.752 0.31 . . . . 0.0 110.634 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.43 ' H ' ' C ' ' A' ' 104' ' ' SER . 95.4 m 58.22 58.62 3.4 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.089 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.646 HG12 HD22 ' A' ' 102' ' ' LEU . 1.2 mp -75.4 116.73 18.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.583 0.706 . . . . 0.0 110.569 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.45 -21.04 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.128 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.79 178.25 41.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.48 151.38 77.24 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 55.6 Cg_endo -87.98 128.5 9.27 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.681 0.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.8 95.81 10.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.064 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 81.9 mt -113.47 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.506 . . . . 0.0 110.914 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 31.2 pt -114.45 148.76 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.537 -176.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.2 tt -95.48 111.61 23.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 97.9 t -107.91 132.62 55.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.65 163.74 51.85 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.417 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.48 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 82.0 Cg_exo -48.01 -31.24 15.54 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.355 2.703 . . . . 0.0 114.46 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.552 ' HB3' ' CE ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -88.39 -1.57 58.11 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.444 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 88.45 29.23 19.9 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.838 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.552 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 11.1 mtmm -110.72 138.26 47.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 28.5 mt -75.12 118.4 20.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.483 -174.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.411 ' HB ' HD22 ' A' ' 115' ' ' LEU . 27.9 t -94.96 -38.32 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.89 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.317 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 18.3 pttm -150.15 147.1 27.33 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.935 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 61.97 35.79 15.98 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.502 1.126 . . . . 0.0 111.555 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.49 141.64 57.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.97 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -97.16 166.05 11.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.139 -174.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -35.96 -72.61 0.13 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.2 -35.91 69.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.923 0.362 . . . . 0.0 110.432 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -55.78 -46.15 78.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.727 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.3 pp -66.85 -38.78 87.03 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.452 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.3 t80 -65.34 -50.8 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -57.4 -42.14 81.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.716 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.2 m -69.04 -47.01 66.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.546 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' LEU . 52.5 t -64.79 -43.91 96.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 4.3 tt0 -63.85 -39.27 93.83 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -57.82 -33.27 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.385 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -87.69 -61.84 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t . . . . . 0 N--CA 1.465 0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.74 -170.91 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.505 0.193 . . . . 0.0 111.149 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 2.9 t -153.74 137.19 15.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.562 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.5 -1.29 88.94 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.8 m -82.01 128.25 33.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.095 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 48.7 t -69.04 129.66 33.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.83 0.348 . . . . 0.0 110.123 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -93.45 141.6 24.12 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.441 -177.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 22.4 Cg_exo -66.12 163.3 32.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.167 2.578 . . . . 0.0 111.96 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.71 113.92 24.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.011 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.6 141.9 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -120.64 105.12 10.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.914 0.388 . . . . 0.0 110.05 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.76 167.94 14.5 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.811 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.8 mt -105.61 128.09 59.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -173.13 4.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.035 0.445 . . . . 0.0 111.273 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' ILE . 75.0 mt -64.6 -30.38 71.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.965 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.14 -32.86 59.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.33 22.01 6.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.546 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -95.15 141.19 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 p -82.31 106.01 13.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.77 146.31 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.859 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 m -112.57 157.43 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.172 0.51 . . . . 0.0 111.202 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 32' ' ' VAL . 62.5 tp -61.96 -24.71 67.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 8.4 t30 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.12 -9.83 59.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.441 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -113.88 1.63 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.34 . . . . 0.0 110.51 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' CD ' ' HA ' ' A' ' 25' ' ' ASN . 26.3 mtpp -63.61 171.21 2.74 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.395 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.21 83.03 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.583 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -137.55 165.47 26.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.51 114.04 14.79 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 24' ' ' LEU . 46.4 t -111.18 111.7 37.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.015 0.435 . . . . 0.0 111.31 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.559 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.3 tp -90.75 113.88 26.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 42.8 t -102.47 119.45 50.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.438 0.161 . . . . 0.0 110.942 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.39 116.81 33.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.86 116.87 29.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.485 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.98 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 11.7 p-90 -150.61 -178.4 6.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HE1' ' HB2' ' A' ' 110' ' ' PHE . 2.2 p90 -170.58 160.08 7.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.926 169.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.52 6.72 3.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.87 -16.73 67.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.086 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 96.3 m -120.88 121.43 38.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.029 0.443 . . . . 0.0 110.483 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 3.8 m -59.11 -33.36 70.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.459 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -66.73 -31.51 72.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.538 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 72.9 m -58.45 -41.12 84.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -85.12 -12.12 53.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.511 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.5 mptp? -75.69 -28.76 58.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.901 0.382 . . . . 0.0 110.311 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 11.8 mm-40 -79.9 -16.12 55.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.329 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 90.8 m -50.48 -52.13 58.11 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 52.7 Cg_exo -53.0 -42.08 67.02 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.133 1.888 . . . . 0.0 112.803 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 95.7 m-85 -69.11 -38.26 78.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 132' ' ' LEU . 79.2 mt -63.35 -50.32 70.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 50.5 tp -59.19 -40.54 86.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.475 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -52.2 -51.94 55.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.829 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -68.04 -43.66 78.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.445 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.9 t80 -60.93 -48.8 80.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.47 -29.02 69.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.51 -38.05 55.79 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.467 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 94.4 m-85 -120.23 6.74 10.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -61.65 -36.59 81.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.364 0.602 . . . . 0.0 110.84 -176.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.573 ' N ' ' HG2' ' A' ' 59' ' ' LYS . 2.9 p30 -82.76 6.78 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 58' ' ' PHE . 55.1 mttp -116.5 15.28 15.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.12 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.53 30.98 25.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.719 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 49.5 t80 -133.89 143.33 48.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -146.92 163.78 35.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 109.955 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 55' ' ' TYR . 20.2 mt -116.57 125.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.896 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 57.9 t80 -108.41 99.23 8.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.324 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' NE2' ' A' ' 90' ' ' GLN . . . -87.15 135.19 13.01 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.019 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 93' ' ' LEU . 3.2 m -133.4 112.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.574 0.702 . . . . 0.0 110.886 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 92' ' ' LEU . 29.7 t -113.12 154.62 26.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.776 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.9 t -123.91 41.41 3.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.739 0.781 . . . . 0.0 109.018 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.05 169.88 0.15 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -60.66 -38.46 84.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.589 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 38.5 mtt180 -144.72 169.27 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.045 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 1.12 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 31.7 tt0 -75.64 -41.06 55.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.589 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 mp0 -60.78 -36.18 78.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 18.4 t0 -66.65 -48.62 68.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.322 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.665 ' HZ2' ' HG3' ' A' ' 90' ' ' GLN . 34.2 t90 -56.77 -48.25 78.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.143 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 1.12 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 1.6 mptp? -58.83 -38.08 77.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.214 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -60.92 -45.53 94.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.896 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.68 -44.73 96.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.096 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.431 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 70.0 mt -64.34 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.244 0.545 . . . . 0.0 110.753 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.88 -31.19 72.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.305 0.574 . . . . 0.0 110.306 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 41.7 mt-10 -80.32 -53.03 7.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.392 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 81' ' ' ILE . 13.4 p-10 -91.52 -17.98 24.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.67 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER 67.41 38.5 3.19 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.305 0.574 . . . . 0.0 111.221 -179.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.3 p -72.76 67.62 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.325 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.12 85.57 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 52' ' ' LEU . 7.4 p90 -141.04 -149.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.01 64.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.713 0.688 . . . . 0.0 109.849 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' ' HZ2' ' A' ' 77' ' ' TRP . 8.6 tp-100 -90.97 123.42 34.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.242 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.72 152.72 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.188 0.518 . . . . 0.0 110.888 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 69' ' ' SER . 45.4 tp -90.3 129.88 36.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.574 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 68' ' ' VAL . 79.5 mt -70.03 125.3 26.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.2 mt-30 -65.12 147.93 52.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.6 -16.75 63.96 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.867 0.365 . . . . 0.0 111.144 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.27 -49.43 8.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.45 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -50.91 -36.73 39.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.061 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' GLN . 25.1 t -45.01 -41.85 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.456 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 9.6 mtmp? -56.24 -64.27 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 111.682 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.7 -36.44 65.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.906 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 105' ' ' TYR . 55.7 t -68.72 -55.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.257 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.673 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 15.8 mt -60.4 -42.18 95.4 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.555 -175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -62.04 -62.07 2.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.519 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.2 m -55.59 -32.11 62.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HE2' HG13 ' A' ' 101' ' ' VAL . 62.8 m-85 -83.03 22.14 0.98 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.763 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 26.7 p 47.96 48.85 17.69 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.38 1.072 . . . . 0.0 110.56 -175.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 79.6 mt -97.67 110.73 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.689 -175.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.56 18.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.43 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.69 -178.43 41.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.596 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.475 ' HB2' ' HE1' ' A' ' 38' ' ' PHE . 97.7 m-85 -134.84 157.39 77.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.937 0.369 . . . . 0.0 110.293 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.61 168.85 25.87 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.762 -1.349 . . . . 0.0 112.91 -1.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.671 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.6 128.97 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 125' ' ' LYS . 41.7 pt -123.11 153.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.64 113.35 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.1 t -101.1 140.58 19.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.598 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.74 167.29 30.78 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.04 -35.27 50.09 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.82 2.347 . . . . 0.0 113.969 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.4 mt-10 -79.46 -24.23 42.53 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.511 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.36 27.99 3.44 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.538 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -106.05 148.32 27.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.791 0.795 . . . . 0.0 109.309 172.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' THR . 38.2 mt -80.3 104.52 8.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.88 -28.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.75 138.47 30.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.774 ' HG3' HG22 ' A' ' 114' ' ' ILE . 20.8 ttpp -129.81 155.5 45.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.327 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 125' ' ' LYS . 2.3 mm-40 66.08 42.95 3.05 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.897 0.748 . . . . 0.0 110.931 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB3' HD23 ' A' ' 132' ' ' LEU . 83.2 mt -82.16 156.07 24.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.876 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.759 ' HD3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -162.28 167.28 24.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.955 -172.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 44.02 -129.65 6.72 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.933 0.771 . . . . 0.0 113.944 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -77.03 -24.21 52.1 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.62 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 12.5 m-20 -53.67 -27.27 26.62 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.287 0.367 . . . . 0.0 110.43 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 136' ' ' VAL . 71.6 mt -56.18 -64.57 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.357 0.598 . . . . 0.0 109.736 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -58.34 -42.65 87.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.981 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 1.9 t-20 -51.13 -52.32 44.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.483 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -72.26 -34.24 68.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.176 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 132' ' ' LEU . 56.2 t -71.71 -42.31 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.879 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -61.17 -34.85 75.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.77 0.795 . . . . 0.0 109.364 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 12.9 ttmt -64.17 -51.04 65.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.57 -54.86 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t . . . . . 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 111.405 -172.532 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.549 ' N ' ' HG ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.654 0.264 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -64.51 111.2 2.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.92 1.81 52.08 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.447 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.549 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 19.4 m -87.58 131.66 34.33 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.774 -0.25 . . . . 0.0 110.424 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 52.0 t -69.64 132.82 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -100.28 148.35 34.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.553 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 30.0 Cg_exo -64.35 163.21 27.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.566 2.844 . . . . 0.0 112.516 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.28 131.75 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.592 HD12 HG22 ' A' ' 101' ' ' VAL . 18.1 mm -87.33 148.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -133.61 94.23 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.322 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 175.9 16.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.646 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.97 117.07 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.27 -174.8 5.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.026 0.441 . . . . 0.0 111.438 -171.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.32 -30.61 66.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.789 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -69.27 -25.68 64.39 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.053 0.454 . . . . 0.0 111.067 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.07 20.89 29.31 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -103.18 148.84 25.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -77.3 97.97 5.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.93 137.41 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.197 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -176.83 3.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -79.42 -28.94 41.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.202 0.525 . . . . 0.0 110.198 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -66.82 -19.92 65.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.258 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.62 -31.87 71.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 111.204 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -115.62 20.55 14.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.413 0.625 . . . . 0.0 109.78 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 57.5 tttp -84.06 66.76 9.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.991 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.05 17.91 0.19 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.875 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -149.64 175.21 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -80.27 112.57 17.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.42 114.32 37.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.164 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 tp -92.03 109.85 21.21 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 33.6 t -91.19 117.47 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.822 0.344 . . . . 0.0 110.945 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.93 103.04 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.348 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HA ' HG23 ' A' ' 68' ' ' VAL . 39.3 m-85 -82.19 114.72 20.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 11.4 p-90 -155.08 173.68 16.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 122.186 0.993 . . . . 0.0 112.731 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -164.71 154.15 13.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.894 -1.957 . . . . 0.0 107.064 165.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.43 -29.35 66.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.09 -38.19 95.15 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.063 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.1 p -87.55 96.62 10.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.407 0.622 . . . . 0.0 110.231 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.552 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.3 m -68.15 -11.2 58.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.155 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -69.82 -42.46 73.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.91 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . 20.7 p -67.84 -29.6 68.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 6.6 mmp_? -75.57 -14.29 60.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.135 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.6 mptm? -79.13 -21.68 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.732 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -94.92 -3.58 48.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.255 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 94.1 m -51.16 -51.52 67.33 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.346 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.0 Cg_endo -51.72 -39.05 67.49 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.374 2.05 . . . . 0.0 112.495 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.18 -39.77 62.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.989 0.423 . . . . 0.0 110.629 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 113' ' ' ILE . 97.0 mt -63.18 -45.49 91.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.275 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.37 -41.36 96.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.511 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -57.74 -53.29 59.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.396 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD1' ' A' ' 133' ' ' TYR . 19.6 m -61.93 -42.51 99.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.116 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.641 ' HB2' HD12 ' A' ' 65' ' ' ILE . 56.4 t80 -59.73 -56.32 23.36 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.523 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 28.0 m-80 -58.08 -35.43 71.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.66 48.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 92.5 m-85 -120.2 0.78 10.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 60' ' ' ASP . 14.6 ptmm? -60.18 161.6 6.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.241 0.543 . . . . 0.0 111.048 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 32.0 m-20 73.7 -49.69 0.68 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.8 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 44.4 mttp -60.64 -88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.786 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.36 15.79 3.9 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.788 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.97 141.59 44.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -150.6 149.54 30.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.253 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -103.21 129.74 54.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.966 0.412 . . . . 0.0 110.172 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t80 -119.35 98.89 6.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.001 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.74 122.57 6.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.191 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.61 ' HB ' HD21 ' A' ' 93' ' ' LEU . 15.4 m -100.43 111.88 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.656 0.741 . . . . 0.0 110.126 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -104.76 136.51 44.14 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.369 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.552 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.7 t -122.62 32.38 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.045 0.926 . . . . 0.0 109.065 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.4 175.78 0.54 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.285 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -79.05 -57.77 3.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.315 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB3' ' OD2' ' A' ' 76' ' ' ASP . 22.5 tpt180 -123.78 152.01 42.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.317 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 17.1 tt0 -64.7 -35.04 79.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.483 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -58.22 -47.07 84.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.739 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 2.1 p30 -73.51 -36.19 65.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.743 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.463 ' O ' HG12 ' A' ' 81' ' ' ILE . 26.6 t90 -54.4 -54.83 35.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -57.94 -43.13 86.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.87 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -57.0 -50.1 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.764 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.14 88.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 77' ' ' TRP . 39.3 mm -59.82 -39.95 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.108 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.91 -32.76 63.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.27 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.67 -49.34 14.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.125 0.488 . . . . 0.0 110.897 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.97 -19.6 60.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.903 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt 64.3 27.09 13.77 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.312 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 p -87.99 82.32 7.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.11 87.7 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.559 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -150.97 -159.66 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.853 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.24 83.94 7.24 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.357 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -94.74 136.12 35.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.928 0.394 . . . . 0.0 110.695 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 25.5 m -125.83 137.3 58.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.689 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.2 tp -87.79 116.07 25.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 68' ' ' VAL . 74.5 mt -57.45 130.86 48.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.487 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 98' ' ' VAL . 66.1 mt-30 -64.63 151.94 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.9 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.006 0.432 . . . . 0.0 111.869 -170.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.68 -42.85 12.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.9 t70 -54.07 -31.65 52.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.464 0.705 . . . . 0.0 111.793 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 94' ' ' GLN . 52.6 t -48.0 -33.99 4.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.175 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 54.9 mttp -57.67 -65.62 0.6 Allowed 'General case' 0 C--O 1.223 -0.319 0 O-C-N 123.035 0.209 . . . . 0.0 111.495 -175.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 104' ' ' SER . 24.9 t70 -63.02 -43.48 98.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.394 -170.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 12' ' ' ILE . 37.0 t -53.95 -63.21 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.25 0.548 . . . . 0.0 110.397 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 40.4 mt -66.61 -42.12 87.34 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 12.8 mt-10 -67.34 -64.17 0.91 Allowed 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 122.009 -0.432 . . . . 0.0 111.144 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 38.6 m -62.26 -32.55 73.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB2' HG12 ' A' ' 107' ' ' ILE . 74.7 m-85 -77.48 7.7 5.14 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.723 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m 61.85 53.35 3.15 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.246 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.7 mm -105.43 98.99 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.905 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.87 13.36 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.772 0.796 . . . . 0.0 110.739 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.64 -162.61 34.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.641 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.39 156.17 69.74 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.969 0.384 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB3' ' A' ' 44' ' ' CYS . 82.7 Cg_endo -96.63 164.12 14.18 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.102 -1.208 . . . . 0.0 113.13 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -145.11 130.74 18.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 51' ' ' LEU . 70.5 mt -128.27 113.37 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.759 0.314 . . . . 0.0 110.835 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.832 HG22 ' HG3' ' A' ' 125' ' ' LYS . 42.1 pt -112.51 156.57 13.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.359 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.8 118.56 31.16 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -112.28 136.36 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -78.59 166.76 40.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -50.51 -44.05 41.76 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.871 2.381 . . . . 0.0 113.561 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.0 mt-10 -65.21 -29.6 70.42 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.046 -0.409 . . . . 0.0 110.589 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.35 33.04 2.6 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.418 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.629 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -110.51 146.56 35.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.97 0.885 . . . . 0.0 109.194 170.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 25.6 mt -71.17 116.34 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.946 178.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.44 -37.44 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.25 24.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.832 ' HG3' HG22 ' A' ' 114' ' ' ILE . 88.7 tttt -123.7 128.16 49.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.51 . . . . 0.0 111.337 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.539 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 44.1 mt-10 58.72 74.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.71 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.779 ' HB2' HD23 ' A' ' 132' ' ' LEU . 43.8 mt -91.3 155.34 18.6 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.529 HH12 ' HG2' ' A' ' 111' ' ' PRO . 28.4 mmt180 -128.07 161.7 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.25 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 50.92 -137.78 27.14 Favored Glycine 0 N--CA 1.452 -0.26 0 O-C-N 123.983 0.802 . . . . 0.0 113.168 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.37 -16.43 58.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 17.7 m-20 -60.52 -27.26 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.283 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 ' HB2' ' A' ' 127' ' ' LEU . 23.6 mt -51.45 -58.18 6.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.742 167.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 54' ' ' THR . 67.3 t80 -62.81 -48.75 77.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 89.3 m-20 -51.7 -47.18 64.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 m -67.84 -44.07 78.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.5 t -63.94 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 15.7 tt0 -66.28 -44.09 84.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 0.0 110.564 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -59.87 -29.14 68.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 -60.66 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.0 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t . . . . . 0 C--N 1.33 -0.273 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.259 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.213 0 CA-C-O 121.13 0.491 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.963 HG23 ' HA ' ' A' ' 123' ' ' VAL . 90.7 m -104.26 130.17 52.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.886 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.67 -10.5 45.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.779 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -77.95 127.06 31.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 54.8 t -69.7 132.87 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.537 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 105' ' ' TYR . . . -88.2 146.5 38.27 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.591 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.8 Cg_exo -61.82 163.3 19.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.315 2.676 . . . . 0.0 112.094 173.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 130.73 34.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.36 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' SER . 51.7 mt -94.1 138.88 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.146 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.17 101.42 8.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 0.0 110.55 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.84 156.59 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.783 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -98.98 122.21 50.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.449 ' CG ' ' HZ2' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -80.84 -175.3 5.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.023 0.439 . . . . 0.0 111.282 -173.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.37 -31.65 69.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.991 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.506 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 8.8 mtmp? -80.11 -18.66 49.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 111.294 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 25.73 13.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.119 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.97 144.18 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 94.57 6.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.039 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.29 143.24 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.816 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 15.7 m -119.47 170.35 9.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.72 0.295 . . . . 0.0 110.274 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 34.6 tp -68.17 -7.74 32.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.207 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 28.3 p-10 -65.52 -32.37 73.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.39 -31.82 71.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.683 0.754 . . . . 0.0 111.087 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.493 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 95.1 m-85 -85.07 -2.92 58.54 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 120' ' ' GLY . 51.4 mttt -84.03 99.55 10.51 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.371 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 118' ' ' PRO . . . 132.94 -9.13 5.17 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -121.01 165.55 15.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.32 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.92 117.37 23.89 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 8.5 t -109.32 115.82 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.866 0.365 . . . . 0.0 111.856 -169.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 132' ' ' LEU . 34.3 tp -97.01 105.02 17.09 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 15.8 t -96.45 108.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.938 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -102.98 116.83 33.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.26 121.37 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.177 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 69' ' ' SER . 29.9 p-90 -152.97 -178.24 6.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -175.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -168.73 162.8 11.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.487 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -30.95 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.65 65.22 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.801 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.92 99.64 6.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.162 0.506 . . . . 0.0 110.634 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.514 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 59.2 m -63.6 -35.04 79.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.384 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 71.3 t-105 -60.67 -33.95 73.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.452 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 111' ' ' PRO . 58.3 m -60.08 -37.88 81.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.504 0.669 . . . . 0.0 110.341 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.706 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 42.2 mtm180 -84.96 -12.21 53.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.648 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 43' ' ' TRP . 51.5 mmtt -70.76 -21.74 62.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.201 0.524 . . . . 0.0 110.865 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.09 -2.05 58.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.973 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 86.7 m -52.48 -49.0 88.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 71.6 Cg_exo -50.68 -44.53 40.11 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.011 1.807 . . . . 0.0 112.454 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -69.27 -39.22 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.71 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.47 -48.57 80.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.41 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.22 -40.42 85.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.43 -50.9 70.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -62.18 -46.56 88.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.449 ' HB2' HD12 ' A' ' 65' ' ' ILE . 60.6 t80 -55.53 -51.98 65.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.011 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -67.42 -25.97 66.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.83 -27.94 30.53 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 92.9 m-85 -120.59 1.28 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 59.5 pttt -61.35 -27.57 68.6 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.112 0.482 . . . . 0.0 111.786 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.14 -6.5 59.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.275 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -110.92 31.41 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.424 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 39.21 64.81 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.575 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 51.0 t80 -135.6 140.42 44.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 t -150.06 147.51 27.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.293 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -87.61 126.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -97.85 93.9 6.61 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -78.11 107.15 2.4 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.826 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -106.96 111.97 37.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 120.734 0.302 . . . . 0.0 110.421 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 32.6 t -116.06 160.01 20.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.047 0.451 . . . . 0.0 110.43 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.516 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.3 t -131.31 30.44 4.49 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.493 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -51.84 147.95 6.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.553 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -78.93 -10.75 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.019 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 46.7 mtm180 -137.72 149.4 46.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.653 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 15.8 tt0 -72.68 -32.9 66.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 1.7 mp0 -60.34 -40.89 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.084 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.36 -37.16 68.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.019 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -61.33 -51.2 69.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.306 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -59.17 -39.24 81.88 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.901 0.381 . . . . 0.0 110.419 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 4.0 ttpm? -61.89 -48.45 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.742 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.35 75.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.373 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.11 -41.24 91.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.268 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -70.82 -37.59 73.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.4 mt-10 -54.22 -48.28 71.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.262 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.706 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.7 m-20 -104.02 0.81 30.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 63.2 mmtt 58.61 34.76 24.09 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.6 p -82.67 75.79 9.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.475 0.655 . . . . 0.0 111.048 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 69.3 m-85 -87.85 89.47 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.507 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -158.55 -177.15 6.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.04 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.57 100.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 41.0 mt-30 -123.78 151.71 43.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.678 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.86 154.51 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.824 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.85 130.33 46.03 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.516 HD12 ' HB ' ' A' ' 70' ' ' THR . 80.9 mt -65.32 140.24 58.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.693 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.2 mt-30 -73.08 157.98 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -57.94 -36.82 73.05 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.84 -31.14 18.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.67 0.271 . . . . 0.0 111.075 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -35.89 82.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.217 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 87.0 t -48.5 -45.82 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.014 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.16 -62.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.531 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.98 -55.45 12.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.38 -51.91 29.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 O-C-N 123.345 0.403 . . . . 0.0 111.927 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 34.8 mt -61.97 -51.39 68.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.943 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.79 -60.3 4.06 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.389 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.1 m -50.67 -38.26 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.054 0.942 . . . . 0.0 113.385 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.464 ' HE1' ' HB1' ' A' ' 9' ' ' ALA . 17.2 m-85 -78.05 13.74 1.34 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.354 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 34.9 m 63.47 44.19 5.5 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.785 0.678 . . . . 0.0 109.614 -179.417 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 61.2 mt -105.94 92.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.137 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.3 -0.01 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.787 0.803 . . . . 0.0 109.013 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.75 155.66 26.64 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.026 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.64 152.73 79.1 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 44' ' ' CYS . 92.0 Cg_endo -85.51 134.21 18.21 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.593 -1.419 . . . . 0.0 112.736 -0.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -103.32 114.0 27.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 132' ' ' LEU . 61.8 mt -113.97 130.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 29.6 pt -133.34 143.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.3 tp -107.47 118.01 35.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 60.3 t -107.31 138.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.611 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -84.36 167.98 24.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 2.3 Cg_endo -46.01 -42.61 20.67 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.184 2.589 . . . . 0.0 114.195 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.503 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 40.7 mt-10 -76.4 -24.54 54.07 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 122.175 -0.328 . . . . 0.0 111.497 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 109.6 33.13 2.74 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.867 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 119' ' ' GLU . 2.1 mptt -100.59 149.45 23.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.774 0.787 . . . . 0.0 109.476 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 5' ' ' THR . 50.7 mt -85.37 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.321 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.963 ' HA ' HG23 ' A' ' 5' ' ' THR . 4.9 p -86.09 -50.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -115.64 153.97 30.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 13.1 pttm -169.46 153.75 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.148 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 68.43 13.79 9.04 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.273 0.983 . . . . 0.0 111.413 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.573 HD11 ' HB1' ' A' ' 124' ' ' ALA . 68.2 mt -70.28 156.78 38.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.814 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 3.5 mmp_? -101.22 170.45 8.24 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.58 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 132' ' ' LEU . . . -47.23 -68.49 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.29 -31.16 69.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 0.0 110.187 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.91 -38.7 92.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.094 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 33' ' ' LEU . 63.6 mt -52.16 -51.06 60.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.24 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -59.09 -50.72 72.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -61.91 -42.44 99.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.276 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.598 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 15.9 m -72.78 -39.67 66.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.727 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 132' ' ' LEU . 72.6 t -67.18 -35.61 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -59.76 -55.17 37.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 18.8 pttp -63.31 -17.33 62.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.058 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.96 -61.43 1.71 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 173.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.5 t . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -169.415 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.6 ' N ' ' HG ' ' A' ' 7' ' ' SER . . . . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.54 0.21 . . . . 0.0 111.286 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -127.38 128.97 46.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.18 89.96 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.6 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 5.5 m -84.43 140.95 31.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.456 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.42 127.32 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.81 0.338 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 124.96 59.25 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.166 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 25.1 Cg_exo -63.47 158.54 44.86 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.741 2.294 . . . . 0.0 112.311 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 116.13 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.941 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 101' ' ' VAL . 43.3 mm -96.29 150.64 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.166 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 9.0 t -131.19 138.91 49.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.85 29.05 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.644 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 92' ' ' LEU . 66.6 mt -79.73 113.87 19.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.476 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 11.9 p30 -81.92 179.1 7.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.721 -173.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.28 -15.59 60.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.693 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 2.0 mppt? -77.23 -32.76 56.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 109.722 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.91 18.41 4.72 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.985 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 18' ' ' LYS . 8.4 m-80 -113.97 149.08 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.718 0.294 . . . . 0.0 110.6 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.81 90.58 6.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 p -106.36 166.14 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.984 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.708 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 8.3 m -105.13 173.97 6.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.65 HD11 HG11 ' A' ' 32' ' ' VAL . 63.1 tp -57.04 -23.11 44.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 3.3 p-10 -65.59 -16.9 64.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.29 -36.56 78.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 0.0 110.75 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -119.71 10.97 11.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 48.6 tttp -72.7 121.94 20.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.509 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.96 -23.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 27.5 mttm -103.09 174.71 5.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.22 109.32 5.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 165.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.65 HG11 HD11 ' A' ' 24' ' ' LEU . 57.5 t -94.52 108.07 20.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.18 -171.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.4 tp -85.64 109.94 18.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' ILE . 39.6 t -88.73 121.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.253 0.549 . . . . 0.0 110.369 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -104.99 108.99 20.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.007 -172.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.495 ' HZ ' ' HD2' ' A' ' 105' ' ' TYR . 88.1 m-85 -94.37 115.11 27.27 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 5.0 p-90 -155.64 176.59 12.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 0.0 111.475 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -170.07 149.25 3.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.109 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . . . -72.7 5.05 3.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.986 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.13 -14.39 56.16 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.9 t -99.35 134.36 42.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -67.37 -40.26 85.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.439 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -75.36 -28.5 59.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.657 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 85.6 m -58.54 -37.65 76.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.533 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.62 -21.27 66.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.323 0.582 . . . . 0.0 110.714 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.3 mptp? -86.35 -31.9 21.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -78.91 -25.27 43.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.049 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.5 m -50.98 -51.21 69.59 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 73.1 Cg_exo -52.05 -39.58 69.83 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.278 1.985 . . . . 0.0 112.988 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -71.19 -35.32 71.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 110.813 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.719 HD21 HD13 ' A' ' 113' ' ' ILE . 89.5 mt -66.77 -44.66 80.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.345 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.27 -44.31 92.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.358 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 34.2 ttpt -53.52 -56.36 17.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.707 175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.4 m -65.22 -42.8 93.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.51 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HB2' HD12 ' A' ' 65' ' ' ILE . 83.3 t80 -61.95 -51.64 67.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.639 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.604 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 49.4 t30 -55.7 -42.17 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.291 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 70.3 m-85 -106.72 -1.12 23.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 56' ' ' ASN . 12.0 pttp -62.85 -25.79 68.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.078 0.466 . . . . 0.0 110.574 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -23.26 64.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.668 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -110.85 -161.96 0.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.556 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.75 47.59 3.32 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.672 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 79.0 t80 -142.71 153.46 43.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 14.8 t -162.56 170.33 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.676 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 55' ' ' TYR . 44.4 mt -120.2 124.43 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 59.8 t80 -105.26 95.81 6.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.277 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -83.14 135.44 13.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.142 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.8 m -125.84 118.89 53.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.622 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -125.66 151.17 46.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.53 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -131.18 45.38 2.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 108.997 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 39' ' ' ALA . 1.3 m-20 -60.62 -176.5 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.9 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -62.31 -39.8 94.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.286 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 13.0 tpt180 -151.23 158.29 43.71 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.405 -171.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 25.5 tt0 -66.88 -44.94 79.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.702 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.537 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.1 pm0 -70.5 -27.81 64.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.828 0.346 . . . . 0.0 110.084 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 21.7 t0 -62.01 -42.57 99.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -68.0 -49.69 60.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.825 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -52.72 -44.43 66.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.262 0.554 . . . . 0.0 110.287 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 13.9 ttpp -61.69 -44.29 97.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.062 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.1 78.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.966 0.413 . . . . 0.0 111.193 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.46 ' HA ' ' OG ' ' A' ' 86' ' ' SER . 79.8 mt -62.53 -43.71 98.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.127 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -66.01 -38.84 89.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.72 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.7 mt-10 -58.47 -58.61 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 111.329 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.824 ' HB3' HG21 ' A' ' 48' ' ' THR . 1.1 m-20 -85.2 -5.88 59.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.366 -173.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 3.9 mptp? 61.22 34.03 18.93 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.511 0.672 . . . . 0.0 110.451 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -80.09 58.32 2.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.278 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -79.77 75.06 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.45 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 25.4 p90 -140.84 -168.35 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.709 170.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 11.2 m120 -74.46 86.86 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 -174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.7 mt-30 -113.42 148.27 36.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.43 150.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.318 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 49.0 tp -88.38 114.1 24.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.558 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 68' ' ' VAL . 85.6 mt -69.18 135.51 50.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.295 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.658 ' O ' HG23 ' A' ' 98' ' ' VAL . 61.7 mt-30 -72.11 148.26 45.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 74.2 mmtt -63.06 -30.07 71.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -169.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 22.2 t70 -83.85 -40.16 19.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.871 0.367 . . . . 0.0 110.083 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.1 t70 -56.19 -40.54 74.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.765 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 94' ' ' GLN . 96.8 t -48.39 -37.85 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.563 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 3.6 ttpp -54.74 -56.0 23.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.228 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.86 -40.47 68.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.818 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 12' ' ' ILE . 61.9 t -57.17 -60.52 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 49.4 mt -57.13 -57.26 13.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.854 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.68 -61.73 2.12 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.355 0.409 . . . . 0.0 110.711 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 106' ' ' CYS . 39.7 m -53.23 -41.51 65.46 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 124.206 0.941 . . . . 0.0 112.858 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.495 ' HD2' ' HZ ' ' A' ' 36' ' ' PHE . 6.6 m-85 -74.17 12.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.187 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.434 ' H ' ' C ' ' A' ' 104' ' ' SER . 36.3 t 62.95 41.28 8.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.2 mm -112.64 122.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.357 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.18 21.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.665 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.01 168.23 40.97 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.391 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.6 150.7 77.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.583 0.353 . . . . 0.0 110.094 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.35 137.92 8.61 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.025 -1.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -134.09 139.18 45.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.719 HD13 HD21 ' A' ' 51' ' ' LEU . 61.5 mt -128.77 136.7 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.522 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 125' ' ' LYS . 33.0 pt -126.36 159.65 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.45 117.1 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.621 0.248 . . . . 0.0 110.636 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 117' ' ' ASP . 74.1 t -111.84 127.36 69.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.563 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 2.8 p30 -67.68 163.35 49.52 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.815 175.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -49.95 -37.21 46.13 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.309 2.673 . . . . 0.0 113.248 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.47 -36.76 83.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.349 0.595 . . . . 0.0 110.339 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.65 37.51 1.42 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.357 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.563 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.1 mtmp? -117.35 141.93 47.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.854 0.359 . . . . 0.0 110.096 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 mt -80.67 104.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.6 -40.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.2 0.524 . . . . 0.0 110.451 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.69 156.4 42.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.203 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.842 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 0.9 OUTLIER -154.22 171.89 18.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.235 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.842 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 8.7 mm-40 60.75 32.36 20.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.174 0.921 . . . . 0.0 110.32 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.64 134.79 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -77.88 147.34 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.633 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.76 -51.19 7.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.22 -34.33 76.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.6 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.76 -34.05 27.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.071 -168.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.5 pp -58.2 -32.47 68.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.752 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -71.18 -42.34 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -61.17 -42.71 99.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -69.06 -53.22 21.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.807 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 132' ' ' LEU . 27.4 m -61.02 -38.81 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 -64.96 -41.54 95.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.346 177.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -66.48 -23.15 66.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.909 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.14 -61.36 1.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.1 t . . . . . 0 C--N 1.329 -0.297 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.281 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.269 0 CA-C-O 120.452 0.168 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -132.36 134.64 45.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.685 0.279 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.33 -11.76 68.62 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.614 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 t -78.25 151.4 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.87 129.0 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.457 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.52 139.8 41.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' A' ' 105' ' ' TYR . 51.8 Cg_exo -54.63 154.41 20.44 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.928 2.419 . . . . 0.0 112.599 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 91.68 6.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.33 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.526 HG21 HG11 ' A' ' 68' ' ' VAL . 45.6 mt -64.25 135.03 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.158 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 m -133.06 100.4 4.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 110.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.78 176.93 16.82 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.506 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.0 123.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -174.7 5.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.029 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -64.7 -25.12 67.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.62 -21.93 51.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.1 0.476 . . . . 0.0 110.894 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.24 19.66 27.59 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -96.5 145.14 25.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 p -80.99 99.36 8.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.43 131.12 54.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.873 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 m -110.4 171.57 7.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.972 0.415 . . . . 0.0 110.981 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.7 -23.81 63.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 110.409 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 8.2 t30 -64.31 -31.47 72.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.375 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -72.74 -5.22 36.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.433 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 7.23 14.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 9.0 mtpm? -71.39 92.35 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.385 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.64 -24.35 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -121.51 172.85 7.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.526 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 m-85 -78.19 116.64 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.65 ' HB ' HG23 ' A' ' 116' ' ' VAL . 22.6 t -102.92 119.85 51.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.11 0.481 . . . . 0.0 111.208 -172.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 17.4 tp -94.06 116.18 28.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 46.1 t -102.17 115.89 44.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.613 0.244 . . . . 0.0 110.947 -174.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -92.91 103.72 16.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 68' ' ' VAL . 91.6 m-85 -83.77 114.12 21.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.541 ' HZ3' HH12 ' A' ' 45' ' ' ARG . 11.1 p-90 -158.3 178.66 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.6 0.714 . . . . 0.0 112.537 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -169.82 154.25 5.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.95 171.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 86.99 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.476 0.655 . . . . 0.0 110.337 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.1 -46.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.16 101.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.41 0.624 . . . . 0.0 109.464 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 m -66.12 -7.64 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.831 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.479 ' HE1' ' HD2' ' A' ' 128' ' ' ARG . 67.4 t-105 -78.77 -23.66 45.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.4 m -58.24 -42.4 86.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.541 HH12 ' HZ3' ' A' ' 37' ' ' TRP . 4.7 mpt_? -62.74 -16.48 57.8 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.234 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 2.2 mptm? -85.38 -31.55 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -23.61 30.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.143 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 10.7 m -48.96 -50.18 63.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -47.42 -47.55 17.42 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.42 2.08 . . . . 0.0 113.041 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 67.4 m-85 -75.46 -35.4 60.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.512 HD21 HD13 ' A' ' 113' ' ' ILE . 92.0 mt -58.24 -52.61 64.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.63 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.11 -42.94 99.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.346 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HZ1' ' HE1' ' A' ' 133' ' ' TYR . 27.4 tptp -55.07 -52.15 64.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.14 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 63' ' ' PHE . 30.8 m -64.11 -45.44 88.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.147 -178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -58.24 -51.59 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.24 -38.8 92.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.316 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.09 67.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.441 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 21.5 m-85 -120.36 6.7 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.4 pttp -54.47 -50.34 67.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.68 -43.7 65.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.118 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -55.04 -71.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.46 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.07 33.12 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.4 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 78.4 t80 -137.06 139.01 41.02 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 50.3 m -149.58 141.11 23.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' TYR . 33.5 mt -98.36 135.46 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.2 t80 -121.8 95.9 4.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.843 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.5 124.3 6.52 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.979 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 1.005 ' HB ' HD21 ' A' ' 93' ' ' LEU . 17.3 m -105.65 111.51 35.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.085 0.945 . . . . 0.0 109.78 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.606 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 7.3 m -104.81 137.67 42.24 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.164 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.1 t -126.36 42.16 3.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.234 1.016 . . . . 0.0 108.868 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.606 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 8.8 m-20 -61.72 176.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.306 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -80.63 -19.09 46.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.499 -168.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 5.8 tpt85 -165.64 161.72 18.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.6 tt0 -67.16 -44.15 80.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.286 0.494 . . . . 0.0 110.119 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.57 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 1.8 mp0 -59.41 -39.61 83.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.512 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.14 -46.43 87.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.154 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.429 ' O ' HG13 ' A' ' 81' ' ' ILE . 21.0 t90 -59.08 -52.66 64.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.579 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.8 mptm? -53.81 -46.59 71.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 0.0 110.163 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.19 -42.35 94.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.378 175.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.57 76.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.6 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 77' ' ' TRP . 79.0 mt -63.13 -47.81 90.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -66.63 -37.69 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -58.17 -45.47 87.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.338 0.655 . . . . 0.0 111.075 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 48' ' ' THR . 15.2 t70 -87.2 -26.43 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.895 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.5 mptp? 70.99 21.09 5.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.006 0.523 . . . . 0.0 111.144 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -82.25 76.0 9.15 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.892 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -84.48 78.62 9.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.41 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -151.62 -172.61 4.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -69.79 108.46 3.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.196 0.522 . . . . 0.0 111.123 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.51 152.3 40.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.8 146.39 29.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.058 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.26 129.25 35.41 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 1.005 HD21 ' HB ' ' A' ' 68' ' ' VAL . 65.4 mt -63.92 138.47 58.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 98' ' ' VAL . 75.1 mt-30 -80.11 169.49 17.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.811 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -51.67 -46.87 63.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.6 m-20 -87.67 -33.73 18.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.616 0.246 . . . . 0.0 110.455 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.482 ' OD1' HD22 ' A' ' 93' ' ' LEU . 17.4 t70 -55.97 -45.01 79.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.2 t -49.64 -53.11 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.851 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 9.5 mtmp? -60.31 -62.79 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.48 -174.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.49 -42.06 65.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.747 -168.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.538 HG13 ' HE2' ' A' ' 105' ' ' TYR . 53.5 t -68.48 -54.4 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 121.344 -0.142 . . . . 0.0 111.233 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 48.9 mt -58.52 -43.51 89.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.047 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.23 -61.26 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.013 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.8 m -49.25 -40.59 34.78 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.555 ' HB2' HG12 ' A' ' 107' ' ' ILE . 84.8 m-85 -76.52 11.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.046 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.7 m 60.18 42.45 15.34 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 109.904 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 105' ' ' TYR . 36.1 mm -91.76 74.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.691 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.92 -19.04 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.897 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.9 148.69 20.17 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.428 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.34 155.48 48.38 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG2' ' HD1' ' A' ' 43' ' ' TRP . 2.3 Cg_endo -82.54 166.81 68.85 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.279 -0.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.477 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -144.39 109.08 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.106 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.512 HD13 HD21 ' A' ' 51' ' ' LEU . 79.2 mt -114.73 127.0 72.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.757 0.313 . . . . 0.0 110.267 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 46.6 pt -124.23 160.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.105 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -124.9 114.18 18.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.65 HG23 ' HB ' ' A' ' 32' ' ' VAL . 4.7 m -104.99 144.65 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.024 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.597 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.5 OUTLIER -76.07 172.91 8.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.439 177.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -51.71 -24.78 18.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.931 2.421 . . . . 0.0 113.721 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -88.61 1.01 55.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.191 -0.318 . . . . 0.0 111.796 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.04 27.54 58.05 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.709 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -111.62 142.19 44.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.128 0.49 . . . . 0.0 110.241 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.3 mt -72.96 104.68 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.284 -173.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.87 -26.46 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 110.298 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -144.87 151.02 38.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 20.3 pttp -161.66 154.26 20.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.89 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 28.9 mt-10 62.55 29.93 17.05 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.368 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.21 165.66 22.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.273 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HD2' ' HE1' ' A' ' 43' ' ' TRP . 18.1 mmt180 -115.87 166.25 12.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -42.29 -64.18 1.62 Allowed Glycine 0 C--O 1.234 0.124 0 O-C-N 124.012 0.82 . . . . 0.0 114.432 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.02 -36.58 68.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.837 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.37 -50.24 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.6 pp -57.13 -34.4 68.36 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.872 0.368 . . . . 0.0 110.187 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 50.1 t80 -64.84 -57.43 8.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.094 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.22 -43.83 87.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 17.6 m -65.94 -49.04 69.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.897 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.24 -40.95 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.146 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.441 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 15.1 tt0 -65.29 -36.66 84.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.351 0.596 . . . . 0.0 109.897 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 14.1 ttpp -61.73 -39.94 93.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.788 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.27 -53.79 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.3 t . . . . . 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -169.367 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . . . . . . . . 0 N--CA 1.456 -0.155 0 CA-C-O 120.548 0.214 . . . . 0.0 111.017 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 p -134.69 131.59 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.0 -3.79 86.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.458 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.486 ' HG ' ' N ' ' A' ' 4' ' ' ALA . 9.8 m -69.33 130.17 41.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.368 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.03 133.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 0.0 110.289 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -88.59 137.75 30.23 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.24 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 32.2 Cg_exo -61.34 162.28 20.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.012 2.475 . . . . 0.0 112.011 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.6 96.9 9.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.792 0.33 . . . . 0.0 111.618 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.29 140.25 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.832 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -133.55 89.55 2.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.05 0.929 . . . . 0.0 110.286 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.45 155.51 18.98 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.417 -174.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.7 mt -86.11 130.18 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.606 0.241 . . . . 0.0 110.56 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -79.4 -174.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.94 -7.13 46.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 34.8 mttp -99.78 -35.68 9.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.549 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.37 10.5 2.99 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.314 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.8 m-80 -91.77 134.18 34.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 p -83.17 98.15 9.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.855 0.359 . . . . 0.0 110.215 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.16 137.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.009 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -97.37 156.6 16.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.194 0.521 . . . . 0.0 111.437 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 tp -61.13 -27.25 68.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.618 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.532 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.0 t30 -65.85 -31.08 71.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.05 -7.64 54.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 110.811 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.84 3.14 18.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.91 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 85.5 mttt -66.38 178.69 1.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.021 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.05 10.56 85.42 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.497 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -143.17 167.43 22.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.9 110.47 17.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 168.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.2 109.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.908 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.7 tp -85.61 110.28 19.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 114' ' ' ILE . 58.6 t -98.57 107.99 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.094 0.474 . . . . 0.0 110.664 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.21 121.44 42.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.245 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.24 117.31 28.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.778 0.323 . . . . 0.0 110.166 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.8 p-90 -144.14 177.21 8.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.011 0.434 . . . . 0.0 111.181 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -170.67 162.0 7.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.042 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.33 83.4 2.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 0.0 110.661 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.8 -44.41 0.15 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.472 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.63 117.72 12.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 43.3 m -68.61 -29.81 68.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 23.1 m95 -73.43 -40.69 64.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.463 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 73.2 m -59.52 -25.5 64.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -84.94 -19.93 31.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' A' ' 42' ' ' SER . 13.6 mptt -85.7 -23.83 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 111.235 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 43' ' ' TRP . 4.0 mm-40 -78.27 -20.44 51.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.384 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.675 HG21 ' HB3' ' A' ' 84' ' ' ASP . 6.4 m -52.45 -50.89 77.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 82.4 Cg_exo -49.9 -48.13 20.68 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.164 1.909 . . . . 0.0 112.643 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -67.54 -39.65 85.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.583 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -63.22 -41.29 99.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.89 -42.24 99.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.88 -41.95 98.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.993 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.3 m -60.65 -46.49 90.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.797 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.618 ' HB2' HD12 ' A' ' 65' ' ' ILE . 84.0 t80 -56.1 -57.78 10.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 93.2 m-20 -60.8 -32.54 71.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.057 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.29 41.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 90.2 m-85 -112.06 -2.17 15.12 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.759 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.5 ptmm? -62.91 155.68 26.52 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.269 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 14.3 m-20 66.9 10.04 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.476 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.3 mttp -123.25 25.04 8.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.879 0.371 . . . . 0.0 110.958 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.87 27.7 33.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.153 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.46 140.93 46.59 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 160.34 42.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 55' ' ' TYR . 64.0 mt -112.86 126.97 70.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -110.95 95.14 5.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.79 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.26 109.5 2.94 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.884 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.619 HG13 HD21 ' A' ' 93' ' ' LEU . 75.2 t -98.03 112.13 29.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -113.29 145.6 40.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.947 -178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' HD12 ' A' ' 93' ' ' LEU . 3.8 t -126.46 45.92 2.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.616 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.52 171.42 12.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.639 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.536 HH22 HG11 ' A' ' 98' ' ' VAL . 22.0 mmt180 -115.52 2.93 13.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.692 0.758 . . . . 0.0 109.208 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 76' ' ' ASP . 85.6 mtt180 -124.05 124.26 42.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.035 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.0 tt0 -75.81 -33.91 60.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -60.46 -51.28 70.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.737 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 73' ' ' ARG . 0.3 OUTLIER -64.57 -37.42 87.5 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.82 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.11 -52.36 65.21 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 110.73 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.5 mptm? -57.14 -44.94 83.84 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.306 0.574 . . . . 0.0 110.668 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -68.49 -33.81 74.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.082 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.97 82.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.34 -37.68 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.663 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -65.91 -38.1 87.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.647 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 52.1 mt-10 -57.82 -60.06 4.28 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.461 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.675 ' HB3' HG21 ' A' ' 48' ' ' THR . 39.1 m-20 -85.11 -12.87 51.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.286 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 60.05 37.94 20.88 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 110.972 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.0 p -77.0 114.32 15.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.237 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -112.57 84.98 2.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.583 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 11.1 p90 -158.6 -170.03 2.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.46 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.22 90.05 2.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 110.913 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -109.84 133.13 53.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.675 0.274 . . . . 0.0 110.48 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.28 155.19 41.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.717 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.98 123.52 47.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.619 HD21 HG13 ' A' ' 68' ' ' VAL . 82.1 mt -62.74 140.51 58.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.0 111.166 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 98' ' ' VAL . 44.8 mt-30 -73.41 166.62 22.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.912 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 20.2 mtpt -51.02 -58.43 6.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.508 0.67 . . . . 0.0 111.534 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.27 -26.87 38.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.45 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.429 ' OD2' HD22 ' A' ' 93' ' ' LEU . 28.0 t70 -64.25 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.022 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.2 t -49.8 -42.94 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.15 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -58.56 -56.73 18.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.45 -44.66 62.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.469 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.68 -59.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 123.066 0.229 . . . . 0.0 111.378 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 37.2 mt -59.53 -42.85 93.22 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.45 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.77 -62.17 2.07 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.224 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 59.3 p -53.72 -40.21 65.9 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.111 0.882 . . . . 0.0 113.167 -167.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.453 ' HB2' HG12 ' A' ' 107' ' ' ILE . 75.4 m-85 -75.62 12.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 42.8 m 64.45 39.29 7.04 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.478 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.8 mm -92.82 86.83 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.008 -173.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.48 -7.06 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.287 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.05 163.06 35.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.553 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.1 156.27 54.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 93.4 Cg_endo -80.12 175.73 43.41 Favored 'Cis proline' 0 C--N 1.346 0.444 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.719 -0.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -159.94 125.92 4.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.959 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.1 135.05 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.16 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.611 HG22 ' HG3' ' A' ' 125' ' ' LYS . 34.7 pt -132.34 146.11 33.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 53.6 tp -107.74 112.6 25.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.982 0.42 . . . . 0.0 110.024 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.402 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 96.2 t -100.5 135.04 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.772 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.1 OUTLIER -80.42 167.09 35.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 4.1 Cg_endo -47.41 -36.33 23.26 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.61 2.873 . . . . 0.0 114.327 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.67 -29.66 61.31 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.839 0.352 . . . . 0.0 111.236 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.402 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 112.49 31.05 2.68 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.671 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -112.67 140.29 47.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.18 107.49 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.39 -24.86 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 111.035 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -140.6 133.81 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.911 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 25.6 ttpp -134.5 137.04 43.56 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.256 -174.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.911 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 49.3 mt-10 68.75 51.6 0.59 Allowed 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.158 0.911 . . . . 0.0 111.666 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.41 157.23 23.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.516 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 11.1 tpt85 -134.18 150.54 51.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.411 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 49.38 -141.02 12.77 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.656 0.598 . . . . 0.0 113.927 168.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.65 -10.92 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.341 0.591 . . . . 0.0 110.138 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.3 m-20 -58.86 -33.17 70.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.126 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -65.89 -36.58 83.8 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.407 ' N ' HD12 ' A' ' 132' ' ' LEU . 49.2 t80 -65.42 -50.3 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.017 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -60.71 -34.37 74.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.32 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.0 m -65.65 -51.03 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 132' ' ' LEU . 86.2 t -63.15 -36.1 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 5.2 tp10 -57.98 -44.12 86.91 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.893 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -76.38 -16.39 59.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.059 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.65 -58.1 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.221 -0.299 . . . . 0.0 111.73 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.5 t . . . . . 0 C--N 1.327 -0.4 0 CA-C-O 120.876 0.369 . . . . 0.0 111.655 -173.267 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . . . . . . 0 N--CA 1.455 -0.201 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.3 p -136.65 125.21 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.931 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.74 59.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.927 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.5 p -75.33 132.68 41.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.944 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.2 p -72.3 137.1 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.477 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -107.48 145.56 31.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.2 Cg_exo -61.7 154.08 62.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.071 2.514 . . . . 0.0 112.464 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.27 139.14 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.185 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' SER . 53.5 mt -95.03 137.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -120.55 107.87 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 0.0 110.543 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.01 154.11 23.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.719 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.16 122.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -178.82 3.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 95.3 mt -59.56 -31.03 69.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.818 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -78.93 -35.66 42.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.5 3.05 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.08 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -105.88 145.9 30.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 p -77.32 104.53 7.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.236 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.91 143.29 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.999 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 10.2 m -123.04 162.39 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.637 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 32.3 tp -63.76 -7.42 7.7 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.539 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.8 -29.6 70.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.457 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.64 -27.76 63.3 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.844 0.83 . . . . 0.0 110.847 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.637 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 88.0 m-85 -87.88 4.03 46.21 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -171.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -84.3 87.45 7.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.798 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.79 -9.7 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.34 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -117.05 163.38 16.34 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -84.95 120.66 26.75 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 6.8 t -106.35 124.33 61.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.094 0.473 . . . . 0.0 112.091 -169.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 113' ' ' ILE . 2.7 tm? -104.19 98.02 7.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.6 t -92.5 124.26 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 21.0 t0 -120.19 144.83 47.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.255 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 110' ' ' PHE . 96.9 m-85 -117.04 119.64 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.127 174.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.715 ' HZ2' HD11 ' A' ' 81' ' ' ILE . 54.1 p-90 -148.07 175.09 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.453 0.644 . . . . 0.0 112.027 -176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CD1' ' HE2' ' A' ' 110' ' ' PHE . 1.5 p90 -162.37 166.12 25.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.157 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.7 65.89 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -171.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.57 -38.13 90.16 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.432 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.6 p -85.95 101.83 13.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.373 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.5 m -71.47 5.07 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -174.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -85.8 -30.27 23.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.31 -0.243 . . . . 0.0 111.294 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 45' ' ' ARG . 21.1 p -68.56 -28.61 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.759 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.608 ' HD2' ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -77.62 -14.58 59.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.402 0.62 . . . . 0.0 109.408 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 42' ' ' SER . 2.1 mptm? -79.54 -24.32 42.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 42.5 mt-10 -100.16 -0.24 39.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.22 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.526 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 85.5 m -50.43 -52.65 53.11 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.92 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.8 Cg_endo -54.43 -40.99 80.77 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.545 2.163 . . . . 0.0 113.156 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.448 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.9 m-85 -67.61 -44.6 77.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.983 0.421 . . . . 0.0 110.351 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.78 -40.82 97.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.605 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.25 -46.52 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.94 -46.91 87.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.205 0.526 . . . . 0.0 110.312 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 32.0 m -62.1 -49.7 74.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.73 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.6 t80 -62.34 -40.73 97.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.64 0.257 . . . . 0.0 110.967 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.16 -34.15 75.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.287 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.74 -26.91 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 51.1 m-85 -102.8 -8.55 20.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -56.49 -35.01 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.31 0.95 56.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 88.1 mttt -105.54 19.71 20.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.036 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.39 37.47 70.06 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.4 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 39.7 t80 -130.67 143.53 50.81 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -145.76 136.2 24.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.0 mt -88.26 117.68 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -100.31 93.43 5.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.176 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -87.6 112.2 3.81 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 34.1 t -104.86 119.03 53.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.025 0.441 . . . . 0.0 110.712 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.8 t -124.22 156.17 37.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 4.3 t -137.96 51.3 1.89 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.822 0.82 . . . . 0.0 109.027 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.576 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -66.67 -176.89 0.52 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.906 -174.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 3.6 ptm180 -77.23 -26.68 52.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.17 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 10.6 ttt180 -149.27 128.4 12.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.962 -166.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.7 tt0 -61.06 -42.25 98.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 pt-20 -64.57 -41.6 96.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 80.7 m-20 -66.28 -34.15 77.36 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.621 ' O ' HG12 ' A' ' 81' ' ' ILE . 31.2 t90 -61.48 -60.65 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HD2' ' CE3' ' A' ' 77' ' ' TRP . 2.6 mptm? -52.23 -43.02 64.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 0.0 110.903 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 29.5 ttmt -59.39 -49.67 76.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.857 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.77 88.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.626 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.715 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 44.2 mm -56.19 -45.7 81.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.738 0.304 . . . . 0.0 110.961 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 10.7 tp10 -58.87 -59.26 5.73 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 4.8 mm-40 -69.62 -33.56 72.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 45' ' ' ARG . 35.2 t70 -71.51 -12.25 61.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 110.352 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.722 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 44.0 mmtt 64.54 32.55 11.55 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.093 175.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.449 ' HB3' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -96.42 79.51 3.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.713 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -91.46 89.94 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -175.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -156.63 176.68 12.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -64.96 97.58 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.74 0.65 . . . . 0.0 111.711 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.55 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 51.4 mt-30 -123.56 149.64 45.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.41 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.21 150.42 31.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.24 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.43 118.7 35.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.316 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 53.9 mt -62.94 137.19 58.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.368 0.604 . . . . 0.0 111.962 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 98' ' ' VAL . 22.4 mt-30 -73.5 145.79 45.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -70.64 -16.1 62.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.681 0.753 . . . . 0.0 111.123 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 99' ' ' LYS . 3.2 p-10 -78.7 -46.81 18.21 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.399 171.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.23 -34.69 75.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.137 0.575 . . . . 0.0 111.517 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 94' ' ' GLN . 48.7 t -43.59 -43.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.727 . . . . 0.0 112.703 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 96' ' ' ASP . 60.6 mttp -54.97 -63.15 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.557 -169.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.0 -48.63 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.8 t -52.38 -47.93 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.504 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.526 HD22 HG13 ' A' ' 107' ' ' ILE . 25.7 mt -62.63 -59.36 5.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.58 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.62 -61.52 2.23 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.209 0.318 . . . . 0.0 110.793 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 70.9 m -56.29 -37.05 69.34 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 124.211 0.945 . . . . 0.0 112.606 -172.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.2 m-85 -77.17 13.65 1.08 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 120.956 0.408 . . . . 0.0 110.8 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 49.2 t 63.9 60.74 1.01 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.202 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.526 HG13 HD22 ' A' ' 102' ' ' LEU . 9.4 mm -85.44 93.59 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.074 0.94 . . . . 0.0 111.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.13 -31.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.78 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.64 151.66 22.89 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.349 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.65 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.5 p90 -147.2 160.04 40.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 118.948 -0.548 . . . . 0.0 109.78 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.65 ' C ' ' HA ' ' A' ' 110' ' ' PHE . 3.8 Cg_endo -43.54 145.96 1.79 Allowed 'Cis proline' 0 C--N 1.364 1.347 0 CA-C-N 120.325 1.152 . . . . 0.0 114.944 2.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 65.9 t60 -140.91 95.21 2.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.083 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 33' ' ' LEU . 96.6 mt -101.61 114.5 41.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -172.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 105' ' ' TYR . 48.2 pt -127.15 166.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.742 0.306 . . . . 0.0 110.983 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.0 118.14 32.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 78.6 t -110.85 138.55 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.045 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -92.52 170.07 9.67 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 1.5 Cg_endo -48.56 -36.84 32.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.35 2.7 . . . . 0.0 114.107 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.07 -22.07 62.16 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.955 -0.466 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 23.53 11.29 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.208 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 78.8 mttt -99.04 141.74 31.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.828 0.346 . . . . 0.0 110.096 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' THR . 33.2 mt -81.82 98.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.16 -21.89 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.173 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.48 142.19 21.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 4' ' ' ALA . 10.8 ptmm? -129.71 138.54 51.19 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.315 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 67.78 46.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.17 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 86.7 mt -70.35 151.16 45.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 171.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.694 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 8.4 mmm180 -124.9 146.04 49.53 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.101 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 44.31 -125.51 5.94 Favored Glycine 0 C--O 1.224 -0.479 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.305 169.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.33 -20.92 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 111.037 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.694 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -51.03 -42.98 60.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 177.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -59.62 -34.35 72.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 54' ' ' THR . 40.8 t80 -68.92 -53.45 20.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -61.15 -42.97 99.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.517 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.448 ' O ' ' HD1' ' A' ' 139' ' ' PHE . 24.3 m -66.75 -43.38 84.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.454 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 63' ' ' PHE . 77.9 t -67.54 -40.98 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.88 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -62.44 -34.27 76.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.488 0.661 . . . . 0.0 109.437 177.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 27.7 ttpp -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.846 179.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.448 ' HD1' ' O ' ' A' ' 135' ' ' THR . 60.7 m-85 -80.68 -61.73 1.88 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.981 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.203 -169.115 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.295 0 CA-C-O 120.689 0.28 . . . . 0.0 110.539 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -70.61 119.13 14.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.508 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.89 -18.41 5.93 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.4 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 p -78.14 154.37 31.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.619 0.247 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.41 139.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.145 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.53 137.66 28.73 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.578 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 53.7 Cg_exo -53.7 146.48 44.33 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.796 2.331 . . . . 0.0 112.014 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.13 119.55 14.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.108 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 24' ' ' LEU . 45.1 mm -93.24 129.35 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.671 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -134.61 108.1 7.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.29 170.71 14.73 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.356 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 15.7 mt -100.24 115.91 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 27.6 p30 -75.04 -174.46 2.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.475 0.655 . . . . 0.0 112.63 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 96.4 mt -60.22 -29.82 68.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.055 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 -38.0 30.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 110.297 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.93 21.79 2.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.318 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.658 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -97.58 141.83 30.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -84.58 101.44 12.11 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.46 150.11 19.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 24.5 m -110.59 164.52 12.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.807 0.337 . . . . 0.0 111.238 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 12' ' ' ILE . 3.5 pp -63.85 -27.12 68.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.29 0.567 . . . . 0.0 110.129 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.79 -32.84 72.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.392 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.28 -4.05 51.74 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.395 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -118.77 8.69 11.88 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 118' ' ' PRO . 36.1 mtmt -72.18 159.69 33.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.501 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.95 -28.31 7.05 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 2.5 mptp? -108.56 169.79 8.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.58 ' HE2' HG11 ' A' ' 123' ' ' VAL . 4.1 m-85 -76.04 115.63 15.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 166.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 116' ' ' VAL . 3.0 m -96.08 115.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.795 0.807 . . . . 0.0 111.741 -171.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tm? -84.66 109.11 17.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.527 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -99.19 107.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.32 129.47 47.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.057 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.73 115.76 31.22 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.795 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 28.4 p-90 -147.9 172.67 13.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 111.523 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.459 ' HB2' ' CG ' ' A' ' 71' ' ' ASP . 20.4 p90 -167.27 155.99 9.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.089 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.59 -24.7 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.524 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.46 -32.64 73.49 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.123 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 33.7 m -93.31 117.98 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.256 0.551 . . . . 0.0 110.676 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.524 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 11.1 m -65.19 -16.49 63.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -82.91 -32.06 27.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.795 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 78.7 m -58.71 -32.05 68.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.086 0.47 . . . . 0.0 110.632 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -73.52 -14.41 61.21 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.608 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -86.64 -44.69 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.065 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mp0 -68.31 -22.32 64.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.588 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.601 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 99.8 m -57.43 -53.18 68.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 83.0 Cg_exo -49.97 -41.57 47.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.455 2.103 . . . . 0.0 112.945 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.6 m-85 -65.65 -43.15 90.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.304 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.85 -38.43 85.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.416 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.406 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 5.5 tt -61.63 -44.75 96.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.829 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.851 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 38.1 ttpt -63.74 -42.73 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.005 0.431 . . . . 0.0 110.341 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 m -58.68 -46.72 86.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.1 t80 -64.47 -46.56 82.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.544 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.851 ' ND2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 p30 -68.41 -32.74 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.981 -173.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.83 -27.93 21.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 137' ' ' GLU . 51.3 m-85 -105.69 -5.49 19.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 13.6 pttm -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.067 0.46 . . . . 0.0 110.991 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.48 -3.24 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.299 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.405 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 75.8 mttt -97.93 3.23 49.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.094 0.473 . . . . 0.0 110.299 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.86 43.39 5.43 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.504 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 41.7 t80 -145.64 127.11 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -130.57 155.88 45.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.0 mt -105.09 120.61 55.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.229 0.537 . . . . 0.0 110.93 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 88.1 t80 -104.2 97.27 7.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.743 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.608 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -91.81 136.65 13.38 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.218 -175.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 5.1 m -121.35 114.9 44.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.662 0.744 . . . . 0.0 110.023 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -90.85 151.48 21.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.275 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.879 ' HA ' ' NZ ' ' A' ' 95' ' ' LYS . 6.5 t -136.09 38.67 2.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.468 0.652 . . . . 0.0 111.983 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.459 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 18.2 m-20 -76.34 167.54 21.66 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.991 167.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.695 ' HD2' ' HG3' ' A' ' 95' ' ' LYS . 13.6 mmm180 -96.43 -11.59 25.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 73' ' ' ARG . 40.8 mtp180 -111.21 108.32 17.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.866 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.5 tt0 -69.64 -31.16 69.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.984 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -69.82 -36.22 75.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.26 -28.2 56.99 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -62.18 -52.76 62.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.217 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.9 mptm? -56.22 -42.48 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.279 0.562 . . . . 0.0 110.081 175.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 25.1 tttm -59.42 -50.22 74.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.231 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.511 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -56.56 -41.45 76.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 111.623 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.456 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 43.5 mm -63.47 -37.95 80.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.801 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -73.52 -33.44 64.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.692 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.2 mt-10 -65.26 -59.53 3.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 48' ' ' THR . 2.5 m-20 -77.51 -9.72 59.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.815 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 38.9 mmtm 59.94 35.04 21.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.47 0.652 . . . . 0.0 111.063 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 p -87.65 76.93 8.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.429 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 76.2 m-85 -88.48 91.66 8.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.716 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.406 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 26.7 p90 -151.52 -177.45 6.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.816 169.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.536 HD22 ' HD1' ' A' ' 66' ' ' TYR . 4.1 p-10 -72.51 88.82 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.805 0.812 . . . . 0.0 111.694 -174.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.608 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt-30 -111.09 144.75 39.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.186 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 29.6 m -132.91 145.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.439 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.65 109.54 19.74 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 12' ' ' ILE . 9.0 mt -62.15 147.43 47.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.47 141.73 53.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.879 ' NZ ' ' HA ' ' A' ' 70' ' ' THR . 5.3 mmmt -75.4 -28.68 59.53 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.536 -161.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 2.0 m-20 -89.95 -4.98 57.18 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.416 ' OD2' HD22 ' A' ' 93' ' ' LEU . 1.6 t70 -88.16 -48.17 7.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.562 172.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -45.13 -40.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.893 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 96' ' ' ASP . 39.6 mtpt -47.52 -59.52 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.977 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.49 -45.77 71.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.59 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.08 -41.8 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.177 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 98' ' ' VAL . 94.6 mt -58.53 -53.84 53.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.419 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.72 -52.47 56.11 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.557 0.536 . . . . 0.0 109.712 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 m -53.28 -30.87 41.0 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.578 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 29.9 m-85 -80.44 8.32 7.91 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.867 -0.521 . . . . 0.0 110.892 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.401 ' O ' HD13 ' A' ' 107' ' ' ILE . 21.9 t 66.2 46.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.716 0.806 . . . . 0.0 109.106 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 20.0 mm -116.44 129.38 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.63 14.0 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.208 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.1 166.87 38.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 119.434 -1.365 . . . . 0.0 114.246 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -130.9 157.54 77.66 Favored Pre-proline 0 N--CA 1.463 0.212 0 C-N-CA 123.032 0.533 . . . . 0.0 110.581 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.22 169.96 71.35 Favored 'Cis proline' 0 C--N 1.352 0.744 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.113 -1.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.437 ' CE1' HG23 ' A' ' 114' ' ' ILE . 39.8 t-80 -147.01 134.51 20.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.675 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.561 HG21 HD22 ' A' ' 132' ' ' LEU . 4.9 mp -129.63 145.08 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.449 177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.581 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 27.7 pt -133.42 163.28 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 172.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.463 HD22 ' HD2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -123.35 118.13 26.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 32' ' ' VAL . 76.6 t -108.84 138.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.99 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 46.7 m-20 -62.62 160.73 32.81 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.0 Cg_exo -59.91 -15.34 32.25 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.555 2.17 . . . . 0.0 111.726 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -83.18 -29.66 28.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.843 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.56 32.79 3.29 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.595 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.564 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 10.1 mtmp? -111.92 150.87 29.88 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.684 -0.303 . . . . 0.0 110.473 176.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.38 96.36 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.58 HG11 ' HE2' ' A' ' 31' ' ' TYR . 14.1 p -83.45 -29.21 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.128 0.49 . . . . 0.0 110.572 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.96 149.21 27.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.993 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.574 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 13.0 ptmm? -151.23 163.36 39.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 23.7 mm-40 76.36 4.44 3.63 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.233 0.958 . . . . 0.0 112.026 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.44 ' O ' ' HD3' ' A' ' 128' ' ' ARG . 43.5 mt -59.7 136.11 57.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 127' ' ' LEU . 23.5 mmt-85 -133.78 173.19 11.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.932 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 45.09 -135.4 7.18 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 124.1 0.875 . . . . 0.0 114.127 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.34 -13.95 59.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.676 0.274 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.7 -27.4 67.86 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.561 HD22 HG21 ' A' ' 113' ' ' ILE . 79.7 mt -47.66 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 172.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -49.91 75.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.623 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 85.1 m-20 -65.49 -26.49 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.506 -174.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 16.9 m -77.29 -33.3 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 132' ' ' LEU . 24.4 t -63.33 -42.97 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.807 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.564 ' HG2' ' CZ ' ' A' ' 58' ' ' PHE . 58.3 mm-40 -67.22 -41.06 86.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.034 0.445 . . . . 0.0 110.554 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 22.0 ttpt -56.45 -56.48 20.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.143 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.29 -61.08 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.313 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t . . . . . 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -169.761 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' OG ' ' A' ' 7' ' ' SER . . . . . . . . 0 C--O 1.234 0.242 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -74.93 109.26 8.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.88 -6.2 20.06 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.97 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 4' ' ' ALA . 50.0 m -76.86 138.7 39.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.706 0.288 . . . . 0.0 110.536 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.0 p -73.96 138.82 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 105' ' ' TYR . . . -92.55 150.83 40.51 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.353 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.53 163.18 11.07 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.328 2.685 . . . . 0.0 112.267 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.66 102.46 13.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.853 0.359 . . . . 0.0 111.718 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 105' ' ' TYR . 50.6 mm -69.78 138.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.572 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.7 t -142.97 137.56 29.46 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.4 172.67 36.08 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.584 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -85.89 118.05 31.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.34 -176.99 3.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.177 0.513 . . . . 0.0 111.198 -173.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.93 -29.45 63.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.683 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 29.9 mttp -85.99 -43.85 12.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.65 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.29 15.36 1.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.409 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.6 m-80 -96.51 154.19 17.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -83.96 93.57 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 0.0 110.333 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.17 138.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.753 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -116.68 163.41 16.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.224 0.535 . . . . 0.0 111.407 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . 62.1 tp -63.47 -23.93 67.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.886 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.4 t30 -64.19 -28.39 69.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.11 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -77.06 -4.58 45.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.1 2.51 16.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.34 0.59 . . . . 0.0 109.42 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 41.2 mtpt -71.49 111.71 7.02 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.738 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.91 -22.41 2.47 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -115.05 170.51 8.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.619 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.09 117.23 21.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 20.8 t -99.0 116.93 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -90.86 104.1 16.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 47.9 t -98.67 108.85 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.937 0.399 . . . . 0.0 110.92 -174.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.5 115.83 29.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.29 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.2 115.66 26.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 3.1 p-90 -155.7 -177.29 6.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.362 0.601 . . . . 0.0 111.452 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 41' ' ' CYS . 17.9 p90 -157.19 152.78 26.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.853 171.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 77' ' ' TRP . . . -58.19 -45.12 88.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 111.838 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . 0.854 ' HA3' HH12 ' A' ' 72' ' ' ARG . . . -82.76 45.79 3.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.401 -177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.693 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 46.0 t -132.43 136.19 46.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 p -88.43 -15.09 36.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 39.9 m95 -85.92 -52.53 5.67 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.781 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 12.8 p -63.36 -24.66 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.26 0.552 . . . . 0.0 110.634 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.437 ' NH2' ' HB2' ' A' ' 83' ' ' GLU . 4.8 tpt180 -72.02 -14.39 61.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.888 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.75 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.2 mptm? -79.99 -40.08 28.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.882 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.459 ' OE1' ' HG3' ' A' ' 111' ' ' PRO . 25.7 mp0 -80.33 -9.58 59.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.655 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 38.3 m -50.74 -50.22 74.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 51.9 Cg_exo -55.4 -42.52 67.39 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.052 1.835 . . . . 0.0 112.617 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.08 -36.79 80.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 47' ' ' GLU . 96.0 mt -64.27 -41.69 96.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.513 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.84 -44.56 96.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.165 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -55.96 -48.88 74.97 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.393 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 33.9 m -62.55 -52.06 64.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.253 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.6 t80 -58.59 -43.4 89.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.68 0.276 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -61.79 -39.71 92.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.891 0.377 . . . . 0.0 111.293 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.63 -20.42 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.443 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 77.0 m-85 -121.94 9.12 9.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 17.5 pttm -64.23 -41.14 97.14 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.606 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -24.79 41.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.113 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 92.6 mttt -76.76 -172.11 2.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.169 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 49.64 3.27 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 83.5 t80 -143.62 146.49 33.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.8 m -156.86 136.96 12.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 55' ' ' TYR . 43.5 mt -89.32 133.46 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.909 0.385 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.76 101.97 9.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.177 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.13 115.61 4.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.444 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.501 HG13 ' CD1' ' A' ' 93' ' ' LEU . 44.2 t -98.39 111.34 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 38.5 t -118.72 139.5 51.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.355 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -134.77 35.58 3.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.428 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.593 ' OD1' ' HD2' ' A' ' 72' ' ' ARG . 4.2 t70 -65.8 165.63 12.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.777 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.854 HH12 ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.58 -25.24 61.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.836 -175.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 7.2 tpt180 -141.2 131.14 24.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.585 -173.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 22.2 tt0 -69.83 -32.83 71.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 0.0 110.002 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.505 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 3.5 mp0 -57.66 -42.46 83.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.814 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 31.5 t70 -73.07 -39.86 65.51 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 27.6 t90 -52.64 -52.12 57.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.654 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.552 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -62.46 -44.08 97.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.792 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 18.3 tttm -57.4 -45.73 84.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.85 -45.52 82.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.572 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.0 -34.86 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.885 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.53 -30.01 70.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.0 110.208 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.437 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . 67.7 mt-10 -75.89 -60.5 2.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.066 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -83.77 -18.91 36.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.81 -169.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 72.88 28.12 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.592 0.557 . . . . 0.0 110.622 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -67.01 81.06 0.12 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.936 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -96.39 88.99 4.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.15 178.29 10.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.022 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.66 102.72 2.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -173.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 77' ' ' TRP . 44.6 mt-30 -119.85 155.06 33.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.321 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.66 143.74 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.501 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.43 112.31 24.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.501 ' CD1' HG13 ' A' ' 68' ' ' VAL . 8.0 mp -71.83 157.35 38.05 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.307 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -89.88 178.93 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.527 0.68 . . . . 0.0 111.08 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.517 ' H ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.38 -15.03 59.58 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.322 -178.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.491 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -83.98 -55.5 4.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.622 -175.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.6 p30 -79.75 -30.7 40.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.556 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -49.05 -32.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mmtt -53.76 -63.5 1.13 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.711 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -55.67 -55.74 28.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.442 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.485 HG21 HD23 ' A' ' 93' ' ' LEU . 61.5 t -46.43 -55.85 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.915 0.76 . . . . 0.0 112.129 -176.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.834 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 25.8 mt -62.07 -34.84 77.03 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.643 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.21 -63.04 1.46 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.098 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 106' ' ' CYS . 60.8 p -53.4 -45.28 69.25 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 124.798 1.311 . . . . 0.0 113.27 -164.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.631 ' CE1' HD11 ' A' ' 12' ' ' ILE . 85.0 m-85 -75.75 13.15 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.089 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.428 ' H ' ' C ' ' A' ' 104' ' ' SER . 34.7 m 62.66 57.71 1.74 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.139 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.834 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 2.1 mp -85.43 110.88 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.825 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.16 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.956 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.53 178.48 34.73 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.914 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.6 151.96 79.59 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 43' ' ' TRP . 86.1 Cg_endo -77.34 151.52 92.97 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.32 0.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.59 113.61 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 HH21 ' A' ' 128' ' ' ARG . 86.8 mt -117.74 139.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.4 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.576 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 44.0 pt -134.9 145.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.92 0.39 . . . . 0.0 111.148 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.38 110.08 22.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 88.7 t -102.42 136.94 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.059 -175.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.77 169.85 19.06 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -55.18 -29.14 64.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.802 2.334 . . . . 0.0 113.988 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.63 -4.25 55.65 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.33 30.15 22.97 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.609 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 30.0 mttm -108.96 145.58 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.837 0.351 . . . . 0.0 110.522 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.8 mt -80.17 105.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.16 -48.49 21.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.492 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.01 169.42 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.184 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.6 pttp -159.7 172.59 17.45 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.05 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 2.0 mm-40 64.94 23.31 12.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.652 1.181 . . . . 0.0 111.318 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HB2' HD23 ' A' ' 132' ' ' LEU . 83.9 mt -61.21 148.33 41.27 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.822 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.526 HH21 HD12 ' A' ' 113' ' ' ILE . 2.9 mmp_? -125.22 151.48 45.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -171.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 40.05 -126.19 2.54 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 124.175 0.922 . . . . 0.0 114.785 170.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.46 -10.04 59.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.674 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.873 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 24.8 t70 -66.39 -33.46 75.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.5 mt -48.92 -52.95 21.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 170.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.44 -59.06 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.555 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.6 p30 -66.94 -31.75 72.54 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.314 -172.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 19.1 m -70.66 -37.35 73.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.36 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.3 t -61.16 -49.33 85.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.338 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -61.44 -50.39 72.98 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 15.7 ttpt -48.53 -37.44 17.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.517 0.727 . . . . 0.0 111.734 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -87.96 -48.5 7.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -169.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.215 0 CA-C-O 120.823 0.344 . . . . 0.0 111.427 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.983 HG23 ' HA ' ' A' ' 123' ' ' VAL . 24.9 m -56.72 130.23 44.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.159 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.97 -8.01 36.01 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.066 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -78.47 138.2 38.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.56 126.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.54 76.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.549 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 162.15 25.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.051 2.501 . . . . 0.0 111.839 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.97 100.47 11.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.783 0.325 . . . . 0.0 111.712 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 101' ' ' VAL . 56.4 mt -72.19 132.47 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.176 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -128.53 97.87 4.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 175.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.89 165.17 12.07 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.543 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 66.2 mt -98.93 122.93 51.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.613 0.244 . . . . 0.0 110.46 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 31.5 p30 -74.19 -173.84 1.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.971 0.415 . . . . 0.0 111.547 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.84 -16.92 63.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.072 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 1.1 mtpt -87.98 -35.59 17.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.98 21.31 3.52 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.47 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -98.45 142.59 29.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -81.78 102.25 10.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.806 0.336 . . . . 0.0 110.232 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.89 142.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.074 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -103.94 -177.96 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.975 0.416 . . . . 0.0 110.545 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -80.39 -21.56 42.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.587 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 50.5 m-80 -68.31 -24.79 64.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.46 -25.61 68.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.11 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -112.4 13.34 20.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.086 0.469 . . . . 0.0 110.317 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 25' ' ' ASN . 22.6 tttm -68.99 171.35 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.445 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.98 64.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.4 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -141.16 176.17 9.05 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB3' HD11 ' A' ' 115' ' ' LEU . 54.1 m-85 -78.77 109.68 13.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 47.2 t -96.78 123.32 49.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 19.5 tp -90.54 116.95 28.84 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 114' ' ' ILE . 16.7 t -105.05 102.99 14.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.455 ' OD1' HG23 ' A' ' 65' ' ' ILE . 6.5 m-20 -98.4 110.15 22.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.762 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 110' ' ' PHE . 53.2 m-85 -92.74 116.8 29.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.783 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 12.9 p-90 -154.65 -179.18 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 45.0 p90 -170.01 157.1 6.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.528 168.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.99 -16.99 62.86 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.12 -21.32 69.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.582 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 m -92.2 131.32 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 0.0 110.274 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -88.39 -28.26 21.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.694 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -67.75 -34.57 77.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.135 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 80.0 m -51.95 -38.63 57.22 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.67 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -64.44 -28.33 69.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.774 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -84.96 -11.34 55.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.181 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -98.04 -21.78 16.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.418 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 84' ' ' ASP . 51.4 m -49.93 -48.23 78.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.2 Cg_endo -48.61 -45.88 25.97 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.205 1.937 . . . . 0.0 112.36 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.94 -37.63 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.238 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 ' OD2' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -55.93 -48.55 75.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 175.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.417 ' HA ' ' HZ3' ' A' ' 88' ' ' TRP . 63.0 tp -63.63 -42.67 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.965 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 47.4 tttm -60.0 -43.72 95.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 27.1 m -53.11 -46.1 68.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.205 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.4 t80 -56.83 -61.99 2.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.67 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.9 p-10 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.22 -20.06 29.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.521 ' HZ ' ' HA ' ' A' ' 137' ' ' GLU . 75.1 m-85 -115.65 -15.2 11.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptmm? -56.28 -23.13 34.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.005 0.431 . . . . 0.0 111.646 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 3.5 m-20 -106.87 17.25 23.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 89.5 mttt -121.64 14.73 11.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.137 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.99 44.18 9.25 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.515 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 55.3 t80 -139.0 135.23 34.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -135.74 145.65 46.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.96 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -103.72 126.75 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.971 0.415 . . . . 0.0 110.619 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -112.94 96.52 5.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.692 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -75.01 114.54 4.36 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.389 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.998 HG13 HD21 ' A' ' 93' ' ' LEU . 50.0 t -98.69 111.11 27.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 14.7 m -116.7 125.73 52.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 93' ' ' LEU . 10.1 t -113.5 52.13 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.518 1.152 . . . . 0.0 108.604 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 t70 -70.2 178.96 2.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.128 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -104.3 -21.97 13.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.921 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 51.9 mtt-85 -141.63 150.46 42.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.8 tt0 -75.62 -37.19 59.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.1 mp0 -62.01 -41.36 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.578 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -74.44 -35.63 63.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.001 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -60.73 -51.96 67.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.434 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.2 mptm? -59.13 -37.17 76.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 27.1 ttpt -59.22 -50.02 75.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.768 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.89 83.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.182 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.44 -38.82 77.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.378 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.75 -55.36 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.892 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.5 mt-10 -53.07 -49.0 67.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.545 . . . . 0.0 111.639 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 48' ' ' THR . 6.4 m-20 -85.45 -16.43 39.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.453 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HD2' ' OH ' ' A' ' 87' ' ' TYR . 46.9 mmtm 61.74 40.54 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.653 0.739 . . . . 0.0 110.092 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -80.63 86.46 5.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.183 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' OH ' ' HD2' ' A' ' 85' ' ' LYS . 57.4 m-85 -87.66 78.94 8.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.276 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.417 ' HZ3' ' HA ' ' A' ' 52' ' ' LEU . 23.6 p90 -161.42 175.16 12.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 174.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.47 110.47 9.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.974 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.692 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 48.6 mt-30 -123.39 145.97 48.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.3 m -132.65 149.97 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' SER . 20.7 tp -94.2 132.2 38.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.998 HD21 HG13 ' A' ' 68' ' ' VAL . 72.3 mt -73.45 149.94 42.01 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 98' ' ' VAL . 49.8 mt-30 -80.72 171.18 15.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.412 175.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.15 -39.65 90.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 13.5 m-20 -87.21 -33.62 19.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.181 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.562 ' OD2' HD22 ' A' ' 93' ' ' LEU . 16.1 t70 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.821 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 94' ' ' GLN . 78.8 t -66.86 -65.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 110.124 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 20.5 pttp -62.55 -62.62 1.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -170.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 9.0 m-20 -67.94 -36.63 80.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.738 0.304 . . . . 0.0 111.622 -169.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 12' ' ' ILE . 59.3 t -79.27 -50.26 18.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.943 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 87.9 mt -56.23 -47.81 77.71 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.89 -47.33 80.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.4 m -54.81 -33.04 61.06 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.99 0.806 . . . . 0.0 112.446 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -79.24 7.75 7.15 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.14 -0.35 . . . . 0.0 111.436 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.5 t 66.57 54.13 0.89 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -171.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 73.8 mt -133.3 93.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.6 -1.5 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.861 0.839 . . . . 0.0 109.392 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.77 165.31 28.83 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.176 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 95.4 m-85 -127.19 160.7 58.39 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.654 0.227 . . . . 0.0 110.707 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 5.5 Cg_exo -81.89 172.08 53.64 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.948 -1.271 . . . . 0.0 112.721 -0.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.674 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -155.39 122.53 5.48 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.622 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.1 131.44 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 125' ' ' LYS . 25.9 pt -130.5 158.32 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' TYR . 58.9 tp -124.51 127.59 47.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.142 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 5.5 m -119.1 145.13 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -59.78 163.3 7.54 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.131 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.32 -22.26 64.54 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -70.19 -34.0 72.42 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.784 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.23 32.68 3.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.05 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -117.42 147.86 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 125' ' ' LYS . 34.9 mt -86.19 119.57 34.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.594 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 5' ' ' THR . 13.2 m -101.75 -35.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.014 0.435 . . . . 0.0 110.832 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.8 140.74 40.72 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HD2' HG21 ' A' ' 122' ' ' ILE . 9.4 ptmm? -156.81 153.43 28.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.232 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.674 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 32.4 mt-10 70.0 25.47 4.82 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.205 0.941 . . . . 0.0 110.968 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.9 mt -67.91 159.12 31.17 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.621 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.1 mmp_? -128.9 134.53 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 43.12 -114.58 0.86 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 168.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 134' ' ' ASN . 4.2 m-20 -63.12 -35.43 80.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.867 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 7.7 t70 -63.63 -39.74 95.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.822 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.0 pp -57.2 -44.47 83.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.52 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.402 ' N ' HD12 ' A' ' 132' ' ' LEU . 68.4 t80 -70.64 -46.47 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 11.2 t-20 -50.2 -57.21 8.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.8 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.559 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 19.8 m -72.74 -34.38 67.0 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.998 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 HD22 ' A' ' 115' ' ' LEU . 38.2 t -63.21 -42.32 96.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.325 174.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.521 ' HA ' ' HZ ' ' A' ' 58' ' ' PHE . 3.2 tp10 -61.21 -53.02 62.17 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 9.2 mtmp? -57.5 -27.58 62.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.733 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -83.15 -61.09 1.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.408 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.0 t . . . . . 0 N--CA 1.466 0.331 0 O-C-N 123.441 0.463 . . . . 0.0 111.543 -173.16 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.241 0.61 0 N-CA-C 110.446 -0.205 . . . . 0.0 110.446 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -146.34 140.12 26.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.663 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.39 4.52 62.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.477 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -81.06 143.45 32.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 121' ' ' LYS . 31.6 t -69.64 133.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.469 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.58 146.63 31.66 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 -175.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.04 162.31 26.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.888 2.392 . . . . 0.0 111.975 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.39 113.58 25.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.832 0.349 . . . . 0.0 111.547 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.95 137.02 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -134.72 104.88 6.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.86 172.18 18.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.139 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 15' ' ' ILE . 3.8 mp -98.01 119.18 45.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -173.56 3.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 -171.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 81' ' ' ILE . 96.6 mt -62.45 -33.49 74.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.669 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -74.99 -30.68 61.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.608 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.54 19.36 7.93 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.523 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.609 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -100.35 144.25 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -87.04 92.46 9.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.66 147.46 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.527 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.42 168.0 9.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 -174.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.72 -35.37 74.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.643 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 3.2 p-10 -66.81 -17.55 64.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.78 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -74.25 -24.15 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.126 0.489 . . . . 0.0 110.501 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -105.35 8.51 33.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 110.25 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.8 tttp -62.46 160.3 13.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.074 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.28 10.17 57.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.271 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -141.43 177.6 8.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 115' ' ' LEU . 97.3 m-85 -85.17 107.03 17.04 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 64' ' ' THR . 42.0 t -100.43 109.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 -174.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 28.1 tp -86.77 118.18 26.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -104.89 115.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.699 0.285 . . . . 0.0 110.835 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -101.79 111.04 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.262 0.553 . . . . 0.0 111.413 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -93.77 118.07 30.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.422 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -151.16 176.93 10.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -170.3 151.39 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.384 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.11 1.85 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.403 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.65 54.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.689 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.0 t -103.48 116.31 32.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.564 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 9.5 m -67.97 -26.53 65.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -73.22 -36.2 66.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.92 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.0 m -59.99 -35.58 75.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HE ' ' CG ' ' A' ' 84' ' ' ASP . 26.4 mmm-85 -67.39 -22.21 65.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.546 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 42' ' ' SER . 4.9 mptp? -85.88 -11.45 53.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.327 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 43.8 mt-10 -105.65 -6.87 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.611 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.9 m -54.05 -47.09 98.2 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.953 175.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.9 Cg_endo -51.68 -36.81 62.67 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.624 2.216 . . . . 0.0 113.036 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 41.0 m-85 -67.55 -39.62 84.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.031 0.443 . . . . 0.0 110.069 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.59 HD21 HD13 ' A' ' 113' ' ' ILE . 88.5 mt -63.7 -43.12 97.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.692 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -64.15 -43.41 95.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.463 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -54.56 -44.85 73.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.341 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HD1' ' A' ' 58' ' ' PHE . 33.2 m -63.76 -48.7 75.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.66 ' HB2' HD12 ' A' ' 65' ' ' ILE . 53.2 t80 -60.07 -36.04 76.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.843 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -73.34 -33.49 65.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.11 -18.92 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HD1' ' O ' ' A' ' 54' ' ' THR . 84.1 m-85 -111.54 10.98 21.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -75.19 -3.94 35.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 0.0 111.116 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -98.34 -2.33 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.006 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -122.99 174.43 7.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.469 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.05 61.95 2.57 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 74.4 t80 -133.68 130.42 38.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.787 0.327 . . . . 0.0 110.334 -176.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 12.3 p -135.73 137.82 42.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.283 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 55' ' ' TYR . 36.8 mt -97.34 124.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 80.4 t80 -113.25 104.79 12.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.876 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.963 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -86.24 142.12 18.72 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.566 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.7 111.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 15.0 m -115.07 155.17 27.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.008 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -143.96 40.12 1.37 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.935 0.874 . . . . 0.0 108.658 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 4.5 m-20 -71.37 175.78 5.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.399 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -70.21 -45.57 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.409 -172.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 3.5 tpt180 -145.68 150.62 36.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 28.4 tt0 -62.28 -41.81 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 110.459 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.33 -44.21 95.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.254 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.64 -39.78 84.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.152 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -58.48 -54.13 50.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.626 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -57.22 -40.55 77.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 2.7 ttpm? -60.51 -49.44 77.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.363 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.569 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -58.15 -40.54 81.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.136 0.493 . . . . 0.0 111.1 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 86' ' ' SER . 80.3 mt -61.67 -38.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.887 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -71.77 -46.41 58.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 46.5 mt-10 -54.69 -54.33 43.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.143 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.611 ' HB3' HG21 ' A' ' 48' ' ' THR . 5.5 m-20 -85.56 0.18 53.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.068 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 70.0 mmtt 58.4 37.82 25.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.574 0.702 . . . . 0.0 110.706 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 81' ' ' ILE . 36.4 t -82.59 68.15 8.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.708 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -87.1 76.29 9.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.963 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 30.8 p90 -148.67 -174.57 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 169.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.16 90.94 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.504 -171.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.963 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 91.6 mt-30 -108.0 138.76 43.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.912 0.386 . . . . 0.0 111.017 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.09 146.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.95 126.41 37.02 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 98' ' ' VAL . 47.5 mt -67.92 145.7 54.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 0.0 111.383 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.5 mt-30 -67.76 156.0 38.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.433 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -60.92 -44.89 96.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.008 0.433 . . . . 0.0 111.614 -170.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.29 -19.49 31.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.4 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.431 ' CB ' ' HB2' ' A' ' 94' ' ' GLN . 37.0 t70 -80.87 -27.8 36.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.976 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' GLN . 58.3 t -47.91 -51.35 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -47.73 80.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.559 -176.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -67.78 -50.2 58.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.03 -173.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.97 -56.05 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.315 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.0 mt -57.49 -46.0 84.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.75 -60.71 2.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 m -51.31 -38.58 53.74 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 124.716 1.26 . . . . 0.0 113.292 -170.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -82.07 17.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.463 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.423 ' HB2' ' HZ1' ' A' ' 125' ' ' LYS . 63.8 m 62.88 42.19 7.97 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 123.378 0.671 . . . . 0.0 110.077 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 63.4 mt -100.16 89.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.058 -176.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.5 -18.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.23 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.68 152.48 24.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.006 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -108.75 156.12 39.47 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 95.2 Cg_endo -78.29 177.01 40.62 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 123.238 -1.568 . . . . 0.0 112.779 0.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.06 117.62 4.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 51' ' ' LEU . 58.6 mt -127.98 138.43 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.471 ' HB ' HG23 ' A' ' 122' ' ' ILE . 49.2 pt -134.3 158.63 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.013 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 136' ' ' VAL . 60.9 tp -118.59 115.46 24.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.27 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.31 129.98 47.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.567 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 8.2 p30 -78.53 166.99 38.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.203 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 6.4 Cg_endo -50.5 -35.88 47.25 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.965 2.443 . . . . 0.0 113.196 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 45.3 mt-10 -63.01 -37.4 87.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.62 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.46 3.89 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HG2' HG22 ' A' ' 8' ' ' VAL . 28.4 mtmm -111.77 151.76 28.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.815 0.341 . . . . 0.0 110.259 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 114' ' ' ILE . 18.0 mt -87.64 92.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.315 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -73.12 -26.98 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 0.0 110.748 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -133.92 119.03 18.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.555 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HG2' ' CD ' ' A' ' 126' ' ' GLU . 60.8 tttm -127.46 157.72 39.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.557 -174.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.564 ' CD ' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER 50.24 48.69 21.81 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.999 0.812 . . . . 0.0 110.989 -176.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 132' ' ' LEU . 83.7 mt -72.49 157.37 37.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 13.8 tpt180 -128.7 142.38 51.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.464 -173.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 35.65 -132.45 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.02 -10.85 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.562 . . . . 0.0 110.111 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.1 m-20 -55.1 -33.47 62.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.266 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 4.3 pp -64.7 -41.42 96.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.912 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.442 ' N ' HD12 ' A' ' 132' ' ' LEU . 32.1 t80 -60.79 -52.14 66.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.712 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -60.07 -36.18 76.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.224 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 85.8 m -71.08 -46.55 61.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.146 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 115' ' ' LEU . 96.1 t -67.49 -45.82 84.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.113 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -58.53 -45.72 88.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.409 0.623 . . . . 0.0 109.606 179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -56.94 -54.4 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.673 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.4 t80 -65.02 -56.76 11.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.745 -170.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.33 -174.795 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 120.694 0.283 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 p -110.17 112.61 24.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.49 -4.36 40.25 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 p -71.96 128.23 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.13 135.66 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -92.36 144.04 28.3 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.686 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 52.6 Cg_exo -55.27 158.44 12.18 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.232 2.622 . . . . 0.0 112.602 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.1 95.33 10.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.184 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.576 HD11 ' CE1' ' A' ' 105' ' ' TYR . 21.5 mm -59.12 131.84 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.462 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -126.96 88.09 2.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 161.58 13.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.976 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.32 125.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.801 0.334 . . . . 0.0 110.372 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -169.5 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.337 0.589 . . . . 0.0 111.681 -173.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.93 -30.09 71.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.931 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.65 -36.24 62.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 0.0 110.28 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.99 16.01 8.17 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.167 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.578 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.64 140.27 32.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -77.48 97.33 4.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 110.249 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.91 147.48 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.796 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.7 m -108.86 156.77 19.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.152 0.501 . . . . 0.0 111.367 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.59 -27.82 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.525 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -25.42 67.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.6 -9.59 58.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.409 0.623 . . . . 0.0 110.528 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.35 4.56 17.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.195 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -62.15 170.28 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.198 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.13 83.4 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.794 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 35.1 mttp -141.01 156.87 45.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 63' ' ' PHE . 85.7 m-85 -72.63 115.6 12.1 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 57.6 t -103.12 107.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.328 -172.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.439 ' HB3' HG12 ' A' ' 65' ' ' ILE . 38.9 tp -86.24 106.49 17.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.85 125.86 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.013 0.435 . . . . 0.0 110.891 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 12.9 t0 -112.06 96.23 5.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.426 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' HG13 ' A' ' 68' ' ' VAL . 96.0 m-85 -82.07 114.94 20.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 69' ' ' SER . 22.3 p-90 -153.55 175.45 13.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.062 0.934 . . . . 0.0 112.604 -172.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -167.76 162.84 14.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.691 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.95 -19.31 65.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.56 64.65 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.246 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.4 p -95.89 97.99 10.07 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.65 0.738 . . . . 0.0 109.943 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -64.77 -36.18 83.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.981 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -56.27 -41.18 75.44 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -64.93 -28.56 69.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.007 0.432 . . . . 0.0 110.252 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -81.26 -14.14 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.411 0.624 . . . . 0.0 110.083 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -79.69 -21.86 44.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.212 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -90.31 -7.11 54.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.879 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 98.6 m -48.58 -48.45 68.36 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.7 Cg_endo -49.36 -44.79 33.0 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.33 2.02 . . . . 0.0 112.633 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -73.82 -40.05 63.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.829 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.8 mt -57.21 -51.94 67.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.81 -43.04 94.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -62.63 -44.61 95.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.035 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.48 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 59.8 m -59.7 -46.17 89.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 37.5 t80 -65.69 -36.02 82.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.03 -43.64 98.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.091 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.01 -27.12 30.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD2' ' O ' ' A' ' 54' ' ' THR . 92.1 m-85 -114.57 10.83 16.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 20.1 pttp -64.76 -29.33 70.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 111.31 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.22 10.51 29.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.193 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 80.0 mttt -121.36 -174.16 2.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.769 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.37 57.88 4.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.954 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.414 ' HD1' ' HB2' ' A' ' 31' ' ' TYR . 80.3 t80 -144.0 142.53 30.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.784 0.326 . . . . 0.0 110.179 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -151.45 150.29 30.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -102.34 125.11 56.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -105.66 98.08 7.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.844 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 90' ' ' GLN . . . -79.87 137.42 18.65 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 36' ' ' PHE . 1.5 p -138.45 123.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.107 0.48 . . . . 0.0 110.591 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.5 t -128.87 163.87 24.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.222 0.534 . . . . 0.0 111.439 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.792 ' HB ' HD12 ' A' ' 93' ' ' LEU . 4.3 t -147.75 44.16 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.726 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.529 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 2.9 t70 -71.01 -178.93 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.399 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.529 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 13.1 ptt180 -67.1 -29.59 69.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.741 -173.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 56.4 mtt-85 -143.4 158.28 43.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.743 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.784 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 32.3 tt0 -75.72 -38.79 58.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.3 mp0 -60.72 -44.82 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.794 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 1.9 m-20 -62.52 -42.39 99.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.573 ' CE3' ' HD2' ' A' ' 78' ' ' LYS . 32.6 t90 -56.94 -52.74 64.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.917 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 3.7 mptp? -54.15 -50.63 66.53 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.29 0.566 . . . . 0.0 110.593 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 25.0 ttpp -60.46 -44.62 95.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.173 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.34 84.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 65.6 mt -60.39 -43.66 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.512 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -68.6 -46.46 69.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.008 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -59.73 -45.01 93.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.173 0.511 . . . . 0.0 111.138 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.29 -15.71 51.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.247 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HD2' ' HE2' ' A' ' 87' ' ' TYR . 66.6 mmtt 65.02 33.32 9.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.835 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.9 m -92.34 85.59 5.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 98.6 m-85 -91.77 84.25 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.42 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -153.02 -173.3 4.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -69.52 96.6 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 32.6 mt-30 -123.18 143.63 49.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.143 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.3 158.3 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 111.301 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.2 tp -103.55 132.33 49.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.429 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 70' ' ' THR . 88.7 mt -61.94 140.51 58.31 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.256 0.348 . . . . 0.0 111.169 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.691 ' O ' HG23 ' A' ' 98' ' ' VAL . 42.9 mt-30 -90.06 169.3 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -49.24 -55.07 13.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.237 0.541 . . . . 0.0 111.744 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -82.19 -36.57 27.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.674 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 13.3 t70 -56.77 -36.92 70.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.629 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.2 t -52.06 -37.31 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.776 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.9 tptt -62.76 -58.8 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.384 -175.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.07 -49.59 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.592 0.234 . . . . 0.0 111.157 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -53.7 -59.69 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.714 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.776 ' HA ' HD12 ' A' ' 107' ' ' ILE . 35.1 mt -65.0 -30.41 71.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.988 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.26 -63.92 1.3 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.582 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.3 m -65.39 -23.44 66.96 Favored 'General case' 0 C--N 1.338 0.077 0 O-C-N 124.213 0.946 . . . . 0.0 113.423 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.576 ' CE1' HD11 ' A' ' 12' ' ' ILE . 54.5 m-85 -81.74 15.38 2.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.302 173.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 46.9 t 55.22 44.46 27.59 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.325 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 102' ' ' LEU . 61.4 mt -86.22 93.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.068 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.6 m -106.28 19.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.261 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.98 168.89 26.72 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.836 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 87.0 m-85 -122.94 159.03 55.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.3 Cg_endo -86.52 171.55 38.7 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.359 -0.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -136.93 104.26 5.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.9 177.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.93 114.92 47.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 38.1 pt -124.93 159.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.06 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 4.0 tt -116.99 116.3 27.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 95.7 t -102.66 142.99 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.475 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -77.36 165.56 50.81 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.4 Cg_endo -49.0 -29.84 16.51 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.313 2.675 . . . . 0.0 114.09 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . 0.787 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -91.75 2.06 56.75 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 86.75 26.34 32.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.436 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.787 ' HZ3' ' HB3' ' A' ' 119' ' ' GLU . 28.4 mttp -107.66 142.36 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.043 0.422 . . . . 0.0 110.465 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.7 mt -76.29 109.73 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.939 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.37 -36.21 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.066 0.46 . . . . 0.0 110.3 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 21.4 pttm -163.08 151.79 14.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.283 -0.167 . . . . 0.0 111.003 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 60.28 48.49 8.01 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.885 0.74 . . . . 0.0 111.09 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.66 156.94 21.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.939 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HD2' ' H ' ' A' ' 129' ' ' GLY . 8.6 tpt180 -101.44 147.71 26.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -38.27 -58.31 1.66 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.37 -38.0 73.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.168 0.509 . . . . 0.0 110.102 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.8 t70 -83.27 -26.85 30.31 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' A' ' 129' ' ' GLY . 75.5 mt -46.26 -57.62 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.1 -47.9 80.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.98 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 94.0 m-20 -53.72 -53.36 53.15 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.236 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.654 ' HA ' ' CE ' ' A' ' 138' ' ' LYS . 4.8 m -62.24 -36.12 81.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' LEU . 50.8 t -69.21 -44.89 80.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.43 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -67.53 -29.83 69.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.652 0.739 . . . . 0.0 109.962 177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.654 ' CE ' ' HA ' ' A' ' 135' ' ' THR . 26.9 ttpt -78.87 -54.2 6.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.966 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . 0.489 ' CD2' HG23 ' A' ' 135' ' ' THR . 61.1 m-85 -87.07 -48.79 7.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 80.3 t . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.792 0.33 . . . . 0.0 110.274 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -152.81 154.1 34.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.12 -1.27 70.31 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -91.69 146.43 23.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.595 -0.302 . . . . 0.0 110.461 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.42 138.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.397 . . . . 0.0 110.095 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.81 149.95 40.67 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.738 -175.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 35.6 Cg_exo -62.9 163.53 21.86 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.522 2.815 . . . . 0.0 112.088 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.89 105.0 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.083 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.36 148.32 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.603 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 13.7 t -136.61 134.99 37.97 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.18 31.18 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.355 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -88.9 119.46 36.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -175.72 5.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.088 0.47 . . . . 0.0 111.127 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 90' ' ' GLN . 95.4 mt -65.07 -28.93 69.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.945 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.58 -28.99 28.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.44 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 25.22 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.251 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.27 148.17 25.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 p -76.82 94.35 3.86 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.04 130.67 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.4 m -102.58 161.85 13.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.51 -14.86 46.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.615 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 30.2 p-10 -67.28 -20.86 65.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.915 0.388 . . . . 0.0 111.2 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.13 -23.04 47.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.46 5.53 31.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -79.98 63.21 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.702 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.6 13.17 0.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.064 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -144.31 171.38 14.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 120.78 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.317 172.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 64' ' ' THR . 46.1 t -112.47 112.79 41.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.494 -171.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 113' ' ' ILE . 10.0 tt -90.58 119.32 30.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 51.5 t -103.77 121.32 55.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.801 0.334 . . . . 0.0 110.915 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 29.9 m-20 -84.98 136.75 33.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.418 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.26 114.55 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -158.18 173.36 16.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.691 0.758 . . . . 0.0 112.342 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -170.05 166.59 9.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.614 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.73 65.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -51.47 24.97 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.148 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.4 p -71.45 101.9 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.454 0.645 . . . . 0.0 110.432 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 18.9 m -69.39 -5.45 23.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.081 -171.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . 0.515 ' HD1' ' HG3' ' A' ' 111' ' ' PRO . 72.4 t-105 -85.37 -29.31 24.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.952 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 75.8 m -57.81 -34.5 69.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 110.631 176.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.573 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 8.6 mmt85 -66.79 -18.38 65.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 110.388 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.7 mptt -85.09 -33.18 22.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.937 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.27 -20.27 37.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.418 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.578 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 46.5 m -48.61 -50.5 59.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.4 Cg_exo -49.65 -45.27 32.19 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.266 1.978 . . . . 0.0 112.843 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.93 -31.82 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.935 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.51 -47.95 81.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.275 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.49 -40.94 96.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.174 0.511 . . . . 0.0 109.965 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.67 -46.44 81.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.591 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.3 m -65.12 -49.29 70.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.275 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.608 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.1 t80 -57.63 -42.37 83.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 111.44 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -78.06 -35.47 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.468 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -85.37 -19.88 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 136' ' ' VAL . 44.6 m-85 -106.22 -4.95 19.61 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 16.9 pttp -67.39 167.15 13.11 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 1.9 m-20 73.94 -36.9 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.656 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 82.1 mttt -61.69 -41.12 97.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.374 0.607 . . . . 0.0 110.167 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.36 44.62 0.14 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 56.7 t80 -140.59 144.66 35.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -173.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 44.7 m -150.64 142.23 23.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.6 mt -98.77 134.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 110.139 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -112.89 95.86 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.409 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 35' ' ' ASP . . . -76.96 103.3 1.77 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.397 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 53.7 t -99.05 117.21 43.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.265 0.555 . . . . 0.0 110.614 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 t -128.97 156.61 43.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.116 0.484 . . . . 0.0 110.763 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -136.76 48.76 2.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 10.8 t70 -65.29 -176.12 0.29 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.552 -171.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.7 mtm180 -54.15 -50.31 67.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.01 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 55.3 mtp180 -145.65 175.04 10.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.766 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 42.0 tt0 -75.14 -38.63 60.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.92 -42.27 99.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.328 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.624 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 3.4 m-20 -75.56 -28.22 58.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.443 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 21.1 t90 -64.68 -48.22 75.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.2 mptm? -58.9 -37.43 76.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.048 0.451 . . . . 0.0 110.002 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 36.1 ttmt -63.05 -45.68 91.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.932 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.35 74.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 110.943 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.09 -36.97 76.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.079 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 10.1 tp10 -63.0 -40.88 99.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 173.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.1 mt-10 -62.65 -59.7 4.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.265 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.573 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.2 m-20 -82.53 -16.99 46.6 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -172.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 62.99 35.16 13.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 111.12 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 p -81.7 86.17 6.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.951 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -90.4 86.18 6.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -155.42 -175.26 5.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.168 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.52 96.78 0.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.321 0.582 . . . . 0.0 111.446 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.0 mm-40 -99.05 140.15 33.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.132 177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.68 137.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.1 tp -92.85 125.94 37.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' OD2' ' A' ' 97' ' ' ASP . 65.9 mt -72.58 137.88 46.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.665 ' O ' HG23 ' A' ' 98' ' ' VAL . 24.8 mt-30 -67.07 147.05 53.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.27 -16.74 61.92 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.191 0.519 . . . . 0.0 110.759 -170.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.15 -33.87 22.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.432 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.448 ' OD2' HD22 ' A' ' 93' ' ' LEU . 7.1 t70 -72.27 -32.55 66.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 94' ' ' GLN . 75.3 t -50.09 -37.09 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.533 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -56.75 -63.76 1.1 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.786 0.803 . . . . 0.0 111.626 -172.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.05 -39.94 63.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.804 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 68.3 t -58.24 -50.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 19.3 mt -56.21 -62.06 1.97 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.981 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -50.76 70.97 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.532 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 t -57.63 -33.09 67.91 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.651 0.594 . . . . 0.0 112.365 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.483 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 51.2 m-85 -83.8 16.11 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 2.8 m 67.98 38.82 2.67 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.436 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 78.8 mt -119.94 110.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.116 -170.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.69 20.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.366 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.83 -172.4 40.6 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.658 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.44 156.17 69.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 117.181 0.49 . . . . 0.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.786 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 92.3 Cg_endo -86.36 167.6 47.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.784 -1.34 . . . . 0.0 113.237 -0.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.92 118.64 8.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 132' ' ' LEU . 4.1 mp -111.49 120.59 62.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 39.9 pt -122.08 158.1 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.561 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -122.86 117.41 25.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.926 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 117' ' ' ASP . 93.3 t -113.1 135.47 52.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.103 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 26.3 m-20 -66.96 163.89 40.04 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.749 174.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.85 -27.72 85.03 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.108 1.872 . . . . 0.0 111.404 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.44 -29.87 68.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.761 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 100.34 40.4 3.01 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.372 -175.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.613 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.4 mtmp? -112.05 148.8 33.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.95 99.4 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.14 -33.74 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.228 0.537 . . . . 0.0 110.639 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.15 152.94 45.09 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.743 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 2.3 ptpt -166.83 172.86 9.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.783 0.325 . . . . 0.0 111.51 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.743 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 0.7 OUTLIER 59.67 28.88 18.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.242 178.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 132' ' ' LEU . 89.7 mt -78.52 154.2 30.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.48 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -104.33 169.56 8.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.079 179.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -46.6 -70.94 0.59 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.9 -32.84 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.375 0.607 . . . . 0.0 110.987 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 39.9 t0 -73.64 -46.16 48.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.582 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 113' ' ' ILE . 4.5 pp -60.04 -37.0 78.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.505 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.502 ' CE2' ' HE1' ' A' ' 58' ' ' PHE . 53.8 t80 -68.14 -55.27 12.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 5.9 p30 -67.42 -27.09 66.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.693 -174.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 43.3 m -83.58 -33.24 25.42 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.656 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.5 p -74.89 -38.77 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 121.77 -0.581 . . . . 0.0 109.963 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 4.0 tp10 -65.6 -32.86 74.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 24.1 ttmt -56.66 -43.65 80.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.796 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.24 -51.13 6.46 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.9 t . . . . . 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -170.791 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.235 0.311 0 CA-C-O 120.989 0.423 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -99.22 131.05 45.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.605 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.26 -1.45 60.62 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.061 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 p -74.93 138.79 42.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.07 128.42 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 130.5 55.32 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.12 154.85 59.76 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.788 2.325 . . . . 0.0 111.396 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.06 103.9 16.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.372 . . . . 0.0 111.61 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.8 mt -63.07 142.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.866 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.0 t -124.27 87.46 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.625 0.726 . . . . 0.0 110.582 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.56 161.65 15.18 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.0 123.48 45.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.609 0.242 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HA ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -70.95 -175.66 1.18 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.399 0.619 . . . . 0.0 111.883 -172.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.25 -29.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.653 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -81.47 -50.7 9.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.71 23.6 0.31 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.52 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -108.81 137.47 46.69 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 p -79.99 114.29 18.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.738 0.304 . . . . 0.0 111.039 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' THR . 23.9 m -108.78 156.56 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.924 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 8.5 p -107.49 155.76 19.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.013 0.435 . . . . 0.0 110.733 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.4 tp -56.97 -31.62 65.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.867 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 9.9 t30 -71.17 -17.73 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.371 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -68.37 -29.41 68.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.32 -15.06 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.082 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LYS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 1.4 tmtp? -54.14 145.1 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.235 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.37 -0.35 40.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -133.97 172.59 12.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 140' ' ' VAL . 94.8 m-85 -77.67 106.52 9.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.61 108.52 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.881 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 tt -87.02 113.81 23.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 24.3 t -96.03 115.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -103.44 106.67 17.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.545 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.52 ' HA ' HG23 ' A' ' 68' ' ' VAL . 86.5 m-85 -90.5 115.09 27.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.482 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.6 p-90 -159.35 179.82 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.726 0.774 . . . . 0.0 112.348 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -166.63 162.92 16.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.006 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.03 69.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -174.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.38 -46.34 80.53 Favored Glycine 0 C--N 1.332 0.335 0 O-C-N 123.635 0.585 . . . . 0.0 112.688 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.4 p -88.65 78.85 7.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.716 0.77 . . . . 0.0 109.619 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.802 ' HA ' ' HD3' ' A' ' 45' ' ' ARG . 54.8 m -69.4 -1.97 9.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.242 -174.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -74.56 -36.35 63.08 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.529 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 3.3 m -60.7 -35.73 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.875 0.845 . . . . 0.0 108.857 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.802 ' HD3' ' HA ' ' A' ' 42' ' ' SER . 58.5 mtp180 -67.77 -26.6 66.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.886 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptt -86.97 -16.96 34.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.907 0.384 . . . . 0.0 111.603 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -88.62 -10.32 49.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.681 0.753 . . . . 0.0 109.149 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.599 HG23 ' CH2' ' A' ' 88' ' ' TRP . 37.0 m -54.82 -46.22 99.52 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.277 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -46.43 -43.57 21.85 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.369 2.046 . . . . 0.0 113.005 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -70.65 -40.14 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 48' ' ' THR . 97.8 mt -60.02 -37.8 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.504 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.88 -43.74 87.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.72 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.88 -43.27 94.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 174.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 57.8 m -58.17 -48.99 78.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.911 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.2 t80 -56.24 -48.59 76.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 110.991 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.197 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE2' ' A' ' 61' ' ' LYS . . . -91.87 -32.13 15.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 97.1 m-85 -111.43 4.59 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -55.2 -32.49 62.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.47 0.652 . . . . 0.0 111.005 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.69 12.0 31.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.626 -174.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 57' ' ' ALA . 34.7 mttm -122.97 23.04 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.71 47.41 40.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.536 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 69.7 t80 -129.87 136.55 49.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -143.01 131.56 22.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.684 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.7 mt -88.38 122.04 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -108.14 94.83 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.2 133.12 11.57 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.678 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HB ' HD21 ' A' ' 93' ' ' LEU . 9.5 m -119.85 112.99 39.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.472 0.653 . . . . 0.0 110.774 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.7 t -103.88 148.66 25.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.577 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.518 ' HB ' HD12 ' A' ' 93' ' ' LEU . 5.8 t -126.34 33.98 4.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.39 170.01 1.49 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.348 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -69.25 -46.84 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.644 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.64 164.91 23.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.59 -37.32 86.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 2.1 mp0 -55.53 -53.75 52.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.937 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.22 -45.52 90.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -59.03 -53.24 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.951 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -60.53 -40.64 92.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.926 0.394 . . . . 0.0 111.059 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -64.15 -45.85 86.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.38 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.573 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.3 mt -63.74 -42.43 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.366 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -68.05 -41.55 81.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.685 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.88 -51.28 69.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.763 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.48 7.54 42.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.56 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 66.8 mmtt 55.58 36.32 26.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.543 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.5 p -81.47 68.67 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.319 0.581 . . . . 0.0 111.25 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.56 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 62.3 m-85 -81.8 95.62 7.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.938 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CH2' HG23 ' A' ' 48' ' ' THR . 5.3 p90 -160.99 -178.99 7.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.481 171.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -67.64 100.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.458 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -117.54 150.56 38.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 16' ' ' ASP . 35.8 m -133.81 149.34 30.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.46 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.65 123.79 37.21 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 68' ' ' VAL . 69.3 mt -62.78 137.73 58.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.489 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 98' ' ' VAL . 43.9 mt-30 -74.16 166.99 22.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.46 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.88 -48.3 64.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.55 -32.34 22.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.789 0.328 . . . . 0.0 110.417 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB3' ' N ' ' A' ' 94' ' ' GLN . 22.1 t70 -58.05 -42.13 84.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.897 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 93' ' ' LEU . 77.7 t -49.65 -57.93 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 35.3 ttmt -65.26 -59.17 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.313 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.25 -51.7 65.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.451 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -52.47 39.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.1 mt -58.84 -38.39 78.61 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.543 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -61.56 -59.76 4.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.9 m -50.74 -41.14 56.13 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 107' ' ' ILE . 53.5 m-85 -71.76 5.75 2.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.048 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' CYS . . . . . 0.431 ' H ' ' C ' ' A' ' 104' ' ' SER . 85.3 m 61.72 52.24 3.61 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.989 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.0 mm -99.27 125.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.695 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.23 7.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.421 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 162.38 33.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.136 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.583 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 85.2 m-85 -132.1 164.66 41.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' PRO . . . . . 0.754 ' HB2' HH12 ' A' ' 128' ' ' ARG . 15.5 Cg_exo -68.52 157.36 88.33 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.448 0.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.58 104.3 4.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 110.815 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -114.66 122.23 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.286 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 125' ' ' LYS . 39.6 pt -123.94 155.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.539 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 55.0 tp -120.89 116.73 25.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.714 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.62 126.9 54.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.932 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.543 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 1.9 p30 -72.87 164.31 61.66 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -55.93 -28.86 70.51 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.567 2.178 . . . . 0.0 112.802 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -30.01 70.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.334 0.587 . . . . 0.0 110.017 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.81 29.53 4.62 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.388 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 8.6 mtmp? -114.96 149.14 37.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.924 0.393 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.89 98.32 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.955 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 m -86.71 -35.22 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -131.75 151.98 51.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.742 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 9.3 ptpp? -161.37 168.73 23.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.925 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 10.0 mm-40 63.46 19.37 11.65 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.082 0.864 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.28 141.4 57.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.469 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ARG . . . . . 0.754 HH12 ' HB2' ' A' ' 111' ' ' PRO . 17.6 mmt180 -117.78 159.83 22.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.534 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -21.47 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.466 0.658 0 O-C-N 124.647 1.217 . . . . 0.0 116.131 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.82 -36.33 82.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.93 -42.66 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.147 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.5 pp -57.28 -36.94 71.65 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.655 -175.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' TYR . . . . . 0.466 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.6 t80 -65.66 -46.48 78.97 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.54 -49.63 75.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.48 0.657 . . . . 0.0 110.358 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.3 m -62.53 -46.18 89.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.457 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 132' ' ' LEU . 54.1 t -64.84 -39.13 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 3.9 tp10 -58.38 -38.33 77.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.124 0.488 . . . . 0.0 109.851 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.5 ttpp -77.16 -25.68 52.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.854 -177.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -89.51 -47.15 8.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' A' ' 31' ' ' TYR . 37.0 t . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.9 mpp? . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -62.87 -55.39 26.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.181 0.515 . . . . 0.0 109.992 176.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -109.68 151.24 27.14 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.474 175.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -139.45 162.28 35.42 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.324 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 15.7 p -67.39 112.19 4.47 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.661 178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 113.8 -10.39 23.29 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.997 -0.62 . . . . 0.0 111.991 -176.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 33.9 t -79.5 146.25 32.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.678 0.275 . . . . 0.0 110.433 -179.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.5 t -71.94 136.79 24.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.507 -178.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -96.95 142.21 24.2 Favored Pre-proline 0 C--N 1.323 -0.567 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.718 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_exo -62.83 162.4 25.49 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.837 2.358 . . . . 0.0 112.021 175.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.66 133.35 33.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.913 -179.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.553 ' O ' ' HA ' ' A' ' 23' ' ' SER . 5.0 mp -93.37 142.3 13.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.825 178.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 4.0 m -115.74 94.2 4.59 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.109 0.481 . . . . 0.0 110.481 177.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.539 ' HA3' ' HB ' ' A' ' 91' ' ' VAL . . . -116.42 144.84 18.58 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.471 -177.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.42 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 68.4 mt -87.79 132.44 32.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 CA-C-O 120.491 0.186 . . . . 0.0 110.526 179.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.81 -175.68 4.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.897 0.38 . . . . 0.0 110.964 -177.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 97.4 mt -62.14 -28.66 69.8 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.817 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 9.6 mtmp? -84.03 -41.3 17.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.151 -178.113 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.91 18.96 1.31 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.472 -0.871 . . . . 0.0 112.582 -178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.528 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -94.0 144.33 25.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.712 -0.477 . . . . 0.0 109.712 179.092 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 p -82.14 105.89 13.6 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.94 0.4 . . . . 0.0 110.404 176.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.7 t -103.71 135.7 40.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 116.129 -0.487 . . . . 0.0 109.883 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.553 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 2.0 m -108.95 176.89 4.94 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 120.951 0.405 . . . . 0.0 110.542 -176.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 53.4 tp -71.26 -32.91 69.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.964 0.411 . . . . 0.0 110.917 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.65 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 1.7 p-10 -65.06 -22.46 66.97 Favored 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.992 -178.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -72.77 -18.52 61.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.992 0.425 . . . . 0.0 110.971 -177.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 68.6 m-85 -116.21 19.21 15.02 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.156 0.503 . . . . 0.0 109.692 176.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.65 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.9 tttm -80.03 56.14 2.31 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.371 -0.832 . . . . 0.0 111.013 -174.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -152.94 15.86 0.7 Allowed Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 178.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -149.03 171.76 15.86 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 92.3 m-85 -76.46 111.63 12.13 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 172.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' HA ' ' O ' ' A' ' 64' ' ' THR . 48.1 t -97.4 114.32 34.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.061 -173.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.673 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.2 tm? -88.47 105.35 17.56 Favored 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 175.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.517 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 44.1 t -89.89 110.87 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-O 121.006 0.432 . . . . 0.0 110.161 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.441 ' O ' HG22 ' A' ' 68' ' ' VAL . 28.9 t70 -106.61 122.27 46.0 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.46 -178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -94.7 114.19 26.08 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 177.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.448 ' O ' ' HA ' ' A' ' 69' ' ' SER . 16.4 p-90 -148.35 172.45 14.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.708 0.766 . . . . 0.0 111.884 -175.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -170.36 159.92 7.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 114.471 -1.24 . . . . 0.0 108.661 175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.63 69.33 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -171.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -79.79 -6.07 89.2 Favored Glycine 0 CA--C 1.52 0.344 0 C-N-CA 120.737 -0.744 . . . . 0.0 113.09 -179.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 34.9 t -89.75 112.64 23.99 Favored 'General case' 0 C--N 1.327 -0.39 0 O-C-N 122.48 -0.424 . . . . 0.0 110.206 -178.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.421 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -64.23 -42.91 96.34 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.569 -173.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 61.4 t-105 -77.29 -31.66 54.92 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -171.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.619 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 94.5 m -57.6 -38.57 75.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.906 0.384 . . . . 0.0 110.369 177.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -66.44 -18.07 65.15 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.764 179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptp? -85.36 -34.13 21.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.453 -178.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.43 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 45.5 mt-10 -96.44 1.64 51.81 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.979 -0.288 . . . . 0.0 111.594 -176.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.633 HG21 ' HB3' ' A' ' 84' ' ' ASP . 84.4 m -50.21 -51.53 62.02 Favored Pre-proline 0 CA--C 1.544 0.712 0 CA-C-N 116.067 -0.515 . . . . 0.0 112.329 175.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 65.5 Cg_exo -52.52 -43.02 57.95 Favored 'Trans proline' 0 C--N 1.362 1.244 0 C-N-CA 122.259 1.973 . . . . 0.0 113.156 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.43 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.8 m-85 -65.1 -46.0 82.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.751 0.31 . . . . 0.0 110.409 -178.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.1 mt -61.9 -40.21 94.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.633 178.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.408 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 60.9 tp -59.42 -47.29 86.02 Favored 'General case' 0 C--O 1.237 0.431 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.92 -179.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.519 ' HE3' ' CD2' ' A' ' 133' ' ' TYR . 38.6 ttpt -62.87 -47.27 84.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.151 177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 35.7 m -58.55 -47.91 82.63 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.711 -177.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.572 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -60.03 -51.32 70.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 121.008 -0.277 . . . . 0.0 110.868 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 33.3 m-80 -66.55 -26.08 66.96 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -90.71 -27.43 18.98 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.647 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 71.0 m-85 -108.45 -11.86 15.1 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -174.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.695 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 21.6 pttp -54.91 -39.15 68.49 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-O 120.811 0.339 . . . . 0.0 111.388 -176.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -81.51 -36.52 29.12 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.439 -177.702 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HD2' ' CD1' ' A' ' 58' ' ' PHE . 87.9 mttt -58.75 -44.01 90.42 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.712 -179.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.06 43.37 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.877 -0.678 . . . . 0.0 111.428 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.695 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 65.9 t80 -144.08 150.48 38.21 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -172.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.424 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 95.7 m -150.8 132.76 15.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-O 120.853 0.358 . . . . 0.0 110.583 178.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.572 HD12 ' HB2' ' A' ' 55' ' ' TYR . 42.7 mt -92.44 118.72 38.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 121.088 0.47 . . . . 0.0 110.044 177.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 41.4 t80 -102.76 94.43 5.6 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 -179.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.35 112.0 3.76 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.759 -175.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.655 ' HB ' HD21 ' A' ' 93' ' ' LEU . 32.1 m -100.21 116.43 43.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-O 121.485 0.659 . . . . 0.0 111.004 -176.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 7.2 t -128.84 145.39 51.22 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.947 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 1.037 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 11.7 t -145.87 54.79 1.17 Allowed 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 122.014 0.912 . . . . 0.0 110.011 -179.441 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' OD2' ' HG2' ' A' ' 72' ' ' ARG . 0.7 OUTLIER -68.63 -168.51 0.12 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.479 -177.588 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.435 ' HG2' ' OD2' ' A' ' 71' ' ' ASP . 0.6 OUTLIER -60.47 -42.86 97.08 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.862 -172.77 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.504 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 56.8 mtp180 -133.11 163.07 30.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.667 -173.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.563 ' HG3' HD22 ' A' ' 92' ' ' LEU . 16.8 tt0 -75.12 -36.74 61.61 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 172.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.494 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 2.0 mp0 -59.57 -39.68 84.87 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.951 177.908 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.504 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 2.3 m-20 -74.67 -32.36 62.2 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.262 179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.421 ' CE3' ' HB2' ' A' ' 92' ' ' LEU . 29.4 t90 -62.28 -49.03 77.3 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 170.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.424 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.0 mptm? -57.88 -43.44 86.05 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-O 121.045 0.45 . . . . 0.0 110.278 174.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.441 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 3.5 ttpm? -60.15 -45.84 91.7 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.69 179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.94 -38.01 84.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.328 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 82.8 mt -62.99 -38.02 80.9 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 120.821 0.343 . . . . 0.0 110.324 177.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 48.4 tp10 -69.7 -42.23 74.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.402 175.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 36.8 mt-10 -60.49 -56.08 25.77 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.178 178.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.633 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.9 m-20 -75.71 -20.92 58.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.859 -176.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.413 ' HD3' ' HA ' ' A' ' 85' ' ' LYS . 66.3 mmtt 57.49 37.89 27.9 Favored 'General case' 0 CA--C 1.52 -0.183 0 CA-C-O 121.824 0.821 . . . . 0.0 109.98 -172.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.4 p -83.27 82.96 8.04 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 114.664 -1.153 . . . . 0.0 110.87 -176.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 58.6 m-85 -82.78 84.55 7.31 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.516 -176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.408 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 28.7 p90 -154.95 -169.24 3.13 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.119 169.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -72.92 84.26 1.24 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.425 0.631 . . . . 0.0 111.021 -177.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -89.23 136.36 33.06 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.098 -0.955 . . . . 0.0 109.536 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.539 ' HB ' ' HA3' ' A' ' 14' ' ' GLY . 17.1 m -131.01 141.71 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.05 0.452 . . . . 0.0 111.016 177.169 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.563 HD22 ' HG3' ' A' ' 74' ' ' GLU . 53.3 tp -88.24 111.16 21.35 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.626 176.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.037 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 84.3 mt -66.7 124.1 21.96 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.693 -179.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.724 ' O ' HG23 ' A' ' 98' ' ' VAL . 19.1 mt-30 -60.78 143.42 54.57 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 175.28 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 28.5 mmmt -66.95 -23.32 65.95 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 120.582 0.229 . . . . 0.0 111.443 -165.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 -87.44 -36.03 17.94 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.741 0.305 . . . . 0.0 110.749 175.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -62.29 -37.69 86.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.843 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.724 HG23 ' O ' ' A' ' 94' ' ' GLN . 63.2 t -50.63 -47.22 28.17 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.231 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.367 176.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 82.0 mttt -55.05 -55.23 33.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.803 -176.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -66.25 -53.29 38.68 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.204 -177.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 57.6 t -55.68 -54.32 27.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.783 -176.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.604 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 30.5 mt -60.51 -50.63 72.78 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.998 -0.281 . . . . 0.0 111.009 -177.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -56.98 -59.66 4.73 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 120.951 -0.299 . . . . 0.0 110.308 -178.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 69.3 m -54.79 -30.98 58.35 Favored 'General case' 0 N--CA 1.464 0.261 0 O-C-N 124.275 0.984 . . . . 0.0 113.338 -173.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -77.96 10.58 2.75 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 122.133 -0.354 . . . . 0.0 111.143 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 25.7 t 64.29 36.13 9.45 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 -176.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.604 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 39.7 mm -106.0 118.13 53.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.729 -0.669 . . . . 0.0 112.366 -171.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.2 m -130.48 13.79 2.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.201 -0.909 . . . . 0.0 110.214 174.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -156.64 160.47 30.29 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.49 -177.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -133.49 155.98 80.12 Favored Pre-proline 0 C--N 1.33 -0.273 0 C-N-CA 122.446 0.299 . . . . 0.0 110.377 -178.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.619 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 4.2 Cg_exo -82.63 -176.5 16.82 Favored 'Cis proline' 0 C--N 1.348 0.535 0 C-N-CA 124.011 -1.245 . . . . 0.0 112.148 -1.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -163.03 130.8 3.68 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.972 -0.291 . . . . 0.0 110.627 178.293 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.466 HG23 HD11 ' A' ' 33' ' ' LEU . 58.0 mt -125.93 130.76 72.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.732 -178.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.517 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 30.8 pt -129.15 145.46 35.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.903 178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.8 tt -105.71 110.63 23.01 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 179.265 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.5 t -103.83 135.76 40.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.444 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.549 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -82.13 170.37 15.18 Favored Pre-proline 0 CA--C 1.538 0.505 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 177.06 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.549 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 16.5 Cg_endo -59.65 -16.72 38.27 Favored 'Trans proline' 0 C--N 1.352 0.756 0 C-N-CA 122.647 2.232 . . . . 0.0 114.028 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.495 ' HB3' ' HE2' ' A' ' 121' ' ' LYS . 0.4 OUTLIER -88.43 3.94 48.21 Favored 'General case' 0 C--N 1.323 -0.57 0 O-C-N 121.95 -0.469 . . . . 0.0 110.824 175.955 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 76.39 30.04 57.33 Favored Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.985 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.495 ' HE2' ' HB3' ' A' ' 119' ' ' GLU . 27.2 mttm -113.01 141.54 46.73 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.939 0.369 . . . . 0.0 110.077 179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 52.3 mt -77.41 95.62 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 117' ' ' ASP . 42.6 t -73.27 -41.95 57.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.578 -176.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -146.66 167.27 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.63 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.0 pttp -162.68 171.89 16.16 Favored 'General case' 0 C--N 1.323 -0.543 0 C-N-CA 121.206 -0.198 . . . . 0.0 110.819 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.586 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 8.8 mm-40 68.01 16.42 9.54 Favored 'General case' 0 N--CA 1.468 0.474 0 O-C-N 124.286 0.991 . . . . 0.0 111.15 178.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.9 mt -60.64 132.74 54.86 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.352 -0.611 . . . . 0.0 109.352 178.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.525 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.2 mmp_? -116.02 154.52 29.73 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.877 -0.329 . . . . 0.0 111.021 -170.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.556 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 46.05 -131.78 10.54 Favored Glycine 0 C--O 1.224 -0.528 0 O-C-N 123.966 0.792 . . . . 0.0 113.568 170.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.9 -10.74 59.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.533 0.206 . . . . 0.0 110.992 178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.423 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.5 t70 -64.27 -31.84 73.2 Favored 'General case' 0 CA--C 1.513 -0.48 0 C-N-CA 120.977 -0.289 . . . . 0.0 110.388 -178.447 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.556 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 3.3 pp -58.9 -41.15 86.52 Favored 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.852 177.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.52 ' N ' HD12 ' A' ' 132' ' ' LEU . 26.9 t80 -63.6 -54.87 29.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.326 0.584 . . . . 0.0 109.555 172.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.44 ' C ' ' HE3' ' A' ' 138' ' ' LYS . 25.3 m-80 -58.71 -32.41 69.16 Favored 'General case' 0 C--O 1.218 -0.557 0 CA-C-N 115.007 -0.997 . . . . 0.0 112.11 -175.561 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.503 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 21.7 m -73.91 -40.23 63.29 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.281 0.104 . . . . 0.0 111.281 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 132' ' ' LEU . 44.9 t -63.93 -39.28 84.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 C-N-CA 119.993 -0.683 . . . . 0.0 109.501 174.07 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.439 ' OE1' ' HB2' ' A' ' 141' ' ' ASN . 3.0 tp10 -66.17 -41.48 90.25 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.861 176.211 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.503 ' HE3' ' HA ' ' A' ' 135' ' ' THR . 15.8 mtmt -52.51 -40.65 62.67 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.629 -0.714 . . . . 0.0 111.396 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -87.61 -61.5 1.71 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.1 t -83.08 -35.87 12.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.624 0.972 . . . . 0.0 113.624 -164.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.439 ' HB2' ' OE1' ' A' ' 137' ' ' GLU . 66.6 t30 -52.3 -56.75 12.71 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 113.153 0.797 . . . . 0.0 113.153 -168.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.418 ' O ' ' HB3' ' A' ' 143' ' ' ALA . . . -164.16 -173.3 32.67 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 119.814 -1.184 . . . . 0.0 112.901 -176.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 142' ' ' GLY . . . 78.84 6.41 2.27 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.136 0.974 . . . . 0.0 111.501 -178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.45 ' HD2' ' N ' ' A' ' 144' ' ' LYS . 7.4 mptt -131.98 7.77 4.37 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 173.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.07 -36.04 61.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.181 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 95.27 -22.91 36.02 Favored Glycine 0 N--CA 1.442 -0.908 0 CA-C-O 119.343 -0.698 . . . . 0.0 113.239 173.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 9.1 p-80 37.13 79.29 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.905 0 CA-C-O 121.575 0.702 . . . . 0.0 111.151 -174.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 68.2 m-70 -80.58 -20.97 42.13 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.832 -165.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 42.6 m80 -89.0 -44.93 10.04 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.615 -0.434 . . . . 0.0 109.97 175.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 166.88 -36.49 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.14 0.9 . . . . 0.0 109.487 177.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 27.3 m80 -122.93 -35.13 3.07 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.774 174.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.5 m80 . . . . . 0 C--O 1.247 0.935 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 171.916 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.48 1.043 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.576 ' HB3' ' O ' ' A' ' 104' ' ' SER . 0.7 OUTLIER -119.03 -171.99 2.21 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.187 -169.979 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.454 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.4 OUTLIER -90.39 -179.77 5.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.556 178.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -138.4 -167.14 2.12 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.694 -178.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 p -64.3 133.84 53.49 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.83 0.348 . . . . 0.0 111.109 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.12 -20.31 50.65 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 121.101 -0.571 . . . . 0.0 111.747 -177.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.1 m -87.08 156.15 19.84 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' HG2' ' A' ' 121' ' ' LYS . 13.7 p -80.79 132.87 30.64 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.14 0.495 . . . . 0.0 110.793 -177.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -81.96 144.51 51.54 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 115.775 -0.648 . . . . 0.0 111.06 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -67.05 148.68 81.88 Favored 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.585 2.19 . . . . 0.0 112.165 177.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.84 99.8 1.81 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.743 179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.512 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.7 mm -83.25 132.9 30.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.413 179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 46.5 m -131.74 98.99 4.63 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.072 0.463 . . . . 0.0 110.402 176.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.581 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -112.37 -176.23 19.79 Favored Glycine 0 N--CA 1.45 -0.387 0 CA-C-N 115.853 -0.612 . . . . 0.0 111.835 -178.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.419 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 19.7 mt -104.68 135.51 42.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 116.714 0.257 . . . . 0.0 110.924 -176.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.429 ' OD1' ' HB2' ' A' ' 20' ' ' ASN . 1.0 OUTLIER -101.29 -172.6 2.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.656 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.433 HD21 HD12 ' A' ' 81' ' ' ILE . 92.6 mt -59.46 -26.89 65.61 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -176.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.05 -14.7 59.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.87 0.367 . . . . 0.0 111.229 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.01 22.22 57.89 Favored Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 -171.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.457 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -102.02 151.17 22.45 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -179.406 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.5 p -84.42 107.31 16.62 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 116.407 -0.36 . . . . 0.0 110.145 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 52.9 t -107.6 138.43 33.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 19.4 m -106.39 172.11 6.99 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.137 0.494 . . . . 0.0 111.072 -176.205 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.656 HD11 HG11 ' A' ' 32' ' ' VAL . 55.7 tp -80.42 -21.0 42.63 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.197 0.522 . . . . 0.0 110.088 175.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.497 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 4.0 m-20 -65.84 -28.69 69.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.307 -177.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -64.53 -23.89 67.42 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.211 0.529 . . . . 0.0 110.932 -179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -107.38 8.48 29.65 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.006 -177.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.497 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 6.2 mtpp -76.51 69.99 3.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.719 0.771 . . . . 0.0 111.179 -178.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.509 ' HA3' ' CG ' ' A' ' 151' ' ' HIS . . . -165.65 20.37 0.11 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.709 174.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -153.19 -176.45 5.79 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -177.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.411 ' HB3' HD11 ' A' ' 115' ' ' LEU . 64.1 m-85 -95.88 111.62 23.56 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 169.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.69 HG12 ' HB ' ' A' ' 116' ' ' VAL . 9.8 p -101.52 133.46 44.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.898 0 CA-C-O 121.232 0.539 . . . . 0.0 111.407 -172.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.652 HD11 HD22 ' A' ' 132' ' ' LEU . 10.3 tt -97.55 107.27 19.74 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 176.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.558 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 41.4 t -97.52 105.09 16.71 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.828 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -102.56 118.46 36.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.069 -177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.404 ' HA ' HG13 ' A' ' 68' ' ' VAL . 66.5 m-85 -84.43 116.2 22.95 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 174.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.584 ' O ' ' HA ' ' A' ' 69' ' ' SER . 21.9 p-90 -144.4 175.71 9.91 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.626 0.727 . . . . 0.0 111.874 -176.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -168.38 161.01 11.72 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 114.59 -1.187 . . . . 0.0 108.248 171.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -62.54 -32.93 73.96 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 -170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.37 -11.66 85.29 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.196 -178.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.405 ' CB ' ' HG ' ' A' ' 44' ' ' CYS . 48.3 t -74.53 110.62 8.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.257 0.551 . . . . 0.0 109.946 -179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 5.7 m -65.48 -28.31 69.12 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.308 -173.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.532 ' O ' ' HB2' ' A' ' 46' ' ' LYS . 77.2 t-105 -85.52 -30.75 23.17 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.965 0.357 . . . . 0.0 111.965 -175.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.405 ' HG ' ' CB ' ' A' ' 41' ' ' CYS . 90.2 m -58.06 -42.05 84.64 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.444 -0.503 . . . . 0.0 110.111 178.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.3 -13.71 21.2 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.018 176.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.535 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.5 mptt -84.28 -51.23 7.16 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 111.536 0.198 . . . . 0.0 111.536 -177.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.415 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 15.7 pt-20 -99.73 15.78 25.72 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.239 -0.584 . . . . 0.0 112.224 -175.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 22.4 m -51.71 -51.97 65.15 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 111.937 0.347 . . . . 0.0 111.937 170.601 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.5 Cg_exo -54.29 -33.74 77.1 Favored 'Trans proline' 0 C--N 1.36 1.179 0 C-N-CA 121.97 1.78 . . . . 0.0 112.379 177.363 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.415 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.1 m-85 -76.57 -32.23 58.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD23 HD13 ' A' ' 132' ' ' LEU . 95.7 mt -62.94 -52.95 61.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 173.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 67.9 tp -61.07 -40.26 93.02 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.533 179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 71.1 tttt -51.69 -53.86 34.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.718 174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.7 m -67.07 -39.8 86.91 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.581 -0.736 . . . . 0.0 111.11 -177.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.617 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.7 t80 -60.84 -46.75 89.32 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.858 0.361 . . . . 0.0 111.172 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.3 t30 -68.19 -35.97 78.85 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.414 -177.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -77.88 -31.19 51.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -174.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.549 ' HE1' ' OE1' ' A' ' 137' ' ' GLU . 90.3 m-85 -115.48 3.86 14.16 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.905 0.706 . . . . 0.0 112.905 -173.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.7 pttp -55.73 -38.44 69.76 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 120.829 0.347 . . . . 0.0 111.743 -177.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -83.74 -42.12 16.91 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.735 -175.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.414 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 88.3 mttt -55.8 -56.34 21.67 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.232 -176.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 162.92 38.79 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.53 -0.843 . . . . 0.0 111.749 -179.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.529 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 49.4 t80 -135.49 147.28 48.8 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -177.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 85.4 m -153.99 144.06 22.01 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.843 176.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.617 HD12 ' HB2' ' A' ' 55' ' ' TYR . 29.4 mt -95.58 137.82 22.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-O 121.097 0.475 . . . . 0.0 111.033 -178.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.459 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 39.3 t80 -123.43 93.05 3.82 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -90.04 106.8 3.37 Favored Glycine 0 CA--C 1.505 -0.531 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.582 -172.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.554 ' HA ' HG13 ' A' ' 91' ' ' VAL . 3.1 p -99.05 118.25 45.35 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.631 0.729 . . . . 0.0 111.092 -176.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 12.4 t -112.4 152.9 28.11 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.528 -177.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.712 HG22 ' HB2' ' A' ' 93' ' ' LEU . 30.6 p -132.54 48.96 2.36 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 177.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -75.15 -176.05 2.88 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.864 -172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 71.1 mtm180 -69.85 -39.27 76.49 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.924 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HD2' ' OD1' ' A' ' 76' ' ' ASP . 60.9 mtt180 -138.69 152.71 48.26 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.672 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.485 ' O ' ' HG2' ' A' ' 78' ' ' LYS . 33.3 tt0 -65.91 -37.9 87.28 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 173.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.733 ' HA ' ' HG2' ' A' ' 78' ' ' LYS . 3.4 mm-40 -68.78 -36.46 78.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.766 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.57 ' OD1' ' HD2' ' A' ' 73' ' ' ARG . 0.4 OUTLIER -65.25 -34.59 78.73 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 173.551 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.472 ' HB3' ' O ' ' A' ' 74' ' ' GLU . 31.5 t90 -64.37 -48.73 74.4 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.82 173.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.733 ' HG2' ' HA ' ' A' ' 75' ' ' GLU . 8.7 mmtm -55.3 -50.4 69.67 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 121.963 0.887 . . . . 0.0 108.837 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.436 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 1.0 OUTLIER -60.72 -40.06 90.92 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.269 -1.332 . . . . 0.0 111.014 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -61.77 -36.17 80.27 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.692 0.282 . . . . 0.0 110.994 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.433 HD12 HD21 ' A' ' 17' ' ' LEU . 73.1 mt -64.6 -39.64 86.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.127 176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 82' ' ' GLU . 38.0 tp10 -65.6 -34.32 77.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.767 177.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.541 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 53.7 mt-10 -69.76 -52.19 27.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.765 0.793 . . . . 0.0 110.304 175.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -76.78 -18.67 58.29 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.301 -1.318 . . . . 0.0 112.228 -167.534 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.419 ' HD2' ' HA ' ' A' ' 85' ' ' LYS . 8.4 mptt 59.04 21.26 9.15 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-O 121.244 0.545 . . . . 0.0 112.244 -176.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.463 ' HB3' ' CZ2' ' A' ' 88' ' ' TRP . 60.3 m -87.07 85.06 7.21 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.534 176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 93.5 m-85 -96.62 93.31 6.67 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.971 -178.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.463 ' CZ2' ' HB3' ' A' ' 86' ' ' SER . 7.6 p90 -153.26 -172.68 4.32 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.744 174.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 52.1 m-80 -68.49 99.81 1.01 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.278 0.561 . . . . 0.0 110.273 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.32 155.41 30.69 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.171 -177.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.581 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.3 p -140.05 145.63 26.05 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.896 -172.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 27.7 tp -108.21 129.57 55.19 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.375 -0.83 . . . . 0.0 109.483 175.645 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.712 ' HB2' HG22 ' A' ' 70' ' ' THR . 15.3 mt -74.69 142.58 44.44 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.431 177.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.4 mt-30 -75.44 163.34 27.51 Favored 'General case' 0 C--O 1.22 -0.467 0 CA-C-N 116.485 -0.325 . . . . 0.0 110.798 -179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.473 ' CD ' ' H ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -43.63 -55.37 4.37 Favored 'General case' 0 CA--C 1.544 0.738 0 N-CA-C 113.849 1.055 . . . . 0.0 113.849 -176.924 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.473 ' H ' ' CD ' ' A' ' 95' ' ' LYS . 0.9 OUTLIER -87.8 -33.51 18.6 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.204 0.526 . . . . 0.0 110.292 -178.694 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.59 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 14.4 t70 -54.76 -39.2 68.09 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.489 -1.232 . . . . 0.0 111.313 177.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 53.8 t -49.9 -48.12 22.51 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.408 0 CA-C-O 120.959 0.409 . . . . 0.0 110.876 175.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HB3' ' HE3' ' A' ' 99' ' ' LYS . 19.7 ttpp -56.39 -59.45 4.95 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.661 -0.7 . . . . 0.0 112.144 -176.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 61.2 m-20 -69.86 -34.95 74.29 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.577 -171.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.4 t -69.09 -37.43 76.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 121.009 -0.277 . . . . 0.0 110.685 176.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.75 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -66.37 -22.89 66.26 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.67 178.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -82.54 -62.71 1.54 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 119.249 -0.981 . . . . 0.0 108.813 169.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.576 ' O ' ' HB3' ' A' ' 2' ' ' SER . 69.6 m -48.33 -41.55 28.69 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 114.533 1.309 . . . . 0.0 114.533 -164.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.4 m-85 -82.34 17.04 1.81 Allowed 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.226 -0.59 . . . . 0.0 111.714 -177.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 42.6 t 57.36 54.0 7.06 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -176.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.75 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 19.1 mm -80.33 72.87 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.636 0.732 . . . . 0.0 110.541 -177.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.5 p -106.51 -25.34 3.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.683 175.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -110.05 121.18 5.9 Favored Glycine 0 N--CA 1.446 -0.652 0 N-CA-C 111.039 -0.824 . . . . 0.0 111.039 176.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.44 ' CG ' ' HA ' ' A' ' 111' ' ' PRO . 3.3 t80 -123.88 140.74 35.17 Favored Pre-proline 0 C--N 1.32 -0.712 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 -175.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.502 ' HG2' HH12 ' A' ' 128' ' ' ARG . 62.3 Cg_endo -74.9 135.4 40.31 Favored 'Cis proline' 0 C--N 1.349 0.559 0 C-N-CA 123.566 -1.431 . . . . 0.0 112.108 -0.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.521 ' CD2' HD13 ' A' ' 107' ' ' ILE . 49.7 t60 -89.02 100.8 13.5 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.359 -176.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 97.1 mt -102.9 120.86 53.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.128 -0.487 . . . . 0.0 109.883 178.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.558 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 31.5 pt -122.05 159.64 24.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.057 0.456 . . . . 0.0 111.666 -176.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.448 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 tp -121.09 120.61 35.81 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.526 -0.761 . . . . 0.0 109.015 176.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.69 ' HB ' HG12 ' A' ' 32' ' ' VAL . 65.4 t -109.2 133.97 52.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 120.775 0.321 . . . . 0.0 110.664 -177.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.579 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 2.6 p30 -77.0 165.79 49.66 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.502 178.184 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.579 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.7 Cg_endo -54.18 -20.33 18.95 Favored 'Trans proline' 0 C--N 1.35 0.653 0 C-N-CA 122.983 2.455 . . . . 0.0 113.85 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -82.89 -14.33 54.43 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.815 0.34 . . . . 0.0 110.775 -179.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 91.11 30.37 11.18 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.923 -179.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.51 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.6 mtmp? -112.27 152.35 28.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 122.403 -0.469 . . . . 0.0 110.963 175.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.2 mt -84.16 108.69 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.83 178.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 12.7 p -92.61 -30.31 4.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.958 0.409 . . . . 0.0 110.976 -178.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.463 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -144.86 155.41 43.45 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.373 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 17.2 pttp -156.61 162.58 39.86 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.59 -0.277 . . . . 0.0 110.619 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 3.1 mm-40 66.51 20.76 10.85 Favored 'General case' 0 N--CA 1.47 0.549 0 C-N-CA 123.815 0.846 . . . . 0.0 110.72 179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.463 HD21 ' HB1' ' A' ' 124' ' ' ALA . 71.0 mt -64.14 145.05 56.61 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.226 -179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.502 HH12 ' HG2' ' A' ' 111' ' ' PRO . 25.3 mmt180 -132.48 139.98 48.18 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -173.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 39.03 -99.42 0.01 OUTLIER Glycine 0 C--N 1.332 0.338 0 O-C-N 124.521 1.138 . . . . 0.0 115.721 165.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -76.1 -35.28 59.4 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.806 -0.197 . . . . 0.0 111.128 -175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.908 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 27.8 t70 -69.94 -19.45 63.37 Favored 'General case' 0 CA--C 1.515 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.469 -177.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.652 HD22 HD11 ' A' ' 33' ' ' LEU . 95.0 mt -51.86 -59.59 4.15 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 168.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -62.14 -49.14 77.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.127 -0.942 . . . . 0.0 109.922 175.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.908 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 93.8 m-20 -57.41 -41.55 80.55 Favored 'General case' 0 C--O 1.221 -0.399 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.265 -174.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.509 ' HA ' ' HE3' ' A' ' 138' ' ' LYS . 5.1 m -74.6 -36.45 62.97 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -179.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.544 HG23 ' O ' ' A' ' 132' ' ' LEU . 41.6 t -68.87 -41.47 82.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 119.718 -0.793 . . . . 0.0 110.319 177.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.549 ' OE1' ' HE1' ' A' ' 58' ' ' PHE . 1.2 tp10 -67.94 -32.33 72.71 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-O 121.628 0.728 . . . . 0.0 109.246 175.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.738 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 22.1 ttmt -58.55 -56.92 15.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.923 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 88.5 m-85 -89.22 -53.28 4.63 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.883 0.697 . . . . 0.0 112.883 -176.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.452 ' HA ' ' CE1' ' A' ' 147' ' ' HIS . 23.3 t -75.15 -43.14 44.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.46 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 15.7 t30 -73.14 -18.51 61.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.215 0.531 . . . . 0.0 110.86 -176.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.29 168.92 22.26 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.62 -0.8 . . . . 0.0 111.808 176.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -80.1 80.85 6.47 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.14 0.495 . . . . 0.0 110.597 178.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.608 ' O ' ' HG3' ' A' ' 145' ' ' GLU . 1.2 mptm? -117.36 126.28 52.42 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.686 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.608 ' HG3' ' O ' ' A' ' 144' ' ' LYS . 0.1 OUTLIER 54.41 1.25 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 125.335 1.454 . . . . 0.0 114.712 174.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 86.51 -7.15 80.34 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.884 -0.675 . . . . 0.0 112.404 178.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 140' ' ' VAL . 33.4 m-70 68.79 26.55 5.99 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 123.309 0.644 . . . . 0.0 110.614 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 48.4 m80 41.69 61.78 1.77 Allowed 'General case' 0 C--O 1.232 0.179 0 CA-C-N 114.366 -1.288 . . . . 0.0 113.124 176.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 75.39 -31.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.463 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.905 171.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.438 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 14.4 t-80 72.33 151.13 0.11 Allowed 'General case' 0 N--CA 1.47 0.53 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 -173.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.509 ' CG ' ' HA3' ' A' ' 29' ' ' GLY . 2.1 t-160 -61.17 -38.72 87.48 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 121.905 -0.497 . . . . 0.0 110.063 -178.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.438 ' C ' ' HD1' ' A' ' 150' ' ' HIS . 22.1 t60 . . . . . 0 C--O 1.242 0.697 0 N-CA-C 108.501 -0.926 . . . . 0.0 108.501 172.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.556 ' H ' ' HB3' ' A' ' 106' ' ' CYS . 11.5 m -140.12 136.45 33.55 Favored 'General case' 0 C--N 1.322 -0.626 0 O-C-N 123.379 0.424 . . . . 0.0 109.999 -175.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 105' ' ' TYR . 63.9 mt 69.07 146.51 0.06 Allowed 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 121.651 0.739 . . . . 0.0 112.109 -178.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -145.22 172.04 13.69 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.179 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.0 p -68.68 119.18 12.67 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.849 0.357 . . . . 0.0 110.758 179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 106.35 -8.79 41.48 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.936 -177.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 39.8 t -85.24 149.01 25.79 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.726 0.298 . . . . 0.0 110.523 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 42.5 t -69.89 141.56 17.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.129 178.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -85.57 131.2 48.37 Favored Pre-proline 0 C--N 1.326 -0.439 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.144 -179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 37.7 Cg_exo -61.67 153.46 67.06 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 123.017 2.478 . . . . 0.0 112.219 176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -67.63 134.62 51.5 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.782 -175.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.625 HG12 HD23 ' A' ' 24' ' ' LEU . 48.5 mm -104.53 129.5 56.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.595 -0.73 . . . . 0.0 109.474 176.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.432 ' HB ' HE21 ' A' ' 94' ' ' GLN . 0.2 OUTLIER -120.18 93.02 3.92 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.003 0.43 . . . . 0.0 110.636 178.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -119.11 148.04 18.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.378 -175.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.8 mt -87.39 124.39 40.74 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-O 121.354 0.597 . . . . 0.0 111.162 -178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.52 170.25 16.11 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.972 -179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.8 mp -64.96 -14.56 60.45 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.92 -173.151 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.457 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 36.7 mtmm -96.59 2.38 52.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.944 0.402 . . . . 0.0 111.094 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.41 20.02 55.55 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.787 178.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 27.8 m-80 -101.18 132.46 46.65 Favored 'General case' 0 C--N 1.327 -0.395 0 O-C-N 122.544 -0.386 . . . . 0.0 110.129 176.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.1 t -80.97 112.0 17.97 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 176.611 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.2 t -117.69 148.82 20.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.43 -172.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 0.1 OUTLIER -100.43 175.05 5.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.919 0.39 . . . . 0.0 111.193 179.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.625 HD23 HG12 ' A' ' 12' ' ' ILE . 3.8 pp -80.2 -20.07 45.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.817 0.341 . . . . 0.0 110.42 177.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.581 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 29.9 p30 -71.68 -17.89 62.2 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.168 -175.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -64.66 -25.99 68.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.275 0.56 . . . . 0.0 110.958 176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -109.29 2.8 21.05 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.54 -177.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.581 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 12.3 tmtt? -60.02 147.54 38.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.388 -177.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 109.58 5.17 29.91 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.453 -176.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 27.9 mttp -134.89 172.66 12.68 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -82.29 110.57 17.57 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 170.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.598 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 48.4 t -104.4 125.27 59.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.779 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.025 -173.172 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.603 HD21 HD22 ' A' ' 132' ' ' LEU . 22.4 tp -103.06 103.73 13.84 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 177.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.8 t -94.06 125.48 46.65 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.893 -174.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 68' ' ' VAL . 20.0 t0 -113.78 136.43 52.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.639 -179.009 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -110.98 115.59 29.74 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.695 0.283 . . . . 0.0 110.267 178.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 69' ' ' SER . 58.5 p-90 -148.06 178.24 8.7 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.975 0.417 . . . . 0.0 111.369 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -170.28 157.0 5.99 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.187 -0.915 . . . . 0.0 108.806 168.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -51.93 -37.12 51.51 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 112.67 0.619 . . . . 0.0 112.67 -174.677 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.05 -62.99 5.68 Favored Glycine 0 C--N 1.333 0.363 0 O-C-N 123.581 0.55 . . . . 0.0 112.697 -178.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.3 m -81.42 85.4 6.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.46 0.648 . . . . 0.0 109.813 175.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.614 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 28.4 p -70.91 -13.73 62.13 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.451 -176.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 82.0 m95 -66.97 -33.12 74.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.711 -0.222 . . . . 0.0 110.966 178.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 19.9 m -61.82 -38.84 89.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.54 0.686 . . . . 0.0 109.518 173.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.74 ' HD2' ' OD2' ' A' ' 84' ' ' ASP . 41.0 mtm180 -74.04 -12.68 60.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.322 -178.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.614 ' HD3' ' O ' ' A' ' 42' ' ' SER . 10.1 mptt -72.49 -14.06 61.57 Favored 'General case' 0 C--N 1.326 -0.447 0 O-C-N 122.067 -0.395 . . . . 0.0 111.032 178.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.418 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 40.7 mt-10 -101.3 -4.76 26.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.079 0.466 . . . . 0.0 110.636 175.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.559 ' HA ' HD12 ' A' ' 51' ' ' LEU . 56.4 m -60.0 -43.4 94.26 Favored Pre-proline 0 CA--C 1.543 0.684 0 CA-C-N 116.013 -0.54 . . . . 0.0 112.123 177.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.435 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.0 Cg_exo -52.2 -36.47 67.18 Favored 'Trans proline' 0 C--N 1.358 1.071 0 C-N-CA 122.066 1.844 . . . . 0.0 112.669 172.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.418 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 66.2 m-85 -74.05 -34.66 64.15 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.729 0.299 . . . . 0.0 110.246 178.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.559 HD12 ' HA ' ' A' ' 48' ' ' THR . 80.0 mt -60.15 -43.0 96.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.086 171.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.0 tp -60.71 -42.26 96.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.553 179.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -60.36 -47.54 85.62 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.109 0.48 . . . . 0.0 110.393 176.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 28.7 m -62.56 -43.96 97.51 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.012 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.699 ' HB2' HD12 ' A' ' 65' ' ' ILE . 51.2 t80 -65.73 -38.79 90.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.77 0.319 . . . . 0.0 110.604 -179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -65.67 -28.78 69.34 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.272 0.558 . . . . 0.0 110.688 -179.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -81.57 -42.97 19.34 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.83 -0.623 . . . . 0.0 112.309 179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -104.34 13.44 32.06 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -171.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.404 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 50.5 pttt -60.43 -20.7 60.74 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -175.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -116.53 13.04 15.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.791 0.329 . . . . 0.0 111.527 -174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 58.8 mttp -116.08 26.03 10.26 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -172.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 71.35 42.94 55.79 Favored Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.399 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 80.4 t80 -133.73 136.54 44.69 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 114.994 -0.603 . . . . 0.0 109.596 -175.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.443 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 36.7 m -140.85 130.73 24.44 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 120.818 0.342 . . . . 0.0 110.758 179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.699 HD12 ' HB2' ' A' ' 55' ' ' TYR . 58.0 mt -89.91 125.59 42.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 174.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 17.6 t80 -108.7 94.49 5.08 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 -177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.459 ' HA3' ' OE1' ' A' ' 90' ' ' GLN . . . -86.5 117.06 4.54 Favored Glycine 0 N--CA 1.444 -0.772 0 C-N-CA 120.493 -0.86 . . . . 0.0 111.913 -176.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG12 ' CG2' ' A' ' 91' ' ' VAL . 35.3 m -112.97 126.31 70.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 121.461 0.648 . . . . 0.0 110.681 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 46.2 t -122.48 139.37 53.95 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.667 -178.382 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 8.1 t -106.4 42.22 1.31 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 122.104 0.954 . . . . 0.0 108.627 175.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -63.1 177.61 0.58 Allowed 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.37 -1.286 . . . . 0.0 112.875 -170.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 30.2 mtp180 -69.56 -48.36 60.59 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.292 -176.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.436 ' HE ' ' CD ' ' A' ' 75' ' ' GLU . 22.6 tpt180 -143.25 150.48 39.35 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.841 -1.072 . . . . 0.0 108.792 -173.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 1.018 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 30.5 tt0 -63.28 -39.93 95.97 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.436 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -61.31 -41.36 96.86 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.74 176.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.407 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 10.4 t0 -65.21 -45.7 83.67 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 178.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.467 ' O ' HG13 ' A' ' 81' ' ' ILE . 22.7 t90 -58.39 -49.49 77.07 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.774 -1.103 . . . . 0.0 111.651 176.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 1.018 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 0.0 OUTLIER -55.61 -44.09 76.71 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-O 120.994 0.426 . . . . 0.0 110.781 175.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 12.6 ttpp -59.37 -44.83 92.67 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.182 177.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.81 -35.43 79.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.94 0.4 . . . . 0.0 110.805 -179.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 77' ' ' TRP . 93.4 mt -59.82 -40.35 82.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.447 175.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.15 -43.89 66.63 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 178.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -50.07 -58.14 6.14 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.138 178.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.74 ' OD2' ' HD2' ' A' ' 45' ' ' ARG . 8.2 m-20 -84.21 -2.51 57.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.115 -174.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.3 mmtm 58.17 37.09 26.26 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-O 121.381 0.61 . . . . 0.0 111.091 179.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.0 p -79.98 78.37 6.6 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.388 -0.824 . . . . 0.0 110.736 -178.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -83.9 77.75 9.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.305 -178.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.8 p90 -158.6 -179.88 8.49 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.527 173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -63.57 115.69 4.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.31 0.576 . . . . 0.0 111.04 -176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.459 ' OE1' ' HA3' ' A' ' 67' ' ' GLY . 1.4 tp-100 -123.13 141.08 52.35 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.307 -0.86 . . . . 0.0 109.786 -176.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.491 ' CG2' HG12 ' A' ' 68' ' ' VAL . 19.1 m -137.87 145.32 29.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.234 0.54 . . . . 0.0 111.144 175.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.0 tp -92.91 112.67 24.71 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.648 177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 91.8 mt -65.15 133.9 52.57 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.035 0.445 . . . . 0.0 110.768 -178.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.589 ' O ' HG23 ' A' ' 98' ' ' VAL . 33.1 mt-30 -68.75 145.1 54.11 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 175.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 40.3 mmtm -63.59 -29.32 70.59 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 111.724 0.268 . . . . 0.0 111.724 -171.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 36.6 t70 -79.28 -39.73 32.24 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.481 176.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -57.84 -46.17 85.15 Favored 'General case' 0 N--CA 1.467 0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.851 175.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 94' ' ' GLN . 77.2 t -50.14 -37.67 13.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 115.062 -0.972 . . . . 0.0 111.826 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.2 ttpm? -52.82 -64.02 0.95 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-O 121.151 0.5 . . . . 0.0 111.577 -177.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -72.5 -36.89 68.51 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.744 -175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 53.0 t -61.63 -52.01 66.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.272 179.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.578 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 14.2 mt -58.43 -52.6 64.92 Favored 'General case' 0 CA--C 1.514 -0.408 0 C-N-CA 120.789 -0.364 . . . . 0.0 110.848 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -52.99 -61.37 2.34 Favored 'General case' 0 C--O 1.235 0.34 0 O-C-N 123.3 0.375 . . . . 0.0 110.415 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.426 ' O ' ' HG ' ' A' ' 3' ' ' LEU . 28.3 m -57.55 -26.27 61.18 Favored 'General case' 0 N--CA 1.462 0.156 0 O-C-N 124.007 0.817 . . . . 0.0 112.682 -171.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.684 ' HA ' HD12 ' A' ' 3' ' ' LEU . 6.5 m-85 -86.84 20.52 2.56 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.257 -0.275 . . . . 0.0 110.257 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.556 ' HB3' ' H ' ' A' ' 2' ' ' SER . 31.3 p 50.6 43.75 27.49 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.872 1.269 . . . . 0.0 110.348 -175.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.578 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 12.2 mm -113.03 122.38 67.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -170.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 8.4 p -125.8 3.59 4.28 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 CA-C-N 114.585 -1.188 . . . . 0.0 108.98 171.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -160.56 177.16 37.09 Favored Glycine 0 N--CA 1.45 -0.398 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.955 -177.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.691 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 94.5 m-85 -135.25 166.7 26.98 Favored Pre-proline 0 C--N 1.328 -0.341 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 -177.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.691 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 74.4 Cg_endo -75.33 -174.68 14.67 Favored 'Cis proline' 0 C--N 1.353 0.783 0 C-N-CA 124.163 -1.182 . . . . 0.0 113.031 -0.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.409 ' ND1' HD11 ' A' ' 107' ' ' ILE . 72.4 t60 -166.89 106.52 0.61 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.363 -177.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 35.2 mt -118.87 137.16 53.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.399 -179.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.678 HG22 ' HB2' ' A' ' 125' ' ' LYS . 46.9 pt -131.62 154.51 40.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.122 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.699 HD22 HG22 ' A' ' 136' ' ' VAL . 64.3 tp -118.96 119.35 34.07 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.164 176.745 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.598 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 19.2 m -109.41 143.85 18.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.089 0.471 . . . . 0.0 111.347 178.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.57 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 3.3 p30 -78.22 163.78 60.28 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.334 176.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.57 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 11.9 Cg_endo -58.2 -14.23 18.86 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.134 2.556 . . . . 0.0 113.582 178.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.41 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 1.1 mt-10 -81.52 -29.63 33.48 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 177.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.33 19.69 6.16 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.697 177.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.444 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 9.0 mtmp? -111.23 146.32 37.16 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.973 0.416 . . . . 0.0 111.166 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 50.4 mt -82.39 104.32 10.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.324 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.3 m -79.54 -27.26 12.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-O 120.987 0.422 . . . . 0.0 110.983 -179.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.528 ' HB1' HD21 ' A' ' 127' ' ' LEU . . . -155.12 142.94 19.93 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.775 178.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.678 ' HB2' HG22 ' A' ' 114' ' ' ILE . 12.4 pttp -142.79 163.06 33.83 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 121.052 -0.259 . . . . 0.0 110.569 -178.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.525 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 7.3 mm-40 65.95 30.53 9.71 Favored 'General case' 0 N--CA 1.467 0.382 0 O-C-N 124.124 0.89 . . . . 0.0 110.067 -177.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.528 HD21 ' HB1' ' A' ' 124' ' ' ALA . 88.2 mt -67.41 156.82 35.6 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 115.509 -0.769 . . . . 0.0 111.047 -177.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 7.8 mmm180 -116.43 166.9 11.55 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.999 -175.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -30.98 -85.99 0.01 OUTLIER Glycine 0 N--CA 1.472 1.052 0 N-CA-C 116.017 1.167 . . . . 0.0 116.017 -176.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -76.87 -12.52 59.97 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 117.572 0.686 . . . . 0.0 111.571 -178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.608 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.1 t70 -63.43 -42.16 98.69 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.45 173.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 41.3 mt -47.6 -56.66 6.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.488 173.65 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -58.32 -58.92 6.36 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.558 -176.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.608 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.3 p30 -69.02 -37.66 78.77 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.54 -170.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 97.3 m -72.0 -42.12 66.81 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-O 120.676 0.274 . . . . 0.0 110.892 -179.785 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.699 HG22 HD22 ' A' ' 115' ' ' LEU . 46.9 t -65.62 -35.81 76.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 N-CA-C 110.413 -0.218 . . . . 0.0 110.413 176.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -57.02 -45.88 82.77 Favored 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 121.139 0.495 . . . . 0.0 109.823 176.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 142' ' ' GLY . 28.9 mtpp -65.96 -35.59 81.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.766 -178.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -80.28 -55.12 5.13 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.072 0.397 . . . . 0.0 112.072 -178.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 45.7 t -81.88 -50.37 16.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-O 120.784 0.326 . . . . 0.0 111.619 -171.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 23.7 t30 -81.43 -62.7 1.58 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.002 -174.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 138' ' ' LYS . . . 167.17 174.44 36.33 Favored Glycine 0 N--CA 1.445 -0.757 0 C-N-CA 120.265 -0.969 . . . . 0.0 112.655 179.685 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -146.69 169.26 19.4 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 -178.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 17.6 tptp -83.34 -24.36 32.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.192 0.52 . . . . 0.0 109.882 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -80.19 31.65 0.27 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.656 179.162 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -76.51 49.04 2.65 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 116.158 -0.474 . . . . 0.0 112.964 -177.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 68.0 t60 -97.1 10.54 39.06 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 174.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.1 p80 -155.55 150.7 26.76 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.524 -179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -72.6 175.66 6.16 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.59 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 37.2 m80 -68.51 -81.88 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.635 -0.257 . . . . 0.0 110.904 -177.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 28.1 p80 -134.96 12.41 3.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.517 0.675 . . . . 0.0 109.488 174.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 C--O 1.241 0.65 0 CA-C-N 114.969 -1.014 . . . . 0.0 108.55 177.924 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 N--CA 1.483 1.219 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.921 ' HB2' ' HD3' ' A' ' 125' ' ' LYS . 14.8 m 58.94 -169.66 0.13 Allowed 'General case' 0 C--O 1.234 0.265 0 O-C-N 123.549 0.53 . . . . 0.0 111.489 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.878 HD23 ' H ' ' A' ' 3' ' ' LEU . 1.2 pt? -75.61 163.77 27.0 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.373 176.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -76.82 156.1 32.53 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.72 -175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.3 p -74.46 141.15 44.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.784 178.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.6 -13.17 58.13 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 111.782 -177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 32.8 t -78.1 147.92 34.44 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.758 0.313 . . . . 0.0 110.288 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.2 t -71.18 137.33 23.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.934 178.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.64 122.96 57.67 Favored Pre-proline 0 C--N 1.323 -0.572 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.492 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -52.14 134.1 49.06 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 123.061 2.507 . . . . 0.0 111.708 172.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.35 120.22 19.62 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.096 -0.502 . . . . 0.0 112.065 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.891 HG12 HD23 ' A' ' 24' ' ' LEU . 8.4 mm -65.02 133.17 30.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.21 173.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 13.0 m -120.31 87.88 2.83 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.084 0.468 . . . . 0.0 110.287 178.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.584 ' HA3' ' CG2' ' A' ' 91' ' ' VAL . . . -124.01 179.27 16.2 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.689 -0.767 . . . . 0.0 113.212 -173.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 69.4 mt -109.24 130.28 62.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 177.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.92 -176.14 5.64 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.874 0.368 . . . . 0.0 110.724 -176.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.577 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 94.1 mt -58.75 -34.08 70.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.866 -178.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.597 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 32.7 mttp -78.96 -30.22 44.4 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.579 -175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.34 12.01 7.74 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.434 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.597 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 20.7 m-80 -87.14 137.4 32.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.639 0.256 . . . . 0.0 110.462 -179.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.9 p -81.57 93.35 6.69 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.195 -0.668 . . . . 0.0 109.195 172.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.4 m -104.44 154.96 6.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.398 -174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.659 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 20.1 m -117.71 166.4 12.48 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 108.919 -0.771 . . . . 0.0 108.919 171.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.891 HD23 HG12 ' A' ' 12' ' ' ILE . 3.9 pp -68.41 -18.23 64.4 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.279 -0.568 . . . . 0.0 110.533 176.392 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.805 ' HA ' ' HD3' ' A' ' 28' ' ' LYS . 6.2 t-20 -65.36 -35.52 81.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.37 -177.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -70.39 -18.03 63.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.413 -176.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 99.5 m-85 -107.8 4.27 25.37 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.114 0.483 . . . . 0.0 110.138 -174.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.805 ' HD3' ' HA ' ' A' ' 25' ' ' ASN . 41.1 mtpt -69.01 -174.11 0.57 Allowed 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.906 -1.043 . . . . 0.0 111.953 -178.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.446 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.28 10.36 86.27 Favored Glycine 0 N--CA 1.45 -0.374 0 N-CA-C 110.944 -0.862 . . . . 0.0 110.944 -172.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 30.7 mttp -144.84 173.72 11.61 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 -178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.443 ' HB3' HD11 ' A' ' 115' ' ' LEU . 94.5 m-85 -86.97 114.45 23.6 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 169.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.51 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 28.5 t -114.16 135.26 54.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.873 0.368 . . . . 0.0 111.356 -173.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.477 ' HG ' ' CZ ' ' A' ' 63' ' ' PHE . 54.2 mt -91.31 134.71 34.36 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 171.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.473 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 61.5 t -110.2 100.21 10.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 173.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -103.87 108.41 19.73 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.06 -172.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.649 ' CE2' ' HD2' ' A' ' 105' ' ' TYR . 72.3 m-85 -84.1 116.86 23.1 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.55 175.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.634 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 9.3 p-90 -143.04 173.53 11.48 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.301 0.572 . . . . 0.0 110.929 -177.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.439 ' CZ ' ' HB2' ' A' ' 41' ' ' CYS . 28.4 p90 -165.17 148.49 8.33 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.614 171.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -67.26 -15.86 63.95 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.906 -173.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -77.86 -3.06 83.58 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.659 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.439 ' HB2' ' CZ ' ' A' ' 38' ' ' PHE . 50.8 t -120.33 123.96 44.39 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.978 0.418 . . . . 0.0 110.744 179.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.6 t -64.19 -36.52 84.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.807 179.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.491 ' HD1' ' CD ' ' A' ' 111' ' ' PRO . 49.9 t-105 -70.95 -29.19 65.13 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.713 0.292 . . . . 0.0 110.713 -175.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.634 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 98.7 m -65.31 -27.7 68.8 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.121 0.486 . . . . 0.0 110.388 174.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 6.1 mmm180 -85.39 -14.22 46.96 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.594 176.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.616 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.9 mptp? -69.33 -38.35 78.14 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.989 0.423 . . . . 0.0 109.96 174.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.76 -28.94 68.05 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.156 -178.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.633 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 4.6 m -53.93 -52.93 63.56 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -173.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.633 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 53.2 Cg_exo -54.77 -43.72 56.53 Favored 'Trans proline' 0 C--N 1.359 1.082 0 C-N-CA 122.073 1.848 . . . . 0.0 112.827 177.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 29.7 m-85 -67.22 -38.86 85.98 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.308 0.575 . . . . 0.0 109.996 179.341 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.541 ' HG ' HD13 ' A' ' 65' ' ' ILE . 13.3 tp -65.75 -43.38 89.11 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-N 115.329 -0.851 . . . . 0.0 110.812 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.0 tp -62.2 -41.35 98.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.334 -0.393 . . . . 0.0 110.427 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 39.1 ttpt -61.11 -45.92 92.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.189 176.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 37.8 m -62.11 -44.63 96.23 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.838 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.724 ' HB2' HD12 ' A' ' 65' ' ' ILE . 72.8 t80 -56.34 -57.46 12.17 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.076 177.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -61.69 -34.17 75.3 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.739 -172.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.41 -31.47 29.6 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -174.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.531 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 32.5 m-85 -114.67 -2.2 13.12 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -171.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 20.2 pttp -55.0 -37.74 66.97 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 -177.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -88.19 13.55 11.15 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.902 0.382 . . . . 0.0 110.899 -174.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.403 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 65.0 mttm -117.99 20.0 13.44 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.629 -0.259 . . . . 0.0 111.104 -176.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.35 41.81 16.1 Favored Glycine 0 CA--C 1.512 -0.142 0 C-N-CA 120.501 -0.856 . . . . 0.0 111.363 -177.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.531 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 67.3 t80 -136.59 139.75 42.35 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -175.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.2 t -147.64 166.58 26.97 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.868 0.366 . . . . 0.0 110.313 178.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.724 HD12 ' HB2' ' A' ' 55' ' ' TYR . 60.1 mt -122.03 128.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.667 -175.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.485 ' CZ ' HG11 ' A' ' 91' ' ' VAL . 20.5 t80 -113.83 93.56 4.43 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -179.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.53 109.19 3.45 Favored Glycine 0 C--O 1.224 -0.493 0 CA-C-N 115.788 -0.642 . . . . 0.0 112.402 -172.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.401 ' HA ' HG13 ' A' ' 91' ' ' VAL . 20.8 t -97.62 119.48 45.71 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-O 121.127 0.489 . . . . 0.0 111.083 -173.045 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 55.6 p -110.18 164.36 12.72 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.828 -178.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.87 ' HB ' HD12 ' A' ' 93' ' ' LEU . 8.8 t -138.39 28.72 2.47 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.767 0.794 . . . . 0.0 109.149 174.876 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.708 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 22.6 m-20 -73.53 123.93 24.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.467 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.708 ' CZ ' ' HA ' ' A' ' 71' ' ' ASP . 0.0 OUTLIER -60.87 -34.96 75.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 114.536 -1.211 . . . . 0.0 111.512 -176.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.645 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 27.6 mtp180 -93.93 102.49 14.59 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.479 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -68.59 -34.22 75.41 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.612 -0.722 . . . . 0.0 111.497 -176.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.645 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 0.0 OUTLIER -69.38 -31.52 69.96 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.89 -0.324 . . . . 0.0 111.066 -177.198 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.502 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -76.39 -30.09 57.37 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.502 ' O ' HG12 ' A' ' 81' ' ' ILE . 30.0 t90 -61.77 -52.18 65.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.951 175.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.577 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 2.0 mptm? -56.55 -43.72 80.22 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-O 121.207 0.527 . . . . 0.0 110.211 173.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.532 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 19.3 tttm -57.51 -56.84 16.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.184 -0.916 . . . . 0.0 111.596 178.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.577 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -57.27 -36.86 71.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.818 -175.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.782 HD12 HE21 ' A' ' 90' ' ' GLN . 48.1 mm -66.09 -41.98 90.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 121.111 0.481 . . . . 0.0 110.775 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 40.2 tp10 -70.33 -31.53 68.88 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.969 179.566 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.577 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 51.2 mt-10 -64.3 -50.22 68.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.628 -178.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 85' ' ' LYS . 0.7 OUTLIER -92.83 -10.91 35.08 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.845 -0.342 . . . . 0.0 111.311 -176.593 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.551 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 58.3 mmtt 71.12 30.66 2.64 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.882 177.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.4 p -70.28 86.58 0.59 Allowed 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.302 0.572 . . . . 0.0 111.223 176.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.551 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 46.9 m-85 -96.69 99.94 11.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.178 0.513 . . . . 0.0 112.11 -176.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.495 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 6.2 p90 -151.7 -140.81 0.1 Allowed 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.269 -0.878 . . . . 0.0 108.82 170.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 55.7 m-80 -113.31 85.96 2.29 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 118.54 0.609 . . . . 0.0 110.541 178.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.782 HE21 HD12 ' A' ' 81' ' ' ILE . 0.4 OUTLIER -93.85 146.23 24.04 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.476 0.655 . . . . 0.0 110.876 176.988 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.584 ' CG2' ' HA3' ' A' ' 14' ' ' GLY . 1.5 p -137.15 139.62 43.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-N 114.534 -1.212 . . . . 0.0 110.404 -172.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 47.1 tp -99.29 125.98 45.04 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.446 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.87 HD12 ' HB ' ' A' ' 70' ' ' THR . 69.4 mt -58.64 138.25 57.06 Favored 'General case' 0 C--N 1.326 -0.443 0 O-C-N 123.356 0.41 . . . . 0.0 110.597 177.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.646 ' O ' HG23 ' A' ' 98' ' ' VAL . 47.3 mt-30 -85.1 163.08 19.01 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.623 -0.262 . . . . 0.0 110.711 178.252 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.505 ' HD3' ' H ' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -42.95 -49.64 5.93 Favored 'General case' 0 N--CA 1.468 0.45 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -177.251 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.413 ' N ' ' HG2' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -87.8 -41.07 13.53 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.207 0.527 . . . . 0.0 110.316 -179.809 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.433 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 24.7 t70 -53.12 -35.57 59.81 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.728 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.5 t -50.91 -45.24 28.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.595 177.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.419 ' C ' ' HD2' ' A' ' 99' ' ' LYS . 0.3 OUTLIER -66.16 -65.76 0.64 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.913 -171.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -60.92 -40.55 93.64 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.736 -0.665 . . . . 0.0 112.311 -174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.475 HG13 HD12 ' A' ' 12' ' ' ILE . 27.1 t -63.07 -59.63 4.06 Favored 'Isoleucine or valine' 0 C--O 1.241 0.634 0 N-CA-C 111.649 0.24 . . . . 0.0 111.649 -179.209 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.711 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 79.9 mt -59.51 -40.53 87.37 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-O 121.153 0.502 . . . . 0.0 110.384 -178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -58.57 -62.75 1.63 Allowed 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.253 178.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.45 ' C ' ' H ' ' A' ' 106' ' ' CYS . 49.2 p -56.19 -43.89 78.91 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 124.497 1.123 . . . . 0.0 113.511 -167.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.649 ' HD2' ' CE2' ' A' ' 36' ' ' PHE . 16.8 m-30 -73.38 11.43 0.77 Allowed 'General case' 0 C--O 1.238 0.459 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.804 179.048 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.552 ' CB ' ' HA ' ' A' ' 2' ' ' SER . 56.3 m 63.36 56.8 1.61 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.098 177.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.711 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 1.7 mp -81.09 110.82 16.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 119.695 -0.802 . . . . 0.0 110.903 179.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 41.3 t -105.82 -25.69 3.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.038 -0.983 . . . . 0.0 109.343 173.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.82 170.39 35.98 Favored Glycine 0 N--CA 1.447 -0.594 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.619 -179.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -121.72 150.23 54.92 Favored Pre-proline 0 C--N 1.325 -0.483 0 N-CA-C 110.396 -0.224 . . . . 0.0 110.396 -179.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.491 ' CD ' ' HD1' ' A' ' 43' ' ' TRP . 4.4 Cg_exo -78.72 171.32 66.35 Favored 'Cis proline' 0 N--CA 1.463 -0.269 0 C-N-CA 123.718 -1.367 . . . . 0.0 112.511 -0.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 50.4 t60 -145.49 104.3 3.9 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 179.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.504 HD13 HD11 ' A' ' 132' ' ' LEU . 47.0 mt -114.28 139.18 41.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 120.909 0.385 . . . . 0.0 111.344 -172.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.473 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 39.2 pt -133.48 155.53 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.449 177.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.898 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 45.8 tp -114.41 117.2 30.36 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.156 -0.474 . . . . 0.0 109.835 178.319 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.51 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 10.8 m -103.37 144.22 14.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.139 0.495 . . . . 0.0 111.649 -179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.537 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 3.8 p30 -80.26 168.79 23.16 Favored Pre-proline 0 C--N 1.324 -0.535 0 CA-C-N 115.368 -0.833 . . . . 0.0 110.177 176.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.517 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 51.5 Cg_exo -55.41 -23.93 40.92 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.978 2.452 . . . . 0.0 113.596 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -78.48 -32.55 48.31 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.02 0.438 . . . . 0.0 110.442 -178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 114.12 22.92 5.08 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.076 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.537 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.8 mtmp? -107.15 147.84 29.59 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.417 HD12 HD11 ' A' ' 3' ' ' LEU . 49.8 mt -81.93 99.57 5.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 120.736 0.303 . . . . 0.0 110.248 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -81.25 -34.68 13.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.158 0.504 . . . . 0.0 110.32 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.898 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -126.52 128.81 47.47 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 1.011 ' HD2' ' HG2' ' A' ' 126' ' ' GLU . 0.4 OUTLIER -129.52 137.63 50.89 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.802 -0.181 . . . . 0.0 110.897 -169.406 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 1.011 ' HG2' ' HD2' ' A' ' 125' ' ' LYS . 20.4 pt-20 45.79 75.48 0.11 Allowed 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.652 1.181 . . . . 0.0 112.236 -174.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.5 HD11 ' HB1' ' A' ' 124' ' ' ALA . 84.3 mt -100.97 170.29 8.39 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.361 177.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.569 ' HB2' ' OD1' ' A' ' 131' ' ' ASP . 9.1 mmm180 -111.07 177.37 4.68 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.276 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -47.45 -76.82 0.13 Allowed Glycine 0 C--N 1.335 0.494 0 O-C-N 123.741 0.651 . . . . 0.0 114.562 -172.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.56 -15.94 59.73 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.338 -0.507 . . . . 0.0 110.863 -178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.62 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 2.9 m-20 -62.25 -41.07 98.12 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.483 174.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.554 ' HG ' ' O ' ' A' ' 128' ' ' ARG . 84.6 mt -51.03 -54.73 22.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.881 170.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 65.7 t80 -57.39 -58.96 5.96 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 114.455 -1.248 . . . . 0.0 111.869 -175.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.62 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 7.0 p30 -68.8 -28.62 66.93 Favored 'General case' 0 C--N 1.331 -0.218 0 C-N-CA 120.945 -0.302 . . . . 0.0 111.638 -171.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 92.7 m -66.58 -51.72 53.3 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.785 0.326 . . . . 0.0 110.285 177.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.6 t -64.2 -38.48 82.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.923 0.392 . . . . 0.0 110.396 179.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.5 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 12.3 tm-20 -64.28 -41.78 96.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.252 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -76.34 -17.05 59.6 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.564 -0.289 . . . . 0.0 111.287 -178.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -89.42 -62.6 1.44 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.205 0.446 . . . . 0.0 112.205 175.075 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 34.4 t -86.86 -26.76 5.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.997 -168.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 40.6 t30 -98.64 26.94 5.17 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.161 0.505 . . . . 0.0 110.47 -174.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 108.15 150.32 15.16 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.02 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -70.65 -29.81 66.25 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -175.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 73.88 30.85 1.27 Allowed 'General case' 0 N--CA 1.47 0.565 0 O-C-N 123.997 0.811 . . . . 0.0 111.42 179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -39.08 13.94 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.386 175.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 70.94 43.02 58.92 Favored Glycine 0 N--CA 1.444 -0.776 0 CA-C-N 115.833 -0.622 . . . . 0.0 113.013 177.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -60.77 114.57 3.1 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-N 117.105 0.452 . . . . 0.0 110.807 177.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 29.7 m80 66.56 28.96 9.2 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.202 -178.275 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 57.5 t-80 -71.93 79.77 0.9 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.092 0.472 . . . . 0.0 109.93 176.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 56.4 p-80 -105.21 25.87 10.06 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.94 -173.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 72.09 -72.26 0.12 Allowed 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.19 179.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 26.0 p-80 . . . . . 0 C--O 1.245 0.856 0 CA-C-O 118.772 -0.632 . . . . 0.0 110.128 -177.217 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.479 0.982 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.673 ' HA ' ' SG ' ' A' ' 106' ' ' CYS . 85.1 p 49.73 53.11 13.32 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.819 0.699 . . . . 0.0 109.459 -169.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 81.7 mt 58.75 -136.19 0.88 Allowed 'General case' 0 C--O 1.236 0.349 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.492 -170.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.417 ' HB3' ' HB2' ' A' ' 7' ' ' SER . . . -160.16 151.69 19.76 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.587 0.232 . . . . 0.0 110.525 178.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.4 p -72.26 112.6 8.48 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.133 176.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.66 -4.03 39.6 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.49 -0.644 . . . . 0.0 111.49 -175.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.417 ' HB2' ' HB3' ' A' ' 4' ' ' ALA . 47.9 t -86.02 143.53 28.07 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 110.099 -0.334 . . . . 0.0 110.099 178.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.557 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 50.8 t -69.18 136.54 26.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.448 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -93.09 145.84 30.84 Favored Pre-proline 0 C--N 1.324 -0.539 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.653 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -59.46 152.89 58.19 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.846 2.364 . . . . 0.0 112.257 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.78 97.15 7.2 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.146 -177.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.965 HD12 HG22 ' A' ' 101' ' ' VAL . 30.1 mm -86.35 147.6 5.27 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.065 178.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.476 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 11.6 t -142.07 123.52 14.9 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.533 0.682 . . . . 0.0 110.682 177.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -124.5 161.46 18.94 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.069 -176.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.463 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 61.6 mt -96.57 123.37 48.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 120.75 0.309 . . . . 0.0 110.619 -178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 21.8 p30 -79.63 -177.23 5.75 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.892 0.377 . . . . 0.0 111.069 -179.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.425 ' H ' HD12 ' A' ' 17' ' ' LEU . 5.9 mp -68.6 -18.48 64.32 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.618 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.11 -25.39 32.02 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.355 0.597 . . . . 0.0 110.376 178.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 106.12 23.7 7.24 Favored Glycine 0 C--N 1.316 -0.57 0 CA-C-N 114.922 -1.036 . . . . 0.0 111.604 179.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.685 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.5 OUTLIER -101.59 138.8 38.11 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 -177.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.8 p -83.99 94.82 8.37 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.787 0.327 . . . . 0.0 110.167 176.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 22.5 t -98.67 130.99 46.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.077 -177.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.476 ' HA ' ' HA ' ' A' ' 13' ' ' THR . 6.0 m -103.12 167.21 9.97 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.168 0.508 . . . . 0.0 111.088 -174.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.0 tp -61.63 -28.62 69.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.943 177.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.498 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 7.5 t30 -70.79 -20.94 62.54 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.131 -176.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -81.4 -4.63 56.35 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.974 0.416 . . . . 0.0 111.025 -177.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.537 ' HE2' HD22 ' A' ' 89' ' ' ASN . 84.3 m-85 -110.21 5.27 21.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.406 0.622 . . . . 0.0 109.544 179.301 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.498 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 90.2 mttt -70.14 132.91 46.53 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.168 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 127.86 -27.68 4.56 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -172.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.545 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 42.4 mttm -114.84 166.86 11.32 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 114.386 -0.907 . . . . 0.0 108.935 172.36 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.541 ' HB3' HD11 ' A' ' 115' ' ' LEU . 66.9 m-85 -78.14 116.79 18.86 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 168.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 16.9 t -92.63 110.83 23.52 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.117 -172.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.531 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 2.1 tm? -82.86 101.75 11.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 175.461 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.588 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 39.5 t -89.98 118.98 36.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 121.137 0.494 . . . . 0.0 110.257 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.453 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 6.2 t70 -106.24 112.91 26.13 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.618 -175.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.465 ' HD2' ' O ' ' A' ' 112' ' ' HIS . 89.6 m-85 -95.44 115.76 27.87 Favored 'General case' 0 C--O 1.236 0.364 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.477 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.3 p-90 -155.39 177.08 11.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.621 0.724 . . . . 0.0 112.209 -176.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -170.63 167.28 7.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.161 -1.381 . . . . 0.0 107.761 171.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.1 72.23 0.6 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.616 0.722 . . . . 0.0 110.871 177.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -168.37 -44.54 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.675 0 CA-C-N 114.945 -1.025 . . . . 0.0 110.568 179.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 6.9 p -84.6 85.17 7.46 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.488 0.661 . . . . 0.0 109.236 172.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 25.6 m -60.65 -22.06 63.45 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.263 -0.88 . . . . 0.0 112.719 -173.266 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.41 ' HA ' ' CE3' ' A' ' 43' ' ' TRP . 9.4 m95 -70.26 -39.55 74.92 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.544 -0.462 . . . . 0.0 111.472 -176.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 59.9 m -56.4 -43.51 79.36 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-O 121.742 0.782 . . . . 0.0 109.079 173.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 42' ' ' SER . 8.1 mmm180 -59.22 -38.36 79.77 Favored 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.088 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.621 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 1.3 mptp? -86.44 -8.26 57.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -173.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -89.46 -3.74 58.26 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.923 170.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.573 HG23 ' CH2' ' A' ' 88' ' ' TRP . 54.4 m -51.03 -50.74 73.33 Favored Pre-proline 0 CA--C 1.537 0.466 0 CA-C-N 115.78 -0.646 . . . . 0.0 112.536 175.757 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.8 Cg_endo -52.07 -40.55 68.0 Favored 'Trans proline' 0 C--N 1.356 0.964 0 C-N-CA 122.122 1.881 . . . . 0.0 112.461 177.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -72.29 -41.26 66.85 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.96 0.409 . . . . 0.0 110.317 178.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.423 HD23 HD13 ' A' ' 132' ' ' LEU . 83.1 mt -61.34 -42.43 98.68 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.814 175.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 52.8 tp -65.09 -42.56 93.95 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.561 179.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -53.66 -51.49 63.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.418 0.627 . . . . 0.0 109.665 173.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 133' ' ' TYR . 21.5 m -63.68 -49.47 73.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.268 -179.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.629 ' HB2' HD12 ' A' ' 65' ' ' ILE . 23.7 t80 -56.62 -50.28 72.48 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.807 -178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.578 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 38.0 t30 -75.38 -29.5 59.87 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 120.739 -0.384 . . . . 0.0 111.401 -171.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -86.92 -19.67 28.48 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.413 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 40.2 m-85 -121.08 12.81 11.18 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.386 0.513 . . . . 0.0 112.386 -176.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.6 ptmt -70.06 -21.06 63.19 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.08 0.467 . . . . 0.0 110.589 -179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 15.2 p-10 -75.93 -34.06 59.86 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.439 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.413 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 42.6 mttp -87.19 -167.74 2.0 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.559 -175.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.62 57.63 4.18 Favored Glycine 0 C--O 1.224 -0.479 0 C-N-CA 120.689 -0.767 . . . . 0.0 112.036 178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.531 ' CE1' ' HB2' ' A' ' 33' ' ' LEU . 88.9 t80 -141.05 147.29 38.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.801 0.334 . . . . 0.0 110.893 -179.024 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.545 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 9.9 t -158.97 153.14 23.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.604 -0.725 . . . . 0.0 109.274 174.159 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.629 HD12 ' HB2' ' A' ' 55' ' ' TYR . 45.4 mt -106.35 134.79 46.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.877 0.37 . . . . 0.0 110.431 177.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 27.5 t80 -122.1 94.77 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -85.85 126.6 7.87 Favored Glycine 0 N--CA 1.445 -0.7 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.808 -176.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.499 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.0 m -116.21 119.6 62.4 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 121.162 0.506 . . . . 0.0 110.46 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.477 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 40.3 t -122.01 139.0 54.22 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.134 0.492 . . . . 0.0 111.234 -176.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 4.3 t -116.2 59.85 0.73 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 122.095 0.95 . . . . 0.0 108.583 172.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -69.69 -178.57 1.52 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.238 -170.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 mtt180 -67.42 -50.28 60.11 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.042 -0.981 . . . . 0.0 109.28 -178.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.627 ' HB2' ' HB2' ' A' ' 76' ' ' ASP . 47.4 mtt180 -134.11 163.95 28.43 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.504 -1.225 . . . . 0.0 108.415 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.612 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 33.3 tt0 -66.36 -44.67 82.54 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -66.54 -32.26 73.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.037 -0.528 . . . . 0.0 111.269 178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.627 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 0.2 OUTLIER -66.49 -38.57 87.57 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.476 -0.564 . . . . 0.0 109.476 174.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.2 t90 -64.01 -51.06 66.0 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.722 174.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.612 ' HD3' ' O ' ' A' ' 74' ' ' GLU . 1.4 mptm? -49.86 -48.64 51.07 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.84 0.828 . . . . 0.0 109.781 173.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 0.0 OUTLIER -65.42 -38.25 89.37 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.561 -1.2 . . . . 0.0 111.013 -177.715 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.466 ' HA ' ' OE2' ' A' ' 83' ' ' GLU . . . -66.06 -35.98 81.99 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.717 0.294 . . . . 0.0 111.282 -177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 73.5 mt -64.18 -44.13 97.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 175.848 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 34.3 tp10 -67.77 -29.21 68.35 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.889 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.552 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 44.9 mt-10 -59.5 -60.11 4.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.933 0.397 . . . . 0.0 111.57 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.97 4.92 42.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.106 -0.497 . . . . 0.0 112.225 -170.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 4.4 mptp? 62.1 36.52 15.18 Favored 'General case' 0 N--CA 1.468 0.439 0 N-CA-C 112.281 0.475 . . . . 0.0 112.281 175.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 42.6 p -77.33 72.57 3.88 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.932 175.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -86.89 81.07 8.26 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 112.247 0.462 . . . . 0.0 112.247 -174.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.573 ' CH2' HG23 ' A' ' 48' ' ' THR . 9.6 p90 -148.84 -176.63 5.41 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.782 169.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.537 HD22 ' HE2' ' A' ' 27' ' ' PHE . 92.7 m-20 -69.48 98.91 1.17 Allowed 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.166 0.508 . . . . 0.0 110.735 -177.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 32.4 mt-30 -120.15 146.52 45.9 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.681 -0.691 . . . . 0.0 109.634 178.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.5 m -129.65 150.12 34.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.799 -178.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 28.4 tp -89.63 117.33 28.44 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 174.106 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.499 HD11 ' HB ' ' A' ' 68' ' ' VAL . 93.6 mt -70.2 135.99 49.59 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.171 -178.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.673 ' O ' HG23 ' A' ' 98' ' ' VAL . 31.6 mt-30 -58.61 141.56 51.94 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 175.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 30.9 mmmt -65.52 -23.6 66.92 Favored 'General case' 0 C--N 1.316 -0.877 0 C-N-CA 120.752 -0.379 . . . . 0.0 111.726 -168.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.546 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 29.8 t70 -87.35 -36.57 17.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.786 0.327 . . . . 0.0 110.448 173.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.501 ' O ' HG23 ' A' ' 101' ' ' VAL . 5.9 t70 -56.04 -40.93 74.23 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.144 175.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 94' ' ' GLN . 85.3 t -49.83 -35.36 10.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.7 177.05 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.546 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 5.6 ttpm? -53.09 -62.55 1.58 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.643 178.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -62.75 -41.12 99.05 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.78 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.965 HG22 HD12 ' A' ' 12' ' ' ILE . 73.4 t -57.72 -61.72 1.21 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.606 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.408 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.911 ' HA ' HD12 ' A' ' 107' ' ' ILE . 40.1 mt -60.16 -39.25 85.73 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.042 -175.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -67.93 -64.08 0.93 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 120.244 -0.582 . . . . 0.0 110.197 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.7 m -54.6 -41.42 69.92 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 124.3 1.0 . . . . 0.0 113.524 -167.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -76.9 15.18 0.7 Allowed 'General case' 0 C--O 1.237 0.446 0 C-N-CA 120.366 -0.534 . . . . 0.0 110.699 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.673 ' SG ' ' HA ' ' A' ' 2' ' ' SER . 63.0 m 55.37 47.8 20.49 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 115.144 -0.935 . . . . 0.0 109.299 -178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.911 HD12 ' HA ' ' A' ' 102' ' ' LEU . 53.9 mt -88.16 107.11 17.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.466 -173.007 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.5 p -121.02 -8.04 10.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.285 177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -159.33 170.82 35.7 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.457 -0.878 . . . . 0.0 112.524 -177.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.641 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 98.6 m-85 -135.31 164.15 45.84 Favored Pre-proline 0 C--N 1.326 -0.439 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 -179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.641 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.6 Cg_exo -77.26 133.54 31.29 Favored 'Cis proline' 0 C--N 1.349 0.553 0 C-N-CA 124.176 -1.177 . . . . 0.0 112.579 -0.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.606 ' CD2' HG12 ' A' ' 107' ' ' ILE . 14.5 t60 -107.48 111.76 24.21 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 85.1 mt -125.62 131.55 71.92 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.686 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.239 -177.166 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.588 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 45.3 pt -128.17 149.2 32.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 120.738 0.304 . . . . 0.0 110.798 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.541 HD11 ' HB3' ' A' ' 31' ' ' TYR . 47.0 tp -112.91 111.21 21.8 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 177.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.466 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 73.4 t -97.17 133.0 40.45 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.798 -178.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.614 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 4.1 p30 -78.0 164.78 55.09 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.267 177.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -53.05 -24.34 24.84 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.2 2.6 . . . . 0.0 114.094 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.504 ' HB2' ' HE2' ' A' ' 121' ' ' LYS . 41.3 mt-10 -77.0 -37.12 55.71 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.09 0.471 . . . . 0.0 110.055 178.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.05 23.8 2.62 Favored Glycine 0 N--CA 1.448 -0.561 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.76 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.614 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 34.2 mtmt -107.2 155.5 19.85 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 110.189 -0.3 . . . . 0.0 110.189 178.42 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.79 97.71 7.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 177.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.7 p -74.95 -34.51 32.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.155 0.503 . . . . 0.0 110.768 -176.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -151.79 158.02 42.73 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 178.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.51 ' HE2' ' O ' ' A' ' 2' ' ' SER . 20.6 pttp -163.26 175.28 11.07 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.811 -0.356 . . . . 0.0 111.319 -178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.505 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 15.6 mm-40 64.69 20.76 12.23 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.413 -177.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.435 ' HB2' HD23 ' A' ' 132' ' ' LEU . 47.7 mt -59.62 137.68 57.96 Favored 'General case' 0 CA--C 1.52 -0.179 0 CA-C-N 115.397 -0.82 . . . . 0.0 109.614 178.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.41 ' NH2' ' HB2' ' A' ' 111' ' ' PRO . 0.4 OUTLIER -123.38 149.47 44.93 Favored 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 121.057 -0.257 . . . . 0.0 111.275 -170.498 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 43.45 -125.1 4.95 Favored Glycine 0 C--N 1.334 0.424 0 O-C-N 123.768 0.667 . . . . 0.0 114.437 168.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -77.06 -17.0 59.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.622 0.248 . . . . 0.0 110.916 -176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.502 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 31.0 t70 -63.31 -25.72 68.44 Favored 'General case' 0 C--O 1.219 -0.55 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.5 ' O ' HG23 ' A' ' 136' ' ' VAL . 75.8 mt -48.23 -58.52 4.42 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.259 0.552 . . . . 0.0 109.956 169.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.4 ' HA ' HG23 ' A' ' 54' ' ' THR . 40.9 t80 -60.34 -50.91 71.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.481 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.502 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 92.3 m-20 -61.92 -35.19 77.68 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.338 -0.846 . . . . 0.0 111.859 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.618 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 7.5 m -74.66 -30.71 61.7 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.692 0.256 . . . . 0.0 111.692 -179.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.526 ' O ' ' HB ' ' A' ' 140' ' ' VAL . 86.9 t -65.44 -46.31 90.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 119.96 -0.696 . . . . 0.0 110.239 175.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.533 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 2.3 tp10 -68.87 -23.34 64.21 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.442 0.639 . . . . 0.0 109.948 176.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.618 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 23.9 ttpt -77.0 -59.15 2.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.409 -0.814 . . . . 0.0 111.08 -178.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.429 ' CD1' HG23 ' A' ' 135' ' ' THR . 47.2 m-85 -88.2 -51.4 5.79 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.526 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 61.0 t -66.96 -47.25 82.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.875 0.369 . . . . 0.0 111.277 -173.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.533 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 54.1 t30 -76.66 -18.09 58.77 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.5 0.666 . . . . 0.0 110.037 178.386 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 91.45 -25.66 14.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 121.049 -0.596 . . . . 0.0 112.98 175.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 61.28 17.16 7.97 Favored 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 122.862 0.465 . . . . 0.0 111.607 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 51.2 tptt 63.82 77.81 0.31 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-O 121.605 0.717 . . . . 0.0 111.503 -179.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.404 ' CD ' ' H ' ' A' ' 146' ' ' GLY . 0.3 OUTLIER -103.01 155.09 18.61 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 170.82 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.404 ' H ' ' CD ' ' A' ' 145' ' ' GLU . . . 148.15 -45.81 0.72 Allowed Glycine 0 N--CA 1.44 -1.068 0 N-CA-C 110.468 -1.053 . . . . 0.0 110.468 -177.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 34.2 m80 60.03 -165.56 0.2 Allowed 'General case' 0 C--O 1.232 0.154 0 CA-C-O 121.441 0.638 . . . . 0.0 110.828 179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -130.9 29.25 4.75 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 168.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 18.6 t-80 -133.55 123.45 25.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 113.791 -1.55 . . . . 0.0 108.73 -178.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -70.35 100.54 1.76 Allowed 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 112.506 0.558 . . . . 0.0 112.506 -173.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 26.4 p80 -93.39 -2.66 54.43 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 166.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 35.4 t-80 . . . . . 0 C--O 1.245 0.842 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.559 172.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 N--CA 1.482 1.128 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 m 57.93 -163.81 0.19 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.719 0.637 . . . . 0.0 110.404 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.44 ' HB3' HD12 ' A' ' 122' ' ' ILE . 2.8 mm? -73.02 104.4 4.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.053 0.454 . . . . 0.0 110.119 177.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -96.02 -91.12 0.23 Allowed 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.619 -177.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.0 p -147.84 128.04 13.8 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 177.347 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.32 -2.22 86.49 Favored Glycine 0 N--CA 1.449 -0.475 0 N-CA-C 111.231 -0.747 . . . . 0.0 111.231 -176.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.6 m -70.27 123.99 23.05 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 178.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.9 p -73.16 137.72 22.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.956 0.407 . . . . 0.0 110.627 -176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.4 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -96.51 146.54 31.49 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.183 -178.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 27.7 Cg_exo -63.08 163.34 22.99 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 123.353 2.702 . . . . 0.0 112.535 177.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -86.03 115.66 23.76 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 23' ' ' SER . 65.8 mt -83.72 137.98 20.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.137 176.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 19.0 m -126.31 89.24 2.97 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.331 0.586 . . . . 0.0 110.022 176.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -105.14 161.23 14.88 Favored Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.911 -173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.437 ' CG2' ' HA2' ' A' ' 19' ' ' GLY . 52.8 mt -91.71 129.42 42.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 178.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -77.89 -171.68 2.37 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.062 -175.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 90.5 mt -65.11 -27.05 68.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.551 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.421 ' HB3' ' HE2' ' A' ' 18' ' ' LYS . 52.0 mtpt -83.23 -49.66 9.2 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 121.052 0.453 . . . . 0.0 110.198 179.48 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.437 ' HA2' ' CG2' ' A' ' 15' ' ' ILE . . . 137.32 23.29 0.47 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.76 -179.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 15' ' ' ILE . 23.4 m-80 -102.19 149.58 24.16 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.234 -0.284 . . . . 0.0 110.234 -179.238 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.1 p -80.34 99.97 8.18 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.479 0.657 . . . . 0.0 110.679 177.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.3 141.93 17.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.277 179.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.674 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 6.2 m -116.21 166.1 12.41 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.147 0.499 . . . . 0.0 111.259 -174.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 43.8 tp -61.84 -22.67 65.7 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.122 -179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.674 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 2.6 p-10 -66.25 -28.57 68.82 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.811 0.339 . . . . 0.0 110.67 -179.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -72.61 -17.35 61.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.785 -177.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -113.29 3.88 16.15 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.686 -175.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 33.5 mttt -63.11 168.38 4.21 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.681 -179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.48 ' HA2' ' HB3' ' A' ' 118' ' ' PRO . . . 78.33 23.04 66.41 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.302 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -145.09 161.4 39.55 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -78.07 107.58 10.74 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 169.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 52.1 t -109.74 116.93 53.45 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.834 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.581 -171.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.507 HD23 ' HA ' ' A' ' 115' ' ' LEU . 43.8 mt -85.0 109.15 17.98 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 169.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.518 ' O ' ' HA ' ' A' ' 113' ' ' ILE . 61.7 t -89.07 111.15 22.38 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-O 121.004 0.431 . . . . 0.0 109.861 -179.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -105.86 117.13 33.23 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.559 -175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.3 m-85 -98.73 116.1 30.22 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.716 -0.475 . . . . 0.0 109.716 174.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.407 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.5 p-90 -144.63 176.55 9.33 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.444 0.64 . . . . 0.0 111.77 -174.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 13.1 p90 -170.73 168.3 7.44 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 114.412 -1.267 . . . . 0.0 108.225 171.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -60.4 -28.47 68.27 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.334 0.494 . . . . 0.0 112.334 -173.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -63.72 -67.66 1.97 Allowed Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.217 -0.516 . . . . 0.0 112.72 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 93.9 m -75.65 88.29 2.74 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.418 0.627 . . . . 0.0 109.859 177.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.449 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 58.8 p -75.31 11.83 1.11 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.121 -174.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.562 ' HB2' ' HD3' ' A' ' 111' ' ' PRO . 40.1 m95 -63.02 -45.34 92.76 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.475 0.179 . . . . 0.0 110.801 -179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.599 ' HB2' ' HB3' ' A' ' 111' ' ' PRO . 29.9 t -62.34 -31.11 71.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.525 0.679 . . . . 0.0 109.779 174.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.587 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 59.9 mtp180 -76.84 -14.08 59.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.291 -0.868 . . . . 0.0 110.306 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HD3' ' O ' ' A' ' 42' ' ' SER . 14.6 mptt -85.28 -38.36 18.95 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.966 171.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -87.04 3.64 45.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.807 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.587 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 93.4 m -53.09 -50.38 82.44 Favored Pre-proline 0 CA--C 1.539 0.53 0 N-CA-C 112.623 0.601 . . . . 0.0 112.623 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.567 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -48.24 -42.54 33.36 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.331 2.021 . . . . 0.0 113.0 176.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 87.7 m-85 -68.89 -47.39 65.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.484 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 94.2 mt -58.31 -46.65 85.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.799 178.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.413 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 65.4 tp -62.25 -43.11 99.58 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.818 -178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 43.7 tttp -62.05 -47.49 84.45 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.038 177.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 14.1 m -63.34 -48.24 78.8 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.003 -179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.47 ' HB2' HD12 ' A' ' 65' ' ' ILE . 89.7 t80 -58.78 -49.96 75.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.83 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.537 ' HA ' ' HD3' ' A' ' 59' ' ' LYS . 39.6 t-20 -60.13 -42.52 94.98 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.099 0.476 . . . . 0.0 110.546 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -67.76 -34.26 76.47 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 112.866 0.691 . . . . 0.0 112.866 -175.583 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.735 ' HZ ' ' HG3' ' A' ' 137' ' ' GLU . 77.2 m-85 -120.69 7.34 10.51 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 113.385 0.883 . . . . 0.0 113.385 -169.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HD3' ' HA ' ' A' ' 56' ' ' ASN . 16.7 pttm -57.88 -33.8 69.1 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.359 0.6 . . . . 0.0 111.37 -177.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.97 7.88 45.69 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.23 -175.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.9 mttp -120.15 26.46 9.23 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -175.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 81.57 26.7 50.0 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.627 176.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.469 ' CD2' ' HB2' ' A' ' 58' ' ' PHE . 66.3 t80 -134.75 142.88 46.86 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -179.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -152.56 165.44 35.15 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.034 0.445 . . . . 0.0 110.55 176.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.47 HD12 ' HB2' ' A' ' 55' ' ' TYR . 56.3 mt -120.18 124.99 73.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 115.995 -0.548 . . . . 0.0 109.597 177.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.417 ' HA ' ' HB2' ' A' ' 89' ' ' ASN . 10.9 t80 -101.21 94.51 6.0 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.34 -175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.29 102.71 2.81 Favored Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 121.128 -0.558 . . . . 0.0 112.137 -175.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 38.3 t -98.88 113.62 34.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.873 0 CA-C-O 121.013 0.435 . . . . 0.0 110.737 -174.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 10.5 t -102.56 150.7 23.14 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.353 177.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.55 ' HB ' HD12 ' A' ' 93' ' ' LEU . 7.9 t -131.52 28.58 4.62 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.159 176.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -57.37 167.94 0.87 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-N 115.158 -0.928 . . . . 0.0 112.292 -178.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.495 ' HB2' ' OD2' ' A' ' 76' ' ' ASP . 16.6 mtm180 -53.75 -71.67 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 114.939 -1.028 . . . . 0.0 111.163 -176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 44.0 mtm180 -109.67 172.28 6.95 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.263 -177.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.492 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 36.2 tt0 -74.3 -33.11 63.11 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 175.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -61.73 -41.2 97.32 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.012 176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.495 ' OD2' ' HB2' ' A' ' 72' ' ' ARG . 59.7 m-20 -60.85 -49.37 77.74 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.997 177.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.445 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 24.0 t90 -57.75 -47.87 81.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.108 178.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.492 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.7 mptm? -62.17 -41.6 98.46 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.53 -0.304 . . . . 0.0 111.419 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 9.6 tmtm? -70.41 -37.99 74.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.829 0.347 . . . . 0.0 110.55 -177.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -57.56 -49.64 75.71 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.424 176.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 78.3 mt -60.18 -33.98 55.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.533 0.683 . . . . 0.0 110.408 178.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.92 -28.84 70.33 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.463 -0.79 . . . . 0.0 111.014 178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 38.9 mt-10 -84.03 -59.98 2.24 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.619 0.247 . . . . 0.0 110.878 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -75.85 -22.25 56.41 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 115.846 -0.616 . . . . 0.0 112.488 -172.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 43.5 mmtm 70.88 32.39 2.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.183 0.516 . . . . 0.0 110.413 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 18.5 p -67.44 100.88 0.89 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.665 174.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -118.13 74.58 0.96 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.189 0.519 . . . . 0.0 111.893 -177.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.546 ' HH2' HG23 ' A' ' 48' ' ' THR . 3.3 p90 -133.94 -154.07 0.57 Allowed 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 169.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.417 ' HB2' ' HA ' ' A' ' 66' ' ' TYR . 11.6 m120 -72.45 80.96 1.05 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 118.355 0.525 . . . . 0.0 110.353 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 8.2 mm100 -82.69 125.24 31.0 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.024 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 22.2 m -134.02 143.24 38.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.347 175.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.404 ' HB2' ' CE3' ' A' ' 77' ' ' TRP . 34.3 tp -102.57 123.97 47.26 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 176.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.55 HD12 ' HB ' ' A' ' 70' ' ' THR . 93.0 mt -63.33 134.09 55.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.842 0.353 . . . . 0.0 110.679 178.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.613 ' O ' HG23 ' A' ' 98' ' ' VAL . 36.2 mt-30 -67.69 149.27 50.22 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 173.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -62.44 -17.8 60.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.026 0.441 . . . . 0.0 111.082 -176.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -85.63 -48.9 8.44 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.416 171.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -59.68 -33.26 71.35 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.884 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 94' ' ' GLN . 44.3 t -47.01 -43.86 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.373 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.7 176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -60.74 -63.04 1.44 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.878 -172.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -74.21 -33.1 63.29 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.889 -171.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.468 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 55.7 t -70.01 -57.37 8.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 116.711 -0.222 . . . . 0.0 111.463 179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.646 HD22 HG12 ' A' ' 107' ' ' ILE . 26.6 mt -59.7 -47.37 85.9 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.961 -0.295 . . . . 0.0 111.235 -176.29 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -56.76 -61.82 2.16 Favored 'General case' 0 C--O 1.241 0.611 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.259 -178.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 106' ' ' CYS . 19.0 t -62.82 -28.24 69.87 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 124.344 1.027 . . . . 0.0 112.805 -167.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.468 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 24.4 m-85 -74.93 8.63 2.36 Favored 'General case' 0 C--O 1.236 0.39 0 CA-C-O 120.752 0.31 . . . . 0.0 110.634 175.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.43 ' H ' ' C ' ' A' ' 104' ' ' SER . 95.4 m 58.22 58.62 3.4 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-N 115.424 -0.807 . . . . 0.0 110.089 -175.255 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.646 HG12 HD22 ' A' ' 102' ' ' LEU . 1.2 mp -75.4 116.73 18.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-O 121.583 0.706 . . . . 0.0 110.569 177.833 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.0 p -125.45 -21.04 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-N 115.03 -0.986 . . . . 0.0 110.128 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.79 178.25 41.2 Favored Glycine 0 N--CA 1.445 -0.705 0 N-CA-C 111.719 -0.553 . . . . 0.0 111.719 -179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -133.48 151.38 77.24 Favored Pre-proline 0 C--N 1.325 -0.5 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 -179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.599 ' HB3' ' HB2' ' A' ' 44' ' ' CYS . 55.6 Cg_endo -87.98 128.5 9.27 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.544 -1.44 . . . . 0.0 112.681 0.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 64.6 t60 -89.8 95.81 10.41 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.064 -178.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.518 ' HA ' ' O ' ' A' ' 34' ' ' VAL . 81.9 mt -113.47 110.75 33.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-O 121.164 0.506 . . . . 0.0 110.914 -172.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 31.2 pt -114.45 148.76 17.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.841 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.537 -176.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 33' ' ' LEU . 6.2 tt -95.48 111.61 23.48 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 177.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.444 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 97.9 t -107.91 132.62 55.1 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.172 -175.367 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -68.65 163.74 51.85 Favored Pre-proline 0 CA--C 1.535 0.375 0 CA-C-N 115.872 -0.603 . . . . 0.0 110.417 176.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.48 ' HB3' ' HA2' ' A' ' 29' ' ' GLY . 82.0 Cg_exo -48.01 -31.24 15.54 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.355 2.703 . . . . 0.0 114.46 178.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.552 ' HB3' ' CE ' ' A' ' 121' ' ' LYS . 0.9 OUTLIER -88.39 -1.57 58.11 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.734 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.444 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 88.45 29.23 19.9 Favored Glycine 0 N--CA 1.447 -0.613 0 C-N-CA 120.458 -0.877 . . . . 0.0 112.838 177.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.552 ' CE ' ' HB3' ' A' ' 119' ' ' GLU . 11.1 mtmm -110.72 138.26 47.33 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.998 0.428 . . . . 0.0 110.635 175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.44 HD12 ' HB3' ' A' ' 3' ' ' LEU . 28.5 mt -75.12 118.4 20.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 116.011 -0.54 . . . . 0.0 111.483 -174.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.411 ' HB ' HD22 ' A' ' 115' ' ' LEU . 27.9 t -94.96 -38.32 8.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.043 179.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -145.12 164.89 29.87 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.317 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.459 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 18.3 pttm -150.15 147.1 27.33 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.935 -175.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 61.97 35.79 15.98 Favored 'General case' 0 C--O 1.233 0.212 0 O-C-N 124.502 1.126 . . . . 0.0 111.555 176.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.6 mt -66.49 141.64 57.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.97 177.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.601 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -97.16 166.05 11.76 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.394 -0.367 . . . . 0.0 111.139 -174.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.446 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -35.96 -72.61 0.13 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 115.076 0.79 . . . . 0.0 115.076 -176.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -72.2 -35.91 69.05 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.923 0.362 . . . . 0.0 110.432 -179.377 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -55.78 -46.15 78.0 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.727 -177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.452 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.3 pp -66.85 -38.78 87.03 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 110.221 -0.289 . . . . 0.0 110.221 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.452 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.3 t80 -65.34 -50.8 64.22 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.855 0.36 . . . . 0.0 110.171 177.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -57.4 -42.14 81.66 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.716 -179.455 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 47.2 m -69.04 -47.01 66.47 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.546 178.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 132' ' ' LEU . 52.5 t -64.79 -43.91 96.43 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.158 0 N-CA-C 111.62 0.23 . . . . 0.0 111.62 -178.383 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.735 ' HG3' ' HZ ' ' A' ' 58' ' ' PHE . 4.3 tt0 -63.85 -39.27 93.83 Favored 'General case' 0 C--N 1.333 -0.121 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 23.2 ttpp -57.82 -33.27 68.42 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.385 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 37.3 m-85 -87.69 -61.84 1.63 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 178.112 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 43.7 t -72.91 -40.39 59.81 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-O 120.896 0.379 . . . . 0.0 111.74 -170.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.593 ' HB3' ' HG2' ' A' ' 137' ' ' GLU . 61.9 t30 -84.28 -32.77 24.21 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 178.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 76.61 167.3 25.74 Favored Glycine 0 N--CA 1.448 -0.501 0 CA-C-N 115.157 -0.928 . . . . 0.0 113.459 171.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -93.39 -7.32 44.98 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.113 0.483 . . . . 0.0 109.903 174.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 29.4 tptp -56.85 120.83 8.56 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.538 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.737 ' OE1' ' HA ' ' A' ' 149' ' ' HIS . 7.2 tp10 -59.44 140.32 56.29 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.586 -0.734 . . . . 0.0 109.811 174.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 105.14 -41.47 2.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.899 -0.667 . . . . 0.0 112.164 -177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -67.5 -37.62 83.1 Favored 'General case' 0 N--CA 1.462 0.14 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -154.49 101.77 2.37 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.868 -1.06 . . . . 0.0 108.141 169.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.737 ' HA ' ' OE1' ' A' ' 145' ' ' GLU . 31.9 p80 -49.37 131.15 20.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 114.893 -1.049 . . . . 0.0 112.924 -170.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 53.4 m-70 -85.07 -20.64 30.09 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.258 -0.883 . . . . 0.0 109.503 175.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 21.6 p80 -150.93 -162.32 1.52 Allowed 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.711 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 22.0 p80 . . . . . 0 C--O 1.246 0.873 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 172.89 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 110.121 -0.325 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.733 ' HA ' ' HB3' ' A' ' 106' ' ' CYS . 13.9 m -89.27 131.13 35.52 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.774 -179.445 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.556 HD22 ' HB3' ' A' ' 7' ' ' SER . 73.1 mt -113.94 154.14 28.09 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 176.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -128.02 -79.61 0.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 121.019 -0.272 . . . . 0.0 111.149 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.503 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 2.9 t -153.74 137.19 15.85 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.285 0.564 . . . . 0.0 110.562 178.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 83.5 -1.29 88.94 Favored Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -174.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.556 ' HB3' HD22 ' A' ' 3' ' ' LEU . 6.8 m -82.01 128.25 33.9 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.323 -0.439 . . . . 0.0 110.095 179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 48.7 t -69.04 129.66 33.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.83 0.348 . . . . 0.0 110.123 -178.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.441 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -93.45 141.6 24.12 Favored Pre-proline 0 C--N 1.322 -0.59 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.441 -177.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 22.4 Cg_exo -66.12 163.3 32.07 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 123.167 2.578 . . . . 0.0 111.96 175.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.71 113.92 24.78 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.011 -179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 60.8 mt -74.6 141.9 15.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.161 176.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.2 m -120.64 105.12 10.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.914 0.388 . . . . 0.0 110.05 176.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.76 167.94 14.5 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.811 -173.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.8 mt -105.61 128.09 59.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.907 -0.405 . . . . 0.0 109.907 177.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.68 -173.13 4.46 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.035 0.445 . . . . 0.0 111.273 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.419 HD21 ' CD1' ' A' ' 81' ' ' ILE . 75.0 mt -64.6 -30.38 71.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.965 -178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -76.14 -32.86 59.32 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.914 0.388 . . . . 0.0 110.694 179.095 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 111.33 22.01 6.33 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 111.07 -0.812 . . . . 0.0 111.07 -175.306 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.546 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -95.15 141.19 29.06 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 -179.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 22.7 p -82.31 106.01 13.85 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 176.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 12.7 p -119.77 146.31 24.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.859 -176.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.1 m -112.57 157.43 21.18 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.172 0.51 . . . . 0.0 111.202 -175.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.455 HD11 HG11 ' A' ' 32' ' ' VAL . 62.5 tp -61.96 -24.71 67.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.586 176.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' CD ' ' A' ' 28' ' ' LYS . 8.4 t30 -62.52 -33.89 75.81 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.868 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 37.4 m-20 -73.12 -9.83 59.14 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.441 -175.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 73.5 m-85 -113.88 1.63 14.82 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.815 0.34 . . . . 0.0 110.51 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' CD ' ' HA ' ' A' ' 25' ' ' ASN . 26.3 mtpp -63.61 171.21 2.74 Favored 'General case' 0 C--O 1.237 0.427 0 CA-C-N 115.476 -0.784 . . . . 0.0 111.395 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.91 9.21 83.03 Favored Glycine 0 N--CA 1.453 -0.17 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.583 -175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.2 mttp -137.55 165.47 26.24 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.2 m-85 -76.51 114.04 14.79 Favored 'General case' 0 C--N 1.317 -0.829 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.455 HG11 HD11 ' A' ' 24' ' ' LEU . 46.4 t -111.18 111.7 37.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-O 121.015 0.435 . . . . 0.0 111.31 -172.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.559 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.3 tp -90.75 113.88 26.1 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 175.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.407 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 42.8 t -102.47 119.45 50.84 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-O 120.438 0.161 . . . . 0.0 110.942 -175.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -103.39 116.81 33.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.301 0.572 . . . . 0.0 111.442 179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -96.86 116.87 29.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.485 175.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.98 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 11.7 p-90 -150.61 -178.4 6.54 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.821 0.343 . . . . 0.0 111.241 -176.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.475 ' HE1' ' HB2' ' A' ' 110' ' ' PHE . 2.2 p90 -170.58 160.08 7.07 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-N 115.158 -0.928 . . . . 0.0 108.926 169.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.52 6.72 3.5 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -174.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -83.87 -16.73 67.1 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.086 176.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.555 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 96.3 m -120.88 121.43 38.08 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.029 0.443 . . . . 0.0 110.483 178.141 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.413 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 3.8 m -59.11 -33.36 70.76 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.459 -178.142 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.1 m95 -66.73 -31.51 72.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.538 -176.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.98 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 72.9 m -58.45 -41.12 84.42 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.849 0.357 . . . . 0.0 111.142 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 14.4 mtm180 -85.12 -12.12 53.6 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.967 -177.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.511 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.5 mptp? -75.69 -28.76 58.76 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.901 0.382 . . . . 0.0 110.311 174.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.404 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 11.8 mm-40 -79.9 -16.12 55.96 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.329 179.015 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.622 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 90.8 m -50.48 -52.13 58.11 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 112.538 0.569 . . . . 0.0 112.538 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.622 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 52.7 Cg_exo -53.0 -42.08 67.02 Favored 'Trans proline' 0 C--N 1.36 1.137 0 C-N-CA 122.133 1.888 . . . . 0.0 112.803 176.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.404 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 95.7 m-85 -69.11 -38.26 78.83 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.943 0.401 . . . . 0.0 110.743 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.496 HD23 HD13 ' A' ' 132' ' ' LEU . 79.2 mt -63.35 -50.32 70.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.279 175.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.422 ' HB2' ' HZ3' ' A' ' 88' ' ' TRP . 50.5 tp -59.19 -40.54 86.03 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.507 . . . . 0.0 110.475 179.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 11.4 tttp -52.2 -51.94 55.17 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.365 -0.834 . . . . 0.0 110.829 173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 16.7 m -68.04 -43.66 78.21 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.445 -178.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.658 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.9 t80 -60.93 -48.8 80.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.898 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 63.2 t30 -66.47 -29.02 69.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.08 -177.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -76.51 -38.05 55.79 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -179.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.467 ' HA ' ' HD2' ' A' ' 61' ' ' LYS . 94.4 m-85 -120.23 6.74 10.72 Favored 'General case' 0 N--CA 1.467 0.394 0 N-CA-C 114.408 1.262 . . . . 0.0 114.408 -166.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.573 ' HG2' ' N ' ' A' ' 60' ' ' ASP . 0.0 OUTLIER -61.65 -36.59 81.24 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.364 0.602 . . . . 0.0 110.84 -176.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.573 ' N ' ' HG2' ' A' ' 59' ' ' LYS . 2.9 p30 -82.76 6.78 17.02 Favored 'General case' 0 CA--C 1.515 -0.398 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.509 -175.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 58' ' ' PHE . 55.1 mttp -116.5 15.28 15.64 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.12 -174.054 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.53 30.98 25.76 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.386 -0.912 . . . . 0.0 111.719 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.564 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 49.5 t80 -133.89 143.33 48.2 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 -177.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.0 t -146.92 163.78 35.05 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.951 0.405 . . . . 0.0 109.955 176.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.658 HD12 ' HB2' ' A' ' 55' ' ' TYR . 20.2 mt -116.57 125.31 73.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.157 -0.474 . . . . 0.0 109.896 179.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.407 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 57.9 t80 -108.41 99.23 8.65 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.3 -0.864 . . . . 0.0 109.324 -175.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' NE2' ' A' ' 90' ' ' GLN . . . -87.15 135.19 13.01 Favored Glycine 0 N--CA 1.441 -0.997 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.019 -176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.548 ' HB ' HD21 ' A' ' 93' ' ' LEU . 3.2 m -133.4 112.2 17.19 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-O 121.574 0.702 . . . . 0.0 110.886 -179.456 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.419 ' O ' HD12 ' A' ' 92' ' ' LEU . 29.7 t -113.12 154.62 26.33 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.776 177.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.461 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.9 t -123.91 41.41 3.49 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.739 0.781 . . . . 0.0 109.018 178.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -54.05 169.88 0.15 Allowed 'General case' 0 C--O 1.241 0.611 0 CA-C-N 114.681 -1.145 . . . . 0.0 113.533 -175.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 18.8 mtm180 -60.66 -38.46 84.97 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.257 -175.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.589 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 38.5 mtt180 -144.72 169.27 18.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.045 177.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 1.12 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 31.7 tt0 -75.64 -41.06 55.16 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 177.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.589 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.2 mp0 -60.78 -36.18 78.34 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 18.4 t0 -66.65 -48.62 68.82 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 114.458 -1.246 . . . . 0.0 110.322 177.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.665 ' HZ2' ' HG3' ' A' ' 90' ' ' GLN . 34.2 t90 -56.77 -48.25 78.28 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.143 174.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 1.12 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 1.6 mptp? -58.83 -38.08 77.86 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 120.96 0.41 . . . . 0.0 110.214 175.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.496 ' HB3' ' O ' ' A' ' 76' ' ' ASP . 0.1 OUTLIER -60.92 -45.53 94.27 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.896 178.506 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.68 -44.73 96.14 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.802 -0.636 . . . . 0.0 111.096 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.431 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 70.0 mt -64.34 -35.7 74.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.244 0.545 . . . . 0.0 110.753 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -62.88 -31.19 72.18 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.305 0.574 . . . . 0.0 110.306 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.443 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 41.7 mt-10 -80.32 -53.03 7.01 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.392 -178.2 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.431 ' OD1' ' HA ' ' A' ' 81' ' ' ILE . 13.4 p-10 -91.52 -17.98 24.83 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -170.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.67 ' HD3' ' N ' ' A' ' 85' ' ' LYS . 0.0 OUTLIER 67.41 38.5 3.19 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.305 0.574 . . . . 0.0 111.221 -179.212 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.3 p -72.76 67.62 0.81 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.175 -0.921 . . . . 0.0 111.325 173.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -96.12 85.57 4.05 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -175.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.422 ' HZ3' ' HB2' ' A' ' 52' ' ' LEU . 7.4 p90 -141.04 -149.85 0.29 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 168.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.3 m120 -73.01 64.56 0.71 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 118.713 0.688 . . . . 0.0 109.849 175.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.665 ' HG3' ' HZ2' ' A' ' 77' ' ' TRP . 8.6 tp-100 -90.97 123.42 34.44 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.242 -175.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.1 m -132.72 152.72 36.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.188 0.518 . . . . 0.0 110.888 179.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 69' ' ' SER . 45.4 tp -90.3 129.88 36.47 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.574 177.398 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.548 HD21 ' HB ' ' A' ' 68' ' ' VAL . 79.5 mt -70.03 125.3 26.35 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 109.727 -0.472 . . . . 0.0 109.727 176.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.551 ' O ' HG23 ' A' ' 98' ' ' VAL . 40.2 mt-30 -65.12 147.93 52.58 Favored 'General case' 0 C--N 1.319 -0.743 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 175.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 74.1 mmtt -68.6 -16.75 63.96 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 120.867 0.365 . . . . 0.0 111.144 -172.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.27 -49.43 8.19 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.45 171.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -50.91 -36.73 39.84 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.061 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 94' ' ' GLN . 25.1 t -45.01 -41.85 2.42 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.456 176.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.4 ' HB2' ' NZ ' ' A' ' 99' ' ' LYS . 9.6 mtmp? -56.24 -64.27 0.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.57 0.7 . . . . 0.0 111.682 -175.348 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -73.7 -36.44 65.27 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.714 -1.13 . . . . 0.0 110.906 -169.206 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.497 HG13 ' HE2' ' A' ' 105' ' ' TYR . 55.7 t -68.72 -55.85 14.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.257 -179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.673 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 15.8 mt -60.4 -42.18 95.4 Favored 'General case' 0 C--O 1.224 -0.254 0 C-N-CA 121.11 -0.236 . . . . 0.0 111.555 -175.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -62.04 -62.07 2.04 Favored 'General case' 0 C--O 1.241 0.625 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.519 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 67.2 m -55.59 -32.11 62.78 Favored 'General case' 0 N--CA 1.465 0.323 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -168.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.497 ' HE2' HG13 ' A' ' 101' ' ' VAL . 62.8 m-85 -83.03 22.14 0.98 Allowed 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.763 178.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.733 ' HB3' ' HA ' ' A' ' 2' ' ' SER . 26.7 p 47.96 48.85 17.69 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 124.38 1.072 . . . . 0.0 110.56 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.673 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 79.6 mt -97.67 110.73 25.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.689 -175.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 28.3 m -115.56 18.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.43 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 167.69 -178.43 41.6 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 121.014 -0.613 . . . . 0.0 111.596 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.475 ' HB2' ' HE1' ' A' ' 38' ' ' PHE . 97.7 m-85 -134.84 157.39 77.24 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-N 116.937 0.369 . . . . 0.0 110.293 -178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -91.61 168.85 25.87 Favored 'Cis proline' 0 C--N 1.347 0.462 0 C-N-CA 123.762 -1.349 . . . . 0.0 112.91 -1.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 63.4 m-70 -146.69 132.46 18.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.037 -0.529 . . . . 0.0 109.671 175.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.7 mp -124.6 128.97 73.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 177.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.774 HG22 ' HG3' ' A' ' 125' ' ' LYS . 41.7 pt -123.11 153.2 28.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.992 -177.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 3.5 tt -112.64 113.35 25.44 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 90.1 t -101.1 140.58 19.55 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.598 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.74 167.29 30.78 Favored Pre-proline 0 CA--C 1.533 0.309 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 178.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -51.04 -35.27 50.09 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.82 2.347 . . . . 0.0 113.969 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.4 mt-10 -79.46 -24.23 42.53 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 120.931 -0.307 . . . . 0.0 111.511 -178.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.36 27.99 3.44 Favored Glycine 0 N--CA 1.446 -0.673 0 C-N-CA 120.255 -0.974 . . . . 0.0 114.538 170.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 0.5 OUTLIER -106.05 148.32 27.89 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 117.791 0.795 . . . . 0.0 109.309 172.369 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.503 ' O ' ' HA ' ' A' ' 5' ' ' THR . 38.2 mt -80.3 104.52 8.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 13.7 p -82.88 -28.05 8.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 121.068 0.461 . . . . 0.0 110.709 -177.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -142.75 138.47 30.51 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.774 ' HG3' HG22 ' A' ' 114' ' ' ILE . 20.8 ttpp -129.81 155.5 45.87 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.627 -0.261 . . . . 0.0 110.327 -175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.426 ' HG2' ' HG2' ' A' ' 125' ' ' LYS . 2.3 mm-40 66.08 42.95 3.05 Favored 'General case' 0 C--O 1.236 0.359 0 O-C-N 123.897 0.748 . . . . 0.0 110.931 175.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.487 ' HB3' HD23 ' A' ' 132' ' ' LEU . 83.2 mt -82.16 156.07 24.65 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.876 177.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.759 ' HD3' ' N ' ' A' ' 128' ' ' ARG . 0.0 OUTLIER -162.28 167.28 24.16 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.217 -0.447 . . . . 0.0 109.955 -172.765 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 44.02 -129.65 6.72 Favored Glycine 0 C--N 1.333 0.412 0 O-C-N 123.933 0.771 . . . . 0.0 113.944 171.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -77.03 -24.21 52.1 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 121.016 -0.274 . . . . 0.0 110.62 177.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 12.5 m-20 -53.67 -27.27 26.62 Favored 'General case' 0 N--CA 1.467 0.4 0 O-C-N 123.287 0.367 . . . . 0.0 110.43 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.529 ' O ' HG23 ' A' ' 136' ' ' VAL . 71.6 mt -56.18 -64.57 0.82 Allowed 'General case' 0 N--CA 1.462 0.141 0 CA-C-O 121.357 0.598 . . . . 0.0 109.736 173.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 33.2 t80 -58.34 -42.65 87.34 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 114.871 -1.059 . . . . 0.0 109.981 177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 1.9 t-20 -51.13 -52.32 44.98 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.551 -1.204 . . . . 0.0 111.483 -178.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 25.3 m -72.26 -34.24 68.09 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.677 -0.692 . . . . 0.0 111.176 -176.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 132' ' ' LEU . 56.2 t -71.71 -42.31 70.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.616 -0.265 . . . . 0.0 110.879 179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.576 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 3.9 tp10 -61.17 -34.85 75.69 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.77 0.795 . . . . 0.0 109.364 175.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.467 ' HE3' ' HB2' ' A' ' 138' ' ' LYS . 12.9 ttmt -64.17 -51.04 65.75 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.427 -178.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -87.57 -54.86 4.05 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -176.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.2 t -67.83 -48.52 75.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 120.842 0.353 . . . . 0.0 111.405 -172.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.576 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 35.2 t30 -76.4 -23.83 54.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.42 0.629 . . . . 0.0 109.908 179.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -82.38 14.46 34.56 Favored Glycine 0 N--CA 1.449 -0.435 0 CA-C-N 115.775 -0.648 . . . . 0.0 112.391 177.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -79.55 -12.0 59.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.847 0.356 . . . . 0.0 111.061 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -95.3 -77.76 0.46 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.029 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -90.12 -0.53 57.65 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.169 -174.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.86 162.81 53.12 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.691 -0.766 . . . . 0.0 111.511 176.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.2 t-80 -73.77 84.06 1.64 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.216 0.531 . . . . 0.0 110.217 -177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 26.6 p-80 -81.68 151.53 27.52 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.263 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.9 t-80 -80.67 132.91 35.64 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.55 -171.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 26.7 m80 -99.89 163.36 12.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 174.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.444 ' CG ' ' H ' ' A' ' 152' ' ' HIS . 8.4 p80 -119.89 -78.35 0.59 Allowed 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 120.701 -0.399 . . . . 0.0 110.994 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.444 ' H ' ' CG ' ' A' ' 151' ' ' HIS . 7.7 t60 . . . . . 0 C--N 1.321 -0.667 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -174.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.0 mmm . . . . . 0 N--CA 1.481 1.091 0 N-CA-C 109.603 -0.518 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.0 t -78.19 88.28 4.27 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.242 0.544 . . . . 0.0 109.759 -178.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.548 ' HB2' HD12 ' A' ' 122' ' ' ILE . 72.6 mt -78.53 133.84 37.33 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.271 -179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -105.73 -168.81 1.5 Allowed 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.342 -179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 24.9 p -64.51 111.2 2.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.0 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.92 1.81 52.08 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.447 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.517 ' HB2' ' HB3' ' A' ' 3' ' ' LEU . 19.4 m -87.58 131.66 34.33 Favored 'General case' 0 C--N 1.326 -0.422 0 O-C-N 122.774 -0.25 . . . . 0.0 110.424 178.009 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 52.0 t -69.64 132.82 32.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.996 -176.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -100.28 148.35 34.78 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.553 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 30.0 Cg_exo -64.35 163.21 27.34 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 123.566 2.844 . . . . 0.0 112.516 176.364 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -98.28 131.75 44.35 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.843 0.354 . . . . 0.0 111.414 -177.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.592 HD12 HG22 ' A' ' 101' ' ' VAL . 18.1 mm -87.33 148.37 4.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.572 -177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 7.9 m -133.61 94.23 3.26 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.052 0.453 . . . . 0.0 110.322 175.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.96 175.9 16.36 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.646 -173.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.0 mt -104.97 117.07 50.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 177.051 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.422 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 1.0 OUTLIER -82.27 -174.8 5.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.026 0.441 . . . . 0.0 111.438 -171.674 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.3 mt -58.32 -30.61 66.82 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.789 -177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 37.7 mtmm -69.27 -25.68 64.39 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-O 121.053 0.454 . . . . 0.0 111.067 178.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 94.07 20.89 29.31 Favored Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 -171.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.504 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -103.18 148.84 25.28 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 -179.212 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.3 p -77.3 97.97 5.04 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 174.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 85.6 t -106.93 137.41 37.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.197 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -100.64 -176.83 3.3 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.938 -178.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 55.8 tp -79.42 -28.94 41.75 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.202 0.525 . . . . 0.0 110.198 177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.713 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 0.8 OUTLIER -66.82 -19.92 65.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.258 -176.925 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -61.62 -31.87 71.98 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.074 0.464 . . . . 0.0 111.204 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -115.62 20.55 14.6 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.413 0.625 . . . . 0.0 109.78 -178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.713 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 57.5 tttp -84.06 66.76 9.4 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.991 -174.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -161.05 17.91 0.19 Allowed Glycine 0 N--CA 1.448 -0.56 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.875 175.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 64.9 mttm -149.64 175.21 11.75 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 -177.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.4 m-85 -80.27 112.57 17.72 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 174.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 59.3 t -99.42 114.32 37.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.333 -0.849 . . . . 0.0 111.164 -173.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 26.7 tp -92.03 109.85 21.21 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 174.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 33.6 t -91.19 117.47 34.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-O 120.822 0.344 . . . . 0.0 110.945 -175.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.2 t0 -97.93 103.04 14.94 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.348 -178.614 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.46 ' HA ' HG23 ' A' ' 68' ' ' VAL . 39.3 m-85 -82.19 114.72 20.89 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 175.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.443 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 11.4 p-90 -155.08 173.68 16.24 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 122.186 0.993 . . . . 0.0 112.731 -174.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 27.8 p90 -164.71 154.15 13.34 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 112.894 -1.957 . . . . 0.0 107.064 165.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.43 -29.35 66.05 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 112.106 0.41 . . . . 0.0 112.106 -170.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -61.09 -38.19 95.15 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 116.143 -0.48 . . . . 0.0 113.063 -178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 18.1 p -87.55 96.62 10.47 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.407 0.622 . . . . 0.0 110.231 179.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.552 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.3 m -68.15 -11.2 58.76 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.89 -0.596 . . . . 0.0 112.155 -176.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 28.4 m95 -69.82 -42.46 73.63 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 111.886 0.328 . . . . 0.0 111.886 -176.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.91 ' HB3' ' HB3' ' A' ' 111' ' ' PRO . 20.7 p -67.84 -29.6 68.79 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.116 0.484 . . . . 0.0 109.877 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.544 ' HA ' ' OG1' ' A' ' 48' ' ' THR . 6.6 mmp_? -75.57 -14.29 60.39 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.135 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.552 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.6 mptm? -79.13 -21.68 46.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.732 173.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -94.92 -3.58 48.39 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.605 -0.725 . . . . 0.0 110.255 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.544 ' OG1' ' HA ' ' A' ' 45' ' ' ARG . 94.1 m -51.16 -51.52 67.33 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.024 -0.535 . . . . 0.0 112.346 177.025 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.0 Cg_endo -51.72 -39.05 67.49 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.374 2.05 . . . . 0.0 112.495 178.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 80.6 m-85 -74.18 -39.77 62.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.989 0.423 . . . . 0.0 110.629 -179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.519 HD21 HD13 ' A' ' 113' ' ' ILE . 97.0 mt -63.18 -45.49 91.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.275 175.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 42.7 tp -61.37 -41.36 96.96 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.511 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -57.74 -53.29 59.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.396 175.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.417 ' HA ' ' HD1' ' A' ' 133' ' ' TYR . 19.6 m -61.93 -42.51 99.19 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.116 -179.01 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.641 ' HB2' HD12 ' A' ' 65' ' ' ILE . 56.4 t80 -59.73 -56.32 23.36 Favored 'General case' 0 C--O 1.222 -0.391 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.552 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.523 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 28.0 m-80 -58.08 -35.43 71.38 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 111.918 0.34 . . . . 0.0 111.918 -176.258 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -78.45 -31.66 48.12 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.632 0.605 . . . . 0.0 112.632 -175.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.505 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 92.5 m-85 -120.2 0.78 10.73 Favored 'General case' 0 CA--C 1.517 -0.323 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -169.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.527 ' HG3' ' OD2' ' A' ' 60' ' ' ASP . 14.6 ptmm? -60.18 161.6 6.81 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.241 0.543 . . . . 0.0 111.048 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.527 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 32.0 m-20 73.7 -49.69 0.68 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 113.899 -1.501 . . . . 0.0 111.8 173.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 44.4 mttp -60.64 -88.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.786 -173.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -136.36 15.79 3.9 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.788 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -135.97 141.59 44.46 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.005 -0.369 . . . . 0.0 110.005 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.8 t -150.6 149.54 30.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.253 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.641 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -103.21 129.74 54.55 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 120.966 0.412 . . . . 0.0 110.172 177.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t80 -119.35 98.89 6.37 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.446 -0.797 . . . . 0.0 109.001 -178.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -87.74 122.57 6.3 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.191 -175.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.61 ' HB ' HD21 ' A' ' 93' ' ' LEU . 15.4 m -100.43 111.88 31.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-O 121.656 0.741 . . . . 0.0 110.126 178.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.4 m -104.76 136.51 44.14 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.369 -175.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.552 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.7 t -122.62 32.38 5.77 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 122.045 0.926 . . . . 0.0 109.065 178.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -61.4 175.78 0.54 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.285 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.5 mmp_? -79.05 -57.77 3.57 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.315 -169.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.555 ' HB3' ' OD2' ' A' ' 76' ' ' ASP . 22.5 tpt180 -123.78 152.01 42.68 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.317 -175.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.58 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 17.1 tt0 -64.7 -35.04 79.77 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.105 0.479 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.483 ' CD ' ' HE ' ' A' ' 73' ' ' ARG . 2.8 mp0 -58.22 -47.07 84.65 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.739 177.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.555 ' OD2' ' HB3' ' A' ' 73' ' ' ARG . 2.1 p30 -73.51 -36.19 65.7 Favored 'General case' 0 N--CA 1.464 0.247 0 C-N-CA 120.526 -0.47 . . . . 0.0 110.743 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.463 ' O ' HG12 ' A' ' 81' ' ' ILE . 26.6 t90 -54.4 -54.83 35.45 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.772 171.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.58 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -57.94 -43.13 86.12 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.8 0.333 . . . . 0.0 110.87 177.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 55.9 tttm -57.0 -50.1 73.75 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.764 178.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.13 -39.14 88.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.397 -178.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 77' ' ' TRP . 39.3 mm -59.82 -39.95 81.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-O 120.813 0.339 . . . . 0.0 111.108 178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 37.0 tp10 -73.91 -32.76 63.7 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.27 -179.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -77.67 -49.34 14.71 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.125 0.488 . . . . 0.0 110.897 179.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -73.97 -19.6 60.62 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.903 -177.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 61.0 mmtt 64.3 27.09 13.77 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.312 174.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.7 p -87.99 82.32 7.25 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-O 121.199 0.523 . . . . 0.0 110.683 179.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 95.4 m-85 -87.11 87.7 7.51 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.559 -177.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 14.3 p90 -150.97 -159.66 1.06 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.853 170.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -82.24 83.94 7.24 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 121.067 -0.253 . . . . 0.0 111.357 -173.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 7.1 mp0 -94.74 136.12 35.43 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.928 0.394 . . . . 0.0 110.695 173.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.422 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 25.5 m -125.83 137.3 58.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.689 174.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.2 tp -87.79 116.07 25.69 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 177.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.61 HD21 ' HB ' ' A' ' 68' ' ' VAL . 74.5 mt -57.45 130.86 48.19 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.397 -0.82 . . . . 0.0 110.487 -178.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.645 ' O ' HG23 ' A' ' 98' ' ' VAL . 66.1 mt-30 -64.63 151.94 43.5 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 177.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.9 ' HA ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -61.61 -28.91 69.7 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.006 0.432 . . . . 0.0 111.869 -170.516 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -87.68 -42.85 12.36 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.475 174.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.529 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.9 t70 -54.07 -31.65 52.34 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.464 0.705 . . . . 0.0 111.793 178.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.645 HG23 ' O ' ' A' ' 94' ' ' GLN . 52.6 t -48.0 -33.99 4.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.175 178.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 54.9 mttp -57.67 -65.62 0.6 Allowed 'General case' 0 C--O 1.223 -0.319 0 O-C-N 123.035 0.209 . . . . 0.0 111.495 -175.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.485 ' O ' ' HB2' ' A' ' 104' ' ' SER . 24.9 t70 -63.02 -43.48 98.61 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.394 -170.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.592 HG22 HD12 ' A' ' 12' ' ' ILE . 37.0 t -53.95 -63.21 0.55 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.705 0 CA-C-O 121.25 0.548 . . . . 0.0 110.397 179.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.64 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 40.4 mt -66.61 -42.12 87.34 Favored 'General case' 0 C--O 1.221 -0.433 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.234 -175.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.571 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 12.8 mt-10 -67.34 -64.17 0.91 Allowed 'General case' 0 N--CA 1.435 -1.209 0 O-C-N 122.009 -0.432 . . . . 0.0 111.144 -179.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.485 ' HB2' ' O ' ' A' ' 100' ' ' ASP . 38.6 m -62.26 -32.55 73.27 Favored 'General case' 0 CA--C 1.521 -0.15 0 N-CA-C 113.78 1.03 . . . . 0.0 113.78 -165.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.513 ' HB2' HG12 ' A' ' 107' ' ' ILE . 74.7 m-85 -77.48 7.7 5.14 Favored 'General case' 0 C--O 1.237 0.439 0 C-N-CA 119.67 -0.812 . . . . 0.0 110.723 176.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 59.0 m 61.85 53.35 3.15 Favored 'General case' 0 CA--C 1.511 -0.523 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.246 -174.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.64 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 47.7 mm -105.43 98.99 7.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 114.976 -1.011 . . . . 0.0 110.905 -176.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.8 p -100.87 13.36 5.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-O 121.772 0.796 . . . . 0.0 110.739 -178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 172.64 -162.61 34.36 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.693 -0.765 . . . . 0.0 111.641 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -140.39 156.17 69.74 Favored Pre-proline 0 C--N 1.322 -0.593 0 CA-C-N 116.969 0.384 . . . . 0.0 110.081 -179.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.91 ' HB3' ' HB3' ' A' ' 44' ' ' CYS . 82.7 Cg_endo -96.63 164.12 14.18 Favored 'Cis proline' 0 N--CA 1.458 -0.595 0 C-N-CA 124.102 -1.208 . . . . 0.0 113.13 -0.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -145.11 130.74 18.92 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.519 HD13 HD21 ' A' ' 51' ' ' LEU . 70.5 mt -128.27 113.37 29.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.759 0.314 . . . . 0.0 110.835 -177.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.832 HG22 ' HG3' ' A' ' 125' ' ' LYS . 42.1 pt -112.51 156.57 13.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.359 -176.021 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.9 tt -119.8 118.56 31.16 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.638 -0.504 . . . . 0.0 109.638 178.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 87.3 t -112.28 136.36 48.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.621 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.629 ' OD1' ' HD2' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -78.59 166.76 40.43 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.018 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.523 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -50.51 -44.05 41.76 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.871 2.381 . . . . 0.0 113.561 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.461 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 44.0 mt-10 -65.21 -29.6 70.42 Favored 'General case' 0 C--O 1.234 0.258 0 O-C-N 122.046 -0.409 . . . . 0.0 110.589 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 110.35 33.04 2.6 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.712 -0.756 . . . . 0.0 114.418 171.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.629 ' HD2' ' OD1' ' A' ' 117' ' ' ASP . 0.0 OUTLIER -110.51 146.56 35.79 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 117.97 0.885 . . . . 0.0 109.194 170.893 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.548 HD12 ' HB2' ' A' ' 3' ' ' LEU . 25.6 mt -71.17 116.34 12.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.946 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 25.0 t -84.44 -37.44 12.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.179 -178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.62 145.25 24.22 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.39 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.832 ' HG3' HG22 ' A' ' 114' ' ' ILE . 88.7 tttt -123.7 128.16 49.21 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.17 0.51 . . . . 0.0 111.337 -177.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.539 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 44.1 mt-10 58.72 74.44 0.44 Allowed 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.385 -1.28 . . . . 0.0 113.71 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.779 ' HB2' HD23 ' A' ' 132' ' ' LEU . 43.8 mt -91.3 155.34 18.6 Favored 'General case' 0 C--N 1.319 -0.742 0 N-CA-C 107.606 -1.257 . . . . 0.0 107.606 168.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.529 HH12 ' HG2' ' A' ' 111' ' ' PRO . 28.4 mmt180 -128.07 161.7 28.6 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.25 -174.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 50.92 -137.78 27.14 Favored Glycine 0 N--CA 1.452 -0.26 0 O-C-N 123.983 0.802 . . . . 0.0 113.168 173.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -77.37 -16.43 58.87 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.551 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 17.7 m-20 -60.52 -27.26 67.48 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.283 179.28 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.779 HD23 ' HB2' ' A' ' 127' ' ' LEU . 23.6 mt -51.45 -58.18 6.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.742 167.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.417 ' HD1' ' HA ' ' A' ' 54' ' ' THR . 67.3 t80 -62.81 -48.75 77.74 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.654 179.307 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 89.3 m-20 -51.7 -47.18 64.04 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -178.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 27.3 m -67.84 -44.07 78.05 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.9 -179.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.5 t -63.94 -41.43 92.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.887 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.505 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 15.7 tt0 -66.28 -44.09 84.56 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.904 0.383 . . . . 0.0 110.564 179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 2.7 ttpp -59.87 -29.14 68.11 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.663 178.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 18.0 t80 -89.23 -60.66 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.097 -0.502 . . . . 0.0 112.0 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 47.3 t -83.7 -44.4 18.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 N-CA-C 112.371 0.508 . . . . 0.0 112.371 -170.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.461 ' CB ' ' HG3' ' A' ' 137' ' ' GLU . 52.3 t-20 -62.31 -50.63 70.9 Favored 'General case' 0 N--CA 1.466 0.325 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 70.66 -166.5 51.47 Favored Glycine 0 N--CA 1.449 -0.483 0 CA-C-N 115.517 -0.765 . . . . 0.0 113.06 175.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.21 122.9 12.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.799 0.333 . . . . 0.0 111.056 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -126.59 1.84 6.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.071 0.462 . . . . 0.0 110.498 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -85.94 -36.71 19.69 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.669 -173.637 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 122.03 64.15 0.23 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.785 -0.721 . . . . 0.0 111.795 -178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 2.2 m80 -62.86 -30.79 71.78 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 61.4 t60 -80.94 95.55 6.79 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.019 0.438 . . . . 0.0 110.227 -179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 64.1 m170 -84.75 179.48 7.34 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.64 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 17.1 p80 -151.84 48.95 0.79 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.313 0.578 . . . . 0.0 109.654 175.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -173.62 -55.37 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.111 -178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 57.4 t-80 . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.167 -0.924 . . . . 0.0 109.037 176.479 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' HE2' ' HG3' ' A' ' 125' ' ' LYS . 25.1 ptp . . . . . 0 N--CA 1.481 1.08 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.668 ' HB2' ' SG ' ' A' ' 106' ' ' CYS . 9.5 m -123.95 -1.67 8.31 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.33 0.586 . . . . 0.0 109.711 176.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.428 ' HG ' ' SG ' ' A' ' 106' ' ' CYS . 98.4 mt -106.98 155.73 19.48 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.665 178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -91.25 -171.28 2.91 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.13 0.491 . . . . 0.0 111.238 -176.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.963 HG23 ' HA ' ' A' ' 123' ' ' VAL . 90.7 m -104.26 130.17 52.07 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.049 -0.523 . . . . 0.0 109.886 177.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.67 -10.5 45.53 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.779 -178.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 10.8 p -77.95 127.06 31.77 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 54.8 t -69.7 132.87 32.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.537 -178.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.464 ' HB1' ' HE1' ' A' ' 105' ' ' TYR . . . -88.2 146.5 38.27 Favored Pre-proline 0 C--N 1.321 -0.638 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.591 -177.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.8 Cg_exo -61.82 163.3 19.28 Favored 'Trans proline' 0 C--N 1.349 0.562 0 C-N-CA 123.315 2.676 . . . . 0.0 112.094 173.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -87.46 130.73 34.58 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.36 -177.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 23' ' ' SER . 51.7 mt -94.1 138.88 19.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.146 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.17 101.42 8.44 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.946 0.403 . . . . 0.0 110.55 178.73 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -123.84 156.59 18.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.248 -0.977 . . . . 0.0 112.783 -176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -98.98 122.21 50.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 177.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.449 ' CG ' ' HZ2' ' A' ' 18' ' ' LYS . 0.8 OUTLIER -80.84 -175.3 5.26 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.023 0.439 . . . . 0.0 111.282 -173.854 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 96.8 mt -59.37 -31.65 69.41 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.573 -0.739 . . . . 0.0 111.991 -177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.506 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 8.8 mtmp? -80.11 -18.66 49.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.86 0.362 . . . . 0.0 111.294 -178.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 95.31 25.73 13.52 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.119 -177.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.97 144.18 27.78 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.244 -0.65 . . . . 0.0 109.244 178.684 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 p -80.29 94.57 6.13 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.922 0.391 . . . . 0.0 110.039 175.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 40.4 t -97.29 143.24 12.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.903 -0.59 . . . . 0.0 109.816 -178.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 15.7 m -119.47 170.35 9.23 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.72 0.295 . . . . 0.0 110.274 -179.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.493 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 34.6 tp -68.17 -7.74 32.66 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.207 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.477 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 28.3 p-10 -65.52 -32.37 73.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.405 -177.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -68.39 -31.82 71.46 Favored 'General case' 0 CA--C 1.511 -0.529 0 CA-C-O 121.683 0.754 . . . . 0.0 111.087 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.493 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 95.1 m-85 -85.07 -2.92 58.54 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 -171.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.463 ' HE2' ' HA3' ' A' ' 120' ' ' GLY . 51.4 mttt -84.03 99.55 10.51 Favored 'General case' 0 N--CA 1.435 -1.175 0 CA-C-N 113.88 -1.509 . . . . 0.0 109.371 177.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 118' ' ' PRO . . . 132.94 -9.13 5.17 Favored Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 -169.533 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 32.1 mttp -121.01 165.55 15.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 114.928 -0.636 . . . . 0.0 109.32 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -84.92 117.37 23.89 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 169.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 8.5 t -109.32 115.82 50.53 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-O 120.866 0.365 . . . . 0.0 111.856 -169.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.523 HD11 HD22 ' A' ' 132' ' ' LEU . 34.3 tp -97.01 105.02 17.09 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 171.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.426 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 15.8 t -96.45 108.55 21.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-O 120.988 0.423 . . . . 0.0 110.938 -173.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -102.98 116.83 33.3 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.406 179.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -95.26 121.37 36.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.177 177.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 69' ' ' SER . 29.9 p-90 -152.97 -178.24 6.79 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.95 0.405 . . . . 0.0 111.279 -175.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -168.73 162.8 11.82 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.095 -0.957 . . . . 0.0 108.487 168.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -58.45 -30.95 67.33 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.398 0.518 . . . . 0.0 112.398 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -58.76 -50.65 65.22 Favored Glycine 0 CA--C 1.519 0.306 0 C-N-CA 121.141 -0.552 . . . . 0.0 112.801 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 86.2 m -78.92 99.64 6.89 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.162 0.506 . . . . 0.0 110.634 -179.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.514 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 59.2 m -63.6 -35.04 79.18 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.384 -179.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.599 ' HA ' ' HG2' ' A' ' 46' ' ' LYS . 71.3 t-105 -60.67 -33.95 73.6 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.658 -0.246 . . . . 0.0 111.452 -176.101 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HA ' ' HG3' ' A' ' 111' ' ' PRO . 58.3 m -60.08 -37.88 81.23 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.504 0.669 . . . . 0.0 110.341 177.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.706 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 42.2 mtm180 -84.96 -12.21 53.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.216 -0.902 . . . . 0.0 111.648 -176.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.599 ' HG2' ' HA ' ' A' ' 43' ' ' TRP . 51.5 mmtt -70.76 -21.74 62.48 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.201 0.524 . . . . 0.0 110.865 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 mm-40 -90.09 -2.05 58.04 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.973 178.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.52 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 86.7 m -52.48 -49.0 88.09 Favored Pre-proline 0 CA--C 1.539 0.542 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.52 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 71.6 Cg_exo -50.68 -44.53 40.11 Favored 'Trans proline' 0 C--N 1.357 1.022 0 C-N-CA 122.011 1.807 . . . . 0.0 112.454 177.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 91.3 m-85 -69.27 -39.22 78.52 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.71 -179.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 96.6 mt -61.47 -48.57 80.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.41 175.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 46.0 tp -59.22 -40.42 85.76 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.729 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.43 -50.9 70.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.354 176.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 24.2 m -62.18 -46.56 88.38 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.959 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.449 ' HB2' HD12 ' A' ' 65' ' ' ILE . 60.6 t80 -55.53 -51.98 65.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.011 179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 30.3 m-80 -67.42 -25.97 66.19 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -174.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -82.83 -27.94 30.53 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.53 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 92.9 m-85 -120.59 1.28 10.59 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -174.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 59.5 pttt -61.35 -27.57 68.6 Favored 'General case' 0 N--CA 1.469 0.508 0 CA-C-O 121.112 0.482 . . . . 0.0 111.786 -176.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -82.14 -6.5 59.23 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.275 -177.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 49.5 mttp -110.92 31.41 6.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.424 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.89 39.21 64.81 Favored Glycine 0 C--O 1.227 -0.329 0 C-N-CA 120.6 -0.81 . . . . 0.0 111.575 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.53 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 51.0 t80 -135.6 140.42 44.59 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.749 -0.463 . . . . 0.0 109.749 -176.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 7.3 t -150.06 147.51 27.9 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.293 177.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.449 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -87.61 126.16 41.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 173.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 7.8 t80 -97.85 93.9 6.61 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.724 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -78.11 107.15 2.4 Favored Glycine 0 N--CA 1.444 -0.783 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.826 -176.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.8 t -106.96 111.97 37.93 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.897 0 CA-C-O 120.734 0.302 . . . . 0.0 110.421 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 32.6 t -116.06 160.01 20.9 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.047 0.451 . . . . 0.0 110.43 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.516 ' HB ' HD12 ' A' ' 93' ' ' LEU . 12.3 t -131.31 30.44 4.49 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.542 -0.753 . . . . 0.0 109.493 178.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 34.2 m-20 -51.84 147.95 6.31 Favored 'General case' 0 CA--C 1.518 -0.257 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.553 175.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -78.93 -10.75 59.91 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.019 -171.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.422 ' HB3' ' OE1' ' A' ' 75' ' ' GLU . 46.7 mtm180 -137.72 149.4 46.45 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.813 -0.63 . . . . 0.0 109.653 175.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.53 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 15.8 tt0 -72.68 -32.9 66.15 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.422 ' OE1' ' HB3' ' A' ' 73' ' ' ARG . 1.7 mp0 -60.34 -40.89 92.27 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.084 178.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -72.36 -37.16 68.88 Favored 'General case' 0 CA--C 1.515 -0.395 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.019 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.9 t90 -61.33 -51.2 69.82 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.306 175.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.53 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -59.17 -39.24 81.88 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.901 0.381 . . . . 0.0 110.419 175.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.407 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 4.0 ttpm? -61.89 -48.45 80.44 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.938 -0.573 . . . . 0.0 110.742 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -63.65 -33.35 75.43 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.373 -176.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.9 mt -64.11 -41.24 91.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.268 175.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.2 tp10 -70.82 -37.59 73.21 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.424 176.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.4 mt-10 -54.22 -48.28 71.24 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.262 176.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.706 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.7 m-20 -104.02 0.81 30.31 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -173.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.499 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 63.2 mmtt 58.61 34.76 24.09 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.998 0.428 . . . . 0.0 111.52 179.387 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.6 p -82.67 75.79 9.56 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.475 0.655 . . . . 0.0 111.048 -178.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.499 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 69.3 m-85 -87.85 89.47 8.01 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.982 -0.553 . . . . 0.0 111.507 -177.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 12.1 p90 -158.55 -177.15 6.32 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.04 172.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -68.57 100.95 1.18 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.059 0.457 . . . . 0.0 111.184 -175.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.724 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 41.0 mt-30 -123.78 151.71 43.01 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.678 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.3 m -135.86 154.51 34.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.085 0.469 . . . . 0.0 110.824 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.1 tp -99.85 130.33 46.03 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 174.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.516 HD12 ' HB ' ' A' ' 70' ' ' THR . 80.9 mt -65.32 140.24 58.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.894 0.378 . . . . 0.0 111.693 -177.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 98' ' ' VAL . 84.2 mt-30 -73.08 157.98 36.25 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 174.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 23.1 pttm -57.94 -36.82 73.05 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -170.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.7 m-20 -88.84 -31.14 18.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.67 0.271 . . . . 0.0 111.075 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -65.1 -35.89 82.58 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.217 -177.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 94' ' ' GLN . 87.0 t -48.5 -45.82 14.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.014 174.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -60.16 -62.66 1.71 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.531 -171.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -67.98 -55.45 12.64 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.112 -174.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 75.4 t -52.38 -51.91 29.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 O-C-N 123.345 0.403 . . . . 0.0 111.927 -174.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 34.8 mt -61.97 -51.39 68.27 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 120.798 -0.361 . . . . 0.0 110.943 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -58.79 -60.3 4.06 Favored 'General case' 0 C--N 1.324 -0.507 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.389 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 66.1 m -50.67 -38.26 45.57 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 124.054 0.942 . . . . 0.0 113.385 -172.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.464 ' HE1' ' HB1' ' A' ' 9' ' ' ALA . 17.2 m-85 -78.05 13.74 1.34 Allowed 'General case' 0 C--O 1.235 0.315 0 C-N-CA 120.609 -0.436 . . . . 0.0 111.354 179.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.668 ' SG ' ' HB2' ' A' ' 2' ' ' SER . 34.9 m 63.47 44.19 5.5 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 123.785 0.678 . . . . 0.0 109.614 -179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 61.2 mt -105.94 92.73 2.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 C-N-CA 120.143 -0.623 . . . . 0.0 112.137 -173.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 13.7 t -109.3 -0.01 9.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-O 121.787 0.803 . . . . 0.0 109.013 172.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -146.75 155.66 26.64 Favored Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.507 -0.77 . . . . 0.0 112.026 -178.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.64 152.73 79.1 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 -178.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.535 ' HG3' ' HA ' ' A' ' 44' ' ' CYS . 92.0 Cg_endo -85.51 134.21 18.21 Favored 'Cis proline' 0 C--N 1.348 0.527 0 C-N-CA 123.593 -1.419 . . . . 0.0 112.736 -0.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 2.6 t-80 -103.32 114.0 27.94 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.481 HD13 HD11 ' A' ' 132' ' ' LEU . 61.8 mt -113.97 130.34 68.3 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.941 -173.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.426 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 29.6 pt -133.34 143.98 37.53 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.964 179.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.73 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 52.3 tp -107.47 118.01 35.59 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 177.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.538 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 60.3 t -107.31 138.33 33.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.611 -175.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.546 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.4 OUTLIER -84.36 167.98 24.13 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.538 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 2.3 Cg_endo -46.01 -42.61 20.67 Favored 'Trans proline' 0 C--N 1.351 0.704 0 C-N-CA 123.184 2.589 . . . . 0.0 114.195 178.933 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.503 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 40.7 mt-10 -76.4 -24.54 54.07 Favored 'General case' 0 C--O 1.237 0.403 0 O-C-N 122.175 -0.328 . . . . 0.0 111.497 -178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.479 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 109.6 33.13 2.74 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.514 -0.85 . . . . 0.0 113.867 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.503 ' HE3' ' HB2' ' A' ' 119' ' ' GLU . 2.1 mptt -100.59 149.45 23.72 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 117.774 0.787 . . . . 0.0 109.476 174.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 5' ' ' THR . 50.7 mt -85.37 97.42 5.6 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-O 120.89 0.376 . . . . 0.0 110.321 177.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.963 ' HA ' HG23 ' A' ' 5' ' ' THR . 4.9 p -86.09 -50.28 14.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -178.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.73 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -115.64 153.97 30.32 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.455 ' HG3' ' HE2' ' A' ' 1' ' ' MET . 13.1 pttm -169.46 153.75 5.35 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 121.194 -0.202 . . . . 0.0 111.148 -173.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.441 ' CG ' ' HB3' ' A' ' 1' ' ' MET . 2.7 mm-40 68.43 13.79 9.04 Favored 'General case' 0 N--CA 1.47 0.562 0 O-C-N 124.273 0.983 . . . . 0.0 111.413 176.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.573 HD11 ' HB1' ' A' ' 124' ' ' ALA . 68.2 mt -70.28 156.78 38.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.814 -178.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.521 ' O ' ' HG ' ' A' ' 132' ' ' LEU . 3.5 mmp_? -101.22 170.45 8.24 Favored 'General case' 0 C--O 1.219 -0.504 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.58 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 132' ' ' LEU . . . -47.23 -68.49 1.14 Allowed Glycine 0 CA--C 1.518 0.271 0 N-CA-C 114.77 0.668 . . . . 0.0 114.77 -173.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 6.9 t70 -69.29 -31.16 69.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 121.197 0.522 . . . . 0.0 110.187 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -62.91 -38.7 92.01 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.094 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.523 HD22 HD11 ' A' ' 33' ' ' LEU . 63.6 mt -52.16 -51.06 60.33 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.24 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -59.09 -50.72 72.97 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.452 -179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 47.6 m-80 -61.91 -42.44 99.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.276 -178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.598 ' HA ' ' HG2' ' A' ' 138' ' ' LYS . 15.9 m -72.78 -39.67 66.55 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.727 -179.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 132' ' ' LEU . 72.6 t -67.18 -35.61 74.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 175.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.45 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 3.3 tp10 -59.76 -55.17 37.65 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.598 ' HG2' ' HA ' ' A' ' 135' ' ' THR . 18.8 pttp -63.31 -17.33 62.42 Favored 'General case' 0 N--CA 1.438 -1.038 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.058 -177.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-30 -88.96 -61.43 1.71 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 173.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.5 t -82.24 -36.31 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -169.415 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.45 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 51.3 t-20 -71.15 -63.4 1.11 Allowed 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 -179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 39.89 -135.42 1.86 Allowed Glycine 0 C--N 1.337 0.617 0 O-C-N 124.413 1.071 . . . . 0.0 114.662 173.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -108.55 128.12 54.54 Favored 'General case' 0 C--N 1.327 -0.411 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 178.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.407 ' HD2' ' N ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -138.58 -17.24 1.13 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.921 0.391 . . . . 0.0 111.04 -171.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.564 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.1 OUTLIER -93.71 -27.13 16.7 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.679 179.173 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -61.83 147.34 48.49 Favored Glycine 0 N--CA 1.446 -0.655 0 CA-C-N 115.437 -0.802 . . . . 0.0 112.254 177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 52.8 t-80 -59.64 109.33 0.89 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.968 0.413 . . . . 0.0 110.921 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 84.1 m-70 -78.92 163.72 25.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.028 -179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 30.0 p80 -81.37 145.5 30.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 -178.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.509 ' HD1' ' C ' ' A' ' 152' ' ' HIS . 1.8 p80 -62.19 154.73 26.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.0 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -93.31 -18.29 22.61 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.403 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.509 ' C ' ' HD1' ' A' ' 150' ' ' HIS . 10.5 m-70 . . . . . 0 C--O 1.241 0.622 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.56 ' HA ' ' SG ' ' A' ' 106' ' ' CYS . 27.2 ptm . . . . . 0 N--CA 1.482 1.135 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 m -133.26 -75.66 0.49 Allowed 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.815 0.34 . . . . 0.0 110.13 179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.591 HD22 ' HB3' ' A' ' 7' ' ' SER . 68.7 mt -105.55 143.8 33.2 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 178.235 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -135.25 -90.99 0.31 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.54 0.21 . . . . 0.0 111.286 -178.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.6 p -127.38 128.97 46.74 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.94 5.18 89.96 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 111.466 -0.654 . . . . 0.0 111.466 -177.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.591 ' HB3' HD22 ' A' ' 3' ' ' LEU . 5.5 m -84.43 140.95 31.16 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.613 -0.294 . . . . 0.0 110.456 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 63.5 t -72.42 127.32 34.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.81 0.338 . . . . 0.0 110.491 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.63 124.96 59.25 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.166 -177.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 25.1 Cg_exo -63.47 158.54 44.86 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.741 2.294 . . . . 0.0 112.311 177.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -74.62 116.13 14.96 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.941 -179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.824 HD12 HG22 ' A' ' 101' ' ' VAL . 43.3 mm -96.29 150.64 4.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.166 179.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.441 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 9.0 t -131.19 138.91 49.61 Favored 'General case' 0 N--CA 1.45 -0.445 0 CA-C-O 121.413 0.625 . . . . 0.0 110.743 178.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.92 160.85 29.05 Favored Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 121.054 -0.593 . . . . 0.0 111.644 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.486 ' HB ' ' HB3' ' A' ' 92' ' ' LEU . 66.6 mt -79.73 113.87 19.72 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 177.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.476 ' CG ' ' HD3' ' A' ' 18' ' ' LYS . 11.9 p30 -81.92 179.1 7.95 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.721 -173.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.1 mt -74.28 -15.59 60.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.693 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.476 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 2.0 mppt? -77.23 -32.76 56.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.351 0.596 . . . . 0.0 109.722 179.239 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 118.91 18.41 4.72 Favored Glycine 0 N--CA 1.448 -0.538 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.985 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.44 HD22 ' HB2' ' A' ' 18' ' ' LYS . 8.4 m-80 -113.97 149.08 35.82 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.718 0.294 . . . . 0.0 110.6 -177.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.0 p -81.81 90.58 6.41 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 168.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 3.8 p -106.36 166.14 3.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.984 -169.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.708 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 8.3 m -105.13 173.97 6.08 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.781 0.324 . . . . 0.0 110.603 178.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.65 HD11 HG11 ' A' ' 32' ' ' VAL . 63.1 tp -57.04 -23.11 44.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.846 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.708 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 3.3 p-10 -65.59 -16.9 64.16 Favored 'General case' 0 N--CA 1.465 0.278 0 N-CA-C 111.988 0.366 . . . . 0.0 111.988 -176.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -60.29 -36.56 78.16 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.237 0.542 . . . . 0.0 110.75 178.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -119.71 10.97 11.83 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.831 -178.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.678 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 48.6 tttp -72.7 121.94 20.65 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.509 -179.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 150.96 -23.71 1.01 Allowed Glycine 0 N--CA 1.451 -0.306 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.576 ' HD3' ' HB ' ' A' ' 64' ' ' THR . 27.5 mttm -103.09 174.71 5.75 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 174.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.1 m-85 -72.22 109.32 5.89 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 165.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.65 HG11 HD11 ' A' ' 24' ' ' LEU . 57.5 t -94.52 108.07 20.24 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.075 0 CA-C-N 115.153 -0.931 . . . . 0.0 111.18 -171.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.528 ' HB3' HG12 ' A' ' 65' ' ' ILE . 23.4 tp -85.64 109.94 18.92 Favored 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.542 ' HB ' HG12 ' A' ' 114' ' ' ILE . 39.6 t -88.73 121.57 39.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-O 121.253 0.549 . . . . 0.0 110.369 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.439 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 0.1 OUTLIER -104.99 108.99 20.81 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.816 -1.084 . . . . 0.0 111.007 -172.625 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.495 ' HZ ' ' HD2' ' A' ' 105' ' ' TYR . 88.1 m-85 -94.37 115.11 27.27 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 110.066 -0.346 . . . . 0.0 110.066 177.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 5.0 p-90 -155.64 176.59 12.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.363 0.602 . . . . 0.0 111.475 -177.305 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -170.07 149.25 3.54 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.592 -1.185 . . . . 0.0 109.109 171.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.431 ' H ' ' CG ' ' A' ' 71' ' ' ASP . . . -72.7 5.05 3.38 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.986 -174.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -92.13 -14.39 56.16 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.108 174.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 41.9 t -99.35 134.36 42.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.856 0.36 . . . . 0.0 110.422 -179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.3 m -67.37 -40.26 85.72 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.439 -179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -75.36 -28.5 59.59 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.657 -174.028 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.535 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 85.6 m -58.54 -37.65 76.12 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.533 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 15.2 mmt180 -66.62 -21.27 66.12 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-O 121.323 0.582 . . . . 0.0 110.714 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.431 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 5.3 mptp? -86.35 -31.9 21.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.756 -176.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.8 mm-40 -78.91 -25.27 43.74 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.049 -177.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.824 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.5 m -50.98 -51.21 69.59 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -176.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.587 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 73.1 Cg_exo -52.05 -39.58 69.83 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 122.278 1.985 . . . . 0.0 112.988 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -71.19 -35.32 71.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.821 0.343 . . . . 0.0 110.813 -179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.719 HD21 HD13 ' A' ' 113' ' ' ILE . 89.5 mt -66.77 -44.66 80.79 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.345 175.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 56.1 tp -59.27 -44.31 92.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.358 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 53' ' ' LYS . 34.2 ttpt -53.52 -56.36 17.66 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-N 115.68 -0.691 . . . . 0.0 110.707 175.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 13.4 m -65.22 -42.8 93.11 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.236 -0.893 . . . . 0.0 111.51 -176.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.722 ' HB2' HD12 ' A' ' 65' ' ' ILE . 83.3 t80 -61.95 -51.64 67.28 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.639 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.604 ' HA ' ' HE3' ' A' ' 59' ' ' LYS . 49.4 t30 -55.7 -42.17 74.83 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.291 -176.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -69.31 -43.25 74.14 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -177.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 70.3 m-85 -106.72 -1.12 23.01 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 -170.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.604 ' HE3' ' HA ' ' A' ' 56' ' ' ASN . 12.0 pttp -62.85 -25.79 68.45 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.078 0.466 . . . . 0.0 110.574 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.45 -23.26 64.59 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.044 -0.98 . . . . 0.0 110.668 176.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 38.9 mttm -110.85 -161.96 0.77 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.556 -172.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -79.75 47.59 3.32 Favored Glycine 0 C--O 1.224 -0.474 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.672 -178.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.54 ' HB3' ' HB3' ' A' ' 58' ' ' PHE . 79.0 t80 -142.71 153.46 43.38 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 -178.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.576 ' HB ' ' HD3' ' A' ' 30' ' ' LYS . 14.8 t -162.56 170.33 18.77 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.676 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.722 HD12 ' HB2' ' A' ' 55' ' ' TYR . 44.4 mt -120.2 124.43 72.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.075 0.464 . . . . 0.0 110.425 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.449 ' HA ' ' O ' ' A' ' 89' ' ' ASN . 59.8 t80 -105.26 95.81 6.09 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.277 -178.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 35' ' ' ASP . . . -83.14 135.44 13.91 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.142 -177.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.521 ' HB ' HD11 ' A' ' 93' ' ' LEU . 16.8 m -125.84 118.89 53.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 CA-C-O 121.274 0.559 . . . . 0.0 110.622 178.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 26.6 t -125.66 151.17 46.9 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.53 179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.1 t -131.18 45.38 2.82 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.751 0.786 . . . . 0.0 108.997 176.329 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.431 ' CG ' ' H ' ' A' ' 39' ' ' ALA . 1.3 m-20 -60.62 -176.5 0.06 Allowed 'General case' 0 C--O 1.239 0.509 0 CA-C-N 115.122 -0.944 . . . . 0.0 112.9 -177.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 32.5 mtt85 -62.31 -39.8 94.21 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.286 -172.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.537 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 13.0 tpt180 -151.23 158.29 43.71 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.405 -171.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.421 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 25.5 tt0 -66.88 -44.94 79.61 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.702 -178.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.537 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 2.1 pm0 -70.5 -27.81 64.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.828 0.346 . . . . 0.0 110.084 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' HA ' ' HE3' ' A' ' 79' ' ' LYS . 21.7 t0 -62.01 -42.57 99.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 171.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 25.1 t90 -68.0 -49.69 60.05 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.825 177.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.421 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -52.72 -44.43 66.37 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.262 0.554 . . . . 0.0 110.287 174.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.429 ' HE3' ' HA ' ' A' ' 76' ' ' ASP . 13.9 ttpp -61.69 -44.29 97.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.062 177.222 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.93 -36.1 78.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.966 0.413 . . . . 0.0 111.193 -178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.46 ' HA ' ' OG ' ' A' ' 86' ' ' SER . 79.8 mt -62.53 -43.71 98.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.127 175.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -66.01 -38.84 89.48 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.72 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.402 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.7 mt-10 -58.47 -58.61 7.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.879 0.371 . . . . 0.0 111.329 178.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.824 ' HB3' HG21 ' A' ' 48' ' ' THR . 1.1 m-20 -85.2 -5.88 59.3 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.366 -173.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.44 ' N ' ' HD2' ' A' ' 85' ' ' LYS . 3.9 mptp? 61.22 34.03 18.93 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-O 121.511 0.672 . . . . 0.0 110.451 -175.577 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.46 ' OG ' ' HA ' ' A' ' 81' ' ' ILE . 0.3 OUTLIER -80.09 58.32 2.94 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.278 179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -79.77 75.06 6.46 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.45 -176.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.41 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 25.4 p90 -140.84 -168.35 2.57 Favored 'General case' 0 C--N 1.327 -0.383 0 C-N-CA 121.004 -0.279 . . . . 0.0 110.709 170.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.449 ' O ' ' HA ' ' A' ' 66' ' ' TYR . 11.2 m120 -74.46 86.86 2.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.731 -174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.416 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 20.7 mt-30 -113.42 148.27 36.19 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.724 0.297 . . . . 0.0 110.566 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.9 m -131.43 150.78 34.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.318 177.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.486 ' HB3' ' HB ' ' A' ' 15' ' ' ILE . 49.0 tp -88.38 114.1 24.65 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.558 176.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.521 HD11 ' HB ' ' A' ' 68' ' ' VAL . 85.6 mt -69.18 135.51 50.74 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.295 -179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.658 ' O ' HG23 ' A' ' 98' ' ' VAL . 61.7 mt-30 -72.11 148.26 45.9 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 178.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.438 ' HD3' ' HA ' ' A' ' 95' ' ' LYS . 74.2 mmtt -63.06 -30.07 71.31 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 112.214 0.45 . . . . 0.0 112.214 -169.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.525 ' O ' ' HB3' ' A' ' 99' ' ' LYS . 22.2 t70 -83.85 -40.16 19.02 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.871 0.367 . . . . 0.0 110.083 174.482 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 94' ' ' GLN . 2.1 t70 -56.19 -40.54 74.13 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.765 179.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.658 HG23 ' O ' ' A' ' 94' ' ' GLN . 96.8 t -48.39 -37.85 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.527 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.563 179.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.525 ' HB3' ' O ' ' A' ' 96' ' ' ASP . 3.6 ttpp -54.74 -56.0 23.91 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.228 179.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -71.86 -40.47 68.97 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.818 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.824 HG22 HD12 ' A' ' 12' ' ' ILE . 61.9 t -57.17 -60.52 1.96 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.591 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.008 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.509 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 49.4 mt -57.13 -57.26 13.34 Favored 'General case' 0 CA--C 1.514 -0.442 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.854 -176.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -54.68 -61.73 2.12 Favored 'General case' 0 C--O 1.24 0.568 0 O-C-N 123.355 0.409 . . . . 0.0 110.711 -174.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.434 ' C ' ' H ' ' A' ' 106' ' ' CYS . 39.7 m -53.23 -41.51 65.46 Favored 'General case' 0 C--N 1.342 0.262 0 O-C-N 124.206 0.941 . . . . 0.0 112.858 -171.746 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.495 ' HD2' ' HZ ' ' A' ' 36' ' ' PHE . 6.6 m-85 -74.17 12.26 0.77 Allowed 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 120.798 -0.361 . . . . 0.0 111.187 179.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.56 ' SG ' ' HA ' ' A' ' 1' ' ' MET . 36.3 t 62.95 41.28 8.6 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.047 -0.723 . . . . 0.0 109.047 -177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.509 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.2 mm -112.64 122.32 66.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.357 -174.261 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.3 m -131.18 21.89 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.665 -179.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -174.01 168.23 40.97 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 119.847 -1.168 . . . . 0.0 113.391 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -131.6 150.7 77.06 Favored Pre-proline 0 C--N 1.329 -0.307 0 C-N-CA 122.583 0.353 . . . . 0.0 110.094 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -92.35 137.92 8.61 Favored 'Cis proline' 0 N--CA 1.455 -0.742 0 C-N-CA 123.728 -1.364 . . . . 0.0 112.025 -1.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 13.4 m-70 -134.09 139.18 45.77 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.719 HD13 HD21 ' A' ' 51' ' ' LEU . 61.5 mt -128.77 136.7 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.522 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.558 HG22 ' HB2' ' A' ' 125' ' ' LYS . 33.0 pt -126.36 159.65 35.04 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.478 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 69.1 tp -120.45 117.1 26.83 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.621 0.248 . . . . 0.0 110.636 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.407 HG12 ' O ' ' A' ' 117' ' ' ASP . 74.1 t -111.84 127.36 69.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.652 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.563 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 2.8 p30 -67.68 163.35 49.52 Favored Pre-proline 0 C--N 1.327 -0.392 0 CA-C-N 116.712 -0.222 . . . . 0.0 110.815 175.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.547 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -49.95 -37.21 46.13 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.309 2.673 . . . . 0.0 113.248 179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 31.3 mt-10 -62.47 -36.76 83.48 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 121.349 0.595 . . . . 0.0 110.339 -179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 112.65 37.51 1.42 Allowed Glycine 0 N--CA 1.446 -0.647 0 CA-C-N 115.534 -0.757 . . . . 0.0 112.357 -178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.563 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 9.1 mtmp? -117.35 141.93 47.72 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.854 0.359 . . . . 0.0 110.096 174.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 mt -80.67 104.45 9.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.097 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 21.6 t -75.6 -40.06 40.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 121.2 0.524 . . . . 0.0 110.451 -177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -148.69 156.4 42.33 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.61 -0.723 . . . . 0.0 109.203 178.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.842 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 0.9 OUTLIER -154.22 171.89 18.49 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 120.893 -0.323 . . . . 0.0 111.235 -178.117 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.842 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 8.7 mm-40 60.75 32.36 20.2 Favored 'General case' 0 N--CA 1.465 0.322 0 O-C-N 124.174 0.921 . . . . 0.0 110.32 -178.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 90.6 mt -74.64 134.79 41.99 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.876 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 12.7 tpt180 -77.88 147.34 35.13 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.633 174.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -43.76 -51.19 7.0 Favored Glycine 0 CA--C 1.522 0.504 0 N-CA-C 114.103 0.401 . . . . 0.0 114.103 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -68.22 -34.33 76.04 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.176 0.512 . . . . 0.0 110.6 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -82.76 -34.05 27.22 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.266 -0.879 . . . . 0.0 112.071 -168.492 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 136' ' ' VAL . 4.5 pp -58.2 -32.47 68.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.464 -0.334 . . . . 0.0 110.752 -178.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 81.3 t80 -71.18 -42.34 69.16 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 65.3 m-20 -61.17 -42.71 99.06 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.273 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 1.4 p -69.06 -53.22 21.53 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.807 -179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 132' ' ' LEU . 27.4 m -61.02 -38.81 80.35 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.721 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -177.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.428 ' HG3' ' HB3' ' A' ' 141' ' ' ASN . 37.0 tt0 -64.96 -41.54 95.38 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.509 -0.314 . . . . 0.0 110.346 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 20.8 ttpp -66.48 -23.15 66.22 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.909 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -88.14 -61.36 1.73 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.84 0.352 . . . . 0.0 111.716 176.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 44.1 t -84.5 -47.47 17.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -169.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.428 ' HB3' ' HG3' ' A' ' 137' ' ' GLU . 63.7 t30 -78.1 -56.88 4.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.265 0.555 . . . . 0.0 110.362 -174.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -94.86 67.39 1.28 Allowed Glycine 0 N--CA 1.444 -0.794 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 176.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -43.55 129.68 5.24 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 113.159 0.8 . . . . 0.0 113.159 -173.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.458 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 30.0 mmtm -128.49 85.91 2.39 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.594 176.526 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -115.97 -39.26 3.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.891 -174.285 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 123.13 35.14 0.73 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 111.123 -0.791 . . . . 0.0 111.123 -176.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -42.53 110.76 0.2 Allowed 'General case' 0 N--CA 1.465 0.291 0 CA-C-O 121.734 0.778 . . . . 0.0 112.222 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -117.46 3.51 12.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.114 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 7.3 p-80 -154.89 126.05 7.22 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.443 178.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -169.9 99.97 0.3 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.948 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -117.51 148.81 41.52 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 . . . . . 0 C--O 1.247 0.963 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 171.142 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.2 ttp . . . . . 0 N--CA 1.482 1.144 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.502 ' HB3' ' O ' ' A' ' 105' ' ' TYR . 0.9 OUTLIER -71.26 74.61 0.71 Allowed 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 -173.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.518 ' HB2' HD12 ' A' ' 122' ' ' ILE . 89.4 mt 57.62 17.04 3.74 Favored 'General case' 0 N--CA 1.47 0.571 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 170.527 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 56.7 -135.12 1.22 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.452 0.168 . . . . 0.0 110.915 179.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.2 p -132.36 134.64 45.43 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.685 0.279 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 95.33 -11.76 68.62 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 112.614 178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 28.9 t -78.25 151.4 33.09 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.804 0.335 . . . . 0.0 110.237 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 39.0 t -73.87 129.0 36.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.457 -178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.52 139.8 41.31 Favored Pre-proline 0 C--N 1.322 -0.62 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.458 178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.477 ' HD2' ' CZ ' ' A' ' 105' ' ' TYR . 51.8 Cg_exo -54.63 154.41 20.44 Favored 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.928 2.419 . . . . 0.0 112.599 177.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -82.28 91.68 6.81 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.33 -176.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.526 HG21 HG11 ' A' ' 68' ' ' VAL . 45.6 mt -64.25 135.03 28.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.158 175.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.8 m -133.06 100.4 4.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.02 0.438 . . . . 0.0 110.473 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -115.78 176.93 16.82 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.451 -0.881 . . . . 0.0 112.506 -175.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 68.1 mt -114.0 123.08 69.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -81.89 -174.7 5.2 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 120.928 0.394 . . . . 0.0 111.029 -174.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.449 ' H ' HD12 ' A' ' 17' ' ' LEU . 6.1 mp -64.7 -25.12 67.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.855 -175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.62 -21.93 51.53 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.1 0.476 . . . . 0.0 110.894 178.282 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.24 19.66 27.59 Favored Glycine 0 N--CA 1.445 -0.753 0 N-CA-C 111.301 -0.72 . . . . 0.0 111.301 -173.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.513 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.8 OUTLIER -96.5 145.14 25.95 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.821 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.9 p -80.99 99.36 8.39 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.837 0.351 . . . . 0.0 110.3 177.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.43 131.12 54.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.873 -179.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.6 m -110.4 171.57 7.38 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.972 0.415 . . . . 0.0 110.981 -175.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 57.0 tp -69.7 -23.81 63.48 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.278 0.561 . . . . 0.0 110.409 176.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.468 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 8.2 t30 -64.31 -31.47 72.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.592 -0.731 . . . . 0.0 111.375 -178.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -72.74 -5.22 36.29 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.433 -175.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -115.75 7.23 14.59 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.468 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 9.0 mtpm? -71.39 92.35 1.07 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.385 179.061 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 167.64 -24.35 0.12 Allowed Glycine 0 N--CA 1.449 -0.5 0 N-CA-C 110.591 -1.004 . . . . 0.0 110.591 -176.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -121.51 172.85 7.78 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 174.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.526 ' HB3' HD11 ' A' ' 115' ' ' LEU . 93.4 m-85 -78.19 116.64 18.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 172.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.65 ' HB ' HG23 ' A' ' 116' ' ' VAL . 22.6 t -102.92 119.85 51.91 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.11 0.481 . . . . 0.0 111.208 -172.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.441 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 17.4 tp -94.06 116.18 28.58 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 46.1 t -102.17 115.89 44.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.613 0.244 . . . . 0.0 110.947 -174.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -92.91 103.72 16.02 Favored 'General case' 0 CA--C 1.516 -0.357 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.647 -179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.532 ' HA ' HG23 ' A' ' 68' ' ' VAL . 91.6 m-85 -83.77 114.12 21.38 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.134 -1.062 . . . . 0.0 108.134 170.326 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.541 ' HZ3' HH12 ' A' ' 45' ' ' ARG . 11.1 p-90 -158.3 178.66 9.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.6 0.714 . . . . 0.0 112.537 -173.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 49.3 p90 -169.82 154.25 5.23 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-N 114.266 -1.334 . . . . 0.0 108.95 171.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.96 86.99 0.14 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.476 0.655 . . . . 0.0 110.337 176.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -176.1 -46.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.437 -1.065 . . . . 0.0 110.437 179.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -78.16 101.72 7.18 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.41 0.624 . . . . 0.0 109.464 173.443 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 13.2 m -66.12 -7.64 18.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.509 -0.769 . . . . 0.0 112.831 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.479 ' HE1' ' HD2' ' A' ' 128' ' ' ARG . 67.4 t-105 -78.77 -23.66 45.18 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.97 -0.292 . . . . 0.0 110.852 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 73.4 m -58.24 -42.4 86.29 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.541 HH12 ' HZ3' ' A' ' 37' ' ' TRP . 4.7 mpt_? -62.74 -16.48 57.8 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.234 178.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.446 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 2.2 mptm? -85.38 -31.55 22.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.3 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -84.04 -23.61 30.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.113 0.482 . . . . 0.0 110.143 -175.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.55 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 10.7 m -48.96 -50.18 63.91 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 114.237 1.199 . . . . 0.0 114.237 -175.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.55 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 81.8 Cg_exo -47.42 -47.55 17.42 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 122.42 2.08 . . . . 0.0 113.041 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.632 ' HB3' ' HB2' ' A' ' 133' ' ' TYR . 67.4 m-85 -75.46 -35.4 60.88 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.28 -179.605 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.512 HD21 HD13 ' A' ' 113' ' ' ILE . 92.0 mt -58.24 -52.61 64.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.63 177.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 55.1 tp -61.11 -42.94 99.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.346 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.598 ' HZ1' ' HE1' ' A' ' 133' ' ' TYR . 27.4 tptp -55.07 -52.15 64.11 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.14 174.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.416 HG22 ' CE2' ' A' ' 63' ' ' PHE . 30.8 m -64.11 -45.44 88.62 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.147 -178.018 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.59 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.8 t80 -58.24 -51.59 69.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.575 178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.5 t30 -64.24 -38.8 92.35 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.316 -176.265 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -72.6 -34.09 67.15 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.329 0.863 . . . . 0.0 113.329 -175.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CE1' ' HB2' ' A' ' 141' ' ' ASN . 21.5 m-85 -120.36 6.7 10.65 Favored 'General case' 0 C--O 1.237 0.413 0 N-CA-C 112.979 0.733 . . . . 0.0 112.979 -170.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.622 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 19.4 pttp -54.47 -50.34 67.97 Favored 'General case' 0 C--O 1.239 0.513 0 CA-C-O 121.005 0.431 . . . . 0.0 111.877 -177.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -71.68 -43.7 65.54 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.118 -175.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.644 ' NZ ' ' HA ' ' A' ' 141' ' ' ASN . 48.4 mtpt -55.04 -71.43 0.08 Allowed 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.462 -0.79 . . . . 0.0 111.46 -175.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -175.07 33.12 0.1 OUTLIER Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.157 -1.02 . . . . 0.0 112.4 -177.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.622 ' O ' ' HA ' ' A' ' 59' ' ' LYS . 78.4 t80 -137.06 139.01 41.02 Favored 'General case' 0 C--N 1.32 -0.702 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.464 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 50.3 m -149.58 141.11 23.39 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 177.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.59 HD12 ' HB2' ' A' ' 55' ' ' TYR . 33.5 mt -98.36 135.46 33.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.076 0.465 . . . . 0.0 110.695 -178.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.443 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 45.2 t80 -121.8 95.9 4.85 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.26 -0.882 . . . . 0.0 108.843 -179.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -83.5 124.3 6.52 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.687 -0.768 . . . . 0.0 111.979 -176.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 1.005 ' HB ' HD21 ' A' ' 93' ' ' LEU . 17.3 m -105.65 111.51 35.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 122.085 0.945 . . . . 0.0 109.78 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.606 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 7.3 m -104.81 137.67 42.24 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.164 -171.912 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.641 ' HB ' HD12 ' A' ' 93' ' ' LEU . 9.1 t -126.36 42.16 3.37 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 122.234 1.016 . . . . 0.0 108.868 175.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.606 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 8.8 m-20 -61.72 176.76 0.48 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 114.678 -1.147 . . . . 0.0 111.306 -178.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.8 mmm180 -80.63 -19.09 46.14 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.499 -168.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.57 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 5.8 tpt85 -165.64 161.72 18.45 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 -177.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.436 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.6 tt0 -67.16 -44.15 80.48 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 118.286 0.494 . . . . 0.0 110.119 -178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.57 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 1.8 mp0 -59.41 -39.61 83.97 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.512 175.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -63.14 -46.43 87.3 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.098 -0.955 . . . . 0.0 110.154 175.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.429 ' O ' HG13 ' A' ' 81' ' ' ILE . 21.0 t90 -59.08 -52.66 64.79 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.579 176.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.436 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.8 mptm? -53.81 -46.59 71.14 Favored 'General case' 0 C--O 1.238 0.479 0 CA-C-O 121.281 0.562 . . . . 0.0 110.163 176.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.485 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 0.7 OUTLIER -60.19 -42.35 94.85 Favored 'General case' 0 C--O 1.222 -0.384 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.378 175.659 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -64.54 -33.57 76.22 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.6 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.429 HG13 ' O ' ' A' ' 77' ' ' TRP . 79.0 mt -63.13 -47.81 90.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 175.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 30.4 tp10 -66.63 -37.69 85.36 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.463 176.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -58.17 -45.47 87.43 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 123.338 0.655 . . . . 0.0 111.075 177.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.523 ' O ' HG21 ' A' ' 48' ' ' THR . 15.2 t70 -87.2 -26.43 23.54 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.284 -0.871 . . . . 0.0 111.895 -171.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 84' ' ' ASP . 4.5 mptp? 70.99 21.09 5.06 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.006 0.523 . . . . 0.0 111.144 -173.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.7 p -82.25 76.0 9.15 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.892 175.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -84.48 78.62 9.79 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.41 -176.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 19.7 p90 -151.62 -172.61 4.27 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.521 173.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.437 HD22 ' N ' ' A' ' 89' ' ' ASN . 0.9 OUTLIER -69.79 108.46 3.95 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.196 0.522 . . . . 0.0 111.123 -175.029 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 77.3 mt-30 -122.51 152.3 40.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.533 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.8 146.39 29.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.058 176.758 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 20.3 tp -88.26 129.25 35.41 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 174.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 1.005 HD21 ' HB ' ' A' ' 68' ' ' VAL . 65.4 mt -63.92 138.47 58.48 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.944 -176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.559 ' O ' HG23 ' A' ' 98' ' ' VAL . 75.1 mt-30 -80.11 169.49 17.75 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.811 -178.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -51.67 -46.87 63.95 Favored 'General case' 0 N--CA 1.466 0.352 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 -175.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.925 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 23.6 m-20 -87.67 -33.73 18.69 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.616 0.246 . . . . 0.0 110.455 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.482 ' OD1' HD22 ' A' ' 93' ' ' LEU . 17.4 t70 -55.97 -45.01 79.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.637 -179.512 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 94' ' ' GLN . 76.2 t -49.64 -53.11 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.851 176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.925 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 9.5 mtmp? -60.31 -62.79 1.61 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.48 -174.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -72.49 -42.06 65.28 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.747 -168.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.538 HG13 ' HE2' ' A' ' 105' ' ' TYR . 53.5 t -68.48 -54.4 21.7 Favored 'Isoleucine or valine' 0 C--O 1.239 0.541 0 C-N-CA 121.344 -0.142 . . . . 0.0 111.233 -178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.487 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 48.9 mt -58.52 -43.51 89.17 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.047 -176.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -60.23 -61.26 2.73 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.013 177.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 71.8 m -49.25 -40.59 34.78 Favored 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 113.882 1.067 . . . . 0.0 113.882 -169.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.555 ' HB2' HG12 ' A' ' 107' ' ' ILE . 84.8 m-85 -76.52 11.89 1.46 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.546 -0.462 . . . . 0.0 111.046 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 92.7 m 60.18 42.45 15.34 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.366 0.666 . . . . 0.0 109.904 -175.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.555 HG12 ' HB2' ' A' ' 105' ' ' TYR . 36.1 mm -91.76 74.71 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-O 121.593 0.711 . . . . 0.0 110.691 -175.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 22.3 t -88.92 -19.04 7.68 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.897 177.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -138.9 148.69 20.17 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.428 -177.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -116.34 155.48 48.38 Favored Pre-proline 0 C--N 1.325 -0.482 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG2' ' HD1' ' A' ' 43' ' ' TRP . 2.3 Cg_endo -82.54 166.81 68.85 Favored 'Cis proline' 0 C--N 1.346 0.433 0 C-N-CA 123.841 -1.316 . . . . 0.0 112.279 -0.273 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.477 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.1 OUTLIER -144.39 109.08 4.91 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.106 178.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.512 HD13 HD21 ' A' ' 51' ' ' LEU . 79.2 mt -114.73 127.0 72.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-O 120.757 0.313 . . . . 0.0 110.267 -179.314 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 46.6 pt -124.23 160.35 28.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.105 -177.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.709 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 66.9 tp -124.9 114.18 18.84 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.005 0.431 . . . . 0.0 110.275 -179.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.65 HG23 ' HB ' ' A' ' 32' ' ' VAL . 4.7 m -104.99 144.65 14.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.698 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.024 178.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.597 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.5 OUTLIER -76.07 172.91 8.18 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 115.741 -0.663 . . . . 0.0 109.439 177.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.597 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 7.3 Cg_endo -51.71 -24.78 18.71 Favored 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 122.931 2.421 . . . . 0.0 113.721 176.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.459 ' HB2' ' OD2' ' A' ' 117' ' ' ASP . 0.7 OUTLIER -88.61 1.01 55.78 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.191 -0.318 . . . . 0.0 111.796 179.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 78.04 27.54 58.05 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.709 174.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.9 mttt -111.62 142.19 44.25 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.128 0.49 . . . . 0.0 110.241 179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.518 HD12 ' HB2' ' A' ' 3' ' ' LEU . 39.3 mt -72.96 104.68 2.16 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.284 -173.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 31.4 m -94.87 -26.46 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 121.232 0.539 . . . . 0.0 110.298 177.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.709 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -144.87 151.02 38.08 Favored 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 175.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.506 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 20.3 pttp -161.66 154.26 20.18 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.348 -0.541 . . . . 0.0 111.89 -174.821 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.477 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 28.9 mt-10 62.55 29.93 17.05 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.147 -0.933 . . . . 0.0 111.368 169.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 64.8 mt -80.21 165.66 22.18 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.273 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.479 ' HD2' ' HE1' ' A' ' 43' ' ' TRP . 18.1 mmt180 -115.87 166.25 12.17 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 176.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -42.29 -64.18 1.62 Allowed Glycine 0 C--O 1.234 0.124 0 O-C-N 124.012 0.82 . . . . 0.0 114.432 -174.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -56.02 -36.58 68.12 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.942 0.401 . . . . 0.0 110.837 -177.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -80.37 -50.24 10.4 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.196 -174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.461 HD12 ' N ' ' A' ' 133' ' ' TYR . 4.6 pp -57.13 -34.4 68.36 Favored 'General case' 0 CA--C 1.519 -0.219 0 CA-C-O 120.872 0.368 . . . . 0.0 110.187 -177.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.632 ' HB2' ' HB3' ' A' ' 50' ' ' TYR . 50.1 t80 -64.84 -57.43 8.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.094 174.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -58.22 -43.83 87.89 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.079 -179.185 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.418 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 17.6 m -65.94 -49.04 69.36 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.897 -178.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 77.7 t -69.24 -40.95 80.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.146 -178.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 15.1 tt0 -65.29 -36.66 84.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.351 0.596 . . . . 0.0 109.897 178.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.418 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 14.1 ttpp -61.73 -39.94 93.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.788 176.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 42.8 m-85 -88.27 -53.79 4.52 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 40.3 t -82.78 -21.47 9.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 112.23 0.455 . . . . 0.0 112.23 -169.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.644 ' HA ' ' NZ ' ' A' ' 61' ' ' LYS . 65.8 t30 -93.89 -62.09 1.42 Allowed 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 119.973 -0.691 . . . . 0.0 110.475 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 178.23 116.88 0.51 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.894 -0.67 . . . . 0.0 111.993 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -74.5 -44.54 50.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.927 0.394 . . . . 0.0 111.12 -178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.1 mmmt -123.11 137.53 54.9 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.334 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -85.52 18.85 2.59 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.925 -0.579 . . . . 0.0 111.107 -177.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -95.0 123.36 7.56 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.213 -177.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.7 p-80 -70.08 109.5 4.61 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.255 0.55 . . . . 0.0 110.61 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -92.57 2.94 56.42 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.32 0.581 . . . . 0.0 110.011 -179.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 24.2 t-80 -78.8 68.5 4.78 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.578 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.7 t-80 -155.1 6.65 0.25 Allowed 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.704 176.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 85.9 t60 61.78 79.6 0.25 Allowed 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 115.511 -0.768 . . . . 0.0 111.134 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 t60 . . . . . 0 C--O 1.242 0.698 0 CA-C-O 118.213 -0.899 . . . . 0.0 108.797 176.28 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.483 1.189 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.4 m -89.05 166.45 13.87 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 176.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.521 HD22 ' HB3' ' A' ' 7' ' ' SER . 77.0 mt -83.63 144.83 29.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.236 179.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.5 ' HA ' ' HE2' ' A' ' 125' ' ' LYS . . . -135.18 -92.58 0.29 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.718 -0.219 . . . . 0.0 111.017 -179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.4 p -134.69 131.59 37.86 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.133 179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 86.0 -3.79 86.69 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.458 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.521 ' HB3' HD22 ' A' ' 3' ' ' LEU . 9.8 m -69.33 130.17 41.83 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.496 -0.352 . . . . 0.0 110.368 -179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.4 p -73.03 133.38 31.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 121.106 0.479 . . . . 0.0 110.289 179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -88.59 137.75 30.23 Favored Pre-proline 0 C--N 1.322 -0.607 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.24 -177.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 32.2 Cg_exo -61.34 162.28 20.84 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 123.012 2.475 . . . . 0.0 112.011 175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.6 96.9 9.81 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.792 0.33 . . . . 0.0 111.618 -176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.29 140.25 19.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.832 173.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 5.7 t -133.55 89.55 2.61 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 122.05 0.929 . . . . 0.0 110.286 174.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -101.45 155.51 18.98 Favored Glycine 0 N--CA 1.445 -0.759 0 CA-C-N 115.49 -0.777 . . . . 0.0 112.417 -174.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 72.7 mt -86.11 130.18 36.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 CA-C-O 120.606 0.241 . . . . 0.0 110.56 -178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.404 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -79.4 -174.45 4.21 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.304 -179.205 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -71.94 -7.13 46.77 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -174.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.525 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 34.8 mttp -99.78 -35.68 9.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.829 0.347 . . . . 0.0 110.549 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.37 10.5 2.99 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.314 -177.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.525 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.8 m-80 -91.77 134.18 34.97 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 -179.13 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.0 p -83.17 98.15 9.21 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.855 0.359 . . . . 0.0 110.215 177.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 24.5 t -99.16 137.08 27.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.009 -177.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -97.37 156.6 16.38 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.194 0.521 . . . . 0.0 111.437 -174.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 66.2 tp -61.13 -27.25 68.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.618 176.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.532 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.0 t30 -65.85 -31.08 71.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.839 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 39.6 m-20 -75.05 -7.64 54.26 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.206 0.527 . . . . 0.0 110.811 -176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 67.7 m-85 -110.84 3.14 18.72 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.201 -0.454 . . . . 0.0 109.91 -179.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.532 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 85.5 mttt -66.38 178.69 1.15 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.021 -177.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.05 10.56 85.42 Favored Glycine 0 N--CA 1.449 -0.491 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.497 -175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 34.2 mttp -143.17 167.43 22.13 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -178.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -81.9 110.47 17.21 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 168.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.3 t -104.2 109.46 27.4 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.933 0 CA-C-N 115.492 -0.776 . . . . 0.0 110.908 -172.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 28.7 tp -85.61 110.28 19.14 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 176.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.559 ' HB ' HG13 ' A' ' 114' ' ' ILE . 58.6 t -98.57 107.99 21.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.094 0.474 . . . . 0.0 110.664 -176.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -102.21 121.44 42.25 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.245 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -90.24 117.31 28.89 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.778 0.323 . . . . 0.0 110.166 177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.567 ' O ' ' HA ' ' A' ' 69' ' ' SER . 15.8 p-90 -144.14 177.21 8.75 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 121.011 0.434 . . . . 0.0 111.181 -177.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 47.4 p90 -170.67 162.0 7.7 Favored 'General case' 0 C--O 1.24 0.569 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.042 173.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.33 83.4 2.45 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.39 0.614 . . . . 0.0 110.661 -179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 173.8 -44.41 0.15 Allowed Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.472 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 53.8 t -70.63 117.72 12.51 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 177.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 43.3 m -68.61 -29.81 68.41 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.468 -177.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.45 ' O ' ' HG2' ' A' ' 47' ' ' GLU . 23.1 m95 -73.43 -40.69 64.04 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 121.234 -0.186 . . . . 0.0 111.463 -176.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.499 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 73.2 m -59.52 -25.5 64.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.832 0.349 . . . . 0.0 111.013 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 47.4 mmm-85 -84.94 -19.93 31.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.187 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HD3' ' O ' ' A' ' 42' ' ' SER . 13.6 mptt -85.7 -23.83 27.22 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.636 0.255 . . . . 0.0 111.235 -178.506 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 43' ' ' TRP . 4.0 mm-40 -78.27 -20.44 51.61 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.384 -179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.675 HG21 ' HB3' ' A' ' 84' ' ' ASP . 6.4 m -52.45 -50.89 77.52 Favored Pre-proline 0 CA--C 1.542 0.646 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 -177.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.591 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 82.4 Cg_exo -49.9 -48.13 20.68 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 122.164 1.909 . . . . 0.0 112.643 176.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -67.54 -39.65 85.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.304 0.574 . . . . 0.0 110.057 179.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.583 HD23 ' CZ2' ' A' ' 88' ' ' TRP . 13.3 tp -63.22 -41.29 99.1 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.726 -179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 tp -62.89 -42.24 99.7 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.612 178.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 28.4 ttpp -61.88 -41.95 98.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.993 176.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 30.3 m -60.65 -46.49 90.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.703 -0.68 . . . . 0.0 110.797 176.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.618 ' HB2' HD12 ' A' ' 65' ' ' ILE . 84.0 t80 -56.1 -57.78 10.73 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.991 178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.575 ' HA ' ' HD2' ' A' ' 59' ' ' LYS . 93.2 m-20 -60.8 -32.54 71.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 112.057 -175.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -79.7 -33.29 41.16 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -175.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.529 ' CZ ' ' HA ' ' A' ' 137' ' ' GLU . 90.2 m-85 -112.06 -2.17 15.12 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.616 -0.434 . . . . 0.0 111.759 -170.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.575 ' HD2' ' HA ' ' A' ' 56' ' ' ASN . 14.5 ptmm? -62.91 155.68 26.52 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.269 178.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' HG3' ' A' ' 59' ' ' LYS . 14.3 m-20 66.9 10.04 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.213 -1.358 . . . . 0.0 111.476 175.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.466 ' HG3' ' O ' ' A' ' 59' ' ' LYS . 47.3 mttp -123.25 25.04 8.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.879 0.371 . . . . 0.0 110.958 -177.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.87 27.7 33.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.59 -0.814 . . . . 0.0 112.153 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -134.46 140.93 46.59 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 14.8 t -147.79 160.34 42.84 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.262 176.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.618 HD12 ' HB2' ' A' ' 55' ' ' TYR . 64.0 mt -112.86 126.97 70.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.93 179.854 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 24.8 t80 -110.95 95.14 5.36 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.79 -176.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -80.26 109.5 2.94 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.884 -178.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.619 HG13 HD21 ' A' ' 93' ' ' LEU . 75.2 t -98.03 112.13 29.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 N-CA-C 110.047 -0.353 . . . . 0.0 110.047 -178.228 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 0.9 OUTLIER -113.29 145.6 40.78 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.947 -178.537 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.512 ' HB ' HD12 ' A' ' 93' ' ' LEU . 3.8 t -126.46 45.92 2.57 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.807 0.813 . . . . 0.0 110.616 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -72.52 171.42 12.41 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.639 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.536 HH22 HG11 ' A' ' 98' ' ' VAL . 22.0 mmt180 -115.52 2.93 13.94 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.692 0.758 . . . . 0.0 109.208 175.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.413 ' HB3' ' H ' ' A' ' 76' ' ' ASP . 85.6 mtt180 -124.05 124.26 42.14 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 114.286 -1.325 . . . . 0.0 110.035 175.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.588 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.0 tt0 -75.81 -33.91 60.13 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 174.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.472 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 1.0 OUTLIER -60.46 -51.28 70.15 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.737 178.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.413 ' H ' ' HB3' ' A' ' 73' ' ' ARG . 0.3 OUTLIER -64.57 -37.42 87.5 Favored 'General case' 0 C--O 1.223 -0.32 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.82 179.64 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.1 t90 -61.11 -52.36 65.21 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-O 120.712 0.291 . . . . 0.0 110.73 176.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.588 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.5 mptm? -57.14 -44.94 83.84 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.306 0.574 . . . . 0.0 110.668 176.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.498 ' HB3' ' HE3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -68.49 -33.81 74.8 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.082 -177.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.97 82.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.027 0.441 . . . . 0.0 110.721 178.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.34 -37.68 80.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.663 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 47.1 tp10 -65.91 -38.1 87.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.647 175.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 52.1 mt-10 -57.82 -60.06 4.28 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-O 121.051 0.453 . . . . 0.0 111.461 178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.675 ' HB3' HG21 ' A' ' 48' ' ' THR . 39.1 m-20 -85.11 -12.87 51.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.286 -172.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 66.8 mmtt 60.05 37.94 20.88 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 121.366 0.603 . . . . 0.0 110.972 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 37.0 p -77.0 114.32 15.68 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.237 179.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.3 m-85 -112.57 84.98 2.07 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.748 -0.381 . . . . 0.0 111.277 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.583 ' CZ2' HD23 ' A' ' 51' ' ' LEU . 11.1 p90 -158.6 -170.03 2.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.46 174.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 13.4 m120 -74.22 90.05 2.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.624 0.249 . . . . 0.0 110.913 -174.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -109.84 133.13 53.5 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.675 0.274 . . . . 0.0 110.48 179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 26.7 m -131.28 155.19 41.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.717 -179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 22.0 tp -104.98 123.52 47.92 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 176.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.619 HD21 HG13 ' A' ' 68' ' ' VAL . 82.1 mt -62.74 140.51 58.74 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.81 0.338 . . . . 0.0 111.166 -178.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.609 ' O ' HG23 ' A' ' 98' ' ' VAL . 44.8 mt-30 -73.41 166.62 22.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.912 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.471 ' HE2' ' HB3' ' A' ' 95' ' ' LYS . 20.2 mtpt -51.02 -58.43 6.09 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 121.508 0.67 . . . . 0.0 111.534 -176.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -80.27 -26.87 38.75 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.45 -176.183 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.429 ' OD2' HD22 ' A' ' 93' ' ' LEU . 28.0 t70 -64.25 -38.2 90.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.346 -0.843 . . . . 0.0 111.022 -179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.609 HG23 ' O ' ' A' ' 94' ' ' GLN . 55.2 t -49.8 -42.94 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.353 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.15 175.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 15.9 ttpp -58.56 -56.73 18.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.695 -177.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -72.45 -44.66 62.06 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.469 -173.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 76.2 t -60.68 -59.23 4.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 O-C-N 123.066 0.229 . . . . 0.0 111.378 -178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.564 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 37.2 mt -59.53 -42.85 93.22 Favored 'General case' 0 C--O 1.225 -0.226 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.45 -175.49 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -59.77 -62.17 2.07 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 120.463 -0.495 . . . . 0.0 110.224 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 59.3 p -53.72 -40.21 65.9 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 124.111 0.882 . . . . 0.0 113.167 -167.182 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.486 ' HA ' HD12 ' A' ' 3' ' ' LEU . 75.4 m-85 -75.62 12.03 1.15 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.752 0.31 . . . . 0.0 111.254 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 42.8 m 64.45 39.29 7.04 Favored 'General case' 0 CA--C 1.516 -0.338 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.478 179.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.564 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 44.8 mm -92.82 86.83 2.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 119.902 -0.719 . . . . 0.0 111.008 -173.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -94.48 -7.06 10.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.287 177.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -164.05 163.06 35.71 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.553 -178.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -120.1 156.27 54.87 Favored Pre-proline 0 C--N 1.325 -0.479 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 -179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.499 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 93.4 Cg_endo -80.12 175.73 43.41 Favored 'Cis proline' 0 C--N 1.346 0.444 0 C-N-CA 123.632 -1.403 . . . . 0.0 112.719 -0.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.609 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 0.3 OUTLIER -159.94 125.92 4.21 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.959 176.514 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 71.0 mt -126.1 135.05 65.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.16 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.611 HG22 ' HG3' ' A' ' 125' ' ' LYS . 34.7 pt -132.34 146.11 33.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 120.877 0.37 . . . . 0.0 111.057 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 53.6 tp -107.74 112.6 25.35 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 120.982 0.42 . . . . 0.0 110.024 177.385 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.402 ' CG1' ' HA2' ' A' ' 120' ' ' GLY . 96.2 t -100.5 135.04 38.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 115.617 -0.72 . . . . 0.0 110.772 -177.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.542 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.1 OUTLIER -80.42 167.09 35.58 Favored Pre-proline 0 C--N 1.325 -0.473 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.384 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.542 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 4.1 Cg_endo -47.41 -36.33 23.26 Favored 'Trans proline' 0 C--N 1.353 0.765 0 C-N-CA 123.61 2.873 . . . . 0.0 114.327 179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -74.67 -29.66 61.31 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.839 0.352 . . . . 0.0 111.236 -179.002 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.402 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 112.49 31.05 2.68 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.671 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 8.0 mtmp? -112.67 140.29 47.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.852 0.358 . . . . 0.0 110.284 177.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 48.7 mt -79.18 107.49 11.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.441 -178.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 28.5 m -90.39 -24.86 5.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-O 120.96 0.41 . . . . 0.0 111.035 -179.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.502 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -140.6 133.81 29.6 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.911 ' HG2' ' HG3' ' A' ' 126' ' ' GLU . 25.6 ttpp -134.5 137.04 43.56 Favored 'General case' 0 C--N 1.322 -0.63 0 C-N-CA 120.874 -0.331 . . . . 0.0 111.256 -174.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.911 ' HG3' ' HG2' ' A' ' 125' ' ' LYS . 49.3 mt-10 68.75 51.6 0.59 Allowed 'General case' 0 C--N 1.331 -0.208 0 O-C-N 124.158 0.911 . . . . 0.0 111.666 172.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 89.8 mt -82.41 157.23 23.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.516 174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.441 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 11.1 tpt85 -134.18 150.54 51.09 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.658 -0.247 . . . . 0.0 110.411 -173.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 49.38 -141.02 12.77 Favored Glycine 0 C--N 1.337 0.59 0 O-C-N 123.656 0.598 . . . . 0.0 113.927 168.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.65 -10.92 59.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.341 0.591 . . . . 0.0 110.138 177.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.3 m-20 -58.86 -33.17 70.17 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.126 178.073 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -65.89 -36.58 83.8 Favored 'General case' 0 C--O 1.231 0.1 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.407 ' N ' HD12 ' A' ' 132' ' ' LEU . 49.2 t80 -65.42 -50.3 65.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.017 177.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -60.71 -34.37 74.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.32 -178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 33.0 m -65.65 -51.03 62.67 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 120.932 0.396 . . . . 0.0 110.279 176.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 132' ' ' LEU . 86.2 t -63.15 -36.1 74.58 Favored 'Isoleucine or valine' 0 C--O 1.233 0.204 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.485 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.529 ' HA ' ' CZ ' ' A' ' 58' ' ' PHE . 5.2 tp10 -57.98 -44.12 86.91 Favored 'General case' 0 C--O 1.224 -0.248 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.893 176.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 3.3 ttpp -76.38 -16.39 59.73 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.881 -0.599 . . . . 0.0 111.059 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -86.65 -58.1 2.74 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.221 -0.299 . . . . 0.0 111.73 177.168 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 50.5 t -83.36 -55.03 7.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.876 0.369 . . . . 0.0 111.655 -173.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 13.2 t30 -78.01 -64.89 1.05 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.247 0.546 . . . . 0.0 111.155 -175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -99.82 54.6 0.93 Allowed Glycine 0 N--CA 1.443 -0.864 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.7 -176.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -56.06 -55.65 30.36 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.088 0.471 . . . . 0.0 110.415 177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 33.6 mmtp -136.1 9.25 3.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.368 172.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.459 ' HB3' ' H ' ' A' ' 146' ' ' GLY . 1.2 tm-20 -95.48 -87.19 0.29 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.387 -0.824 . . . . 0.0 110.114 -176.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.459 ' H ' ' HB3' ' A' ' 145' ' ' GLU . . . 85.49 39.79 8.13 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.545 -0.836 . . . . 0.0 112.295 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . 0.441 ' HB3' ' O ' ' A' ' 146' ' ' GLY . 50.4 t-80 77.44 -52.47 0.54 Allowed 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.411 0.684 . . . . 0.0 111.855 174.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 31.8 m170 45.46 -107.35 0.13 Allowed 'General case' 0 N--CA 1.465 0.298 0 O-C-N 123.638 0.586 . . . . 0.0 111.198 -176.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 46.0 t60 53.9 92.87 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.338 0 O-C-N 123.939 0.775 . . . . 0.0 112.185 177.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 29.6 m170 -98.16 165.2 12.0 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.581 178.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 60.1 t60 -152.61 148.37 27.24 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.03 -0.532 . . . . 0.0 109.994 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 40.6 p-80 . . . . . 0 C--N 1.323 -0.563 0 N-CA-C 107.842 -1.17 . . . . 0.0 107.842 168.027 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' O ' ' HB2' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.011 0 N-CA-C 110.159 -0.311 . . . . 0.0 110.159 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 1' ' ' MET . 38.9 t 172.76 140.33 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.009 -179.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.531 HD22 ' HB2' ' A' ' 7' ' ' SER . 97.2 mt -110.75 130.49 55.56 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 172.206 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.589 ' HA ' ' HD2' ' A' ' 125' ' ' LYS . . . -102.06 -90.12 0.36 Allowed 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 111.904 0.335 . . . . 0.0 111.904 -173.319 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 122' ' ' ILE . 17.3 p -136.65 125.21 23.64 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.931 -176.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 92.62 -16.74 59.4 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.927 178.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.531 ' HB2' HD22 ' A' ' 3' ' ' LEU . 4.5 p -75.33 132.68 41.14 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.64 -0.28 . . . . 0.0 110.944 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.568 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.2 p -72.3 137.1 24.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.477 179.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' HB1' ' CE1' ' A' ' 105' ' ' TYR . . . -107.48 145.56 31.51 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.125 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 31.2 Cg_exo -61.7 154.08 62.9 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 123.071 2.514 . . . . 0.0 112.464 176.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -73.27 139.14 45.95 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.185 -177.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 23' ' ' SER . 53.5 mt -95.03 137.88 22.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.527 -179.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 2.5 m -120.55 107.87 13.37 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.945 0.402 . . . . 0.0 110.543 178.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -139.01 154.11 23.12 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.18 -1.01 . . . . 0.0 112.719 -177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 59.5 mt -89.16 122.96 41.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -74.98 -178.82 3.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.342 0.591 . . . . 0.0 111.884 -172.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.459 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 95.3 mt -59.56 -31.03 69.06 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.292 -0.867 . . . . 0.0 111.818 -178.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -78.93 -35.66 42.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.827 0.346 . . . . 0.0 110.385 -178.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.33 21.5 3.05 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.08 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -105.88 145.9 30.65 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 110.299 -0.26 . . . . 0.0 110.299 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.5 p -77.32 104.53 7.88 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.236 177.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.5 t -103.91 143.29 15.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.999 -178.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 10.2 m -123.04 162.39 22.49 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.637 ' HA ' ' HD2' ' A' ' 27' ' ' PHE . 32.3 tp -63.76 -7.42 7.7 Favored 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.539 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 -65.8 -29.6 70.11 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.457 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -71.64 -27.76 63.3 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.844 0.83 . . . . 0.0 110.847 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.637 ' HD2' ' HA ' ' A' ' 24' ' ' LEU . 88.0 m-85 -87.88 4.03 46.21 Favored 'General case' 0 C--N 1.312 -1.028 0 N-CA-C 107.95 -1.13 . . . . 0.0 107.95 -171.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 12.1 mttm -84.3 87.45 7.2 Favored 'General case' 0 N--CA 1.437 -1.114 0 CA-C-N 113.696 -1.593 . . . . 0.0 109.798 177.053 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 139.79 -9.7 3.11 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.34 -173.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 31.5 mttp -117.05 163.38 16.34 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 175.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -84.95 120.66 26.75 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 170.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 6.8 t -106.35 124.33 61.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-O 121.094 0.473 . . . . 0.0 112.091 -169.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.609 HD11 HG23 ' A' ' 113' ' ' ILE . 2.7 tm? -104.19 98.02 7.89 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 173.779 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 48.6 t -92.5 124.26 44.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.652 -0.249 . . . . 0.0 111.069 -173.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.444 ' HA ' ' O ' ' A' ' 112' ' ' HIS . 21.0 t0 -120.19 144.83 47.5 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.255 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 110' ' ' PHE . 96.9 m-85 -117.04 119.64 35.91 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.127 174.051 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.715 ' HZ2' HD11 ' A' ' 81' ' ' ILE . 54.1 p-90 -148.07 175.09 11.29 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.453 0.644 . . . . 0.0 112.027 -176.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CD1' ' HE2' ' A' ' 110' ' ' PHE . 1.5 p90 -162.37 166.12 25.57 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.846 -1.07 . . . . 0.0 108.157 170.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -61.99 -22.7 65.89 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 -171.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -67.57 -38.13 90.16 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.962 -0.637 . . . . 0.0 113.432 -177.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 15.6 p -85.95 101.83 13.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.177 0.513 . . . . 0.0 110.373 -178.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 13.5 m -71.47 5.07 2.52 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.54 0.57 . . . . 0.0 112.54 -174.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 60.8 m95 -85.8 -30.27 23.14 Favored 'General case' 0 C--N 1.326 -0.42 0 O-C-N 122.31 -0.243 . . . . 0.0 111.294 179.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.608 ' SG ' ' HD2' ' A' ' 45' ' ' ARG . 21.1 p -68.56 -28.61 67.12 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.759 -177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.608 ' HD2' ' SG ' ' A' ' 44' ' ' CYS . 0.8 OUTLIER -77.62 -14.58 59.6 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-O 121.402 0.62 . . . . 0.0 109.408 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HD3' ' O ' ' A' ' 42' ' ' SER . 2.1 mptm? -79.54 -24.32 42.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.245 178.4 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.448 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 42.5 mt-10 -100.16 -0.24 39.24 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.22 -178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.526 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 85.5 m -50.43 -52.65 53.11 Favored Pre-proline 0 CA--C 1.541 0.601 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.92 175.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 48' ' ' THR . 10.8 Cg_endo -54.43 -40.99 80.77 Favored 'Trans proline' 0 C--N 1.359 1.121 0 C-N-CA 122.545 2.163 . . . . 0.0 113.156 178.771 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.448 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 51.9 m-85 -67.61 -44.6 77.67 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 120.983 0.421 . . . . 0.0 110.351 -178.926 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.9 mt -63.78 -40.82 97.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.605 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 60.9 tp -59.25 -46.52 88.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.679 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt -59.94 -46.91 87.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.205 0.526 . . . . 0.0 110.312 177.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.401 ' HA ' ' HD2' ' A' ' 133' ' ' TYR . 32.0 m -62.1 -49.7 74.85 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.73 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.558 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.6 t80 -62.34 -40.73 97.33 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.64 0.257 . . . . 0.0 110.967 -177.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -68.16 -34.15 75.79 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.287 -177.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.446 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.74 -26.91 23.95 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' HB3' ' HB3' ' A' ' 63' ' ' PHE . 51.1 m-85 -102.8 -8.55 20.7 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -174.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -56.49 -35.01 67.49 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 111.909 0.336 . . . . 0.0 111.909 -175.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -89.31 0.95 56.41 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.768 -176.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 88.1 mttt -105.54 19.71 20.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.036 -176.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.39 37.47 70.06 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.4 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.597 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 39.7 t80 -130.67 143.53 50.81 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 -176.023 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 t -145.76 136.2 24.07 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.447 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.558 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.0 mt -88.26 117.68 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 175.685 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -100.31 93.43 5.67 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.176 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.55 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -87.6 112.2 3.81 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.314 -178.291 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 36' ' ' PHE . 34.1 t -104.86 119.03 53.23 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-O 121.025 0.441 . . . . 0.0 110.712 -174.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.8 t -124.22 156.17 37.29 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.36 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.44 ' HB ' ' HB2' ' A' ' 93' ' ' LEU . 4.3 t -137.96 51.3 1.89 Allowed 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.822 0.82 . . . . 0.0 109.027 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.576 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 1.0 OUTLIER -66.67 -176.89 0.52 Allowed 'General case' 0 C--O 1.239 0.519 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.906 -174.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.576 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 3.6 ptm180 -77.23 -26.68 52.89 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.83 -1.077 . . . . 0.0 111.17 -175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.576 ' HB2' ' HG3' ' A' ' 72' ' ' ARG . 10.6 ttt180 -149.27 128.4 12.78 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.962 -166.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.41 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 18.7 tt0 -61.06 -42.25 98.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.308 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.574 ' O ' ' HB2' ' A' ' 79' ' ' LYS . 7.4 pt-20 -64.57 -41.6 96.19 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.736 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' N ' ' HG3' ' A' ' 75' ' ' GLU . 80.7 m-20 -66.28 -34.15 77.36 Favored 'General case' 0 CA--C 1.522 -0.131 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 178.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.621 ' O ' HG12 ' A' ' 81' ' ' ILE . 31.2 t90 -61.48 -60.65 3.39 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.07 173.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.503 ' HD2' ' CE3' ' A' ' 77' ' ' TRP . 2.6 mptm? -52.23 -43.02 64.07 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.245 0.545 . . . . 0.0 110.903 176.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.574 ' HB2' ' O ' ' A' ' 75' ' ' GLU . 29.5 ttmt -59.39 -49.67 76.9 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 110.857 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -66.79 -40.77 88.27 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.626 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.715 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 44.2 mm -56.19 -45.7 81.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.738 0.304 . . . . 0.0 110.961 178.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.722 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 10.7 tp10 -58.87 -59.26 5.73 Favored 'General case' 0 C--O 1.22 -0.471 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.742 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.504 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . 4.8 mm-40 -69.62 -33.56 72.83 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 113.245 0.832 . . . . 0.0 113.245 -172.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.419 ' CG ' HH21 ' A' ' 45' ' ' ARG . 35.2 t70 -71.51 -12.25 61.28 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.327 0.584 . . . . 0.0 110.352 177.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.722 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 44.0 mmtt 64.54 32.55 11.55 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.093 175.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.449 ' HB3' HG23 ' A' ' 48' ' ' THR . 0.3 OUTLIER -96.42 79.51 3.09 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.087 -0.96 . . . . 0.0 110.713 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -91.46 89.94 7.44 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.425 -175.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 22.2 p90 -156.63 176.68 12.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.652 171.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -64.96 97.58 0.24 Allowed 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.74 0.65 . . . . 0.0 111.711 -175.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.55 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 51.4 mt-30 -123.56 149.64 45.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.41 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.2 m -134.21 150.42 31.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.169 0.509 . . . . 0.0 111.24 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 30.2 tp -98.43 118.7 35.7 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.43 -0.805 . . . . 0.0 109.316 174.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.44 ' HB2' ' HB ' ' A' ' 70' ' ' THR . 53.9 mt -62.94 137.19 58.2 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.368 0.604 . . . . 0.0 111.962 -177.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.68 ' O ' HG23 ' A' ' 98' ' ' VAL . 22.4 mt-30 -73.5 145.79 45.37 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 107.765 -1.198 . . . . 0.0 107.765 169.193 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm -70.64 -16.1 62.79 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.681 0.753 . . . . 0.0 111.123 -170.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.536 ' HA ' ' HZ3' ' A' ' 99' ' ' LYS . 3.2 p-10 -78.7 -46.81 18.21 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.399 171.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -69.23 -34.69 75.22 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.137 0.575 . . . . 0.0 111.517 -178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.68 HG23 ' O ' ' A' ' 94' ' ' GLN . 48.7 t -43.59 -43.38 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 C-N-CA 123.516 0.727 . . . . 0.0 112.703 -178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.536 ' HZ3' ' HA ' ' A' ' 96' ' ' ASP . 60.6 mttp -54.97 -63.15 1.24 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.651 -0.704 . . . . 0.0 112.557 -169.875 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -71.0 -48.63 52.06 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.725 -173.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 81.8 t -52.38 -47.93 45.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.504 -176.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.526 HD22 HG13 ' A' ' 107' ' ' ILE . 25.7 mt -62.63 -59.36 5.03 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.58 178.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -52.62 -61.52 2.23 Favored 'General case' 0 C--O 1.241 0.65 0 O-C-N 123.209 0.318 . . . . 0.0 110.793 -176.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.411 ' C ' ' H ' ' A' ' 106' ' ' CYS . 70.9 m -56.29 -37.05 69.34 Favored 'General case' 0 C--N 1.338 0.091 0 O-C-N 124.211 0.945 . . . . 0.0 112.606 -172.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.488 ' CD2' HD11 ' A' ' 114' ' ' ILE . 4.2 m-85 -77.17 13.65 1.08 Allowed 'General case' 0 C--O 1.24 0.555 0 CA-C-O 120.956 0.408 . . . . 0.0 110.8 179.198 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.411 ' H ' ' C ' ' A' ' 104' ' ' SER . 49.2 t 63.9 60.74 1.01 Allowed 'General case' 0 C--O 1.235 0.32 0 CA-C-N 115.231 -0.895 . . . . 0.0 110.202 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.526 HG13 HD22 ' A' ' 102' ' ' LEU . 9.4 mm -85.44 93.59 3.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 122.074 0.94 . . . . 0.0 111.203 177.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 45.9 t -105.13 -31.76 2.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 114.576 -1.193 . . . . 0.0 108.78 171.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -157.64 151.66 22.89 Favored Glycine 0 N--CA 1.445 -0.752 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.349 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.65 ' HA ' ' C ' ' A' ' 111' ' ' PRO . 13.5 p90 -147.2 160.04 40.78 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 118.948 -0.548 . . . . 0.0 109.78 179.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.65 ' C ' ' HA ' ' A' ' 110' ' ' PHE . 3.8 Cg_endo -43.54 145.96 1.79 Allowed 'Cis proline' 0 C--N 1.364 1.347 0 CA-C-N 120.325 1.152 . . . . 0.0 114.944 2.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 35' ' ' ASP . 65.9 t60 -140.91 95.21 2.81 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.083 -173.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.609 HG23 HD11 ' A' ' 33' ' ' LEU . 96.6 mt -101.61 114.5 41.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.251 -172.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.488 HD11 ' CD2' ' A' ' 105' ' ' TYR . 48.2 pt -127.15 166.78 23.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 120.742 0.306 . . . . 0.0 110.983 179.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.0 118.14 32.59 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.819 -0.437 . . . . 0.0 109.819 -178.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.505 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 78.6 t -110.85 138.55 38.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.045 178.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.525 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.2 OUTLIER -92.52 170.07 9.67 Favored Pre-proline 0 CA--C 1.538 0.484 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.142 -179.316 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 1.5 Cg_endo -48.56 -36.84 32.77 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.35 2.7 . . . . 0.0 114.107 176.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -71.07 -22.07 62.16 Favored 'General case' 0 C--O 1.234 0.257 0 O-C-N 121.955 -0.466 . . . . 0.0 110.926 178.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 99.15 23.53 11.29 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.218 -0.515 . . . . 0.0 112.208 179.11 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.568 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 78.8 mttt -99.04 141.74 31.41 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.828 0.346 . . . . 0.0 110.096 179.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.443 ' O ' ' HA ' ' A' ' 5' ' ' THR . 33.2 mt -81.82 98.59 4.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 27.3 m -82.16 -21.89 9.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.173 -177.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.48 142.19 21.91 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 178.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.589 ' HD2' ' HA ' ' A' ' 4' ' ' ALA . 10.8 ptmm? -129.71 138.54 51.19 Favored 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.315 -176.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 67.78 46.0 1.35 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 114.989 -1.005 . . . . 0.0 112.17 167.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.437 ' O ' ' HD2' ' A' ' 128' ' ' ARG . 86.7 mt -70.35 151.16 45.55 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 171.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.694 ' O ' ' HB3' ' A' ' 131' ' ' ASP . 8.4 mmm180 -124.9 146.04 49.53 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.113 -0.635 . . . . 0.0 112.101 -171.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.455 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 44.31 -125.51 5.94 Favored Glycine 0 C--O 1.224 -0.479 0 CA-C-N 116.045 -0.525 . . . . 0.0 114.305 169.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -78.33 -20.92 50.41 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.793 0.33 . . . . 0.0 111.037 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.694 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 0.2 OUTLIER -51.03 -42.98 60.82 Favored 'General case' 0 CA--C 1.516 -0.356 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.824 177.223 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.4 pp -59.62 -34.35 72.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.602 -177.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.401 ' HD2' ' HA ' ' A' ' 54' ' ' THR . 40.8 t80 -68.92 -53.45 20.91 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.891 -0.411 . . . . 0.0 109.891 176.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -61.15 -42.97 99.51 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.517 -175.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.448 ' O ' ' HD1' ' A' ' 139' ' ' PHE . 24.3 m -66.75 -43.38 84.28 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.454 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.443 HG11 ' CE2' ' A' ' 63' ' ' PHE . 77.9 t -67.54 -40.98 85.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 C-N-CA 120.617 -0.433 . . . . 0.0 110.88 178.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.516 ' O ' ' HB3' ' A' ' 141' ' ' ASN . 2.8 tp10 -62.44 -34.27 76.45 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.488 0.661 . . . . 0.0 109.437 177.154 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 1.037 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 27.7 ttpp -62.26 -41.93 98.89 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.846 179.422 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.53 ' HA ' ' HB2' ' A' ' 145' ' ' GLU . 60.7 m-85 -80.68 -61.73 1.88 Allowed 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.981 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 60.6 t -72.88 -40.63 60.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.203 -169.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.516 ' HB3' ' O ' ' A' ' 137' ' ' GLU . 12.0 t30 -86.05 1.65 49.55 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.4 0.619 . . . . 0.0 110.295 -175.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 67.99 32.58 77.32 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.624 -0.716 . . . . 0.0 112.968 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 1.037 ' HB3' ' HA ' ' A' ' 138' ' ' LYS . . . -68.02 -30.88 70.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.598 0.237 . . . . 0.0 110.931 179.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' HB2' ' CG ' ' A' ' 138' ' ' LYS . 35.1 mmtm -142.97 -42.77 0.3 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.914 176.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.53 ' HB2' ' HA ' ' A' ' 139' ' ' PHE . 5.6 mp0 -81.87 20.45 0.97 Allowed 'General case' 0 C--O 1.236 0.346 0 CA-C-O 121.174 0.511 . . . . 0.0 111.02 179.192 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -65.54 144.72 47.65 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 111.379 -0.689 . . . . 0.0 111.379 176.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 64.9 m170 -83.18 57.91 4.19 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.121 0.486 . . . . 0.0 110.93 -174.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 10.6 t60 69.71 -58.11 0.53 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.745 -1.116 . . . . 0.0 111.913 177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -85.28 125.61 33.04 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.177 0.513 . . . . 0.0 110.316 -177.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.503 ' O ' ' HB2' ' A' ' 151' ' ' HIS . 4.6 p-80 -102.73 -14.54 16.62 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.451 -178.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.503 ' HB2' ' O ' ' A' ' 150' ' ' HIS . 3.0 t60 165.36 -38.49 0.0 OUTLIER 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 105.191 -2.152 . . . . 0.0 105.191 -178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 5.7 m170 . . . . . 0 C--O 1.244 0.813 0 CA-C-N 112.32 -2.218 . . . . 0.0 106.655 164.247 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.4 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.456 ' HB2' HD13 ' A' ' 3' ' ' LEU . 19.0 m 68.36 -66.74 0.22 Allowed 'General case' 0 N--CA 1.465 0.294 0 O-C-N 124.173 0.921 . . . . 0.0 110.606 -175.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.49 HD13 ' N ' ' A' ' 3' ' ' LEU . 0.0 OUTLIER -121.04 -177.73 3.57 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 174.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -143.87 166.44 24.92 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.385 -0.37 . . . . 0.0 110.539 -179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.7 p -70.61 119.13 14.31 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.508 178.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 127.89 -18.41 5.93 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.4 -177.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 55.5 p -78.14 154.37 31.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.619 0.247 . . . . 0.0 110.756 -179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.41 139.94 19.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.145 179.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -89.53 137.66 28.73 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.022 -177.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.578 ' HD2' ' CE1' ' A' ' 105' ' ' TYR . 53.7 Cg_exo -53.7 146.48 44.33 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.796 2.331 . . . . 0.0 112.014 174.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -70.13 119.55 14.49 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.108 -173.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.664 HG12 HD23 ' A' ' 24' ' ' LEU . 45.1 mm -93.24 129.35 43.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.671 174.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.1 m -134.61 108.1 7.86 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 174.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -121.29 170.71 14.73 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.552 -0.832 . . . . 0.0 112.356 -176.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.426 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 15.7 mt -100.24 115.91 42.48 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.843 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 179.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.503 ' HA ' ' HA ' ' A' ' 91' ' ' VAL . 27.6 p30 -75.04 -174.46 2.27 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.475 0.655 . . . . 0.0 112.63 -172.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.608 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 96.4 mt -60.22 -29.82 68.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.055 -177.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -80.48 -38.0 30.72 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.266 0.555 . . . . 0.0 110.297 -178.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.93 21.79 2.82 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.233 -0.894 . . . . 0.0 111.318 -176.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.658 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -97.58 141.83 30.14 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 -179.161 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.9 p -84.58 101.44 12.11 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 174.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 18.7 t -117.46 150.11 19.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 N-CA-C 110.097 -0.334 . . . . 0.0 110.097 -175.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 24.5 m -110.59 164.52 12.65 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.807 0.337 . . . . 0.0 111.238 -176.327 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.664 HD23 HG12 ' A' ' 12' ' ' ILE . 3.5 pp -63.85 -27.12 68.95 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-O 121.29 0.567 . . . . 0.0 110.129 178.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.0 t30 -60.79 -32.84 72.17 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.392 -178.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -80.28 -4.05 51.74 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.395 -171.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -118.77 8.69 11.88 Favored 'General case' 0 CA--C 1.515 -0.384 0 CA-C-O 121.355 0.598 . . . . 0.0 109.809 178.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.587 ' HB3' ' O ' ' A' ' 118' ' ' PRO . 36.1 mtmt -72.18 159.69 33.69 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.501 178.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 117.95 -28.31 7.05 Favored Glycine 0 N--CA 1.448 -0.538 0 N-CA-C 109.838 -1.305 . . . . 0.0 109.838 -171.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.534 ' HG3' ' O ' ' A' ' 152' ' ' HIS . 2.5 mptp? -108.56 169.79 8.43 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.243 -1.021 . . . . 0.0 108.243 169.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.58 ' HE2' HG11 ' A' ' 123' ' ' VAL . 4.1 m-85 -76.04 115.63 15.94 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 166.237 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.917 HG23 ' HB ' ' A' ' 116' ' ' VAL . 3.0 m -96.08 115.4 35.22 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 CA-C-O 121.795 0.807 . . . . 0.0 111.741 -171.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.699 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 2.8 tm? -84.66 109.11 17.76 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 114.598 -1.183 . . . . 0.0 108.527 176.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -99.19 107.31 20.35 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 120.968 0.413 . . . . 0.0 110.319 -177.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -101.32 129.47 47.31 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.057 -178.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -102.73 115.76 31.22 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 176.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.795 ' HB2' ' HB3' ' A' ' 44' ' ' CYS . 28.4 p-90 -147.9 172.67 13.8 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.147 0.499 . . . . 0.0 111.523 -177.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.459 ' HB2' ' CG ' ' A' ' 71' ' ' ASP . 20.4 p90 -167.27 155.99 9.9 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.089 171.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.59 -24.7 67.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.524 -173.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -59.46 -32.64 73.49 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 115.976 -0.556 . . . . 0.0 113.123 179.463 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.451 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 33.7 m -93.31 117.98 30.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.256 0.551 . . . . 0.0 110.676 177.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.524 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 11.1 m -65.19 -16.49 63.58 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.596 -0.729 . . . . 0.0 111.689 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 53.6 m95 -82.91 -32.06 27.46 Favored 'General case' 0 C--O 1.222 -0.369 0 CA-C-N 116.663 -0.244 . . . . 0.0 111.008 -179.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.795 ' HB3' ' HB2' ' A' ' 37' ' ' TRP . 78.7 m -58.71 -32.05 68.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.086 0.47 . . . . 0.0 110.632 177.449 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 16.3 mmt180 -73.52 -14.41 61.21 Favored 'General case' 0 C--O 1.223 -0.306 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.608 177.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' O ' ' HD2' ' A' ' 49' ' ' PRO . 14.2 mptt -86.64 -44.69 11.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.065 179.256 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.425 ' HA ' ' HD2' ' A' ' 50' ' ' TYR . 1.5 mp0 -68.31 -22.32 64.71 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.588 178.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.601 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 99.8 m -57.43 -53.18 68.23 Favored Pre-proline 0 CA--C 1.543 0.698 0 N-CA-C 112.319 0.489 . . . . 0.0 112.319 -178.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.605 ' HD2' ' O ' ' A' ' 46' ' ' LYS . 83.0 Cg_exo -49.97 -41.57 47.69 Favored 'Trans proline' 0 C--N 1.356 0.962 0 C-N-CA 122.455 2.103 . . . . 0.0 112.945 174.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.425 ' HD2' ' HA ' ' A' ' 47' ' ' GLU . 97.6 m-85 -65.65 -43.15 90.3 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-O 121.047 0.451 . . . . 0.0 110.304 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 98.0 mt -60.85 -38.43 85.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.416 176.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.406 ' HA ' ' CZ3' ' A' ' 88' ' ' TRP . 5.5 tt -61.63 -44.75 96.4 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.162 -0.472 . . . . 0.0 109.829 179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.851 ' HA ' ' ND2' ' A' ' 56' ' ' ASN . 38.1 ttpt -63.74 -42.73 97.83 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.005 0.431 . . . . 0.0 110.341 176.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 44.8 m -58.68 -46.72 86.61 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.009 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 68.1 t80 -64.47 -46.56 82.53 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.399 -0.364 . . . . 0.0 111.544 -177.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.851 ' ND2' ' HA ' ' A' ' 53' ' ' LYS . 11.4 p30 -68.41 -32.74 73.0 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.707 -0.397 . . . . 0.0 111.981 -173.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -87.83 -27.93 21.94 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CZ ' ' HG2' ' A' ' 137' ' ' GLU . 51.3 m-85 -105.69 -5.49 19.95 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.522 ' HA ' ' O ' ' A' ' 63' ' ' PHE . 13.6 pttm -60.63 -29.73 69.42 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.067 0.46 . . . . 0.0 110.991 -176.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -92.48 -3.24 55.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.299 -177.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.836 ' HB3' ' HE1' ' A' ' 149' ' ' HIS . 75.8 mttt -97.93 3.23 49.66 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.094 0.473 . . . . 0.0 110.299 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.86 43.39 5.43 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.504 -177.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.699 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 41.7 t80 -145.64 127.11 15.01 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 10.9 t -130.57 155.88 45.77 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.0 mt -105.09 120.61 55.96 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 CA-C-O 121.229 0.537 . . . . 0.0 110.93 -177.301 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.626 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 88.1 t80 -104.2 97.27 7.25 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 114.86 -1.064 . . . . 0.0 108.743 180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.608 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -91.81 136.65 13.38 Favored Glycine 0 N--CA 1.442 -0.938 0 C-N-CA 120.004 -1.093 . . . . 0.0 112.218 -175.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 91' ' ' VAL . 5.1 m -121.35 114.9 44.94 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 121.662 0.744 . . . . 0.0 110.023 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.3 t -90.85 151.48 21.13 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.275 179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.879 ' HA ' ' NZ ' ' A' ' 95' ' ' LYS . 6.5 t -136.09 38.67 2.76 Favored 'General case' 0 N--CA 1.433 -1.315 0 CA-C-O 121.468 0.652 . . . . 0.0 111.983 -177.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.459 ' CG ' ' HB2' ' A' ' 38' ' ' PHE . 18.2 m-20 -76.34 167.54 21.66 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.991 167.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.695 ' HD2' ' HG3' ' A' ' 95' ' ' LYS . 13.6 mmm180 -96.43 -11.59 25.42 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 173.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.442 HH11 ' HD3' ' A' ' 73' ' ' ARG . 40.8 mtp180 -111.21 108.32 17.93 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.866 -178.334 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.414 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.5 tt0 -69.64 -31.16 69.08 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.984 -177.094 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.1 pm0 -69.82 -36.22 75.43 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 -175.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.536 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 1.0 OUTLIER -76.26 -28.2 56.99 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 177.679 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.4 t90 -62.18 -52.76 62.5 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 120.857 -0.337 . . . . 0.0 110.217 171.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.608 ' HE2' ' HA ' ' A' ' 17' ' ' LEU . 1.9 mptm? -56.22 -42.48 77.31 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.279 0.562 . . . . 0.0 110.081 175.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 25.1 tttm -59.42 -50.22 74.78 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.231 176.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.511 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -56.56 -41.45 76.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.001 0.429 . . . . 0.0 111.623 -178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.456 HD11 ' HZ2' ' A' ' 37' ' ' TRP . 43.5 mm -63.47 -37.95 80.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.801 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -73.52 -33.44 64.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.692 176.572 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.547 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.2 mt-10 -65.26 -59.53 3.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.795 177.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' HB3' HG21 ' A' ' 48' ' ' THR . 2.5 m-20 -77.51 -9.72 59.07 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.815 -176.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.429 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 38.9 mmtm 59.94 35.04 21.65 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 121.47 0.652 . . . . 0.0 111.063 -179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.2 p -87.65 76.93 8.79 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.072 -177.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.429 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 76.2 m-85 -88.48 91.66 8.88 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.716 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.406 ' CZ3' ' HA ' ' A' ' 52' ' ' LEU . 26.7 p90 -151.52 -177.45 6.1 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.235 -0.439 . . . . 0.0 109.816 169.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.536 HD22 ' HD1' ' A' ' 66' ' ' TYR . 4.1 p-10 -72.51 88.82 1.24 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.805 0.812 . . . . 0.0 111.694 -174.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.608 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 55.2 mt-30 -111.09 144.75 39.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.186 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.503 ' HA ' ' HA ' ' A' ' 16' ' ' ASP . 29.6 m -132.91 145.52 34.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.439 175.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 16.3 tp -87.65 109.54 19.74 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 175.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.661 HD21 HG23 ' A' ' 12' ' ' ILE . 9.0 mt -62.15 147.43 47.63 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 108.609 -0.885 . . . . 0.0 108.609 176.452 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 40.8 mt-30 -69.47 141.73 53.91 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.879 ' NZ ' ' HA ' ' A' ' 70' ' ' THR . 5.3 mmmt -75.4 -28.68 59.53 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 120.093 -0.643 . . . . 0.0 111.536 -161.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.747 ' HA ' ' HD3' ' A' ' 99' ' ' LYS . 2.0 m-20 -89.95 -4.98 57.18 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.364 178.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.416 ' OD2' HD22 ' A' ' 93' ' ' LEU . 1.6 t70 -88.16 -48.17 7.91 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.562 172.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.555 ' O ' ' HG ' ' A' ' 102' ' ' LEU . 0.4 OUTLIER -45.13 -40.56 2.37 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.257 0 CA-C-N 114.779 -1.1 . . . . 0.0 111.893 179.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.747 ' HD3' ' HA ' ' A' ' 96' ' ' ASP . 39.6 mtpt -47.52 -59.52 3.19 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.977 -177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -68.49 -45.77 71.47 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.59 -175.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 45.9 t -58.08 -41.8 81.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.177 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 98' ' ' VAL . 94.6 mt -58.53 -53.84 53.82 Favored 'General case' 0 CA--C 1.516 -0.361 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.419 177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -52.72 -52.47 56.11 Favored 'General case' 0 C--N 1.329 -0.284 0 O-C-N 123.557 0.536 . . . . 0.0 109.712 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 34.0 m -53.28 -30.87 41.0 Favored 'General case' 0 CA--C 1.536 0.407 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -176.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.578 ' CE1' ' HD2' ' A' ' 10' ' ' PRO . 29.9 m-85 -80.44 8.32 7.91 Favored 'General case' 0 C--O 1.239 0.543 0 O-C-N 121.867 -0.521 . . . . 0.0 110.892 175.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.401 ' O ' HD13 ' A' ' 107' ' ' ILE . 21.9 t 66.2 46.73 2.0 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 123.716 0.806 . . . . 0.0 109.106 -174.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.496 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 20.0 mm -116.44 129.38 72.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.398 0 N-CA-C 112.57 0.581 . . . . 0.0 112.57 -171.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 23.7 m -129.63 14.0 2.47 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.208 -178.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.1 166.87 38.98 Favored Glycine 0 C--N 1.335 0.52 0 C-N-CA 119.434 -1.365 . . . . 0.0 114.246 -177.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -130.9 157.54 77.66 Favored Pre-proline 0 N--CA 1.463 0.212 0 C-N-CA 123.032 0.533 . . . . 0.0 110.581 -179.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.22 169.96 71.35 Favored 'Cis proline' 0 C--N 1.352 0.744 0 C-N-CA 123.626 -1.406 . . . . 0.0 112.113 -1.338 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.437 ' CE1' HG23 ' A' ' 114' ' ' ILE . 39.8 t-80 -147.01 134.51 20.87 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 120.583 -0.447 . . . . 0.0 111.675 -178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.561 HG21 HD22 ' A' ' 132' ' ' LEU . 4.9 mp -129.63 145.08 36.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.449 177.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.581 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 27.7 pt -133.42 163.28 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.896 0.379 . . . . 0.0 110.557 172.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.463 HD22 ' HD2' ' A' ' 31' ' ' TYR . 0.6 OUTLIER -123.35 118.13 26.8 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 177.505 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.917 ' HB ' HG23 ' A' ' 32' ' ' VAL . 76.6 t -108.84 138.13 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.99 -177.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 46.7 m-20 -62.62 160.73 32.81 Favored Pre-proline 0 C--O 1.233 0.195 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.341 175.435 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.587 ' O ' ' HB3' ' A' ' 28' ' ' LYS . 25.0 Cg_exo -59.91 -15.34 32.25 Favored 'Trans proline' 0 CA--C 1.53 0.315 0 C-N-CA 122.555 2.17 . . . . 0.0 111.726 173.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 14.7 mt-10 -83.18 -29.66 28.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.843 178.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 107.56 32.79 3.29 Favored Glycine 0 N--CA 1.45 -0.38 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.595 -174.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.564 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 10.1 mtmp? -111.92 150.87 29.88 Favored 'General case' 0 C--N 1.326 -0.444 0 O-C-N 122.684 -0.303 . . . . 0.0 110.473 176.648 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 49.7 mt -81.38 96.36 3.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.58 HG11 ' HE2' ' A' ' 31' ' ' TYR . 14.1 p -83.45 -29.21 7.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.128 0.49 . . . . 0.0 110.572 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -152.96 149.21 27.98 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.993 179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.574 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 13.0 ptmm? -151.23 163.36 39.04 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 178.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.574 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 23.7 mm-40 76.36 4.44 3.63 Favored 'General case' 0 N--CA 1.467 0.396 0 O-C-N 124.233 0.958 . . . . 0.0 112.026 177.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.44 ' O ' ' HD3' ' A' ' 128' ' ' ARG . 43.5 mt -59.7 136.11 57.89 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 109.095 -0.706 . . . . 0.0 109.095 174.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.44 ' HD3' ' O ' ' A' ' 127' ' ' LEU . 23.5 mmt-85 -133.78 173.19 11.81 Favored 'General case' 0 C--N 1.325 -0.469 0 C-N-CA 121.024 -0.27 . . . . 0.0 110.932 -176.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 45.09 -135.4 7.18 Favored Glycine 0 C--N 1.336 0.542 0 O-C-N 124.1 0.875 . . . . 0.0 114.127 172.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -78.34 -13.95 59.62 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.676 0.274 . . . . 0.0 111.018 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -60.7 -27.4 67.86 Favored 'General case' 0 C--O 1.222 -0.384 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.561 HD22 HG21 ' A' ' 113' ' ' ILE . 79.7 mt -47.66 -61.37 1.97 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.595 172.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 45.6 t80 -60.85 -49.91 75.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.623 179.372 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.524 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 85.1 m-20 -65.49 -26.49 67.95 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.238 -0.892 . . . . 0.0 111.506 -174.324 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 16.9 m -77.29 -33.3 55.76 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 111.456 0.169 . . . . 0.0 111.456 176.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 132' ' ' LEU . 24.4 t -63.33 -42.97 98.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 C-N-CA 120.122 -0.631 . . . . 0.0 109.807 176.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.952 ' HA ' HD22 ' A' ' 141' ' ' ASN . 58.3 mm-40 -67.22 -41.06 86.36 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.034 0.445 . . . . 0.0 110.554 173.074 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 22.0 ttpt -56.45 -56.48 20.66 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.457 -0.792 . . . . 0.0 111.143 179.358 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -88.29 -61.08 1.79 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.313 -174.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 48.8 t -68.99 -31.54 50.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 N-CA-C 112.234 0.457 . . . . 0.0 112.234 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.952 HD22 ' HA ' ' A' ' 137' ' ' GLU . 56.9 m-80 -93.69 -15.05 25.67 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.936 0.398 . . . . 0.0 110.699 178.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 73.1 16.32 78.54 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.008 -177.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 73.82 16.46 3.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.622 0.769 . . . . 0.0 112.358 -179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -163.08 127.12 2.92 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.323 0.583 . . . . 0.0 111.218 173.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -98.3 138.61 35.3 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.795 177.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 159.76 -58.37 0.32 Allowed Glycine 0 CA--C 1.506 -0.51 0 N-CA-C 110.221 -1.152 . . . . 0.0 110.221 -176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -76.12 77.36 2.95 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 168.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 43.6 m-70 -52.87 127.29 23.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.062 -0.972 . . . . 0.0 112.487 -167.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.836 ' HE1' ' HB3' ' A' ' 61' ' ' LYS . 2.8 p80 -88.16 27.75 1.17 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.146 -178.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 48.4 m-70 72.43 143.92 0.07 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-N 115.385 -0.825 . . . . 0.0 112.357 173.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -90.79 93.16 9.11 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.116 176.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.534 ' O ' ' HG3' ' A' ' 30' ' ' LYS . 9.7 p80 . . . . . 0 C--O 1.243 0.712 0 CA-C-O 119.164 -0.446 . . . . 0.0 110.838 -176.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 97.7 mmm . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 110.206 -0.294 . . . . 0.0 110.206 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 36.5 m -151.04 -171.22 3.87 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 85.5 mt -64.83 -87.36 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 175.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . 0.467 ' HB3' ' OG ' ' A' ' 7' ' ' SER . . . 178.79 155.16 0.43 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.792 175.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 p -74.93 109.26 8.24 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 115.88 -6.2 20.06 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.876 -0.678 . . . . 0.0 111.97 -175.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.467 ' OG ' ' HB3' ' A' ' 4' ' ' ALA . 50.0 m -76.86 138.7 39.95 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.706 0.288 . . . . 0.0 110.536 178.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.499 ' HA ' ' HA ' ' A' ' 121' ' ' LYS . 8.0 p -73.96 138.82 20.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.274 -178.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.499 ' HB1' ' CE2' ' A' ' 105' ' ' TYR . . . -92.55 150.83 40.51 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.353 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_exo -58.53 163.18 11.07 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 123.328 2.685 . . . . 0.0 112.267 174.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -85.66 102.46 13.61 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.853 0.359 . . . . 0.0 111.718 -174.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.631 HD11 ' CE1' ' A' ' 105' ' ' TYR . 50.6 mm -69.78 138.56 21.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.572 175.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 10.7 t -142.97 137.56 29.46 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 170.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -159.4 172.67 36.08 Favored Glycine 0 N--CA 1.447 -0.622 0 C-N-CA 120.033 -1.08 . . . . 0.0 112.584 -178.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.436 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -85.89 118.05 31.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.407 ' CG ' ' H ' ' A' ' 18' ' ' LYS . 0.1 OUTLIER -75.34 -176.99 3.34 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.177 0.513 . . . . 0.0 111.198 -173.219 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 89.3 mt -56.93 -29.45 63.12 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.683 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.495 ' HB2' ' ND2' ' A' ' 20' ' ' ASN . 29.9 mttp -85.99 -43.85 12.82 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.65 -178.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 133.29 15.36 1.3 Allowed Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.886 -0.673 . . . . 0.0 112.409 -177.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.495 ' ND2' ' HB2' ' A' ' 18' ' ' LYS . 15.6 m-80 -96.51 154.19 17.41 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.5 p -83.96 93.57 8.08 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.886 0.374 . . . . 0.0 110.333 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 61.1 t -100.17 138.95 22.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.753 -179.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.7 m -116.68 163.41 16.17 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.224 0.535 . . . . 0.0 111.407 -174.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 12' ' ' ILE . 62.1 tp -63.47 -23.93 67.61 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.886 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.548 ' HA ' ' HG3' ' A' ' 28' ' ' LYS . 9.4 t30 -64.19 -28.39 69.71 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.11 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -77.06 -4.58 45.0 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.234 -175.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -112.1 2.51 16.81 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.34 0.59 . . . . 0.0 109.42 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.548 ' HG3' ' HA ' ' A' ' 25' ' ' ASN . 41.2 mtpt -71.49 111.71 7.02 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.738 -178.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 141.91 -22.41 2.47 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.366 -1.093 . . . . 0.0 110.366 -175.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 74.3 mttt -115.05 170.51 8.3 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.091 -0.555 . . . . 0.0 109.619 173.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 91.1 m-85 -81.09 117.23 21.49 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 20.8 t -99.0 116.93 43.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.832 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.972 -172.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 0.9 OUTLIER -90.86 104.1 16.73 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 175.55 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.576 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 47.9 t -98.67 108.85 22.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.937 0.399 . . . . 0.0 110.92 -174.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.0 m-20 -98.5 115.83 29.41 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.563 -0.744 . . . . 0.0 110.29 178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -89.2 115.66 26.87 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 175.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.535 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 3.1 p-90 -155.7 -177.29 6.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.362 0.601 . . . . 0.0 111.452 -174.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.468 ' CE2' ' HB2' ' A' ' 41' ' ' CYS . 17.9 p90 -157.19 152.78 26.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.03 -0.986 . . . . 0.0 108.853 171.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.408 ' HB2' ' HA ' ' A' ' 77' ' ' TRP . . . -58.19 -45.12 88.15 Favored 'General case' 0 C--N 1.326 -0.425 0 O-C-N 123.556 0.535 . . . . 0.0 111.838 -171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . 0.854 ' HA3' HH12 ' A' ' 72' ' ' ARG . . . -82.76 45.79 3.48 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.716 -0.754 . . . . 0.0 113.401 -177.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.693 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 46.0 t -132.43 136.19 46.58 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 173.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.75 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 4.4 p -88.43 -15.09 36.36 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.684 0.624 . . . . 0.0 112.684 -174.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.566 ' HB3' ' HD3' ' A' ' 111' ' ' PRO . 39.9 m95 -85.92 -52.53 5.67 Favored 'General case' 0 C--O 1.22 -0.497 0 C-N-CA 120.713 -0.395 . . . . 0.0 111.781 -178.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.693 ' SG ' ' HB3' ' A' ' 41' ' ' CYS . 12.8 p -63.36 -24.66 67.95 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.26 0.552 . . . . 0.0 110.634 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.437 ' NH2' ' HB2' ' A' ' 83' ' ' GLU . 4.8 tpt180 -72.02 -14.39 61.86 Favored 'General case' 0 N--CA 1.439 -1.018 0 CA-C-N 115.626 -0.715 . . . . 0.0 110.888 176.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.75 ' HD3' ' O ' ' A' ' 42' ' ' SER . 1.2 mptm? -79.99 -40.08 28.69 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.882 -176.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.459 ' OE1' ' HG3' ' A' ' 111' ' ' PRO . 25.7 mp0 -80.33 -9.58 59.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.655 178.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.59 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 38.3 m -50.74 -50.22 74.69 Favored Pre-proline 0 CA--C 1.544 0.721 0 N-CA-C 112.551 0.574 . . . . 0.0 112.551 -176.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.59 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 51.9 Cg_exo -55.4 -42.52 67.39 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.052 1.835 . . . . 0.0 112.617 175.626 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 89.4 m-85 -68.08 -36.79 80.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 0.0 110.614 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 47' ' ' GLU . 96.0 mt -64.27 -41.69 96.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.513 176.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 58.7 tp -61.84 -44.56 96.6 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.165 177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -55.96 -48.88 74.97 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.393 174.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.402 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 33.9 m -62.55 -52.06 64.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.253 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.738 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.6 t80 -58.59 -43.4 89.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.68 0.276 . . . . 0.0 110.883 -178.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 59.0 t30 -61.79 -39.71 92.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.891 0.377 . . . . 0.0 111.293 -177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.63 -20.42 33.68 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 113.098 0.777 . . . . 0.0 113.098 -175.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.443 ' HD1' ' HD2' ' A' ' 61' ' ' LYS . 77.0 m-85 -121.94 9.12 9.95 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 113.028 0.751 . . . . 0.0 113.028 -173.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.458 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 17.5 pttm -64.23 -41.14 97.14 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.203 0.525 . . . . 0.0 111.606 -175.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.64 -24.79 41.64 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.39 -0.823 . . . . 0.0 111.113 -175.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.443 ' HD2' ' HD1' ' A' ' 58' ' ' PHE . 92.6 mttt -76.76 -172.11 2.14 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.169 178.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -78.15 49.64 3.27 Favored Glycine 0 C--O 1.227 -0.307 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.212 178.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 83.5 t80 -143.62 146.49 33.3 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 110.115 -0.328 . . . . 0.0 110.115 -176.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 94.8 m -156.86 136.96 12.71 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 175.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.738 HD12 ' HB2' ' A' ' 55' ' ' TYR . 43.5 mt -89.32 133.46 31.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.909 0.385 . . . . 0.0 110.388 179.326 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -116.76 101.97 9.02 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.532 -0.758 . . . . 0.0 109.177 -178.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -81.13 115.61 4.05 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.444 -176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.501 HG13 ' CD1' ' A' ' 93' ' ' LEU . 44.2 t -98.39 111.34 27.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.449 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 38.5 t -118.72 139.5 51.45 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.355 -178.621 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 5.7 t -134.77 35.58 3.12 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.428 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.593 ' OD1' ' HD2' ' A' ' 72' ' ' ARG . 4.2 t70 -65.8 165.63 12.49 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.777 -178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.854 HH12 ' HA3' ' A' ' 40' ' ' GLY . 0.0 OUTLIER -72.58 -25.24 61.26 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.836 -175.152 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.505 ' HG3' ' OE1' ' A' ' 75' ' ' GLU . 7.2 tpt180 -141.2 131.14 24.49 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.585 -173.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.552 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 22.2 tt0 -69.83 -32.83 71.46 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.024 0.44 . . . . 0.0 110.002 -179.353 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.505 ' OE1' ' HG3' ' A' ' 73' ' ' ARG . 3.5 mp0 -57.66 -42.46 83.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.814 179.265 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.472 ' HA ' ' HB3' ' A' ' 79' ' ' LYS . 31.5 t70 -73.07 -39.86 65.51 Favored 'General case' 0 C--O 1.223 -0.307 0 CA-C-O 120.895 0.379 . . . . 0.0 110.158 179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.526 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 27.6 t90 -52.64 -52.12 57.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.654 173.081 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.552 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 1.9 mptm? -62.46 -44.08 97.26 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-O 120.797 0.332 . . . . 0.0 110.792 176.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.472 ' HB3' ' HA ' ' A' ' 76' ' ' ASP . 18.3 tttm -57.4 -45.73 84.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.326 179.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.85 -45.52 82.35 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.572 178.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 87.2 mt -62.0 -34.86 65.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.885 179.449 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -66.53 -30.01 70.23 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.111 0.482 . . . . 0.0 110.208 177.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.437 ' HB2' ' NH2' ' A' ' 45' ' ' ARG . 67.7 mt-10 -75.89 -60.5 2.29 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.066 178.514 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.8 p30 -83.77 -18.91 36.17 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.81 -169.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.5 mmtm 72.88 28.12 2.05 Favored 'General case' 0 C--N 1.329 -0.326 0 O-C-N 123.592 0.557 . . . . 0.0 110.622 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -67.01 81.06 0.12 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.316 -0.856 . . . . 0.0 110.936 174.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -96.39 88.99 4.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.381 -178.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 31.1 p90 -155.15 178.29 10.38 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.022 169.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -71.66 102.72 2.85 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.145 -173.038 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.407 ' HB2' ' HZ2' ' A' ' 77' ' ' TRP . 44.6 mt-30 -119.85 155.06 33.36 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.321 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.3 m -133.66 143.74 37.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.927 -0.578 . . . . 0.0 110.501 177.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 31.2 tp -96.43 112.31 24.1 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 172.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.501 ' CD1' HG13 ' A' ' 68' ' ' VAL . 8.0 mp -71.83 157.35 38.05 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.307 -176.704 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -89.88 178.93 6.1 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.527 0.68 . . . . 0.0 111.08 -178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.517 ' H ' ' HE3' ' A' ' 95' ' ' LYS . 0.0 OUTLIER -77.38 -15.03 59.58 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.322 -178.132 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.491 ' N ' ' HD2' ' A' ' 95' ' ' LYS . 0.7 OUTLIER -83.98 -55.5 4.19 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 114.657 -1.156 . . . . 0.0 110.622 -175.975 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.418 ' O ' HG23 ' A' ' 101' ' ' VAL . 4.6 p30 -79.75 -30.7 40.89 Favored 'General case' 0 N--CA 1.446 -0.632 0 CA-C-N 115.627 -0.715 . . . . 0.0 112.556 -170.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 3.8 t -49.05 -32.25 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 112.266 0.469 . . . . 0.0 112.266 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 95' ' ' LYS . 73.8 mmtt -53.76 -63.5 1.13 Allowed 'General case' 0 C--O 1.238 0.458 0 CA-C-O 121.247 0.546 . . . . 0.0 110.711 -179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -55.67 -55.74 28.56 Favored 'General case' 0 C--O 1.222 -0.383 0 CA-C-N 114.856 -1.065 . . . . 0.0 110.442 178.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.485 HG21 HD23 ' A' ' 93' ' ' LEU . 61.5 t -46.43 -55.85 1.46 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.578 0 O-C-N 123.915 0.76 . . . . 0.0 112.129 -176.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.834 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 25.8 mt -62.07 -34.84 77.03 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.643 -176.519 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -77.21 -63.04 1.46 Allowed 'General case' 0 C--N 1.316 -0.882 0 C-N-CA 119.075 -1.05 . . . . 0.0 110.098 176.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 106' ' ' CYS . 60.8 p -53.4 -45.28 69.25 Favored 'General case' 0 N--CA 1.466 0.352 0 O-C-N 124.798 1.311 . . . . 0.0 113.27 -164.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.631 ' CE1' HD11 ' A' ' 12' ' ' ILE . 85.0 m-85 -75.75 13.15 0.87 Allowed 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.782 -0.367 . . . . 0.0 111.089 -178.318 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.428 ' H ' ' C ' ' A' ' 104' ' ' SER . 34.7 m 62.66 57.71 1.74 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.139 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.834 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 2.1 mp -85.43 110.88 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 C-N-CA 119.42 -0.912 . . . . 0.0 110.825 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 44.9 t -113.16 -27.35 2.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.956 175.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -158.53 178.48 34.73 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.816 -0.707 . . . . 0.0 111.914 -178.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -131.6 151.96 79.59 Favored Pre-proline 0 C--N 1.326 -0.448 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.566 ' HD3' ' HB3' ' A' ' 43' ' ' TRP . 86.1 Cg_endo -77.34 151.52 92.97 Favored 'Cis proline' 0 C--N 1.345 0.373 0 C-N-CA 123.212 -1.578 . . . . 0.0 112.32 0.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 23.0 t60 -121.59 113.61 20.03 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.813 -179.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.526 HD12 HH21 ' A' ' 128' ' ' ARG . 86.8 mt -117.74 139.44 44.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.4 -175.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.576 ' CG1' ' HB ' ' A' ' 34' ' ' VAL . 44.0 pt -134.9 145.45 32.3 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-O 120.92 0.39 . . . . 0.0 111.148 177.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 5.2 tt -104.38 110.08 22.19 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 176.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.504 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 88.7 t -102.42 136.94 32.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.059 -175.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.458 ' O ' HG12 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -77.77 169.85 19.06 Favored Pre-proline 0 CA--C 1.538 0.508 0 N-CA-C 109.984 -0.376 . . . . 0.0 109.984 175.843 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_exo -55.18 -29.14 64.93 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.802 2.334 . . . . 0.0 113.988 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.63 -4.25 55.65 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 120.94 0.4 . . . . 0.0 110.99 -179.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 86.33 30.15 22.97 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.609 176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.499 ' HA ' ' HA ' ' A' ' 8' ' ' VAL . 30.0 mttm -108.96 145.58 35.24 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.837 0.351 . . . . 0.0 110.522 178.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 23.8 mt -80.17 105.15 9.4 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.405 -177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 30.8 t -79.16 -48.49 21.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.492 -178.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -149.01 169.42 20.67 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.184 178.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.634 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 19.6 pttp -159.7 172.59 17.45 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.568 -0.453 . . . . 0.0 112.05 -179.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.634 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 2.0 mm-40 64.94 23.31 12.57 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.652 1.181 . . . . 0.0 111.318 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.403 ' HB2' HD23 ' A' ' 132' ' ' LEU . 83.9 mt -61.21 148.33 41.27 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 109.822 177.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.526 HH21 HD12 ' A' ' 113' ' ' ILE . 2.9 mmp_? -125.22 151.48 45.84 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -171.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 40.05 -126.19 2.54 Favored Glycine 0 C--N 1.336 0.534 0 O-C-N 124.175 0.922 . . . . 0.0 114.785 170.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.46 -10.04 59.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.682 -0.259 . . . . 0.0 111.674 -177.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.873 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 24.8 t70 -66.39 -33.46 75.76 Favored 'General case' 0 CA--C 1.512 -0.505 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.589 ' O ' HG23 ' A' ' 136' ' ' VAL . 53.5 mt -48.92 -52.95 21.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.559 170.041 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 64.2 t80 -63.44 -59.06 5.17 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.047 -0.979 . . . . 0.0 111.555 -178.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.873 ' ND2' ' HA ' ' A' ' 131' ' ' ASP . 4.6 p30 -66.94 -31.75 72.54 Favored 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.314 -172.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.617 ' HA ' ' HE2' ' A' ' 138' ' ' LYS . 19.1 m -70.66 -37.35 73.68 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.36 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 132' ' ' LEU . 81.3 t -61.16 -49.33 85.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.338 175.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.427 ' HG3' ' HB2' ' A' ' 141' ' ' ASN . 6.0 tp10 -61.44 -50.39 72.98 Favored 'General case' 0 C--O 1.223 -0.339 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 176.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.617 ' HE2' ' HA ' ' A' ' 135' ' ' THR . 15.7 ttpt -48.53 -37.44 17.69 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 123.517 0.727 . . . . 0.0 111.734 179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 13.7 t80 -87.96 -48.5 7.73 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -178.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 39.5 t -87.91 -25.48 5.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 N-CA-C 113.202 0.815 . . . . 0.0 113.202 -169.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.427 ' HB2' ' HG3' ' A' ' 137' ' ' GLU . 25.6 t-20 -54.53 -53.11 58.81 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 112.557 0.576 . . . . 0.0 112.557 -172.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 127.52 -39.18 1.98 Allowed Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.361 -0.923 . . . . 0.0 112.038 -177.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . -63.37 -40.01 96.08 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.947 0.403 . . . . 0.0 110.462 176.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.6 mmmp? 62.92 -165.79 0.23 Allowed 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.003 174.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.483 ' H ' ' CD ' ' A' ' 145' ' ' GLU . 0.0 OUTLIER -112.81 -12.0 13.39 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.381 178.06 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -75.14 77.27 1.18 Allowed Glycine 0 N--CA 1.445 -0.725 0 CA-C-N 115.221 -0.899 . . . . 0.0 112.387 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -61.54 165.33 4.98 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.687 0.28 . . . . 0.0 110.533 176.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -67.01 -33.88 76.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.564 0.579 . . . . 0.0 112.564 -168.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 43.3 t-80 -86.14 96.56 9.94 Favored 'General case' 0 C--N 1.325 -0.482 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.682 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 14.9 m80 -151.65 -175.22 5.11 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.432 177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 63.5 t-80 -139.88 140.71 36.55 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 74.9 t60 . . . . . 0 C--O 1.246 0.888 0 CA-C-O 118.259 -0.877 . . . . 0.0 108.81 170.433 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.492 ' HB3' ' H ' ' A' ' 2' ' ' SER . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.11 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.492 ' H ' ' HB3' ' A' ' 1' ' ' MET . 16.5 m 50.12 -95.16 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.608 0.763 . . . . 0.0 112.048 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -75.9 114.85 14.98 Favored 'General case' 0 C--N 1.328 -0.367 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -102.76 -166.88 1.32 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.823 0.344 . . . . 0.0 111.427 -175.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.983 HG23 ' HA ' ' A' ' 123' ' ' VAL . 24.9 m -56.72 130.23 44.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.159 179.311 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 107.97 -8.01 36.01 Favored Glycine 0 N--CA 1.448 -0.502 0 C-N-CA 120.589 -0.815 . . . . 0.0 112.066 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.9 m -78.47 138.2 38.33 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.1 t -82.56 126.77 40.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.25 132.54 76.19 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.549 -175.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -62.7 162.15 25.96 Favored 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.051 2.501 . . . . 0.0 111.839 173.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.97 100.47 11.66 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.783 0.325 . . . . 0.0 111.712 -175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.64 HG12 HG11 ' A' ' 101' ' ' VAL . 56.4 mt -72.19 132.47 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.176 175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 6.6 m -128.53 97.87 4.85 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.954 -0.388 . . . . 0.0 109.954 175.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -111.89 165.17 12.07 Favored Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.543 -176.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.462 ' HA ' ' O ' ' A' ' 20' ' ' ASN . 66.2 mt -98.93 122.93 51.21 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 CA-C-O 120.613 0.244 . . . . 0.0 110.46 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.509 ' OD2' ' HB2' ' A' ' 20' ' ' ASN . 31.5 p30 -74.19 -173.84 1.77 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.971 0.415 . . . . 0.0 111.547 -176.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 6.2 mp -68.84 -16.92 63.91 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.187 -0.461 . . . . 0.0 112.072 -175.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.417 ' HD3' ' CG ' ' A' ' 16' ' ' ASP . 1.1 mtpt -87.98 -35.59 17.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.276 0.56 . . . . 0.0 110.489 179.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 119.98 21.31 3.52 Favored Glycine 0 N--CA 1.446 -0.67 0 CA-C-N 115.119 -0.946 . . . . 0.0 111.47 -176.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.634 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -98.45 142.59 29.87 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 110.112 -0.329 . . . . 0.0 110.112 -178.981 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.0 p -81.78 102.25 10.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.806 0.336 . . . . 0.0 110.232 176.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 47.3 t -111.89 142.7 23.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.074 -177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 18.7 m -103.94 -177.96 3.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.975 0.416 . . . . 0.0 110.545 -178.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.491 HD23 ' H ' ' A' ' 24' ' ' LEU . 2.6 pt? -80.39 -21.56 42.19 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.587 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.437 ' HA ' ' HD2' ' A' ' 28' ' ' LYS . 50.5 m-80 -68.31 -24.79 64.89 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.907 -176.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -63.46 -25.61 68.35 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.11 -179.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -112.4 13.34 20.24 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.086 0.469 . . . . 0.0 110.317 -178.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.437 ' HD2' ' HA ' ' A' ' 25' ' ' ASN . 22.6 tttm -68.99 171.35 8.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.445 -173.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 90.08 9.98 64.97 Favored Glycine 0 C--O 1.228 -0.28 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.4 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 21.7 mttp -141.16 176.17 9.05 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.599 ' HB3' HD11 ' A' ' 115' ' ' LEU . 54.1 m-85 -78.77 109.68 13.24 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.355 -0.98 . . . . 0.0 108.355 170.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' CG2' ' A' ' 116' ' ' VAL . 47.2 t -96.78 123.32 49.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.603 -173.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.733 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 19.5 tp -90.54 116.95 28.84 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 174.178 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.52 ' HB ' HG12 ' A' ' 114' ' ' ILE . 16.7 t -105.05 102.99 14.63 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 N-CA-C 109.435 -0.58 . . . . 0.0 109.435 -178.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' OD1' HG23 ' A' ' 65' ' ' ILE . 6.5 m-20 -98.4 110.15 22.79 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.762 -174.148 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.426 ' HB3' ' HE2' ' A' ' 110' ' ' PHE . 53.2 m-85 -92.74 116.8 29.35 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.154 -0.476 . . . . 0.0 109.783 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 12.9 p-90 -154.65 -179.18 7.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.24 -175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.447 ' HB2' ' HA ' ' A' ' 71' ' ' ASP . 45.0 p90 -170.01 157.1 6.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 114.864 -1.062 . . . . 0.0 108.528 168.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.99 -16.99 62.86 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 -170.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -66.12 -21.32 69.84 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 121.065 -0.588 . . . . 0.0 112.582 178.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . 0.411 ' HB2' ' SG ' ' A' ' 44' ' ' CYS . 66.7 m -92.2 131.32 37.52 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.063 0.458 . . . . 0.0 110.274 177.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 11.1 m -88.39 -28.26 21.06 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.694 -177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 69.1 t-105 -67.75 -34.57 77.1 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.528 -0.305 . . . . 0.0 111.135 -179.305 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 41' ' ' CYS . 80.0 m -51.95 -38.63 57.22 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 120.86 0.362 . . . . 0.0 110.67 174.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.495 ' HA ' ' OD1' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -64.44 -28.33 69.6 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.774 179.153 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 1.6 mptm? -84.96 -11.34 55.73 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.181 -177.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -98.04 -21.78 16.61 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.418 178.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.658 HG21 ' HB3' ' A' ' 84' ' ' ASP . 51.4 m -49.93 -48.23 78.72 Favored Pre-proline 0 CA--C 1.538 0.494 0 N-CA-C 113.778 1.029 . . . . 0.0 113.778 -178.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.535 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.2 Cg_endo -48.61 -45.88 25.97 Favored 'Trans proline' 0 C--N 1.358 1.056 0 C-N-CA 122.205 1.937 . . . . 0.0 112.36 177.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 48.2 m-85 -76.94 -37.63 54.93 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.238 -179.813 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.403 HD11 ' OD2' ' A' ' 35' ' ' ASP . 0.2 OUTLIER -55.93 -48.55 75.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.463 175.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.417 ' HA ' ' HZ3' ' A' ' 88' ' ' TRP . 63.0 tp -63.63 -42.67 98.13 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.965 -179.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . 0.67 ' HA ' ' OD1' ' A' ' 56' ' ' ASN . 47.4 tttm -60.0 -43.72 95.02 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 177.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.429 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 27.1 m -53.11 -46.1 68.55 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.205 174.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.543 ' HB2' HD12 ' A' ' 65' ' ' ILE . 88.4 t80 -56.83 -61.99 2.05 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.998 177.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.67 ' OD1' ' HA ' ' A' ' 53' ' ' LYS . 1.9 p-10 -65.08 -29.8 70.7 Favored 'General case' 0 N--CA 1.464 0.275 0 N-CA-C 112.384 0.513 . . . . 0.0 112.384 -172.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -86.22 -20.06 29.07 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -177.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.521 ' HZ ' ' HA ' ' A' ' 137' ' ' GLU . 75.1 m-85 -115.65 -15.2 11.4 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.631 0.604 . . . . 0.0 112.631 -172.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 12.0 ptmm? -56.28 -23.13 34.55 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.005 0.431 . . . . 0.0 111.646 178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 3.5 m-20 -106.87 17.25 23.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.957 -179.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 89.5 mttt -121.64 14.73 11.01 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 116.431 -0.35 . . . . 0.0 111.137 179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 79.99 44.18 9.25 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.417 -0.896 . . . . 0.0 111.515 -176.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.733 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 55.3 t80 -139.0 135.23 34.07 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -174.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.2 p -135.74 145.65 46.85 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.96 -179.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.543 HD12 ' HB2' ' A' ' 55' ' ' TYR . 57.8 mt -103.72 126.75 58.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 120.971 0.415 . . . . 0.0 110.619 -179.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 49.1 t80 -112.94 96.52 5.99 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 178.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.692 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -75.01 114.54 4.36 Favored Glycine 0 N--CA 1.443 -0.854 0 CA-C-N 115.553 -0.749 . . . . 0.0 112.389 -176.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.998 HG13 HD21 ' A' ' 93' ' ' LEU . 50.0 t -98.69 111.11 27.5 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.221 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.431 ' O ' ' HA ' ' A' ' 92' ' ' LEU . 14.7 m -116.7 125.73 52.13 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.917 -176.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.601 ' HB ' HD12 ' A' ' 93' ' ' LEU . 10.1 t -113.5 52.13 0.82 Allowed 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 122.518 1.152 . . . . 0.0 108.604 175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 38' ' ' PHE . 3.0 t70 -70.2 178.96 2.56 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.128 -173.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -104.3 -21.97 13.43 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.184 -0.462 . . . . 0.0 109.921 -174.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.533 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 51.9 mtt-85 -141.63 150.46 42.0 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.011 177.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.542 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 16.8 tt0 -75.62 -37.19 59.93 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 176.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.533 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.1 mp0 -62.01 -41.36 97.99 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.578 179.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 1.5 t70 -74.44 -35.63 63.37 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.001 -178.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.0 t90 -60.73 -51.96 67.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.434 173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.542 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.2 mptm? -59.13 -37.17 76.6 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-O 120.86 0.362 . . . . 0.0 110.324 175.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.475 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 27.1 ttpt -59.22 -50.02 75.63 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.768 176.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -59.94 -38.89 83.7 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.182 -178.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 82.2 mt -59.44 -38.82 77.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.378 176.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -66.75 -55.36 15.34 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.892 175.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 49.5 mt-10 -53.07 -49.0 67.28 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.246 0.545 . . . . 0.0 111.639 -176.98 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HB3' HG21 ' A' ' 48' ' ' THR . 6.4 m-20 -85.45 -16.43 39.7 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.393 -0.821 . . . . 0.0 112.453 -173.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HD2' ' OH ' ' A' ' 87' ' ' TYR . 46.9 mmtm 61.74 40.54 12.93 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.653 0.739 . . . . 0.0 110.092 -177.071 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 p -80.63 86.46 5.88 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.096 -0.956 . . . . 0.0 111.183 -178.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' OH ' ' HD2' ' A' ' 85' ' ' LYS . 57.4 m-85 -87.66 78.94 8.38 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.276 -177.495 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.417 ' HZ3' ' HA ' ' A' ' 52' ' ' LEU . 23.6 p90 -161.42 175.16 12.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.544 174.431 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.4 m120 -75.47 110.47 9.88 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.974 -174.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.692 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 48.6 mt-30 -123.39 145.97 48.35 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.617 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.3 m -132.65 149.97 32.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.213 -178.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.431 ' HA ' ' O ' ' A' ' 69' ' ' SER . 20.7 tp -94.2 132.2 38.99 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 175.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.998 HD21 HG13 ' A' ' 68' ' ' VAL . 72.3 mt -73.45 149.94 42.01 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.355 0.502 . . . . 0.0 112.355 -173.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.618 ' O ' HG23 ' A' ' 98' ' ' VAL . 49.8 mt-30 -80.72 171.18 15.34 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.412 175.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -61.15 -39.65 90.87 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.591 ' HA ' ' HE3' ' A' ' 99' ' ' LYS . 13.5 m-20 -87.21 -33.62 19.27 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.049 0.452 . . . . 0.0 110.181 178.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.562 ' OD2' HD22 ' A' ' 93' ' ' LEU . 16.1 t70 -63.14 -26.75 68.96 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.821 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.618 HG23 ' O ' ' A' ' 94' ' ' GLN . 78.8 t -66.86 -65.06 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 CA-C-O 121.109 0.481 . . . . 0.0 110.124 175.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.591 ' HE3' ' HA ' ' A' ' 96' ' ' ASP . 20.5 pttp -62.55 -62.62 1.62 Allowed 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 113.534 0.938 . . . . 0.0 113.534 -170.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . 0.408 ' H ' ' HG3' ' A' ' 99' ' ' LYS . 9.0 m-20 -67.94 -36.63 80.44 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.738 0.304 . . . . 0.0 111.622 -169.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.64 HG11 HG12 ' A' ' 12' ' ' ILE . 59.3 t -79.27 -50.26 18.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.943 -173.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.512 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 87.9 mt -56.23 -47.81 77.71 Favored 'General case' 0 CA--C 1.516 -0.337 0 CA-C-N 116.438 -0.347 . . . . 0.0 110.8 179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -56.89 -47.33 80.75 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 -178.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 75.4 m -54.81 -33.04 61.06 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.99 0.806 . . . . 0.0 112.446 -177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 -79.24 7.75 7.15 Favored 'General case' 0 C--O 1.237 0.431 0 O-C-N 122.14 -0.35 . . . . 0.0 111.436 176.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.403 ' HB2' ' HB2' ' A' ' 2' ' ' SER . 42.5 t 66.57 54.13 0.89 Allowed 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.833 -0.802 . . . . 0.0 108.833 -171.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.512 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 73.8 mt -133.3 93.17 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.97 -175.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.5 p -105.6 -1.5 9.93 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.861 0.839 . . . . 0.0 109.392 172.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.77 165.31 28.83 Favored Glycine 0 C--N 1.332 0.335 0 CA-C-N 115.495 -0.775 . . . . 0.0 112.176 -178.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 95.4 m-85 -127.19 160.7 58.39 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 116.654 0.227 . . . . 0.0 110.707 -177.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.504 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 5.5 Cg_exo -81.89 172.08 53.64 Favored 'Cis proline' 0 C--N 1.349 0.597 0 C-N-CA 123.948 -1.271 . . . . 0.0 112.721 -0.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.674 ' CD2' ' HG2' ' A' ' 126' ' ' GLU . 1.0 OUTLIER -155.39 122.53 5.48 Favored 'General case' 0 C--O 1.219 -0.506 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.622 178.755 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.1 mp -120.1 131.44 72.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 179.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.578 HG22 ' HB2' ' A' ' 125' ' ' LYS . 25.9 pt -130.5 158.32 42.91 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-O 120.831 0.348 . . . . 0.0 111.439 -178.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.599 HD11 ' HB3' ' A' ' 31' ' ' TYR . 58.9 tp -124.51 127.59 47.68 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.142 178.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.544 ' CG2' ' HB ' ' A' ' 32' ' ' VAL . 5.5 m -119.1 145.13 25.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -176.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -59.78 163.3 7.54 Favored Pre-proline 0 C--O 1.233 0.225 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.131 172.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_exo -59.32 -22.26 64.54 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.204 1.936 . . . . 0.0 111.031 168.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -70.19 -34.0 72.42 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.784 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 105.23 32.68 3.92 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.05 -176.034 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -117.42 147.86 42.31 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.855 -0.424 . . . . 0.0 109.855 177.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.648 HG21 ' HD2' ' A' ' 125' ' ' LYS . 34.9 mt -86.19 119.57 34.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.594 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.983 ' HA ' HG23 ' A' ' 5' ' ' THR . 13.2 m -101.75 -35.21 4.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.014 0.435 . . . . 0.0 110.832 176.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -137.8 140.74 40.72 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.648 ' HD2' HG21 ' A' ' 122' ' ' ILE . 9.4 ptmm? -156.81 153.43 28.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.232 -177.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.674 ' HG2' ' CD2' ' A' ' 112' ' ' HIS . 32.4 mt-10 70.0 25.47 4.82 Favored 'General case' 0 C--N 1.331 -0.23 0 O-C-N 124.205 0.941 . . . . 0.0 110.968 172.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 57.9 mt -67.91 159.12 31.17 Favored 'General case' 0 C--O 1.237 0.41 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.621 176.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.496 ' NE ' ' HA ' ' A' ' 128' ' ' ARG . 2.1 mmp_? -128.9 134.53 48.3 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.202 0.445 . . . . 0.0 112.202 -173.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.644 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . 43.12 -114.58 0.86 Allowed Glycine 0 C--N 1.335 0.522 0 N-CA-C 114.973 0.749 . . . . 0.0 114.973 168.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . 0.482 ' O ' ' HB2' ' A' ' 134' ' ' ASN . 4.2 m-20 -63.12 -35.43 80.24 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.832 0.349 . . . . 0.0 110.867 -178.479 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.443 ' HB3' ' O ' ' A' ' 128' ' ' ARG . 7.7 t70 -63.63 -39.74 95.13 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.822 -177.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.644 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.0 pp -57.2 -44.47 83.66 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 120.205 -0.598 . . . . 0.0 110.52 -177.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.402 ' N ' HD12 ' A' ' 132' ' ' LEU . 68.4 t80 -70.64 -46.47 63.23 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.482 ' HB2' ' O ' ' A' ' 130' ' ' ASP . 11.2 t-20 -50.2 -57.21 8.26 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.688 -1.142 . . . . 0.0 111.8 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.559 ' HA ' ' NZ ' ' A' ' 138' ' ' LYS . 19.8 m -72.74 -34.38 67.0 Favored 'General case' 0 N--CA 1.446 -0.645 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.998 -176.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.422 HG22 HD22 ' A' ' 115' ' ' LEU . 38.2 t -63.21 -42.32 96.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 120.439 -0.505 . . . . 0.0 110.325 174.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.521 ' HA ' ' HZ ' ' A' ' 58' ' ' PHE . 3.2 tp10 -61.21 -53.02 62.17 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 175.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.559 ' NZ ' ' HA ' ' A' ' 135' ' ' THR . 9.2 mtmp? -57.5 -27.58 62.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.733 -179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 77.4 t80 -83.15 -61.09 1.95 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.766 -0.197 . . . . 0.0 111.408 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 66.0 t -63.15 -35.27 71.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.331 0 O-C-N 123.441 0.463 . . . . 0.0 111.543 -173.16 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 46.2 m-80 -77.9 90.79 4.13 Favored 'General case' 0 N--CA 1.446 -0.663 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 176.984 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -32.36 -47.84 0.29 Allowed Glycine 0 CA--C 1.52 0.374 0 CA-C-N 113.741 -1.572 . . . . 0.0 114.659 -179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.462 ' HB1' ' HA2' ' A' ' 146' ' ' GLY . . . -61.42 109.88 1.29 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.882 0.373 . . . . 0.0 111.071 179.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -93.65 -52.5 4.44 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.502 0.668 . . . . 0.0 109.65 179.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.9 -12.65 19.64 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.902 -1.045 . . . . 0.0 109.876 175.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . 0.462 ' HA2' ' HB1' ' A' ' 143' ' ' ALA . . . 111.23 -34.09 5.49 Favored Glycine 0 N--CA 1.446 -0.672 0 CA-C-N 115.506 -0.77 . . . . 0.0 112.855 175.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 98.8 m-70 56.26 81.12 0.13 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 121.045 0.45 . . . . 0.0 110.252 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 57.9 t-80 -62.69 93.59 0.06 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.188 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 98.2 m-70 -81.33 -69.25 0.62 Allowed 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 175.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 15.5 p80 -145.81 18.62 1.46 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.018 174.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 -69.05 92.22 0.52 Allowed 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 177.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 12.1 t-160 . . . . . 0 C--O 1.246 0.915 0 O-C-N 124.127 0.892 . . . . 0.0 110.104 -170.008 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.522 ' HB3' ' HG3' ' A' ' 126' ' ' GLU . 27.8 ttt . . . . . 0 N--CA 1.485 1.3 0 N-CA-C 110.531 -0.174 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.9 m -60.4 -48.97 79.44 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.07 0.462 . . . . 0.0 110.517 -179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.636 ' HG ' ' SG ' ' A' ' 106' ' ' CYS . 76.9 mt -96.8 34.71 1.64 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.642 175.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . 52.9 -140.13 0.96 Allowed 'General case' 0 C--O 1.241 0.61 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.446 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.0 p -146.34 140.12 26.17 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.663 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 94.39 4.52 62.47 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.98 -0.629 . . . . 0.0 112.477 -178.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 49.8 m -81.06 143.45 32.46 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 110.275 -0.268 . . . . 0.0 110.275 177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.578 HG22 ' HG2' ' A' ' 121' ' ' LYS . 31.6 t -69.64 133.69 31.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.469 -177.026 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.58 146.63 31.66 Favored Pre-proline 0 C--N 1.325 -0.482 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.684 -175.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -63.04 162.31 26.56 Favored 'Trans proline' 0 C--N 1.348 0.542 0 C-N-CA 122.888 2.392 . . . . 0.0 111.975 174.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.39 113.58 25.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.832 0.349 . . . . 0.0 111.547 -175.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 58.2 mt -81.95 137.02 21.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.719 178.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.3 m -134.72 104.88 6.21 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.015 174.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -126.86 172.18 18.45 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.619 -0.8 . . . . 0.0 112.139 -177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.497 HD12 ' N ' ' A' ' 15' ' ' ILE . 3.8 mp -98.01 119.18 45.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 -177.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -78.46 -173.56 3.39 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.481 -171.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 81' ' ' ILE . 96.6 mt -62.45 -33.49 74.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.669 -179.023 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -74.99 -30.68 61.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.608 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 110.54 19.36 7.93 Favored Glycine 0 N--CA 1.449 -0.492 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.523 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.609 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.6 OUTLIER -100.35 144.25 29.58 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.017 -0.734 . . . . 0.0 109.017 -179.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.5 t -87.04 92.46 9.05 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 11.5 p -97.66 147.46 6.53 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.527 -175.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -108.42 168.0 9.63 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 -174.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 56.5 tp -69.72 -35.37 74.98 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.643 178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.557 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 3.2 p-10 -66.81 -17.55 64.93 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.78 -179.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -74.25 -24.15 59.25 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.126 0.489 . . . . 0.0 110.501 -179.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -105.35 8.51 33.75 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.199 0.524 . . . . 0.0 110.25 177.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.557 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 41.8 tttp -62.46 160.3 13.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.074 -174.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.28 10.17 57.36 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.795 -0.716 . . . . 0.0 112.271 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 22.7 mttp -141.43 177.6 8.01 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.491 ' HB3' HD11 ' A' ' 115' ' ' LEU . 97.3 m-85 -85.17 107.03 17.04 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 170.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.484 ' HA ' ' O ' ' A' ' 64' ' ' THR . 42.0 t -100.43 109.99 26.42 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.902 -174.247 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 63' ' ' PHE . 28.1 tp -86.77 118.18 26.0 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 176.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.56 ' HA ' ' O ' ' A' ' 66' ' ' TYR . 38.2 t -104.89 115.36 46.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 120.699 0.285 . . . . 0.0 110.835 -176.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 6.6 p-10 -101.79 111.04 23.16 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.262 0.553 . . . . 0.0 111.413 -179.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -93.77 118.07 30.94 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.422 175.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 15.2 p-90 -151.16 176.93 10.71 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.142 0.496 . . . . 0.0 111.304 -175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 1.2 p90 -170.3 151.39 3.8 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 114.826 -1.079 . . . . 0.0 109.384 170.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -70.29 5.11 1.85 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.403 -176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -80.47 -26.65 54.01 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.689 175.335 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 49.0 t -103.48 116.31 32.16 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.564 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 9.5 m -67.97 -26.53 65.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.561 -177.22 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 8.9 t-105 -73.22 -36.2 66.44 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.92 -176.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . . . . . . . . . 65.0 m -59.99 -35.58 75.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.049 0.452 . . . . 0.0 110.429 177.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.488 ' HE ' ' CG ' ' A' ' 84' ' ' ASP . 26.4 mmm-85 -67.39 -22.21 65.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.546 -179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.564 ' HD3' ' O ' ' A' ' 42' ' ' SER . 4.9 mptp? -85.88 -11.45 53.21 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.327 -177.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.452 ' HA ' ' CD2' ' A' ' 50' ' ' TYR . 43.8 mt-10 -105.65 -6.87 18.85 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.276 179.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.611 HG21 ' HB3' ' A' ' 84' ' ' ASP . 3.9 m -54.05 -47.09 98.2 Favored Pre-proline 0 CA--C 1.542 0.645 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.953 175.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 48' ' ' THR . 8.9 Cg_endo -51.68 -36.81 62.67 Favored 'Trans proline' 0 C--N 1.36 1.155 0 C-N-CA 122.624 2.216 . . . . 0.0 113.036 175.526 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.452 ' CD2' ' HA ' ' A' ' 47' ' ' GLU . 41.0 m-85 -67.55 -39.62 84.98 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.031 0.443 . . . . 0.0 110.069 179.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.59 HD21 HD13 ' A' ' 113' ' ' ILE . 88.5 mt -63.7 -43.12 97.55 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.692 176.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.4 tp -64.15 -43.41 95.28 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.463 178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.8 tttm -54.56 -44.85 73.26 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.661 -0.699 . . . . 0.0 110.341 175.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.513 ' O ' ' HD1' ' A' ' 58' ' ' PHE . 33.2 m -63.76 -48.7 75.91 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.439 -0.8 . . . . 0.0 111.223 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.66 ' HB2' HD12 ' A' ' 65' ' ' ILE . 53.2 t80 -60.07 -36.04 76.49 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.211 0.529 . . . . 0.0 110.843 -178.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -73.34 -33.49 65.14 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.305 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -88.11 -18.92 27.78 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 113.082 0.771 . . . . 0.0 113.082 -175.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.513 ' HD1' ' O ' ' A' ' 54' ' ' THR . 84.1 m-85 -111.54 10.98 21.27 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 -176.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 58.0 pttt -75.19 -3.94 35.94 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.076 0.465 . . . . 0.0 111.116 -178.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 13.9 p-10 -98.34 -2.33 39.58 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.006 177.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.1 mttp -122.99 174.43 7.19 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.469 -173.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -75.05 61.95 2.57 Favored Glycine 0 C--N 1.331 0.288 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 33' ' ' LEU . 74.4 t80 -133.68 130.42 38.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.787 0.327 . . . . 0.0 110.334 -176.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.484 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 12.3 p -135.73 137.82 42.1 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.283 178.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.66 HD12 ' HB2' ' A' ' 55' ' ' TYR . 36.8 mt -97.34 124.9 50.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.116 0.484 . . . . 0.0 110.271 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 34' ' ' VAL . 80.4 t80 -113.25 104.79 12.69 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.334 -0.848 . . . . 0.0 108.876 -179.446 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.963 ' HA3' ' HG2' ' A' ' 90' ' ' GLN . . . -86.24 142.12 18.72 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.566 -176.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.8 t -122.7 111.83 31.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-O 121.273 0.559 . . . . 0.0 109.661 178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.428 ' HB3' ' OD1' ' A' ' 71' ' ' ASP . 15.0 m -115.07 155.17 27.54 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.595 -0.729 . . . . 0.0 111.008 -175.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -143.96 40.12 1.37 Allowed 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.935 0.874 . . . . 0.0 108.658 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.428 ' OD1' ' HB3' ' A' ' 69' ' ' SER . 4.5 m-20 -71.37 175.78 5.16 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.598 -1.183 . . . . 0.0 113.399 -171.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 17.9 mtm180 -70.21 -45.57 66.3 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 114.512 -1.222 . . . . 0.0 112.409 -172.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.404 ' HA ' ' HD2' ' A' ' 73' ' ' ARG . 3.5 tpt180 -145.68 150.62 36.63 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 -176.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.465 ' HG2' ' HD3' ' A' ' 78' ' ' LYS . 28.4 tt0 -62.28 -41.81 98.8 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.773 0.321 . . . . 0.0 110.459 -178.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -60.33 -44.21 95.71 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.254 178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -67.64 -39.78 84.6 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.152 179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 26.6 t90 -58.48 -54.13 50.46 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.184 -0.916 . . . . 0.0 110.626 175.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.465 ' HD3' ' HG2' ' A' ' 74' ' ' GLU . 2.1 mptm? -57.22 -40.55 77.74 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.033 0.444 . . . . 0.0 110.427 176.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 83' ' ' GLU . 2.7 ttpm? -60.51 -49.44 77.56 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.546 -0.752 . . . . 0.0 110.363 177.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.569 ' HA ' ' OE1' ' A' ' 83' ' ' GLU . . . -58.15 -40.54 81.61 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.136 0.493 . . . . 0.0 111.1 -178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 86' ' ' SER . 80.3 mt -61.67 -38.36 80.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.887 177.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' ' HD3' ' A' ' 85' ' ' LYS . 0.0 OUTLIER -71.77 -46.41 58.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 179.715 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.569 ' OE1' ' HA ' ' A' ' 80' ' ' ALA . 46.5 mt-10 -54.69 -54.33 43.22 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.143 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.611 ' HB3' HG21 ' A' ' 48' ' ' THR . 5.5 m-20 -85.56 0.18 53.23 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.068 -174.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.47 ' HD3' ' O ' ' A' ' 82' ' ' GLU . 70.0 mmtt 58.4 37.82 25.77 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 121.574 0.702 . . . . 0.0 110.706 -178.744 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 81' ' ' ILE . 36.4 t -82.59 68.15 8.93 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.708 -177.334 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -87.1 76.29 9.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.963 -175.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.405 ' CZ3' ' HA ' ' A' ' 86' ' ' SER . 30.8 p90 -148.67 -174.57 4.65 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.372 -0.233 . . . . 0.0 110.372 169.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -80.16 90.94 5.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.657 -0.247 . . . . 0.0 111.504 -171.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.963 ' HG2' ' HA3' ' A' ' 67' ' ' GLY . 91.6 mt-30 -108.0 138.76 43.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 120.912 0.386 . . . . 0.0 111.017 178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 33.7 m -119.09 146.48 23.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.892 -179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 36.6 tp -91.95 126.41 37.02 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 176.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.552 HD13 ' HA ' ' A' ' 98' ' ' VAL . 47.5 mt -67.92 145.7 54.32 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.923 0.392 . . . . 0.0 111.383 -179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.653 ' O ' HG23 ' A' ' 98' ' ' VAL . 45.5 mt-30 -67.76 156.0 38.01 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.433 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 18.2 mtpt -60.92 -44.89 96.56 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 121.008 0.433 . . . . 0.0 111.614 -170.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -85.29 -19.49 31.48 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.4 -178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.431 ' CB ' ' HB2' ' A' ' 94' ' ' GLN . 37.0 t70 -80.87 -27.8 36.22 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.976 -176.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.653 HG23 ' O ' ' A' ' 94' ' ' GLN . 58.3 t -47.91 -51.35 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.671 178.48 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -57.22 -47.73 80.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.559 -176.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -67.78 -50.2 58.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.03 -173.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 84.4 t -61.97 -56.05 20.19 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.315 -175.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.544 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.0 mt -57.49 -46.0 84.23 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.783 -177.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -54.75 -60.71 2.99 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 59.6 m -51.31 -38.58 53.74 Favored 'General case' 0 N--CA 1.462 0.147 0 O-C-N 124.716 1.26 . . . . 0.0 113.292 -170.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -82.07 17.74 1.53 Allowed 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.395 -0.522 . . . . 0.0 111.463 -179.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.636 ' SG ' ' HG ' ' A' ' 3' ' ' LEU . 63.8 m 62.88 42.19 7.97 Favored 'General case' 0 CA--C 1.515 -0.404 0 C-N-CA 123.378 0.671 . . . . 0.0 110.077 -179.428 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 63.4 mt -100.16 89.07 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 C-N-CA 119.71 -0.796 . . . . 0.0 111.058 -176.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.8 t -95.5 -18.69 6.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.23 173.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -147.68 152.48 24.59 Favored Glycine 0 N--CA 1.444 -0.811 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.006 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -108.75 156.12 39.47 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 110.481 -0.192 . . . . 0.0 110.481 -179.673 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.442 ' HG3' ' OE2' ' A' ' 47' ' ' GLU . 95.2 Cg_endo -78.29 177.01 40.62 Favored 'Cis proline' 0 C--N 1.344 0.308 0 C-N-CA 123.238 -1.568 . . . . 0.0 112.779 0.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -155.06 117.62 4.28 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 176.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 51' ' ' LEU . 58.6 mt -127.98 138.43 54.73 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.403 -175.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.471 ' HB ' HG23 ' A' ' 122' ' ' ILE . 49.2 pt -134.3 158.63 42.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.013 -178.104 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.768 HD22 HG22 ' A' ' 136' ' ' VAL . 60.9 tp -118.59 115.46 24.6 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.27 176.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 86.4 t -98.31 129.98 47.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.673 179.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.567 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 8.2 p30 -78.53 166.99 38.87 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.203 176.747 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 6.4 Cg_endo -50.5 -35.88 47.25 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 122.965 2.443 . . . . 0.0 113.196 177.031 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.436 ' HB2' ' OD1' ' A' ' 117' ' ' ASP . 45.3 mt-10 -63.01 -37.4 87.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.117 0.484 . . . . 0.0 110.62 178.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 113.7 26.46 3.89 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.835 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.578 ' HG2' HG22 ' A' ' 8' ' ' VAL . 28.4 mtmm -111.77 151.76 28.61 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.815 0.341 . . . . 0.0 110.259 -179.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.471 HG23 ' HB ' ' A' ' 114' ' ' ILE . 18.0 mt -87.64 92.09 3.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.315 -178.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 16.9 m -73.12 -26.98 23.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.156 0.503 . . . . 0.0 110.748 -178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.568 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -133.92 119.03 18.59 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.555 177.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.564 ' HG2' ' CD ' ' A' ' 126' ' ' GLU . 60.8 tttm -127.46 157.72 39.29 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 121.079 -0.248 . . . . 0.0 110.557 -174.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.564 ' CD ' ' HG2' ' A' ' 125' ' ' LYS . 0.0 OUTLIER 50.24 48.69 21.81 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 123.999 0.812 . . . . 0.0 110.989 -176.761 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 132' ' ' LEU . 83.7 mt -72.49 157.37 37.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.327 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' A' ' 131' ' ' ASP . 13.8 tpt180 -128.7 142.38 51.03 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.464 -173.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 35.65 -132.45 0.68 Allowed Glycine 0 C--N 1.343 0.923 0 N-CA-C 115.186 0.835 . . . . 0.0 115.186 167.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -79.02 -10.85 59.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.281 0.562 . . . . 0.0 110.111 176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' ARG . 4.1 m-20 -55.1 -33.47 62.85 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.266 178.025 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 127' ' ' LEU . 4.3 pp -64.7 -41.42 96.03 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.912 178.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.442 ' N ' HD12 ' A' ' 132' ' ' LEU . 32.1 t80 -60.79 -52.14 66.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.712 178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -60.07 -36.18 76.78 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.348 -0.842 . . . . 0.0 111.224 -178.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 85.8 m -71.08 -46.55 61.63 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.146 178.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.768 HG22 HD22 ' A' ' 115' ' ' LEU . 96.1 t -67.49 -45.82 84.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.704 -0.225 . . . . 0.0 111.113 -178.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.472 ' HG3' HD22 ' A' ' 141' ' ' ASN . 2.6 tp10 -58.53 -45.72 88.29 Favored 'General case' 0 CA--C 1.521 -0.158 0 CA-C-O 121.409 0.623 . . . . 0.0 109.606 179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -56.94 -54.4 47.06 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.673 175.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.921 ' HA ' ' HB3' ' A' ' 143' ' ' ALA . 42.4 t80 -65.02 -56.76 11.2 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.641 -0.709 . . . . 0.0 111.745 -170.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 64.5 t -64.27 -42.43 95.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.33 -174.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.472 HD22 ' HG3' ' A' ' 137' ' ' GLU . 92.1 m-20 -81.06 -61.29 2.0 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.245 -0.434 . . . . 0.0 112.125 -173.022 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -113.92 -27.01 3.63 Favored Glycine 0 CA--C 1.52 0.388 0 C-N-CA 120.324 -0.941 . . . . 0.0 114.919 -167.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.921 ' HB3' ' HA ' ' A' ' 139' ' ' PHE . . . -73.62 72.79 1.46 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.853 0.826 . . . . 0.0 111.734 -175.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 35.3 mtmm -141.89 33.46 1.58 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.082 -0.963 . . . . 0.0 109.15 178.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.453 ' HB3' ' CD2' ' A' ' 148' ' ' HIS . 17.8 mm-40 -72.2 90.81 1.25 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.577 -175.379 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.92 21.62 6.19 Favored Glycine 0 N--CA 1.446 -0.645 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.661 173.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 26.7 p80 -120.34 32.21 6.12 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.074 0.464 . . . . 0.0 110.829 -177.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . 0.453 ' CD2' ' HB3' ' A' ' 145' ' ' GLU . 23.6 p80 -125.06 131.34 53.36 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.009 0.433 . . . . 0.0 111.239 -177.329 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . 0.484 ' H ' ' CD2' ' A' ' 149' ' ' HIS . 1.8 p80 -79.84 -174.58 4.46 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.958 174.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 90.0 m-70 -59.04 -50.56 73.6 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.524 0.202 . . . . 0.0 111.118 -175.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 15.2 p-80 167.47 -19.91 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 124.364 1.066 . . . . 0.0 108.197 171.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 7.8 p80 . . . . . 0 C--O 1.24 0.594 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 165.492 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.746 ' HG2' ' H ' ' A' ' 2' ' ' SER . 32.6 ttp . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.746 ' H ' ' HG2' ' A' ' 1' ' ' MET . 5.0 p -57.15 -56.35 22.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.162 0.505 . . . . 0.0 109.89 175.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 84.3 mt -115.71 161.54 18.56 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.423 172.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -137.98 -163.67 1.49 Allowed 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.694 0.283 . . . . 0.0 110.451 -178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 14.2 p -110.17 112.61 24.7 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.381 -0.6 . . . . 0.0 109.381 173.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 105.49 -4.36 40.25 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 111.242 -0.743 . . . . 0.0 111.242 -174.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 14.5 p -71.96 128.23 35.07 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.972 -0.381 . . . . 0.0 109.972 177.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.7 p -69.13 135.66 27.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 121.092 0.473 . . . . 0.0 110.77 -177.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -92.36 144.04 28.3 Favored Pre-proline 0 C--N 1.322 -0.627 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.686 -178.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 52.6 Cg_exo -55.27 158.44 12.18 Favored 'Trans proline' 0 C--N 1.344 0.327 0 C-N-CA 123.232 2.622 . . . . 0.0 112.602 177.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -91.1 95.33 10.02 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.184 -175.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.576 HD11 ' CE1' ' A' ' 105' ' ' TYR . 21.5 mm -59.12 131.84 23.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.462 178.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 8.0 m -126.96 88.09 2.76 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 174.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -117.36 161.58 13.15 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.976 -171.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 60.3 mt -87.32 125.52 41.07 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 120.801 0.334 . . . . 0.0 110.372 179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.04 -169.5 2.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.337 0.589 . . . . 0.0 111.681 -173.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 92.8 mt -62.93 -30.09 71.29 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.694 -0.684 . . . . 0.0 111.931 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 36.7 mtmm -74.65 -36.24 62.85 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.312 0.577 . . . . 0.0 110.28 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 113.99 16.01 8.17 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.441 -0.799 . . . . 0.0 111.167 -175.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.578 HD22 ' N ' ' A' ' 20' ' ' ASN . 0.7 OUTLIER -97.64 140.27 32.3 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 -179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.9 p -77.48 97.33 4.95 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 121.099 0.476 . . . . 0.0 110.249 175.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 21.6 t -101.91 147.48 8.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 CA-C-N 115.792 -0.64 . . . . 0.0 109.796 -176.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 6.7 m -108.86 156.77 19.28 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.152 0.501 . . . . 0.0 111.367 -174.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.3 tp -62.59 -27.82 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.525 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.78 -25.42 67.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.563 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 51.1 m-20 -74.6 -9.59 58.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.409 0.623 . . . . 0.0 110.528 -177.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -112.35 4.56 17.7 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.195 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 39.8 mttt -62.15 170.28 2.32 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 115.394 -0.821 . . . . 0.0 112.198 -177.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 83.78 9.13 83.4 Favored Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.794 -178.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' PRO . 35.1 mttp -141.01 156.87 45.96 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 -177.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.414 ' HB2' ' HD1' ' A' ' 63' ' ' PHE . 85.7 m-85 -72.63 115.6 12.1 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 171.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 116' ' ' VAL . 57.6 t -103.12 107.56 22.38 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.878 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.328 -172.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.439 ' HB3' HG12 ' A' ' 65' ' ' ILE . 38.9 tp -86.24 106.49 17.36 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 26.8 t -89.85 125.86 42.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 121.013 0.435 . . . . 0.0 110.891 -173.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' HB3' ' HA2' ' A' ' 67' ' ' GLY . 12.9 t0 -112.06 96.23 5.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.426 -177.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.559 ' HA ' HG13 ' A' ' 68' ' ' VAL . 96.0 m-85 -82.07 114.94 20.96 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 175.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.478 ' O ' ' HA ' ' A' ' 69' ' ' SER . 22.3 p-90 -153.55 175.45 13.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 122.062 0.934 . . . . 0.0 112.604 -172.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 31.8 p90 -167.76 162.84 14.07 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 113.528 -1.669 . . . . 0.0 106.691 168.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.95 -19.31 65.82 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 -172.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.0 -29.56 64.65 Favored Glycine 0 CA--C 1.521 0.43 0 CA-C-N 115.692 -0.686 . . . . 0.0 113.246 179.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 24.4 p -95.89 97.99 10.07 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.65 0.738 . . . . 0.0 109.943 178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 4.8 m -64.77 -36.18 83.49 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.113 -0.949 . . . . 0.0 111.981 -172.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 35.0 t-105 -56.27 -41.18 75.44 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 112.137 0.421 . . . . 0.0 112.137 -172.75 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.423 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 0.1 OUTLIER -64.93 -28.56 69.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.007 0.432 . . . . 0.0 110.252 -179.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -81.26 -14.14 57.73 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.411 0.624 . . . . 0.0 110.083 -179.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 2.0 mptm? -79.69 -21.86 44.15 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.212 176.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -90.31 -7.11 54.17 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.879 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.552 ' N ' ' HD2' ' A' ' 49' ' ' PRO . 98.6 m -48.58 -48.45 68.36 Favored Pre-proline 0 CA--C 1.54 0.576 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 48' ' ' THR . 5.7 Cg_endo -49.36 -44.79 33.0 Favored 'Trans proline' 0 C--N 1.357 1.001 0 C-N-CA 122.33 2.02 . . . . 0.0 112.633 178.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 79.4 m-85 -73.82 -40.05 63.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.829 178.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 99.8 mt -57.21 -51.94 67.34 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.88 0.371 . . . . 0.0 110.501 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.3 tp -59.81 -43.04 94.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.656 179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 31.9 tptt -62.63 -44.61 95.84 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.457 -0.338 . . . . 0.0 111.035 177.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.48 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 59.8 m -59.7 -46.17 89.91 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.795 178.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.619 ' HB2' HD12 ' A' ' 65' ' ' ILE . 37.5 t80 -65.69 -36.02 82.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.068 0.461 . . . . 0.0 109.966 178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 14.4 t-20 -62.03 -43.64 98.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 112.091 179.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -83.01 -27.12 30.61 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -174.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.48 ' HD2' ' O ' ' A' ' 54' ' ' THR . 92.1 m-85 -114.57 10.83 16.88 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 112.012 0.375 . . . . 0.0 112.012 -173.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 55' ' ' TYR . 20.1 pttp -64.76 -29.33 70.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 111.31 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -92.22 10.51 29.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.894 -0.594 . . . . 0.0 110.193 -177.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.511 ' HZ3' ' CD ' ' A' ' 145' ' ' GLU . 80.0 mttt -121.36 -174.16 2.79 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.769 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -80.37 57.88 4.67 Favored Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 120.742 -0.742 . . . . 0.0 111.954 177.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.414 ' HD1' ' HB2' ' A' ' 31' ' ' TYR . 80.3 t80 -144.0 142.53 30.75 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.784 0.326 . . . . 0.0 110.179 -177.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 15.3 t -151.45 150.29 30.24 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 175.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.619 HD12 ' HB2' ' A' ' 55' ' ' TYR . 52.1 mt -102.34 125.11 56.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 177.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 56.1 t80 -105.66 98.08 7.82 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.883 -0.598 . . . . 0.0 109.844 -177.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.476 ' O ' ' HA ' ' A' ' 90' ' ' GLN . . . -79.87 137.42 18.65 Favored Glycine 0 N--CA 1.441 -1.027 0 N-CA-C 111.031 -0.828 . . . . 0.0 111.031 178.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.559 HG13 ' HA ' ' A' ' 36' ' ' PHE . 1.5 p -138.45 123.3 22.46 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-O 121.107 0.48 . . . . 0.0 110.591 -179.205 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 8.5 t -128.87 163.87 24.31 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.222 0.534 . . . . 0.0 111.439 -174.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.792 ' HB ' HD12 ' A' ' 93' ' ' LEU . 4.3 t -147.75 44.16 1.09 Allowed 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.726 179.511 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.529 ' OD1' ' HG2' ' A' ' 72' ' ' ARG . 2.9 t70 -71.01 -178.93 2.1 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.399 -174.055 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.529 ' HG2' ' OD1' ' A' ' 71' ' ' ASP . 13.1 ptt180 -67.1 -29.59 69.39 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.741 -173.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.498 ' HD3' ' OE2' ' A' ' 75' ' ' GLU . 56.4 mtt-85 -143.4 158.28 43.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.743 -177.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.784 ' HG2' ' HE2' ' A' ' 78' ' ' LYS . 32.3 tt0 -75.72 -38.79 58.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 173.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.498 ' OE2' ' HD3' ' A' ' 73' ' ' ARG . 1.3 mp0 -60.72 -44.82 96.15 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.089 -0.959 . . . . 0.0 109.794 178.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.459 ' HB2' ' HB2' ' A' ' 73' ' ' ARG . 1.9 m-20 -62.52 -42.39 99.49 Favored 'General case' 0 CA--C 1.517 -0.308 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.57 176.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.573 ' CE3' ' HD2' ' A' ' 78' ' ' LYS . 32.6 t90 -56.94 -52.74 64.02 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.917 176.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.784 ' HE2' ' HG2' ' A' ' 74' ' ' GLU . 3.7 mptp? -54.15 -50.63 66.53 Favored 'General case' 0 N--CA 1.47 0.531 0 CA-C-O 121.29 0.566 . . . . 0.0 110.593 176.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 79' ' ' LYS . 25.0 ttpp -60.46 -44.62 95.69 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.173 -178.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -60.77 -38.34 84.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.022 -179.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.413 HG13 ' O ' ' A' ' 77' ' ' TRP . 65.6 mt -60.39 -43.66 94.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.512 177.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 27.9 tp10 -68.6 -46.46 69.25 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.008 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -59.73 -45.01 93.5 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.173 0.511 . . . . 0.0 111.138 179.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -82.29 -15.71 51.98 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.247 -175.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.403 ' HD2' ' HE2' ' A' ' 87' ' ' TYR . 66.6 mmtt 65.02 33.32 9.77 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.835 177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 34.9 m -92.34 85.59 5.44 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.325 176.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.403 ' HE2' ' HD2' ' A' ' 85' ' ' LYS . 98.6 m-85 -91.77 84.25 5.39 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.42 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 26.2 p90 -153.02 -173.3 4.53 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.786 0.327 . . . . 0.0 111.012 171.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 88.7 m-20 -69.52 96.6 0.93 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.136 -175.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 67' ' ' GLY . 32.6 mt-30 -123.18 143.63 49.89 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.143 179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.7 m -130.3 158.3 42.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 121.09 0.471 . . . . 0.0 111.301 -179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 40.2 tp -103.55 132.33 49.9 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.429 175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.792 HD12 ' HB ' ' A' ' 70' ' ' THR . 88.7 mt -61.94 140.51 58.31 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 123.256 0.348 . . . . 0.0 111.169 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.691 ' O ' HG23 ' A' ' 98' ' ' VAL . 42.9 mt-30 -90.06 169.3 11.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.249 178.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 16.0 mtpp -49.24 -55.07 13.78 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 121.237 0.541 . . . . 0.0 111.744 -173.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 10.4 p-10 -82.19 -36.57 27.16 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.674 -179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.445 ' HB3' ' H ' ' A' ' 94' ' ' GLN . 13.3 t70 -56.77 -36.92 70.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.629 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 94' ' ' GLN . 54.2 t -52.06 -37.31 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.776 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 99' ' ' LYS . 33.9 tptt -62.76 -58.8 6.17 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.384 -175.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -64.07 -49.59 71.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.592 0.234 . . . . 0.0 111.157 -174.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 68.8 t -53.7 -59.69 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.542 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.714 -178.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.776 ' HA ' HD12 ' A' ' 107' ' ' ILE . 35.1 mt -65.0 -30.41 71.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.988 -174.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -80.26 -63.92 1.3 Allowed 'General case' 0 C--N 1.312 -1.033 0 C-N-CA 120.217 -0.593 . . . . 0.0 110.582 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 62.3 m -65.39 -23.44 66.96 Favored 'General case' 0 C--N 1.338 0.077 0 O-C-N 124.213 0.946 . . . . 0.0 113.423 -164.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.576 ' CE1' HD11 ' A' ' 12' ' ' ILE . 54.5 m-85 -81.74 15.38 2.2 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.19 -0.604 . . . . 0.0 110.302 173.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . . . . . . . . . 46.9 t 55.22 44.46 27.59 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.325 -178.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.776 HD12 ' HA ' ' A' ' 102' ' ' LEU . 61.4 mt -86.22 93.36 3.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 C-N-CA 119.549 -0.86 . . . . 0.0 111.068 -174.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 31.6 m -106.28 19.45 5.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.261 177.264 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.98 168.89 26.72 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.836 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.426 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 87.0 m-85 -122.94 159.03 55.6 Favored Pre-proline 0 C--N 1.324 -0.535 0 N-CA-C 110.45 -0.204 . . . . 0.0 110.45 179.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.426 ' HA ' ' HB3' ' A' ' 110' ' ' PHE . 2.3 Cg_endo -86.52 171.55 38.7 Favored 'Cis proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.58 -1.425 . . . . 0.0 112.359 -0.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -136.93 104.26 5.41 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.9 177.317 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 54.1 mt -115.93 114.92 47.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.546 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 38.1 pt -124.93 159.2 31.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.06 -175.155 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 4.0 tt -116.99 116.3 27.11 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 179.32 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.544 ' HB ' ' HB ' ' A' ' 32' ' ' VAL . 95.7 t -102.66 142.99 15.72 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.462 -0.79 . . . . 0.0 110.475 -176.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.406 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 0.0 OUTLIER -77.36 165.56 50.81 Favored Pre-proline 0 C--N 1.327 -0.386 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 178.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 30' ' ' LYS . 5.4 Cg_endo -49.0 -29.84 16.51 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.313 2.675 . . . . 0.0 114.09 178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.787 ' HB3' ' HZ3' ' A' ' 121' ' ' LYS . 0.5 OUTLIER -91.75 2.06 56.75 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 -177.392 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.426 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 86.75 26.34 32.44 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.412 -0.899 . . . . 0.0 113.436 175.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.787 ' HZ3' ' HB3' ' A' ' 119' ' ' GLU . 28.4 mttp -107.66 142.36 37.75 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 117.043 0.422 . . . . 0.0 110.465 175.406 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 46.7 mt -76.29 109.73 10.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.939 -177.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 8.0 p -95.37 -36.21 6.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.066 0.46 . . . . 0.0 110.3 177.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.565 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -134.43 157.02 47.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 114' ' ' ILE . 21.4 pttm -163.08 151.79 14.4 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 121.283 -0.167 . . . . 0.0 111.003 -176.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 60.28 48.49 8.01 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.885 0.74 . . . . 0.0 111.09 177.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 84.6 mt -84.66 156.94 21.29 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.507 -0.77 . . . . 0.0 110.939 -178.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.506 ' HD2' ' H ' ' A' ' 129' ' ' GLY . 8.6 tpt180 -101.44 147.71 26.03 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 178.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.805 ' HA2' HD12 ' A' ' 132' ' ' LEU . . . -38.27 -58.31 1.66 Allowed Glycine 0 C--N 1.333 0.387 0 N-CA-C 114.842 0.697 . . . . 0.0 114.842 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -57.37 -38.0 73.53 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.168 0.509 . . . . 0.0 110.102 -178.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' HA ' ' HB2' ' A' ' 134' ' ' ASN . 32.8 t70 -83.27 -26.85 30.31 Favored 'General case' 0 C--O 1.219 -0.512 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.06 -174.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.805 HD12 ' HA2' ' A' ' 129' ' ' GLY . 75.5 mt -46.26 -57.62 4.41 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.894 0.378 . . . . 0.0 110.497 173.035 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -63.1 -47.9 80.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.98 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.45 ' HB2' ' HA ' ' A' ' 131' ' ' ASP . 94.0 m-20 -53.72 -53.36 53.15 Favored 'General case' 0 C--O 1.219 -0.543 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.236 -179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.654 ' HA ' ' CE ' ' A' ' 138' ' ' LYS . 4.8 m -62.24 -36.12 81.04 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -175.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.508 HG23 ' O ' ' A' ' 132' ' ' LEU . 50.8 t -69.21 -44.89 80.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 C-N-CA 119.993 -0.683 . . . . 0.0 110.43 177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 141' ' ' ASN . 1.3 tp10 -67.53 -29.83 69.34 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-O 121.652 0.739 . . . . 0.0 109.962 177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.654 ' CE ' ' HA ' ' A' ' 135' ' ' THR . 26.9 ttpt -78.87 -54.2 6.3 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.003 -0.999 . . . . 0.0 111.966 -176.466 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.489 ' CD2' HG23 ' A' ' 135' ' ' THR . 61.1 m-85 -87.07 -48.79 7.79 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.465 ' HB ' ' O ' ' A' ' 136' ' ' VAL . 80.3 t -65.92 -42.61 92.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.772 0.32 . . . . 0.0 111.202 -173.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.488 ' HB2' ' O ' ' A' ' 137' ' ' GLU . 86.4 m-20 -81.9 -25.91 34.58 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.982 0.42 . . . . 0.0 110.997 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.02 16.46 64.25 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.411 -173.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . . . . . . . . . . . 60.21 17.47 6.98 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 123.228 0.611 . . . . 0.0 112.106 -178.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.449 ' HD3' ' HA ' ' A' ' 144' ' ' LYS . 34.9 mmtm -147.53 -52.16 0.2 Allowed 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 -178.036 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.511 ' CD ' ' HZ3' ' A' ' 61' ' ' LYS . 43.0 mt-10 71.11 -31.12 0.22 Allowed 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.422 0.689 . . . . 0.0 112.011 -177.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -77.61 -158.73 10.49 Favored Glycine 0 N--CA 1.449 -0.495 0 N-CA-C 111.276 -0.73 . . . . 0.0 111.276 171.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 54.8 t-80 59.07 59.16 2.86 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 121.57 0.7 . . . . 0.0 109.521 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -80.47 4.68 17.43 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.317 -173.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 23.8 m170 -110.97 140.74 45.24 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 176.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 24.6 p-80 -118.77 87.04 2.65 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.596 0.713 . . . . 0.0 111.346 -179.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . . . . . . . . . 79.6 m-70 -132.89 -42.88 0.89 Allowed 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 171.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 25.0 p80 . . . . . 0 C--O 1.249 1.076 0 CA-C-N 114.631 -1.168 . . . . 0.0 108.53 174.134 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.4 ttt . . . . . 0 N--CA 1.485 1.303 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 52.1 m 73.47 -93.45 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 114.088 1.144 . . . . 0.0 114.088 168.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.1 mt -130.53 -165.17 1.51 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.122 0.487 . . . . 0.0 111.668 -164.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -144.82 -80.23 0.18 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.274 175.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 t -152.81 154.1 34.46 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 78.12 -1.27 70.31 Favored Glycine 0 N--CA 1.451 -0.303 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 6.1 m -91.69 146.43 23.78 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.595 -0.302 . . . . 0.0 110.461 -177.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.6 p -79.42 138.57 19.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-O 120.933 0.397 . . . . 0.0 110.095 179.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' HA ' ' HD3' ' A' ' 10' ' ' PRO . . . -109.81 149.95 40.67 Favored Pre-proline 0 C--N 1.323 -0.548 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.738 -175.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 9' ' ' ALA . 35.6 Cg_exo -62.9 163.53 21.86 Favored 'Trans proline' 0 C--N 1.346 0.423 0 C-N-CA 123.522 2.815 . . . . 0.0 112.088 175.151 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -93.89 105.0 17.04 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.083 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 37.5 mt -63.36 148.32 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.603 177.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.506 ' HA ' ' HA ' ' A' ' 23' ' ' SER . 13.7 t -136.61 134.99 37.97 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 171.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -151.7 171.18 31.18 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.355 -177.261 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.443 HD12 ' N ' ' A' ' 15' ' ' ILE . 4.4 mp -88.9 119.46 36.07 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.769 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.39 -175.72 5.29 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.088 0.47 . . . . 0.0 111.127 -173.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.469 HD21 ' HB2' ' A' ' 90' ' ' GLN . 95.4 mt -65.07 -28.93 69.8 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.945 -177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -83.58 -28.99 28.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.129 0.49 . . . . 0.0 110.44 -179.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 112.86 25.22 4.6 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.251 177.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 19.2 m-80 -102.27 148.17 25.77 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 177.011 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 38.5 p -76.82 94.35 3.86 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 172.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 53.2 t -102.04 130.67 51.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.367 -176.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.543 ' HB2' ' OD1' ' A' ' 25' ' ' ASN . 10.4 m -102.58 161.85 13.39 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 178.086 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 46.7 tp -62.51 -14.86 46.48 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.615 -178.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.543 ' OD1' ' HB2' ' A' ' 23' ' ' SER . 30.2 p-10 -67.28 -20.86 65.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.915 0.388 . . . . 0.0 111.2 -177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 23.7 t0 -78.13 -23.04 47.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.631 0.729 . . . . 0.0 110.881 -179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -105.46 5.53 31.66 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . . . . . . . . . 40.8 mttt -79.98 63.21 4.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.702 -179.04 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -160.6 13.17 0.16 Allowed Glycine 0 N--CA 1.449 -0.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 111.064 171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 51.9 mttp -144.31 171.38 14.41 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -80.32 120.78 24.83 Favored 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 120.026 -0.67 . . . . 0.0 109.317 172.281 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.476 ' HA ' ' O ' ' A' ' 64' ' ' THR . 46.1 t -112.47 112.79 41.99 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.978 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.494 -171.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . 0.504 HD21 HG23 ' A' ' 113' ' ' ILE . 10.0 tt -90.58 119.32 30.74 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 172.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.551 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 51.5 t -103.77 121.32 55.09 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 120.801 0.334 . . . . 0.0 110.915 -174.144 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' O ' ' HB ' ' A' ' 68' ' ' VAL . 29.9 m-20 -84.98 136.75 33.47 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.698 -0.683 . . . . 0.0 109.418 176.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -118.26 114.55 23.16 Favored 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 165.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . . . . . . . . . 13.0 p-90 -158.18 173.36 16.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.691 0.758 . . . . 0.0 112.342 -172.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 38.5 p90 -170.05 166.59 9.14 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.614 169.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -63.24 -20.73 65.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.831 0.678 . . . . 0.0 112.831 -171.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -69.71 -51.47 24.97 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 121.007 -0.616 . . . . 0.0 113.148 -176.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 1.4 p -71.45 101.9 2.54 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.454 0.645 . . . . 0.0 110.432 -179.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.435 ' O ' ' HD3' ' A' ' 46' ' ' LYS . 18.9 m -69.39 -5.45 23.61 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.362 -0.835 . . . . 0.0 113.081 -171.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . 0.515 ' HD1' ' HG3' ' A' ' 111' ' ' PRO . 72.4 t-105 -85.37 -29.31 24.55 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.964 -0.295 . . . . 0.0 110.952 178.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.786 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 75.8 m -57.81 -34.5 69.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.788 0.328 . . . . 0.0 110.631 176.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.573 ' HD2' ' OD1' ' A' ' 84' ' ' ASP . 8.6 mmt85 -66.79 -18.38 65.35 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-O 121.372 0.606 . . . . 0.0 110.388 178.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 43' ' ' TRP . 14.7 mptt -85.09 -33.18 22.47 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.822 -0.627 . . . . 0.0 110.937 -177.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -82.27 -20.27 37.89 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.418 -177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.578 ' HB ' ' HD3' ' A' ' 49' ' ' PRO . 46.5 m -48.61 -50.5 59.03 Favored Pre-proline 0 CA--C 1.542 0.661 0 N-CA-C 113.652 0.982 . . . . 0.0 113.652 -177.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 48' ' ' THR . 74.4 Cg_exo -49.65 -45.27 32.19 Favored 'Trans proline' 0 C--N 1.357 0.974 0 C-N-CA 122.266 1.978 . . . . 0.0 112.843 178.203 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 69.9 m-85 -74.93 -31.82 61.62 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.935 -179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 95.4 mt -62.51 -47.95 81.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.839 0.352 . . . . 0.0 110.275 176.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.5 tp -61.49 -40.94 96.4 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-O 121.174 0.511 . . . . 0.0 109.965 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 29.0 tptp -56.67 -46.44 81.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.591 175.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 72.3 m -65.12 -49.29 70.5 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.275 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.608 ' HB2' HD12 ' A' ' 65' ' ' ILE . 85.1 t80 -57.63 -42.37 83.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.788 0.328 . . . . 0.0 111.44 -177.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 64.8 t30 -78.06 -35.47 49.5 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.468 -175.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.421 ' O ' ' HE3' ' A' ' 61' ' ' LYS . . . -85.37 -19.88 30.74 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -176.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.656 ' CZ ' HG13 ' A' ' 136' ' ' VAL . 44.6 m-85 -106.22 -4.95 19.61 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -176.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' HG3' ' OD1' ' A' ' 60' ' ' ASP . 16.9 pttp -67.39 167.15 13.11 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 176.948 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' OD1' ' HG3' ' A' ' 59' ' ' LYS . 1.9 m-20 73.94 -36.9 0.35 Allowed 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.656 179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 57' ' ' ALA . 82.1 mttt -61.69 -41.12 97.15 Favored 'General case' 0 N--CA 1.462 0.161 0 CA-C-O 121.374 0.607 . . . . 0.0 110.167 177.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 132.36 44.62 0.14 Allowed Glycine 0 N--CA 1.451 -0.356 0 N-CA-C 110.364 -1.095 . . . . 0.0 110.364 -173.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.444 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 56.7 t80 -140.59 144.66 35.96 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 -173.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . 0.476 ' O ' ' HA ' ' A' ' 32' ' ' VAL . 44.7 m -150.64 142.23 23.56 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 178.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.608 HD12 ' HB2' ' A' ' 55' ' ' TYR . 32.6 mt -98.77 134.45 37.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.981 0.419 . . . . 0.0 110.139 179.242 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 19.6 t80 -112.89 95.86 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.409 -175.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' HB2' ' A' ' 35' ' ' ASP . . . -76.96 103.3 1.77 Allowed Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.397 -175.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.489 ' HB ' ' O ' ' A' ' 35' ' ' ASP . 53.7 t -99.05 117.21 43.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.265 0.555 . . . . 0.0 110.614 -179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 16.0 t -128.97 156.61 43.51 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.116 0.484 . . . . 0.0 110.763 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.1 t -136.76 48.76 2.09 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.482 ' CG ' ' H ' ' A' ' 72' ' ' ARG . 10.8 t70 -65.29 -176.12 0.29 Allowed 'General case' 0 C--O 1.239 0.538 0 CA-C-N 114.312 -1.313 . . . . 0.0 112.552 -171.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.482 ' H ' ' CG ' ' A' ' 71' ' ' ASP . 50.7 mtm180 -54.15 -50.31 67.26 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 114.526 -1.216 . . . . 0.0 111.01 -178.095 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.624 ' HD3' ' OD2' ' A' ' 76' ' ' ASP . 55.3 mtp180 -145.65 175.04 10.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.37 -0.832 . . . . 0.0 108.766 -177.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . 0.413 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 42.0 tt0 -75.14 -38.63 60.92 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 171.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -62.92 -42.27 99.74 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.328 177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.624 ' OD2' ' HD3' ' A' ' 73' ' ' ARG . 3.4 m-20 -75.56 -28.22 58.91 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.094 178.4 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.443 ' CZ3' ' HE3' ' A' ' 78' ' ' LYS . 21.1 t90 -64.68 -48.22 75.54 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 110.062 -0.347 . . . . 0.0 110.062 171.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.443 ' HE3' ' CZ3' ' A' ' 77' ' ' TRP . 2.2 mptm? -58.9 -37.43 76.61 Favored 'General case' 0 N--CA 1.462 0.149 0 CA-C-O 121.048 0.451 . . . . 0.0 110.002 173.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.427 ' O ' ' HB3' ' A' ' 82' ' ' GLU . 36.1 ttmt -63.05 -45.68 91.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.932 177.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -62.56 -33.35 74.76 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.918 0.389 . . . . 0.0 110.943 -179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 77.0 mt -69.09 -36.97 76.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.079 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.427 ' HB3' ' O ' ' A' ' 79' ' ' LYS . 10.1 tp10 -63.0 -40.88 99.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.015 173.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . 0.421 ' HG3' ' O ' ' A' ' 79' ' ' LYS . 50.1 mt-10 -62.65 -59.7 4.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.265 179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.573 ' OD1' ' HD2' ' A' ' 45' ' ' ARG . 1.2 m-20 -82.53 -16.99 46.6 Favored 'General case' 0 N--CA 1.466 0.364 0 N-CA-C 112.81 0.67 . . . . 0.0 112.81 -172.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 42.4 mmtm 62.99 35.16 13.41 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 121.318 0.58 . . . . 0.0 111.12 -178.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 2.3 p -81.7 86.17 6.47 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.571 -0.741 . . . . 0.0 110.951 -179.329 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 40.9 m-85 -90.4 86.18 6.38 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.357 0.503 . . . . 0.0 112.357 -175.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . . . . . . . . . 36.1 p90 -155.42 -175.26 5.34 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.168 167.307 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -65.52 96.78 0.27 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.321 0.582 . . . . 0.0 111.446 -174.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . 0.469 ' HB2' HD21 ' A' ' 17' ' ' LEU . 76.0 mm-40 -99.05 140.15 33.64 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.132 177.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.5 m -132.68 137.14 54.7 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.113 0.482 . . . . 0.0 110.413 176.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 43.1 tp -92.85 125.94 37.7 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 176.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.448 HD22 ' OD2' ' A' ' 97' ' ' ASP . 65.9 mt -72.58 137.88 46.48 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.787 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.665 ' O ' HG23 ' A' ' 98' ' ' VAL . 24.8 mt-30 -67.07 147.05 53.66 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 169.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -72.27 -16.74 61.92 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 121.191 0.519 . . . . 0.0 110.759 -170.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -85.15 -33.87 22.24 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.432 174.519 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.448 ' OD2' HD22 ' A' ' 93' ' ' LEU . 7.1 t70 -72.27 -32.55 66.74 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.381 -179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.665 HG23 ' O ' ' A' ' 94' ' ' GLN . 75.3 t -50.09 -37.09 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.429 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.533 -175.245 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 14.8 mtmm -56.75 -63.76 1.1 Allowed 'General case' 0 C--O 1.238 0.5 0 CA-C-O 121.786 0.803 . . . . 0.0 111.626 -172.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -74.05 -39.94 63.16 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 114.5 -1.227 . . . . 0.0 110.804 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.483 ' O ' ' HD2' ' A' ' 105' ' ' TYR . 68.3 t -58.24 -50.2 79.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.923 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.551 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 19.3 mt -56.21 -62.06 1.97 Allowed 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 121.028 -0.269 . . . . 0.0 110.981 179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -56.57 -50.76 70.97 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 120.776 -0.369 . . . . 0.0 110.532 -174.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . . . . . . . . . 16.3 t -57.63 -33.09 67.91 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 123.651 0.594 . . . . 0.0 112.365 -173.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.483 ' HD2' ' O ' ' A' ' 101' ' ' VAL . 51.2 m-85 -83.8 16.11 2.93 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.097 0.475 . . . . 0.0 110.538 176.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.638 ' HB2' ' NZ ' ' A' ' 125' ' ' LYS . 2.8 m 67.98 38.82 2.67 Favored 'General case' 0 CA--C 1.519 -0.239 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.436 178.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 78.8 mt -119.94 110.02 27.79 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.116 -170.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 24.4 m -118.69 20.22 6.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.404 -0.817 . . . . 0.0 110.366 176.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -175.83 -172.4 40.6 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.658 -178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -140.44 156.17 69.65 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 117.181 0.49 . . . . 0.0 110.2 -179.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.786 ' HB3' ' SG ' ' A' ' 44' ' ' CYS . 92.3 Cg_endo -86.36 167.6 47.58 Favored 'Cis proline' 0 C--N 1.349 0.587 0 C-N-CA 123.784 -1.34 . . . . 0.0 113.237 -0.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -145.92 118.64 8.62 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.778 174.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . 0.601 HG21 HD22 ' A' ' 132' ' ' LEU . 4.1 mp -111.49 120.59 62.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.603 ' HA ' ' HA ' ' A' ' 125' ' ' LYS . 39.9 pt -122.08 158.1 26.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.951 0.405 . . . . 0.0 111.561 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 63.6 tp -122.86 117.41 25.55 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.946 -0.57 . . . . 0.0 109.926 177.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 117' ' ' ASP . 93.3 t -113.1 135.47 52.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.103 -175.827 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.56 ' OD2' ' HB2' ' A' ' 121' ' ' LYS . 26.3 m-20 -66.96 163.89 40.04 Favored Pre-proline 0 N--CA 1.464 0.242 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.749 174.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -58.85 -27.72 85.03 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.108 1.872 . . . . 0.0 111.404 174.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.0 mt-10 -68.44 -29.87 68.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.761 176.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . 0.404 ' HA2' ' CG1' ' A' ' 116' ' ' VAL . . . 100.34 40.4 3.01 Favored Glycine 0 N--CA 1.444 -0.819 0 CA-C-N 115.56 -0.745 . . . . 0.0 112.372 -175.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.613 ' HB2' ' HZ2' ' A' ' 121' ' ' LYS . 9.4 mtmp? -112.05 148.8 33.11 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 110.011 -0.366 . . . . 0.0 110.011 173.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 13.3 mt -91.95 99.4 9.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 179.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 7.5 p -87.14 -33.74 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.228 0.537 . . . . 0.0 110.639 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -141.15 152.94 45.09 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.743 ' HD3' ' HG2' ' A' ' 126' ' ' GLU . 2.3 ptpt -166.83 172.86 9.99 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.783 0.325 . . . . 0.0 111.51 -177.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.743 ' HG2' ' HD3' ' A' ' 125' ' ' LYS . 0.7 OUTLIER 59.67 28.88 18.4 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 114.923 -1.035 . . . . 0.0 110.242 178.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.562 HD13 ' HA ' ' A' ' 132' ' ' LEU . 89.7 mt -78.52 154.2 30.66 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.408 -0.814 . . . . 0.0 111.48 -174.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.439 ' H ' ' HB3' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -104.33 169.56 8.41 Favored 'General case' 0 C--O 1.219 -0.54 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.079 179.052 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.52 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -46.6 -70.94 0.59 Allowed Glycine 0 CA--C 1.522 0.497 0 N-CA-C 114.062 0.385 . . . . 0.0 114.062 -178.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -59.9 -32.84 71.12 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.375 0.607 . . . . 0.0 110.987 179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.635 ' HA ' ' ND2' ' A' ' 134' ' ' ASN . 39.9 t0 -73.64 -46.16 48.38 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.582 -173.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.601 HD22 HG21 ' A' ' 113' ' ' ILE . 4.5 pp -60.04 -37.0 78.5 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.771 -0.195 . . . . 0.0 110.505 -176.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.502 ' CE2' ' HE1' ' A' ' 58' ' ' PHE . 53.8 t80 -68.14 -55.27 12.99 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.798 -179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . 0.651 ' O ' ' HB2' ' A' ' 138' ' ' LYS . 5.9 p30 -67.42 -27.09 66.78 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.361 -0.536 . . . . 0.0 110.693 -174.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . 0.454 ' O ' ' HB3' ' A' ' 138' ' ' LYS . 43.3 m -83.58 -33.24 25.42 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 111.621 0.23 . . . . 0.0 111.621 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.656 HG13 ' CZ ' ' A' ' 58' ' ' PHE . 8.5 p -74.89 -38.77 44.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 O-C-N 121.77 -0.581 . . . . 0.0 109.963 177.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.563 ' HB2' ' HZ ' ' A' ' 58' ' ' PHE . 4.0 tp10 -65.6 -32.86 74.67 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 134' ' ' ASN . 24.1 ttmt -56.66 -43.65 80.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 114.783 -1.098 . . . . 0.0 110.796 177.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -86.24 -51.13 6.46 Favored 'General case' 0 N--CA 1.464 0.24 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -179.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.26 -34.66 31.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 N-CA-C 112.25 0.463 . . . . 0.0 112.25 -170.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . 0.46 ' HB2' ' OE2' ' A' ' 137' ' ' GLU . 55.6 t30 -98.68 -49.91 4.43 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.764 0.316 . . . . 0.0 110.423 -177.313 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 66.36 -159.8 47.23 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-N 115.735 -0.666 . . . . 0.0 113.039 177.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.476 ' C ' ' HD2' ' A' ' 144' ' ' LYS . . . -80.03 150.54 30.34 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.476 ' HD2' ' C ' ' A' ' 143' ' ' ALA . 20.7 mmmt -114.89 129.67 56.75 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.492 -176.171 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -128.96 152.93 48.05 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . 133.89 151.97 6.62 Favored Glycine 0 N--CA 1.442 -0.929 0 N-CA-C 111.878 -0.489 . . . . 0.0 111.878 -177.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 64.88 23.37 12.63 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.954 0.407 . . . . 0.0 111.437 175.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 13.0 m170 -81.34 -3.19 51.93 Favored 'General case' 0 C--N 1.328 -0.347 0 O-C-N 122.222 -0.299 . . . . 0.0 111.481 178.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -159.15 130.76 6.34 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.548 ' O ' ' HB3' ' A' ' 151' ' ' HIS . 57.4 t60 -129.49 147.18 51.27 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 175.786 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.548 ' HB3' ' O ' ' A' ' 150' ' ' HIS . 20.4 t60 72.67 151.72 0.12 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 123.645 0.591 . . . . 0.0 109.699 -173.012 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . . . . . . . . . 18.6 t60 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.158 -0.925 . . . . 0.0 110.158 176.484 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 ptp . . . . . 0 N--CA 1.48 1.052 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.753 ' HA ' ' HB2' ' A' ' 106' ' ' CYS . 62.1 m -143.83 -179.01 6.2 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 123.039 0.212 . . . . 0.0 110.483 -178.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 95.6 mt -60.23 162.86 5.49 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-O 121.209 0.528 . . . . 0.0 112.087 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -78.98 -171.21 2.52 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.247 -178.241 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.4 p -99.22 131.05 45.53 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.605 178.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 97.26 -1.45 60.62 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.061 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 30.1 p -74.93 138.79 42.58 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 110.436 -0.209 . . . . 0.0 110.436 178.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.9 t -69.07 128.42 32.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 110.027 -0.36 . . . . 0.0 110.027 179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -83.74 130.5 55.32 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.406 -176.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -62.12 154.85 59.76 Favored 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 122.788 2.325 . . . . 0.0 111.396 173.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -88.06 103.9 16.16 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.882 0.372 . . . . 0.0 111.61 -175.031 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.562 ' O ' ' HA ' ' A' ' 23' ' ' SER . 39.8 mt -63.07 142.82 16.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.866 173.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 22' ' ' VAL . 2.0 t -124.27 87.46 2.73 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.625 0.726 . . . . 0.0 110.582 176.458 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -104.56 161.65 15.18 Favored Glycine 0 N--CA 1.445 -0.704 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.43 -175.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 61.3 mt -93.0 123.48 45.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.609 0.242 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.511 ' HA ' HG12 ' A' ' 91' ' ' VAL . 0.4 OUTLIER -70.95 -175.66 1.18 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.399 0.619 . . . . 0.0 111.883 -172.49 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 88.3 mt -60.25 -29.55 68.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.287 -0.869 . . . . 0.0 111.653 -178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -81.47 -50.7 9.11 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.114 0.483 . . . . 0.0 110.243 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 139.71 23.6 0.31 Allowed Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.52 -178.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -108.81 137.47 46.69 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 31.0 p -79.99 114.29 18.8 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.738 0.304 . . . . 0.0 111.039 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 13' ' ' THR . 23.9 m -108.78 156.56 9.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.924 177.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.562 ' HA ' ' O ' ' A' ' 12' ' ' ILE . 8.5 p -107.49 155.76 19.71 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.013 0.435 . . . . 0.0 110.733 177.335 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 49.4 tp -56.97 -31.62 65.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.867 177.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.684 ' HA ' ' HB2' ' A' ' 28' ' ' LYS . 9.9 t30 -71.17 -17.73 62.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.371 -174.517 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -68.37 -29.41 68.12 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.169 0.509 . . . . 0.0 110.373 178.109 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -97.32 -15.06 20.92 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.082 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LYS . . . . . 0.684 ' HB2' ' HA ' ' A' ' 25' ' ' ASN . 1.4 tmtp? -54.14 145.1 17.95 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 114.995 -1.002 . . . . 0.0 110.235 178.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.37 -0.35 40.35 Favored Glycine 0 N--CA 1.447 -0.621 0 N-CA-C 109.999 -1.24 . . . . 0.0 109.999 -171.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LYS . . . . . . . . . . . . . 23.5 mttp -133.97 172.59 12.6 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.498 ' CG ' HG22 ' A' ' 140' ' ' VAL . 94.8 m-85 -77.67 106.52 9.53 Favored 'General case' 0 C--N 1.318 -0.79 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 171.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.9 t -102.61 108.52 24.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.881 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 8.8 tt -87.02 113.81 23.1 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 174.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.454 ' HB ' ' CG1' ' A' ' 114' ' ' ILE . 24.3 t -96.03 115.23 34.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 -178.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -103.44 106.67 17.24 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.545 -176.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.52 ' HA ' HG23 ' A' ' 68' ' ' VAL . 86.5 m-85 -90.5 115.09 27.38 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.482 ' O ' ' HA ' ' A' ' 69' ' ' SER . 10.6 p-90 -159.35 179.82 8.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.726 0.774 . . . . 0.0 112.348 -177.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -166.63 162.92 16.75 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.045 -1.434 . . . . 0.0 108.006 171.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -56.99 -36.03 69.88 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 111.762 0.282 . . . . 0.0 111.762 -174.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -55.38 -46.34 80.53 Favored Glycine 0 C--N 1.332 0.335 0 O-C-N 123.635 0.585 . . . . 0.0 112.688 179.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 7.4 p -88.65 78.85 7.66 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.716 0.77 . . . . 0.0 109.619 177.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.802 ' HA ' ' HD3' ' A' ' 45' ' ' ARG . 54.8 m -69.4 -1.97 9.78 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.242 -174.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' TRP . . . . . . . . . . . . . 16.2 m95 -74.56 -36.35 63.08 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.999 -0.28 . . . . 0.0 110.529 178.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' CYS . . . . . 0.481 ' SG ' ' HB3' ' A' ' 111' ' ' PRO . 3.3 m -60.7 -35.73 77.04 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.875 0.845 . . . . 0.0 108.857 174.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.802 ' HD3' ' HA ' ' A' ' 42' ' ' SER . 58.5 mtp180 -67.77 -26.6 66.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.886 179.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 42' ' ' SER . 5.9 mptt -86.97 -16.96 34.24 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.907 0.384 . . . . 0.0 111.603 -179.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -88.62 -10.32 49.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.681 0.753 . . . . 0.0 109.149 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.599 HG23 ' CH2' ' A' ' 88' ' ' TRP . 37.0 m -54.82 -46.22 99.52 Favored Pre-proline 0 CA--C 1.543 0.68 0 CA-C-N 114.787 -1.097 . . . . 0.0 113.277 177.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 91.3 Cg_exo -46.43 -43.57 21.85 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.369 2.046 . . . . 0.0 113.005 177.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . . . . . . . . . 61.7 m-85 -70.65 -40.14 73.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.495 -0.32 . . . . 0.0 110.745 178.314 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 48' ' ' THR . 97.8 mt -60.02 -37.8 80.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.504 175.265 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 62.7 tp -65.88 -43.74 87.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.72 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 42.5 tttp -59.88 -43.27 94.84 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 174.504 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.506 ' O ' ' HD2' ' A' ' 58' ' ' PHE . 57.8 m -58.17 -48.99 78.59 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.911 177.086 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TYR . . . . . 0.412 ' HB2' HD12 ' A' ' 65' ' ' ILE . 79.2 t80 -56.24 -48.59 76.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.022 0.439 . . . . 0.0 110.991 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -72.26 -19.99 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.983 -0.553 . . . . 0.0 112.197 -177.098 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.497 ' O ' ' HE2' ' A' ' 61' ' ' LYS . . . -91.87 -32.13 15.43 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.208 0.447 . . . . 0.0 112.208 -177.008 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.538 ' O ' ' HB3' ' A' ' 63' ' ' PHE . 97.1 m-85 -111.43 4.59 19.03 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -171.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.3 pttm -55.2 -32.49 62.27 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.47 0.652 . . . . 0.0 111.005 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -95.69 12.0 31.38 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.626 -174.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.497 ' HE2' ' O ' ' A' ' 57' ' ' ALA . 34.7 mttm -122.97 23.04 9.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.796 0.332 . . . . 0.0 110.999 -175.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 70.71 47.41 40.81 Favored Glycine 0 C--N 1.33 0.21 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.536 -179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.538 ' HB3' ' O ' ' A' ' 58' ' ' PHE . 69.7 t80 -129.87 136.55 49.67 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.848 -0.427 . . . . 0.0 109.848 -176.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 30.7 m -143.01 131.56 22.39 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.684 178.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.412 HD12 ' HB2' ' A' ' 55' ' ' TYR . 55.7 mt -88.38 122.04 39.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 176.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -108.14 94.83 5.28 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -84.2 133.12 11.57 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.815 -0.707 . . . . 0.0 111.678 -176.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.768 ' HB ' HD21 ' A' ' 93' ' ' LEU . 9.5 m -119.85 112.99 39.23 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.472 0.653 . . . . 0.0 110.774 -179.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 37' ' ' TRP . 14.7 t -103.88 148.66 25.88 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.577 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.518 ' HB ' HD12 ' A' ' 93' ' ' LEU . 5.8 t -126.34 33.98 4.91 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -60.39 170.01 1.49 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.348 -178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.9 mtp180 -69.25 -46.84 66.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.644 -176.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -130.64 164.91 23.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.504 -177.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -65.59 -37.32 86.29 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 171.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.427 ' H ' ' CD ' ' A' ' 75' ' ' GLU . 2.1 mp0 -55.53 -53.75 52.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.937 178.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -59.22 -45.52 90.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.81 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 21.1 t90 -59.03 -53.24 60.68 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.951 178.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -60.53 -40.64 92.26 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.926 0.394 . . . . 0.0 111.059 179.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 28.1 ttpp -64.15 -45.85 86.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.562 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.38 81.12 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.573 -178.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 83.3 mt -63.74 -42.43 95.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.366 176.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 32.5 tp10 -68.05 -41.55 81.83 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.685 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -56.88 -51.28 69.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.141 -0.482 . . . . 0.0 111.763 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -101.48 7.54 42.4 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -174.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.56 ' HD2' ' CE2' ' A' ' 87' ' ' TYR . 66.8 mmtt 55.58 36.32 26.95 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.543 174.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.47 ' HB3' HG21 ' A' ' 48' ' ' THR . 3.5 p -81.47 68.67 7.89 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.319 0.581 . . . . 0.0 111.25 179.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.56 ' CE2' ' HD2' ' A' ' 85' ' ' LYS . 62.3 m-85 -81.8 95.62 7.35 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.938 -176.186 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TRP . . . . . 0.599 ' CH2' HG23 ' A' ' 48' ' ' THR . 5.3 p90 -160.99 -178.99 7.17 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.481 171.231 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 49.7 m-80 -67.64 100.6 0.91 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.458 -177.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLN . . . . . . . . . . . . . 63.3 mt-30 -117.54 150.56 38.77 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.751 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . 0.511 HG12 ' HA ' ' A' ' 16' ' ' ASP . 35.8 m -133.81 149.34 30.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.46 177.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 26.1 tp -93.65 123.79 37.21 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.768 HD21 ' HB ' ' A' ' 68' ' ' VAL . 69.3 mt -62.78 137.73 58.34 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.489 -177.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLN . . . . . 0.604 ' O ' HG23 ' A' ' 98' ' ' VAL . 43.9 mt-30 -74.16 166.99 22.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.46 -178.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -51.88 -48.3 64.15 Favored 'General case' 0 N--CA 1.465 0.305 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -173.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -85.55 -32.34 22.2 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.789 0.328 . . . . 0.0 110.417 177.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . 0.449 ' HB3' ' N ' ' A' ' 94' ' ' GLN . 22.1 t70 -58.05 -42.13 84.77 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.897 -178.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.693 HG22 ' HB2' ' A' ' 93' ' ' LEU . 77.7 t -49.65 -57.93 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 121.384 0.611 . . . . 0.0 110.626 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 103' ' ' GLU . 35.3 ttmt -65.26 -59.17 4.36 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.313 -175.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -55.25 -51.7 65.78 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.906 -0.588 . . . . 0.0 112.451 -176.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -67.9 -52.47 39.1 Favored 'Isoleucine or valine' 0 C--O 1.239 0.523 0 N-CA-C 111.861 0.319 . . . . 0.0 111.861 -175.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.609 ' O ' ' HB ' ' A' ' 107' ' ' ILE . 77.1 mt -58.84 -38.39 78.61 Favored 'General case' 0 C--O 1.224 -0.264 0 CA-C-O 120.791 0.329 . . . . 0.0 110.543 -179.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 99' ' ' LYS . 0.4 OUTLIER -61.56 -59.76 4.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 176.889 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 106' ' ' CYS . 66.9 m -50.74 -41.14 56.13 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . 0.544 ' HB2' HG12 ' A' ' 107' ' ' ILE . 53.5 m-85 -71.76 5.75 2.36 Favored 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 120.761 -0.376 . . . . 0.0 111.048 179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' CYS . . . . . 0.753 ' HB2' ' HA ' ' A' ' 2' ' ' SER . 85.3 m 61.72 52.24 3.61 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.386 -0.825 . . . . 0.0 108.989 -173.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 102' ' ' LEU . 48.0 mm -99.27 125.46 52.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.355 -0.839 . . . . 0.0 110.695 -178.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.23 7.93 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.421 178.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -173.84 162.38 33.11 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.136 -177.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.583 ' HB3' ' HA ' ' A' ' 111' ' ' PRO . 85.2 m-85 -132.1 164.66 41.6 Favored Pre-proline 0 C--N 1.329 -0.309 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' PRO . . . . . 0.754 ' HB2' HH12 ' A' ' 128' ' ' ARG . 15.5 Cg_exo -68.52 157.36 88.33 Favored 'Cis proline' 0 C--N 1.351 0.686 0 C-N-CA 124.362 -1.099 . . . . 0.0 112.448 0.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -141.58 104.3 4.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.85 0.357 . . . . 0.0 110.815 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 91.6 mt -114.66 122.23 68.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.286 179.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.485 HG22 ' HB2' ' A' ' 125' ' ' LYS . 39.6 pt -123.94 155.8 30.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.539 179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.425 ' HB3' ' HB3' ' A' ' 124' ' ' ALA . 55.0 tp -120.89 116.73 25.7 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.714 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 55.3 t -100.62 126.9 54.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.932 176.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.543 ' HB2' ' HD2' ' A' ' 118' ' ' PRO . 1.9 p30 -72.87 164.31 61.66 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.267 177.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 117' ' ' ASP . 9.4 Cg_endo -55.93 -28.86 70.51 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.567 2.178 . . . . 0.0 112.802 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -65.88 -30.01 70.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.334 0.587 . . . . 0.0 110.017 177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 106.81 29.53 4.62 Favored Glycine 0 N--CA 1.449 -0.438 0 CA-C-N 115.579 -0.737 . . . . 0.0 112.388 175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.429 ' HB2' ' NZ ' ' A' ' 121' ' ' LYS . 8.6 mtmp? -114.96 149.14 37.81 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.924 0.393 . . . . 0.0 110.824 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 43.4 mt -84.89 98.32 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.955 177.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . . . . . . . . . 3.8 m -86.71 -35.22 8.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 120.913 0.387 . . . . 0.0 111.337 -178.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 115' ' ' LEU . . . -131.75 151.98 51.26 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.742 -178.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.486 ' HG3' ' HG2' ' A' ' 126' ' ' GLU . 9.3 ptpp? -161.37 168.73 23.34 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.229 -0.441 . . . . 0.0 109.925 177.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . 0.486 ' HG2' ' HG3' ' A' ' 125' ' ' LYS . 10.0 mm-40 63.46 19.37 11.65 Favored 'General case' 0 N--CA 1.467 0.406 0 O-C-N 124.082 0.864 . . . . 0.0 110.759 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 72.8 mt -67.28 141.4 57.22 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.469 -177.366 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.754 HH12 ' HB2' ' A' ' 111' ' ' PRO . 17.6 mmt180 -117.78 159.83 22.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.534 -178.481 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . 0.605 ' O ' ' HG ' ' A' ' 132' ' ' LEU . . . -21.47 -80.01 0.01 OUTLIER Glycine 0 N--CA 1.466 0.658 0 O-C-N 124.647 1.217 . . . . 0.0 116.131 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -62.82 -36.33 82.86 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.128 0.49 . . . . 0.0 111.175 -175.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -73.93 -42.66 60.25 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.547 -0.751 . . . . 0.0 112.147 -173.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LEU . . . . . 0.605 ' HG ' ' O ' ' A' ' 129' ' ' GLY . 4.5 pp -57.28 -36.94 71.65 Favored 'General case' 0 C--O 1.224 -0.261 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.655 -175.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' TYR . . . . . 0.466 ' N ' HD12 ' A' ' 132' ' ' LEU . 87.6 t80 -65.66 -46.48 78.97 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.54 -49.63 75.72 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.48 0.657 . . . . 0.0 110.358 178.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' THR . . . . . . . . . . . . . 99.3 m -62.53 -46.18 89.57 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.457 179.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 132' ' ' LEU . 54.1 t -64.84 -39.13 84.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.91 -0.132 . . . . 0.0 111.02 179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . 0.51 ' HA ' ' CE1' ' A' ' 58' ' ' PHE . 3.9 tp10 -58.38 -38.33 77.06 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-O 121.124 0.488 . . . . 0.0 109.851 177.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LYS . . . . . 0.518 ' HG2' ' HB3' ' A' ' 143' ' ' ALA . 2.5 ttpp -77.16 -25.68 52.2 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.854 -177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' A' ' 144' ' ' LYS . 31.4 m-85 -89.51 -47.15 8.17 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.675 0.62 . . . . 0.0 112.675 178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.498 HG22 ' CG ' ' A' ' 31' ' ' TYR . 37.0 t -87.61 -48.98 14.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -172.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ASN . . . . . . . . . . . . . 20.7 t30 -84.05 -64.86 1.09 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.74 -171.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 143' ' ' ALA . . . -137.09 146.91 18.9 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.155 -1.021 . . . . 0.0 112.444 -176.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ALA . . . . . 0.518 ' HB3' ' HG2' ' A' ' 138' ' ' LYS . . . 81.29 22.15 0.34 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 123.873 0.869 . . . . 0.0 111.98 179.54 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 139' ' ' PHE . 49.9 tptt -72.95 -26.93 61.55 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 166.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.3 158.15 16.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.272 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLY . . . . . . . . . . . . . . . -125.39 78.71 0.37 Allowed Glycine 0 N--CA 1.445 -0.734 0 C-N-CA 120.821 -0.704 . . . . 0.0 111.766 177.05 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 40.6 m80 -118.29 159.85 22.66 Favored 'General case' 0 C--N 1.324 -0.527 0 O-C-N 122.625 -0.338 . . . . 0.0 110.622 178.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -68.81 -22.8 64.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -178.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' HIS . . . . . . . . . . . . . 44.9 m170 67.16 170.56 0.26 Allowed 'General case' 0 N--CA 1.468 0.473 0 O-C-N 123.62 0.575 . . . . 0.0 111.055 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 50.2 t60 -119.44 4.82 11.15 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.557 0.694 . . . . 0.0 109.361 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 152' ' ' HIS . 15.4 t-80 -123.91 -17.05 6.42 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.402 -178.267 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' HIS . . . . . 0.469 ' HB2' ' O ' ' A' ' 151' ' ' HIS . 72.8 m80 . . . . . 0 C--O 1.25 1.08 0 O-C-N 124.616 1.198 . . . . 0.0 108.127 -159.27 . . . . . . . . 1 1 . 1 stop_ save_